ID   A0A024QZI9_HUMAN        Unreviewed;       594 AA.
AC   A0A024QZI9;
DT   09-JUL-2014, integrated into UniProtKB/TrEMBL.
DT   09-JUL-2014, sequence version 1.
DT   28-FEB-2018, entry version 28.
DE   SubName: Full=Apobec-1 complementation factor, isoform CRA_c {ECO:0000313|EMBL:EAW54137.1};
GN   Name=ACF {ECO:0000313|EMBL:EAW54137.1};
GN   ORFNames=hCG_1811530 {ECO:0000313|EMBL:EAW54137.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:EAW54137.1};
RN   [1] {ECO:0000313|EMBL:EAW54137.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D.,
RA   Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q.,
RA   Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G.,
RA   Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S.,
RA   Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J.,
RA   Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R.,
RA   Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A.,
RA   Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K.,
RA   Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V.,
RA   Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z.,
RA   Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A.,
RA   Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V.,
RA   Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B.,
RA   Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J.,
RA   Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C.,
RA   Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L.,
RA   Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S.,
RA   Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A.,
RA   Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D.,
RA   Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L.,
RA   Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N.,
RA   Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S.,
RA   Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F.,
RA   Kline L., Koduru S., Love A., Mann F., May D., McCawley S.,
RA   McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K.,
RA   Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N.,
RA   Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M.,
RA   Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F.,
RA   Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A.,
RA   Mi H., Lazareva B., Hatton T., Narechania A., Diemer K.,
RA   Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R.,
RA   Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J.,
RA   Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H.,
RA   Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D.,
RA   Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A.,
RA   Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S.,
RA   Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L.,
RA   Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W.,
RA   McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M.,
RA   Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAW54137.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; CH471083; EAW54137.1; -; Genomic_DNA.
DR   RefSeq; NP_001185749.1; NM_001198820.1.
DR   RefSeq; NP_620311.1; NM_138933.2.
DR   UniGene; Hs.282795; -.
DR   ProteinModelPortal; A0A024QZI9; -.
DR   SMR; A0A024QZI9; -.
DR   PRIDE; A0A024QZI9; -.
DR   GeneID; 29974; -.
DR   KEGG; hsa:29974; -.
DR   CTD; 29974; -.
DR   EuPathDB; HostDB:ENSG00000148584.14; -.
DR   GeneCards; ACF; -.
DR   MalaCards; ACF; -.
DR   eggNOG; KOG0117; Eukaryota.
DR   eggNOG; ENOG410XTJ5; LUCA.
DR   GenomeRNAi; 29974; -.
DR   Bgee; ENSG00000148584; -.
DR   ExpressionAtlas; A0A024QZI9; baseline and differential.
DR   GO; GO:0030895; C:apolipoprotein B mRNA editing enzyme complex; IEA:InterPro.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0003727; F:single-stranded RNA binding; IEA:InterPro.
DR   GO; GO:0016556; P:mRNA modification; IEA:InterPro.
DR   CDD; cd12486; RRM1_ACF; 1.
DR   CDD; cd12498; RRM3_ACF; 1.
DR   Gene3D; 3.30.70.330; -; 3.
DR   InterPro; IPR033111; A1CF.
DR   InterPro; IPR034538; ACF_RRM1.
DR   InterPro; IPR034539; ACF_RRM3.
DR   InterPro; IPR006535; HnRNP_R/Q_splicing_fac.
DR   InterPro; IPR012677; Nucleotide-bd_a/b_plait_sf.
DR   InterPro; IPR035979; RBD_domain_sf.
DR   InterPro; IPR000504; RRM_dom.
DR   PANTHER; PTHR43980:SF2; PTHR43980:SF2; 1.
DR   Pfam; PF00076; RRM_1; 3.
DR   SMART; SM00360; RRM; 3.
DR   SUPFAM; SSF54928; SSF54928; 2.
DR   TIGRFAMs; TIGR01648; hnRNP-R-Q; 1.
DR   PROSITE; PS50102; RRM; 3.
PE   4: Predicted;
KW   RNA-binding {ECO:0000256|PROSITE-ProRule:PRU00176}.
FT   DOMAIN       64    142       RRM. {ECO:0000259|PROSITE:PS50102}.
FT   DOMAIN      144    226       RRM. {ECO:0000259|PROSITE:PS50102}.
FT   DOMAIN      239    311       RRM. {ECO:0000259|PROSITE:PS50102}.
SQ   SEQUENCE   594 AA;  65024 MW;  2F2C8897629F9E3C CRC64;
     MEAVCLGTCP EPEASMSTAI PGLKKGNNAL QSIILQTLLE KENGQRKYGG PPPGWDAAPP
     ERGCEIFIGK LPRDLFEDEL IPLCEKIGKI YEMRMMMDFN GNNRGYAFVT FSNKVEAKNA
     IKQLNNYEIR NGRLLGVCAS VDNCRLFVGG IPKTKKREEI LSEMKKVTEG VVDVIVYPSA
     ADKTKNRGFA FVEYESHRAA AMARRKLLPG RIQLWGHGIA VDWAEPEVEV DEDTMSSVKI
     LYVRNLMLST SEEMIEKEFN NIKPGAVERV KKIRDYAFVH FSNREDAVEA MKALNGKVLD
     GSPIEVTLAK PVDKDSYVRY TRGTGGRGTM LQGEYTYSLG QVYDPTTTYL GAPVFYAPQT
     YAAIPSLHFP ATKGHLSNRA IIRAPSVRGA AGVRGLGGRG YLAYTGLGRG YQVKGDKRED
     KLYDILPGME LTPMNPVTLK PQGIKLAPQI LEEICQKNNW GQPVYQLHSA IGQDQRQLFL
     YKITIPALAS QNPAIHPFTP PKLSAFVDEA KTYAAEYTLQ TLGIPTDGGD GTMATAAAAA
     TAFPGYAVPN ATAPVSAAQL KQAVTLGQDL AAYTTYEVYP TFAVTARGDG YGTF
//
ID   A0A024QZJ5_HUMAN        Unreviewed;       586 AA.
AC   A0A024QZJ5;
DT   09-JUL-2014, integrated into UniProtKB/TrEMBL.
DT   09-JUL-2014, sequence version 1.
DT   28-FEB-2018, entry version 28.
DE   SubName: Full=Apobec-1 complementation factor, isoform CRA_b {ECO:0000313|EMBL:EAW54136.1};
GN   Name=ACF {ECO:0000313|EMBL:EAW54136.1};
GN   ORFNames=hCG_1811530 {ECO:0000313|EMBL:EAW54136.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:EAW54136.1};
RN   [1] {ECO:0000313|EMBL:EAW54136.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D.,
RA   Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q.,
RA   Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G.,
RA   Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S.,
RA   Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J.,
RA   Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R.,
RA   Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A.,
RA   Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K.,
RA   Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V.,
RA   Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z.,
RA   Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A.,
RA   Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V.,
RA   Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B.,
RA   Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J.,
RA   Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C.,
RA   Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L.,
RA   Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S.,
RA   Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A.,
RA   Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D.,
RA   Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L.,
RA   Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N.,
RA   Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S.,
RA   Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F.,
RA   Kline L., Koduru S., Love A., Mann F., May D., McCawley S.,
RA   McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K.,
RA   Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N.,
RA   Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M.,
RA   Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F.,
RA   Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A.,
RA   Mi H., Lazareva B., Hatton T., Narechania A., Diemer K.,
RA   Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R.,
RA   Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J.,
RA   Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H.,
RA   Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D.,
RA   Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A.,
RA   Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S.,
RA   Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L.,
RA   Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W.,
RA   McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M.,
RA   Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAW54136.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; CH471083; EAW54136.1; -; Genomic_DNA.
DR   RefSeq; NP_001185747.1; NM_001198818.1.
DR   RefSeq; NP_055391.2; NM_014576.3.
DR   RefSeq; XP_016871649.1; XM_017016160.1.
DR   UniGene; Hs.282795; -.
DR   ProteinModelPortal; A0A024QZJ5; -.
DR   SMR; A0A024QZJ5; -.
DR   PRIDE; A0A024QZJ5; -.
DR   GeneID; 29974; -.
DR   CTD; 29974; -.
DR   EuPathDB; HostDB:ENSG00000148584.14; -.
DR   GeneCards; ACF; -.
DR   MalaCards; ACF; -.
DR   eggNOG; KOG0117; Eukaryota.
DR   eggNOG; ENOG410XTJ5; LUCA.
DR   GenomeRNAi; 29974; -.
DR   Bgee; ENSG00000148584; -.
DR   ExpressionAtlas; A0A024QZJ5; baseline and differential.
DR   GO; GO:0030895; C:apolipoprotein B mRNA editing enzyme complex; IEA:InterPro.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0003727; F:single-stranded RNA binding; IEA:InterPro.
DR   GO; GO:0016556; P:mRNA modification; IEA:InterPro.
DR   CDD; cd12486; RRM1_ACF; 1.
DR   CDD; cd12498; RRM3_ACF; 1.
DR   Gene3D; 3.30.70.330; -; 3.
DR   InterPro; IPR033111; A1CF.
DR   InterPro; IPR034538; ACF_RRM1.
DR   InterPro; IPR034539; ACF_RRM3.
DR   InterPro; IPR006535; HnRNP_R/Q_splicing_fac.
DR   InterPro; IPR012677; Nucleotide-bd_a/b_plait_sf.
DR   InterPro; IPR035979; RBD_domain_sf.
DR   InterPro; IPR000504; RRM_dom.
DR   PANTHER; PTHR43980:SF2; PTHR43980:SF2; 1.
DR   Pfam; PF00076; RRM_1; 3.
DR   SMART; SM00360; RRM; 3.
DR   SUPFAM; SSF54928; SSF54928; 3.
DR   TIGRFAMs; TIGR01648; hnRNP-R-Q; 1.
DR   PROSITE; PS50102; RRM; 3.
PE   4: Predicted;
KW   RNA-binding {ECO:0000256|PROSITE-ProRule:PRU00176}.
FT   DOMAIN       56    134       RRM. {ECO:0000259|PROSITE:PS50102}.
FT   DOMAIN      136    218       RRM. {ECO:0000259|PROSITE:PS50102}.
FT   DOMAIN      231    303       RRM. {ECO:0000259|PROSITE:PS50102}.
SQ   SEQUENCE   586 AA;  64256 MW;  A836BBA98FD1BD51 CRC64;
     MESNHKSGDG LSGTQKEAAL RALVQRTGYS LVQENGQRKY GGPPPGWDAA PPERGCEIFI
     GKLPRDLFED ELIPLCEKIG KIYEMRMMMD FNGNNRGYAF VTFSNKVEAK NAIKQLNNYE
     IRNGRLLGVC ASVDNCRLFV GGIPKTKKRE EILSEMKKVT EGVVDVIVYP SAADKTKNRG
     FAFVEYESHR AAAMARRKLL PGRIQLWGHG IAVDWAEPEV EVDEDTMSSV KILYVRNLML
     STSEEMIEKE FNNIKPGAVE RVKKIRDYAF VHFSNREDAV EAMKALNGKV LDGSPIEVTL
     AKPVDKDSYV RYTRGTGGRG TMLQGEYTYS LGQVYDPTTT YLGAPVFYAP QTYAAIPSLH
     FPATKGHLSN RAIIRAPSVR GAAGVRGLGG RGYLAYTGLG RGYQVKGDKR EDKLYDILPG
     MELTPMNPVT LKPQGIKLAP QILEEICQKN NWGQPVYQLH SAIGQDQRQL FLYKITIPAL
     ASQNPAIHPF TPPKLSAFVD EAKTYAAEYT LQTLGIPTDG GDGTMATAAA AATAFPGYAV
     PNATAPVSAA QLKQAVTLGQ DLAAYTTYEV YPTFAVTARG DGYGTF
//
ID   A0A024QZM7_HUMAN        Unreviewed;       594 AA.
AC   A0A024QZM7;
DT   09-JUL-2014, integrated into UniProtKB/TrEMBL.
DT   09-JUL-2014, sequence version 1.
DT   28-FEB-2018, entry version 29.
DE   SubName: Full=Apobec-1 complementation factor, isoform CRA_a {ECO:0000313|EMBL:EAW54138.1};
GN   Name=ACF {ECO:0000313|EMBL:EAW54138.1};
GN   ORFNames=hCG_1811530 {ECO:0000313|EMBL:EAW54138.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:EAW54138.1};
RN   [1] {ECO:0000313|EMBL:EAW54138.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D.,
RA   Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q.,
RA   Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G.,
RA   Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S.,
RA   Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J.,
RA   Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R.,
RA   Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A.,
RA   Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K.,
RA   Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V.,
RA   Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z.,
RA   Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A.,
RA   Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V.,
RA   Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B.,
RA   Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J.,
RA   Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C.,
RA   Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L.,
RA   Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S.,
RA   Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A.,
RA   Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D.,
RA   Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L.,
RA   Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N.,
RA   Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S.,
RA   Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F.,
RA   Kline L., Koduru S., Love A., Mann F., May D., McCawley S.,
RA   McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K.,
RA   Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N.,
RA   Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M.,
RA   Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F.,
RA   Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A.,
RA   Mi H., Lazareva B., Hatton T., Narechania A., Diemer K.,
RA   Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R.,
RA   Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J.,
RA   Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H.,
RA   Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D.,
RA   Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A.,
RA   Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S.,
RA   Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L.,
RA   Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W.,
RA   McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M.,
RA   Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAW54138.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; CH471083; EAW54138.1; -; Genomic_DNA.
DR   RefSeq; NP_620310.1; NM_138932.2.
DR   RefSeq; XP_005269775.1; XM_005269718.2.
DR   RefSeq; XP_005269777.1; XM_005269720.3.
DR   UniGene; Hs.282795; -.
DR   ProteinModelPortal; A0A024QZM7; -.
DR   SMR; A0A024QZM7; -.
DR   PRIDE; A0A024QZM7; -.
DR   GeneID; 29974; -.
DR   CTD; 29974; -.
DR   EuPathDB; HostDB:ENSG00000148584.14; -.
DR   GeneCards; ACF; -.
DR   MalaCards; ACF; -.
DR   eggNOG; KOG0117; Eukaryota.
DR   eggNOG; ENOG410XTJ5; LUCA.
DR   PhylomeDB; A0A024QZM7; -.
DR   GenomeRNAi; 29974; -.
DR   Bgee; ENSG00000148584; -.
DR   ExpressionAtlas; A0A024QZM7; baseline and differential.
DR   GO; GO:0030895; C:apolipoprotein B mRNA editing enzyme complex; IEA:InterPro.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0003727; F:single-stranded RNA binding; IEA:InterPro.
DR   GO; GO:0016556; P:mRNA modification; IEA:InterPro.
DR   CDD; cd12486; RRM1_ACF; 1.
DR   CDD; cd12498; RRM3_ACF; 1.
DR   Gene3D; 3.30.70.330; -; 3.
DR   InterPro; IPR033111; A1CF.
DR   InterPro; IPR034538; ACF_RRM1.
DR   InterPro; IPR034539; ACF_RRM3.
DR   InterPro; IPR006535; HnRNP_R/Q_splicing_fac.
DR   InterPro; IPR012677; Nucleotide-bd_a/b_plait_sf.
DR   InterPro; IPR035979; RBD_domain_sf.
DR   InterPro; IPR000504; RRM_dom.
DR   PANTHER; PTHR43980:SF2; PTHR43980:SF2; 1.
DR   Pfam; PF00076; RRM_1; 3.
DR   SMART; SM00360; RRM; 3.
DR   SUPFAM; SSF54928; SSF54928; 3.
DR   TIGRFAMs; TIGR01648; hnRNP-R-Q; 1.
DR   PROSITE; PS50102; RRM; 3.
PE   4: Predicted;
KW   RNA-binding {ECO:0000256|PROSITE-ProRule:PRU00176}.
FT   DOMAIN       56    134       RRM. {ECO:0000259|PROSITE:PS50102}.
FT   DOMAIN      136    218       RRM. {ECO:0000259|PROSITE:PS50102}.
FT   DOMAIN      231    303       RRM. {ECO:0000259|PROSITE:PS50102}.
SQ   SEQUENCE   594 AA;  65202 MW;  AA5EF76BD8815807 CRC64;
     MESNHKSGDG LSGTQKEAAL RALVQRTGYS LVQENGQRKY GGPPPGWDAA PPERGCEIFI
     GKLPRDLFED ELIPLCEKIG KIYEMRMMMD FNGNNRGYAF VTFSNKVEAK NAIKQLNNYE
     IRNGRLLGVC ASVDNCRLFV GGIPKTKKRE EILSEMKKVT EGVVDVIVYP SAADKTKNRG
     FAFVEYESHR AAAMARRKLL PGRIQLWGHG IAVDWAEPEV EVDEDTMSSV KILYVRNLML
     STSEEMIEKE FNNIKPGAVE RVKKIRDYAF VHFSNREDAV EAMKALNGKV LDGSPIEVTL
     AKPVDKDSYV RYTRGTGGRG TMLQGEYTYS LGQVYDPTTT YLGAPVFYAP QTYAAIPSLH
     FPATKGHLSN RAIIRAPSVR EIYMNVPVGA AGVRGLGGRG YLAYTGLGRG YQVKGDKRED
     KLYDILPGME LTPMNPVTLK PQGIKLAPQI LEEICQKNNW GQPVYQLHSA IGQDQRQLFL
     YKITIPALAS QNPAIHPFTP PKLSAFVDEA KTYAAEYTLQ TLGIPTDGGD GTMATAAAAA
     TAFPGYAVPN ATAPVSAAQL KQAVTLGQDL AAYTTYEVYP TFAVTARGDG YGTF
//
ID   B4E1E3_HUMAN            Unreviewed;       587 AA.
AC   B4E1E3;
DT   23-SEP-2008, integrated into UniProtKB/TrEMBL.
DT   23-SEP-2008, sequence version 1.
DT   28-FEB-2018, entry version 60.
DE   SubName: Full=cDNA FLJ61033, highly similar to APOBEC1 complementation factor {ECO:0000313|EMBL:BAG64755.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAG64755.1};
RN   [1] {ECO:0000313|EMBL:BAG64755.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Liver {ECO:0000313|EMBL:BAG64755.1};
RA   Wakamatsu A., Yamamoto J., Kimura K., Ishii S., Watanabe K.,
RA   Sugiyama A., Murakawa K., Kaida T., Tsuchiya K., Fukuzumi Y.,
RA   Kumagai A., Oishi Y., Yamamoto S., Ono Y., Komori Y., Yamazaki M.,
RA   Kisu Y., Nishikawa T., Sugano S., Nomura N., Isogai T.;
RT   "NEDO human cDNA sequencing project focused on splicing variants.";
RL   Submitted (OCT-2007) to the EMBL/GenBank/DDBJ databases.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK303801; BAG64755.1; -; mRNA.
DR   RefSeq; NP_001185748.1; NM_001198819.1.
DR   RefSeq; NP_001185749.1; NM_001198820.1.
DR   UniGene; Hs.282795; -.
DR   ProteinModelPortal; B4E1E3; -.
DR   PeptideAtlas; B4E1E3; -.
DR   PRIDE; B4E1E3; -.
DR   GeneID; 29974; -.
DR   KEGG; hsa:29974; -.
DR   CTD; 29974; -.
DR   eggNOG; KOG0117; Eukaryota.
DR   eggNOG; ENOG410XTJ5; LUCA.
DR   HOGENOM; HOG000186083; -.
DR   HOVERGEN; HBG051917; -.
DR   GenomeRNAi; 29974; -.
DR   Genevisible; B4E1E3; HS.
DR   GO; GO:0030895; C:apolipoprotein B mRNA editing enzyme complex; IEA:InterPro.
DR   GO; GO:0003727; F:single-stranded RNA binding; IEA:InterPro.
DR   GO; GO:0016556; P:mRNA modification; IEA:InterPro.
DR   CDD; cd12486; RRM1_ACF; 1.
DR   CDD; cd12498; RRM3_ACF; 1.
DR   Gene3D; 3.30.70.330; -; 3.
DR   InterPro; IPR033111; A1CF.
DR   InterPro; IPR034538; ACF_RRM1.
DR   InterPro; IPR034539; ACF_RRM3.
DR   InterPro; IPR006535; HnRNP_R/Q_splicing_fac.
DR   InterPro; IPR012677; Nucleotide-bd_a/b_plait_sf.
DR   InterPro; IPR035979; RBD_domain_sf.
DR   InterPro; IPR000504; RRM_dom.
DR   PANTHER; PTHR43980:SF2; PTHR43980:SF2; 1.
DR   Pfam; PF00076; RRM_1; 3.
DR   SMART; SM00360; RRM; 3.
DR   SUPFAM; SSF54928; SSF54928; 2.
DR   TIGRFAMs; TIGR01648; hnRNP-R-Q; 1.
DR   PROSITE; PS50102; RRM; 3.
PE   2: Evidence at transcript level;
KW   RNA-binding {ECO:0000256|PROSITE-ProRule:PRU00176}.
FT   DOMAIN       49    127       RRM. {ECO:0000259|PROSITE:PS50102}.
FT   DOMAIN      129    211       RRM. {ECO:0000259|PROSITE:PS50102}.
FT   DOMAIN      224    296       RRM. {ECO:0000259|PROSITE:PS50102}.
SQ   SEQUENCE   587 AA;  64453 MW;  FAB6C3ABA54CD26A CRC64;
     MSTAIPGLKK GNNALQSIIL QTLLEKENGQ RKYGGPPPGW DAAPPERGCE IFIGKLPRDL
     FEDELIPLCE KIGKIYEMRM MMDFNGNNRG YAFVTFSNKV EAKNAIKQLN NYEIRNGRLL
     GVCASVDNCR LFVGGIPKTK KREEILSEMK KVTEGVVDVI VYPSAADKTK NRGFAFVEYE
     SHRAAAMARR KLLPGRIQLW GHGIAVDWAE PEVEVDEDTM SSVKILYVRN LMLSTSEEMI
     EKEFNNIKPG AVERVKKIRD YAFVHFSNRE DAVEAMKALN GKVLDGSPIE VTLAKPVDKD
     SYVRYTRGTG GRGTMLQGEY TYSLGQVYDP TTTYLGAPVF YAPQTYAAIP SLHFPATKGH
     LSNRAIIRAP SVREIYMNVP VGAAGVRGLG GRGYLAYTGL GRGYQVKGDK REDKLYDILP
     GMELTPMNPV TLKPQGIKLA PQILEEICQK NNWGQPVYQL HSAIGQDQRQ LFLYEITIPA
     LASQNPAIHP FTPPKLSAFV DEAKTYAAEY TLQTLGIPTD GGDGTMATAA AAATAFPGYA
     VPNATAPVSA AQLKQAVTLG QDLAAYTTYE VYPTFAVTAR GDGYGTF
//
ID   F8W9F8_HUMAN            Unreviewed;       602 AA.
AC   F8W9F8;
DT   21-SEP-2011, integrated into UniProtKB/TrEMBL.
DT   29-OCT-2014, sequence version 2.
DT   28-MAR-2018, entry version 58.
DE   SubName: Full=APOBEC1 complementation factor {ECO:0000313|Ensembl:ENSP00000378868};
GN   Name=A1CF {ECO:0000313|Ensembl:ENSP00000378868};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000378868, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Ensembl:ENSP00000378868, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164054; DOI=10.1038/nature02462;
RA   Deloukas P., Earthrowl M.E., Grafham D.V., Rubenfield M., French L.,
RA   Steward C.A., Sims S.K., Jones M.C., Searle S., Scott C., Howe K.,
RA   Hunt S.E., Andrews T.D., Gilbert J.G.R., Swarbreck D., Ashurst J.L.,
RA   Taylor A., Battles J., Bird C.P., Ainscough R., Almeida J.P.,
RA   Ashwell R.I.S., Ambrose K.D., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Bates K., Beasley H., Bray-Allen S., Brown A.J.,
RA   Brown J.Y., Burford D.C., Burrill W., Burton J., Cahill P., Camire D.,
RA   Carter N.P., Chapman J.C., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Corby N., Coulson A., Dhami P., Dutta I., Dunn M., Faulkner L.,
RA   Frankish A., Frankland J.A., Garner P., Garnett J., Gribble S.,
RA   Griffiths C., Grocock R., Gustafson E., Hammond S., Harley J.L.,
RA   Hart E., Heath P.D., Ho T.P., Hopkins B., Horne J., Howden P.J.,
RA   Huckle E., Hynds C., Johnson C., Johnson D., Kana A., Kay M.,
RA   Kimberley A.M., Kershaw J.K., Kokkinaki M., Laird G.K., Lawlor S.,
RA   Lee H.M., Leongamornlert D.A., Laird G., Lloyd C., Lloyd D.M.,
RA   Loveland J., Lovell J., McLaren S., McLay K.E., McMurray A.,
RA   Mashreghi-Mohammadi M., Matthews L., Milne S., Nickerson T.,
RA   Nguyen M., Overton-Larty E., Palmer S.A., Pearce A.V., Peck A.I.,
RA   Pelan S., Phillimore B., Porter K., Rice C.M., Rogosin A., Ross M.T.,
RA   Sarafidou T., Sehra H.K., Shownkeen R., Skuce C.D., Smith M.,
RA   Standring L., Sycamore N., Tester J., Thorpe A., Torcasso W.,
RA   Tracey A., Tromans A., Tsolas J., Wall M., Walsh J., Wang H.,
RA   Weinstock K., West A.P., Willey D.L., Whitehead S.L., Wilming L.,
RA   Wray P.W., Young L., Chen Y., Lovering R.C., Moschonas N.K.,
RA   Siebert R., Fechtel K., Bentley D., Durbin R., Hubbard T.,
RA   Doucette-Stamm L., Beck S., Smith D.R., Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 10.";
RL   Nature 429:375-381(2004).
RN   [2] {ECO:0000313|Ensembl:ENSP00000378868}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (JUL-2011) to UniProtKB.
RN   [3] {ECO:0000213|PubMed:24275569}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AL512366; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL589794; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   RefSeq; NP_001185748.1; NM_001198819.1.
DR   RefSeq; XP_011538031.1; XM_011539729.2.
DR   UniGene; Hs.282795; -.
DR   ProteinModelPortal; F8W9F8; -.
DR   EPD; F8W9F8; -.
DR   PeptideAtlas; F8W9F8; -.
DR   PRIDE; F8W9F8; -.
DR   Ensembl; ENST00000395489; ENSP00000378868; ENSG00000148584.
DR   GeneID; 29974; -.
DR   UCSC; uc010qho.3; human.
DR   CTD; 29974; -.
DR   EuPathDB; HostDB:ENSG00000148584.14; -.
DR   HGNC; HGNC:24086; A1CF.
DR   OpenTargets; ENSG00000148584; -.
DR   eggNOG; KOG0117; Eukaryota.
DR   eggNOG; ENOG410XTJ5; LUCA.
DR   GeneTree; ENSGT00550000074366; -.
DR   OMA; LIQRTGY; -.
DR   OrthoDB; EOG091G0EUB; -.
DR   ChiTaRS; A1CF; human.
DR   GenomeRNAi; 29974; -.
DR   Proteomes; UP000005640; Chromosome 10.
DR   Bgee; ENSG00000148584; -.
DR   ExpressionAtlas; F8W9F8; baseline and differential.
DR   GO; GO:0030895; C:apolipoprotein B mRNA editing enzyme complex; IEA:InterPro.
DR   GO; GO:0005737; C:cytoplasm; IEA:Ensembl.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0003727; F:single-stranded RNA binding; IEA:InterPro.
DR   GO; GO:0016554; P:cytidine to uridine editing; IEA:Ensembl.
DR   GO; GO:0007566; P:embryo implantation; IEA:Ensembl.
DR   GO; GO:0010609; P:mRNA localization resulting in posttranscriptional regulation of gene expression; IEA:Ensembl.
DR   GO; GO:0016556; P:mRNA modification; IEA:Ensembl.
DR   CDD; cd12486; RRM1_ACF; 1.
DR   CDD; cd12498; RRM3_ACF; 1.
DR   Gene3D; 3.30.70.330; -; 3.
DR   InterPro; IPR033111; A1CF.
DR   InterPro; IPR034538; ACF_RRM1.
DR   InterPro; IPR034539; ACF_RRM3.
DR   InterPro; IPR006535; HnRNP_R/Q_splicing_fac.
DR   InterPro; IPR012677; Nucleotide-bd_a/b_plait_sf.
DR   InterPro; IPR035979; RBD_domain_sf.
DR   InterPro; IPR000504; RRM_dom.
DR   PANTHER; PTHR43980:SF2; PTHR43980:SF2; 1.
DR   Pfam; PF00076; RRM_1; 3.
DR   SMART; SM00360; RRM; 3.
DR   SUPFAM; SSF54928; SSF54928; 3.
DR   TIGRFAMs; TIGR01648; hnRNP-R-Q; 1.
DR   PROSITE; PS50102; RRM; 3.
PE   1: Evidence at protein level;
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   Proteomics identification {ECO:0000213|EPD:F8W9F8,
KW   ECO:0000213|MaxQB:F8W9F8, ECO:0000213|PeptideAtlas:F8W9F8};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640};
KW   RNA-binding {ECO:0000256|PROSITE-ProRule:PRU00176}.
FT   DOMAIN       64    142       RRM. {ECO:0000259|PROSITE:PS50102}.
FT   DOMAIN      144    226       RRM. {ECO:0000259|PROSITE:PS50102}.
FT   DOMAIN      239    311       RRM. {ECO:0000259|PROSITE:PS50102}.
SQ   SEQUENCE   602 AA;  65971 MW;  EF5B389E70154C87 CRC64;
     MEAVCLGTCP EPEASMSTAI PGLKKGNNAL QSIILQTLLE KENGQRKYGG PPPGWDAAPP
     ERGCEIFIGK LPRDLFEDEL IPLCEKIGKI YEMRMMMDFN GNNRGYAFVT FSNKVEAKNA
     IKQLNNYEIR NGRLLGVCAS VDNCRLFVGG IPKTKKREEI LSEMKKVTEG VVDVIVYPSA
     ADKTKNRGFA FVEYESHRAA AMARRKLLPG RIQLWGHGIA VDWAEPEVEV DEDTMSSVKI
     LYVRNLMLST SEEMIEKEFN NIKPGAVERV KKIRDYAFVH FSNREDAVEA MKALNGKVLD
     GSPIEVTLAK PVDKDSYVRY TRGTGGRGTM LQGEYTYSLG QVYDPTTTYL GAPVFYAPQT
     YAAIPSLHFP ATKGHLSNRA IIRAPSVREI YMNVPVGAAG VRGLGGRGYL AYTGLGRGYQ
     VKGDKREDKL YDILPGMELT PMNPVTLKPQ GIKLAPQILE EICQKNNWGQ PVYQLHSAIG
     QDQRQLFLYK ITIPALASQN PAIHPFTPPK LSAFVDEAKT YAAEYTLQTL GIPTDGGDGT
     MATAAAAATA FPGYAVPNAT APVSAAQLKQ AVTLGQDLAA YTTYEVYPTF AVTARGDGYG
     TF
//
ID   A1CF_HUMAN              Reviewed;         594 AA.
AC   Q9NQ94; A1L4F2; A8K7G7; B7ZM14; Q5SZQ0; Q9NQ93; Q9NQX8; Q9NQX9;
AC   Q9NXC9; Q9NZD3;
DT   20-DEC-2005, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2000, sequence version 1.
DT   28-FEB-2018, entry version 154.
DE   RecName: Full=APOBEC1 complementation factor;
DE   AltName: Full=APOBEC1-stimulating protein;
GN   Name=A1CF; Synonyms=ACF, ASP {ECO:0000312|EMBL:CAB94754.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1] {ECO:0000305, ECO:0000312|EMBL:CAB94754.1}
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2), FUNCTION, AND
RP   INTERACTION WITH APOBEC1.
RC   TISSUE=Liver {ECO:0000312|EMBL:CAB94754.1}, and
RC   Small intestine {ECO:0000312|EMBL:CAB94755.1};
RX   PubMed=10781591; DOI=10.1074/jbc.M001786200;
RA   Lellek H., Kirsten R., Diehl I., Apostel F., Buck F., Greeve J.;
RT   "Purification and molecular cloning of a novel essential component of
RT   the apolipoprotein B mRNA editing enzyme-complex.";
RL   J. Biol. Chem. 275:19848-19856(2000).
RN   [2] {ECO:0000305, ECO:0000312|EMBL:AAF34824.1}
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), FUNCTION, INTERACTION WITH
RP   APOBEC1, AND TISSUE SPECIFICITY.
RX   PubMed=10669759; DOI=10.1128/MCB.20.5.1846-1854.2000;
RA   Mehta A., Kinter M.T., Sherman N.E., Driscoll D.M.;
RT   "Molecular cloning of APOBEC-1 complementation factor, a novel RNA-
RT   binding protein involved in the editing of apolipoprotein B mRNA.";
RL   Mol. Cell. Biol. 20:1846-1854(2000).
RN   [3] {ECO:0000305, ECO:0000312|EMBL:AAF76221.1}
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 2 AND 3).
RC   TISSUE=Liver;
RA   Sowden M.P., Smith H.C.;
RT   "Human APOBEC-1 complementation factor related protein.";
RL   Submitted (MAY-2000) to the EMBL/GenBank/DDBJ databases.
RN   [4] {ECO:0000305, ECO:0000312|EMBL:BAA91086.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 2 AND 4).
RC   TISSUE=Small intestine;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5] {ECO:0000312|EMBL:CAI14235.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164054; DOI=10.1038/nature02462;
RA   Deloukas P., Earthrowl M.E., Grafham D.V., Rubenfield M., French L.,
RA   Steward C.A., Sims S.K., Jones M.C., Searle S., Scott C., Howe K.,
RA   Hunt S.E., Andrews T.D., Gilbert J.G.R., Swarbreck D., Ashurst J.L.,
RA   Taylor A., Battles J., Bird C.P., Ainscough R., Almeida J.P.,
RA   Ashwell R.I.S., Ambrose K.D., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Bates K., Beasley H., Bray-Allen S., Brown A.J.,
RA   Brown J.Y., Burford D.C., Burrill W., Burton J., Cahill P., Camire D.,
RA   Carter N.P., Chapman J.C., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Corby N., Coulson A., Dhami P., Dutta I., Dunn M., Faulkner L.,
RA   Frankish A., Frankland J.A., Garner P., Garnett J., Gribble S.,
RA   Griffiths C., Grocock R., Gustafson E., Hammond S., Harley J.L.,
RA   Hart E., Heath P.D., Ho T.P., Hopkins B., Horne J., Howden P.J.,
RA   Huckle E., Hynds C., Johnson C., Johnson D., Kana A., Kay M.,
RA   Kimberley A.M., Kershaw J.K., Kokkinaki M., Laird G.K., Lawlor S.,
RA   Lee H.M., Leongamornlert D.A., Laird G., Lloyd C., Lloyd D.M.,
RA   Loveland J., Lovell J., McLaren S., McLay K.E., McMurray A.,
RA   Mashreghi-Mohammadi M., Matthews L., Milne S., Nickerson T.,
RA   Nguyen M., Overton-Larty E., Palmer S.A., Pearce A.V., Peck A.I.,
RA   Pelan S., Phillimore B., Porter K., Rice C.M., Rogosin A., Ross M.T.,
RA   Sarafidou T., Sehra H.K., Shownkeen R., Skuce C.D., Smith M.,
RA   Standring L., Sycamore N., Tester J., Thorpe A., Torcasso W.,
RA   Tracey A., Tromans A., Tsolas J., Wall M., Walsh J., Wang H.,
RA   Weinstock K., West A.P., Willey D.L., Whitehead S.L., Wilming L.,
RA   Wray P.W., Young L., Chen Y., Lovering R.C., Moschonas N.K.,
RA   Siebert R., Fechtel K., Bentley D., Durbin R.M., Hubbard T.,
RA   Doucette-Stamm L., Beck S., Smith D.R., Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 10.";
RL   Nature 429:375-381(2004).
RN   [6] {ECO:0000305, ECO:0000312|EMBL:AAF76221.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 4).
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   INTERACTION WITH SYNCRIP.
RX   PubMed=11134005; DOI=10.1074/jbc.M006435200;
RA   Blanc V., Navaratnam N., Henderson J.O., Anant S., Kennedy S.,
RA   Jarmuz A., Scott J., Davidson N.O.;
RT   "Identification of GRY-RBP as an apolipoprotein B RNA-binding protein
RT   that interacts with both apobec-1 and apobec-1 complementation factor
RT   to modulate C to U editing.";
RL   J. Biol. Chem. 276:10272-10283(2001).
RN   [9] {ECO:0000305}
RP   GENE STRUCTURE, AND ALTERNATIVE SPLICING.
RX   PubMed=11718896; DOI=10.1016/S0167-4781(01)00295-0;
RA   Henderson J.O., Blanc V., Davidson N.O.;
RT   "Isolation, characterization and developmental regulation of the human
RT   apobec-1 complementation factor (ACF) gene.";
RL   Biochim. Biophys. Acta 1522:22-30(2001).
RN   [10] {ECO:0000305}
RP   RNA-BINDING DOMAIN, AND MUTAGENESIS OF PHE-59; PHE-100; PHE-139;
RP   PHE-183; TYR-234 AND PHE-270.
RX   PubMed=11871661; DOI=10.1017/S1355838202015649;
RA   Mehta A., Driscoll D.M.;
RT   "Identification of domains in apobec-1 complementation factor required
RT   for RNA binding and apolipoprotein-B mRNA editing.";
RL   RNA 8:69-82(2002).
RN   [11] {ECO:0000305}
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=12881431; DOI=10.1093/emboj/cdg369;
RA   Chester A., Somasekaram A., Tzimina M., Jarmuz A., Gisbourne J.,
RA   O'Keefe R., Scott J., Navaratnam N.;
RT   "The apolipoprotein B mRNA editing complex performs a multifunctional
RT   cycle and suppresses nonsense-mediated decay.";
RL   EMBO J. 22:3971-3982(2003).
RN   [12] {ECO:0000305}
RP   NUCLEAR LOCALIZATION SIGNAL, AND INTERACTION WITH TNPO2.
RX   PubMed=12896982; DOI=10.1074/jbc.M302951200;
RA   Blanc V., Kennedy S., Davidson N.O.;
RT   "A novel nuclear localization signal in the auxiliary domain of
RT   apobec-1 complementation factor regulates nucleocytoplasmic import and
RT   shuttling.";
RL   J. Biol. Chem. 278:41198-41204(2003).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-499, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [14] {ECO:0000305, ECO:0000312|EMBL:AAF76221.1}
RP   STRUCTURE BY NMR OF 223-308.
RG   RIKEN structural genomics initiative (RSGI);
RT   "Solution structure of the RNA recognition motif of human APOBEC-1
RT   complementation factor, ACF.";
RL   Submitted (NOV-2005) to the PDB data bank.
CC   -!- FUNCTION: Essential component of the apolipoprotein B mRNA editing
CC       enzyme complex which is responsible for the postranscriptional
CC       editing of a CAA codon for Gln to a UAA codon for stop in APOB
CC       mRNA. Binds to APOB mRNA and is probably responsible for docking
CC       the catalytic subunit, APOBEC1, to the mRNA to allow it to
CC       deaminate its target cytosine. The complex also protects the
CC       edited APOB mRNA from nonsense-mediated decay.
CC       {ECO:0000269|PubMed:10669759, ECO:0000269|PubMed:10781591,
CC       ECO:0000269|PubMed:12881431}.
CC   -!- SUBUNIT: Part of the apolipoprotein B mRNA editing complex with
CC       APOBEC1. Interacts with TNPO2; TNPO2 may be responsible for
CC       transport of A1CF into the nucleus. Interacts with SYNCRIP.
CC       Interacts with CELF2/CUGBP2 (By similarity). {ECO:0000250}.
CC   -!- INTERACTION:
CC       Q5BKX5-3:C19orf54; NbExp=4; IntAct=EBI-2809489, EBI-11976299;
CC       O95810:CAVIN2; NbExp=3; IntAct=EBI-10311892, EBI-742141;
CC       Q13643:FHL3; NbExp=3; IntAct=EBI-2809489, EBI-741101;
CC       O76011:KRT34; NbExp=4; IntAct=EBI-2809489, EBI-1047093;
CC       Q04864:REL; NbExp=3; IntAct=EBI-2809489, EBI-307352;
CC       Q13077:TRAF1; NbExp=5; IntAct=EBI-2809489, EBI-359224;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:12881431}.
CC       Endoplasmic reticulum {ECO:0000250}. Cytoplasm
CC       {ECO:0000269|PubMed:12881431}. Note=Predominantly nuclear where it
CC       localizes to heterochromatin. Also cytoplasmic where it is found
CC       at the outer surface of the endoplasmic reticulum (By similarity).
CC       Shuttles between the nucleus and cytoplasm. May be transported
CC       into the nucleus by the nuclear import protein TNPO2/TRN2 or by
CC       APOBEC1. {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=6;
CC       Name=1 {ECO:0000269|PubMed:10781591};
CC         IsoId=Q9NQ94-1; Sequence=Displayed;
CC       Name=2 {ECO:0000269|PubMed:10669759, ECO:0000269|PubMed:10781591};
CC         IsoId=Q9NQ94-2; Sequence=VSP_051929;
CC         Note=Major isoform found in 66-78% of cDNA clones.
CC         {ECO:0000269|PubMed:11718896};
CC       Name=3;
CC         IsoId=Q9NQ94-3; Sequence=VSP_051926, VSP_051929;
CC       Name=4 {ECO:0000305};
CC         IsoId=Q9NQ94-4; Sequence=VSP_051927, VSP_051929;
CC         Note=Does not exhibit APOBEC1 complementation activity.
CC         {ECO:0000269|PubMed:11718896, ECO:0000305};
CC       Name=5 {ECO:0000269|PubMed:11718896};
CC         IsoId=Q9NQ94-5; Sequence=VSP_051925;
CC         Note=Does not exhibit APOBEC1 complementation activity.
CC         {ECO:0000269|PubMed:11718896};
CC       Name=6 {ECO:0000269|PubMed:11718896};
CC         IsoId=Q9NQ94-6; Sequence=VSP_051928;
CC         Note=Minor isoform found in 2-3% of cDNA clones.
CC         {ECO:0000269|PubMed:11718896};
CC   -!- TISSUE SPECIFICITY: Widely expressed with highest levels in brain,
CC       liver, pancreas, colon and spleen. {ECO:0000269|PubMed:10669759}.
CC   -!- DOMAIN: The RRM domains are necessary but not sufficient for
CC       binding to APOB mRNA. Additional residues in the pre-RRM and C-
CC       terminal regions are required for RNA-binding and for
CC       complementing APOBEC1 activity. {ECO:0000269|PubMed:11871661}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAA91086.1; Type=Frameshift; Positions=148; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AJ272078; CAB94754.1; -; mRNA.
DR   EMBL; AJ272079; CAB94755.1; -; mRNA.
DR   EMBL; AF209192; AAF34824.1; -; mRNA.
DR   EMBL; AF271789; AAF76221.1; -; mRNA.
DR   EMBL; AF271790; AAF76222.1; -; mRNA.
DR   EMBL; AK000324; BAA91086.1; ALT_FRAME; mRNA.
DR   EMBL; AK291982; BAF84671.1; -; mRNA.
DR   EMBL; AL512366; CAI14233.1; -; Genomic_DNA.
DR   EMBL; AL589794; CAI14233.1; JOINED; Genomic_DNA.
DR   EMBL; AL512366; CAI14235.1; -; Genomic_DNA.
DR   EMBL; AL589794; CAI14235.1; JOINED; Genomic_DNA.
DR   EMBL; AL512366; CAI14236.1; -; Genomic_DNA.
DR   EMBL; AL589794; CAI14236.1; JOINED; Genomic_DNA.
DR   EMBL; AL589794; CAI15762.1; -; Genomic_DNA.
DR   EMBL; AL512366; CAI15762.1; JOINED; Genomic_DNA.
DR   EMBL; AL589794; CAI15763.1; -; Genomic_DNA.
DR   EMBL; AL512366; CAI15763.1; JOINED; Genomic_DNA.
DR   EMBL; AL589794; CAI15764.1; -; Genomic_DNA.
DR   EMBL; AL512366; CAI15764.1; JOINED; Genomic_DNA.
DR   EMBL; CH471083; EAW54133.1; -; Genomic_DNA.
DR   EMBL; CH471083; EAW54134.1; -; Genomic_DNA.
DR   EMBL; CH471083; EAW54135.1; -; Genomic_DNA.
DR   EMBL; BC130519; AAI30520.1; -; mRNA.
DR   EMBL; BC144196; AAI44197.1; -; mRNA.
DR   CCDS; CCDS7241.1; -. [Q9NQ94-2]
DR   CCDS; CCDS7242.1; -. [Q9NQ94-1]
DR   CCDS; CCDS7243.1; -. [Q9NQ94-4]
DR   RefSeq; NP_001185747.1; NM_001198818.1. [Q9NQ94-2]
DR   RefSeq; NP_001185748.1; NM_001198819.1.
DR   RefSeq; NP_001185749.1; NM_001198820.1. [Q9NQ94-4]
DR   RefSeq; NP_055391.2; NM_014576.3. [Q9NQ94-2]
DR   RefSeq; NP_620310.1; NM_138932.2. [Q9NQ94-1]
DR   RefSeq; NP_620311.1; NM_138933.2. [Q9NQ94-4]
DR   RefSeq; XP_005269775.1; XM_005269718.2. [Q9NQ94-1]
DR   RefSeq; XP_005269777.1; XM_005269720.3. [Q9NQ94-1]
DR   RefSeq; XP_016871649.1; XM_017016160.1. [Q9NQ94-2]
DR   UniGene; Hs.282795; -.
DR   PDB; 2CPD; NMR; -; A=223-308.
DR   PDBsum; 2CPD; -.
DR   ProteinModelPortal; Q9NQ94; -.
DR   SMR; Q9NQ94; -.
DR   BioGrid; 119004; 11.
DR   IntAct; Q9NQ94; 22.
DR   STRING; 9606.ENSP00000282641; -.
DR   iPTMnet; Q9NQ94; -.
DR   PhosphoSitePlus; Q9NQ94; -.
DR   BioMuta; A1CF; -.
DR   DMDM; 74761651; -.
DR   MaxQB; Q9NQ94; -.
DR   PaxDb; Q9NQ94; -.
DR   PeptideAtlas; Q9NQ94; -.
DR   PRIDE; Q9NQ94; -.
DR   Ensembl; ENST00000282641; ENSP00000282641; ENSG00000148584. [Q9NQ94-2]
DR   Ensembl; ENST00000373993; ENSP00000363105; ENSG00000148584. [Q9NQ94-1]
DR   Ensembl; ENST00000373995; ENSP00000363107; ENSG00000148584. [Q9NQ94-4]
DR   Ensembl; ENST00000373997; ENSP00000363109; ENSG00000148584. [Q9NQ94-2]
DR   Ensembl; ENST00000374001; ENSP00000363113; ENSG00000148584. [Q9NQ94-2]
DR   Ensembl; ENST00000395495; ENSP00000378873; ENSG00000148584. [Q9NQ94-4]
DR   GeneID; 29974; -.
DR   KEGG; hsa:29974; -.
DR   UCSC; uc001jjh.4; human. [Q9NQ94-1]
DR   CTD; 29974; -.
DR   DisGeNET; 29974; -.
DR   EuPathDB; HostDB:ENSG00000148584.14; -.
DR   GeneCards; A1CF; -.
DR   HGNC; HGNC:24086; A1CF.
DR   HPA; HPA037779; -.
DR   HPA; HPA044079; -.
DR   neXtProt; NX_Q9NQ94; -.
DR   OpenTargets; ENSG00000148584; -.
DR   PharmGKB; PA162375098; -.
DR   eggNOG; KOG0117; Eukaryota.
DR   eggNOG; ENOG410XTJ5; LUCA.
DR   GeneTree; ENSGT00550000074366; -.
DR   HOVERGEN; HBG051917; -.
DR   InParanoid; Q9NQ94; -.
DR   PhylomeDB; Q9NQ94; -.
DR   TreeFam; TF314932; -.
DR   Reactome; R-HSA-72200; mRNA Editing: C to U Conversion.
DR   Reactome; R-HSA-75094; Formation of the Editosome.
DR   ChiTaRS; A1CF; human.
DR   EvolutionaryTrace; Q9NQ94; -.
DR   GeneWiki; ACF_(gene); -.
DR   GenomeRNAi; 29974; -.
DR   PRO; PR:Q9NQ94; -.
DR   Proteomes; UP000005640; Chromosome 10.
DR   Bgee; ENSG00000148584; -.
DR   CleanEx; HS_A1CF; -.
DR   ExpressionAtlas; Q9NQ94; baseline and differential.
DR   Genevisible; Q9NQ94; HS.
DR   GO; GO:0030895; C:apolipoprotein B mRNA editing enzyme complex; IDA:UniProtKB.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005783; C:endoplasmic reticulum; IEA:UniProtKB-SubCell.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0003723; F:RNA binding; TAS:ProtInc.
DR   GO; GO:0003727; F:single-stranded RNA binding; IDA:UniProtKB.
DR   GO; GO:0016554; P:cytidine to uridine editing; TAS:Reactome.
DR   GO; GO:0016556; P:mRNA modification; IEA:InterPro.
DR   GO; GO:0006397; P:mRNA processing; IEA:UniProtKB-KW.
DR   GO; GO:0050821; P:protein stabilization; IDA:UniProtKB.
DR   CDD; cd12486; RRM1_ACF; 1.
DR   CDD; cd12498; RRM3_ACF; 1.
DR   Gene3D; 3.30.70.330; -; 3.
DR   InterPro; IPR033111; A1CF.
DR   InterPro; IPR034538; ACF_RRM1.
DR   InterPro; IPR034539; ACF_RRM3.
DR   InterPro; IPR006535; HnRNP_R/Q_splicing_fac.
DR   InterPro; IPR012677; Nucleotide-bd_a/b_plait_sf.
DR   InterPro; IPR035979; RBD_domain_sf.
DR   InterPro; IPR000504; RRM_dom.
DR   PANTHER; PTHR43980:SF2; PTHR43980:SF2; 1.
DR   Pfam; PF00076; RRM_1; 3.
DR   SMART; SM00360; RRM; 3.
DR   SUPFAM; SSF54928; SSF54928; 3.
DR   TIGRFAMs; TIGR01648; hnRNP-R-Q; 1.
DR   PROSITE; PS50102; RRM; 3.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Complete proteome; Cytoplasm;
KW   Endoplasmic reticulum; mRNA processing; Nucleus; Phosphoprotein;
KW   Polymorphism; Reference proteome; Repeat; RNA-binding.
FT   CHAIN         1    594       APOBEC1 complementation factor.
FT                                /FTId=PRO_0000081482.
FT   DOMAIN       56    134       RRM 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00176}.
FT   DOMAIN      136    218       RRM 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00176}.
FT   DOMAIN      231    303       RRM 3. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00176}.
FT   REGION      360    409       Required for nuclear localization.
FT                                {ECO:0000269|PubMed:12896982}.
FT   MOD_RES     499    499       Phosphothreonine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   VAR_SEQ       1     84       Missing (in isoform 5).
FT                                {ECO:0000303|PubMed:11718896}.
FT                                /FTId=VSP_051925.
FT   VAR_SEQ       1     33       MESNHKSGDGLSGTQKEAALRALVQRTGYSLVQ -> MLCS
FT                                PSFCKLCWKRKK (in isoform 3).
FT                                {ECO:0000303|Ref.3}.
FT                                /FTId=VSP_051926.
FT   VAR_SEQ       1     33       MESNHKSGDGLSGTQKEAALRALVQRTGYSLVQ -> MEAV
FT                                CLGTCPEPEASMSTAIPGLKKGNNALQSIILQTLLEK (in
FT                                isoform 4). {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_051927.
FT   VAR_SEQ     202    256       Missing (in isoform 6).
FT                                {ECO:0000303|PubMed:11718896}.
FT                                /FTId=VSP_051928.
FT   VAR_SEQ     381    388       Missing (in isoform 2, isoform 3 and
FT                                isoform 4). {ECO:0000303|PubMed:10669759,
FT                                ECO:0000303|PubMed:10781591,
FT                                ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|Ref.3}.
FT                                /FTId=VSP_051929.
FT   VARIANT     555    555       V -> M (in dbSNP:rs9073).
FT                                /FTId=VAR_052201.
FT   VARIANT     558    558       A -> S (in dbSNP:rs11817448).
FT                                /FTId=VAR_059821.
FT   MUTAGEN      59     59       F->A: Greatly reduced RNA binding.
FT                                {ECO:0000269|PubMed:11871661}.
FT   MUTAGEN     100    100       F->A: Greatly reduced RNA binding.
FT                                {ECO:0000269|PubMed:11871661}.
FT   MUTAGEN     139    139       F->A: Greatly reduced RNA binding.
FT                                {ECO:0000269|PubMed:11871661}.
FT   MUTAGEN     183    183       F->A: Greatly reduced RNA binding.
FT                                {ECO:0000269|PubMed:11871661}.
FT   MUTAGEN     234    234       Y->A: Slightly reduced RNA binding.
FT                                {ECO:0000269|PubMed:11871661}.
FT   MUTAGEN     270    270       F->A: Slightly reduced RNA binding.
FT                                {ECO:0000269|PubMed:11871661}.
FT   CONFLICT    191    191       A -> T (in Ref. 2; AAF34824).
FT                                {ECO:0000305}.
FT   CONFLICT    277    277       E -> K (in Ref. 2 and 3). {ECO:0000305}.
FT   STRAND      232    237       {ECO:0000244|PDB:2CPD}.
FT   HELIX       244    252       {ECO:0000244|PDB:2CPD}.
FT   STRAND      259    264       {ECO:0000244|PDB:2CPD}.
FT   STRAND      266    275       {ECO:0000244|PDB:2CPD}.
FT   HELIX       276    286       {ECO:0000244|PDB:2CPD}.
FT   STRAND      287    291       {ECO:0000244|PDB:2CPD}.
FT   STRAND      294    299       {ECO:0000244|PDB:2CPD}.
SQ   SEQUENCE   594 AA;  65202 MW;  AA5EF76BD8815807 CRC64;
     MESNHKSGDG LSGTQKEAAL RALVQRTGYS LVQENGQRKY GGPPPGWDAA PPERGCEIFI
     GKLPRDLFED ELIPLCEKIG KIYEMRMMMD FNGNNRGYAF VTFSNKVEAK NAIKQLNNYE
     IRNGRLLGVC ASVDNCRLFV GGIPKTKKRE EILSEMKKVT EGVVDVIVYP SAADKTKNRG
     FAFVEYESHR AAAMARRKLL PGRIQLWGHG IAVDWAEPEV EVDEDTMSSV KILYVRNLML
     STSEEMIEKE FNNIKPGAVE RVKKIRDYAF VHFSNREDAV EAMKALNGKV LDGSPIEVTL
     AKPVDKDSYV RYTRGTGGRG TMLQGEYTYS LGQVYDPTTT YLGAPVFYAP QTYAAIPSLH
     FPATKGHLSN RAIIRAPSVR EIYMNVPVGA AGVRGLGGRG YLAYTGLGRG YQVKGDKRED
     KLYDILPGME LTPMNPVTLK PQGIKLAPQI LEEICQKNNW GQPVYQLHSA IGQDQRQLFL
     YKITIPALAS QNPAIHPFTP PKLSAFVDEA KTYAAEYTLQ TLGIPTDGGD GTMATAAAAA
     TAFPGYAVPN ATAPVSAAQL KQAVTLGQDL AAYTTYEVYP TFAVTARGDG YGTF
//
ID   AKT3_HUMAN              Reviewed;         479 AA.
AC   Q9Y243; Q0VAA6; Q5VTI1; Q5VTI2; Q96QV3; Q9UFP5;
DT   01-DEC-2000, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1999, sequence version 1.
DT   28-MAR-2018, entry version 191.
DE   RecName: Full=RAC-gamma serine/threonine-protein kinase;
DE            EC=2.7.11.1;
DE   AltName: Full=Protein kinase Akt-3;
DE   AltName: Full=Protein kinase B gamma;
DE            Short=PKB gamma;
DE   AltName: Full=RAC-PK-gamma;
DE   AltName: Full=STK-2;
GN   Name=AKT3; Synonyms=PKBG;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND MUTAGENESIS.
RX   PubMed=10092583; DOI=10.1074/jbc.274.14.9133;
RA   Brodbeck D., Cron P., Hemmings B.A.;
RT   "A human protein kinase B gamma with regulatory phosphorylation sites
RT   in the activation loop and in the C-terminal hydrophobic domain.";
RL   J. Biol. Chem. 274:9133-9136(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=10208883; DOI=10.1006/bbrc.1999.0559;
RA   Nakatani K., Sakaue H., Thompson D.A., Weigel R.J., Roth R.A.;
RT   "Identification of a human Akt3 (protein kinase B gamma) which
RT   contains the regulatory serine phosphorylation site.";
RL   Biochem. Biophys. Res. Commun. 257:906-910(1999).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Brain;
RX   PubMed=10491192; DOI=10.1046/j.1432-1327.1999.00774.x;
RA   Masure S., Haefner B., Wesselink J.-J., Hoefnagel E., Mortier E.,
RA   Verhasselt P., Tuytelaars A., Gordon R., Richardson A.;
RT   "Molecular cloning, expression and characterization of the human
RT   serine/threonine kinase Akt-3.";
RL   Eur. J. Biochem. 265:353-360(1999).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RA   Li X., Yu L., Huang H., Zhang M., Zhao Y., Zhao S.;
RT   "Cloning of a novel human cDNA, STK-2, which encodes a rat serine-
RT   threonine protein kinase (STK) homolog.";
RL   Submitted (AUG-1998) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Testis;
RX   PubMed=11230166; DOI=10.1101/gr.GR1547R;
RA   Wiemann S., Weil B., Wellenreuther R., Gassenhuber J., Glassl S.,
RA   Ansorge W., Boecher M., Bloecker H., Bauersachs S., Blum H.,
RA   Lauber J., Duesterhoeft A., Beyer A., Koehrer K., Strack N.,
RA   Mewes H.-W., Ottenwaelder B., Obermaier B., Tampe J., Heubner D.,
RA   Wambutt R., Korn B., Klein M., Poustka A.;
RT   "Towards a catalog of human genes and proteins: sequencing and
RT   analysis of 500 novel complete protein coding human cDNAs.";
RL   Genome Res. 11:422-435(2001).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2), AND MUTAGENESIS OF
RP   THR-305 AND THR-447.
RX   PubMed=11387345; DOI=10.1074/jbc.M104633200;
RA   Brodbeck D., Hill M.M., Hemmings B.A.;
RT   "Two splice variants of PKB gamma have different regulatory capacity
RT   depending on the presence or absence of the regulatory phosphorylation
RT   site Ser-472 in the C-terminal hydrophobic domain.";
RL   J. Biol. Chem. 276:29550-29558(2001).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [10]
RP   CHARACTERIZATION, AND PHOSPHORYLATION AT THR-305 BY PDPK1.
RX   PubMed=9512493; DOI=10.1042/bj3310299;
RA   Walker K.S., Deak M., Paterson A., Hudson K., Cohen P., Alessi D.R.;
RT   "Activation of protein kinase B beta and gamma isoforms by insulin in
RT   vivo and by 3-phosphoinositide-dependent protein kinase-1 in vitro:
RT   comparison with protein kinase B alpha.";
RL   Biochem. J. 331:299-308(1998).
RN   [11]
RP   PHOSPHORYLATION AT SER-472.
RX   PubMed=12162751; DOI=10.1021/bi026065r;
RA   Hodgkinson C.P., Sale E.M., Sale G.J.;
RT   "Characterization of PDK2 activity against protein kinase B gamma.";
RL   Biochemistry 41:10351-10359(2002).
RN   [12]
RP   INTERACTION WITH TCL1A.
RX   PubMed=11707444; DOI=10.1074/jbc.M107069200;
RA   Laine J., Kuenstle G., Obata T., Noguchi M.;
RT   "Differential regulation of Akt kinase isoforms by the members of the
RT   TCL1 oncogene family.";
RL   J. Biol. Chem. 277:3743-3751(2002).
RN   [13]
RP   INTERACTION WITH TCL1A.
RX   PubMed=11839817; DOI=10.1128/MCB.22.5.1513-1525.2002;
RA   Kuenstle G., Laine J., Pierron G., Kagami S., Nakajima H., Hoh F.,
RA   Roumestand C., Stern M.H., Noguchi M.;
RT   "Identification of Akt association and oligomerization domains of the
RT   Akt kinase coactivator TCL1.";
RL   Mol. Cell. Biol. 22:1513-1525(2002).
RN   [14]
RP   INVOLVEMENT IN TUMORS.
RX   PubMed=15466193; DOI=10.1158/0008-5472.CAN-04-1399;
RA   Stahl J.M., Sharma A., Cheung M., Zimmerman M., Cheng J.Q.,
RA   Bosenberg M.W., Kester M., Sandirasegarane L., Robertson G.P.;
RT   "Deregulated Akt3 activity promotes development of malignant
RT   melanoma.";
RL   Cancer Res. 64:7002-7010(2004).
RN   [15]
RP   INVOLVEMENT IN CANCER.
RX   PubMed=17178867; DOI=10.1158/0008-5472.CAN-06-1968;
RA   Cristiano B.E., Chan J.C., Hannan K.M., Lundie N.A., Marmy-Conus N.J.,
RA   Campbell I.G., Phillips W.A., Robbie M., Hannan R.D., Pearson R.B.;
RT   "A specific role for AKT3 in the genesis of ovarian cancer through
RT   modulation of G(2)-M phase transition.";
RL   Cancer Res. 66:11718-11725(2006).
RN   [16]
RP   BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=16540465; DOI=10.1074/jbc.M601384200;
RA   Zhang X., Zhang S., Yamane H., Wahl R., Ali A., Lofgren J.A.,
RA   Kendall R.L.;
RT   "Kinetic mechanism of AKT/PKB enzyme family.";
RL   J. Biol. Chem. 281:13949-13956(2006).
RN   [17]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Embryonic kidney;
RX   PubMed=17525332; DOI=10.1126/science.1140321;
RA   Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,
RA   Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,
RA   Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.;
RT   "ATM and ATR substrate analysis reveals extensive protein networks
RT   responsive to DNA damage.";
RL   Science 316:1160-1166(2007).
RN   [18]
RP   FUNCTION.
RX   PubMed=18524868; DOI=10.1096/fj.08-106468;
RA   Wright G.L., Maroulakou I.G., Eldridge J., Liby T.L., Sridharan V.,
RA   Tsichlis P.N., Muise-Helmericks R.C.;
RT   "VEGF stimulation of mitochondrial biogenesis: requirement of AKT3
RT   kinase.";
RL   FASEB J. 22:3264-3275(2008).
RN   [19]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT SER-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [20]
RP   UBIQUITINATION BY TTC3.
RX   PubMed=20059950; DOI=10.1016/j.devcel.2009.09.007;
RA   Suizu F., Hiramuki Y., Okumura F., Matsuda M., Okumura A.J.,
RA   Hirata N., Narita M., Kohno T., Yokota J., Bohgaki M., Obuse C.,
RA   Hatakeyama S., Obata T., Noguchi M.;
RT   "The E3 ligase TTC3 facilitates ubiquitination and degradation of
RT   phosphorylated Akt.";
RL   Dev. Cell 17:800-810(2009).
RN   [21]
RP   INTERACTION WITH TRAF6.
RX   PubMed=19713527; DOI=10.1126/science.1175065;
RA   Yang W.-L., Wang J., Chan C.-H., Lee S.-W., Campos A.D., Lamothe B.,
RA   Hur L., Grabiner B.C., Lin X., Darnay B.G., Lin H.-K.;
RT   "The E3 ligase TRAF6 regulates Akt ubiquitination and activation.";
RL   Science 325:1134-1138(2009).
RN   [22]
RP   SUBCELLULAR LOCATION.
RX   PubMed=20018949; DOI=10.1152/ajpcell.00375.2009;
RA   Santi S.A., Lee H.;
RT   "The Akt isoforms are present at distinct subcellular locations.";
RL   Am. J. Physiol. 298:C580-C591(2010).
RN   [23]
RP   INVOLVEMENT IN TUMORS.
RX   PubMed=20167810; DOI=10.1093/neuonc/nop026;
RA   Mure H., Matsuzaki K., Kitazato K.T., Mizobuchi Y., Kuwayama K.,
RA   Kageji T., Nagahiro S.;
RT   "Akt2 and Akt3 play a pivotal role in malignant gliomas.";
RL   Neuro-oncol. 12:221-232(2010).
RN   [24]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [25]
RP   FUNCTION.
RX   PubMed=21191416; DOI=10.1038/jid.2010.361;
RA   Moriya C., Jinnin M., Yamane K., Maruo K., Muchemwa F.C., Igata T.,
RA   Makino T., Fukushima S., Ihn H.;
RT   "Expression of matrix metalloproteinase-13 is controlled by IL-13 via
RT   PI3K/Akt3 and PKC-delta in normal human dermal fibroblasts.";
RL   J. Invest. Dermatol. 131:655-661(2011).
RN   [26]
RP   REVIEW ON FUNCTION.
RX   PubMed=21620960; DOI=10.1016/j.cellsig.2011.05.004;
RA   Hers I., Vincent E.E., Tavare J.M.;
RT   "Akt signalling in health and disease.";
RL   Cell. Signal. 23:1515-1527(2011).
RN   [27]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-447, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [28]
RP   X-RAY CRYSTALLOGRAPHY (1.46 ANGSTROMS) OF 1-118.
RA   Vollmar M., Wang J., Zhang Y., Elkins J.M., Burgess-Brown N.,
RA   Chaikuad A., Pike A.C.W., Von Delft F., Bountra C., Arrowsmith C.H.,
RA   Weigelt J., Edwards A., Knapp S.;
RT   "The crystal structure of the PH domain of human Akt3 protein
RT   kinase.";
RL   Submitted (DEC-2009) to the PDB data bank.
RN   [29]
RP   VARIANT [LARGE SCALE ANALYSIS] ARG-171.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
RN   [30]
RP   VARIANT MELANOMA LYS-17, AND CHARACTERIZATION OF VARIANT MELANOMA
RP   LYS-17.
RX   PubMed=18813315; DOI=10.1038/sj.bjc.6604637;
RA   Davies M.A., Stemke-Hale K., Tellez C., Calderone T.L., Deng W.,
RA   Prieto V.G., Lazar A.J., Gershenwald J.E., Mills G.B.;
RT   "A novel AKT3 mutation in melanoma tumours and cell lines.";
RL   Br. J. Cancer 99:1265-1268(2008).
RN   [31]
RP   VARIANTS MPPH2 SER-229 AND TRP-465.
RX   PubMed=22729224; DOI=10.1038/ng.2331;
RA   Riviere J.B., Mirzaa G.M., O'Roak B.J., Beddaoui M., Alcantara D.,
RA   Conway R.L., St-Onge J., Schwartzentruber J.A., Gripp K.W.,
RA   Nikkel S.M., Worthylake T., Sullivan C.T., Ward T.R., Butler H.E.,
RA   Kramer N.A., Albrecht B., Armour C.M., Armstrong L., Caluseriu O.,
RA   Cytrynbaum C., Drolet B.A., Innes A.M., Lauzon J.L., Lin A.E.,
RA   Mancini G.M., Meschino W.S., Reggin J.D., Saggar A.K.,
RA   Lerman-Sagie T., Uyanik G., Weksberg R., Zirn B., Beaulieu C.L.,
RA   Majewski J., Bulman D.E., O'Driscoll M., Shendure J., Graham J.M. Jr.,
RA   Boycott K.M., Dobyns W.B.;
RT   "De novo germline and postzygotic mutations in AKT3, PIK3R2 and PIK3CA
RT   cause a spectrum of related megalencephaly syndromes.";
RL   Nat. Genet. 44:934-940(2012).
RN   [32]
RP   VARIANT MPPH2 LYS-17.
RX   PubMed=22729223; DOI=10.1038/ng.2329;
RA   Lee J.H., Huynh M., Silhavy J.L., Kim S., Dixon-Salazar T.,
RA   Heiberg A., Scott E., Bafna V., Hill K.J., Collazo A., Funari V.,
RA   Russ C., Gabriel S.B., Mathern G.W., Gleeson J.G.;
RT   "De novo somatic mutations in components of the PI3K-AKT3-mTOR pathway
RT   cause hemimegalencephaly.";
RL   Nat. Genet. 44:941-945(2012).
RN   [33]
RP   VARIANT MPPH2 LYS-17.
RX   PubMed=22500628; DOI=10.1016/j.neuron.2012.03.010;
RA   Poduri A., Evrony G.D., Cai X., Elhosary P.C., Beroukhim R.,
RA   Lehtinen M.K., Hills L.B., Heinzen E.L., Hill A., Hill R.S.,
RA   Barry B.J., Bourgeois B.F., Riviello J.J., Barkovich A.J., Black P.M.,
RA   Ligon K.L., Walsh C.A.;
RT   "Somatic activation of AKT3 causes hemispheric developmental brain
RT   malformations.";
RL   Neuron 74:41-48(2012).
RN   [34]
RP   VARIANT MPPH2 SER-229.
RX   PubMed=23745724; DOI=10.1111/cge.12188;
RA   Nakamura K., Kato M., Tohyama J., Shiohama T., Hayasaka K.,
RA   Nishiyama K., Kodera H., Nakashima M., Tsurusaki Y., Miyake N.,
RA   Matsumoto N., Saitsu H.;
RT   "AKT3 and PIK3R2 mutations in two patients with megalencephaly-related
RT   syndromes: MCAP and MPPH.";
RL   Clin. Genet. 85:396-398(2014).
CC   -!- FUNCTION: AKT3 is one of 3 closely related serine/threonine-
CC       protein kinases (AKT1, AKT2 and AKT3) called the AKT kinase, and
CC       which regulate many processes including metabolism, proliferation,
CC       cell survival, growth and angiogenesis. This is mediated through
CC       serine and/or threonine phosphorylation of a range of downstream
CC       substrates. Over 100 substrate candidates have been reported so
CC       far, but for most of them, no isoform specificity has been
CC       reported. AKT3 is the least studied AKT isoform. It plays an
CC       important role in brain development and is crucial for the
CC       viability of malignant glioma cells. AKT3 isoform may also be the
CC       key molecule in up-regulation and down-regulation of MMP13 via
CC       IL13. Required for the coordination of mitochondrial biogenesis
CC       with growth factor-induced increases in cellular energy demands.
CC       Down-regulation by RNA interference reduces the expression of the
CC       phosphorylated form of BAD, resulting in the induction of caspase-
CC       dependent apoptosis. {ECO:0000269|PubMed:18524868,
CC       ECO:0000269|PubMed:21191416}.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- ENZYME REGULATION: Two specific sites, one in the kinase domain
CC       (Thr-305) and the other in the C-terminal regulatory region (Ser-
CC       472), need to be phosphorylated for its full activation (By
CC       similarity). IGF-1 leads to the activation of AKT3, which may play
CC       a role in regulating cell survival. {ECO:0000250}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=87.9 uM for ATP (for purified and in vitro activated AKT3)
CC         {ECO:0000269|PubMed:16540465};
CC         KM=12.4 uM for peptide substrate (for purified and in vitro
CC         activated AKT3) {ECO:0000269|PubMed:16540465};
CC         KM=118.7 uM for ATP (for recombinant myristoylated AKT3
CC         expressed and immunoprecipitated from Rat-1 cells)
CC         {ECO:0000269|PubMed:16540465};
CC         KM=2.3 uM for peptide substrate (for recombinant myristoylated
CC         AKT3 expressed and immunoprecipitated from Rat-1 cells)
CC         {ECO:0000269|PubMed:16540465};
CC   -!- SUBUNIT: Interacts (via PH domain) with TCL1A; this enhances AKT3
CC       phosphorylation and activation. Interacts with TRAF6. Interacts
CC       with KCTD20 (By similarity). Interacts with BTBD10 (By
CC       similarity). {ECO:0000250|UniProtKB:Q9WUA6,
CC       ECO:0000269|PubMed:11707444, ECO:0000269|PubMed:11839817,
CC       ECO:0000269|PubMed:19713527}.
CC   -!- INTERACTION:
CC       P42574:CASP3; NbExp=2; IntAct=EBI-296115, EBI-524064;
CC       Q16543:CDC37; NbExp=2; IntAct=EBI-296115, EBI-295634;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:20018949}.
CC       Cytoplasm {ECO:0000269|PubMed:20018949}. Membrane
CC       {ECO:0000269|PubMed:20018949}; Peripheral membrane protein
CC       {ECO:0000269|PubMed:20018949}. Note=Membrane-associated after cell
CC       stimulation leading to its translocation.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1; Synonyms=PKB gamma;
CC         IsoId=Q9Y243-1; Sequence=Displayed;
CC       Name=2; Synonyms=PKB gamma 1;
CC         IsoId=Q9Y243-2; Sequence=VSP_004947;
CC   -!- TISSUE SPECIFICITY: In adult tissues, it is highly expressed in
CC       brain, lung and kidney, but weakly in heart, testis and liver. In
CC       fetal tissues, it is highly expressed in heart, liver and brain
CC       and not at all in kidney.
CC   -!- DOMAIN: Binding of the PH domain to the phosphatidylinositol 3-
CC       kinase alpha (PI(3)K) results in its targeting to the plasma
CC       membrane.
CC   -!- PTM: Phosphorylation on Thr-305 and Ser-472 is required for full
CC       activity. {ECO:0000250}.
CC   -!- PTM: Ubiquitinated. When fully phosphorylated and translocated
CC       into the nucleus, undergoes 'Lys-48'-polyubiquitination catalyzed
CC       by TTC3, leading to its degradation by the proteasome.
CC       {ECO:0000269|PubMed:12162751, ECO:0000269|PubMed:20059950,
CC       ECO:0000269|PubMed:9512493}.
CC   -!- PTM: O-GlcNAcylation at Thr-302 and Thr-309 inhibits activating
CC       phosphorylation at Thr-305 via disrupting the interaction between
CC       AKT and PDK1. {ECO:0000250}.
CC   -!- DISEASE: Note=AKT3 is a key modulator of several tumors like
CC       melanoma, glioma and ovarian cancer. Active AKT3 increases
CC       progressively during melanoma tumor progression with highest
CC       levels present in advanced-stage metastatic melanomas. Promotes
CC       melanoma tumorigenesis by decreasing apoptosis. Plays a key role
CC       in the genesis of ovarian cancers through modulation of G2/M phase
CC       transition. With AKT2, plays a pivotal role in the biology of
CC       glioblastoma.
CC   -!- DISEASE: Megalencephaly-polymicrogyria-polydactyly-hydrocephalus
CC       syndrome 2 (MPPH2) [MIM:615937]: A syndrome characterized by
CC       megalencephaly, hydrocephalus, and polymicrogyria; polydactyly may
CC       also be seen. There is considerable phenotypic similarity between
CC       this disorder and the megalencephaly-capillary malformation
CC       syndrome. {ECO:0000269|PubMed:22500628,
CC       ECO:0000269|PubMed:22729223, ECO:0000269|PubMed:22729224,
CC       ECO:0000269|PubMed:23745724}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. AGC Ser/Thr
CC       protein kinase family. RAC subfamily. {ECO:0000305}.
CC   -!- CAUTION: In light of strong homologies in the primary amino acid
CC       sequence, the 3 AKT kinases were long surmised to play redundant
CC       and overlapping roles. More recent studies has brought into
CC       question the redundancy within AKT kinase isoforms and instead
CC       pointed to isoform specific functions in different cellular events
CC       and diseases. AKT1 is more specifically involved in cellular
CC       survival pathways, by inhibiting apoptotic processes; whereas AKT2
CC       is more specific for the insulin receptor signaling pathway.
CC       Moreover, while AKT1 and AKT2 are often implicated in many aspects
CC       of cellular transformation, the 2 isoforms act in a complementary
CC       opposing manner. The role of AKT3 is less clear, though it appears
CC       to be predominantly expressed in brain. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/AKT3ID615ch1q44.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF124141; AAD29089.1; -; mRNA.
DR   EMBL; AF135794; AAD24196.1; -; mRNA.
DR   EMBL; AF085234; AAL40392.1; -; mRNA.
DR   EMBL; AJ245709; CAB53537.1; -; mRNA.
DR   EMBL; AL117525; CAB55977.1; ALT_TERM; mRNA.
DR   EMBL; AY005799; AAF91073.1; -; mRNA.
DR   EMBL; AL591721; CAH71866.1; -; Genomic_DNA.
DR   EMBL; AC096539; CAH71866.1; JOINED; Genomic_DNA.
DR   EMBL; AL592151; CAH71866.1; JOINED; Genomic_DNA.
DR   EMBL; AL662889; CAH71866.1; JOINED; Genomic_DNA.
DR   EMBL; AL591721; CAH71867.1; -; Genomic_DNA.
DR   EMBL; AC096539; CAH71867.1; JOINED; Genomic_DNA.
DR   EMBL; AL592151; CAH71867.1; JOINED; Genomic_DNA.
DR   EMBL; AL662889; CAH71867.1; JOINED; Genomic_DNA.
DR   EMBL; AL592151; CAH72891.1; -; Genomic_DNA.
DR   EMBL; AC096539; CAH72891.1; JOINED; Genomic_DNA.
DR   EMBL; AL591721; CAH72891.1; JOINED; Genomic_DNA.
DR   EMBL; AL662889; CAH72891.1; JOINED; Genomic_DNA.
DR   EMBL; AL592151; CAH72892.1; -; Genomic_DNA.
DR   EMBL; AC096539; CAH72892.1; JOINED; Genomic_DNA.
DR   EMBL; AL591721; CAH72892.1; JOINED; Genomic_DNA.
DR   EMBL; AL662889; CAH72892.1; JOINED; Genomic_DNA.
DR   EMBL; AL662889; CAH73072.1; -; Genomic_DNA.
DR   EMBL; AC096539; CAH73072.1; JOINED; Genomic_DNA.
DR   EMBL; AL591721; CAH73072.1; JOINED; Genomic_DNA.
DR   EMBL; AL592151; CAH73072.1; JOINED; Genomic_DNA.
DR   EMBL; AL662889; CAH73073.1; -; Genomic_DNA.
DR   EMBL; AC096539; CAH73073.1; JOINED; Genomic_DNA.
DR   EMBL; AL591721; CAH73073.1; JOINED; Genomic_DNA.
DR   EMBL; AL592151; CAH73073.1; JOINED; Genomic_DNA.
DR   EMBL; CH471148; EAW77093.1; -; Genomic_DNA.
DR   EMBL; CH471148; EAW77094.1; -; Genomic_DNA.
DR   EMBL; BC121154; AAI21155.1; -; mRNA.
DR   CCDS; CCDS31076.1; -. [Q9Y243-2]
DR   CCDS; CCDS31077.1; -. [Q9Y243-1]
DR   PIR; A59380; A59380.
DR   PIR; T17287; T17287.
DR   RefSeq; NP_001193658.1; NM_001206729.1. [Q9Y243-2]
DR   RefSeq; NP_005456.1; NM_005465.4. [Q9Y243-1]
DR   RefSeq; NP_859029.1; NM_181690.2. [Q9Y243-2]
DR   RefSeq; XP_005273051.1; XM_005272994.4. [Q9Y243-1]
DR   RefSeq; XP_005273052.1; XM_005272995.2. [Q9Y243-1]
DR   UniGene; Hs.498292; -.
DR   PDB; 2X18; X-ray; 1.46 A; A/B/C/D/E/F/G/H=1-118.
DR   PDBsum; 2X18; -.
DR   ProteinModelPortal; Q9Y243; -.
DR   SMR; Q9Y243; -.
DR   BioGrid; 115318; 27.
DR   DIP; DIP-32584N; -.
DR   IntAct; Q9Y243; 8.
DR   MINT; Q9Y243; -.
DR   STRING; 9606.ENSP00000263826; -.
DR   BindingDB; Q9Y243; -.
DR   ChEMBL; CHEMBL4816; -.
DR   GuidetoPHARMACOLOGY; 2286; -.
DR   iPTMnet; Q9Y243; -.
DR   PhosphoSitePlus; Q9Y243; -.
DR   BioMuta; AKT3; -.
DR   DMDM; 12643943; -.
DR   PaxDb; Q9Y243; -.
DR   PeptideAtlas; Q9Y243; -.
DR   PRIDE; Q9Y243; -.
DR   DNASU; 10000; -.
DR   Ensembl; ENST00000263826; ENSP00000263826; ENSG00000117020. [Q9Y243-1]
DR   Ensembl; ENST00000336199; ENSP00000336943; ENSG00000117020. [Q9Y243-2]
DR   Ensembl; ENST00000366539; ENSP00000355497; ENSG00000117020. [Q9Y243-1]
DR   Ensembl; ENST00000366540; ENSP00000355498; ENSG00000117020. [Q9Y243-2]
DR   Ensembl; ENST00000613395; ENSP00000479922; ENSG00000275199. [Q9Y243-2]
DR   Ensembl; ENST00000619536; ENSP00000483054; ENSG00000275199. [Q9Y243-2]
DR   Ensembl; ENST00000621586; ENSP00000479081; ENSG00000275199. [Q9Y243-1]
DR   GeneID; 10000; -.
DR   KEGG; hsa:10000; -.
DR   UCSC; uc001hzz.2; human. [Q9Y243-1]
DR   CTD; 10000; -.
DR   DisGeNET; 10000; -.
DR   EuPathDB; HostDB:ENSG00000117020.16; -.
DR   GeneCards; AKT3; -.
DR   HGNC; HGNC:393; AKT3.
DR   HPA; CAB013090; -.
DR   HPA; HPA026441; -.
DR   MalaCards; AKT3; -.
DR   MIM; 611223; gene.
DR   MIM; 615937; phenotype.
DR   neXtProt; NX_Q9Y243; -.
DR   OpenTargets; ENSG00000117020; -.
DR   Orphanet; 99802; Hemimegalencephaly.
DR   Orphanet; 83473; Megalencephaly - polymicrogyria - postaxial polydactyly - hydrocephalus.
DR   PharmGKB; PA24686; -.
DR   eggNOG; KOG0598; Eukaryota.
DR   eggNOG; ENOG410XNPH; LUCA.
DR   GeneTree; ENSGT00890000139324; -.
DR   HOGENOM; HOG000233033; -.
DR   HOVERGEN; HBG108317; -.
DR   InParanoid; Q9Y243; -.
DR   KO; K04456; -.
DR   OMA; CQIMSVD; -.
DR   OrthoDB; EOG091G06FF; -.
DR   PhylomeDB; Q9Y243; -.
DR   TreeFam; TF102004; -.
DR   BRENDA; 2.7.11.1; 2681.
DR   Reactome; R-HSA-111447; Activation of BAD and translocation to mitochondria.
DR   Reactome; R-HSA-114604; GPVI-mediated activation cascade.
DR   Reactome; R-HSA-1257604; PIP3 activates AKT signaling.
DR   Reactome; R-HSA-1358803; Downregulation of ERBB2:ERBB3 signaling.
DR   Reactome; R-HSA-198323; AKT phosphorylates targets in the cytosol.
DR   Reactome; R-HSA-198693; AKT phosphorylates targets in the nucleus.
DR   Reactome; R-HSA-199418; Negative regulation of the PI3K/AKT network.
DR   Reactome; R-HSA-211163; AKT-mediated inactivation of FOXO1A.
DR   Reactome; R-HSA-389357; CD28 dependent PI3K/Akt signaling.
DR   Reactome; R-HSA-389513; CTLA4 inhibitory signaling.
DR   Reactome; R-HSA-392451; G beta:gamma signalling through PI3Kgamma.
DR   Reactome; R-HSA-5218920; VEGFR2 mediated vascular permeability.
DR   Reactome; R-HSA-5628897; TP53 Regulates Metabolic Genes.
DR   Reactome; R-HSA-5674400; Constitutive Signaling by AKT1 E17K in Cancer.
DR   Reactome; R-HSA-6804757; Regulation of TP53 Degradation.
DR   Reactome; R-HSA-6804758; Regulation of TP53 Activity through Acetylation.
DR   Reactome; R-HSA-6804759; Regulation of TP53 Activity through Association with Co-factors.
DR   Reactome; R-HSA-69202; Cyclin E associated events during G1/S transition.
DR   Reactome; R-HSA-8876198; RAB GEFs exchange GTP for GDP on RABs.
DR   Reactome; R-HSA-8941332; RUNX2 regulates genes involved in cell migration.
DR   Reactome; R-HSA-8948751; Regulation of PTEN stability and activity.
DR   SABIO-RK; Q9Y243; -.
DR   SignaLink; Q9Y243; -.
DR   SIGNOR; Q9Y243; -.
DR   ChiTaRS; AKT3; human.
DR   GeneWiki; AKT3; -.
DR   GenomeRNAi; 10000; -.
DR   PRO; PR:Q9Y243; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000117020; -.
DR   CleanEx; HS_AKT3; -.
DR   ExpressionAtlas; Q9Y243; baseline and differential.
DR   Genevisible; Q9Y243; HS.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0005622; C:intracellular; IBA:GO_Central.
DR   GO; GO:0016020; C:membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0005524; F:ATP binding; IDA:UniProtKB.
DR   GO; GO:0004672; F:protein kinase activity; TAS:ProtInc.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB.
DR   GO; GO:0048854; P:brain morphogenesis; IEA:Ensembl.
DR   GO; GO:0048873; P:homeostasis of number of cells within a tissue; IEA:Ensembl.
DR   GO; GO:0035556; P:intracellular signal transduction; IBA:GO_Central.
DR   GO; GO:0000002; P:mitochondrial genome maintenance; IMP:UniProtKB.
DR   GO; GO:2000773; P:negative regulation of cellular senescence; IMP:BHF-UCL.
DR   GO; GO:0018105; P:peptidyl-serine phosphorylation; IBA:GO_Central.
DR   GO; GO:1905653; P:positive regulation of artery morphogenesis; IEA:Ensembl.
DR   GO; GO:0043536; P:positive regulation of blood vessel endothelial cell migration; IDA:BHF-UCL.
DR   GO; GO:0090050; P:positive regulation of cell migration involved in sprouting angiogenesis; IMP:BHF-UCL.
DR   GO; GO:0045793; P:positive regulation of cell size; IEA:Ensembl.
DR   GO; GO:0001938; P:positive regulation of endothelial cell proliferation; IMP:BHF-UCL.
DR   GO; GO:0032008; P:positive regulation of TOR signaling; IEA:Ensembl.
DR   GO; GO:1905564; P:positive regulation of vascular endothelial cell proliferation; IDA:BHF-UCL.
DR   GO; GO:0006468; P:protein phosphorylation; TAS:ProtInc.
DR   GO; GO:0007165; P:signal transduction; IMP:UniProtKB.
DR   CDD; cd05593; STKc_PKB_gamma; 1.
DR   Gene3D; 2.30.29.30; -; 1.
DR   InterPro; IPR000961; AGC-kinase_C.
DR   InterPro; IPR034675; Akt3.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR011993; PH-like_dom_sf.
DR   InterPro; IPR001849; PH_domain.
DR   InterPro; IPR017892; Pkinase_C.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   Pfam; PF00169; PH; 1.
DR   Pfam; PF00069; Pkinase; 1.
DR   Pfam; PF00433; Pkinase_C; 1.
DR   SMART; SM00233; PH; 1.
DR   SMART; SM00133; S_TK_X; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS51285; AGC_KINASE_CTER; 1.
DR   PROSITE; PS50003; PH_DOMAIN; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; ATP-binding;
KW   Complete proteome; Cytoplasm; Disease mutation; Disulfide bond;
KW   Glycoprotein; Kinase; Membrane; Nucleotide-binding; Nucleus;
KW   Phosphoprotein; Polymorphism; Reference proteome;
KW   Serine/threonine-protein kinase; Transferase; Ubl conjugation.
FT   INIT_MET      1      1       Removed. {ECO:0000244|PubMed:19413330}.
FT   CHAIN         2    479       RAC-gamma serine/threonine-protein
FT                                kinase.
FT                                /FTId=PRO_0000085611.
FT   DOMAIN        5    107       PH. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00145}.
FT   DOMAIN      148    405       Protein kinase. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   DOMAIN      406    479       AGC-kinase C-terminal.
FT   NP_BIND     154    162       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   ACT_SITE    271    271       Proton acceptor. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159, ECO:0000255|PROSITE-
FT                                ProRule:PRU10027}.
FT   BINDING     177    177       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   MOD_RES       2      2       N-acetylserine.
FT                                {ECO:0000244|PubMed:19413330}.
FT   MOD_RES     305    305       Phosphothreonine; by PDPK1.
FT                                {ECO:0000269|PubMed:9512493}.
FT   MOD_RES     447    447       Phosphothreonine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     472    472       Phosphoserine; by PKC/PRKCZ.
FT                                {ECO:0000269|PubMed:12162751}.
FT   CARBOHYD    302    302       O-linked (GlcNAc) threonine.
FT                                {ECO:0000250}.
FT   CARBOHYD    309    309       O-linked (GlcNAc) threonine.
FT                                {ECO:0000250}.
FT   DISULFID     59     76       {ECO:0000250}.
FT   DISULFID    293    307       {ECO:0000250}.
FT   VAR_SEQ     452    479       YDEDGMDCMDNERRPHFPQFSYSASGRE -> CQQSDCGML
FT                                GNWKK (in isoform 2).
FT                                {ECO:0000303|PubMed:11230166,
FT                                ECO:0000303|PubMed:11387345,
FT                                ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_004947.
FT   VARIANT      17     17       E -> K (in MPPH2 and melanoma; results in
FT                                activation of AKT; dbSNP:rs397514606).
FT                                {ECO:0000269|PubMed:18813315,
FT                                ECO:0000269|PubMed:22500628,
FT                                ECO:0000269|PubMed:22729223}.
FT                                /FTId=VAR_065830.
FT   VARIANT     171    171       G -> R (in a glioblastoma multiforme
FT                                sample; somatic mutation).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040358.
FT   VARIANT     229    229       N -> S (in MPPH2; dbSNP:rs397514605).
FT                                {ECO:0000269|PubMed:22729224,
FT                                ECO:0000269|PubMed:23745724}.
FT                                /FTId=VAR_069260.
FT   VARIANT     465    465       R -> W (in MPPH2; disease phenotype
FT                                overlaps with megalencephaly-capillary
FT                                malformation syndrome;
FT                                dbSNP:rs587776935).
FT                                {ECO:0000269|PubMed:22729224}.
FT                                /FTId=VAR_069261.
FT   MUTAGEN     305    305       T->A: No activation after pervanadate
FT                                treatment. {ECO:0000269|PubMed:11387345}.
FT   MUTAGEN     305    305       T->D: 2-fold increase of phosphorylation
FT                                steady state level, no activation after
FT                                pervanadate treatment.
FT                                {ECO:0000269|PubMed:11387345}.
FT   MUTAGEN     447    447       T->A: No effect.
FT                                {ECO:0000269|PubMed:11387345}.
FT   MUTAGEN     447    447       T->D: No effect.
FT                                {ECO:0000269|PubMed:11387345}.
FT   MUTAGEN     472    472       S->A: 67% decrease of activity after
FT                                pervanadate treatment.
FT                                {ECO:0000269|PubMed:10092583}.
FT   MUTAGEN     472    472       S->D: 1.4-fold increase of
FT                                phosphorylation steady state level, 50%
FT                                decrease of activity after pervanadate
FT                                treatment. {ECO:0000269|PubMed:10092583}.
FT   CONFLICT    279    279       L -> R (in Ref. 9; AAI21155).
FT                                {ECO:0000305}.
FT   STRAND        6     15       {ECO:0000244|PDB:2X18}.
FT   STRAND       17     30       {ECO:0000244|PDB:2X18}.
FT   STRAND       33     41       {ECO:0000244|PDB:2X18}.
FT   HELIX        44     46       {ECO:0000244|PDB:2X18}.
FT   STRAND       51     55       {ECO:0000244|PDB:2X18}.
FT   STRAND       60     64       {ECO:0000244|PDB:2X18}.
FT   STRAND       66     68       {ECO:0000244|PDB:2X18}.
FT   STRAND       71     75       {ECO:0000244|PDB:2X18}.
FT   TURN         80     82       {ECO:0000244|PDB:2X18}.
FT   STRAND       84     88       {ECO:0000244|PDB:2X18}.
FT   HELIX        92    113       {ECO:0000244|PDB:2X18}.
SQ   SEQUENCE   479 AA;  55775 MW;  F08BDDE6502E78FB CRC64;
     MSDVTIVKEG WVQKRGEYIK NWRPRYFLLK TDGSFIGYKE KPQDVDLPYP LNNFSVAKCQ
     LMKTERPKPN TFIIRCLQWT TVIERTFHVD TPEEREEWTE AIQAVADRLQ RQEEERMNCS
     PTSQIDNIGE EEMDASTTHH KRKTMNDFDY LKLLGKGTFG KVILVREKAS GKYYAMKILK
     KEVIIAKDEV AHTLTESRVL KNTRHPFLTS LKYSFQTKDR LCFVMEYVNG GELFFHLSRE
     RVFSEDRTRF YGAEIVSALD YLHSGKIVYR DLKLENLMLD KDGHIKITDF GLCKEGITDA
     ATMKTFCGTP EYLAPEVLED NDYGRAVDWW GLGVVMYEMM CGRLPFYNQD HEKLFELILM
     EDIKFPRTLS SDAKSLLSGL LIKDPNKRLG GGPDDAKEIM RHSFFSGVNW QDVYDKKLVP
     PFKPQVTSET DTRYFDEEFT AQTITITPPE KYDEDGMDCM DNERRPHFPQ FSYSASGRE
//
ID   A0A024R178_HUMAN        Unreviewed;       606 AA.
AC   A0A024R178;
DT   09-JUL-2014, integrated into UniProtKB/TrEMBL.
DT   09-JUL-2014, sequence version 1.
DT   28-MAR-2018, entry version 37.
DE   SubName: Full=V-raf murine sarcoma 3611 viral oncogene homolog, isoform CRA_b {ECO:0000313|EMBL:EAW59312.1};
DE   SubName: Full=V-raf murine sarcoma 3611 viral oncogene-like protein isoform 1 {ECO:0000313|EMBL:ALQ33372.1};
GN   Name=ARAF {ECO:0000313|EMBL:EAW59312.1};
GN   ORFNames=hCG_29140 {ECO:0000313|EMBL:EAW59312.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:EAW59312.1};
RN   [1] {ECO:0000313|EMBL:EAW59312.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D.,
RA   Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q.,
RA   Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G.,
RA   Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S.,
RA   Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J.,
RA   Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R.,
RA   Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A.,
RA   Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K.,
RA   Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V.,
RA   Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z.,
RA   Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A.,
RA   Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V.,
RA   Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B.,
RA   Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J.,
RA   Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C.,
RA   Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L.,
RA   Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S.,
RA   Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A.,
RA   Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D.,
RA   Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L.,
RA   Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N.,
RA   Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S.,
RA   Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F.,
RA   Kline L., Koduru S., Love A., Mann F., May D., McCawley S.,
RA   McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K.,
RA   Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N.,
RA   Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M.,
RA   Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F.,
RA   Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A.,
RA   Mi H., Lazareva B., Hatton T., Narechania A., Diemer K.,
RA   Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R.,
RA   Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J.,
RA   Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H.,
RA   Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D.,
RA   Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A.,
RA   Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S.,
RA   Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L.,
RA   Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W.,
RA   McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M.,
RA   Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAW59312.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3] {ECO:0000313|EMBL:ALQ33372.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=26871637; DOI=10.1016/j.cell.2016.01.029;
RA   Yang X., Coulombe-Huntington J., Kang S., Sheynkman G.M., Hao T.,
RA   Richardson A., Sun S., Yang F., Shen Y.A., Murray R., Spirohn K.,
RA   Begg B.E., Duran-Frigola M., MacWilliams A., Pevzner S.J., Zhong Q.,
RA   Trigg S.A., Tam S., Ghamsari L., Sahni N., Yi S., Rodriguez M.D.,
RA   Balcha D., Tan G., Costanzo M., Andrews B., Boone C., Zhou X.J.,
RA   Salehi-Ashtiani K., Charloteaux B., Chen A., Calderwood M.A., Aloy P.,
RA   Roth F.P., Hill D.E., Iakoucheva L.M., Xia Y., Vidal M.;
RT   "Widespread Expansion of Protein Interaction Capabilities by
RT   Alternative Splicing.";
RL   Cell 164:805-817(2016).
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC       {ECO:0000256|SAAS:SAAS00786134}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; KU177914; ALQ33372.1; -; mRNA.
DR   EMBL; CH471164; EAW59311.1; -; Genomic_DNA.
DR   EMBL; CH471164; EAW59312.1; -; Genomic_DNA.
DR   RefSeq; NP_001645.1; NM_001654.4.
DR   RefSeq; XP_011542210.1; XM_011543908.2.
DR   UniGene; Hs.446641; -.
DR   GeneID; 369; -.
DR   KEGG; hsa:369; -.
DR   CTD; 369; -.
DR   EuPathDB; HostDB:ENSG00000078061.12; -.
DR   eggNOG; KOG0193; Eukaryota.
DR   eggNOG; ENOG410Y4UP; LUCA.
DR   KO; K08845; -.
DR   ChiTaRS; ARAF; human.
DR   GenomeRNAi; 369; -.
DR   Bgee; ENSG00000078061; -.
DR   GO; GO:0005622; C:intracellular; IEA:GOC.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IEA:UniProtKB-KW.
DR   GO; GO:0005057; F:signal transducer activity, downstream of receptor; IEA:InterPro.
DR   GO; GO:0035556; P:intracellular signal transduction; IEA:InterPro.
DR   CDD; cd00029; C1; 1.
DR   InterPro; IPR020454; DAG/PE-bd.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR002219; PE/DAG-bd.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR003116; RBD_dom.
DR   InterPro; IPR001245; Ser-Thr/Tyr_kinase_cat_dom.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   InterPro; IPR029071; Ubiquitin-like_domsf.
DR   Pfam; PF00130; C1_1; 1.
DR   Pfam; PF07714; Pkinase_Tyr; 1.
DR   Pfam; PF02196; RBD; 1.
DR   PRINTS; PR00008; DAGPEDOMAIN.
DR   SMART; SM00109; C1; 1.
DR   SMART; SM00455; RBD; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF54236; SSF54236; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
DR   PROSITE; PS50898; RBD; 1.
DR   PROSITE; PS00479; ZF_DAG_PE_1; 1.
DR   PROSITE; PS50081; ZF_DAG_PE_2; 1.
PE   2: Evidence at transcript level;
KW   ATP-binding {ECO:0000256|SAAS:SAAS00783584};
KW   Kinase {ECO:0000256|SAAS:SAAS00784476};
KW   Metal-binding {ECO:0000256|SAAS:SAAS00515414};
KW   Nucleotide-binding {ECO:0000256|SAAS:SAAS00783584};
KW   Serine/threonine-protein kinase {ECO:0000256|SAAS:SAAS00784476};
KW   Transferase {ECO:0000256|SAAS:SAAS00784476};
KW   Zinc {ECO:0000256|SAAS:SAAS00515409}.
FT   DOMAIN       19     91       RBD. {ECO:0000259|PROSITE:PS50898}.
FT   DOMAIN       98    144       Phorbol-ester/DAG-type.
FT                                {ECO:0000259|PROSITE:PS50081}.
FT   DOMAIN      310    570       Protein kinase.
FT                                {ECO:0000259|PROSITE:PS50011}.
FT   NON_TER     606    606       {ECO:0000313|EMBL:ALQ33372.1}.
SQ   SEQUENCE   606 AA;  67585 MW;  D23E5711304AA468 CRC64;
     MEPPRGPPAN GAEPSRAVGT VKVYLPNKQR TVVTVRDGMS VYDSLDKALK VRGLNQDCCV
     VYRLIKGRKT VTAWDTAIAP LDGEELIVEV LEDVPLTMHN FVRKTFFSLA FCDFCLKFLF
     HGFRCQTCGY KFHQHCSSKV PTVCVDMSTN RQQFYHSVQD LSGGSRQHEA PSNRPLNELL
     TPQGPSPRTQ HCDPEHFPFP APANAPLQRI RSTSTPNVHM VSTTAPMDSN LIQLTGQSFS
     TDAAGSRGGS DGTPRGSPSP ASVSSGRKSP HSKSPAEQRE RKSLADDKKK VKNLGYRDSG
     YYWEVPPSEV QLLKRIGTGS FGTVFRGRWH GDVAVKVLKV SQPTAEQAQA FKNEMQVLRK
     TRHVNILLFM GFMTRPGFAI ITQWCEGSSL YHHLHVADTR FDMVQLIDVA RQTAQGMDYL
     HAKNIIHRDL KSNNIFLHEG LTVKIGDFGL ATVKTRWSGA QPLEQPSGSV LWMAAEVIRM
     QDPNPYSFQS DVYAYGVVLY ELMTGSLPYS HIGCRDQIIF MVGRGYLSPD LSKISSNCPK
     AMRRLLSDCL KFQREERPLF PQILATIELL QRSLPKIERS ASEPSLHRTQ ADELPACLLS
     AARLVP
//
ID   ARAF_HUMAN              Reviewed;         606 AA.
AC   P10398; P07557; Q5H9B2; Q5H9B3;
DT   01-APR-1988, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-1996, sequence version 2.
DT   28-MAR-2018, entry version 205.
DE   RecName: Full=Serine/threonine-protein kinase A-Raf;
DE            EC=2.7.11.1;
DE   AltName: Full=Proto-oncogene A-Raf;
DE   AltName: Full=Proto-oncogene A-Raf-1;
DE   AltName: Full=Proto-oncogene Pks;
GN   Name=ARAF; Synonyms=ARAF1, PKS, PKS2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=3029685; DOI=10.1093/nar/15.2.595;
RA   Beck T.W., Huleihel M., Gunnell M., Bonner T.I., Rapp U.R.;
RT   "The complete coding sequence of the human A-raf-1 oncogene and
RT   transforming activity of a human A-raf carrying retrovirus.";
RL   Nucleic Acids Res. 15:595-609(1987).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   TISSUE=Placenta;
RX   PubMed=8020955; DOI=10.1006/geno.1994.1125;
RA   Lee J.-E., Beck T.W., Brennscheidt U., DeGennaro L.J., Rapp U.R.;
RT   "The complete sequence and promoter activity of the human A-raf-1 gene
RT   (ARAF1).";
RL   Genomics 20:43-55(1994).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), FUNCTION (ISOFORM 2), AND
RP   ALTERNATIVE SPLICING.
RX   PubMed=17535970; DOI=10.1083/jcb.200703195;
RA   Yokoyama T., Takano K., Yoshida A., Katada F., Sun P., Takenawa T.,
RA   Andoh T., Endo T.;
RT   "DA-Raf1, a competent intrinsic dominant-negative antagonist of the
RT   Ras-ERK pathway, is required for myogenic differentiation.";
RL   J. Cell Biol. 177:781-793(2007).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor
RT   vector.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Placenta;
RA   Li W.B., Gruber C., Jessee J., Polayes D.;
RT   "Full-length cDNA libraries and normalization.";
RL   Submitted (APR-2003) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15772651; DOI=10.1038/nature03440;
RA   Ross M.T., Grafham D.V., Coffey A.J., Scherer S., McLay K., Muzny D.,
RA   Platzer M., Howell G.R., Burrows C., Bird C.P., Frankish A.,
RA   Lovell F.L., Howe K.L., Ashurst J.L., Fulton R.S., Sudbrak R., Wen G.,
RA   Jones M.C., Hurles M.E., Andrews T.D., Scott C.E., Searle S.,
RA   Ramser J., Whittaker A., Deadman R., Carter N.P., Hunt S.E., Chen R.,
RA   Cree A., Gunaratne P., Havlak P., Hodgson A., Metzker M.L.,
RA   Richards S., Scott G., Steffen D., Sodergren E., Wheeler D.A.,
RA   Worley K.C., Ainscough R., Ambrose K.D., Ansari-Lari M.A., Aradhya S.,
RA   Ashwell R.I., Babbage A.K., Bagguley C.L., Ballabio A., Banerjee R.,
RA   Barker G.E., Barlow K.F., Barrett I.P., Bates K.N., Beare D.M.,
RA   Beasley H., Beasley O., Beck A., Bethel G., Blechschmidt K., Brady N.,
RA   Bray-Allen S., Bridgeman A.M., Brown A.J., Brown M.J., Bonnin D.,
RA   Bruford E.A., Buhay C., Burch P., Burford D., Burgess J., Burrill W.,
RA   Burton J., Bye J.M., Carder C., Carrel L., Chako J., Chapman J.C.,
RA   Chavez D., Chen E., Chen G., Chen Y., Chen Z., Chinault C.,
RA   Ciccodicola A., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Clerc-Blankenburg K., Clifford K., Cobley V., Cole C.G., Conquer J.S.,
RA   Corby N., Connor R.E., David R., Davies J., Davis C., Davis J.,
RA   Delgado O., Deshazo D., Dhami P., Ding Y., Dinh H., Dodsworth S.,
RA   Draper H., Dugan-Rocha S., Dunham A., Dunn M., Durbin K.J., Dutta I.,
RA   Eades T., Ellwood M., Emery-Cohen A., Errington H., Evans K.L.,
RA   Faulkner L., Francis F., Frankland J., Fraser A.E., Galgoczy P.,
RA   Gilbert J., Gill R., Gloeckner G., Gregory S.G., Gribble S.,
RA   Griffiths C., Grocock R., Gu Y., Gwilliam R., Hamilton C., Hart E.A.,
RA   Hawes A., Heath P.D., Heitmann K., Hennig S., Hernandez J.,
RA   Hinzmann B., Ho S., Hoffs M., Howden P.J., Huckle E.J., Hume J.,
RA   Hunt P.J., Hunt A.R., Isherwood J., Jacob L., Johnson D., Jones S.,
RA   de Jong P.J., Joseph S.S., Keenan S., Kelly S., Kershaw J.K., Khan Z.,
RA   Kioschis P., Klages S., Knights A.J., Kosiura A., Kovar-Smith C.,
RA   Laird G.K., Langford C., Lawlor S., Leversha M., Lewis L., Liu W.,
RA   Lloyd C., Lloyd D.M., Loulseged H., Loveland J.E., Lovell J.D.,
RA   Lozado R., Lu J., Lyne R., Ma J., Maheshwari M., Matthews L.H.,
RA   McDowall J., McLaren S., McMurray A., Meidl P., Meitinger T.,
RA   Milne S., Miner G., Mistry S.L., Morgan M., Morris S., Mueller I.,
RA   Mullikin J.C., Nguyen N., Nordsiek G., Nyakatura G., O'dell C.N.,
RA   Okwuonu G., Palmer S., Pandian R., Parker D., Parrish J.,
RA   Pasternak S., Patel D., Pearce A.V., Pearson D.M., Pelan S.E.,
RA   Perez L., Porter K.M., Ramsey Y., Reichwald K., Rhodes S.,
RA   Ridler K.A., Schlessinger D., Schueler M.G., Sehra H.K.,
RA   Shaw-Smith C., Shen H., Sheridan E.M., Shownkeen R., Skuce C.D.,
RA   Smith M.L., Sotheran E.C., Steingruber H.E., Steward C.A., Storey R.,
RA   Swann R.M., Swarbreck D., Tabor P.E., Taudien S., Taylor T.,
RA   Teague B., Thomas K., Thorpe A., Timms K., Tracey A., Trevanion S.,
RA   Tromans A.C., d'Urso M., Verduzco D., Villasana D., Waldron L.,
RA   Wall M., Wang Q., Warren J., Warry G.L., Wei X., West A.,
RA   Whitehead S.L., Whiteley M.N., Wilkinson J.E., Willey D.L.,
RA   Williams G., Williams L., Williamson A., Williamson H., Wilming L.,
RA   Woodmansey R.L., Wray P.W., Yen J., Zhang J., Zhou J., Zoghbi H.,
RA   Zorilla S., Buck D., Reinhardt R., Poustka A., Rosenthal A.,
RA   Lehrach H., Meindl A., Minx P.J., Hillier L.W., Willard H.F.,
RA   Wilson R.K., Waterston R.H., Rice C.M., Vaudin M., Coulson A.,
RA   Nelson D.L., Weinstock G., Sulston J.E., Durbin R.M., Hubbard T.,
RA   Gibbs R.A., Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence of the human X chromosome.";
RL   Nature 434:325-337(2005).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Kidney;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 292-589 (ISOFORM 1).
RX   PubMed=3529082; DOI=10.1073/pnas.83.17.6312;
RA   Mark G.E., Seeley T.W., Shows T.B., Mountz J.D.;
RT   "Pks, a raf-related sequence in humans.";
RL   Proc. Natl. Acad. Sci. U.S.A. 83:6312-6316(1986).
RN   [9]
RP   INTERACTION WITH NELFD.
RX   PubMed=11952167; DOI=10.1023/A:1014437024129;
RA   Yin X.L., Chen S., Gu J.X.;
RT   "Identification of TH1 as an interaction partner of A-Raf kinase.";
RL   Mol. Cell. Biochem. 231:69-74(2002).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-257, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=16964243; DOI=10.1038/nbt1240;
RA   Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;
RT   "A probability-based approach for high-throughput protein
RT   phosphorylation analysis and site localization.";
RL   Nat. Biotechnol. 24:1285-1292(2006).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18220336; DOI=10.1021/pr0705441;
RA   Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,
RA   Yates J.R. III;
RT   "Combining protein-based IMAC, peptide-based IMAC, and MudPIT for
RT   efficient phosphoproteomic analysis.";
RL   J. Proteome Res. 7:1346-1351(2008).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-186, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-318, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [16]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [17]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [18]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [19]
RP   FUNCTION IN TOR SIGNALING.
RX   PubMed=22609986; DOI=10.1038/ncb2507;
RA   Gan X., Wang J., Wang C., Sommer E., Kozasa T., Srinivasula S.,
RA   Alessi D., Offermanns S., Simon M.I., Wu D.;
RT   "PRR5L degradation promotes mTORC2-mediated PKC-delta phosphorylation
RT   and cell migration downstream of Galpha12.";
RL   Nat. Cell Biol. 14:686-696(2012).
RN   [20]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-157; SER-162; THR-253;
RP   SER-257 AND SER-269, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE
RP   SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [21]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-181; SER-186 AND
RP   SER-257, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [22]
RP   STRUCTURE BY NMR OF 19-91.
RG   RIKEN structural genomics initiative (RSGI);
RT   "Solution structure of the N-terminal RAS-binding domain (RBD) in
RT   human A-RAF kinase.";
RL   Submitted (JUL-2005) to the PDB data bank.
RN   [23]
RP   VARIANTS [LARGE SCALE ANALYSIS] THR-98; CYS-331 AND ASP-578.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Involved in the transduction of mitogenic signals from
CC       the cell membrane to the nucleus. May also regulate the TOR
CC       signaling cascade. {ECO:0000269|PubMed:22609986}.
CC   -!- FUNCTION: Isoform 2: Serves as a positive regulator of myogenic
CC       differentiation by inducing cell cycle arrest, the expression of
CC       myogenin and other muscle-specific proteins, and myotube
CC       formation. {ECO:0000269|PubMed:22609986}.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- COFACTOR:
CC       Name=Zn(2+); Xref=ChEBI:CHEBI:29105; Evidence={ECO:0000250};
CC       Note=Binds 2 Zn(2+) ions per subunit. {ECO:0000250};
CC   -!- SUBUNIT: Interacts with TH1L/NELFD. {ECO:0000269|PubMed:11952167}.
CC   -!- INTERACTION:
CC       P00966:ASS1; NbExp=4; IntAct=EBI-365961, EBI-536842;
CC       P15056:BRAF; NbExp=3; IntAct=EBI-365961, EBI-365980;
CC       Q9UNS2:COPS3; NbExp=3; IntAct=EBI-365961, EBI-350590;
CC       P31327:CPS1; NbExp=3; IntAct=EBI-365961, EBI-536811;
CC       Q12805:EFEMP1; NbExp=3; IntAct=EBI-365961, EBI-536772;
CC       P01112:HRAS; NbExp=3; IntAct=EBI-365961, EBI-350145;
CC       P08238:HSP90AB1; NbExp=6; IntAct=EBI-365961, EBI-352572;
CC       O43187:IRAK2; NbExp=2; IntAct=EBI-365961, EBI-447733;
CC       Q92985:IRF7; NbExp=2; IntAct=EBI-365961, EBI-968267;
CC       P36507:MAP2K2; NbExp=6; IntAct=EBI-365961, EBI-1056930;
CC       Q8IXH7:NELFCD; NbExp=5; IntAct=EBI-365961, EBI-536725;
CC       O95848:NUDT14; NbExp=3; IntAct=EBI-365961, EBI-536866;
CC       Q96KB5:PBK; NbExp=3; IntAct=EBI-365961, EBI-536853;
CC       P27986:PIK3R1; NbExp=3; IntAct=EBI-365961, EBI-79464;
CC       P14618:PKM; NbExp=2; IntAct=EBI-365961, EBI-353408;
CC       O94906:PRPF6; NbExp=4; IntAct=EBI-365961, EBI-536755;
CC       P53611:RABGGTB; NbExp=3; IntAct=EBI-365961, EBI-536715;
CC       P62070:RRAS2; NbExp=3; IntAct=EBI-365961, EBI-491037;
CC       P31947:SFN; NbExp=2; IntAct=EBI-365961, EBI-476295;
CC       O43615:TIMM44; NbExp=3; IntAct=EBI-365961, EBI-861737;
CC       Q3ZCQ8:TIMM50; NbExp=4; IntAct=EBI-365961, EBI-355175;
CC       P58753:TIRAP; NbExp=2; IntAct=EBI-365961, EBI-528644;
CC       P62258:YWHAE; NbExp=3; IntAct=EBI-365961, EBI-356498;
CC       P61981:YWHAG; NbExp=4; IntAct=EBI-365961, EBI-359832;
CC       P63104:YWHAZ; NbExp=5; IntAct=EBI-365961, EBI-347088;
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P10398-1; Sequence=Displayed;
CC       Name=2; Synonyms=DA-Raf1;
CC         IsoId=P10398-2; Sequence=VSP_045609, VSP_045610;
CC         Note=Has a wider tissue distribution than isoform 1, and acts as
CC         dominant-negative antagonist.;
CC   -!- TISSUE SPECIFICITY: Predominantly in urogenital tissues.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. TKL Ser/Thr
CC       protein kinase family. RAF subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X04790; CAA28476.1; -; mRNA.
DR   EMBL; L24038; AAA65219.1; -; Genomic_DNA.
DR   EMBL; U01337; AAB03517.1; -; Genomic_DNA.
DR   EMBL; AB158254; BAE66645.1; -; mRNA.
DR   EMBL; BT019864; AAV38667.1; -; mRNA.
DR   EMBL; AL542736; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; Z84466; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC002466; AAH02466.1; -; mRNA.
DR   EMBL; M13829; AAB08754.1; -; mRNA.
DR   CCDS; CCDS35232.1; -. [P10398-1]
DR   CCDS; CCDS59164.1; -. [P10398-2]
DR   PIR; A53026; TVHUAF.
DR   RefSeq; NP_001243125.1; NM_001256196.1.
DR   RefSeq; NP_001243126.1; NM_001256197.1. [P10398-2]
DR   RefSeq; NP_001645.1; NM_001654.4. [P10398-1]
DR   RefSeq; XP_011542210.1; XM_011543908.2. [P10398-1]
DR   UniGene; Hs.446641; -.
DR   PDB; 1WXM; NMR; -; A=19-91.
DR   PDB; 2MSE; NMR; -; D=19-91.
DR   PDBsum; 1WXM; -.
DR   PDBsum; 2MSE; -.
DR   ProteinModelPortal; P10398; -.
DR   SMR; P10398; -.
DR   BioGrid; 106864; 93.
DR   DIP; DIP-31374N; -.
DR   IntAct; P10398; 89.
DR   MINT; P10398; -.
DR   STRING; 9606.ENSP00000366244; -.
DR   BindingDB; P10398; -.
DR   ChEMBL; CHEMBL1169596; -.
DR   DrugBank; DB00171; Adenosine triphosphate.
DR   GuidetoPHARMACOLOGY; 1933; -.
DR   iPTMnet; P10398; -.
DR   PhosphoSitePlus; P10398; -.
DR   BioMuta; ARAF; -.
DR   DMDM; 1730068; -.
DR   EPD; P10398; -.
DR   MaxQB; P10398; -.
DR   PaxDb; P10398; -.
DR   PeptideAtlas; P10398; -.
DR   PRIDE; P10398; -.
DR   TopDownProteomics; P10398-1; -. [P10398-1]
DR   DNASU; 369; -.
DR   Ensembl; ENST00000377039; ENSP00000366238; ENSG00000078061. [P10398-2]
DR   Ensembl; ENST00000377045; ENSP00000366244; ENSG00000078061. [P10398-1]
DR   GeneID; 369; -.
DR   KEGG; hsa:369; -.
DR   UCSC; uc031tjj.2; human. [P10398-1]
DR   CTD; 369; -.
DR   DisGeNET; 369; -.
DR   EuPathDB; HostDB:ENSG00000078061.12; -.
DR   GeneCards; ARAF; -.
DR   HGNC; HGNC:646; ARAF.
DR   HPA; HPA046188; -.
DR   HPA; HPA066326; -.
DR   MalaCards; ARAF; -.
DR   MIM; 311010; gene.
DR   neXtProt; NX_P10398; -.
DR   OpenTargets; ENSG00000078061; -.
DR   PharmGKB; PA24928; -.
DR   eggNOG; KOG0193; Eukaryota.
DR   eggNOG; ENOG410Y4UP; LUCA.
DR   GeneTree; ENSGT00900000140880; -.
DR   HOGENOM; HOG000252972; -.
DR   HOVERGEN; HBG001886; -.
DR   InParanoid; P10398; -.
DR   KO; K08845; -.
DR   PhylomeDB; P10398; -.
DR   TreeFam; TF317006; -.
DR   BRENDA; 2.7.10.2; 2681.
DR   Reactome; R-HSA-5673000; RAF activation.
DR   Reactome; R-HSA-5674135; MAP2K and MAPK activation.
DR   Reactome; R-HSA-5675221; Negative regulation of MAPK pathway.
DR   Reactome; R-HSA-6802946; Signaling by moderate kinase activity BRAF mutants.
DR   Reactome; R-HSA-6802948; Signaling by high-kinase activity BRAF mutants.
DR   Reactome; R-HSA-6802949; Signaling by RAS mutants.
DR   Reactome; R-HSA-6802952; Signaling by BRAF and RAF fusions.
DR   Reactome; R-HSA-6802955; Paradoxical activation of RAF signaling by kinase inactive BRAF.
DR   SignaLink; P10398; -.
DR   SIGNOR; P10398; -.
DR   ChiTaRS; ARAF; human.
DR   EvolutionaryTrace; P10398; -.
DR   GeneWiki; ARAF; -.
DR   GenomeRNAi; 369; -.
DR   PRO; PR:P10398; -.
DR   Proteomes; UP000005640; Chromosome X.
DR   Bgee; ENSG00000078061; -.
DR   CleanEx; HS_ARAF; -.
DR   ExpressionAtlas; P10398; baseline and differential.
DR   Genevisible; P10398; HS.
DR   GO; GO:0005829; C:cytosol; IBA:GO_Central.
DR   GO; GO:0005739; C:mitochondrion; IBA:GO_Central.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0004709; F:MAP kinase kinase kinase activity; IBA:GO_Central.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0031434; F:mitogen-activated protein kinase kinase binding; IBA:GO_Central.
DR   GO; GO:0004672; F:protein kinase activity; TAS:ProtInc.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB.
DR   GO; GO:0030154; P:cell differentiation; IBA:GO_Central.
DR   GO; GO:0006464; P:cellular protein modification process; TAS:ProtInc.
DR   GO; GO:0000165; P:MAPK cascade; TAS:Reactome.
DR   GO; GO:0007275; P:multicellular organism development; IBA:GO_Central.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; IDA:UniProtKB.
DR   GO; GO:0009968; P:negative regulation of signal transduction; IBA:GO_Central.
DR   GO; GO:0070374; P:positive regulation of ERK1 and ERK2 cascade; IBA:GO_Central.
DR   GO; GO:0033138; P:positive regulation of peptidyl-serine phosphorylation; IDA:UniProtKB.
DR   GO; GO:0032434; P:regulation of proteasomal ubiquitin-dependent protein catabolic process; IMP:UniProtKB.
DR   GO; GO:0032006; P:regulation of TOR signaling; IMP:UniProtKB.
DR   CDD; cd00029; C1; 1.
DR   InterPro; IPR020454; DAG/PE-bd.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR002219; PE/DAG-bd.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR003116; RBD_dom.
DR   InterPro; IPR001245; Ser-Thr/Tyr_kinase_cat_dom.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   InterPro; IPR029071; Ubiquitin-like_domsf.
DR   Pfam; PF00130; C1_1; 1.
DR   Pfam; PF07714; Pkinase_Tyr; 1.
DR   Pfam; PF02196; RBD; 1.
DR   PRINTS; PR00008; DAGPEDOMAIN.
DR   SMART; SM00109; C1; 1.
DR   SMART; SM00455; RBD; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF54236; SSF54236; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
DR   PROSITE; PS50898; RBD; 1.
DR   PROSITE; PS00479; ZF_DAG_PE_1; 1.
DR   PROSITE; PS50081; ZF_DAG_PE_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; ATP-binding; Complete proteome;
KW   Kinase; Metal-binding; Nucleotide-binding; Phosphoprotein;
KW   Polymorphism; Proto-oncogene; Reference proteome;
KW   Serine/threonine-protein kinase; Transferase; Zinc; Zinc-finger.
FT   CHAIN         1    606       Serine/threonine-protein kinase A-Raf.
FT                                /FTId=PRO_0000085622.
FT   DOMAIN       19     91       RBD. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00262}.
FT   DOMAIN      310    570       Protein kinase. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   ZN_FING      98    144       Phorbol-ester/DAG-type.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00226}.
FT   NP_BIND     316    324       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   ACT_SITE    429    429       Proton acceptor. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159, ECO:0000255|PROSITE-
FT                                ProRule:PRU10027}.
FT   METAL        99     99       Zinc 1. {ECO:0000250}.
FT   METAL       112    112       Zinc 2. {ECO:0000250}.
FT   METAL       115    115       Zinc 2. {ECO:0000250}.
FT   METAL       125    125       Zinc 1. {ECO:0000250}.
FT   METAL       128    128       Zinc 1. {ECO:0000250}.
FT   METAL       133    133       Zinc 2. {ECO:0000250}.
FT   METAL       136    136       Zinc 2. {ECO:0000250}.
FT   METAL       144    144       Zinc 1. {ECO:0000250}.
FT   BINDING     336    336       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   MOD_RES     157    157       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     162    162       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     181    181       Phosphothreonine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     186    186       Phosphoserine.
FT                                {ECO:0000244|PubMed:18691976,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     253    253       Phosphothreonine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     257    257       Phosphoserine.
FT                                {ECO:0000244|PubMed:16964243,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     269    269       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     318    318       Phosphothreonine.
FT                                {ECO:0000244|PubMed:19690332}.
FT   VAR_SEQ     186    186       S -> R (in isoform 2).
FT                                {ECO:0000303|PubMed:17535970,
FT                                ECO:0000303|Ref.5}.
FT                                /FTId=VSP_045609.
FT   VAR_SEQ     187    606       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:17535970,
FT                                ECO:0000303|Ref.5}.
FT                                /FTId=VSP_045610.
FT   VARIANT      98     98       M -> T (in dbSNP:rs56197559).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040375.
FT   VARIANT     331    331       G -> C (in a colorectal adenocarcinoma
FT                                sample; somatic mutation).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040376.
FT   VARIANT     578    578       E -> D (in dbSNP:rs55852926).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040377.
FT   CONFLICT    368    368       L -> P (in Ref. 8; AAB08754).
FT                                {ECO:0000305}.
FT   CONFLICT    378    378       F -> V (in Ref. 8; AAB08754).
FT                                {ECO:0000305}.
FT   CONFLICT    469    469       S -> P (in Ref. 8; AAB08754).
FT                                {ECO:0000305}.
FT   CONFLICT    478    478       I -> T (in Ref. 8; AAB08754).
FT                                {ECO:0000305}.
FT   STRAND       19     24       {ECO:0000244|PDB:1WXM}.
FT   STRAND       26     28       {ECO:0000244|PDB:1WXM}.
FT   STRAND       30     34       {ECO:0000244|PDB:1WXM}.
FT   HELIX        42     50       {ECO:0000244|PDB:1WXM}.
FT   TURN         51     53       {ECO:0000244|PDB:2MSE}.
FT   STRAND       56     67       {ECO:0000244|PDB:1WXM}.
FT   STRAND       69     72       {ECO:0000244|PDB:1WXM}.
FT   STRAND       74     78       {ECO:0000244|PDB:1WXM}.
FT   HELIX        79     81       {ECO:0000244|PDB:2MSE}.
FT   STRAND       82     84       {ECO:0000244|PDB:2MSE}.
FT   STRAND       85     90       {ECO:0000244|PDB:1WXM}.
SQ   SEQUENCE   606 AA;  67585 MW;  D23E5711304AA468 CRC64;
     MEPPRGPPAN GAEPSRAVGT VKVYLPNKQR TVVTVRDGMS VYDSLDKALK VRGLNQDCCV
     VYRLIKGRKT VTAWDTAIAP LDGEELIVEV LEDVPLTMHN FVRKTFFSLA FCDFCLKFLF
     HGFRCQTCGY KFHQHCSSKV PTVCVDMSTN RQQFYHSVQD LSGGSRQHEA PSNRPLNELL
     TPQGPSPRTQ HCDPEHFPFP APANAPLQRI RSTSTPNVHM VSTTAPMDSN LIQLTGQSFS
     TDAAGSRGGS DGTPRGSPSP ASVSSGRKSP HSKSPAEQRE RKSLADDKKK VKNLGYRDSG
     YYWEVPPSEV QLLKRIGTGS FGTVFRGRWH GDVAVKVLKV SQPTAEQAQA FKNEMQVLRK
     TRHVNILLFM GFMTRPGFAI ITQWCEGSSL YHHLHVADTR FDMVQLIDVA RQTAQGMDYL
     HAKNIIHRDL KSNNIFLHEG LTVKIGDFGL ATVKTRWSGA QPLEQPSGSV LWMAAEVIRM
     QDPNPYSFQS DVYAYGVVLY ELMTGSLPYS HIGCRDQIIF MVGRGYLSPD LSKISSNCPK
     AMRRLLSDCL KFQREERPLF PQILATIELL QRSLPKIERS ASEPSLHRTQ ADELPACLLS
     AARLVP
//
ID   Q96II5_HUMAN            Unreviewed;       609 AA.
AC   Q96II5; A6NIT1;
DT   01-DEC-2001, integrated into UniProtKB/TrEMBL.
DT   01-DEC-2001, sequence version 1.
DT   25-APR-2018, entry version 151.
DE   SubName: Full=ARAF protein {ECO:0000313|EMBL:AAH07514.1};
DE   SubName: Full=Serine/threonine-protein kinase A-Raf {ECO:0000313|Ensembl:ENSP00000290277};
GN   Name=ARAF {ECO:0000313|EMBL:AAH07514.1,
GN   ECO:0000313|Ensembl:ENSP00000290277};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:AAH07514.1};
RN   [1] {ECO:0000313|EMBL:AAH07514.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Lymph {ECO:0000313|EMBL:AAH07514.1};
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RA   Gerhard D.S., Wagner L., Feingold E.A., Shenmen C.M., Grouse L.H.,
RA   Schuler G., Klein S.L., Old S., Rasooly R., Good P., Guyer M.,
RA   Peck A.M., Derge J.G., Lipman D., Collins F.S., Jang W., Sherry S.,
RA   Feolo M., Misquitta L., Lee E., Rotmistrovsky K., Greenhut S.F.,
RA   Schaefer C.F., Buetow K., Bonner T.I., Haussler D., Kent J.,
RA   Kiekhaus M., Furey T., Brent M., Prange C., Schreiber K., Shapiro N.,
RA   Bhat N.K., Hopkins R.F., Hsie F., Driscoll T., Soares M.B.,
RA   Casavant T.L., Scheetz T.E., Brown-stein M.J., Usdin T.B.,
RA   Toshiyuki S., Carninci P., Piao Y., Dudekula D.B., Ko M.S.,
RA   Kawakami K., Suzuki Y., Sugano S., Gruber C.E., Smith M.R.,
RA   Simmons B., Moore T., Waterman R., Johnson S.L., Ruan Y., Wei C.L.,
RA   Mathavan S., Gunaratne P.H., Wu J., Garcia A.M., Hulyk S.W., Fuh E.,
RA   Yuan Y., Sneed A., Kowis C., Hodgson A., Muzny D.M., McPherson J.,
RA   Gibbs R.A., Fahey J., Helton E., Ketteman M., Madan A., Rodrigues S.,
RA   Sanchez A., Whiting M., Madari A., Young A.C., Wetherby K.D.,
RA   Granite S.J., Kwong P.N., Brinkley C.P., Pearson R.L., Bouffard G.G.,
RA   Blakesly R.W., Green E.D., Dickson M.C., Rodriguez A.C., Grimwood J.,
RA   Schmutz J., Myers R.M., Butterfield Y.S., Griffith M., Griffith O.L.,
RA   Krzywinski M.I., Liao N., Morin R., Morrin R., Palmquist D.,
RA   Petrescu A.S., Skalska U., Smailus D.E., Stott J.M., Schnerch A.,
RA   Schein J.E., Jones S.J., Holt R.A., Baross A., Marra M.A., Clifton S.,
RA   Makowski K.A., Bosak S., Malek J.;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [2] {ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15772651; DOI=10.1038/nature03440;
RA   Ross M.T., Grafham D.V., Coffey A.J., Scherer S., McLay K., Muzny D.,
RA   Platzer M., Howell G.R., Burrows C., Bird C.P., Frankish A.,
RA   Lovell F.L., Howe K.L., Ashurst J.L., Fulton R.S., Sudbrak R., Wen G.,
RA   Jones M.C., Hurles M.E., Andrews T.D., Scott C.E., Searle S.,
RA   Ramser J., Whittaker A., Deadman R., Carter N.P., Hunt S.E., Chen R.,
RA   Cree A., Gunaratne P., Havlak P., Hodgson A., Metzker M.L.,
RA   Richards S., Scott G., Steffen D., Sodergren E., Wheeler D.A.,
RA   Worley K.C., Ainscough R., Ambrose K.D., Ansari-Lari M.A., Aradhya S.,
RA   Ashwell R.I., Babbage A.K., Bagguley C.L., Ballabio A., Banerjee R.,
RA   Barker G.E., Barlow K.F., Barrett I.P., Bates K.N., Beare D.M.,
RA   Beasley H., Beasley O., Beck A., Bethel G., Blechschmidt K., Brady N.,
RA   Bray-Allen S., Bridgeman A.M., Brown A.J., Brown M.J., Bonnin D.,
RA   Bruford E.A., Buhay C., Burch P., Burford D., Burgess J., Burrill W.,
RA   Burton J., Bye J.M., Carder C., Carrel L., Chako J., Chapman J.C.,
RA   Chavez D., Chen E., Chen G., Chen Y., Chen Z., Chinault C.,
RA   Ciccodicola A., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Clerc-Blankenburg K., Clifford K., Cobley V., Cole C.G., Conquer J.S.,
RA   Corby N., Connor R.E., David R., Davies J., Davis C., Davis J.,
RA   Delgado O., Deshazo D., Dhami P., Ding Y., Dinh H., Dodsworth S.,
RA   Draper H., Dugan-Rocha S., Dunham A., Dunn M., Durbin K.J., Dutta I.,
RA   Eades T., Ellwood M., Emery-Cohen A., Errington H., Evans K.L.,
RA   Faulkner L., Francis F., Frankland J., Fraser A.E., Galgoczy P.,
RA   Gilbert J., Gill R., Gloeckner G., Gregory S.G., Gribble S.,
RA   Griffiths C., Grocock R., Gu Y., Gwilliam R., Hamilton C., Hart E.A.,
RA   Hawes A., Heath P.D., Heitmann K., Hennig S., Hernandez J.,
RA   Hinzmann B., Ho S., Hoffs M., Howden P.J., Huckle E.J., Hume J.,
RA   Hunt P.J., Hunt A.R., Isherwood J., Jacob L., Johnson D., Jones S.,
RA   de Jong P.J., Joseph S.S., Keenan S., Kelly S., Kershaw J.K., Khan Z.,
RA   Kioschis P., Klages S., Knights A.J., Kosiura A., Kovar-Smith C.,
RA   Laird G.K., Langford C., Lawlor S., Leversha M., Lewis L., Liu W.,
RA   Lloyd C., Lloyd D.M., Loulseged H., Loveland J.E., Lovell J.D.,
RA   Lozado R., Lu J., Lyne R., Ma J., Maheshwari M., Matthews L.H.,
RA   McDowall J., McLaren S., McMurray A., Meidl P., Meitinger T.,
RA   Milne S., Miner G., Mistry S.L., Morgan M., Morris S., Mueller I.,
RA   Mullikin J.C., Nguyen N., Nordsiek G., Nyakatura G., O'dell C.N.,
RA   Okwuonu G., Palmer S., Pandian R., Parker D., Parrish J.,
RA   Pasternak S., Patel D., Pearce A.V., Pearson D.M., Pelan S.E.,
RA   Perez L., Porter K.M., Ramsey Y., Reichwald K., Rhodes S.,
RA   Ridler K.A., Schlessinger D., Schueler M.G., Sehra H.K.,
RA   Shaw-Smith C., Shen H., Sheridan E.M., Shownkeen R., Skuce C.D.,
RA   Smith M.L., Sotheran E.C., Steingruber H.E., Steward C.A., Storey R.,
RA   Swann R.M., Swarbreck D., Tabor P.E., Taudien S., Taylor T.,
RA   Teague B., Thomas K., Thorpe A., Timms K., Tracey A., Trevanion S.,
RA   Tromans A.C., d'Urso M., Verduzco D., Villasana D., Waldron L.,
RA   Wall M., Wang Q., Warren J., Warry G.L., Wei X., West A.,
RA   Whitehead S.L., Whiteley M.N., Wilkinson J.E., Willey D.L.,
RA   Williams G., Williams L., Williamson A., Williamson H., Wilming L.,
RA   Woodmansey R.L., Wray P.W., Yen J., Zhang J., Zhou J., Zoghbi H.,
RA   Zorilla S., Buck D., Reinhardt R., Poustka A., Rosenthal A.,
RA   Lehrach H., Meindl A., Minx P.J., Hillier L.W., Willard H.F.,
RA   Wilson R.K., Waterston R.H., Rice C.M., Vaudin M., Coulson A.,
RA   Nelson D.L., Weinstock G., Sulston J.E., Durbin R.M., Hubbard T.,
RA   Gibbs R.A., Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence of the human X chromosome.";
RL   Nature 434:325-337(2005).
RN   [3] {ECO:0000313|Ensembl:ENSP00000290277}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [4] {ECO:0000213|PubMed:17081983}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [5] {ECO:0000213|PubMed:16964243}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=16964243; DOI=10.1038/nbt1240;
RA   Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;
RT   "A probability-based approach for high-throughput protein
RT   phosphorylation analysis and site localization.";
RL   Nat. Biotechnol. 24:1285-1292(2006).
RN   [6] {ECO:0000213|PubMed:18220336}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=18220336; DOI=10.1021/pr0705441;
RA   Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.D., Yates J.R.;
RT   "Combining protein-based IMAC, peptide-based IMAC, and MudPIT for
RT   efficient phosphoproteomic analysis.";
RL   J. Proteome Res. 7:1346-1351(2008).
RN   [7] {ECO:0000213|PubMed:18691976}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [8] {ECO:0000213|PubMed:18669648}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [9] {ECO:0000213|PubMed:19690332}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:ra46-RA46(2009).
RN   [10] {ECO:0000213|PubMed:20068231}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:ra3-RA3(2010).
RN   [11] {ECO:0000213|PubMed:21269460}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Burckstummer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [12] {ECO:0000213|PubMed:21406692}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:rs3-RS3(2011).
RN   [13] {ECO:0000313|Ensembl:ENSP00000290277}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (FEB-2012) to UniProtKB.
RN   [14] {ECO:0000213|PubMed:23186163}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=23186163;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [15] {ECO:0000213|PubMed:24275569}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC       {ECO:0000256|SAAS:SAAS00786134}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; KF459100; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; Z84466; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC007514; AAH07514.1; -; mRNA.
DR   RefSeq; NP_001243125.1; NM_001256196.1.
DR   UniGene; Hs.446641; -.
DR   Ensembl; ENST00000290277; ENSP00000290277; ENSG00000078061.
DR   GeneID; 369; -.
DR   UCSC; uc033ecb.2; human.
DR   CTD; 369; -.
DR   EuPathDB; HostDB:ENSG00000078061.12; -.
DR   HGNC; HGNC:646; ARAF.
DR   OpenTargets; ENSG00000078061; -.
DR   eggNOG; KOG0193; Eukaryota.
DR   eggNOG; ENOG410Y4UP; LUCA.
DR   GeneTree; ENSGT00900000140880; -.
DR   HOGENOM; HOG000252972; -.
DR   HOVERGEN; HBG001886; -.
DR   HOVERGEN; HBG055881; -.
DR   OMA; QHRDPEH; -.
DR   OrthoDB; EOG091G09SB; -.
DR   ChiTaRS; ARAF; human.
DR   GenomeRNAi; 369; -.
DR   Proteomes; UP000005640; Chromosome X.
DR   Bgee; ENSG00000078061; -.
DR   GO; GO:0005829; C:cytosol; IEA:Ensembl.
DR   GO; GO:0005739; C:mitochondrion; IEA:Ensembl.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0004709; F:MAP kinase kinase kinase activity; IEA:Ensembl.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0020021; P:immortalization of host cell; IEA:Ensembl.
DR   CDD; cd00029; C1; 1.
DR   InterPro; IPR020454; DAG/PE-bd.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR002219; PE/DAG-bd.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR003116; RBD_dom.
DR   InterPro; IPR001245; Ser-Thr/Tyr_kinase_cat_dom.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   InterPro; IPR029071; Ubiquitin-like_domsf.
DR   Pfam; PF00130; C1_1; 1.
DR   Pfam; PF07714; Pkinase_Tyr; 1.
DR   Pfam; PF02196; RBD; 1.
DR   PRINTS; PR00008; DAGPEDOMAIN.
DR   SMART; SM00109; C1; 1.
DR   SMART; SM00455; RBD; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF54236; SSF54236; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
DR   PROSITE; PS50898; RBD; 1.
DR   PROSITE; PS00479; ZF_DAG_PE_1; 1.
DR   PROSITE; PS50081; ZF_DAG_PE_2; 1.
PE   1: Evidence at protein level;
KW   ATP-binding {ECO:0000256|SAAS:SAAS00783584};
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   Kinase {ECO:0000256|SAAS:SAAS00784476};
KW   Metal-binding {ECO:0000256|SAAS:SAAS00515414};
KW   Nucleotide-binding {ECO:0000256|SAAS:SAAS00783584};
KW   Proteomics identification {ECO:0000213|EPD:Q96II5,
KW   ECO:0000213|MaxQB:Q96II5, ECO:0000213|PeptideAtlas:Q96II5};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640};
KW   Serine/threonine-protein kinase {ECO:0000256|SAAS:SAAS00784476};
KW   Transferase {ECO:0000256|SAAS:SAAS00784476};
KW   Zinc {ECO:0000256|SAAS:SAAS00515409}.
FT   DOMAIN       19     91       RBD. {ECO:0000259|PROSITE:PS50898}.
FT   DOMAIN       98    144       Phorbol-ester/DAG-type.
FT                                {ECO:0000259|PROSITE:PS50081}.
FT   DOMAIN      313    573       Protein kinase.
FT                                {ECO:0000259|PROSITE:PS50011}.
SQ   SEQUENCE   609 AA;  67926 MW;  38B52E7C303E06CF CRC64;
     MEPPRGPPAN GAEPSRAVGT VKVYLPNKQR TVVTVRDGMS VYDSLDKALK VRGLNQDCCV
     VYRLIKGRKT VTAWDTAIAP LDGEELIVEV LEDVPLTMHN FVRKTFFSLA FCDFCLKFLF
     HGFRCQTCGY KFHQHCSSKV PTVCVDMSTN RQQPSRFYHS VQDLSGGSRQ HEAPSNRPLN
     ELLTPQGPSP RTQHCDPEHF PFPAPANAPL QRIRSTSTPN VHMVSTTAPM DSNLIQLTGQ
     SFSTDAAGSR GGSDGTPRGS PSPASVSSGR KSPHSKSPAE QRERKSLADD KKKVKNLGYR
     DSGYYWEVPP SEVQLLKRIG TGSFGTVFRG RWHGDVAVKV LKVSQPTAEQ AQAFKNEMQV
     LRKTRHVNIL LFMGFMTRPG FAIITQWCEG SSLYHHLHVA DTRFDMVQLI DVARQTAQGM
     DYLHAKNIIH RDLKSNNIFL HEGLTVKIGD FGLATVKTRW SGAQPLEQPS GSVLWMAAEV
     IRMQDPNPYS FQSDVYAYGV VLYELMTGSL PYSHIGCRDQ IIFMVGRGYL SPDLSKISSN
     CPKAMRRLLS DCLKFQREER PLFPQILATI ELLQRSLPKI ERSASEPSLH RTQADELPAC
     LLSAARLVP
//
ID   RHG05_HUMAN             Reviewed;        1502 AA.
AC   Q13017; A1L375; A1L376; A8KAA1; D3DS89; D3DS90; Q05BE8; Q05BU8;
AC   Q59ER0; Q6DHZ3;
DT   28-FEB-2003, integrated into UniProtKB/Swiss-Prot.
DT   10-JUN-2008, sequence version 2.
DT   25-APR-2018, entry version 163.
DE   RecName: Full=Rho GTPase-activating protein 5;
DE   AltName: Full=Rho-type GTPase-activating protein 5;
DE   AltName: Full=p190-B {ECO:0000303|PubMed:28894085, ECO:0000303|PubMed:8537347};
GN   Name=ARHGAP5; Synonyms=RHOGAP5;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, SUBUNIT, SUBCELLULAR
RP   LOCATION, AND TISSUE SPECIFICITY.
RC   TISSUE=Mesangial cell;
RX   PubMed=8537347; DOI=10.1074/jbc.270.52.30919;
RA   Burbelo P.D., Miyamoto S., Utani A., Brill S., Yamada K.M., Hall A.,
RA   Yamada Y.;
RT   "p190-B, a new member of the Rho GAP family, and Rho are induced to
RT   cluster after integrin cross-linking.";
RL   J. Biol. Chem. 270:30919-30926(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1; 3 AND 4).
RC   TISSUE=Brain, Testis, and Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1-1239 (ISOFORM 1).
RC   TISSUE=Trachea;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 364-1499 (ISOFORM 2).
RC   TISSUE=Brain;
RA   Totoki Y., Toyoda A., Takeda T., Sakaki Y., Tanaka A., Yokoyama S.,
RA   Ohara O., Nagase T., Kikuno R.F.;
RL   Submitted (MAR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NITRATION [LARGE SCALE ANALYSIS] AT TYR-550, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Pituitary adenoma;
RX   PubMed=16777052; DOI=10.1016/j.ab.2006.05.024;
RA   Zhan X., Desiderio D.M.;
RT   "Nitroproteins from a human pituitary adenoma tissue discovered with a
RT   nitrotyrosine affinity column and tandem mass spectrometry.";
RL   Anal. Biochem. 354:279-289(2006).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-765 AND SER-1202, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-968; SER-1115; SER-1176;
RP   SER-1195; SER-1202 AND SER-1218, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1195 AND SER-1202, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-765; SER-951 AND
RP   SER-1202, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1173 AND SER-1176, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-590; SER-765; SER-968;
RP   SER-1173; SER-1176; SER-1195; SER-1202 AND SER-1218, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1173 AND SER-1195, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [16]
RP   STRUCTURE BY NMR OF 1245-1456.
RG   RIKEN structural genomics initiative (RSGI);
RT   "Solution structure of the N-terminus extended RhoGAP domain from
RT   human Rho GTPase activating protein 5 variant.";
RL   Submitted (AUG-2007) to the PDB data bank.
RN   [17] {ECO:0000244|PDB:5U4V}
RP   X-RAY CRYSTALLOGRAPHY (2.60 ANGSTROMS) OF 590-763, AND DOMAIN.
RX   PubMed=28894085; DOI=10.1038/s41467-017-00483-x;
RA   Stiegler A.L., Boggon T.J.;
RT   "p190RhoGAP proteins contain pseudoGTPase domains.";
RL   Nat. Commun. 8:506-506(2017).
CC   -!- FUNCTION: GTPase-activating protein for Rho family members
CC       (PubMed:8537347). {ECO:0000269|PubMed:8537347}.
CC   -!- SUBUNIT: May interact with RASA1/p120GAP.
CC       {ECO:0000305|PubMed:8537347}.
CC   -!- INTERACTION:
CC       P61588:Rnd3 (xeno); NbExp=2; IntAct=EBI-7237884, EBI-6930266;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:8537347}. Cell
CC       membrane {ECO:0000269|PubMed:8537347}; Peripheral membrane protein
CC       {ECO:0000269|PubMed:8537347}. Note=Also membrane-associated in a
CC       fibrillar pattern that colocalizes with the alpha5-beta1 integrin
CC       receptor (ITGA5/ITGB1) for fibronectin.
CC       {ECO:0000269|PubMed:8537347}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1;
CC         IsoId=Q13017-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q13017-2; Sequence=VSP_034166;
CC         Note=No experimental confirmation available.;
CC       Name=3;
CC         IsoId=Q13017-3; Sequence=VSP_034164, VSP_034167;
CC         Note=No experimental confirmation available.;
CC       Name=4;
CC         IsoId=Q13017-4; Sequence=VSP_034165;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Detected in skin fibroblasts (at protein
CC       level) (PubMed:8537347). {ECO:0000269|PubMed:8537347}.
CC   -!- DOMAIN: The pG1 pseudoGTPase domain does not bind GTP.
CC       {ECO:0000269|PubMed:28894085}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAA95963.1; Type=Frameshift; Positions=Several; Evidence={ECO:0000305};
CC       Sequence=AAH32723.1; Type=Miscellaneous discrepancy; Note=Contaminating sequence. Potential poly-A sequence.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U17032; AAA95963.1; ALT_FRAME; mRNA.
DR   EMBL; CH471078; EAW65935.1; -; Genomic_DNA.
DR   EMBL; CH471078; EAW65936.1; -; Genomic_DNA.
DR   EMBL; CH471078; EAW65937.1; -; Genomic_DNA.
DR   EMBL; CH471078; EAW65938.1; -; Genomic_DNA.
DR   EMBL; BC032723; AAH32723.1; ALT_SEQ; mRNA.
DR   EMBL; BC050059; AAH50059.1; -; mRNA.
DR   EMBL; BC075799; AAH75799.1; -; mRNA.
DR   EMBL; BC129928; AAI29929.1; -; mRNA.
DR   EMBL; BC129929; AAI29930.1; -; mRNA.
DR   EMBL; AK292966; BAF85655.1; -; mRNA.
DR   EMBL; AB209751; BAD92988.1; -; mRNA.
DR   CCDS; CCDS32062.1; -. [Q13017-1]
DR   CCDS; CCDS45095.1; -. [Q13017-2]
DR   PIR; B59431; B59431.
DR   RefSeq; NP_001025226.1; NM_001030055.1. [Q13017-1]
DR   RefSeq; NP_001164.2; NM_001173.2. [Q13017-2]
DR   RefSeq; XP_005267692.1; XM_005267635.3. [Q13017-1]
DR   RefSeq; XP_005267693.1; XM_005267636.3. [Q13017-1]
DR   RefSeq; XP_016876776.1; XM_017021287.1. [Q13017-1]
DR   RefSeq; XP_016876777.1; XM_017021288.1. [Q13017-2]
DR   UniGene; Hs.592313; -.
DR   PDB; 2EE4; NMR; -; A=1255-1456.
DR   PDB; 2EE5; NMR; -; A=1245-1456.
DR   PDB; 5U4V; X-ray; 2.60 A; A=590-763.
DR   PDBsum; 2EE4; -.
DR   PDBsum; 2EE5; -.
DR   PDBsum; 5U4V; -.
DR   ProteinModelPortal; Q13017; -.
DR   SMR; Q13017; -.
DR   BioGrid; 106887; 15.
DR   IntAct; Q13017; 2.
DR   MINT; Q13017; -.
DR   STRING; 9606.ENSP00000371897; -.
DR   iPTMnet; Q13017; -.
DR   PhosphoSitePlus; Q13017; -.
DR   BioMuta; ARHGAP5; -.
DR   DMDM; 190358871; -.
DR   EPD; Q13017; -.
DR   MaxQB; Q13017; -.
DR   PaxDb; Q13017; -.
DR   PeptideAtlas; Q13017; -.
DR   PRIDE; Q13017; -.
DR   Ensembl; ENST00000345122; ENSP00000371897; ENSG00000100852. [Q13017-1]
DR   Ensembl; ENST00000396582; ENSP00000379827; ENSG00000100852. [Q13017-3]
DR   Ensembl; ENST00000433497; ENSP00000407395; ENSG00000100852. [Q13017-4]
DR   Ensembl; ENST00000539826; ENSP00000441692; ENSG00000100852. [Q13017-1]
DR   Ensembl; ENST00000556611; ENSP00000452222; ENSG00000100852. [Q13017-2]
DR   GeneID; 394; -.
DR   KEGG; hsa:394; -.
DR   UCSC; uc001wrl.4; human. [Q13017-1]
DR   CTD; 394; -.
DR   DisGeNET; 394; -.
DR   EuPathDB; HostDB:ENSG00000100852.12; -.
DR   GeneCards; ARHGAP5; -.
DR   HGNC; HGNC:675; ARHGAP5.
DR   HPA; HPA046993; -.
DR   HPA; HPA056507; -.
DR   MIM; 602680; gene.
DR   neXtProt; NX_Q13017; -.
DR   OpenTargets; ENSG00000100852; -.
DR   PharmGKB; PA24959; -.
DR   eggNOG; KOG4271; Eukaryota.
DR   eggNOG; ENOG410XR4E; LUCA.
DR   GeneTree; ENSGT00900000140972; -.
DR   HOVERGEN; HBG051844; -.
DR   InParanoid; Q13017; -.
DR   KO; K13709; -.
DR   OMA; FKYITEA; -.
DR   OrthoDB; EOG091G00ZO; -.
DR   PhylomeDB; Q13017; -.
DR   TreeFam; TF324451; -.
DR   Reactome; R-HSA-194840; Rho GTPase cycle.
DR   SignaLink; Q13017; -.
DR   SIGNOR; Q13017; -.
DR   ChiTaRS; ARHGAP5; human.
DR   EvolutionaryTrace; Q13017; -.
DR   GeneWiki; ARHGAP5; -.
DR   GenomeRNAi; 394; -.
DR   PMAP-CutDB; Q13017; -.
DR   PRO; PR:Q13017; -.
DR   Proteomes; UP000005640; Chromosome 14.
DR   Bgee; ENSG00000100852; -.
DR   CleanEx; HS_ARHGAP5; -.
DR   ExpressionAtlas; Q13017; baseline and differential.
DR   Genevisible; Q13017; HS.
DR   GO; GO:0005737; C:cytoplasm; TAS:ProtInc.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005783; C:endoplasmic reticulum; IDA:HPA.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005525; F:GTP binding; IEA:InterPro.
DR   GO; GO:0005096; F:GTPase activator activity; TAS:Reactome.
DR   GO; GO:0003924; F:GTPase activity; TAS:ProtInc.
DR   GO; GO:0042169; F:SH2 domain binding; IPI:UniProtKB.
DR   GO; GO:0007155; P:cell adhesion; TAS:ProtInc.
DR   GO; GO:0030879; P:mammary gland development; IEA:Ensembl.
DR   GO; GO:0051056; P:regulation of small GTPase mediated signal transduction; TAS:Reactome.
DR   GO; GO:0007266; P:Rho protein signal transduction; TAS:ProtInc.
DR   Gene3D; 1.10.10.440; -; 3.
DR   Gene3D; 1.10.555.10; -; 1.
DR   InterPro; IPR002713; FF_domain.
DR   InterPro; IPR036517; FF_domain_sf.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   InterPro; IPR008936; Rho_GTPase_activation_prot.
DR   InterPro; IPR032835; RhoGAP-FF1.
DR   InterPro; IPR000198; RhoGAP_dom.
DR   InterPro; IPR001806; Small_GTPase.
DR   Pfam; PF01846; FF; 1.
DR   Pfam; PF00071; Ras; 1.
DR   Pfam; PF00620; RhoGAP; 1.
DR   Pfam; PF16512; RhoGAP-FF1; 1.
DR   SMART; SM00441; FF; 4.
DR   SMART; SM00324; RhoGAP; 1.
DR   SUPFAM; SSF48350; SSF48350; 1.
DR   SUPFAM; SSF52540; SSF52540; 2.
DR   SUPFAM; SSF81698; SSF81698; 1.
DR   PROSITE; PS51676; FF; 4.
DR   PROSITE; PS51852; PG1; 1.
DR   PROSITE; PS51853; PG2; 1.
DR   PROSITE; PS50238; RHOGAP; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Cell membrane; Complete proteome;
KW   Cytoplasm; GTPase activation; Membrane; Nitration; Phosphoprotein;
KW   Polymorphism; Reference proteome; Repeat.
FT   CHAIN         1   1502       Rho GTPase-activating protein 5.
FT                                /FTId=PRO_0000056702.
FT   DOMAIN      267    325       FF 1.
FT   DOMAIN      366    420       FF 2.
FT   DOMAIN      427    481       FF 3.
FT   DOMAIN      482    548       FF 4.
FT   DOMAIN      590    763       pG1 pseudoGTPase. {ECO:0000255|PROSITE-
FT                                ProRule:PRU01199}.
FT   DOMAIN      779    944       pG2 pseudoGTPase. {ECO:0000255|PROSITE-
FT                                ProRule:PRU01200}.
FT   DOMAIN     1262   1449       Rho-GAP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00172}.
FT   COMPBIAS   1225   1245       Lys-rich.
FT   MOD_RES     550    550       Nitrated tyrosine.
FT                                {ECO:0000244|PubMed:16777052}.
FT   MOD_RES     590    590       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     765    765       Phosphoserine.
FT                                {ECO:0000244|PubMed:18691976,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     951    951       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231}.
FT   MOD_RES     968    968       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES    1115   1115       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   MOD_RES    1173   1173       Phosphoserine.
FT                                {ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES    1176   1176       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES    1195   1195       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES    1202   1202       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:18691976,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES    1218   1218       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:23186163}.
FT   VAR_SEQ       1   1265       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_034164.
FT   VAR_SEQ       1   1261       Missing (in isoform 4).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_034165.
FT   VAR_SEQ    1240   1240       Missing (in isoform 2).
FT                                {ECO:0000303|Ref.5}.
FT                                /FTId=VSP_034166.
FT   VAR_SEQ    1266   1288       DLVTAEKPIPLFVEKCVEFIEDT -> MSLPPPPPGPLPLR
FT                                RRRRRPTLL (in isoform 3).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_034167.
FT   VARIANT      17     17       I -> V (in dbSNP:rs17386818).
FT                                /FTId=VAR_043980.
FT   CONFLICT     80     80       Q -> R (in Ref. 3; AAH50059).
FT                                {ECO:0000305}.
FT   CONFLICT    409    409       E -> G (in Ref. 4; BAF85655).
FT                                {ECO:0000305}.
FT   CONFLICT    541    541       L -> F (in Ref. 5; BAD92988).
FT                                {ECO:0000305}.
FT   CONFLICT    620    620       D -> G (in Ref. 4; BAF85655).
FT                                {ECO:0000305}.
FT   CONFLICT   1383   1383       D -> G (in Ref. 3; AAH50059).
FT                                {ECO:0000305}.
FT   STRAND      595    601       {ECO:0000244|PDB:5U4V}.
FT   HELIX       606    615       {ECO:0000244|PDB:5U4V}.
FT   STRAND      622    625       {ECO:0000244|PDB:5U4V}.
FT   STRAND      628    637       {ECO:0000244|PDB:5U4V}.
FT   STRAND      656    664       {ECO:0000244|PDB:5U4V}.
FT   HELIX       665    683       {ECO:0000244|PDB:5U4V}.
FT   STRAND      696    701       {ECO:0000244|PDB:5U4V}.
FT   HELIX       711    725       {ECO:0000244|PDB:5U4V}.
FT   STRAND      729    732       {ECO:0000244|PDB:5U4V}.
FT   HELIX       743    760       {ECO:0000244|PDB:5U4V}.
FT   STRAND     1258   1262       {ECO:0000244|PDB:2EE4}.
FT   HELIX      1264   1267       {ECO:0000244|PDB:2EE4}.
FT   HELIX      1276   1287       {ECO:0000244|PDB:2EE4}.
FT   TURN       1293   1297       {ECO:0000244|PDB:2EE4}.
FT   HELIX      1302   1314       {ECO:0000244|PDB:2EE4}.
FT   HELIX      1320   1323       {ECO:0000244|PDB:2EE4}.
FT   HELIX      1327   1340       {ECO:0000244|PDB:2EE4}.
FT   STRAND     1341   1343       {ECO:0000244|PDB:2EE4}.
FT   TURN       1348   1350       {ECO:0000244|PDB:2EE4}.
FT   HELIX      1351   1358       {ECO:0000244|PDB:2EE4}.
FT   HELIX      1363   1373       {ECO:0000244|PDB:2EE4}.
FT   TURN       1374   1376       {ECO:0000244|PDB:2EE4}.
FT   HELIX      1381   1397       {ECO:0000244|PDB:2EE4}.
FT   HELIX      1399   1402       {ECO:0000244|PDB:2EE4}.
FT   HELIX      1406   1417       {ECO:0000244|PDB:2EE4}.
FT   STRAND     1425   1427       {ECO:0000244|PDB:2EE5}.
FT   HELIX      1434   1443       {ECO:0000244|PDB:2EE4}.
FT   HELIX      1445   1448       {ECO:0000244|PDB:2EE4}.
SQ   SEQUENCE   1502 AA;  172460 MW;  2E01B5B1D007984D CRC64;
     MMAKNKEPRP PSYTISIVGL SGTEKDKGNC GVGKSCLCNR FVRSKADEYY PEHTSVLSTI
     DFGGRVVNND HFLYWGDIIQ NSEDGVECKI HVIEQTEFID DQTFLPHRST NLQPYIKRAA
     ASKLQSAEKL MYICTDQLGL EQDFEQKQMP EGKLNVDGFL LCIDVSQGCN RKFDDQLKFV
     NNLFVQLSKS KKPVIIAATK CDECVDHYLR EVQAFASNKK NLLVVETSAR FNVNIETCFT
     ALVQMLDKTR SKPKIIPYLD AYKTQRQLVV TATDKFEKLV QTVRDYHATW KTVSNKLKNH
     PDYEEYINLE GTRKARNTFS KHIEQLKQEH IRKRREEYIN TLPRAFNTLL PNLEEIEHLN
     WSEALKLMEK RADFQLCFVV LEKTPWDETD HIDKINDRRI PFDLLSTLEA EKVYQNHVQH
     LISEKRRVEM KEKFKKTLEK IQFISPGQPW EEVMCFVMED EAYKYITEAD SKEVYGRHQR
     EIVEKAKEEF QEMLFEHSEL FYDLDLNATP SSDKMSEIHT VLSEEPRYKA LQKLAPDRES
     LLLKHIGFVY HPTKETCLSG QNCTDIKVEQ LLASSLLQLD HGRLRLYHDS TNIDKVNLFI
     LGKDGLAQEL ANEIRTQSTD DEYALDGKIY ELDLRPVDAK SPYFLSQLWT AAFKPHGCFC
     VFNSIESLSF IGEFIGKIRT EASQIRKDKY MANLPFTLIL ANQRDSISKN LPILRHQGQQ
     LANKLQCPFV DVPAGTYPRK FNETQIKQAL RGVLESVKHN LDVVSPIPAN KDLSEADLRI
     VMCAMCGDPF SVDLILSPFL DSHSCSAAQA GQNNSLMLDK IIGEKRRRIQ ITILSYHSSI
     GVRKDELVHG YILVYSAKRK ASMGMLRAFL SEVQDTIPVQ LVAVTDSQAD FFENEAIKEL
     MTEGEHIATE ITAKFTALYS LSQYHRQTEV FTLFFSDVLE KKNMIENSYL SDNTRESTHQ
     SEDVFLPSPR DCFPYNNYPD SDDDTEAPPP YSPIGDDVQL LPTPSDRSRY RLDLEGNEYP
     IHSTPNCHDH ERNHKVPPPI KPKPVVPKTN VKKLDPNLLK TIEAGIGKNP RKQTSRVPLA
     HPEDMDPSDN YAEPIDTIFK QKGYSDEIYV VPDDSQNRIK IRNSFVNNTQ GDEENGFSDR
     TSKSHGERRP SKYKYKSKTL FSKAKSYYRR THSDASDDEA FTTSKTKRKG RHRGSEEDPL
     LSPVETWKGG IDNPAITSDQ ELDDKKMKKK THKVKEDKKQ KKKTKNFNPP TRRNWESNYF
     GMPLQDLVTA EKPIPLFVEK CVEFIEDTGL CTEGLYRVSG NKTDQDNIQK QFDQDHNINL
     VSMEVTVNAV AGALKAFFAD LPDPLIPYSL HPELLEAAKI PDKTERLHAL KEIVKKFHPV
     NYDVFRYVIT HLNRVSQQHK INLMTADNLS ICFWPTLMRP DFENREFLST TKIHQSVVET
     FIQQCQFFFY NGEIVETTNI VAPPPPSNPG QLVEPMVPLQ LPPPLQPQLI QPQLQTDPLG
     II
//
ID   A0A0X9JFN5_HUMAN        Unreviewed;       242 AA.
AC   A0A0X9JFN5;
DT   13-APR-2016, integrated into UniProtKB/TrEMBL.
DT   13-APR-2016, sequence version 1.
DT   28-MAR-2018, entry version 10.
DE   SubName: Full=BCL-2-like protein 12 isoform 16 {ECO:0000313|EMBL:ALU57790.1};
GN   Name=BCL2L12 {ECO:0000313|EMBL:ALU57790.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:ALU57790.1};
RN   [1] {ECO:0000313|EMBL:ALU57790.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=26797417;
RA   Adamopoulos P.G., Kontos C.K., Tsiakanikas P., Scorilas A.;
RT   "Identification of novel alternative splice variants of the BCL2L12
RT   gene in human cancer cells using next-generation sequencing
RT   methodology.";
RL   Cancer Lett. 0:0-0(2016).
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; KR820282; ALU57790.1; -; mRNA.
DR   RefSeq; XP_016882834.1; XM_017027345.1.
DR   UniGene; Hs.289052; -.
DR   PeptideAtlas; A0A0X9JFN5; -.
DR   GeneID; 83596; -.
DR   CTD; 83596; -.
DR   ChiTaRS; BCL2L12; human.
PE   2: Evidence at transcript level;
SQ   SEQUENCE   242 AA;  26968 MW;  F818AC905E09EF2C CRC64;
     MGRPAGLFPP LCPFLGFRPE ACWERHMQIE RAPSVPPFLR WAGYRPGPVR RRGKVELIKF
     VRVQWRRPQV EWRRRRWGPG PGASMAGSEE LGLREDTLRV LAAFLRRGEA AGSPVPTPPS
     PAQEEPTDFL SRLRRCLPCS LGRGAAPSES PRPCSLPIRP CYGLEPGPAT PDFYALVAQR
     LEQLVQEQLK SPPSPELQGP PSTEKEAILR RLVALLEEEA EVINQKEGIL AVSPVDLNLP
     LD
//
ID   I6LJZ5_HUMAN            Unreviewed;       243 AA.
AC   I6LJZ5;
DT   03-OCT-2012, integrated into UniProtKB/TrEMBL.
DT   03-OCT-2012, sequence version 1.
DT   28-MAR-2018, entry version 28.
DE   SubName: Full=BCL2L12 protein isoform 4 {ECO:0000313|EMBL:ACZ28444.1};
GN   Name=BCL2L12 {ECO:0000313|EMBL:ACZ28444.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:ACZ28444.1};
RN   [1] {ECO:0000313|EMBL:ACZ28444.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=22664385; DOI=10.1016/j.gene.2012.04.084;
RA   Kontos C.K., Scorilas A.;
RT   "Molecular cloning of novel alternatively spliced variants of BCL2L12,
RT   a new member of the BCL2 gene family, and their expression analysis in
RT   cancer cells.";
RL   Gene 505:153-166(2012).
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; FJ868798; ACZ28444.1; -; mRNA.
DR   RefSeq; NP_001269445.1; NM_001282516.1.
DR   UniGene; Hs.289052; -.
DR   SMR; I6LJZ5; -.
DR   PeptideAtlas; I6LJZ5; -.
DR   PRIDE; I6LJZ5; -.
DR   GeneID; 83596; -.
DR   CTD; 83596; -.
DR   eggNOG; ENOG410IVDH; Eukaryota.
DR   eggNOG; ENOG410YTZU; LUCA.
DR   ChiTaRS; BCL2L12; human.
DR   GenomeRNAi; 83596; -.
PE   2: Evidence at transcript level;
SQ   SEQUENCE   243 AA;  27124 MW;  3FA60713C2F14D29 CRC64;
     MGRPAGLFPP LCPFLGFRPE ACWERHMQIE RAPSVPPFLR WAGYRPGPVR RRGKVELIKF
     VRVQWRRPQV EWRRRRWGPG PGASMAGSEE LGLREDTLRV LAAFLRRGEA AGSPVPTPPR
     SPAQEEPTDF LSRLRRCLPC SLGRGAAPSE SPRPCSLPIR PCYGLEPGPA TPDFYALVAQ
     RLEQLVQEQL KSPPSPELQG PPSTEKEAIL RRLVALLEEE AEVINQKEGI LAVSPVDLNL
     PLD
//
ID   I6LJZ6_HUMAN            Unreviewed;       176 AA.
AC   I6LJZ6;
DT   03-OCT-2012, integrated into UniProtKB/TrEMBL.
DT   03-OCT-2012, sequence version 1.
DT   28-MAR-2018, entry version 43.
DE   SubName: Full=BCL2-like 12 (Proline rich), isoform CRA_c {ECO:0000313|EMBL:EAW52516.1};
DE   SubName: Full=BCL2L12 protein isoform 2 {ECO:0000313|EMBL:ACZ28445.1};
GN   Name=BCL2L12 {ECO:0000313|EMBL:ACZ28445.1};
GN   ORFNames=hCG_21122 {ECO:0000313|EMBL:EAW52516.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:ACZ28445.1};
RN   [1] {ECO:0000313|EMBL:EAW52516.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D.,
RA   Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q.,
RA   Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G.,
RA   Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S.,
RA   Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J.,
RA   Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R.,
RA   Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A.,
RA   Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K.,
RA   Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V.,
RA   Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z.,
RA   Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A.,
RA   Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V.,
RA   Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B.,
RA   Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J.,
RA   Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C.,
RA   Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L.,
RA   Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S.,
RA   Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A.,
RA   Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D.,
RA   Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L.,
RA   Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N.,
RA   Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S.,
RA   Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F.,
RA   Kline L., Koduru S., Love A., Mann F., May D., McCawley S.,
RA   McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K.,
RA   Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N.,
RA   Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M.,
RA   Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F.,
RA   Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A.,
RA   Mi H., Lazareva B., Hatton T., Narechania A., Diemer K.,
RA   Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R.,
RA   Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J.,
RA   Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H.,
RA   Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D.,
RA   Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A.,
RA   Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S.,
RA   Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L.,
RA   Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W.,
RA   McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M.,
RA   Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAW52516.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3] {ECO:0000313|EMBL:ACZ28445.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=22664385; DOI=10.1016/j.gene.2012.04.084;
RA   Kontos C.K., Scorilas A.;
RT   "Molecular cloning of novel alternatively spliced variants of BCL2L12,
RT   a new member of the BCL2 gene family, and their expression analysis in
RT   cancer cells.";
RL   Gene 505:153-166(2012).
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; FJ868799; ACZ28445.1; -; mRNA.
DR   EMBL; CH471177; EAW52516.1; -; Genomic_DNA.
DR   RefSeq; NP_001269446.1; NM_001282517.1.
DR   RefSeq; XP_016882835.1; XM_017027346.1.
DR   UniGene; Hs.289052; -.
DR   GeneID; 83596; -.
DR   CTD; 83596; -.
DR   eggNOG; ENOG410IVDH; Eukaryota.
DR   eggNOG; ENOG410YTZU; LUCA.
DR   ChiTaRS; BCL2L12; human.
DR   GenomeRNAi; 83596; -.
PE   2: Evidence at transcript level;
SQ   SEQUENCE   176 AA;  19133 MW;  DC503A642100CAE4 CRC64;
     MGRPAGLFPP LCPFLGFRPE ACWERHMQIE RAPSVPPFLR WAGYRPGPVR RRGKVELIKF
     VRVQWRRPQV EWRRRRWGPG PGASMAGSEE LGLREDTLRV LAAFLRRGEA AGSPVPTPPR
     PSYSRLLCFG GPAAGTAGPR AAEISAQPRI TGSPIDREGS HTAEAGGPAG GGGRSH
//
ID   I6LJZ7_HUMAN            Unreviewed;       269 AA.
AC   I6LJZ7;
DT   03-OCT-2012, integrated into UniProtKB/TrEMBL.
DT   03-OCT-2012, sequence version 1.
DT   25-APR-2018, entry version 38.
DE   SubName: Full=BCL2L12 protein isoform 5 {ECO:0000313|EMBL:ACZ28448.1};
DE   SubName: Full=Bcl-2-like protein 12 {ECO:0000313|Ensembl:ENSP00000483272};
GN   Name=BCL2L12 {ECO:0000313|EMBL:ACZ28448.1,
GN   ECO:0000313|Ensembl:ENSP00000483272};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:ACZ28448.1};
RN   [1] {ECO:0000313|Ensembl:ENSP00000483272, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057824; DOI=10.1038/nature02399;
RA   Grimwood J., Gordon L.A., Olsen A.S., Terry A., Schmutz J.,
RA   Lamerdin J.E., Hellsten U., Goodstein D., Couronne O., Tran-Gyamfi M.,
RA   Aerts A., Altherr M., Ashworth L., Bajorek E., Black S., Branscomb E.,
RA   Caenepeel S., Carrano A.V., Caoile C., Chan Y.M., Christensen M.,
RA   Cleland C.A., Copeland A., Dalin E., Dehal P., Denys M., Detter J.C.,
RA   Escobar J., Flowers D., Fotopulos D., Garcia C., Georgescu A.M.,
RA   Glavina T., Gomez M., Gonzales E., Groza M., Hammon N., Hawkins T.,
RA   Haydu L., Ho I., Huang W., Israni S., Jett J., Kadner K., Kimball H.,
RA   Kobayashi A., Larionov V., Leem S.-H., Lopez F., Lou Y., Lowry S.,
RA   Malfatti S., Martinez D., McCready P.M., Medina C., Morgan J.,
RA   Nelson K., Nolan M., Ovcharenko I., Pitluck S., Pollard M.,
RA   Popkie A.P., Predki P., Quan G., Ramirez L., Rash S., Retterer J.,
RA   Rodriguez A., Rogers S., Salamov A., Salazar A., She X., Smith D.,
RA   Slezak T., Solovyev V., Thayer N., Tice H., Tsai M., Ustaszewska A.,
RA   Vo N., Wagner M., Wheeler J., Wu K., Xie G., Yang J., Dubchak I.,
RA   Furey T.S., DeJong P., Dickson M., Gordon D., Eichler E.E.,
RA   Pennacchio L.A., Richardson P., Stubbs L., Rokhsar D.S., Myers R.M.,
RA   Rubin E.M., Lucas S.M.;
RT   "The DNA sequence and biology of human chromosome 19.";
RL   Nature 428:529-535(2004).
RN   [2] {ECO:0000213|PubMed:18669648}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [3] {ECO:0000313|EMBL:ACZ28448.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=22664385; DOI=10.1016/j.gene.2012.04.084;
RA   Kontos C.K., Scorilas A.;
RT   "Molecular cloning of novel alternatively spliced variants of BCL2L12,
RT   a new member of the BCL2 gene family, and their expression analysis in
RT   cancer cells.";
RL   Gene 505:153-166(2012).
RN   [4] {ECO:0000213|PubMed:22814378}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [5] {ECO:0000213|PubMed:23186163}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=23186163;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [6] {ECO:0000213|PubMed:24129315}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=24129315;
RA   Guo A., Gu H., Zhou J., Mulhern D., Wang Y., Lee K.A., Yang V.,
RA   Aguiar M., Kornhauser J., Jia X., Ren J., Beausoleil S.A., Silva J.C.,
RA   Vemulapalli V., Bedford M.T., Comb M.J.;
RT   "Immunoaffinity enrichment and mass spectrometry analysis of protein
RT   methylation.";
RL   Mol. Cell. Proteomics 13:372-387(2014).
RN   [7] {ECO:0000313|Ensembl:ENSP00000483272}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (SEP-2014) to UniProtKB.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AC011495; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; FJ868802; ACZ28448.1; -; mRNA.
DR   RefSeq; NP_001269448.1; NM_001282519.1.
DR   UniGene; Hs.289052; -.
DR   PeptideAtlas; I6LJZ7; -.
DR   Ensembl; ENST00000619007; ENSP00000483272; ENSG00000126453.
DR   GeneID; 83596; -.
DR   UCSC; uc031rlz.2; human.
DR   CTD; 83596; -.
DR   EuPathDB; HostDB:ENSG00000126453.9; -.
DR   HGNC; HGNC:13787; BCL2L12.
DR   OpenTargets; ENSG00000126453; -.
DR   eggNOG; ENOG410IVDH; Eukaryota.
DR   eggNOG; ENOG410YTZU; LUCA.
DR   GeneTree; ENSGT00390000001825; -.
DR   ChiTaRS; BCL2L12; human.
DR   GenomeRNAi; 83596; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   Bgee; ENSG00000126453; -.
PE   1: Evidence at protein level;
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   Proteomics identification {ECO:0000213|EPD:I6LJZ7,
KW   ECO:0000213|MaxQB:I6LJZ7, ECO:0000213|PeptideAtlas:I6LJZ7};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640}.
SQ   SEQUENCE   269 AA;  29906 MW;  EA91BF1B1009E9DE CRC64;
     MGRPAGLFPP LCPFLGFRPE ACWERHMQIE RAPSVPPFLR WAGYRPGPVR RRGKVELIKF
     VRVQWRRPQV EWRRRRWGPG PGASMAGSEE LGLREDTLRV LAAFLRRGEA AGSPVPTPPR
     SPAQEEPTDF LSRLRRCLPC SLGRGAAPSE SPRPCSLPIR PCYGLEPGPA TPDFYALVAQ
     RLEQLVQEQL KSPPSPELQG PPSTEKEAIL RRLVALLEEE AEVINQKVMG ICPTPWQGQE
     LRNGGHPGCF TRGLELAIGL SSFSEAATR
//
ID   I6LJZ8_HUMAN            Unreviewed;       222 AA.
AC   I6LJZ8;
DT   03-OCT-2012, integrated into UniProtKB/TrEMBL.
DT   03-OCT-2012, sequence version 1.
DT   31-JAN-2018, entry version 25.
DE   SubName: Full=BCL2L12 protein isoform 6 {ECO:0000313|EMBL:ACZ28450.1};
GN   Name=BCL2L12 {ECO:0000313|EMBL:ACZ28450.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:ACZ28450.1};
RN   [1] {ECO:0000313|EMBL:ACZ28450.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=22664385; DOI=10.1016/j.gene.2012.04.084;
RA   Kontos C.K., Scorilas A.;
RT   "Molecular cloning of novel alternatively spliced variants of BCL2L12,
RT   a new member of the BCL2 gene family, and their expression analysis in
RT   cancer cells.";
RL   Gene 505:153-166(2012).
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; FJ911906; ACZ28450.1; -; mRNA.
DR   RefSeq; NP_001269449.1; NM_001282520.1.
DR   UniGene; Hs.289052; -.
DR   PeptideAtlas; I6LJZ8; -.
DR   PRIDE; I6LJZ8; -.
DR   GeneID; 83596; -.
DR   CTD; 83596; -.
DR   eggNOG; ENOG410IVDH; Eukaryota.
DR   eggNOG; ENOG410YTZU; LUCA.
DR   ChiTaRS; BCL2L12; human.
DR   GenomeRNAi; 83596; -.
PE   2: Evidence at transcript level;
SQ   SEQUENCE   222 AA;  24608 MW;  35F5D3B92C575850 CRC64;
     MGRPAGLFPP LCPFLGFRPE ACWERHMQIE RAPSVPPFLR WAGYRPGPVR RRGKVELIKF
     VRVQWRRPQV EWRRRRWGPG PGASMAGSEE LGLREDTLRV LAAFLRRGEA AGSPVPTPPR
     SPAQEEPTDF LSRLRRCLPC SLGRGAAPSE SPRPCSLPIR PCYGLEPGPA TPDFYALVAQ
     RLEQLVQEQL KSPPSPGGHP GCFTRGLELA IGLSSFSEAA TR
//
ID   I6LJZ9_HUMAN            Unreviewed;       193 AA.
AC   I6LJZ9;
DT   03-OCT-2012, integrated into UniProtKB/TrEMBL.
DT   03-OCT-2012, sequence version 1.
DT   25-APR-2018, entry version 37.
DE   SubName: Full=BCL2L12 protein isoform 8 {ECO:0000313|EMBL:ACZ28451.1};
DE   SubName: Full=Bcl-2-like protein 12 {ECO:0000313|Ensembl:ENSP00000482154};
GN   Name=BCL2L12 {ECO:0000313|EMBL:ACZ28451.1,
GN   ECO:0000313|Ensembl:ENSP00000482154};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:ACZ28451.1};
RN   [1] {ECO:0000313|Ensembl:ENSP00000482154, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057824; DOI=10.1038/nature02399;
RA   Grimwood J., Gordon L.A., Olsen A.S., Terry A., Schmutz J.,
RA   Lamerdin J.E., Hellsten U., Goodstein D., Couronne O., Tran-Gyamfi M.,
RA   Aerts A., Altherr M., Ashworth L., Bajorek E., Black S., Branscomb E.,
RA   Caenepeel S., Carrano A.V., Caoile C., Chan Y.M., Christensen M.,
RA   Cleland C.A., Copeland A., Dalin E., Dehal P., Denys M., Detter J.C.,
RA   Escobar J., Flowers D., Fotopulos D., Garcia C., Georgescu A.M.,
RA   Glavina T., Gomez M., Gonzales E., Groza M., Hammon N., Hawkins T.,
RA   Haydu L., Ho I., Huang W., Israni S., Jett J., Kadner K., Kimball H.,
RA   Kobayashi A., Larionov V., Leem S.-H., Lopez F., Lou Y., Lowry S.,
RA   Malfatti S., Martinez D., McCready P.M., Medina C., Morgan J.,
RA   Nelson K., Nolan M., Ovcharenko I., Pitluck S., Pollard M.,
RA   Popkie A.P., Predki P., Quan G., Ramirez L., Rash S., Retterer J.,
RA   Rodriguez A., Rogers S., Salamov A., Salazar A., She X., Smith D.,
RA   Slezak T., Solovyev V., Thayer N., Tice H., Tsai M., Ustaszewska A.,
RA   Vo N., Wagner M., Wheeler J., Wu K., Xie G., Yang J., Dubchak I.,
RA   Furey T.S., DeJong P., Dickson M., Gordon D., Eichler E.E.,
RA   Pennacchio L.A., Richardson P., Stubbs L., Rokhsar D.S., Myers R.M.,
RA   Rubin E.M., Lucas S.M.;
RT   "The DNA sequence and biology of human chromosome 19.";
RL   Nature 428:529-535(2004).
RN   [2] {ECO:0000213|PubMed:18669648}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [3] {ECO:0000313|EMBL:ACZ28451.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=22664385; DOI=10.1016/j.gene.2012.04.084;
RA   Kontos C.K., Scorilas A.;
RT   "Molecular cloning of novel alternatively spliced variants of BCL2L12,
RT   a new member of the BCL2 gene family, and their expression analysis in
RT   cancer cells.";
RL   Gene 505:153-166(2012).
RN   [4] {ECO:0000213|PubMed:22814378}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [5] {ECO:0000213|PubMed:24129315}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=24129315;
RA   Guo A., Gu H., Zhou J., Mulhern D., Wang Y., Lee K.A., Yang V.,
RA   Aguiar M., Kornhauser J., Jia X., Ren J., Beausoleil S.A., Silva J.C.,
RA   Vemulapalli V., Bedford M.T., Comb M.J.;
RT   "Immunoaffinity enrichment and mass spectrometry analysis of protein
RT   methylation.";
RL   Mol. Cell. Proteomics 13:372-387(2014).
RN   [6] {ECO:0000313|Ensembl:ENSP00000482154}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (SEP-2014) to UniProtKB.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AC011495; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; FJ911907; ACZ28451.1; -; mRNA.
DR   RefSeq; NP_001269450.1; NM_001282521.1.
DR   UniGene; Hs.289052; -.
DR   PeptideAtlas; I6LJZ9; -.
DR   Ensembl; ENST00000614495; ENSP00000482154; ENSG00000126453.
DR   GeneID; 83596; -.
DR   UCSC; uc031rlv.2; human.
DR   CTD; 83596; -.
DR   EuPathDB; HostDB:ENSG00000126453.9; -.
DR   HGNC; HGNC:13787; BCL2L12.
DR   OpenTargets; ENSG00000126453; -.
DR   eggNOG; ENOG410IVDH; Eukaryota.
DR   eggNOG; ENOG410YTZU; LUCA.
DR   GeneTree; ENSGT00390000001825; -.
DR   ChiTaRS; BCL2L12; human.
DR   GenomeRNAi; 83596; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   Bgee; ENSG00000126453; -.
PE   1: Evidence at protein level;
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   Proteomics identification {ECO:0000213|EPD:I6LJZ9,
KW   ECO:0000213|MaxQB:I6LJZ9, ECO:0000213|PeptideAtlas:I6LJZ9};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640}.
SQ   SEQUENCE   193 AA;  21446 MW;  85570CAEDBF99664 CRC64;
     MGRPAGLFPP LCPFLGFRPE ACWERHMQIE RAPSVPPFLR WAGYRPGPVR RRGKVELIKF
     VRVQWRRPQV EWRRRRWGPG PGASMAGSEE LGLREDTLRV LAAFLRRGEA AGSPVPTPPR
     SPAQEEPTDF LSRLRRCLPC SLGRGAAPSE SPRPCSLPIR PCYGLEPGGH PGCFTRGLEL
     AIGLSSFSEA ATR
//
ID   B2L12_HUMAN             Reviewed;         334 AA.
AC   Q9HB09; Q3SY11; Q3SY13; Q96I96; Q9HB08;
DT   19-SEP-2002, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2001, sequence version 1.
DT   28-MAR-2018, entry version 133.
DE   RecName: Full=Bcl-2-like protein 12;
DE            Short=Bcl2-L-12;
DE   AltName: Full=Bcl-2-related proline-rich protein;
GN   Name=BCL2L12; Synonyms=BPR;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORMS 1 AND 2).
RX   PubMed=11401436; DOI=10.1006/geno.2000.6455;
RA   Scorilas A., Kyriakopoulou L., Yousef G.M., Ashworth L.K., Kwamie A.,
RA   Diamandis E.P.;
RT   "Molecular cloning, physical mapping, and expression analysis of a
RT   novel gene, BCL2L12, encoding a proline-rich protein with a highly
RT   conserved BH2 domain of the Bcl-2 family.";
RL   Genomics 72:217-221(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057824; DOI=10.1038/nature02399;
RA   Grimwood J., Gordon L.A., Olsen A.S., Terry A., Schmutz J.,
RA   Lamerdin J.E., Hellsten U., Goodstein D., Couronne O., Tran-Gyamfi M.,
RA   Aerts A., Altherr M., Ashworth L., Bajorek E., Black S., Branscomb E.,
RA   Caenepeel S., Carrano A.V., Caoile C., Chan Y.M., Christensen M.,
RA   Cleland C.A., Copeland A., Dalin E., Dehal P., Denys M., Detter J.C.,
RA   Escobar J., Flowers D., Fotopulos D., Garcia C., Georgescu A.M.,
RA   Glavina T., Gomez M., Gonzales E., Groza M., Hammon N., Hawkins T.,
RA   Haydu L., Ho I., Huang W., Israni S., Jett J., Kadner K., Kimball H.,
RA   Kobayashi A., Larionov V., Leem S.-H., Lopez F., Lou Y., Lowry S.,
RA   Malfatti S., Martinez D., McCready P.M., Medina C., Morgan J.,
RA   Nelson K., Nolan M., Ovcharenko I., Pitluck S., Pollard M.,
RA   Popkie A.P., Predki P., Quan G., Ramirez L., Rash S., Retterer J.,
RA   Rodriguez A., Rogers S., Salamov A., Salazar A., She X., Smith D.,
RA   Slezak T., Solovyev V., Thayer N., Tice H., Tsai M., Ustaszewska A.,
RA   Vo N., Wagner M., Wheeler J., Wu K., Xie G., Yang J., Dubchak I.,
RA   Furey T.S., DeJong P., Dickson M., Gordon D., Eichler E.E.,
RA   Pennacchio L.A., Richardson P., Stubbs L., Rokhsar D.S., Myers R.M.,
RA   Rubin E.M., Lucas S.M.;
RT   "The DNA sequence and biology of human chromosome 19.";
RL   Nature 428:529-535(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 3).
RC   TISSUE=Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   SPLICE ISOFORM(S) THAT ARE POTENTIAL NMD TARGET(S).
RX   PubMed=14759258; DOI=10.1186/gb-2004-5-2-r8;
RA   Hillman R.T., Green R.E., Brenner S.E.;
RT   "An unappreciated role for RNA surveillance.";
RL   Genome Biol. 5:R8.1-R8.16(2004).
RN   [5]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-113; THR-117; SER-121
RP   AND SER-242, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [6]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-242, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-242 AND SER-243, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-195; SER-245 AND
RP   SER-273, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [11]
RP   METHYLATION [LARGE SCALE ANALYSIS] AT ARG-144, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Colon carcinoma;
RX   PubMed=24129315; DOI=10.1074/mcp.O113.027870;
RA   Guo A., Gu H., Zhou J., Mulhern D., Wang Y., Lee K.A., Yang V.,
RA   Aguiar M., Kornhauser J., Jia X., Ren J., Beausoleil S.A., Silva J.C.,
RA   Vemulapalli V., Bedford M.T., Comb M.J.;
RT   "Immunoaffinity enrichment and mass spectrometry analysis of protein
RT   methylation.";
RL   Mol. Cell. Proteomics 13:372-387(2014).
CC   -!- INTERACTION:
CC       P08107:HSPA1B; NbExp=2; IntAct=EBI-6969019, EBI-629985;
CC       P0CG48:UBC; NbExp=3; IntAct=EBI-6968951, EBI-3390054;
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q9HB09-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9HB09-2; Sequence=VSP_000522, VSP_000523;
CC         Note=May be produced at very low levels due to a premature stop
CC         codon in the mRNA, leading to nonsense-mediated mRNA decay.;
CC       Name=3;
CC         IsoId=Q9HB09-3; Sequence=VSP_043269;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Expressed mainly in breast, thymus, prostate,
CC       fetal liver, colon, placenta, pancreas, small intestine, spinal
CC       cord, kidney, and bone marrow and to a lesser extent in many other
CC       tissues. Isoform 2 is primarily expressed in skeletal muscle.
CC   -!- SIMILARITY: Belongs to the Bcl-2 family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/BCL2L12ID773ch19q13.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF289220; AAG29495.1; -; Genomic_DNA.
DR   EMBL; AF289220; AAG29496.1; -; Genomic_DNA.
DR   EMBL; AC011495; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC007724; AAH07724.2; -; mRNA.
DR   EMBL; BC104004; AAI04005.1; -; mRNA.
DR   EMBL; BC104005; AAI04006.1; -; mRNA.
DR   EMBL; BC104006; AAI04007.1; -; mRNA.
DR   CCDS; CCDS12776.1; -. [Q9HB09-1]
DR   CCDS; CCDS46144.1; -. [Q9HB09-3]
DR   RefSeq; NP_001035758.1; NM_001040668.1. [Q9HB09-3]
DR   RefSeq; NP_001269445.1; NM_001282516.1.
DR   RefSeq; NP_001269446.1; NM_001282517.1. [Q9HB09-2]
DR   RefSeq; NP_001269448.1; NM_001282519.1.
DR   RefSeq; NP_001269449.1; NM_001282520.1.
DR   RefSeq; NP_001269450.1; NM_001282521.1.
DR   RefSeq; NP_619580.1; NM_138639.1. [Q9HB09-1]
DR   RefSeq; XP_016882835.1; XM_017027346.1. [Q9HB09-2]
DR   UniGene; Hs.289052; -.
DR   ProteinModelPortal; Q9HB09; -.
DR   SMR; Q9HB09; -.
DR   BioGrid; 123692; 9.
DR   IntAct; Q9HB09; 3.
DR   STRING; 9606.ENSP00000246785; -.
DR   iPTMnet; Q9HB09; -.
DR   PhosphoSitePlus; Q9HB09; -.
DR   SwissPalm; Q9HB09; -.
DR   BioMuta; BCL2L12; -.
DR   DMDM; 23396468; -.
DR   EPD; Q9HB09; -.
DR   MaxQB; Q9HB09; -.
DR   PaxDb; Q9HB09; -.
DR   PeptideAtlas; Q9HB09; -.
DR   PRIDE; Q9HB09; -.
DR   DNASU; 83596; -.
DR   Ensembl; ENST00000246785; ENSP00000246785; ENSG00000126453. [Q9HB09-1]
DR   Ensembl; ENST00000441864; ENSP00000393803; ENSG00000126453. [Q9HB09-3]
DR   Ensembl; ENST00000616144; ENSP00000482218; ENSG00000126453. [Q9HB09-1]
DR   GeneID; 83596; -.
DR   KEGG; hsa:83596; -.
DR   UCSC; uc002ppa.4; human. [Q9HB09-1]
DR   CTD; 83596; -.
DR   DisGeNET; 83596; -.
DR   EuPathDB; HostDB:ENSG00000126453.9; -.
DR   GeneCards; BCL2L12; -.
DR   HGNC; HGNC:13787; BCL2L12.
DR   HPA; HPA020856; -.
DR   MIM; 610837; gene.
DR   neXtProt; NX_Q9HB09; -.
DR   OpenTargets; ENSG00000126453; -.
DR   PharmGKB; PA25306; -.
DR   eggNOG; ENOG410IVDH; Eukaryota.
DR   eggNOG; ENOG410YTZU; LUCA.
DR   GeneTree; ENSGT00390000001825; -.
DR   HOGENOM; HOG000294149; -.
DR   HOVERGEN; HBG050647; -.
DR   InParanoid; Q9HB09; -.
DR   OMA; RACWERH; -.
DR   OrthoDB; EOG091G0HI1; -.
DR   PhylomeDB; Q9HB09; -.
DR   TreeFam; TF338350; -.
DR   SIGNOR; Q9HB09; -.
DR   ChiTaRS; BCL2L12; human.
DR   GeneWiki; BCL2L12; -.
DR   GenomeRNAi; 83596; -.
DR   PRO; PR:Q9HB09; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   Bgee; ENSG00000126453; -.
DR   CleanEx; HS_BCL2L12; -.
DR   ExpressionAtlas; Q9HB09; baseline and differential.
DR   Genevisible; Q9HB09; HS.
DR   GO; GO:0016020; C:membrane; HDA:UniProtKB.
DR   GO; GO:0005634; C:nucleus; IDA:MGI.
DR   GO; GO:0002039; F:p53 binding; IEA:Ensembl.
DR   GO; GO:0006915; P:apoptotic process; IEA:UniProtKB-KW.
DR   GO; GO:1990001; P:inhibition of cysteine-type endopeptidase activity involved in apoptotic process; IDA:UniProtKB.
DR   GO; GO:2000773; P:negative regulation of cellular senescence; IEA:Ensembl.
DR   GO; GO:1902166; P:negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; IEA:Ensembl.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; IDA:UniProtKB.
DR   InterPro; IPR036834; Blc2-like_sf.
DR   SUPFAM; SSF56854; SSF56854; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Apoptosis; Complete proteome; Methylation;
KW   Phosphoprotein; Polymorphism; Reference proteome.
FT   CHAIN         1    334       Bcl-2-like protein 12.
FT                                /FTId=PRO_0000143072.
FT   MOTIF       311    322       BH2.
FT   MOD_RES     113    113       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   MOD_RES     117    117       Phosphothreonine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   MOD_RES     121    121       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   MOD_RES     144    144       Omega-N-methylarginine.
FT                                {ECO:0000244|PubMed:24129315}.
FT   MOD_RES     195    195       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     242    242       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692}.
FT   MOD_RES     243    243       Phosphoserine.
FT                                {ECO:0000244|PubMed:21406692}.
FT   MOD_RES     245    245       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     273    273       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   VAR_SEQ     120    120       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_043269.
FT   VAR_SEQ     121    176       SPAQEEPTDFLSRLRRCLPCSLGRGAAPSESPRPCSLPIRP
FT                                CYGLEPGPATPDFYA -> PSYSRLLCFGGPAAGTAGPRAA
FT                                EISAQPRITGSPIDREGSHTAEAGGPAGGGGRSH (in
FT                                isoform 2). {ECO:0000305}.
FT                                /FTId=VSP_000522.
FT   VAR_SEQ     177    334       Missing (in isoform 2). {ECO:0000305}.
FT                                /FTId=VSP_000523.
FT   VARIANT      47     47       G -> V (in dbSNP:rs2060263).
FT                                /FTId=VAR_048419.
FT   CONFLICT    270    270       P -> S (in Ref. 3; AAH07724).
FT                                {ECO:0000305}.
SQ   SEQUENCE   334 AA;  36821 MW;  5398E54C83E7CAB7 CRC64;
     MGRPAGLFPP LCPFLGFRPE ACWERHMQIE RAPSVPPFLR WAGYRPGPVR RRGKVELIKF
     VRVQWRRPQV EWRRRRWGPG PGASMAGSEE LGLREDTLRV LAAFLRRGEA AGSPVPTPPR
     SPAQEEPTDF LSRLRRCLPC SLGRGAAPSE SPRPCSLPIR PCYGLEPGPA TPDFYALVAQ
     RLEQLVQEQL KSPPSPELQG PPSTEKEAIL RRLVALLEEE AEVINQKLAS DPALRSKLVR
     LSSDSFARLV ELFCSRDDSS RPSRACPGPP PPSPEPLARL ALAMELSRRV AGLGGTLAGL
     SVEHVHSFTP WIQAHGGWEG ILAVSPVDLN LPLD
//
ID   A0N0Q1_HUMAN            Unreviewed;       360 AA.
AC   A0N0Q1;
DT   12-DEC-2006, integrated into UniProtKB/TrEMBL.
DT   12-DEC-2006, sequence version 1.
DT   20-DEC-2017, entry version 105.
DE   SubName: Full=Chemokine (C-C motif) receptor 4 {ECO:0000313|EMBL:ABK41942.1};
DE   SubName: Full=Chemokine (C-C motif) receptor 4, isoform CRA_a {ECO:0000313|EMBL:EAW64440.1};
DE   SubName: Full=cDNA FLJ75821, highly similar to Homo sapiens chemokine (C-C motif) receptor 4 (CCR4), mRNA {ECO:0000313|EMBL:BAF85363.1};
GN   Name=CCR4 {ECO:0000313|EMBL:ABK41942.1};
GN   ORFNames=hCG_1776165 {ECO:0000313|EMBL:EAW64440.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:ABK41942.1};
RN   [1] {ECO:0000313|EMBL:EAW64440.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D.,
RA   Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q.,
RA   Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G.,
RA   Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S.,
RA   Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J.,
RA   Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R.,
RA   Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A.,
RA   Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K.,
RA   Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V.,
RA   Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z.,
RA   Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A.,
RA   Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V.,
RA   Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B.,
RA   Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J.,
RA   Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C.,
RA   Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L.,
RA   Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S.,
RA   Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A.,
RA   Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D.,
RA   Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L.,
RA   Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N.,
RA   Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S.,
RA   Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F.,
RA   Kline L., Koduru S., Love A., Mann F., May D., McCawley S.,
RA   McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K.,
RA   Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N.,
RA   Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M.,
RA   Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F.,
RA   Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A.,
RA   Mi H., Lazareva B., Hatton T., Narechania A., Diemer K.,
RA   Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R.,
RA   Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J.,
RA   Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H.,
RA   Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D.,
RA   Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A.,
RA   Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S.,
RA   Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L.,
RA   Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W.,
RA   McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M.,
RA   Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAW64440.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3] {ECO:0000313|EMBL:ABK41942.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Livingston R.J., Shaffer T., McFarland I., Nguyen C.P., Stanaway I.B.,
RA   Rajkumar N., Johnson E.J., da Ponte S.H., Willa H., Ahearn M.O.,
RA   Bertucci C., Acklestad J., Carroll A., Swanson J., Gildersleeve H.I.,
RA   Nickerson D.A.;
RL   Submitted (OCT-2006) to the EMBL/GenBank/DDBJ databases.
RN   [4] {ECO:0000313|EMBL:BAF85363.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Thymus {ECO:0000313|EMBL:BAF85363.1};
RA   Wakamatsu A., Yamamoto J., Kimura K., Ishii S., Watanabe K.,
RA   Sugiyama A., Murakawa K., Kaida T., Tsuchiya K., Fukuzumi Y.,
RA   Kumagai A., Oishi Y., Yamamoto S., Ono Y., Komori Y., Yamazaki M.,
RA   Kisu Y., Nishikawa T., Sugano S., Nomura N., Isogai T.;
RT   "NEDO human cDNA sequencing project.";
RL   Submitted (OCT-2007) to the EMBL/GenBank/DDBJ databases.
CC   -!- SIMILARITY: Belongs to the G-protein coupled receptor 1 family.
CC       {ECO:0000256|RuleBase:RU000688, ECO:0000256|SAAS:SAAS00594957}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; EF064759; ABK41942.1; -; Genomic_DNA.
DR   EMBL; AK292674; BAF85363.1; -; mRNA.
DR   EMBL; CH471055; EAW64440.1; -; Genomic_DNA.
DR   EMBL; CH471055; EAW64441.1; -; Genomic_DNA.
DR   RefSeq; NP_005499.1; NM_005508.4.
DR   RefSeq; XP_016861176.1; XM_017005687.1.
DR   UniGene; Hs.184926; -.
DR   DNASU; 1233; -.
DR   GeneID; 1233; -.
DR   KEGG; hsa:1233; -.
DR   CTD; 1233; -.
DR   EuPathDB; HostDB:ENSG00000183813.6; -.
DR   PharmGKB; PA26169; -.
DR   eggNOG; KOG3656; Eukaryota.
DR   eggNOG; ENOG410XRW9; LUCA.
DR   HOVERGEN; HBG106917; -.
DR   KO; K04179; -.
DR   OMA; FFIMLMS; -.
DR   OrthoDB; EOG091G0B7A; -.
DR   GenomeRNAi; 1233; -.
DR   Bgee; ENSG00000183813; -.
DR   GO; GO:0009897; C:external side of plasma membrane; IEA:Ensembl.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0043025; C:neuronal cell body; IEA:Ensembl.
DR   GO; GO:0016493; F:C-C chemokine receptor activity; IEA:Ensembl.
DR   GO; GO:0006935; P:chemotaxis; IEA:Ensembl.
DR   GO; GO:0048872; P:homeostasis of number of cells; IEA:Ensembl.
DR   GO; GO:0006955; P:immune response; IEA:InterPro.
DR   GO; GO:0006954; P:inflammatory response; IEA:Ensembl.
DR   GO; GO:0001764; P:neuron migration; IEA:Ensembl.
DR   GO; GO:0050927; P:positive regulation of positive chemotaxis; IEA:Ensembl.
DR   GO; GO:0046677; P:response to antibiotic; IEA:Ensembl.
DR   GO; GO:0009617; P:response to bacterium; IEA:Ensembl.
DR   GO; GO:0009314; P:response to radiation; IEA:Ensembl.
DR   GO; GO:0002507; P:tolerance induction; IEA:Ensembl.
DR   InterPro; IPR002239; Chemokine_CCR4.
DR   InterPro; IPR000355; Chemokine_rcpt.
DR   InterPro; IPR000276; GPCR_Rhodpsn.
DR   InterPro; IPR017452; GPCR_Rhodpsn_7TM.
DR   PANTHER; PTHR10489:SF608; PTHR10489:SF608; 1.
DR   Pfam; PF00001; 7tm_1; 1.
DR   PRINTS; PR00657; CCCHEMOKINER.
DR   PRINTS; PR01109; CHEMOKINER4.
DR   PRINTS; PR00237; GPCRRHODOPSN.
DR   SMART; SM01381; 7TM_GPCR_Srsx; 1.
DR   PROSITE; PS00237; G_PROTEIN_RECEP_F1_1; 1.
DR   PROSITE; PS50262; G_PROTEIN_RECEP_F1_2; 1.
PE   2: Evidence at transcript level;
KW   G-protein coupled receptor {ECO:0000256|RuleBase:RU000688,
KW   ECO:0000256|SAAS:SAAS00522141};
KW   Membrane {ECO:0000256|SAAS:SAAS00522140, ECO:0000256|SAM:Phobius};
KW   Receptor {ECO:0000256|RuleBase:RU000688,
KW   ECO:0000256|SAAS:SAAS00522141};
KW   Transducer {ECO:0000256|RuleBase:RU000688,
KW   ECO:0000256|SAAS:SAAS00522141};
KW   Transmembrane {ECO:0000256|SAAS:SAAS00522140,
KW   ECO:0000256|SAM:Phobius};
KW   Transmembrane helix {ECO:0000256|SAAS:SAAS00522140,
KW   ECO:0000256|SAM:Phobius}.
FT   TRANSMEM     45     65       Helical. {ECO:0000256|SAM:Phobius}.
FT   TRANSMEM     77    100       Helical. {ECO:0000256|SAM:Phobius}.
FT   TRANSMEM    112    130       Helical. {ECO:0000256|SAM:Phobius}.
FT   TRANSMEM    151    174       Helical. {ECO:0000256|SAM:Phobius}.
FT   TRANSMEM    200    222       Helical. {ECO:0000256|SAM:Phobius}.
FT   TRANSMEM    243    264       Helical. {ECO:0000256|SAM:Phobius}.
FT   TRANSMEM    284    307       Helical. {ECO:0000256|SAM:Phobius}.
FT   DOMAIN       56    304       G_PROTEIN_RECEP_F1_2.
FT                                {ECO:0000259|PROSITE:PS50262}.
SQ   SEQUENCE   360 AA;  41403 MW;  51EBE12AD1FAFABF CRC64;
     MNPTDIADTT LDESIYSNYY LYESIPKPCT KEGIKAFGEL FLPPLYSLVF VFGLLGNSVV
     VLVLFKYKRL RSMTDVYLLN LAISDLLFVF SLPFWGYYAA DQWVFGLGLC KMISWMYLVG
     FYSGIFFVML MSIDRYLAIV HAVFSLRART LTYGVITSLA TWSVAVFASL PGFLFSTCYT
     ERNHTYCKTK YSLNSTTWKV LSSLEINILG LVIPLGIMLF CYSMIIRTLQ HCKNEKKNKA
     VKMIFAVVVL FLGFWTPYNI VLFLETLVEL EVLQDCTFER YLDYAIQATE TLAFVHCCLN
     PIIYFFLGEK FRKYILQLFK TCRGLFVLCQ YCGLLQIYSA DTPSSSYTQS TMDHDLHDAL
//
ID   CCR4_HUMAN              Reviewed;         360 AA.
AC   P51679; Q9ULY6; Q9ULY7;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-1996, sequence version 1.
DT   28-FEB-2018, entry version 153.
DE   RecName: Full=C-C chemokine receptor type 4;
DE            Short=C-C CKR-4;
DE            Short=CC-CKR-4;
DE            Short=CCR-4;
DE            Short=CCR4;
DE   AltName: Full=K5-5;
DE   AltName: CD_antigen=CD194;
GN   Name=CCR4; Synonyms=CMKBR4;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Spleen;
RX   PubMed=7642634; DOI=10.1074/jbc.270.33.19495;
RA   Power C.A., Meyer A., Nemeth K., Bacon K.B., Hoogewerf A.J.,
RA   Proudfoot A.E.I., Wells T.N.C.;
RT   "Molecular cloning and functional expression of a novel CC chemokine
RT   receptor cDNA from a human basophilic cell line.";
RL   J. Biol. Chem. 270:19495-19500(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS VAL-130 AND SER-178.
RX   PubMed=11196669; DOI=10.1038/sj.gene.6363638;
RA   Kato H., Tsuchiya N., Izumi S., Miyamasu M., Nakajima T., Kawasaki H.,
RA   Hirai K., Tokunaga K.;
RT   "New variations of human CC-chemokine receptors CCR3 and CCR4.";
RL   Genes Immun. 1:97-104(1999).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Kopatz S.A., Aronstam R.S., Sharma S.V.;
RT   "cDNA clones of human proteins involved in signal transduction
RT   sequenced by the Guthrie cDNA resource center (www.cdna.org).";
RL   Submitted (JUN-2003) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Blood;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   FUNCTION.
RX   PubMed=9169480; DOI=10.1074/jbc.272.23.15036;
RA   Imai T., Baba M., Nishimura M., Kakizaki M., Takagi S., Yoshie O.;
RT   "The T cell-directed CC chemokine TARC is a highly specific biological
RT   ligand for CC chemokine receptor 4.";
RL   J. Biol. Chem. 272:15036-15042(1997).
RN   [6]
RP   FUNCTION.
RX   PubMed=9430724; DOI=10.1074/jbc.273.3.1764;
RA   Imai T., Chantry D., Raport C.J., Wood C.L., Nishimura M., Godiska R.,
RA   Yoshie O., Gray P.W.;
RT   "Macrophage-derived chemokine is a functional ligand for the CC
RT   chemokine receptor 4.";
RL   J. Biol. Chem. 273:1764-1768(1998).
RN   [7]
RP   FUNCTION.
RX   PubMed=10466728; DOI=10.1038/23495;
RA   Campbell J.J., Haraldsen G., Pan J., Rottman J., Qin S., Ponath P.,
RA   Andrew D.P., Warnke R., Ruffing N., Kassam N., Wu L., Butcher E.C.;
RT   "The chemokine receptor CCR4 in vascular recognition by cutaneous but
RT   not intestinal memory T cells.";
RL   Nature 400:776-780(1999).
RN   [8]
RP   FUNCTION, TISSUE SPECIFICITY, AND PHOSPHORYLATION.
RX   PubMed=10754297; DOI=10.4049/jimmunol.164.8.4048;
RA   Inngjerdingen M., Damaj B., Maghazachi A.A.;
RT   "Human NK cells express CC chemokine receptors 4 and 8 and respond to
RT   thymus and activation-regulated chemokine, macrophage-derived
RT   chemokine, and I-309.";
RL   J. Immunol. 164:4048-4054(2000).
RN   [9]
RP   FUNCTION.
RX   PubMed=16137713; DOI=10.1016/j.lfs.2005.05.070;
RA   Wang Y., Zhang Y., Yang X., Han W., Liu Y., Xu Q., Zhao R., Di C.,
RA   Song Q., Ma D.;
RT   "Chemokine-like factor 1 is a functional ligand for CC chemokine
RT   receptor 4 (CCR4).";
RL   Life Sci. 78:614-621(2006).
CC   -!- FUNCTION: High affinity receptor for the C-C type chemokines
CC       CCL17/TARC, CCL22/MDC and CKLF isoform 1/CKLF1. The activity of
CC       this receptor is mediated by G(i) proteins which activate a
CC       phosphatidylinositol-calcium second messenger system. Can function
CC       as a chemoattractant homing receptor on circulating memory
CC       lymphocytes and as a coreceptor for some primary HIV-2 isolates.
CC       In the CNS, could mediate hippocampal-neuron survival.
CC       {ECO:0000269|PubMed:10466728, ECO:0000269|PubMed:10754297,
CC       ECO:0000269|PubMed:16137713, ECO:0000269|PubMed:9169480,
CC       ECO:0000269|PubMed:9430724}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane; Multi-pass membrane protein.
CC   -!- TISSUE SPECIFICITY: Predominantly expressed in the thymus, in
CC       peripheral blood leukocytes, including T-cells, mostly CD4+ cells,
CC       and basophils, and in platelets; at lower levels, in the spleen
CC       and in monocytes. Detected also in macrophages, IL-2-activated
CC       natural killer cells and skin-homing memory T-cells, mostly the
CC       ones expressing the cutaneous lymphocyte antigen (CLA). Expressed
CC       in brain microvascular and coronary artery endothelial cells.
CC       {ECO:0000269|PubMed:10754297}.
CC   -!- PTM: In natural killer cells, CCL22 binding induces
CC       phosphorylation on yet undefined Ser/Thr residues, most probably
CC       by beta-adrenergic receptor kinases 1 and 2.
CC       {ECO:0000269|PubMed:10754297}.
CC   -!- SIMILARITY: Belongs to the G-protein coupled receptor 1 family.
CC       {ECO:0000255|PROSITE-ProRule:PRU00521}.
CC   -!- WEB RESOURCE: Name=Wikipedia; Note=CC chemokine receptors entry;
CC       URL="https://en.wikipedia.org/wiki/CC_chemokine_receptors";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X85740; CAA59743.1; -; mRNA.
DR   EMBL; AB023888; BAA86965.1; -; Genomic_DNA.
DR   EMBL; AB023889; BAA86966.1; -; Genomic_DNA.
DR   EMBL; AB023890; BAA86967.1; -; Genomic_DNA.
DR   EMBL; AB023891; BAA86968.1; -; Genomic_DNA.
DR   EMBL; AB023892; BAA86969.1; -; Genomic_DNA.
DR   EMBL; AY322539; AAP84352.1; -; Genomic_DNA.
DR   EMBL; BC069139; AAH69139.1; -; mRNA.
DR   EMBL; BC071751; AAH71751.1; -; mRNA.
DR   EMBL; BC074935; AAH74935.1; -; mRNA.
DR   CCDS; CCDS2656.1; -.
DR   PIR; A57160; A57160.
DR   RefSeq; NP_005499.1; NM_005508.4.
DR   RefSeq; XP_016861176.1; XM_017005687.1.
DR   UniGene; Hs.184926; -.
DR   ProteinModelPortal; P51679; -.
DR   BioGrid; 107638; 6.
DR   DIP; DIP-5848N; -.
DR   IntAct; P51679; 2.
DR   MINT; P51679; -.
DR   STRING; 9606.ENSP00000332659; -.
DR   BindingDB; P51679; -.
DR   ChEMBL; CHEMBL2414; -.
DR   GuidetoPHARMACOLOGY; 61; -.
DR   iPTMnet; P51679; -.
DR   PhosphoSitePlus; P51679; -.
DR   BioMuta; CCR4; -.
DR   DMDM; 1705894; -.
DR   PaxDb; P51679; -.
DR   PeptideAtlas; P51679; -.
DR   PRIDE; P51679; -.
DR   DNASU; 1233; -.
DR   Ensembl; ENST00000330953; ENSP00000332659; ENSG00000183813.
DR   GeneID; 1233; -.
DR   KEGG; hsa:1233; -.
DR   UCSC; uc003cfg.2; human.
DR   CTD; 1233; -.
DR   DisGeNET; 1233; -.
DR   EuPathDB; HostDB:ENSG00000183813.6; -.
DR   GeneCards; CCR4; -.
DR   HGNC; HGNC:1605; CCR4.
DR   HPA; HPA031613; -.
DR   MIM; 604836; gene.
DR   neXtProt; NX_P51679; -.
DR   OpenTargets; ENSG00000183813; -.
DR   PharmGKB; PA26169; -.
DR   eggNOG; KOG3656; Eukaryota.
DR   eggNOG; ENOG410XRW9; LUCA.
DR   GeneTree; ENSGT00760000118785; -.
DR   HOGENOM; HOG000234122; -.
DR   HOVERGEN; HBG106917; -.
DR   InParanoid; P51679; -.
DR   KO; K04179; -.
DR   OMA; FFIMLMS; -.
DR   OrthoDB; EOG091G0B7A; -.
DR   PhylomeDB; P51679; -.
DR   TreeFam; TF330966; -.
DR   Reactome; R-HSA-380108; Chemokine receptors bind chemokines.
DR   Reactome; R-HSA-418594; G alpha (i) signalling events.
DR   SIGNOR; P51679; -.
DR   GeneWiki; CCR4; -.
DR   GenomeRNAi; 1233; -.
DR   PRO; PR:P51679; -.
DR   Proteomes; UP000005640; Chromosome 3.
DR   Bgee; ENSG00000183813; -.
DR   CleanEx; HS_CCR4; -.
DR   ExpressionAtlas; P51679; baseline and differential.
DR   Genevisible; P51679; HS.
DR   GO; GO:0009897; C:external side of plasma membrane; IEA:Ensembl.
DR   GO; GO:0005887; C:integral component of plasma membrane; TAS:ProtInc.
DR   GO; GO:0043025; C:neuronal cell body; IEA:Ensembl.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0016493; F:C-C chemokine receptor activity; IEA:Ensembl.
DR   GO; GO:0004950; F:chemokine receptor activity; TAS:ProtInc.
DR   GO; GO:0006935; P:chemotaxis; TAS:ProtInc.
DR   GO; GO:0007186; P:G-protein coupled receptor signaling pathway; TAS:Reactome.
DR   GO; GO:0048872; P:homeostasis of number of cells; IEA:Ensembl.
DR   GO; GO:0006955; P:immune response; TAS:ProtInc.
DR   GO; GO:0006954; P:inflammatory response; TAS:ProtInc.
DR   GO; GO:0001764; P:neuron migration; IEA:Ensembl.
DR   GO; GO:0007204; P:positive regulation of cytosolic calcium ion concentration; TAS:ProtInc.
DR   GO; GO:0050927; P:positive regulation of positive chemotaxis; IEA:Ensembl.
DR   GO; GO:0046677; P:response to antibiotic; IEA:Ensembl.
DR   GO; GO:0009617; P:response to bacterium; IEA:Ensembl.
DR   GO; GO:0009314; P:response to radiation; IEA:Ensembl.
DR   GO; GO:0002507; P:tolerance induction; IEA:Ensembl.
DR   InterPro; IPR002239; Chemokine_CCR4.
DR   InterPro; IPR000355; Chemokine_rcpt.
DR   InterPro; IPR000276; GPCR_Rhodpsn.
DR   InterPro; IPR017452; GPCR_Rhodpsn_7TM.
DR   PANTHER; PTHR10489:SF608; PTHR10489:SF608; 1.
DR   Pfam; PF00001; 7tm_1; 1.
DR   PRINTS; PR00657; CCCHEMOKINER.
DR   PRINTS; PR01109; CHEMOKINER4.
DR   PRINTS; PR00237; GPCRRHODOPSN.
DR   SMART; SM01381; 7TM_GPCR_Srsx; 1.
DR   PROSITE; PS00237; G_PROTEIN_RECEP_F1_1; 1.
DR   PROSITE; PS50262; G_PROTEIN_RECEP_F1_2; 1.
PE   1: Evidence at protein level;
KW   Cell membrane; Complete proteome; Disulfide bond;
KW   G-protein coupled receptor; Glycoprotein; Membrane; Phosphoprotein;
KW   Polymorphism; Receptor; Reference proteome; Transducer; Transmembrane;
KW   Transmembrane helix.
FT   CHAIN         1    360       C-C chemokine receptor type 4.
FT                                /FTId=PRO_0000069245.
FT   TOPO_DOM      1     39       Extracellular. {ECO:0000255}.
FT   TRANSMEM     40     67       Helical; Name=1. {ECO:0000255}.
FT   TOPO_DOM     68     77       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     78     98       Helical; Name=2. {ECO:0000255}.
FT   TOPO_DOM     99    111       Extracellular. {ECO:0000255}.
FT   TRANSMEM    112    133       Helical; Name=3. {ECO:0000255}.
FT   TOPO_DOM    134    150       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    151    175       Helical; Name=4. {ECO:0000255}.
FT   TOPO_DOM    176    206       Extracellular. {ECO:0000255}.
FT   TRANSMEM    207    226       Helical; Name=5. {ECO:0000255}.
FT   TOPO_DOM    227    242       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    243    267       Helical; Name=6. {ECO:0000255}.
FT   TOPO_DOM    268    284       Extracellular. {ECO:0000255}.
FT   TRANSMEM    285    308       Helical; Name=7. {ECO:0000255}.
FT   TOPO_DOM    309    360       Cytoplasmic. {ECO:0000255}.
FT   CARBOHYD    183    183       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    194    194       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID    110    187       {ECO:0000255|PROSITE-ProRule:PRU00521}.
FT   VARIANT     130    130       L -> V. {ECO:0000269|PubMed:11196669}.
FT                                /FTId=VAR_010669.
FT   VARIANT     178    178       C -> S (in dbSNP:rs753825374).
FT                                {ECO:0000269|PubMed:11196669}.
FT                                /FTId=VAR_010670.
SQ   SEQUENCE   360 AA;  41403 MW;  51EBE12AD1FAFABF CRC64;
     MNPTDIADTT LDESIYSNYY LYESIPKPCT KEGIKAFGEL FLPPLYSLVF VFGLLGNSVV
     VLVLFKYKRL RSMTDVYLLN LAISDLLFVF SLPFWGYYAA DQWVFGLGLC KMISWMYLVG
     FYSGIFFVML MSIDRYLAIV HAVFSLRART LTYGVITSLA TWSVAVFASL PGFLFSTCYT
     ERNHTYCKTK YSLNSTTWKV LSSLEINILG LVIPLGIMLF CYSMIIRTLQ HCKNEKKNKA
     VKMIFAVVVL FLGFWTPYNI VLFLETLVEL EVLQDCTFER YLDYAIQATE TLAFVHCCLN
     PIIYFFLGEK FRKYILQLFK TCRGLFVLCQ YCGLLQIYSA DTPSSSYTQS TMDHDLHDAL
//
ID   A0N0Q0_HUMAN            Unreviewed;       378 AA.
AC   A0N0Q0;
DT   12-DEC-2006, integrated into UniProtKB/TrEMBL.
DT   12-DEC-2006, sequence version 1.
DT   25-APR-2018, entry version 106.
DE   SubName: Full=Chemokine (C-C motif) receptor 7 {ECO:0000313|EMBL:ABK41941.1};
DE   SubName: Full=cDNA FLJ45911 fis, clone PEBLM2005615, highly similar to C-C chemokine receptor type 7 {ECO:0000313|EMBL:BAG54575.1};
GN   Name=CCR7 {ECO:0000313|EMBL:ABK41941.1};
GN   ORFNames=hCG_1643840 {ECO:0000313|EMBL:EAW60669.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:ABK41941.1};
RN   [1] {ECO:0000313|EMBL:EAW60669.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D.,
RA   Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q.,
RA   Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G.,
RA   Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S.,
RA   Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J.,
RA   Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R.,
RA   Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A.,
RA   Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K.,
RA   Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V.,
RA   Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z.,
RA   Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A.,
RA   Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V.,
RA   Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B.,
RA   Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J.,
RA   Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C.,
RA   Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L.,
RA   Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S.,
RA   Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A.,
RA   Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D.,
RA   Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L.,
RA   Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N.,
RA   Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S.,
RA   Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F.,
RA   Kline L., Koduru S., Love A., Mann F., May D., McCawley S.,
RA   McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K.,
RA   Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N.,
RA   Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M.,
RA   Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F.,
RA   Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A.,
RA   Mi H., Lazareva B., Hatton T., Narechania A., Diemer K.,
RA   Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R.,
RA   Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J.,
RA   Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H.,
RA   Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D.,
RA   Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A.,
RA   Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S.,
RA   Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L.,
RA   Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W.,
RA   McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M.,
RA   Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:BAG54575.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Oshima A., Takahashi-Fujii A., Tanase T., Imose N., Takeuchi K.,
RA   Arita M., Musashino K., Yuuki H., Hara H., Sugiyama T., Irie R.,
RA   Otsuki T., Sato H., Wakamatsu A., Ishii S., Yamamoto J., Isono Y.,
RA   Kawai-Hio Y., Saito K., Nishikawa T., Kimura K., Yamashita H.,
RA   Matsuo K., Nakamura Y., Sekine M., Kikuchi H., Kanda K., Wagatsuma M.,
RA   Murakawa K., Kanehori K., Sugiyama A., Kawakami B., Suzuki Y.,
RA   Sugano S., Nagahari K., Masuho Y., Nagai K., Isogai T.;
RT   "NEDO human cDNA sequencing project.";
RL   Submitted (JUL-2003) to the EMBL/GenBank/DDBJ databases.
RN   [3] {ECO:0000313|EMBL:EAW60669.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4] {ECO:0000313|EMBL:ABK41941.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Livingston R.J., Shaffer T., McFarland I., Nguyen C.P., Stanaway I.B.,
RA   Rajkumar N., Johnson E.J., da Ponte S.H., Willa H., Ahearn M.O.,
RA   Bertucci C., Acklestad J., Carroll A., Swanson J., Gildersleeve H.I.,
RA   Nickerson D.A.;
RL   Submitted (OCT-2006) to the EMBL/GenBank/DDBJ databases.
CC   -!- SIMILARITY: Belongs to the G-protein coupled receptor 1 family.
CC       {ECO:0000256|RuleBase:RU000688, ECO:0000256|SAAS:SAAS00594957}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; EF064758; ABK41941.1; -; Genomic_DNA.
DR   EMBL; AK127810; BAG54575.1; -; mRNA.
DR   EMBL; CH471152; EAW60669.1; -; Genomic_DNA.
DR   RefSeq; NP_001829.1; NM_001838.3.
DR   UniGene; Hs.370036; -.
DR   DNASU; 1236; -.
DR   GeneID; 1236; -.
DR   KEGG; hsa:1236; -.
DR   CTD; 1236; -.
DR   EuPathDB; HostDB:ENSG00000126353.3; -.
DR   PharmGKB; PA26172; -.
DR   eggNOG; ENOG410IMBE; Eukaryota.
DR   eggNOG; ENOG4110ZGY; LUCA.
DR   HOVERGEN; HBG106917; -.
DR   KO; K04182; -.
DR   OMA; RCCLNPF; -.
DR   OrthoDB; EOG091G0BDV; -.
DR   GenomeRNAi; 1236; -.
DR   Bgee; ENSG00000126353; -.
DR   GO; GO:0009897; C:external side of plasma membrane; IEA:Ensembl.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005739; C:mitochondrion; IDA:HPA.
DR   GO; GO:0016493; F:C-C chemokine receptor activity; IEA:Ensembl.
DR   GO; GO:0006935; P:chemotaxis; IEA:Ensembl.
DR   GO; GO:0048872; P:homeostasis of number of cells; IEA:Ensembl.
DR   GO; GO:0006955; P:immune response; IEA:Ensembl.
DR   GO; GO:0006954; P:inflammatory response; IEA:InterPro.
DR   GO; GO:0072610; P:interleukin-12 secretion; IEA:Ensembl.
DR   GO; GO:0097029; P:mature conventional dendritic cell differentiation; IEA:Ensembl.
DR   GO; GO:0045060; P:negative thymic T cell selection; IEA:Ensembl.
DR   GO; GO:0002606; P:positive regulation of dendritic cell antigen processing and presentation; IEA:Ensembl.
DR   GO; GO:2000510; P:positive regulation of dendritic cell chemotaxis; IEA:Ensembl.
DR   GO; GO:2000526; P:positive regulation of glycoprotein biosynthetic process involved in immunological synapse formation; IEA:Ensembl.
DR   GO; GO:0002922; P:positive regulation of humoral immune response; IEA:Ensembl.
DR   GO; GO:0002885; P:positive regulation of hypersensitivity; IEA:Ensembl.
DR   GO; GO:2000522; P:positive regulation of immunological synapse formation; IEA:Ensembl.
DR   GO; GO:0032735; P:positive regulation of interleukin-12 production; IEA:Ensembl.
DR   GO; GO:0090023; P:positive regulation of neutrophil chemotaxis; IEA:Ensembl.
DR   GO; GO:2000525; P:positive regulation of T cell costimulation; IEA:Ensembl.
DR   GO; GO:0050862; P:positive regulation of T cell receptor signaling pathway; IEA:Ensembl.
DR   GO; GO:0032649; P:regulation of interferon-gamma production; IEA:Ensembl.
DR   GO; GO:0050706; P:regulation of interleukin-1 beta secretion; IEA:Ensembl.
DR   GO; GO:0032496; P:response to lipopolysaccharide; IEA:Ensembl.
DR   InterPro; IPR001718; Chemokine_CCR7.
DR   InterPro; IPR000355; Chemokine_rcpt.
DR   InterPro; IPR000276; GPCR_Rhodpsn.
DR   InterPro; IPR017452; GPCR_Rhodpsn_7TM.
DR   Pfam; PF00001; 7tm_1; 1.
DR   PRINTS; PR00657; CCCHEMOKINER.
DR   PRINTS; PR00641; CHEMOKINER7.
DR   PRINTS; PR00237; GPCRRHODOPSN.
DR   PROSITE; PS00237; G_PROTEIN_RECEP_F1_1; 1.
DR   PROSITE; PS50262; G_PROTEIN_RECEP_F1_2; 1.
PE   2: Evidence at transcript level;
KW   G-protein coupled receptor {ECO:0000256|RuleBase:RU000688,
KW   ECO:0000256|SAAS:SAAS00522141};
KW   Membrane {ECO:0000256|SAAS:SAAS00522140, ECO:0000256|SAM:Phobius};
KW   Receptor {ECO:0000256|RuleBase:RU000688,
KW   ECO:0000256|SAAS:SAAS00522141}; Signal {ECO:0000256|SAM:SignalP};
KW   Transducer {ECO:0000256|RuleBase:RU000688,
KW   ECO:0000256|SAAS:SAAS00522141};
KW   Transmembrane {ECO:0000256|SAAS:SAAS00522140,
KW   ECO:0000256|SAM:Phobius};
KW   Transmembrane helix {ECO:0000256|SAAS:SAAS00522140,
KW   ECO:0000256|SAM:Phobius}.
FT   SIGNAL        1     24       {ECO:0000256|SAM:SignalP}.
FT   CHAIN        25    378       {ECO:0000256|SAM:SignalP}.
FT                                /FTId=PRO_5014296520.
FT   TRANSMEM     59     84       Helical. {ECO:0000256|SAM:Phobius}.
FT   TRANSMEM     96    116       Helical. {ECO:0000256|SAM:Phobius}.
FT   TRANSMEM    122    150       Helical. {ECO:0000256|SAM:Phobius}.
FT   TRANSMEM    171    191       Helical. {ECO:0000256|SAM:Phobius}.
FT   TRANSMEM    225    249       Helical. {ECO:0000256|SAM:Phobius}.
FT   TRANSMEM    261    279       Helical. {ECO:0000256|SAM:Phobius}.
FT   TRANSMEM    310    329       Helical. {ECO:0000256|SAM:Phobius}.
FT   DOMAIN       75    326       G_PROTEIN_RECEP_F1_2.
FT                                {ECO:0000259|PROSITE:PS50262}.
SQ   SEQUENCE   378 AA;  42874 MW;  D4CB4213841A1BD4 CRC64;
     MDLGKPMKSV LVVALLVIFQ VCLCQDEVTD DYIGDNTTVD YTLFESLCSK KDVRNFKAWF
     LPIMYSIICF VGLLGNGLVV LTYIYFKRLK TMTDTYLLNL AVADILFLLT LPFWAYSAAK
     SWVFGVHFCK LIFAIYKMSF FSGMLLLLCI SIDRYVAIVQ AVSAHRHRAR VLLISKLSCV
     GIWILATVLS IPELLYSDLQ RSSSEQAMRC SLITEHVEAF ITIQVAQMVI GFLVPLLAMS
     FCYLVIIRTL LQARNFERNK AIKVIIAVVV VFIVFQLPYN GVVLAQTVAN FNITSSTCEL
     SKQLNIAYDV TYSLACVRCC VNPFLYAFIG VKFRNDLFKL FKDLGCLSQE QLRQWSSCRH
     IRRSSMSVEA ETTTTFSP
//
ID   J3KSS9_HUMAN            Unreviewed;       372 AA.
AC   J3KSS9;
DT   03-OCT-2012, integrated into UniProtKB/TrEMBL.
DT   03-OCT-2012, sequence version 1.
DT   28-MAR-2018, entry version 45.
DE   SubName: Full=C-C chemokine receptor type 7 {ECO:0000313|Ensembl:ENSP00000462631};
GN   Name=CCR7 {ECO:0000313|Ensembl:ENSP00000462631};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000462631, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Ensembl:ENSP00000462631, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16625196; DOI=10.1038/nature04689;
RA   Zody M.C., Garber M., Adams D.J., Sharpe T., Harrow J., Lupski J.R.,
RA   Nicholson C., Searle S.M., Wilming L., Young S.K., Abouelleil A.,
RA   Allen N.R., Bi W., Bloom T., Borowsky M.L., Bugalter B.E., Butler J.,
RA   Chang J.L., Chen C.K., Cook A., Corum B., Cuomo C.A., de Jong P.J.,
RA   DeCaprio D., Dewar K., FitzGerald M., Gilbert J., Gibson R.,
RA   Gnerre S., Goldstein S., Grafham D.V., Grocock R., Hafez N.,
RA   Hagopian D.S., Hart E., Norman C.H., Humphray S., Jaffe D.B.,
RA   Jones M., Kamal M., Khodiyar V.K., LaButti K., Laird G., Lehoczky J.,
RA   Liu X., Lokyitsang T., Loveland J., Lui A., Macdonald P., Major J.E.,
RA   Matthews L., Mauceli E., McCarroll S.A., Mihalev A.H., Mudge J.,
RA   Nguyen C., Nicol R., O'Leary S.B., Osoegawa K., Schwartz D.C.,
RA   Shaw-Smith C., Stankiewicz P., Steward C., Swarbreck D.,
RA   Venkataraman V., Whittaker C.A., Yang X., Zimmer A.R., Bradley A.,
RA   Hubbard T., Birren B.W., Rogers J., Lander E.S., Nusbaum C.;
RT   "DNA sequence of human chromosome 17 and analysis of rearrangement in
RT   the human lineage.";
RL   Nature 440:1045-1049(2006).
RN   [2] {ECO:0000313|Ensembl:ENSP00000462631}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (AUG-2012) to UniProtKB.
CC   -!- SIMILARITY: Belongs to the G-protein coupled receptor 1 family.
CC       {ECO:0000256|RuleBase:RU000688, ECO:0000256|SAAS:SAAS00594957}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AC004585; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   RefSeq; NP_001288645.1; NM_001301716.1.
DR   RefSeq; NP_001288646.1; NM_001301717.1.
DR   RefSeq; NP_001288647.1; NM_001301718.1.
DR   UniGene; Hs.370036; -.
DR   ProteinModelPortal; J3KSS9; -.
DR   Ensembl; ENST00000579344; ENSP00000462631; ENSG00000126353.
DR   GeneID; 1236; -.
DR   UCSC; uc060eyz.1; human.
DR   CTD; 1236; -.
DR   EuPathDB; HostDB:ENSG00000126353.3; -.
DR   HGNC; HGNC:1608; CCR7.
DR   OpenTargets; ENSG00000126353; -.
DR   eggNOG; ENOG410IMBE; Eukaryota.
DR   eggNOG; ENOG4110ZGY; LUCA.
DR   GeneTree; ENSGT00760000118785; -.
DR   GenomeRNAi; 1236; -.
DR   Proteomes; UP000005640; Chromosome 17.
DR   Bgee; ENSG00000126353; -.
DR   ExpressionAtlas; J3KSS9; baseline and differential.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005739; C:mitochondrion; IDA:HPA.
DR   GO; GO:0016493; F:C-C chemokine receptor activity; IEA:InterPro.
DR   GO; GO:0006935; P:chemotaxis; IEA:InterPro.
DR   GO; GO:0006955; P:immune response; IEA:InterPro.
DR   GO; GO:0006954; P:inflammatory response; IEA:InterPro.
DR   InterPro; IPR001718; Chemokine_CCR7.
DR   InterPro; IPR000355; Chemokine_rcpt.
DR   InterPro; IPR000276; GPCR_Rhodpsn.
DR   InterPro; IPR017452; GPCR_Rhodpsn_7TM.
DR   Pfam; PF00001; 7tm_1; 1.
DR   PRINTS; PR00657; CCCHEMOKINER.
DR   PRINTS; PR00641; CHEMOKINER7.
DR   PRINTS; PR00237; GPCRRHODOPSN.
DR   PROSITE; PS00237; G_PROTEIN_RECEP_F1_1; 1.
DR   PROSITE; PS50262; G_PROTEIN_RECEP_F1_2; 1.
PE   1: Evidence at protein level;
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   G-protein coupled receptor {ECO:0000256|RuleBase:RU000688,
KW   ECO:0000256|SAAS:SAAS00522141};
KW   Membrane {ECO:0000256|SAAS:SAAS00522140, ECO:0000256|SAM:Phobius};
KW   Proteomics identification {ECO:0000213|MaxQB:J3KSS9,
KW   ECO:0000213|PeptideAtlas:J3KSS9};
KW   Receptor {ECO:0000256|RuleBase:RU000688,
KW   ECO:0000256|SAAS:SAAS00522141};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640};
KW   Signal {ECO:0000256|SAM:SignalP};
KW   Transducer {ECO:0000256|RuleBase:RU000688,
KW   ECO:0000256|SAAS:SAAS00522141};
KW   Transmembrane {ECO:0000256|SAAS:SAAS00522140,
KW   ECO:0000256|SAM:Phobius};
KW   Transmembrane helix {ECO:0000256|SAAS:SAAS00522140,
KW   ECO:0000256|SAM:Phobius}.
FT   SIGNAL        1     18       {ECO:0000256|SAM:SignalP}.
FT   CHAIN        19    372       {ECO:0000256|SAM:SignalP}.
FT                                /FTId=PRO_5003772096.
FT   TRANSMEM     53     78       Helical. {ECO:0000256|SAM:Phobius}.
FT   TRANSMEM     90    110       Helical. {ECO:0000256|SAM:Phobius}.
FT   TRANSMEM    116    144       Helical. {ECO:0000256|SAM:Phobius}.
FT   TRANSMEM    165    185       Helical. {ECO:0000256|SAM:Phobius}.
FT   TRANSMEM    219    243       Helical. {ECO:0000256|SAM:Phobius}.
FT   TRANSMEM    255    273       Helical. {ECO:0000256|SAM:Phobius}.
FT   TRANSMEM    304    323       Helical. {ECO:0000256|SAM:Phobius}.
FT   DOMAIN       69    320       G_PROTEIN_RECEP_F1_2.
FT                                {ECO:0000259|PROSITE:PS50262}.
SQ   SEQUENCE   372 AA;  42232 MW;  6BAC116ADF458B5B CRC64;
     MKSVLVVALL VIFQVCLCQD EVTDDYIGDN TTVDYTLFES LCSKKDVRNF KAWFLPIMYS
     IICFVGLLGN GLVVLTYIYF KRLKTMTDTY LLNLAVADIL FLLTLPFWAY SAAKSWVFGV
     HFCKLIFAIY KMSFFSGMLL LLCISIDRYV AIVQAVSAHR HRARVLLISK LSCVGIWILA
     TVLSIPELLY SDLQRSSSEQ AMRCSLITEH VEAFITIQVA QMVIGFLVPL LAMSFCYLVI
     IRTLLQARNF ERNKAIKVII AVVVVFIVFQ LPYNGVVLAQ TVANFNITSS TCELSKQLNI
     AYDVTYSLAC VRCCVNPFLY AFIGVKFRND LFKLFKDLGC LSQEQLRQWS SCRHIRRSSM
     SVEAETTTTF SP
//
ID   CCR7_HUMAN              Reviewed;         378 AA.
AC   P32248;
DT   01-OCT-1993, integrated into UniProtKB/Swiss-Prot.
DT   01-FEB-1996, sequence version 2.
DT   28-FEB-2018, entry version 171.
DE   RecName: Full=C-C chemokine receptor type 7;
DE            Short=C-C CKR-7;
DE            Short=CC-CKR-7;
DE            Short=CCR-7;
DE   AltName: Full=BLR2;
DE   AltName: Full=CDw197;
DE   AltName: Full=Epstein-Barr virus-induced G-protein coupled receptor 1;
DE            Short=EBI1;
DE            Short=EBV-induced G-protein coupled receptor 1;
DE   AltName: Full=MIP-3 beta receptor;
DE   AltName: CD_antigen=CD197;
DE   Flags: Precursor;
GN   Name=CCR7; Synonyms=CMKBR7, EBI1, EVI1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=8383238;
RA   Birkenbach M.P., Josefsen K., Yalamanchili R.R., Lenoir G.M.,
RA   Kieff E.;
RT   "Epstein-Barr virus-induced genes: first lymphocyte-specific G
RT   protein-coupled peptide receptors.";
RL   J. Virol. 67:2209-2220(1993).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA].
RC   TISSUE=Placenta;
RX   PubMed=7851893; DOI=10.1006/geno.1994.1553;
RA   Schweickart V.L., Raport C.J., Godiska R., Byers M.G., Eddy R.L. Jr.,
RA   Shows T.B., Gray P.W.;
RT   "Cloning of human and mouse EBI1, a lymphoid-specific G-protein-
RT   coupled receptor encoded on human chromosome 17q12-q21.2.";
RL   Genomics 23:643-650(1994).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Kopatz S.A., Aronstam R.S., Sharma S.V.;
RT   "cDNA clones of human proteins involved in signal transduction
RT   sequenced by the Guthrie cDNA resource center (www.cdna.org).";
RL   Submitted (APR-2004) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -!- FUNCTION: Receptor for the MIP-3-beta chemokine. Probable mediator
CC       of EBV effects on B-lymphocytes or of normal lymphocyte functions.
CC   -!- SUBCELLULAR LOCATION: Cell membrane; Multi-pass membrane protein.
CC   -!- TISSUE SPECIFICITY: Expressed in various lymphoid tissues and
CC       activated B- and T-lymphocytes, strongly up-regulated in B-cells
CC       infected with Epstein-Barr virus and T-cells infected with
CC       herpesvirus 6 or 7.
CC   -!- INDUCTION: By Epstein-Barr virus (EBV).
CC   -!- SIMILARITY: Belongs to the G-protein coupled receptor 1 family.
CC       {ECO:0000255|PROSITE-ProRule:PRU00521}.
CC   -!- WEB RESOURCE: Name=Wikipedia; Note=CC chemokine receptors entry;
CC       URL="https://en.wikipedia.org/wiki/CC_chemokine_receptors";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; L08176; AAA58615.1; -; mRNA.
DR   EMBL; L31584; AAA74230.1; -; Genomic_DNA.
DR   EMBL; L31582; AAA74230.1; JOINED; Genomic_DNA.
DR   EMBL; L31583; AAA74230.1; JOINED; Genomic_DNA.
DR   EMBL; L31581; AAA74231.1; -; mRNA.
DR   EMBL; AY587876; AAT52232.1; -; mRNA.
DR   EMBL; BC035343; AAH35343.1; -; mRNA.
DR   CCDS; CCDS11369.1; -.
DR   PIR; A45680; A45680.
DR   PIR; B55735; B55735.
DR   RefSeq; NP_001288643.1; NM_001301714.1.
DR   RefSeq; NP_001288645.1; NM_001301716.1.
DR   RefSeq; NP_001288646.1; NM_001301717.1.
DR   RefSeq; NP_001288647.1; NM_001301718.1.
DR   RefSeq; NP_001829.1; NM_001838.3.
DR   UniGene; Hs.370036; -.
DR   ProteinModelPortal; P32248; -.
DR   BioGrid; 107641; 2.
DR   DIP; DIP-5855N; -.
DR   IntAct; P32248; 4.
DR   MINT; P32248; -.
DR   STRING; 9606.ENSP00000246657; -.
DR   BindingDB; P32248; -.
DR   ChEMBL; CHEMBL4594; -.
DR   GuidetoPHARMACOLOGY; 64; -.
DR   iPTMnet; P32248; -.
DR   PhosphoSitePlus; P32248; -.
DR   BioMuta; CCR7; -.
DR   DMDM; 1352335; -.
DR   MaxQB; P32248; -.
DR   PaxDb; P32248; -.
DR   PeptideAtlas; P32248; -.
DR   PRIDE; P32248; -.
DR   DNASU; 1236; -.
DR   Ensembl; ENST00000246657; ENSP00000246657; ENSG00000126353.
DR   GeneID; 1236; -.
DR   KEGG; hsa:1236; -.
DR   UCSC; uc002huw.4; human.
DR   CTD; 1236; -.
DR   DisGeNET; 1236; -.
DR   EuPathDB; HostDB:ENSG00000126353.3; -.
DR   GeneCards; CCR7; -.
DR   HGNC; HGNC:1608; CCR7.
DR   HPA; CAB003796; -.
DR   HPA; HPA031383; -.
DR   HPA; HPA074467; -.
DR   MIM; 600242; gene.
DR   neXtProt; NX_P32248; -.
DR   OpenTargets; ENSG00000126353; -.
DR   PharmGKB; PA26172; -.
DR   eggNOG; ENOG410IMBE; Eukaryota.
DR   eggNOG; ENOG4110ZGY; LUCA.
DR   GeneTree; ENSGT00760000118785; -.
DR   HOGENOM; HOG000234122; -.
DR   HOVERGEN; HBG106917; -.
DR   InParanoid; P32248; -.
DR   KO; K04182; -.
DR   OMA; RCCLNPF; -.
DR   OrthoDB; EOG091G0BDV; -.
DR   PhylomeDB; P32248; -.
DR   TreeFam; TF330966; -.
DR   Reactome; R-HSA-380108; Chemokine receptors bind chemokines.
DR   Reactome; R-HSA-418594; G alpha (i) signalling events.
DR   SIGNOR; P32248; -.
DR   GeneWiki; C-C_chemokine_receptor_type_7; -.
DR   GenomeRNAi; 1236; -.
DR   PRO; PR:P32248; -.
DR   Proteomes; UP000005640; Chromosome 17.
DR   Bgee; ENSG00000126353; -.
DR   CleanEx; HS_CCR7; -.
DR   CleanEx; HS_EVI1; -.
DR   ExpressionAtlas; P32248; baseline and differential.
DR   Genevisible; P32248; HS.
DR   GO; GO:0009986; C:cell surface; IDA:UniProtKB.
DR   GO; GO:0009897; C:external side of plasma membrane; IEA:Ensembl.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005622; C:intracellular; IDA:BHF-UCL.
DR   GO; GO:0005739; C:mitochondrion; IDA:HPA.
DR   GO; GO:0005886; C:plasma membrane; IDA:BHF-UCL.
DR   GO; GO:0016493; F:C-C chemokine receptor activity; ISS:BHF-UCL.
DR   GO; GO:0038117; F:C-C motif chemokine 19 receptor activity; IDA:UniProtKB.
DR   GO; GO:0038121; F:C-C motif chemokine 21 receptor activity; IDA:UniProtKB.
DR   GO; GO:0035757; F:chemokine (C-C motif) ligand 19 binding; IPI:BHF-UCL.
DR   GO; GO:0035758; F:chemokine (C-C motif) ligand 21 binding; IPI:BHF-UCL.
DR   GO; GO:0004930; F:G-protein coupled receptor activity; TAS:BHF-UCL.
DR   GO; GO:0090630; P:activation of GTPase activity; IC:BHF-UCL.
DR   GO; GO:0071345; P:cellular response to cytokine stimulus; IDA:BHF-UCL.
DR   GO; GO:0002407; P:dendritic cell chemotaxis; IC:BHF-UCL.
DR   GO; GO:0001768; P:establishment of T cell polarity; IC:BHF-UCL.
DR   GO; GO:0007186; P:G-protein coupled receptor signaling pathway; TAS:BHF-UCL.
DR   GO; GO:0048872; P:homeostasis of number of cells; IEA:Ensembl.
DR   GO; GO:0006955; P:immune response; IEA:Ensembl.
DR   GO; GO:0006954; P:inflammatory response; NAS:BHF-UCL.
DR   GO; GO:0072610; P:interleukin-12 secretion; ISS:BHF-UCL.
DR   GO; GO:0097022; P:lymphocyte migration into lymph node; TAS:BHF-UCL.
DR   GO; GO:0097029; P:mature conventional dendritic cell differentiation; ISS:BHF-UCL.
DR   GO; GO:0002408; P:myeloid dendritic cell chemotaxis; IDA:BHF-UCL.
DR   GO; GO:2000669; P:negative regulation of dendritic cell apoptotic process; IC:BHF-UCL.
DR   GO; GO:0045060; P:negative thymic T cell selection; IEA:Ensembl.
DR   GO; GO:0030838; P:positive regulation of actin filament polymerization; IC:BHF-UCL.
DR   GO; GO:0045785; P:positive regulation of cell adhesion; IC:BHF-UCL.
DR   GO; GO:2000147; P:positive regulation of cell motility; IC:BHF-UCL.
DR   GO; GO:0001954; P:positive regulation of cell-matrix adhesion; IC:BHF-UCL.
DR   GO; GO:0007204; P:positive regulation of cytosolic calcium ion concentration; TAS:ProtInc.
DR   GO; GO:0002606; P:positive regulation of dendritic cell antigen processing and presentation; ISS:BHF-UCL.
DR   GO; GO:2000510; P:positive regulation of dendritic cell chemotaxis; ISS:BHF-UCL.
DR   GO; GO:0070374; P:positive regulation of ERK1 and ERK2 cascade; IC:BHF-UCL.
DR   GO; GO:0051491; P:positive regulation of filopodium assembly; IC:BHF-UCL.
DR   GO; GO:2000526; P:positive regulation of glycoprotein biosynthetic process involved in immunological synapse formation; ISS:BHF-UCL.
DR   GO; GO:0002922; P:positive regulation of humoral immune response; ISS:BHF-UCL.
DR   GO; GO:0002885; P:positive regulation of hypersensitivity; ISS:BHF-UCL.
DR   GO; GO:0043123; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; IC:BHF-UCL.
DR   GO; GO:2000522; P:positive regulation of immunological synapse formation; ISS:BHF-UCL.
DR   GO; GO:0032735; P:positive regulation of interleukin-12 production; ISS:BHF-UCL.
DR   GO; GO:0046330; P:positive regulation of JNK cascade; IC:BHF-UCL.
DR   GO; GO:0090023; P:positive regulation of neutrophil chemotaxis; IDA:BHF-UCL.
DR   GO; GO:0043552; P:positive regulation of phosphatidylinositol 3-kinase activity; IC:BHF-UCL.
DR   GO; GO:0045860; P:positive regulation of protein kinase activity; IC:BHF-UCL.
DR   GO; GO:0051897; P:positive regulation of protein kinase B signaling; IC:BHF-UCL.
DR   GO; GO:0031274; P:positive regulation of pseudopodium assembly; IC:BHF-UCL.
DR   GO; GO:2000525; P:positive regulation of T cell costimulation; ISS:BHF-UCL.
DR   GO; GO:0050862; P:positive regulation of T cell receptor signaling pathway; IEA:Ensembl.
DR   GO; GO:2000547; P:regulation of dendritic cell dendrite assembly; ISS:BHF-UCL.
DR   GO; GO:0032649; P:regulation of interferon-gamma production; ISS:BHF-UCL.
DR   GO; GO:0050706; P:regulation of interleukin-1 beta secretion; ISS:BHF-UCL.
DR   GO; GO:0051209; P:release of sequestered calcium ion into cytosol; IC:BHF-UCL.
DR   GO; GO:0032496; P:response to lipopolysaccharide; IEA:Ensembl.
DR   GO; GO:0071731; P:response to nitric oxide; IC:BHF-UCL.
DR   GO; GO:0034695; P:response to prostaglandin E; IC:BHF-UCL.
DR   GO; GO:0031529; P:ruffle organization; IC:BHF-UCL.
DR   InterPro; IPR001718; Chemokine_CCR7.
DR   InterPro; IPR000355; Chemokine_rcpt.
DR   InterPro; IPR000276; GPCR_Rhodpsn.
DR   InterPro; IPR017452; GPCR_Rhodpsn_7TM.
DR   Pfam; PF00001; 7tm_1; 1.
DR   PRINTS; PR00657; CCCHEMOKINER.
DR   PRINTS; PR00641; CHEMOKINER7.
DR   PRINTS; PR00237; GPCRRHODOPSN.
DR   PROSITE; PS00237; G_PROTEIN_RECEP_F1_1; 1.
DR   PROSITE; PS50262; G_PROTEIN_RECEP_F1_2; 1.
PE   2: Evidence at transcript level;
KW   Cell membrane; Complete proteome; Disulfide bond;
KW   G-protein coupled receptor; Glycoprotein; Membrane; Polymorphism;
KW   Receptor; Reference proteome; Signal; Transducer; Transmembrane;
KW   Transmembrane helix.
FT   SIGNAL        1     24       {ECO:0000255}.
FT   CHAIN        25    378       C-C chemokine receptor type 7.
FT                                /FTId=PRO_0000012735.
FT   TOPO_DOM     25     59       Extracellular. {ECO:0000255}.
FT   TRANSMEM     60     86       Helical; Name=1. {ECO:0000255}.
FT   TOPO_DOM     87     95       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     96    116       Helical; Name=2. {ECO:0000255}.
FT   TOPO_DOM    117    130       Extracellular. {ECO:0000255}.
FT   TRANSMEM    131    152       Helical; Name=3. {ECO:0000255}.
FT   TOPO_DOM    153    170       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    171    191       Helical; Name=4. {ECO:0000255}.
FT   TOPO_DOM    192    219       Extracellular. {ECO:0000255}.
FT   TRANSMEM    220    247       Helical; Name=5. {ECO:0000255}.
FT   TOPO_DOM    248    263       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    264    289       Helical; Name=6. {ECO:0000255}.
FT   TOPO_DOM    290    313       Extracellular. {ECO:0000255}.
FT   TRANSMEM    314    331       Helical; Name=7. {ECO:0000255}.
FT   TOPO_DOM    332    378       Cytoplasmic. {ECO:0000255}.
FT   CARBOHYD     36     36       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID    129    210       {ECO:0000255|PROSITE-ProRule:PRU00521}.
FT   VARIANT       7      7       M -> V (in dbSNP:rs2228015).
FT                                /FTId=VAR_049383.
FT   CONFLICT    182    183       IW -> SA (in Ref. 1; AAA58615).
FT                                {ECO:0000305}.
FT   CONFLICT    337    337       L -> I (in Ref. 1; AAA58615).
FT                                {ECO:0000305}.
SQ   SEQUENCE   378 AA;  42874 MW;  D4CB4213841A1BD4 CRC64;
     MDLGKPMKSV LVVALLVIFQ VCLCQDEVTD DYIGDNTTVD YTLFESLCSK KDVRNFKAWF
     LPIMYSIICF VGLLGNGLVV LTYIYFKRLK TMTDTYLLNL AVADILFLLT LPFWAYSAAK
     SWVFGVHFCK LIFAIYKMSF FSGMLLLLCI SIDRYVAIVQ AVSAHRHRAR VLLISKLSCV
     GIWILATVLS IPELLYSDLQ RSSSEQAMRC SLITEHVEAF ITIQVAQMVI GFLVPLLAMS
     FCYLVIIRTL LQARNFERNK AIKVIIAVVV VFIVFQLPYN GVVLAQTVAN FNITSSTCEL
     SKQLNIAYDV TYSLACVRCC VNPFLYAFIG VKFRNDLFKL FKDLGCLSQE QLRQWSSCRH
     IRRSSMSVEA ETTTTFSP
//
ID   B4E0L1_HUMAN            Unreviewed;       124 AA.
AC   B4E0L1;
DT   23-SEP-2008, integrated into UniProtKB/TrEMBL.
DT   23-SEP-2008, sequence version 1.
DT   31-JAN-2018, entry version 30.
DE   SubName: Full=cDNA FLJ52125, highly similar to T-cell-specific surface glycoprotein CD28 {ECO:0000313|EMBL:BAG64473.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAG64473.1};
RN   [1] {ECO:0000313|EMBL:BAG64473.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Thymus {ECO:0000313|EMBL:BAG64473.1};
RA   Wakamatsu A., Yamamoto J., Kimura K., Ishii S., Watanabe K.,
RA   Sugiyama A., Murakawa K., Kaida T., Tsuchiya K., Fukuzumi Y.,
RA   Kumagai A., Oishi Y., Yamamoto S., Ono Y., Komori Y., Yamazaki M.,
RA   Kisu Y., Nishikawa T., Sugano S., Nomura N., Isogai T.;
RT   "NEDO human cDNA sequencing project focused on splicing variants.";
RL   Submitted (OCT-2007) to the EMBL/GenBank/DDBJ databases.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK303421; BAG64473.1; -; mRNA.
DR   RefSeq; NP_001230006.1; NM_001243077.1.
DR   RefSeq; NP_001230007.1; NM_001243078.1.
DR   UniGene; Hs.443123; -.
DR   ProteinModelPortal; B4E0L1; -.
DR   MaxQB; B4E0L1; -.
DR   PeptideAtlas; B4E0L1; -.
DR   PRIDE; B4E0L1; -.
DR   GeneID; 940; -.
DR   CTD; 940; -.
DR   eggNOG; ENOG410IXMM; Eukaryota.
DR   eggNOG; ENOG410Z063; LUCA.
DR   HOVERGEN; HBG071197; -.
DR   GenomeRNAi; 940; -.
DR   Genevisible; B4E0L1; HS.
DR   Gene3D; 2.60.40.10; -; 1.
DR   InterPro; IPR013783; Ig-like_fold.
PE   2: Evidence at transcript level;
KW   Signal {ECO:0000256|SAM:SignalP}.
FT   SIGNAL        1     18       {ECO:0000256|SAM:SignalP}.
FT   CHAIN        19    124       {ECO:0000256|SAM:SignalP}.
FT                                /FTId=PRO_5002803440.
SQ   SEQUENCE   124 AA;  14072 MW;  3A91FF25D56AFB29 CRC64;
     MLRLLLALNL FPSIQVTGNK ILVKQSPMLV AYDNAVNLSC KYSYNLFSRE FRASLHKGLD
     SAVEVCVVYG NYSQQLQVYS KTGFNCDGKL GNESVTFYLQ NLYVNHYPCE RETPLSKSPI
     SRTF
//
ID   CD28_HUMAN              Reviewed;         220 AA.
AC   P10747; A8KAC1; Q13964; Q52M23; Q70WG0; Q8NI54; Q8NI55; Q8NI56;
AC   Q8WXJ2; Q9BYV0;
DT   01-JUL-1989, integrated into UniProtKB/Swiss-Prot.
DT   01-JUL-1989, sequence version 1.
DT   28-MAR-2018, entry version 187.
DE   RecName: Full=T-cell-specific surface glycoprotein CD28;
DE   AltName: Full=TP44;
DE   AltName: CD_antigen=CD28;
DE   Flags: Precursor;
GN   Name=CD28;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=2825196; DOI=10.1073/pnas.84.23.8573;
RA   Aruffo A., Seed B.;
RT   "Molecular cloning of a CD28 cDNA by a high-efficiency COS cell
RT   expression system.";
RL   Proc. Natl. Acad. Sci. U.S.A. 84:8573-8577(1987).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORMS 1 AND 3), AND ALTERNATIVE
RP   SPLICING.
RX   PubMed=2162892;
RA   Lee K.P., Taylor C., Petryniak B., Turka L.A., June C.H.,
RA   Thompson C.B.;
RT   "The genomic organization of the CD28 gene. Implications for the
RT   regulation of CD28 mRNA expression and heterogeneity.";
RL   J. Immunol. 145:344-352(1990).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 5).
RX   PubMed=11916166; DOI=10.1016/S0198-8859(01)00354-8;
RA   Deshpande M., Venuprasad K., Parab P.B., Saha B., Mitra D.;
RT   "A novel CD28 mRNA variant and simultaneous presence of various CD28
RT   mRNA isoforms in human T lymphocytes.";
RL   Hum. Immunol. 63:20-23(2002).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 2; 4 AND 6), AND CHARACTERIZATION
RP   (ISOFORM 3).
RC   TISSUE=Peripheral blood T-cell;
RX   PubMed=11877290; DOI=10.1182/blood.V99.6.2138;
RA   Hanawa H., Ma Y., Mikolajczak S.A., Charles M.L., Yoshida T.,
RA   Yoshida R., Strathdee C.A., Litchfield D.W., Ochi A.;
RT   "A novel costimulatory signaling in human T lymphocytes by a splice
RT   variant of CD28.";
RL   Blood 99:2138-2145(2002).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 7).
RA   Gan S.U., Hare J., Krivoshchapov L., Hui K.M., Galea-Lauri J.,
RA   Farzaneh F., Darling D.;
RT   "New human CD28 isoforms generated by a novel splicing event in the
RT   5'UTR.";
RL   Submitted (NOV-2002) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RA   Livingston R.J., Shaffer T., McFarland I., Nguyen C.P., Stanaway I.B.,
RA   Rajkumar N., Johnson E.J., da Ponte S.H., Willa H., Ahearn M.O.,
RA   Bertucci C., Acklestad J., Carroll A., Swanson J., Gildersleeve H.I.,
RA   Nickerson D.A.;
RL   Submitted (OCT-2006) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Synovium, and Trachea;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [10]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [11]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-178 (ISOFORM 1).
RX   PubMed=11735222; DOI=10.1006/geno.2001.6655;
RA   Ling V., Wu P.W., Finnerty H.F., Agostino M.J., Graham J.R., Chen S.,
RA   Jussiff J.M., Fisk G.J., Miller C.P., Collins M.;
RT   "Assembly and annotation of human chromosome 2q33 sequence containing
RT   the CD28, CTLA4, and ICOS gene cluster: analysis by computational,
RT   comparative, and microarray approaches.";
RL   Genomics 78:155-168(2001).
RN   [12]
RP   FUNCTION.
RX   PubMed=8617933;
RA   Blotta M.H., Marshall J.D., DeKruyff R.H., Umetsu D.T.;
RT   "Cross-linking of the CD40 ligand on human CD4+ T lymphocytes
RT   generates a costimulatory signal that up-regulates IL-4 synthesis.";
RL   J. Immunol. 156:3133-3140(1996).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-209, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=15144186; DOI=10.1021/ac035352d;
RA   Brill L.M., Salomon A.R., Ficarro S.B., Mukherji M., Stettler-Gill M.,
RA   Peters E.C.;
RT   "Robust phosphoproteomic profiling of tyrosine phosphorylation sites
RT   from human T cells using immobilized metal affinity chromatography and
RT   tandem mass spectrometry.";
RL   Anal. Chem. 76:2763-2772(2004).
RN   [14]
RP   FUNCTION (ISOFORM 3), SUBCELLULAR LOCATION (ISOFORM 3), INTERACTION
RP   WITH CD40LG (ISOFORM 3), AND PHOSPHORYLATION (ISOFORM 3).
RX   PubMed=15067037; DOI=10.1084/jem.20031705;
RA   Mikolajczak S.A., Ma B.Y., Yoshida T., Yoshida R., Kelvin D.J.,
RA   Ochi A.;
RT   "The modulation of CD40 ligand signaling by transmembrane CD28 splice
RT   variant in human T cells.";
RL   J. Exp. Med. 199:1025-1031(2004).
RN   [15]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-71 AND ASN-129.
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19349973; DOI=10.1038/nbt.1532;
RA   Wollscheid B., Bausch-Fluck D., Henderson C., O'Brien R., Bibel M.,
RA   Schiess R., Aebersold R., Watts J.D.;
RT   "Mass-spectrometric identification and relative quantification of N-
RT   linked cell surface glycoproteins.";
RL   Nat. Biotechnol. 27:378-386(2009).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-189 AND TYR-191, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [17]
RP   X-RAY CRYSTALLOGRAPHY (2.7 ANGSTROMS) OF 17-152 IN COMPLEX WITH THE
RP   FAB FRAGMENT OF A MITOGENIC ANTIBODY, DISULFIDE BONDS, AND
RP   GLYCOSYLATION AT ASN-37 AND ASN-105.
RX   PubMed=15696168; DOI=10.1038/ni1170;
RA   Evans E.J., Esnouf R.M., Manso-Sancho R., Gilbert R.J., James J.R.,
RA   Yu C., Fennelly J.A., Vowles C., Hanke T., Walse B., Hunig T.,
RA   Sorensen P., Stuart D.I., Davis S.J.;
RT   "Crystal structure of a soluble CD28-Fab complex.";
RL   Nat. Immunol. 6:271-279(2005).
RN   [18]
RP   X-RAY CRYSTALLOGRAPHY (1.35 ANGSTROMS) OF 189-196 IN COMPLEX WITH
RP   GRB2, AND INTERACTION WITH GRB2.
RX   PubMed=24098653; DOI=10.1371/journal.pone.0074482;
RA   Higo K., Ikura T., Oda M., Morii H., Takahashi J., Abe R., Ito N.;
RT   "High resolution crystal structure of the Grb2 SH2 domain with a
RT   phosphopeptide derived from CD28.";
RL   PLoS ONE 8:E74482-E74482(2013).
CC   -!- FUNCTION: Involved in T-cell activation, the induction of cell
CC       proliferation and cytokine production and promotion of T-cell
CC       survival. Enhances the production of IL4 and IL10 in T-cells in
CC       conjunction with TCR/CD3 ligation and CD40L costimulation
CC       (PubMed:8617933). Isoform 3 enhances CD40L-mediated activation of
CC       NF-kappa-B and kinases MAPK8 and PAK2 in T-cells
CC       (PubMed:15067037). {ECO:0000269|PubMed:15067037,
CC       ECO:0000269|PubMed:8617933}.
CC   -!- SUBUNIT: Homodimer; disulfide-linked. Interacts with DUSP14. Binds
CC       to CD80/B7-1 and CD86/B7-2/B70. Interacts with GRB2. Isoform 3
CC       interacts with CD40LG (PubMed:15067037).
CC       {ECO:0000269|PubMed:15067037, ECO:0000269|PubMed:15696168,
CC       ECO:0000269|PubMed:24098653}.
CC   -!- INTERACTION:
CC       P01552:entB (xeno); NbExp=5; IntAct=EBI-15945088, EBI-1027464;
CC       P27986:PIK3R1; NbExp=8; IntAct=EBI-4314301, EBI-79464;
CC   -!- SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane
CC       protein.
CC   -!- SUBCELLULAR LOCATION: Isoform 3: Cell surface
CC       {ECO:0000269|PubMed:15067037}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=7;
CC       Name=1;
CC         IsoId=P10747-1; Sequence=Displayed;
CC       Name=2; Synonyms=CD28-S2;
CC         IsoId=P10747-2; Sequence=VSP_002494;
CC       Name=3; Synonyms=CD28i;
CC         IsoId=P10747-3; Sequence=VSP_002495;
CC       Name=4; Synonyms=CD28-S1;
CC         IsoId=P10747-4; Sequence=VSP_002496;
CC       Name=5;
CC         IsoId=P10747-5; Sequence=VSP_002495, VSP_002497, VSP_002498;
CC       Name=6; Synonyms=CD28-S3;
CC         IsoId=P10747-6; Sequence=VSP_002495, VSP_002499;
CC       Name=7;
CC         IsoId=P10747-7; Sequence=VSP_047701;
CC   -!- TISSUE SPECIFICITY: Expressed in T-cells and plasma cells, but not
CC       in less mature B-cells.
CC   -!- PTM: CD40LG induces tyrosine phosphorylation of isoform 3.
CC       {ECO:0000269|PubMed:15067037}.
CC   -!- WEB RESOURCE: Name=Wikipedia; Note=CD28 entry;
CC       URL="https://en.wikipedia.org/wiki/CD28";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; J02988; AAA60581.1; -; mRNA.
DR   EMBL; M37815; AAA51944.1; -; Genomic_DNA.
DR   EMBL; M37812; AAA51944.1; JOINED; Genomic_DNA.
DR   EMBL; M37813; AAA51944.1; JOINED; Genomic_DNA.
DR   EMBL; M37814; AAA51944.1; JOINED; Genomic_DNA.
DR   EMBL; M37815; AAA51945.1; -; Genomic_DNA.
DR   EMBL; M37812; AAA51945.1; JOINED; Genomic_DNA.
DR   EMBL; M37813; AAA51945.1; JOINED; Genomic_DNA.
DR   EMBL; M37814; AAA51945.1; JOINED; Genomic_DNA.
DR   EMBL; AJ295273; CAC29237.1; -; mRNA.
DR   EMBL; AF222341; AAF33792.1; -; mRNA.
DR   EMBL; AF222342; AAF33793.1; -; mRNA.
DR   EMBL; AF222343; AAF33794.1; -; mRNA.
DR   EMBL; AJ517504; CAD57003.1; -; mRNA.
DR   EMBL; EF064755; ABK41938.1; -; Genomic_DNA.
DR   EMBL; AK292986; BAF85675.1; -; mRNA.
DR   EMBL; AK313313; BAG36118.1; -; mRNA.
DR   EMBL; AC125238; AAY24123.1; -; Genomic_DNA.
DR   EMBL; CH471063; EAW70348.1; -; Genomic_DNA.
DR   EMBL; BC093698; AAH93698.1; -; mRNA.
DR   EMBL; BC112085; AAI12086.1; -; mRNA.
DR   EMBL; AF411057; AAL40931.1; -; Genomic_DNA.
DR   CCDS; CCDS2361.1; -. [P10747-1]
DR   CCDS; CCDS58749.1; -. [P10747-2]
DR   PIR; A39983; RWHU28.
DR   RefSeq; NP_001230006.1; NM_001243077.1. [P10747-4]
DR   RefSeq; NP_001230007.1; NM_001243078.1. [P10747-2]
DR   RefSeq; NP_006130.1; NM_006139.3. [P10747-1]
DR   RefSeq; XP_011510496.1; XM_011512194.2. [P10747-7]
DR   RefSeq; XP_011510499.1; XM_011512197.2. [P10747-3]
DR   UniGene; Hs.443123; -.
DR   PDB; 1YJD; X-ray; 2.70 A; C=17-152.
DR   PDB; 3WA4; X-ray; 1.35 A; B=189-196.
DR   PDB; 5AUL; X-ray; 1.10 A; B=189-196.
DR   PDB; 5GJH; X-ray; 1.20 A; B/D=189-196.
DR   PDB; 5GJI; X-ray; 0.90 A; B=189-196.
DR   PDBsum; 1YJD; -.
DR   PDBsum; 3WA4; -.
DR   PDBsum; 5AUL; -.
DR   PDBsum; 5GJH; -.
DR   PDBsum; 5GJI; -.
DR   ProteinModelPortal; P10747; -.
DR   SMR; P10747; -.
DR   BioGrid; 107378; 20.
DR   CORUM; P10747; -.
DR   DIP; DIP-6043N; -.
DR   ELM; P10747; -.
DR   IntAct; P10747; 10.
DR   MINT; P10747; -.
DR   STRING; 9606.ENSP00000324890; -.
DR   ChEMBL; CHEMBL5191; -.
DR   GuidetoPHARMACOLOGY; 2863; -.
DR   iPTMnet; P10747; -.
DR   PhosphoSitePlus; P10747; -.
DR   BioMuta; CD28; -.
DR   DMDM; 115973; -.
DR   MaxQB; P10747; -.
DR   PaxDb; P10747; -.
DR   PeptideAtlas; P10747; -.
DR   PRIDE; P10747; -.
DR   Ensembl; ENST00000324106; ENSP00000324890; ENSG00000178562. [P10747-1]
DR   Ensembl; ENST00000374481; ENSP00000363605; ENSG00000178562. [P10747-2]
DR   Ensembl; ENST00000458610; ENSP00000393648; ENSG00000178562. [P10747-7]
DR   GeneID; 940; -.
DR   KEGG; hsa:940; -.
DR   UCSC; uc002vah.6; human. [P10747-1]
DR   CTD; 940; -.
DR   DisGeNET; 940; -.
DR   EuPathDB; HostDB:ENSG00000178562.17; -.
DR   GeneCards; CD28; -.
DR   HGNC; HGNC:1653; CD28.
DR   HPA; HPA070003; -.
DR   MalaCards; CD28; -.
DR   MIM; 186760; gene.
DR   neXtProt; NX_P10747; -.
DR   OpenTargets; ENSG00000178562; -.
DR   PharmGKB; PA26207; -.
DR   eggNOG; ENOG410IXMM; Eukaryota.
DR   eggNOG; ENOG410Z063; LUCA.
DR   GeneTree; ENSGT00530000063873; -.
DR   HOGENOM; HOG000276892; -.
DR   HOVERGEN; HBG004094; -.
DR   InParanoid; P10747; -.
DR   KO; K06470; -.
DR   OMA; VNGNYSH; -.
DR   OrthoDB; EOG091G0IGY; -.
DR   PhylomeDB; P10747; -.
DR   TreeFam; TF335679; -.
DR   Reactome; R-HSA-1257604; PIP3 activates AKT signaling.
DR   Reactome; R-HSA-164939; Nef mediated downregulation of CD28 cell surface expression.
DR   Reactome; R-HSA-2219530; Constitutive Signaling by Aberrant PI3K in Cancer.
DR   Reactome; R-HSA-389356; CD28 co-stimulation.
DR   Reactome; R-HSA-389357; CD28 dependent PI3K/Akt signaling.
DR   Reactome; R-HSA-389359; CD28 dependent Vav1 pathway.
DR   Reactome; R-HSA-6811558; PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling.
DR   SignaLink; P10747; -.
DR   SIGNOR; P10747; -.
DR   ChiTaRS; CD28; human.
DR   EvolutionaryTrace; P10747; -.
DR   GeneWiki; CD28; -.
DR   GenomeRNAi; 940; -.
DR   PRO; PR:P10747; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   Bgee; ENSG00000178562; -.
DR   CleanEx; HS_CD28; -.
DR   Genevisible; P10747; HS.
DR   GO; GO:0009986; C:cell surface; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0009897; C:external side of plasma membrane; IDA:MGI.
DR   GO; GO:0001772; C:immunological synapse; IEA:Ensembl.
DR   GO; GO:0005887; C:integral component of plasma membrane; TAS:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; IDA:MGI.
DR   GO; GO:0098636; C:protein complex involved in cell adhesion; IDA:MGI.
DR   GO; GO:0015026; F:coreceptor activity; TAS:UniProtKB.
DR   GO; GO:0042802; F:identical protein binding; NAS:UniProtKB.
DR   GO; GO:0046934; F:phosphatidylinositol-4,5-bisphosphate 3-kinase activity; TAS:Reactome.
DR   GO; GO:0002020; F:protease binding; IPI:BHF-UCL.
DR   GO; GO:0019901; F:protein kinase binding; IEA:Ensembl.
DR   GO; GO:0005070; F:SH3/SH2 adaptor activity; IDA:UniProtKB.
DR   GO; GO:0097190; P:apoptotic signaling pathway; IEA:Ensembl.
DR   GO; GO:0007166; P:cell surface receptor signaling pathway; TAS:UniProtKB.
DR   GO; GO:0042089; P:cytokine biosynthetic process; TAS:UniProtKB.
DR   GO; GO:0006959; P:humoral immune response; TAS:UniProtKB.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; TAS:UniProtKB.
DR   GO; GO:0010629; P:negative regulation of gene expression; IMP:UniProtKB.
DR   GO; GO:0045060; P:negative thymic T cell selection; IEA:Ensembl.
DR   GO; GO:0046641; P:positive regulation of alpha-beta T cell proliferation; IEA:Ensembl.
DR   GO; GO:0010628; P:positive regulation of gene expression; IMP:UniProtKB.
DR   GO; GO:0002863; P:positive regulation of inflammatory response to antigenic stimulus; IEA:Ensembl.
DR   GO; GO:0032733; P:positive regulation of interleukin-10 production; IDA:UniProtKB.
DR   GO; GO:0045086; P:positive regulation of interleukin-2 biosynthetic process; IDA:UniProtKB.
DR   GO; GO:0032753; P:positive regulation of interleukin-4 production; IDA:UniProtKB.
DR   GO; GO:0048304; P:positive regulation of isotype switching to IgG isotypes; IEA:Ensembl.
DR   GO; GO:0045840; P:positive regulation of mitotic nuclear division; IDA:UniProtKB.
DR   GO; GO:0014068; P:positive regulation of phosphatidylinositol 3-kinase signaling; IEA:Ensembl.
DR   GO; GO:0051897; P:positive regulation of protein kinase B signaling; TAS:Reactome.
DR   GO; GO:0042102; P:positive regulation of T cell proliferation; IDA:UniProtKB.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; IEA:Ensembl.
DR   GO; GO:0045727; P:positive regulation of translation; NAS:UniProtKB.
DR   GO; GO:0045070; P:positive regulation of viral genome replication; NAS:UniProtKB.
DR   GO; GO:0050690; P:regulation of defense response to virus by virus; TAS:Reactome.
DR   GO; GO:0045589; P:regulation of regulatory T cell differentiation; IEA:Ensembl.
DR   GO; GO:0045066; P:regulatory T cell differentiation; IDA:BHF-UCL.
DR   GO; GO:0042110; P:T cell activation; IGI:BHF-UCL.
DR   GO; GO:0031295; P:T cell costimulation; TAS:UniProtKB.
DR   GO; GO:0050852; P:T cell receptor signaling pathway; IEA:Ensembl.
DR   Gene3D; 2.60.40.10; -; 1.
DR   InterPro; IPR008093; CD28.
DR   InterPro; IPR036179; Ig-like_dom_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR013106; Ig_V-set.
DR   Pfam; PF15910; V-set_2; 1.
DR   PRINTS; PR01717; CD28ANTIGEN.
DR   SMART; SM00406; IGv; 1.
DR   SUPFAM; SSF48726; SSF48726; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Complete proteome; Disulfide bond;
KW   Glycoprotein; Immunoglobulin domain; Membrane; Phosphoprotein;
KW   Reference proteome; Signal; Transmembrane; Transmembrane helix.
FT   SIGNAL        1     18
FT   CHAIN        19    220       T-cell-specific surface glycoprotein
FT                                CD28.
FT                                /FTId=PRO_0000014652.
FT   TOPO_DOM     19    152       Extracellular. {ECO:0000255}.
FT   TRANSMEM    153    179       Helical. {ECO:0000255}.
FT   TOPO_DOM    180    220       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN       28    137       Ig-like V-type.
FT   MOD_RES     189    189       Phosphoserine.
FT                                {ECO:0000244|PubMed:19690332}.
FT   MOD_RES     191    191       Phosphotyrosine.
FT                                {ECO:0000244|PubMed:19690332}.
FT   MOD_RES     209    209       Phosphotyrosine.
FT                                {ECO:0000244|PubMed:15144186}.
FT   CARBOHYD     37     37       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:15696168}.
FT   CARBOHYD     71     71       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:19349973}.
FT   CARBOHYD     92     92       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    105    105       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:15696168}.
FT   CARBOHYD    129    129       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:19349973}.
FT   DISULFID     40    112       {ECO:0000269|PubMed:15696168}.
FT   DISULFID     66     86       {ECO:0000269|PubMed:15696168}.
FT   VAR_SEQ       1     17       MLRLLLALNLFPSIQVT -> MPCGLSALIMCPKGMVAVVV
FT                                AVDDGDSQALA (in isoform 7).
FT                                {ECO:0000303|Ref.5}.
FT                                /FTId=VSP_047701.
FT   VAR_SEQ      19    137       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:11877290}.
FT                                /FTId=VSP_002494.
FT   VAR_SEQ      40    137       CKYSYNLFSREFRASLHKGLDSAVEVCVVYGNYSQQLQVYS
FT                                KTGFNCDGKLGNESVTFYLQNLYVNQTDIYFCKIEVMYPPP
FT                                YLDNEKSNGTIIHVKG -> W (in isoform 4).
FT                                {ECO:0000303|PubMed:11877290}.
FT                                /FTId=VSP_002496.
FT   VAR_SEQ      40    124       CKYSYNLFSREFRASLHKGLDSAVEVCVVYGNYSQQLQVYS
FT                                KTGFNCDGKLGNESVTFYLQNLYVNQTDIYFCKIEVMYPPP
FT                                YLD -> Y (in isoform 3, isoform 5 and
FT                                isoform 6). {ECO:0000303|PubMed:11877290,
FT                                ECO:0000303|PubMed:11916166}.
FT                                /FTId=VSP_002495.
FT   VAR_SEQ     138    139       KH -> EE (in isoform 5).
FT                                {ECO:0000303|PubMed:11916166}.
FT                                /FTId=VSP_002497.
FT   VAR_SEQ     140    220       Missing (in isoform 5).
FT                                {ECO:0000303|PubMed:11916166}.
FT                                /FTId=VSP_002498.
FT   VAR_SEQ     152    207       Missing (in isoform 6).
FT                                {ECO:0000303|PubMed:11877290}.
FT                                /FTId=VSP_002499.
FT   STRAND       27     30       {ECO:0000244|PDB:1YJD}.
FT   STRAND       35     43       {ECO:0000244|PDB:1YJD}.
FT   STRAND       49     58       {ECO:0000244|PDB:1YJD}.
FT   STRAND       64     74       {ECO:0000244|PDB:1YJD}.
FT   STRAND       77     79       {ECO:0000244|PDB:1YJD}.
FT   STRAND       81     83       {ECO:0000244|PDB:1YJD}.
FT   STRAND       85     90       {ECO:0000244|PDB:1YJD}.
FT   STRAND       92    101       {ECO:0000244|PDB:1YJD}.
FT   HELIX       104    106       {ECO:0000244|PDB:1YJD}.
FT   STRAND      108    121       {ECO:0000244|PDB:1YJD}.
FT   STRAND      123    125       {ECO:0000244|PDB:1YJD}.
FT   STRAND      131    134       {ECO:0000244|PDB:1YJD}.
SQ   SEQUENCE   220 AA;  25066 MW;  1D9B6552A5878D0F CRC64;
     MLRLLLALNL FPSIQVTGNK ILVKQSPMLV AYDNAVNLSC KYSYNLFSRE FRASLHKGLD
     SAVEVCVVYG NYSQQLQVYS KTGFNCDGKL GNESVTFYLQ NLYVNQTDIY FCKIEVMYPP
     PYLDNEKSNG TIIHVKGKHL CPSPLFPGPS KPFWVLVVVG GVLACYSLLV TVAFIIFWVR
     SKRSRLLHSD YMNMTPRRPG PTRKHYQPYA PPRDFAAYRS
//
ID   CAD17_HUMAN             Reviewed;         832 AA.
AC   Q12864; Q15336; Q2M2E0;
DT   27-APR-2001, integrated into UniProtKB/Swiss-Prot.
DT   05-OCT-2010, sequence version 3.
DT   25-APR-2018, entry version 155.
DE   RecName: Full=Cadherin-17;
DE   AltName: Full=Intestinal peptide-associated transporter HPT-1;
DE   AltName: Full=Liver-intestine cadherin;
DE            Short=LI-cadherin;
DE   Flags: Precursor;
GN   Name=CDH17;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, TISSUE SPECIFICITY, AND VARIANTS
RP   GLU-115 AND ASP-734.
RC   TISSUE=Colon adenocarcinoma;
RX   PubMed=8153632; DOI=10.1126/science.8153632;
RA   Dantzig A.H., Hoskins J., Tabas L.B., Bright S., Shepard R.L.,
RA   Jenkins I.L., Duckworth D.C., Sportsman J.R., MacKensen D.,
RA   Rosteck P.R. Jr., Skatrud P.L.;
RT   "Association of intestinal peptide transport with a protein related to
RT   the cadherin superfamily.";
RL   Science 264:430-433(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANT THR-446.
RA   Boettinger A., Kreft B., Fieger C., Dlouhy B., Berndorff D.,
RA   Goessner R., Tauber R.;
RT   "Molecular cloning of human LI-cadherin: evidence for a novel type of
RT   cadherin within the cadherin superfamily.";
RL   Submitted (DEC-1994) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16421571; DOI=10.1038/nature04406;
RA   Nusbaum C., Mikkelsen T.S., Zody M.C., Asakawa S., Taudien S.,
RA   Garber M., Kodira C.D., Schueler M.G., Shimizu A., Whittaker C.A.,
RA   Chang J.L., Cuomo C.A., Dewar K., FitzGerald M.G., Yang X.,
RA   Allen N.R., Anderson S., Asakawa T., Blechschmidt K., Bloom T.,
RA   Borowsky M.L., Butler J., Cook A., Corum B., DeArellano K.,
RA   DeCaprio D., Dooley K.T., Dorris L. III, Engels R., Gloeckner G.,
RA   Hafez N., Hagopian D.S., Hall J.L., Ishikawa S.K., Jaffe D.B.,
RA   Kamat A., Kudoh J., Lehmann R., Lokitsang T., Macdonald P.,
RA   Major J.E., Matthews C.D., Mauceli E., Menzel U., Mihalev A.H.,
RA   Minoshima S., Murayama Y., Naylor J.W., Nicol R., Nguyen C.,
RA   O'Leary S.B., O'Neill K., Parker S.C.J., Polley A., Raymond C.K.,
RA   Reichwald K., Rodriguez J., Sasaki T., Schilhabel M., Siddiqui R.,
RA   Smith C.L., Sneddon T.P., Talamas J.A., Tenzin P., Topham K.,
RA   Venkataraman V., Wen G., Yamazaki S., Young S.K., Zeng Q.,
RA   Zimmer A.R., Rosenthal A., Birren B.W., Platzer M., Shimizu N.,
RA   Lander E.S.;
RT   "DNA sequence and analysis of human chromosome 8.";
RL   Nature 439:331-335(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANTS GLU-115 AND
RP   ASP-734.
RC   TISSUE=Cerebellum;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -!- FUNCTION: Cadherins are calcium-dependent cell adhesion proteins.
CC       They preferentially interact with themselves in a homophilic
CC       manner in connecting cells; cadherins may thus contribute to the
CC       sorting of heterogeneous cell types. LI-cadherin may have a role
CC       in the morphological organization of liver and intestine. Involved
CC       in intestinal peptide transport. {ECO:0000269|PubMed:8153632}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000305}; Single-pass
CC       type I membrane protein {ECO:0000305}.
CC   -!- TISSUE SPECIFICITY: Expressed in the gastrointestinal tract and
CC       pancreatic duct. Not detected in kidney, lung, liver, brain,
CC       adrenal gland and skin. {ECO:0000269|PubMed:8153632}.
CC   -!- DOMAIN: Three calcium ions are usually bound at the interface of
CC       each cadherin domain and rigidify the connections, imparting a
CC       strong curvature to the full-length ectodomain. {ECO:0000250}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/CDH17ID40020ch8q22.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U07969; AAA19021.1; -; mRNA.
DR   EMBL; X83228; CAA58231.1; -; mRNA.
DR   EMBL; AP003351; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AP003478; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC112013; AAI12014.1; -; mRNA.
DR   EMBL; BC113464; AAI13465.1; -; mRNA.
DR   CCDS; CCDS6260.1; -.
DR   PIR; S55396; S55396.
DR   RefSeq; NP_001138135.1; NM_001144663.1.
DR   RefSeq; NP_004054.3; NM_004063.3.
DR   UniGene; Hs.591853; -.
DR   ProteinModelPortal; Q12864; -.
DR   SMR; Q12864; -.
DR   IntAct; Q12864; 1.
DR   STRING; 9606.ENSP00000027335; -.
DR   iPTMnet; Q12864; -.
DR   PhosphoSitePlus; Q12864; -.
DR   BioMuta; CDH17; -.
DR   DMDM; 308153624; -.
DR   MaxQB; Q12864; -.
DR   PaxDb; Q12864; -.
DR   PeptideAtlas; Q12864; -.
DR   PRIDE; Q12864; -.
DR   DNASU; 1015; -.
DR   Ensembl; ENST00000027335; ENSP00000027335; ENSG00000079112.
DR   Ensembl; ENST00000450165; ENSP00000401468; ENSG00000079112.
DR   GeneID; 1015; -.
DR   KEGG; hsa:1015; -.
DR   UCSC; uc003ygh.3; human.
DR   CTD; 1015; -.
DR   DisGeNET; 1015; -.
DR   EuPathDB; HostDB:ENSG00000079112.9; -.
DR   GeneCards; CDH17; -.
DR   H-InvDB; HIX0025563; -.
DR   HGNC; HGNC:1756; CDH17.
DR   HPA; CAB025143; -.
DR   HPA; HPA023614; -.
DR   HPA; HPA023616; -.
DR   HPA; HPA026556; -.
DR   MIM; 603017; gene.
DR   neXtProt; NX_Q12864; -.
DR   OpenTargets; ENSG00000079112; -.
DR   PharmGKB; PA26290; -.
DR   eggNOG; KOG3594; Eukaryota.
DR   eggNOG; ENOG410XQHI; LUCA.
DR   GeneTree; ENSGT00740000115559; -.
DR   HOGENOM; HOG000231613; -.
DR   HOVERGEN; HBG050767; -.
DR   InParanoid; Q12864; -.
DR   KO; K06811; -.
DR   OMA; VIDINDQ; -.
DR   OrthoDB; EOG091G033T; -.
DR   PhylomeDB; Q12864; -.
DR   TreeFam; TF316817; -.
DR   Reactome; R-HSA-418990; Adherens junctions interactions.
DR   SIGNOR; Q12864; -.
DR   ChiTaRS; CDH17; human.
DR   GeneWiki; CDH17; -.
DR   GenomeRNAi; 1015; -.
DR   PRO; PR:Q12864; -.
DR   Proteomes; UP000005640; Chromosome 8.
DR   Bgee; ENSG00000079112; -.
DR   CleanEx; HS_CDH17; -.
DR   ExpressionAtlas; Q12864; baseline and differential.
DR   Genevisible; Q12864; HS.
DR   GO; GO:0016323; C:basolateral plasma membrane; IDA:UniProtKB.
DR   GO; GO:0030054; C:cell junction; IDA:HPA.
DR   GO; GO:0009986; C:cell surface; IEA:Ensembl.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005634; C:nucleus; IDA:HPA.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR   GO; GO:0005178; F:integrin binding; IPI:UniProtKB.
DR   GO; GO:0005427; F:proton-dependent oligopeptide secondary active transmembrane transporter activity; ISS:UniProtKB.
DR   GO; GO:0005215; F:transporter activity; TAS:ProtInc.
DR   GO; GO:0034332; P:adherens junction organization; TAS:Reactome.
DR   GO; GO:0016339; P:calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules; ISS:UniProtKB.
DR   GO; GO:0007155; P:cell adhesion; TAS:ProtInc.
DR   GO; GO:0002314; P:germinal center B cell differentiation; IEA:Ensembl.
DR   GO; GO:0007156; P:homophilic cell adhesion via plasma membrane adhesion molecules; ISS:UniProtKB.
DR   GO; GO:0007229; P:integrin-mediated signaling pathway; IMP:UniProtKB.
DR   GO; GO:0002315; P:marginal zone B cell differentiation; IEA:Ensembl.
DR   GO; GO:0035672; P:oligopeptide transmembrane transport; ISS:UniProtKB.
DR   GO; GO:0006857; P:oligopeptide transport; ISS:UniProtKB.
DR   GO; GO:0033626; P:positive regulation of integrin activation by cell surface receptor linked signal transduction; IMP:UniProtKB.
DR   GO; GO:0048536; P:spleen development; IEA:Ensembl.
DR   InterPro; IPR002126; Cadherin.
DR   InterPro; IPR015919; Cadherin-like.
DR   InterPro; IPR020894; Cadherin_CS.
DR   Pfam; PF00028; Cadherin; 5.
DR   PRINTS; PR00205; CADHERIN.
DR   SMART; SM00112; CA; 6.
DR   SUPFAM; SSF49313; SSF49313; 7.
DR   PROSITE; PS00232; CADHERIN_1; 3.
DR   PROSITE; PS50268; CADHERIN_2; 6.
PE   2: Evidence at transcript level;
KW   Calcium; Cell adhesion; Cell membrane; Complete proteome;
KW   Glycoprotein; Membrane; Metal-binding; Polymorphism;
KW   Reference proteome; Repeat; Signal; Transmembrane;
KW   Transmembrane helix; Transport.
FT   SIGNAL        1     22       {ECO:0000255}.
FT   CHAIN        23    832       Cadherin-17.
FT                                /FTId=PRO_0000003812.
FT   TOPO_DOM     23    787       Extracellular. {ECO:0000255}.
FT   TRANSMEM    788    808       Helical. {ECO:0000255}.
FT   TOPO_DOM    809    832       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN       30    128       Cadherin 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00043}.
FT   DOMAIN      129    244       Cadherin 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00043}.
FT   DOMAIN      245    340       Cadherin 3. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00043}.
FT   DOMAIN      341    449       Cadherin 4. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00043}.
FT   DOMAIN      450    566       Cadherin 5. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00043}.
FT   DOMAIN      567    667       Cadherin 6. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00043}.
FT   DOMAIN      668    777       Cadherin 7. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00043}.
FT   CARBOHYD    149    149       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    184    184       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    250    250       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    419    419       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    456    456       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    546    546       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    587    587       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    722    722       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   VARIANT     115    115       K -> E (in dbSNP:rs2243518).
FT                                {ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|PubMed:8153632}.
FT                                /FTId=VAR_055567.
FT   VARIANT     446    446       I -> T (in dbSNP:rs1131829).
FT                                {ECO:0000269|Ref.2}.
FT                                /FTId=VAR_031694.
FT   VARIANT     734    734       E -> D (in dbSNP:rs1051623).
FT                                {ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|PubMed:8153632}.
FT                                /FTId=VAR_031695.
FT   VARIANT     739    739       E -> A (in dbSNP:rs1051624).
FT                                /FTId=VAR_031696.
SQ   SEQUENCE   832 AA;  92219 MW;  2707547DD2DB4202 CRC64;
     MILQAHLHSL CLLMLYLATG YGQEGKFSGP LKPMTFSIYE GQEPSQIIFQ FKANPPAVTF
     ELTGETDNIF VIEREGLLYY NRALDRETRS THNLQVAALD ANGIIVEGPV PITIKVKDIN
     DNRPTFLQSK YEGSVRQNSR PGKPFLYVNA TDLDDPATPN GQLYYQIVIQ LPMINNVMYF
     QINNKTGAIS LTREGSQELN PAKNPSYNLV ISVKDMGGQS ENSFSDTTSV DIIVTENIWK
     APKPVEMVEN STDPHPIKIT QVRWNDPGAQ YSLVDKEKLP RFPFSIDQEG DIYVTQPLDR
     EEKDAYVFYA VAKDEYGKPL SYPLEIHVKV KDINDNPPTC PSPVTVFEVQ ENERLGNSIG
     TLTAHDRDEE NTANSFLNYR IVEQTPKLPM DGLFLIQTYA GMLQLAKQSL KKQDTPQYNL
     TIEVSDKDFK TLCFVQINVI DINDQIPIFE KSDYGNLTLA EDTNIGSTIL TIQATDADEP
     FTGSSKILYH IIKGDSEGRL GVDTDPHTNT GYVIIKKPLD FETAAVSNIV FKAENPEPLV
     FGVKYNASSF AKFTLIVTDV NEAPQFSQHV FQAKVSEDVA IGTKVGNVTA KDPEGLDISY
     SLRGDTRGWL KIDHVTGEIF SVAPLDREAG SPYRVQVVAT EVGGSSLSSV SEFHLILMDV
     NDNPPRLAKD YTGLFFCHPL SAPGSLIFEA TDDDQHLFRG PHFTFSLGSG SLQNDWEVSK
     INGTHARLST RHTEFEEREY VVLIRINDGG RPPLEGIVSL PVTFCSCVEG SCFRPAGHQT
     GIPTVGMAVG ILLTTLLVIG IILAVVFIRI KKDKGKDNVE SAQASEVKPL RS
//
ID   CSF1R_HUMAN             Reviewed;         972 AA.
AC   P07333; B5A955; D3DQG2; Q6LDW5; Q6LDY4; Q86VW7;
DT   01-APR-1988, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-1994, sequence version 2.
DT   25-APR-2018, entry version 208.
DE   RecName: Full=Macrophage colony-stimulating factor 1 receptor;
DE   AltName: Full=CSF-1 receptor;
DE            Short=CSF-1-R;
DE            Short=CSF-1R;
DE            Short=M-CSF-R;
DE            EC=2.7.10.1;
DE   AltName: Full=Proto-oncogene c-Fms;
DE   AltName: CD_antigen=CD115;
DE   Flags: Precursor;
GN   Name=CSF1R; Synonyms=FMS;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=2524025;
RA   Hampe A., Shamoon B.M., Gobet M., Sherr C.J., Galibert F.;
RT   "Nucleotide sequence and structural organization of the human FMS
RT   proto-oncogene.";
RL   Oncogene Res. 4:9-17(1989).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=2421165; DOI=10.1038/320277a0;
RA   Coussens L., van Beveren C., Smith D., Chen E., Mitchell R.L.,
RA   Isacke C.M., Verma I.M., Ullrich A.;
RT   "Structural alteration of viral homologue of receptor proto-oncogene
RT   fms at carboxyl terminus.";
RL   Nature 320:277-280(1986).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   TISSUE=Placenta;
RX   PubMed=9027509; DOI=10.1006/geno.1996.4482;
RA   Andre C., Hampe A., Lachaume P., Martin E., Wang X.P., Manus V.,
RA   Hu W.X., Galibert F.;
RT   "Sequence analysis of two genomic regions containing the KIT and the
RT   FMS receptor tyrosine kinase genes.";
RL   Genomics 39:216-226(1997).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RX   PubMed=18593464; DOI=10.1186/ar2447;
RA   Jin P., Zhang J., Sumariwalla P.F., Ni I., Jorgensen B., Crawford D.,
RA   Phillips S., Feldmann M., Shepard H.M., Paleolog E.M.;
RT   "Novel splice variants derived from the receptor tyrosine kinase
RT   superfamily are potential therapeutics for rheumatoid arthritis.";
RL   Arthritis Res. Ther. 10:R73-R73(2008).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15372022; DOI=10.1038/nature02919;
RA   Schmutz J., Martin J., Terry A., Couronne O., Grimwood J., Lowry S.,
RA   Gordon L.A., Scott D., Xie G., Huang W., Hellsten U., Tran-Gyamfi M.,
RA   She X., Prabhakar S., Aerts A., Altherr M., Bajorek E., Black S.,
RA   Branscomb E., Caoile C., Challacombe J.F., Chan Y.M., Denys M.,
RA   Detter J.C., Escobar J., Flowers D., Fotopulos D., Glavina T.,
RA   Gomez M., Gonzales E., Goodstein D., Grigoriev I., Groza M.,
RA   Hammon N., Hawkins T., Haydu L., Israni S., Jett J., Kadner K.,
RA   Kimball H., Kobayashi A., Lopez F., Lou Y., Martinez D., Medina C.,
RA   Morgan J., Nandkeshwar R., Noonan J.P., Pitluck S., Pollard M.,
RA   Predki P., Priest J., Ramirez L., Retterer J., Rodriguez A.,
RA   Rogers S., Salamov A., Salazar A., Thayer N., Tice H., Tsai M.,
RA   Ustaszewska A., Vo N., Wheeler J., Wu K., Yang J., Dickson M.,
RA   Cheng J.-F., Eichler E.E., Olsen A., Pennacchio L.A., Rokhsar D.S.,
RA   Richardson P., Lucas S.M., Myers R.M., Rubin E.M.;
RT   "The DNA sequence and comparative analysis of human chromosome 5.";
RL   Nature 431:268-274(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-16.
RX   PubMed=2524648; DOI=10.1128/MCB.9.3.1336;
RA   Visvader J., Verma I.M.;
RT   "Differential transcription of exon 1 of the human c-fms gene in
RT   placental trophoblasts and monocytes.";
RL   Mol. Cell. Biol. 9:1336-1341(1989).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-16.
RX   PubMed=3525854;
RA   Wheeler E.F., Roussel M.F., Hampe A., Walker M.H., Fried V.A.,
RA   Look A.T., Rettenmier C.W., Sherr C.J.;
RT   "The amino-terminal domain of the v-fms oncogene product includes a
RT   functional signal peptide that directs synthesis of a transforming
RT   glycoprotein in the absence of feline leukemia virus gag sequences.";
RL   J. Virol. 59:224-233(1986).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-16.
RC   TISSUE=Placenta;
RA   Flick M.B., Sapi E., Kacinski B.M.;
RT   "Expression of a novel exon in the 5' UTR of human c-fms
RT   transcripts.";
RL   Submitted (NOV-1996) to the EMBL/GenBank/DDBJ databases.
RN   [11]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 244-295.
RX   PubMed=4028159; DOI=10.1016/0092-8674(85)90099-6;
RA   Nienhuis A.W., Bunn H.F., Turner P.H., Gopal T.V., Nash W.G.,
RA   O'Brien S.J., Sherr C.J.;
RT   "Expression of the human c-fms proto-oncogene in hematopoietic cells
RT   and its deletion in the 5q- syndrome.";
RL   Cell 42:421-428(1985).
RN   [12]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 874-972 (ISOFORM 1).
RX   PubMed=3532121; DOI=10.1073/pnas.83.20.7800;
RA   Browning P.J., Bunn H.F., Cline A., Shuman M., Nienhuis A.W.;
RT   "'Replacement' of COOH-terminal truncation of v-fms with c-fms
RT   sequences markedly reduces transformation potential.";
RL   Proc. Natl. Acad. Sci. U.S.A. 83:7800-7804(1986).
RN   [13]
RP   FUNCTION IN CELL PROLIFERATION.
RX   PubMed=7683918;
RA   Bourette R.P., Mouchiroud G., Ouazana R., Morle F., Godet J.,
RA   Blanchet J.P.;
RT   "Expression of human colony-stimulating factor-1 (CSF-1) receptor in
RT   murine pluripotent hematopoietic NFS-60 cells induces long-term
RT   proliferation in response to CSF-1 without loss of erythroid
RT   differentiation potential.";
RL   Blood 81:2511-2520(1993).
RN   [14]
RP   INTERACTION WITH SRC; FYN AND YES1, AND MUTAGENESIS OF TYR-809.
RX   PubMed=7681396;
RA   Courtneidge S.A., Dhand R., Pilat D., Twamley G.M., Waterfield M.D.,
RA   Roussel M.F.;
RT   "Activation of Src family kinases by colony stimulating factor-1, and
RT   their association with its receptor.";
RL   EMBO J. 12:943-950(1993).
RN   [15]
RP   INDUCTION BY GLUCOCORTICOIDS.
RX   PubMed=7845678;
RA   Sapi E., Flick M.B., Gilmore-Hebert M., Rodov S., Kacinski B.M.;
RT   "Transcriptional regulation of the c-fms (CSF-1R) proto-oncogene in
RT   human breast carcinoma cells by glucocorticoids.";
RL   Oncogene 10:529-542(1995).
RN   [16]
RP   MUTAGENESIS OF TYR-708 AND ASP-802.
RX   PubMed=10340379; DOI=10.1038/sj.onc.1202646;
RA   Morley G.M., Uden M., Gullick W.J., Dibb N.J.;
RT   "Cell specific transformation by c-fms activating loop mutations is
RT   attributable to constitutive receptor degradation.";
RL   Oncogene 18:3076-3084(1999).
RN   [17]
RP   FUNCTION IN CELLULAR SIGNALING; PHOSPHORYLATION OF INPP5D AND
RP   ACTIVATION OF AKT1.
RX   PubMed=12882960; DOI=10.1074/jbc.M305021200;
RA   Baran C.P., Tridandapani S., Helgason C.D., Humphries R.K.,
RA   Krystal G., Marsh C.B.;
RT   "The inositol 5'-phosphatase SHIP-1 and the Src kinase Lyn negatively
RT   regulate macrophage colony-stimulating factor-induced Akt activity.";
RL   J. Biol. Chem. 278:38628-38636(2003).
RN   [18]
RP   FUNCTION IN REGULATION OF CELL PROLIFERATION; CELL ADHESION; CELL
RP   SHAPE AND INTEGRITY OF CELL JUNCTIONS, MUTAGENESIS OF LEU-301 AND
RP   TYR-969, AND ROLE IN DISEASE.
RX   PubMed=15117969; DOI=10.1083/jcb.200309102;
RA   Wrobel C.N., Debnath J., Lin E., Beausoleil S., Roussel M.F.,
RA   Brugge J.S.;
RT   "Autocrine CSF-1R activation promotes Src-dependent disruption of
RT   mammary epithelial architecture.";
RL   J. Cell Biol. 165:263-273(2004).
RN   [19]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-302 AND ASN-353.
RC   TISSUE=Plasma;
RX   PubMed=16335952; DOI=10.1021/pr0502065;
RA   Liu T., Qian W.-J., Gritsenko M.A., Camp D.G. II, Monroe M.E.,
RA   Moore R.J., Smith R.D.;
RT   "Human plasma N-glycoproteome analysis by immunoaffinity subtraction,
RT   hydrazide chemistry, and mass spectrometry.";
RL   J. Proteome Res. 4:2070-2080(2005).
RN   [20]
RP   FUNCTION AS CSF1 RECEPTOR, CATALYTIC ACTIVITY, AUTOPHOSPHORYLATION,
RP   ROLE IN DISEASE, AND ENZYME REGULATION.
RX   PubMed=16648572; DOI=10.1158/1535-7163.MCT-05-0359;
RA   Guo J., Marcotte P.A., McCall J.O., Dai Y., Pease L.J.,
RA   Michaelides M.R., Davidsen S.K., Glaser K.B.;
RT   "Inhibition of phosphorylation of the colony-stimulating factor-1
RT   receptor (c-Fms) tyrosine kinase in transfected cells by ABT-869 and
RT   other tyrosine kinase inhibitors.";
RL   Mol. Cancer Ther. 5:1007-1013(2006).
RN   [21]
RP   FUNCTION IN CELL PROLIFERATION, CATALYTIC ACTIVITY,
RP   AUTOPHOSPHORYLATION, ROLE IN DISEASE, AND ENZYME REGULATION.
RX   PubMed=17121910; DOI=10.1158/1535-7163.MCT-05-0313;
RA   Ohno H., Kubo K., Murooka H., Kobayashi Y., Nishitoba T., Shibuya M.,
RA   Yoneda T., Isoe T.;
RT   "A c-fms tyrosine kinase inhibitor, Ki20227, suppresses osteoclast
RT   differentiation and osteolytic bone destruction in a bone metastasis
RT   model.";
RL   Mol. Cancer Ther. 5:2634-2643(2006).
RN   [22]
RP   FUNCTION IN REGULATION OF CELL PROLIFERATION AND CELL SHAPE, CATALYTIC
RP   ACTIVITY, UBIQUITINATION, ENZYME REGULATION, AND MUTAGENESIS OF
RP   ASP-802.
RX   PubMed=16170366; DOI=10.1038/sj.onc.1209007;
RA   Taylor J.R., Brownlow N., Domin J., Dibb N.J.;
RT   "FMS receptor for M-CSF (CSF-1) is sensitive to the kinase inhibitor
RT   imatinib and mutation of Asp-802 to Val confers resistance.";
RL   Oncogene 25:147-151(2006).
RN   [23]
RP   FUNCTION AS IL34 RECEPTOR.
RX   PubMed=18467591; DOI=10.1126/science.1154370;
RA   Lin H., Lee E., Hestir K., Leo C., Huang M., Bosch E., Halenbeck R.,
RA   Wu G., Zhou A., Behrens D., Hollenbaugh D., Linnemann T., Qin M.,
RA   Wong J., Chu K., Doberstein S.K., Williams L.T.;
RT   "Discovery of a cytokine and its receptor by functional screening of
RT   the extracellular proteome.";
RL   Science 320:807-811(2008).
RN   [24]
RP   ROLE IN DISEASE, AND ENZYME REGULATION.
RX   PubMed=18814279; DOI=10.1002/ijc.23903;
RA   Hiraga T., Nakamura H.;
RT   "Imatinib mesylate suppresses bone metastases of breast cancer by
RT   inhibiting osteoclasts through the blockade of c-Fms signals.";
RL   Int. J. Cancer 124:215-222(2009).
RN   [25]
RP   ROLE IN DISEASE.
RX   PubMed=19934330; DOI=10.1158/0008-5472.CAN-09-1868;
RA   Patsialou A., Wyckoff J., Wang Y., Goswami S., Stanley E.R.,
RA   Condeelis J.S.;
RT   "Invasion of human breast cancer cells in vivo requires both paracrine
RT   and autocrine loops involving the colony-stimulating factor-1
RT   receptor.";
RL   Cancer Res. 69:9498-9506(2009).
RN   [26]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-699 AND SER-713, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [27]
RP   AUTOPHOSPHORYLATION, AND ENZYME REGULATION.
RX   PubMed=20156689; DOI=10.1016/j.bmc.2010.01.056;
RA   Mashkani B., Griffith R., Ashman L.K.;
RT   "Colony stimulating factor-1 receptor as a target for small molecule
RT   inhibitors.";
RL   Bioorg. Med. Chem. 18:1789-1797(2010).
RN   [28]
RP   FUNCTION AS RECEPTOR FOR IL34 AND CSF1, PHOSPHORYLATION AT TYR-546;
RP   TYR-699; TYR-708; TYR-723 AND TYR-809, AUTOPHOSPHORYLATION, ENZYME
RP   REGULATION, AND INTERACTION WITH IL34 AND CSF1.
RX   PubMed=20489731; DOI=10.1038/cdd.2010.60;
RA   Chihara T., Suzu S., Hassan R., Chutiwitoonchai N., Hiyoshi M.,
RA   Motoyoshi K., Kimura F., Okada S.;
RT   "IL-34 and M-CSF share the receptor Fms but are not identical in
RT   biological activity and signal activation.";
RL   Cell Death Differ. 17:1917-1927(2010).
RN   [29]
RP   FUNCTION IN RELEASE OF PROINFLAMMATORY CHEMOKINES.
RX   PubMed=20829061; DOI=10.1016/j.cyto.2010.08.005;
RA   Eda H., Zhang J., Keith R.H., Michener M., Beidler D.R., Monahan J.B.;
RT   "Macrophage-colony stimulating factor and interleukin-34 induce
RT   chemokines in human whole blood.";
RL   Cytokine 52:215-220(2010).
RN   [30]
RP   FUNCTION AS IL34 AND CSF1 RECEPTOR; ACTIVATION OF MAPK1/ERK2;
RP   MAPK3/ERK1; PHOSPHORYLATION AT TYR-723, AND AUTOPHOSPHORYLATION.
RX   PubMed=20504948; DOI=10.1189/jlb.1209822;
RA   Wei S., Nandi S., Chitu V., Yeung Y.G., Yu W., Huang M.,
RA   Williams L.T., Lin H., Stanley E.R.;
RT   "Functional overlap but differential expression of CSF-1 and IL-34 in
RT   their CSF-1 receptor-mediated regulation of myeloid cells.";
RL   J. Leukoc. Biol. 88:495-505(2010).
RN   [31]
RP   REVIEW ON FUNCTION; SIGNALING PATHWAYS AND PHOSPHORYLATION.
RX   PubMed=15519852; DOI=10.1016/j.tcb.2004.09.016;
RA   Pixley F.J., Stanley E.R.;
RT   "CSF-1 regulation of the wandering macrophage: complexity in action.";
RL   Trends Cell Biol. 14:628-638(2004).
RN   [32]
RP   REVIEW ON FUNCTION IN IMMUNITY AND INFLAMMATION, AND ROLE IN DISEASE.
RX   PubMed=16337366; DOI=10.1016/j.coi.2005.11.006;
RA   Chitu V., Stanley E.R.;
RT   "Colony-stimulating factor-1 in immunity and inflammation.";
RL   Curr. Opin. Immunol. 18:39-48(2006).
RN   [33]
RP   REVIEW ON FUNCTION; SIGNALING PATHWAYS AND PHOSPHORYLATION.
RX   PubMed=18687298; DOI=10.1016/j.intimp.2008.04.016;
RA   Douglass T.G., Driggers L., Zhang J.G., Hoa N., Delgado C.,
RA   Williams C.C., Dan Q., Sanchez R., Jeffes E.W., Wepsic H.T.,
RA   Myers M.P., Koths K., Jadus M.R.;
RT   "Macrophage colony stimulating factor: not just for macrophages
RT   anymore! A gateway into complex biologies.";
RL   Int. Immunopharmacol. 8:1354-1376(2008).
RN   [34]
RP   REVIEW.
RX   PubMed=19132917; DOI=10.1146/annurev.immunol.021908.132557;
RA   Auffray C., Sieweke M.H., Geissmann F.;
RT   "Blood monocytes: development, heterogeneity, and relationship with
RT   dendritic cells.";
RL   Annu. Rev. Immunol. 27:669-692(2009).
RN   [35]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [36]
RP   X-RAY CRYSTALLOGRAPHY (1.80 ANGSTROMS) OF 538-922 IN COMPLEXES WITH
RP   ARYLAMIDE AND QUINOLONE INHIBITORS, AND DOMAIN.
RX   PubMed=17132624; DOI=10.1074/jbc.M608183200;
RA   Schubert C., Schalk-Hihi C., Struble G.T., Ma H.C., Petrounia I.P.,
RA   Brandt B., Deckman I.C., Patch R.J., Player M.R., Spurlino J.C.,
RA   Springer B.A.;
RT   "Crystal structure of the tyrosine kinase domain of colony-stimulating
RT   factor-1 receptor (cFMS) in complex with two inhibitors.";
RL   J. Biol. Chem. 282:4094-4101(2007).
RN   [37]
RP   X-RAY CRYSTALLOGRAPHY (2.70 ANGSTROMS) OF 543-918 IN AUTOINHIBITED
RP   CONFORMATION, AND DOMAIN.
RX   PubMed=17292918; DOI=10.1016/j.jmb.2007.01.036;
RA   Walter M., Lucet I.S., Patel O., Broughton S.E., Bamert R.,
RA   Williams N.K., Fantino E., Wilks A.F., Rossjohn J.;
RT   "The 2.7 A crystal structure of the autoinhibited human c-Fms kinase
RT   domain.";
RL   J. Mol. Biol. 367:839-847(2007).
RN   [38]
RP   X-RAY CRYSTALLOGRAPHY (2.02 ANGSTROMS) OF 538-922 IN COMPLEX WITH
RP   PYRIMIDINOPYRIDONE INHIBITOR, AND CATALYTIC ACTIVITY.
RX   PubMed=18342505; DOI=10.1016/j.bmcl.2008.02.070;
RA   Huang H., Hutta D.A., Hu H., DesJarlais R.L., Schubert C.,
RA   Petrounia I.P., Chaikin M.A., Manthey C.L., Player M.R.;
RT   "Design and synthesis of a pyrido[2,3-d]pyrimidin-5-one class of anti-
RT   inflammatory FMS inhibitors.";
RL   Bioorg. Med. Chem. Lett. 18:2355-2361(2008).
RN   [39]
RP   X-RAY CRYSTALLOGRAPHY (1.95 ANGSTROMS) OF 538-922 IN COMPLEX WITH
RP   INHIBITOR, CATALYTIC ACTIVITY, AND FUNCTION IN INFLAMMATION AND
RP   DISEASE.
RX   PubMed=19193011; DOI=10.1021/jm801406h;
RA   Huang H., Hutta D.A., Rinker J.M., Hu H., Parsons W.H., Schubert C.,
RA   DesJarlais R.L., Crysler C.S., Chaikin M.A., Donatelli R.R., Chen Y.,
RA   Cheng D., Zhou Z., Yurkow E., Manthey C.L., Player M.R.;
RT   "Pyrido[2,3-d]pyrimidin-5-ones: a novel class of antiinflammatory
RT   macrophage colony-stimulating factor-1 receptor inhibitors.";
RL   J. Med. Chem. 52:1081-1099(2009).
RN   [40]
RP   X-RAY CRYSTALLOGRAPHY (2.50 ANGSTROMS) OF 538-922 IN COMPLEXES WITH
RP   INHIBITORS, CATALYTIC ACTIVITY, AND ENZYME REGULATION.
RX   PubMed=20137931; DOI=10.1016/j.bmcl.2010.01.078;
RA   Meyers M.J., Pelc M., Kamtekar S., Day J., Poda G.I., Hall M.K.,
RA   Michener M.L., Reitz B.A., Mathis K.J., Pierce B.S., Parikh M.D.,
RA   Mischke D.A., Long S.A., Parlow J.J., Anderson D.R., Thorarensen A.;
RT   "Structure-based drug design enables conversion of a DFG-in binding
RT   CSF-1R kinase inhibitor to a DFG-out binding mode.";
RL   Bioorg. Med. Chem. Lett. 20:1543-1547(2010).
RN   [41]
RP   VARIANTS [LARGE SCALE ANALYSIS] GLY-32; ARG-362; SER-413; VAL-536;
RP   HIS-693; ASP-920 AND GLN-921.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
RN   [42]
RP   VARIANTS HDLS 774-CYS--ASN-814 DEL; 585-GLY--LYS-619 DELINS ALA;
RP   GLU-589; LYS-633; THR-766; PRO-770; ASN-775; THR-794; TYR-837;
RP   SER-849; PHE-849 DEL; PRO-868; THR-875 AND THR-878, VARIANTS HIS-710;
RP   ARG-747 AND ASP-920, AND CHARACTERIZATION OF VARIANTS HDLS LYS-633;
RP   THR-766 AND THR-875.
RX   PubMed=22197934; DOI=10.1038/ng.1027;
RA   Rademakers R., Baker M., Nicholson A.M., Rutherford N.J., Finch N.,
RA   Soto-Ortolaza A., Lash J., Wider C., Wojtas A., DeJesus-Hernandez M.,
RA   Adamson J., Kouri N., Sundal C., Shuster E.A., Aasly J., MacKenzie J.,
RA   Roeber S., Kretzschmar H.A., Boeve B.F., Knopman D.S., Petersen R.C.,
RA   Cairns N.J., Ghetti B., Spina S., Garbern J., Tselis A.C., Uitti R.,
RA   Das P., Van Gerpen J.A., Meschia J.F., Levy S., Broderick D.F.,
RA   Graff-Radford N., Ross O.A., Miller B.B., Swerdlow R.H., Dickson D.W.,
RA   Wszolek Z.K.;
RT   "Mutations in the colony stimulating factor 1 receptor (CSF1R) gene
RT   cause hereditary diffuse leukoencephalopathy with spheroids.";
RL   Nat. Genet. 44:200-205(2012).
RN   [43]
RP   VARIANTS HDLS ARG-653; PHE-843 AND THR-906.
RX   PubMed=24532199; DOI=10.1007/s00415-014-7257-3;
RA   Battisti C., Di Donato I., Bianchi S., Monti L., Formichi P., Rufa A.,
RA   Taglia I., Cerase A., Dotti M.T., Federico A.;
RT   "Hereditary diffuse leukoencephalopathy with axonal spheroids: three
RT   patients with stroke-like presentation carrying new mutations in the
RT   CSF1R gene.";
RL   J. Neurol. 261:768-772(2014).
CC   -!- FUNCTION: Tyrosine-protein kinase that acts as cell-surface
CC       receptor for CSF1 and IL34 and plays an essential role in the
CC       regulation of survival, proliferation and differentiation of
CC       hematopoietic precursor cells, especially mononuclear phagocytes,
CC       such as macrophages and monocytes. Promotes the release of
CC       proinflammatory chemokines in response to IL34 and CSF1, and
CC       thereby plays an important role in innate immunity and in
CC       inflammatory processes. Plays an important role in the regulation
CC       of osteoclast proliferation and differentiation, the regulation of
CC       bone resorption, and is required for normal bone and tooth
CC       development. Required for normal male and female fertility, and
CC       for normal development of milk ducts and acinar structures in the
CC       mammary gland during pregnancy. Promotes reorganization of the
CC       actin cytoskeleton, regulates formation of membrane ruffles, cell
CC       adhesion and cell migration, and promotes cancer cell invasion.
CC       Activates several signaling pathways in response to ligand
CC       binding. Phosphorylates PIK3R1, PLCG2, GRB2, SLA2 and CBL.
CC       Activation of PLCG2 leads to the production of the cellular
CC       signaling molecules diacylglycerol and inositol 1,4,5-
CC       trisphosphate, that then lead to the activation of protein kinase
CC       C family members, especially PRKCD. Phosphorylation of PIK3R1, the
CC       regulatory subunit of phosphatidylinositol 3-kinase, leads to
CC       activation of the AKT1 signaling pathway. Activated CSF1R also
CC       mediates activation of the MAP kinases MAPK1/ERK2 and/or
CC       MAPK3/ERK1, and of the SRC family kinases SRC, FYN and YES1.
CC       Activated CSF1R transmits signals both via proteins that directly
CC       interact with phosphorylated tyrosine residues in its
CC       intracellular domain, or via adapter proteins, such as GRB2.
CC       Promotes activation of STAT family members STAT3, STAT5A and/or
CC       STAT5B. Promotes tyrosine phosphorylation of SHC1 and INPP5D/SHIP-
CC       1. Receptor signaling is down-regulated by protein phosphatases,
CC       such as INPP5D/SHIP-1, that dephosphorylate the receptor and its
CC       downstream effectors, and by rapid internalization of the
CC       activated receptor. {ECO:0000269|PubMed:12882960,
CC       ECO:0000269|PubMed:15117969, ECO:0000269|PubMed:16170366,
CC       ECO:0000269|PubMed:16337366, ECO:0000269|PubMed:16648572,
CC       ECO:0000269|PubMed:17121910, ECO:0000269|PubMed:18467591,
CC       ECO:0000269|PubMed:18814279, ECO:0000269|PubMed:19193011,
CC       ECO:0000269|PubMed:19934330, ECO:0000269|PubMed:20489731,
CC       ECO:0000269|PubMed:20504948, ECO:0000269|PubMed:20829061,
CC       ECO:0000269|PubMed:7683918}.
CC   -!- CATALYTIC ACTIVITY: ATP + a [protein]-L-tyrosine = ADP + a
CC       [protein]-L-tyrosine phosphate. {ECO:0000255|PROSITE-
CC       ProRule:PRU10028, ECO:0000269|PubMed:16170366,
CC       ECO:0000269|PubMed:16648572, ECO:0000269|PubMed:17121910,
CC       ECO:0000269|PubMed:18342505, ECO:0000269|PubMed:19193011,
CC       ECO:0000269|PubMed:20137931}.
CC   -!- ENZYME REGULATION: Present in an inactive conformation in the
CC       absence of bound ligand. CSF1 or IL34 binding leads to
CC       dimerization and activation by autophosphorylation on tyrosine
CC       residues. Inhibited by imatinib/STI-571 (Gleevec), dasatinib,
CC       sunitinib/SU11248, lestaurtinib/CEP-701, midostaurin/PKC-412,
CC       Ki20227, linifanib/ABT-869, Axitinib/AG013736, sorafenib/BAY 43-
CC       9006 and GW2580. {ECO:0000269|PubMed:16170366,
CC       ECO:0000269|PubMed:16648572, ECO:0000269|PubMed:17121910,
CC       ECO:0000269|PubMed:18814279, ECO:0000269|PubMed:20137931,
CC       ECO:0000269|PubMed:20156689, ECO:0000269|PubMed:20489731}.
CC   -!- SUBUNIT: Interacts with INPPL1/SHIP2 and THOC5 (By similarity).
CC       Monomer. Homodimer. Interacts with CSF1 and IL34. Interaction with
CC       dimeric CSF1 or IL34 leads to receptor homodimerization. Interacts
CC       (tyrosine phosphorylated) with PLCG2 (via SH2 domain). Interacts
CC       (tyrosine phosphorylated) with PIK3R1 (via SH2 domain). Interacts
CC       (tyrosine phosphorylated) with FYN, YES1 and SRC (via SH2 domain).
CC       Interacts (tyrosine phosphorylated) with CBL, GRB2 and SLA2.
CC       {ECO:0000250, ECO:0000269|PubMed:18342505,
CC       ECO:0000269|PubMed:19193011, ECO:0000269|PubMed:20489731,
CC       ECO:0000269|PubMed:7681396}.
CC   -!- INTERACTION:
CC       P09603:CSF1; NbExp=13; IntAct=EBI-2835440, EBI-2872294;
CC       Q6ZMJ4-1:IL34; NbExp=9; IntAct=EBI-2835440, EBI-15978980;
CC   -!- SUBCELLULAR LOCATION: Cell membrane; Single-pass type I membrane
CC       protein.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P07333-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P07333-2; Sequence=VSP_047757, VSP_047758;
CC   -!- TISSUE SPECIFICITY: Expressed in bone marrow and in differentiated
CC       blood mononuclear cells.
CC   -!- INDUCTION: Up-regulated by glucocorticoids.
CC       {ECO:0000269|PubMed:7845678}.
CC   -!- DOMAIN: The juxtamembrane domain functions as autoinhibitory
CC       region. Phosphorylation of tyrosine residues in this region leads
CC       to a conformation change and activation of the kinase.
CC   -!- DOMAIN: The activation loop plays an important role in the
CC       regulation of kinase activity. Phosphorylation of tyrosine
CC       residues in this region leads to a conformation change and
CC       activation of the kinase.
CC   -!- PTM: Autophosphorylated in response to CSF1 or IL34 binding.
CC       Phosphorylation at Tyr-561 is important for normal down-regulation
CC       of signaling by ubiquitination, internalization and degradation.
CC       Phosphorylation at Tyr-561 and Tyr-809 is important for
CC       interaction with SRC family members, including FYN, YES1 and SRC,
CC       and for subsequent activation of these protein kinases.
CC       Phosphorylation at Tyr-699 and Tyr-923 is important for
CC       interaction with GRB2. Phosphorylation at Tyr-723 is important for
CC       interaction with PIK3R1. Phosphorylation at Tyr-708 is important
CC       for normal receptor degradation. Phosphorylation at Tyr-723 and
CC       Tyr-809 is important for interaction with PLCG2. Phosphorylation
CC       at Tyr-969 is important for interaction with CBL.
CC       Dephosphorylation by PTPN2 negatively regulates downstream
CC       signaling and macrophage differentiation.
CC       {ECO:0000269|PubMed:16170366, ECO:0000269|PubMed:20489731}.
CC   -!- PTM: Ubiquitinated. Becomes rapidly polyubiquitinated after
CC       autophosphorylation, leading to its degradation.
CC       {ECO:0000269|PubMed:16170366}.
CC   -!- DISEASE: Note=Aberrant expression of CSF1 or CSF1R can promote
CC       cancer cell proliferation, invasion and formation of metastases.
CC       Overexpression of CSF1 or CSF1R is observed in a significant
CC       percentage of breast, ovarian, prostate, and endometrial cancers.
CC   -!- DISEASE: Note=Aberrant expression of CSF1 or CSF1R may play a role
CC       in inflammatory diseases, such as rheumatoid arthritis,
CC       glomerulonephritis, atherosclerosis, and allograft rejection.
CC   -!- DISEASE: Leukoencephalopathy, diffuse hereditary, with spheroids
CC       (HDLS) [MIM:221820]: An autosomal dominant adult-onset rapidly
CC       progressive neurodegenerative disorder characterized by variable
CC       behavioral, cognitive, and motor changes. Patients often die of
CC       dementia within 6 years of onset. Brain imaging shows patchy
CC       abnormalities in the cerebral white matter, predominantly
CC       affecting the frontal and parietal lobes.
CC       {ECO:0000269|PubMed:22197934, ECO:0000269|PubMed:24532199}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. Tyr protein
CC       kinase family. CSF-1/PDGF receptor subfamily.
CC       {ECO:0000255|PROSITE-ProRule:PRU00159}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/CSF1RID40161ch5q32.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X03663; CAA27300.1; -; mRNA.
DR   EMBL; U63963; AAB51696.1; -; Genomic_DNA.
DR   EMBL; M25786; AAA58421.1; -; mRNA.
DR   EMBL; EU826593; ACF47629.1; -; mRNA.
DR   EMBL; AC011382; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471062; EAW61749.1; -; Genomic_DNA.
DR   EMBL; CH471062; EAW61750.1; -; Genomic_DNA.
DR   EMBL; BC047521; AAH47521.1; -; mRNA.
DR   EMBL; M14002; AAA35849.1; -; Genomic_DNA.
DR   EMBL; U78096; AAB51235.1; -; Genomic_DNA.
DR   EMBL; M11067; AAA35848.1; -; Genomic_DNA.
DR   EMBL; M14193; AAA35834.1; -; mRNA.
DR   CCDS; CCDS4302.1; -. [P07333-1]
DR   PIR; S08123; TVHUMD.
DR   RefSeq; NP_001275634.1; NM_001288705.2. [P07333-1]
DR   RefSeq; NP_005202.2; NM_005211.3. [P07333-1]
DR   UniGene; Hs.586219; -.
DR   PDB; 2I0V; X-ray; 2.80 A; A=538-678, A=753-922.
DR   PDB; 2I0Y; X-ray; 1.90 A; A=538-678, A=753-922.
DR   PDB; 2I1M; X-ray; 1.80 A; A=538-678, A=753-922.
DR   PDB; 2OGV; X-ray; 2.70 A; A=543-918.
DR   PDB; 3BEA; X-ray; 2.02 A; A=538-678, A=753-922.
DR   PDB; 3DPK; X-ray; 1.95 A; A=538-678, A=771-922.
DR   PDB; 3KRJ; X-ray; 2.10 A; A=538-678, A=753-922.
DR   PDB; 3KRL; X-ray; 2.40 A; A=538-678, A=753-922.
DR   PDB; 3LCD; X-ray; 2.50 A; A=538-919.
DR   PDB; 3LCO; X-ray; 3.40 A; A=550-919.
DR   PDB; 4DKD; X-ray; 3.00 A; C=20-299.
DR   PDB; 4HW7; X-ray; 2.90 A; A=542-919.
DR   PDB; 4LIQ; X-ray; 2.60 A; E=2-512.
DR   PDB; 4R7H; X-ray; 2.80 A; A=542-919.
DR   PDB; 4R7I; X-ray; 2.75 A; A=542-919.
DR   PDB; 4WRL; X-ray; 2.80 A; A/C=20-296.
DR   PDB; 4WRM; X-ray; 6.85 A; A=20-504.
DR   PDBsum; 2I0V; -.
DR   PDBsum; 2I0Y; -.
DR   PDBsum; 2I1M; -.
DR   PDBsum; 2OGV; -.
DR   PDBsum; 3BEA; -.
DR   PDBsum; 3DPK; -.
DR   PDBsum; 3KRJ; -.
DR   PDBsum; 3KRL; -.
DR   PDBsum; 3LCD; -.
DR   PDBsum; 3LCO; -.
DR   PDBsum; 4DKD; -.
DR   PDBsum; 4HW7; -.
DR   PDBsum; 4LIQ; -.
DR   PDBsum; 4R7H; -.
DR   PDBsum; 4R7I; -.
DR   PDBsum; 4WRL; -.
DR   PDBsum; 4WRM; -.
DR   ProteinModelPortal; P07333; -.
DR   SMR; P07333; -.
DR   BioGrid; 107823; 23.
DR   DIP; DIP-59421N; -.
DR   IntAct; P07333; 15.
DR   MINT; P07333; -.
DR   STRING; 9606.ENSP00000286301; -.
DR   BindingDB; P07333; -.
DR   ChEMBL; CHEMBL1844; -.
DR   DrugBank; DB07167; 5-CYANO-FURAN-2-CARBOXYLIC ACID [5-HYDROXYMETHYL-2-(4-METHYL-PIPERIDIN-1-YL)-PHENYL]-AMIDE.
DR   DrugBank; DB07202; 6-CHLORO-3-(3-METHYLISOXAZOL-5-YL)-4-PHENYLQUINOLIN-2(1H)-ONE.
DR   DrugBank; DB06080; ABT-869.
DR   DrugBank; DB00619; Imatinib.
DR   DrugBank; DB01268; Sunitinib.
DR   GuidetoPHARMACOLOGY; 1806; -.
DR   iPTMnet; P07333; -.
DR   PhosphoSitePlus; P07333; -.
DR   BioMuta; CSF1R; -.
DR   DMDM; 547770; -.
DR   EPD; P07333; -.
DR   PaxDb; P07333; -.
DR   PeptideAtlas; P07333; -.
DR   PRIDE; P07333; -.
DR   DNASU; 1436; -.
DR   Ensembl; ENST00000286301; ENSP00000286301; ENSG00000182578. [P07333-1]
DR   Ensembl; ENST00000543093; ENSP00000445282; ENSG00000182578. [P07333-2]
DR   GeneID; 1436; -.
DR   KEGG; hsa:1436; -.
DR   UCSC; uc003lrm.3; human. [P07333-1]
DR   CTD; 1436; -.
DR   DisGeNET; 1436; -.
DR   EuPathDB; HostDB:ENSG00000182578.13; -.
DR   GeneCards; CSF1R; -.
DR   GeneReviews; CSF1R; -.
DR   HGNC; HGNC:2433; CSF1R.
DR   HPA; CAB008970; -.
DR   HPA; HPA012323; -.
DR   MalaCards; CSF1R; -.
DR   MIM; 164770; gene.
DR   MIM; 221820; phenotype.
DR   neXtProt; NX_P07333; -.
DR   OpenTargets; ENSG00000182578; -.
DR   Orphanet; 313808; Hereditary diffuse leukoencephalopathy with axonal spheroids and pigmented glia.
DR   PharmGKB; PA26936; -.
DR   eggNOG; KOG0200; Eukaryota.
DR   eggNOG; COG0515; LUCA.
DR   GeneTree; ENSGT00760000118923; -.
DR   HOGENOM; HOG000112008; -.
DR   HOVERGEN; HBG004335; -.
DR   InParanoid; P07333; -.
DR   KO; K05090; -.
DR   OMA; WKIIESY; -.
DR   OrthoDB; EOG091G01TL; -.
DR   PhylomeDB; P07333; -.
DR   TreeFam; TF325768; -.
DR   BRENDA; 2.7.10.1; 2681.
DR   Reactome; R-HSA-449836; Other interleukin signaling.
DR   SignaLink; P07333; -.
DR   SIGNOR; P07333; -.
DR   ChiTaRS; CSF1R; human.
DR   EvolutionaryTrace; P07333; -.
DR   GeneWiki; Colony_stimulating_factor_1_receptor; -.
DR   GenomeRNAi; 1436; -.
DR   PRO; PR:P07333; -.
DR   Proteomes; UP000005640; Chromosome 5.
DR   Bgee; ENSG00000182578; -.
DR   CleanEx; HS_CSF1R; -.
DR   ExpressionAtlas; P07333; baseline and differential.
DR   Genevisible; P07333; HS.
DR   GO; GO:0009986; C:cell surface; ISS:UniProtKB.
DR   GO; GO:1990682; C:CSF1-CSF1R complex; ISS:BHF-UCL.
DR   GO; GO:0005887; C:integral component of plasma membrane; TAS:ProtInc.
DR   GO; GO:0043231; C:intracellular membrane-bounded organelle; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005886; C:plasma membrane; IDA:HPA.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0019955; F:cytokine binding; IDA:UniProtKB.
DR   GO; GO:0005011; F:macrophage colony-stimulating factor receptor activity; IMP:UniProtKB.
DR   GO; GO:0042803; F:protein homodimerization activity; ISS:BHF-UCL.
DR   GO; GO:0019903; F:protein phosphatase binding; IEA:Ensembl.
DR   GO; GO:0007411; P:axon guidance; IEA:Ensembl.
DR   GO; GO:0008283; P:cell proliferation; IMP:UniProtKB.
DR   GO; GO:0045217; P:cell-cell junction maintenance; IMP:UniProtKB.
DR   GO; GO:0071345; P:cellular response to cytokine stimulus; ISS:UniProtKB.
DR   GO; GO:0036006; P:cellular response to macrophage colony-stimulating factor stimulus; IMP:UniProtKB.
DR   GO; GO:0019221; P:cytokine-mediated signaling pathway; IMP:UniProtKB.
DR   GO; GO:0021879; P:forebrain neuron differentiation; IEA:Ensembl.
DR   GO; GO:0030097; P:hemopoiesis; IMP:UniProtKB.
DR   GO; GO:0006954; P:inflammatory response; TAS:UniProtKB.
DR   GO; GO:0045087; P:innate immune response; IEA:UniProtKB-KW.
DR   GO; GO:0038145; P:macrophage colony-stimulating factor signaling pathway; ISS:BHF-UCL.
DR   GO; GO:0030225; P:macrophage differentiation; TAS:UniProtKB.
DR   GO; GO:0060603; P:mammary gland duct morphogenesis; TAS:UniProtKB.
DR   GO; GO:0030224; P:monocyte differentiation; TAS:UniProtKB.
DR   GO; GO:0007275; P:multicellular organism development; TAS:ProtInc.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; IEA:Ensembl.
DR   GO; GO:0008285; P:negative regulation of cell proliferation; IEA:Ensembl.
DR   GO; GO:0021772; P:olfactory bulb development; IEA:Ensembl.
DR   GO; GO:0030316; P:osteoclast differentiation; ISS:UniProtKB.
DR   GO; GO:0018108; P:peptidyl-tyrosine phosphorylation; IDA:UniProtKB.
DR   GO; GO:0046488; P:phosphatidylinositol metabolic process; ISS:UniProtKB.
DR   GO; GO:0048015; P:phosphatidylinositol-mediated signaling; ISS:UniProtKB.
DR   GO; GO:0030335; P:positive regulation of cell migration; ISS:UniProtKB.
DR   GO; GO:2000147; P:positive regulation of cell motility; IMP:UniProtKB.
DR   GO; GO:0008284; P:positive regulation of cell proliferation; IMP:UniProtKB.
DR   GO; GO:0090197; P:positive regulation of chemokine secretion; IMP:UniProtKB.
DR   GO; GO:0070374; P:positive regulation of ERK1 and ERK2 cascade; ISS:UniProtKB.
DR   GO; GO:0001934; P:positive regulation of protein phosphorylation; IMP:UniProtKB.
DR   GO; GO:0071902; P:positive regulation of protein serine/threonine kinase activity; ISS:UniProtKB.
DR   GO; GO:0061098; P:positive regulation of protein tyrosine kinase activity; IMP:UniProtKB.
DR   GO; GO:0042531; P:positive regulation of tyrosine phosphorylation of STAT protein; ISS:UniProtKB.
DR   GO; GO:0046777; P:protein autophosphorylation; IDA:UniProtKB.
DR   GO; GO:2000249; P:regulation of actin cytoskeleton reorganization; ISS:UniProtKB.
DR   GO; GO:0045124; P:regulation of bone resorption; ISS:UniProtKB.
DR   GO; GO:0008360; P:regulation of cell shape; IMP:UniProtKB.
DR   GO; GO:0031529; P:ruffle organization; ISS:UniProtKB.
DR   GO; GO:0007165; P:signal transduction; TAS:ProtInc.
DR   GO; GO:0007169; P:transmembrane receptor protein tyrosine kinase signaling pathway; ISS:UniProtKB.
DR   Gene3D; 2.60.40.10; -; 5.
DR   InterPro; IPR030658; CSF-1_receptor.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR036179; Ig-like_dom_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR003599; Ig_sub.
DR   InterPro; IPR003598; Ig_sub2.
DR   InterPro; IPR013151; Immunoglobulin.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR001245; Ser-Thr/Tyr_kinase_cat_dom.
DR   InterPro; IPR008266; Tyr_kinase_AS.
DR   InterPro; IPR020635; Tyr_kinase_cat_dom.
DR   InterPro; IPR001824; Tyr_kinase_rcpt_3_CS.
DR   Pfam; PF00047; ig; 1.
DR   Pfam; PF07714; Pkinase_Tyr; 1.
DR   PIRSF; PIRSF500947; CSF-1_receptor; 1.
DR   SMART; SM00409; IG; 5.
DR   SMART; SM00408; IGc2; 2.
DR   SMART; SM00219; TyrKc; 1.
DR   SUPFAM; SSF48726; SSF48726; 5.
DR   SUPFAM; SSF56112; SSF56112; 2.
DR   PROSITE; PS50835; IG_LIKE; 3.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00109; PROTEIN_KINASE_TYR; 1.
DR   PROSITE; PS00240; RECEPTOR_TYR_KIN_III; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; ATP-binding; Cell membrane;
KW   Complete proteome; Disease mutation; Disulfide bond; Glycoprotein;
KW   Immunity; Immunoglobulin domain; Inflammatory response;
KW   Innate immunity; Kinase; Membrane; Nucleotide-binding; Phosphoprotein;
KW   Polymorphism; Proto-oncogene; Receptor; Reference proteome; Repeat;
KW   Signal; Transferase; Transmembrane; Transmembrane helix;
KW   Tyrosine-protein kinase; Ubl conjugation.
FT   SIGNAL        1     19       {ECO:0000255}.
FT   CHAIN        20    972       Macrophage colony-stimulating factor 1
FT                                receptor.
FT                                /FTId=PRO_0000016765.
FT   TOPO_DOM     20    517       Extracellular. {ECO:0000255}.
FT   TRANSMEM    518    538       Helical. {ECO:0000255}.
FT   TOPO_DOM    539    972       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN       21    104       Ig-like C2-type 1.
FT   DOMAIN      107    197       Ig-like C2-type 2.
FT   DOMAIN      203    290       Ig-like C2-type 3.
FT   DOMAIN      299    399       Ig-like C2-type 4.
FT   DOMAIN      402    502       Ig-like C2-type 5.
FT   DOMAIN      582    910       Protein kinase. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   NP_BIND     588    596       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   REGION      542    574       Regulatory juxtamembrane domain.
FT   REGION      796    818       Activation loop.
FT   ACT_SITE    778    778       Proton acceptor. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159, ECO:0000255|PROSITE-
FT                                ProRule:PRU10028}.
FT   BINDING     616    616       ATP. {ECO:0000305}.
FT   MOD_RES     546    546       Phosphotyrosine; by autocatalysis.
FT                                {ECO:0000269|PubMed:20489731}.
FT   MOD_RES     561    561       Phosphotyrosine; by autocatalysis.
FT                                {ECO:0000250|UniProtKB:P09581}.
FT   MOD_RES     699    699       Phosphotyrosine; by autocatalysis.
FT                                {ECO:0000244|PubMed:19369195,
FT                                ECO:0000269|PubMed:20489731}.
FT   MOD_RES     708    708       Phosphotyrosine; by autocatalysis.
FT                                {ECO:0000269|PubMed:20489731}.
FT   MOD_RES     713    713       Phosphoserine.
FT                                {ECO:0000244|PubMed:19369195}.
FT   MOD_RES     723    723       Phosphotyrosine; by autocatalysis.
FT                                {ECO:0000269|PubMed:20489731}.
FT   MOD_RES     809    809       Phosphotyrosine; by autocatalysis.
FT                                {ECO:0000269|PubMed:20489731}.
FT   MOD_RES     923    923       Phosphotyrosine; by autocatalysis.
FT                                {ECO:0000250|UniProtKB:P09581}.
FT   MOD_RES     969    969       Phosphotyrosine; by autocatalysis.
FT                                {ECO:0000250|UniProtKB:P09581}.
FT   CARBOHYD     45     45       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD     73     73       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    153    153       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    240    240       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    275    275       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    302    302       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:16335952}.
FT   CARBOHYD    335    335       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    353    353       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:16335952}.
FT   CARBOHYD    412    412       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    428    428       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    480    480       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID     42     84       {ECO:0000255|PROSITE-ProRule:PRU00114}.
FT   DISULFID    127    177       {ECO:0000255|PROSITE-ProRule:PRU00114}.
FT   DISULFID    224    278       {ECO:0000255|PROSITE-ProRule:PRU00114}.
FT   DISULFID    419    485       {ECO:0000255|PROSITE-ProRule:PRU00114}.
FT   VAR_SEQ     297    306       ESAYLNLSSE -> GTPSPSLCPA (in isoform 2).
FT                                {ECO:0000303|PubMed:18593464}.
FT                                /FTId=VSP_047757.
FT   VAR_SEQ     307    972       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:18593464}.
FT                                /FTId=VSP_047758.
FT   VARIANT      32     32       V -> G (in dbSNP:rs56048668).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_042038.
FT   VARIANT     245    245       A -> S (in dbSNP:rs41338945).
FT                                /FTId=VAR_061290.
FT   VARIANT     279    279       V -> M (in dbSNP:rs3829986).
FT                                /FTId=VAR_049718.
FT   VARIANT     362    362       H -> R (in dbSNP:rs10079250).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_042039.
FT   VARIANT     413    413       G -> S (in dbSNP:rs34951517).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_042040.
FT   VARIANT     536    536       L -> V (in dbSNP:rs55942044).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_042041.
FT   VARIANT     585    619       GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLK -> A
FT                                (in HDLS). {ECO:0000269|PubMed:22197934}.
FT                                /FTId=VAR_067396.
FT   VARIANT     589    589       G -> E (in HDLS; dbSNP:rs281860268).
FT                                {ECO:0000269|PubMed:22197934}.
FT                                /FTId=VAR_067397.
FT   VARIANT     633    633       E -> K (in HDLS; impairs
FT                                autophosphorylation upon stimulation with
FT                                CSF1; dbSNP:rs281860269).
FT                                {ECO:0000269|PubMed:22197934}.
FT                                /FTId=VAR_067398.
FT   VARIANT     653    653       C -> R (in HDLS; dbSNP:rs690016559).
FT                                {ECO:0000269|PubMed:24532199}.
FT                                /FTId=VAR_072081.
FT   VARIANT     693    693       P -> H (in a lung squamous cell carcinoma
FT                                sample; somatic mutation).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_042042.
FT   VARIANT     710    710       R -> H (in dbSNP:rs201569135).
FT                                {ECO:0000269|PubMed:22197934}.
FT                                /FTId=VAR_067399.
FT   VARIANT     747    747       G -> R (in dbSNP:rs41355444).
FT                                {ECO:0000269|PubMed:22197934}.
FT                                /FTId=VAR_067400.
FT   VARIANT     766    766       M -> T (in HDLS; impairs
FT                                autophosphorylation upon stimulation with
FT                                CSF1; dbSNP:rs281860270).
FT                                {ECO:0000269|PubMed:22197934}.
FT                                /FTId=VAR_067401.
FT   VARIANT     770    770       A -> P (in HDLS; dbSNP:rs281860271).
FT                                {ECO:0000269|PubMed:22197934}.
FT                                /FTId=VAR_067402.
FT   VARIANT     774    814       Missing (in HDLS).
FT                                {ECO:0000269|PubMed:22197934}.
FT                                /FTId=VAR_067403.
FT   VARIANT     775    775       I -> N (in HDLS; impairs
FT                                autophosphorylation upon stimulation with
FT                                CSF1; dbSNP:rs281860273).
FT                                {ECO:0000269|PubMed:22197934}.
FT                                /FTId=VAR_067404.
FT   VARIANT     794    794       I -> T (in HDLS; dbSNP:rs281860274).
FT                                {ECO:0000269|PubMed:22197934}.
FT                                /FTId=VAR_067405.
FT   VARIANT     837    837       D -> Y (in HDLS; dbSNP:rs387906662).
FT                                {ECO:0000269|PubMed:22197934}.
FT                                /FTId=VAR_067406.
FT   VARIANT     843    843       I -> F (in HDLS; dbSNP:rs690016558).
FT                                {ECO:0000269|PubMed:24532199}.
FT                                /FTId=VAR_072082.
FT   VARIANT     849    849       F -> S (in HDLS; dbSNP:rs281860277).
FT                                {ECO:0000269|PubMed:22197934}.
FT                                /FTId=VAR_067407.
FT   VARIANT     849    849       Missing (in HDLS).
FT                                {ECO:0000269|PubMed:22197934}.
FT                                /FTId=VAR_067408.
FT   VARIANT     868    868       L -> P (in HDLS; dbSNP:rs281860278).
FT                                {ECO:0000269|PubMed:22197934}.
FT                                /FTId=VAR_067409.
FT   VARIANT     875    875       M -> T (in HDLS; dbSNP:rs281860279).
FT                                {ECO:0000269|PubMed:22197934}.
FT                                /FTId=VAR_067410.
FT   VARIANT     878    878       P -> T (in HDLS; dbSNP:rs281860280).
FT                                {ECO:0000269|PubMed:22197934}.
FT                                /FTId=VAR_067411.
FT   VARIANT     906    906       I -> T (in HDLS; dbSNP:rs690016560).
FT                                {ECO:0000269|PubMed:24532199}.
FT                                /FTId=VAR_072083.
FT   VARIANT     920    920       E -> D (in dbSNP:rs34030164).
FT                                {ECO:0000269|PubMed:17344846,
FT                                ECO:0000269|PubMed:22197934}.
FT                                /FTId=VAR_042043.
FT   VARIANT     921    921       R -> Q (in dbSNP:rs56059682).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_042044.
FT   VARIANT     969    969       Y -> C (in dbSNP:rs1801271).
FT                                /FTId=VAR_011953.
FT   MUTAGEN     301    301       L->S: Constitutive kinase activity.
FT                                {ECO:0000269|PubMed:15117969}.
FT   MUTAGEN     708    708       Y->F: Impairs degradation of activated
FT                                CSF1R. {ECO:0000269|PubMed:10340379}.
FT   MUTAGEN     802    802       D->V: Constitutive kinase activity. Loss
FT                                of inhibition by imatinib.
FT                                {ECO:0000269|PubMed:10340379,
FT                                ECO:0000269|PubMed:16170366}.
FT   MUTAGEN     809    809       Y->F: Reduced kinase activity. Reduced
FT                                interaction with SRC, FYN and YES1.
FT                                {ECO:0000269|PubMed:7681396}.
FT   MUTAGEN     969    969       Y->F: Abolishes down-regulation of
FT                                activated CSF1R.
FT                                {ECO:0000269|PubMed:15117969}.
FT   CONFLICT     54     54       P -> A (in Ref. 2; CAA27300).
FT                                {ECO:0000305}.
FT   CONFLICT    247    247       P -> H (in Ref. 7; AAH47521).
FT                                {ECO:0000305}.
FT   CONFLICT    354    354       A -> V (in Ref. 7; AAH47521).
FT                                {ECO:0000305}.
FT   CONFLICT    629    629       A -> S (in Ref. 7; AAH47521).
FT                                {ECO:0000305}.
FT   STRAND       22     25       {ECO:0000244|PDB:4LIQ}.
FT   STRAND       27     32       {ECO:0000244|PDB:4LIQ}.
FT   STRAND       38     43       {ECO:0000244|PDB:4LIQ}.
FT   STRAND       49     51       {ECO:0000244|PDB:4LIQ}.
FT   TURN         55     57       {ECO:0000244|PDB:4LIQ}.
FT   STRAND       58     62       {ECO:0000244|PDB:4LIQ}.
FT   STRAND       64     73       {ECO:0000244|PDB:4LIQ}.
FT   HELIX        76     78       {ECO:0000244|PDB:4LIQ}.
FT   STRAND       80     85       {ECO:0000244|PDB:4LIQ}.
FT   STRAND       95    101       {ECO:0000244|PDB:4LIQ}.
FT   STRAND      108    111       {ECO:0000244|PDB:4LIQ}.
FT   STRAND      113    118       {ECO:0000244|PDB:4LIQ}.
FT   STRAND      123    125       {ECO:0000244|PDB:4LIQ}.
FT   STRAND      127    130       {ECO:0000244|PDB:4LIQ}.
FT   HELIX       132    137       {ECO:0000244|PDB:4LIQ}.
FT   STRAND      139    142       {ECO:0000244|PDB:4LIQ}.
FT   HELIX       143    145       {ECO:0000244|PDB:4WRL}.
FT   STRAND      154    157       {ECO:0000244|PDB:4LIQ}.
FT   TURN        158    160       {ECO:0000244|PDB:4LIQ}.
FT   STRAND      161    166       {ECO:0000244|PDB:4LIQ}.
FT   HELIX       169    171       {ECO:0000244|PDB:4LIQ}.
FT   STRAND      173    181       {ECO:0000244|PDB:4LIQ}.
FT   STRAND      184    187       {ECO:0000244|PDB:4LIQ}.
FT   STRAND      191    196       {ECO:0000244|PDB:4LIQ}.
FT   STRAND      204    208       {ECO:0000244|PDB:4LIQ}.
FT   STRAND      210    215       {ECO:0000244|PDB:4LIQ}.
FT   STRAND      216    218       {ECO:0000244|PDB:4DKD}.
FT   STRAND      220    231       {ECO:0000244|PDB:4LIQ}.
FT   STRAND      234    239       {ECO:0000244|PDB:4LIQ}.
FT   STRAND      248    252       {ECO:0000244|PDB:4LIQ}.
FT   STRAND      257    267       {ECO:0000244|PDB:4LIQ}.
FT   TURN        270    272       {ECO:0000244|PDB:4LIQ}.
FT   STRAND      274    282       {ECO:0000244|PDB:4LIQ}.
FT   STRAND      285    298       {ECO:0000244|PDB:4LIQ}.
FT   STRAND      300    304       {ECO:0000244|PDB:4LIQ}.
FT   STRAND      309    314       {ECO:0000244|PDB:4LIQ}.
FT   STRAND      319    329       {ECO:0000244|PDB:4LIQ}.
FT   STRAND      332    338       {ECO:0000244|PDB:4LIQ}.
FT   STRAND      340    342       {ECO:0000244|PDB:4LIQ}.
FT   STRAND      351    354       {ECO:0000244|PDB:4LIQ}.
FT   STRAND      361    368       {ECO:0000244|PDB:4LIQ}.
FT   HELIX       373    375       {ECO:0000244|PDB:4LIQ}.
FT   STRAND      377    385       {ECO:0000244|PDB:4LIQ}.
FT   STRAND      388    411       {ECO:0000244|PDB:4LIQ}.
FT   STRAND      414    425       {ECO:0000244|PDB:4LIQ}.
FT   STRAND      428    437       {ECO:0000244|PDB:4LIQ}.
FT   TURN        443    445       {ECO:0000244|PDB:4LIQ}.
FT   STRAND      446    454       {ECO:0000244|PDB:4LIQ}.
FT   STRAND      456    459       {ECO:0000244|PDB:4LIQ}.
FT   STRAND      466    473       {ECO:0000244|PDB:4LIQ}.
FT   STRAND      479    488       {ECO:0000244|PDB:4LIQ}.
FT   STRAND      493    498       {ECO:0000244|PDB:4LIQ}.
FT   STRAND      551    553       {ECO:0000244|PDB:4R7H}.
FT   STRAND      556    560       {ECO:0000244|PDB:3BEA}.
FT   HELIX       566    568       {ECO:0000244|PDB:3KRJ}.
FT   HELIX       573    575       {ECO:0000244|PDB:2I1M}.
FT   STRAND      581    590       {ECO:0000244|PDB:2I1M}.
FT   STRAND      592    601       {ECO:0000244|PDB:2I1M}.
FT   STRAND      605    607       {ECO:0000244|PDB:2I1M}.
FT   STRAND      612    618       {ECO:0000244|PDB:2I1M}.
FT   HELIX       624    640       {ECO:0000244|PDB:2I1M}.
FT   STRAND      649    653       {ECO:0000244|PDB:2I1M}.
FT   STRAND      655    658       {ECO:0000244|PDB:2I1M}.
FT   STRAND      660    664       {ECO:0000244|PDB:2I1M}.
FT   HELIX       671    682       {ECO:0000244|PDB:2I1M}.
FT   TURN        684    686       {ECO:0000244|PDB:4R7I}.
FT   TURN        742    744       {ECO:0000244|PDB:2OGV}.
FT   HELIX       753    771       {ECO:0000244|PDB:2I1M}.
FT   HELIX       781    783       {ECO:0000244|PDB:2I1M}.
FT   STRAND      785    787       {ECO:0000244|PDB:2I1M}.
FT   HELIX       788    790       {ECO:0000244|PDB:2I1M}.
FT   STRAND      791    794       {ECO:0000244|PDB:2I1M}.
FT   HELIX       798    800       {ECO:0000244|PDB:2I1M}.
FT   HELIX       803    805       {ECO:0000244|PDB:2I1M}.
FT   TURN        806    808       {ECO:0000244|PDB:3LCO}.
FT   STRAND      809    811       {ECO:0000244|PDB:2I1M}.
FT   STRAND      815    817       {ECO:0000244|PDB:3BEA}.
FT   HELIX       819    821       {ECO:0000244|PDB:2I1M}.
FT   HELIX       824    829       {ECO:0000244|PDB:2I1M}.
FT   HELIX       834    848       {ECO:0000244|PDB:2I1M}.
FT   TURN        849    851       {ECO:0000244|PDB:2I1M}.
FT   HELIX       863    871       {ECO:0000244|PDB:2I1M}.
FT   HELIX       883    892       {ECO:0000244|PDB:2I1M}.
FT   HELIX       897    899       {ECO:0000244|PDB:2I1M}.
FT   HELIX       903    920       {ECO:0000244|PDB:2I1M}.
SQ   SEQUENCE   972 AA;  107984 MW;  A8D99BE237573FE8 CRC64;
     MGPGVLLLLL VATAWHGQGI PVIEPSVPEL VVKPGATVTL RCVGNGSVEW DGPPSPHWTL
     YSDGSSSILS TNNATFQNTG TYRCTEPGDP LGGSAAIHLY VKDPARPWNV LAQEVVVFED
     QDALLPCLLT DPVLEAGVSL VRVRGRPLMR HTNYSFSPWH GFTIHRAKFI QSQDYQCSAL
     MGGRKVMSIS IRLKVQKVIP GPPALTLVPA ELVRIRGEAA QIVCSASSVD VNFDVFLQHN
     NTKLAIPQQS DFHNNRYQKV LTLNLDQVDF QHAGNYSCVA SNVQGKHSTS MFFRVVESAY
     LNLSSEQNLI QEVTVGEGLN LKVMVEAYPG LQGFNWTYLG PFSDHQPEPK LANATTKDTY
     RHTFTLSLPR LKPSEAGRYS FLARNPGGWR ALTFELTLRY PPEVSVIWTF INGSGTLLCA
     ASGYPQPNVT WLQCSGHTDR CDEAQVLQVW DDPYPEVLSQ EPFHKVTVQS LLTVETLEHN
     QTYECRAHNS VGSGSWAFIP ISAGAHTHPP DEFLFTPVVV ACMSIMALLL LLLLLLLYKY
     KQKPKYQVRW KIIESYEGNS YTFIDPTQLP YNEKWEFPRN NLQFGKTLGA GAFGKVVEAT
     AFGLGKEDAV LKVAVKMLKS TAHADEKEAL MSELKIMSHL GQHENIVNLL GACTHGGPVL
     VITEYCCYGD LLNFLRRKAE AMLGPSLSPG QDPEGGVDYK NIHLEKKYVR RDSGFSSQGV
     DTYVEMRPVS TSSNDSFSEQ DLDKEDGRPL ELRDLLHFSS QVAQGMAFLA SKNCIHRDVA
     ARNVLLTNGH VAKIGDFGLA RDIMNDSNYI VKGNARLPVK WMAPESIFDC VYTVQSDVWS
     YGILLWEIFS LGLNPYPGIL VNSKFYKLVK DGYQMAQPAF APKNIYSIMQ ACWALEPTHR
     PTFQQICSFL QEQAQEDRRE RDYTNLPSSS RSGGSGSSSS ELEEESSSEH LTCCEQGDIA
     QPLLQPNNYQ FC
//
ID   F6KRI5_HUMAN            Unreviewed;       537 AA.
AC   F6KRI5;
DT   27-JUL-2011, integrated into UniProtKB/TrEMBL.
DT   27-JUL-2011, sequence version 1.
DT   31-JAN-2018, entry version 36.
DE   SubName: Full=Catenin alpha 2 isoform CTNNA2b {ECO:0000313|EMBL:AEF32484.1};
GN   Name=CTNNA2 {ECO:0000313|EMBL:AEF32484.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:AEF32484.1};
RN   [1] {ECO:0000313|EMBL:AEF32484.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Hippocampus {ECO:0000313|EMBL:AEF32484.1};
RX   PubMed=21708131; DOI=10.1016/j.bbrc.2011.06.085;
RA   Kask M., Pruunsild P., Timmusk T.;
RT   "Bidirectional transcription from human LRRTM2/CTNNA1 and
RT   LRRTM1/CTNNA2 gene loci leads to expression of N-terminally truncated
RT   CTNNA1 and CTNNA2 isoforms.";
RL   Biochem. Biophys. Res. Commun. 411:56-61(2011).
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; HQ589336; AEF32484.1; -; mRNA.
DR   RefSeq; NP_001269529.1; NM_001282600.1.
DR   UniGene; Hs.167368; -.
DR   ProteinModelPortal; F6KRI5; -.
DR   SMR; F6KRI5; -.
DR   PRIDE; F6KRI5; -.
DR   GeneID; 1496; -.
DR   CTD; 1496; -.
DR   EuPathDB; HostDB:ENSG00000066032.18; -.
DR   eggNOG; KOG3681; Eukaryota.
DR   eggNOG; ENOG410XSRU; LUCA.
DR   ChiTaRS; CTNNA2; human.
DR   GenomeRNAi; 1496; -.
DR   Bgee; ENSG00000066032; -.
DR   ExpressionAtlas; F6KRI5; baseline and differential.
DR   GO; GO:0005913; C:cell-cell adherens junction; IEA:InterPro.
DR   GO; GO:0051015; F:actin filament binding; IEA:InterPro.
DR   GO; GO:0045296; F:cadherin binding; IEA:InterPro.
DR   GO; GO:0048854; P:brain morphogenesis; IEA:InterPro.
DR   GO; GO:0007155; P:cell adhesion; IEA:InterPro.
DR   InterPro; IPR036723; Alpha-catenin/vinculin-like_sf.
DR   InterPro; IPR001033; Alpha_catenin.
DR   InterPro; IPR030046; CTNNA2.
DR   InterPro; IPR006077; Vinculin/catenin.
DR   PANTHER; PTHR18914; PTHR18914; 1.
DR   PANTHER; PTHR18914:SF23; PTHR18914:SF23; 1.
DR   Pfam; PF01044; Vinculin; 1.
DR   PRINTS; PR00805; ALPHACATENIN.
DR   SUPFAM; SSF47220; SSF47220; 3.
PE   2: Evidence at transcript level;
SQ   SEQUENCE   537 AA;  59868 MW;  71B24F41F0B4D6FB CRC64;
     MTKKTRDLRR QLRKAVMDHI SDSFLETNVP LLVLIEAAKS GNEKEVKEYA QVFREHANKL
     VEVANLACSI SNNEEGVKLV RMAATQIDSL CPQVINAALT LAARPQSKVA QDNMDVFKDQ
     WEKQVRVLTE AVDDITSVDD FLSVSENHIL EDVNKCVIAL QEGDVDTLDR TAGAIRGRAA
     RVIHIINAEM ENYEAGVYTE KVLEATKLLS ETVMPRFAEQ VEVAIEALSA NVPQPFEENE
     FIDASRLVYD GVRDIRKAVL MIRTPEELED DSDFEQEDYD VRSRTSVQTE DDQLIAGQSA
     RAIMAQLPQE EKAKIAEQVE IFHQEKSKLD AEVAKWDDSG NDIIVLAKQM CMIMMEMTDF
     TRGKGPLKNT SDVINAAKKI AEAGSRMDKL ARAVADQCPD SACKQDLLAY LQRIALYCHQ
     LNICSKVKAE VQNLGGELIV SGLDSATSLI QAAKNLMNAV VLTVKASYVA STKYQKVYGT
     AAVNSPVVSW KMKAPEKKPL VKREKPEEFQ TRVRRGSQKK HISPVQALSE FKAMDSF
//
ID   CTNA2_HUMAN             Reviewed;         953 AA.
AC   P26232; B3KXE5; B7Z2W7; B7Z352; B7Z898; Q4ZFW1; Q53R26; Q53R33;
AC   Q53T67; Q53T71; Q53TM8; Q7Z3L1; Q7Z3Y0;
DT   01-MAY-1992, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 5.
DT   25-APR-2018, entry version 170.
DE   RecName: Full=Catenin alpha-2;
DE   AltName: Full=Alpha N-catenin;
DE   AltName: Full=Alpha-catenin-related protein;
GN   Name=CTNNA2; Synonyms=CAPR;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=8432524; DOI=10.1006/geno.1993.1004;
RA   Claverie J.-M., Hardelin J.-P., Legouis R., Levilliers J.,
RA   Bougueleret L., Mattei M.-G., Petit C.;
RT   "Characterization and chromosomal assignment of a human cDNA encoding
RT   a protein related to the murine 102-kDa cadherin-associated protein
RT   (alpha-catenin).";
RL   Genomics 15:13-20(1993).
RN   [2]
RP   SEQUENCE REVISION TO C-TERMINUS.
RA   Hardelin J.-P.;
RL   Submitted (FEB-2000) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 2; 3; 4 AND 5).
RC   TISSUE=Brain, Hippocampus, and Testis;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 6).
RC   TISSUE=Hippocampus;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=PNS;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   INTERACTION WITH ZNF639, AND SUBCELLULAR LOCATION.
RX   PubMed=16182284; DOI=10.1016/j.yexcr.2005.06.018;
RA   Bogaerts S., Vanlandschoot A., van Hengel J., van Roy F.;
RT   "Nuclear translocation of alphaN-catenin by the novel zinc finger
RT   transcriptional repressor ZASC1.";
RL   Exp. Cell Res. 311:1-13(2005).
RN   [9]
RP   ALTERNATIVE SPLICING (ISOFORM 6).
RX   PubMed=18163523; DOI=10.1002/ajmg.b.30679;
RA   Mexal S., Berger R., Pearce L., Barton A., Logel J., Adams C.E.,
RA   Ross R.G., Freedman R., Leonard S.;
RT   "Regulation of a novel alphaN-catenin splice variant in schizophrenic
RT   smokers.";
RL   Am. J. Med. Genet. B Neuropsychiatr. Genet. 147:759-768(2008).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-640, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
CC   -!- FUNCTION: May function as a linker between cadherin adhesion
CC       receptors and the cytoskeleton to regulate cell-cell adhesion and
CC       differentiation in the nervous system. Regulates morphological
CC       plasticity of synapses and cerebellar and hippocampal lamination
CC       during development. Functions in the control of startle
CC       modulation. {ECO:0000250|UniProtKB:Q61301}.
CC   -!- SUBUNIT: Interacts with CDH1 and CDH2 (By similarity). Interacts
CC       with ZNF639; recruits CTNNA2 to the nucleus (PubMed:16182284).
CC       {ECO:0000250|UniProtKB:P30997, ECO:0000269|PubMed:16182284}.
CC   -!- INTERACTION:
CC       Q9UID6:ZNF639; NbExp=7; IntAct=EBI-3953920, EBI-947476;
CC   -!- SUBCELLULAR LOCATION: Cell membrane
CC       {ECO:0000250|UniProtKB:Q61301}; Peripheral membrane protein
CC       {ECO:0000250|UniProtKB:Q61301}; Cytoplasmic side
CC       {ECO:0000250|UniProtKB:Q61301}. Cytoplasm
CC       {ECO:0000269|PubMed:16182284}. Cytoplasm, cytoskeleton
CC       {ECO:0000250|UniProtKB:Q61301}. Cell junction, adherens junction
CC       {ECO:0000250|UniProtKB:Q61301}. Cell projection, axon
CC       {ECO:0000250|UniProtKB:Q61301}. Nucleus
CC       {ECO:0000269|PubMed:16182284}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=6;
CC       Name=1; Synonyms=AlphaN-catenin II;
CC         IsoId=P26232-1; Sequence=Displayed;
CC       Name=2; Synonyms=AlphaN-catenin I;
CC         IsoId=P26232-2; Sequence=VSP_020337;
CC       Name=3;
CC         IsoId=P26232-3; Sequence=VSP_038009;
CC         Note=No experimental confirmation available.;
CC       Name=4;
CC         IsoId=P26232-4; Sequence=VSP_038008, VSP_020337;
CC       Name=5;
CC         IsoId=P26232-5; Sequence=VSP_038007, VSP_020337;
CC         Note=No experimental confirmation available.;
CC       Name=6; Synonyms=AlphaN-catenin III;
CC         IsoId=P26232-6; Sequence=VSP_038005, VSP_038006, VSP_020337;
CC   -!- SIMILARITY: Belongs to the vinculin/alpha-catenin family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M94151; AAA58407.2; -; mRNA.
DR   EMBL; AK127226; BAG54457.1; -; mRNA.
DR   EMBL; AK295181; BAH12003.1; -; mRNA.
DR   EMBL; AK295493; BAH12088.1; -; mRNA.
DR   EMBL; AK303035; BAH13884.1; -; mRNA.
DR   EMBL; BX537769; CAD97832.1; -; mRNA.
DR   EMBL; AC008067; AAY15073.1; -; Genomic_DNA.
DR   EMBL; AC010975; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC011741; AAX93241.1; -; Genomic_DNA.
DR   EMBL; AC011746; AAY15008.1; -; Genomic_DNA.
DR   EMBL; AC016670; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC016716; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC093322; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC096573; AAY14758.1; -; Genomic_DNA.
DR   EMBL; AC096753; AAY14763.1; -; Genomic_DNA.
DR   EMBL; AC104780; AAX88946.1; -; Genomic_DNA.
DR   EMBL; FJ695201; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471053; EAW99564.1; -; Genomic_DNA.
DR   EMBL; CH471053; EAW99565.1; -; Genomic_DNA.
DR   EMBL; BC052996; AAH52996.1; -; mRNA.
DR   CCDS; CCDS42703.2; -. [P26232-2]
DR   CCDS; CCDS54371.1; -. [P26232-3]
DR   CCDS; CCDS62944.1; -. [P26232-1]
DR   CCDS; CCDS62945.1; -. [P26232-6]
DR   CCDS; CCDS74531.1; -. [P26232-4]
DR   PIR; A45011; A45011.
DR   RefSeq; NP_001158355.1; NM_001164883.1. [P26232-3]
DR   RefSeq; NP_001269526.1; NM_001282597.2. [P26232-1]
DR   RefSeq; NP_001269527.1; NM_001282598.1. [P26232-5]
DR   RefSeq; NP_001269528.1; NM_001282599.1. [P26232-6]
DR   RefSeq; NP_001269529.1; NM_001282600.1. [P26232-4]
DR   RefSeq; NP_001307739.1; NM_001320810.1.
DR   RefSeq; NP_004380.2; NM_004389.3. [P26232-2]
DR   RefSeq; XP_011530857.1; XM_011532555.2. [P26232-1]
DR   RefSeq; XP_011530858.1; XM_011532556.2. [P26232-1]
DR   RefSeq; XP_016858892.1; XM_017003403.1. [P26232-2]
DR   UniGene; Hs.167368; -.
DR   ProteinModelPortal; P26232; -.
DR   SMR; P26232; -.
DR   BioGrid; 107877; 28.
DR   DIP; DIP-60979N; -.
DR   IntAct; P26232; 8.
DR   iPTMnet; P26232; -.
DR   PhosphoSitePlus; P26232; -.
DR   SwissPalm; P26232; -.
DR   BioMuta; CTNNA2; -.
DR   DMDM; 114152793; -.
DR   EPD; P26232; -.
DR   MaxQB; P26232; -.
DR   PeptideAtlas; P26232; -.
DR   PRIDE; P26232; -.
DR   TopDownProteomics; P26232-6; -. [P26232-6]
DR   Ensembl; ENST00000343114; ENSP00000341500; ENSG00000066032. [P26232-6]
DR   Ensembl; ENST00000402739; ENSP00000384638; ENSG00000066032. [P26232-1]
DR   Ensembl; ENST00000466387; ENSP00000418191; ENSG00000066032. [P26232-2]
DR   Ensembl; ENST00000496558; ENSP00000419295; ENSG00000066032. [P26232-2]
DR   Ensembl; ENST00000541047; ENSP00000444675; ENSG00000066032. [P26232-4]
DR   Ensembl; ENST00000629316; ENSP00000486160; ENSG00000066032. [P26232-3]
DR   GeneID; 1496; -.
DR   KEGG; hsa:1496; -.
DR   UCSC; uc010yse.3; human. [P26232-1]
DR   CTD; 1496; -.
DR   DisGeNET; 1496; -.
DR   EuPathDB; HostDB:ENSG00000066032.18; -.
DR   GeneCards; CTNNA2; -.
DR   HGNC; HGNC:2510; CTNNA2.
DR   HPA; CAB037175; -.
DR   MIM; 114025; gene.
DR   neXtProt; NX_P26232; -.
DR   OpenTargets; ENSG00000066032; -.
DR   PharmGKB; PA27013; -.
DR   GeneTree; ENSGT00550000074411; -.
DR   HOVERGEN; HBG000069; -.
DR   InParanoid; P26232; -.
DR   KO; K05691; -.
DR   OMA; WENQVRI; -.
DR   OrthoDB; EOG091G01KR; -.
DR   PhylomeDB; P26232; -.
DR   TreeFam; TF313686; -.
DR   Reactome; R-HSA-375170; CDO in myogenesis.
DR   SIGNOR; P26232; -.
DR   ChiTaRS; CTNNA2; human.
DR   GenomeRNAi; 1496; -.
DR   PRO; PR:P26232; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   Bgee; ENSG00000066032; -.
DR   CleanEx; HS_CTNNA2; -.
DR   ExpressionAtlas; P26232; baseline and differential.
DR   Genevisible; P26232; HS.
DR   GO; GO:0015629; C:actin cytoskeleton; IEA:InterPro.
DR   GO; GO:0005912; C:adherens junction; ISS:UniProtKB.
DR   GO; GO:0030424; C:axon; ISS:UniProtKB.
DR   GO; GO:0016323; C:basolateral plasma membrane; IEA:Ensembl.
DR   GO; GO:0005913; C:cell-cell adherens junction; IEA:Ensembl.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0030027; C:lamellipodium; IEA:Ensembl.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0014069; C:postsynaptic density; IEA:Ensembl.
DR   GO; GO:0051015; F:actin filament binding; IEA:InterPro.
DR   GO; GO:0045296; F:cadherin binding; IDA:BHF-UCL.
DR   GO; GO:0042802; F:identical protein binding; IEA:Ensembl.
DR   GO; GO:0005200; F:structural constituent of cytoskeleton; NAS:UniProtKB.
DR   GO; GO:0007409; P:axonogenesis; ISS:UniProtKB.
DR   GO; GO:0048854; P:brain morphogenesis; ISS:UniProtKB.
DR   GO; GO:0098609; P:cell-cell adhesion; ISS:UniProtKB.
DR   GO; GO:0048813; P:dendrite morphogenesis; ISS:UniProtKB.
DR   GO; GO:0051149; P:positive regulation of muscle cell differentiation; TAS:Reactome.
DR   GO; GO:0060134; P:prepulse inhibition; ISS:UniProtKB.
DR   GO; GO:0021942; P:radial glia guided migration of Purkinje cell; ISS:UniProtKB.
DR   GO; GO:0051823; P:regulation of synapse structural plasticity; ISS:UniProtKB.
DR   InterPro; IPR036723; Alpha-catenin/vinculin-like_sf.
DR   InterPro; IPR001033; Alpha_catenin.
DR   InterPro; IPR030046; CTNNA2.
DR   InterPro; IPR006077; Vinculin/catenin.
DR   InterPro; IPR000633; Vinculin_CS.
DR   PANTHER; PTHR18914; PTHR18914; 1.
DR   PANTHER; PTHR18914:SF23; PTHR18914:SF23; 1.
DR   Pfam; PF01044; Vinculin; 2.
DR   PRINTS; PR00805; ALPHACATENIN.
DR   SUPFAM; SSF47220; SSF47220; 5.
DR   PROSITE; PS00663; VINCULIN_1; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cell adhesion; Cell junction; Cell membrane;
KW   Cell projection; Complete proteome; Cytoplasm; Cytoskeleton;
KW   Developmental protein; Differentiation; Membrane; Nucleus;
KW   Phosphoprotein; Reference proteome.
FT   CHAIN         1    953       Catenin alpha-2.
FT                                /FTId=PRO_0000064263.
FT   MOD_RES     632    632       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:Q61301}.
FT   MOD_RES     640    640       Phosphoserine.
FT                                {ECO:0000244|PubMed:21406692}.
FT   MOD_RES     651    651       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q61301}.
FT   MOD_RES     901    901       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q61301}.
FT   MOD_RES     939    939       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q61301}.
FT   VAR_SEQ       1    368       Missing (in isoform 4).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_038008.
FT   VAR_SEQ       1    351       Missing (in isoform 6).
FT                                {ECO:0000303|PubMed:17974005}.
FT                                /FTId=VSP_038005.
FT   VAR_SEQ       1      1       M -> MSGLICLQYGLWHGQKIDFGGPRRLLQRNRGEGSM
FT                                (in isoform 5).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_038007.
FT   VAR_SEQ     352    352       N -> MDGWRRPLQSVGKVCEKNMKTSEMHTMSGAQ (in
FT                                isoform 6).
FT                                {ECO:0000303|PubMed:17974005}.
FT                                /FTId=VSP_038006.
FT   VAR_SEQ     766    858       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_038009.
FT   VAR_SEQ     811    858       Missing (in isoform 2, isoform 4, isoform
FT                                5 and isoform 6).
FT                                {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|PubMed:17974005}.
FT                                /FTId=VSP_020337.
FT   CONFLICT    122    122       T -> A (in Ref. 3; BAH12003).
FT                                {ECO:0000305}.
FT   CONFLICT    182    182       E -> K (in Ref. 1; AAA58407).
FT                                {ECO:0000305}.
FT   CONFLICT    309    309       S -> SS (in Ref. 5; AAY15008).
FT                                {ECO:0000305}.
FT   CONFLICT    651    652       SR -> RG (in Ref. 1; AAA58407).
FT                                {ECO:0000305}.
SQ   SEQUENCE   953 AA;  105313 MW;  5FC88907B37E8A6C CRC64;
     MTSATSPIIL KWDPKSLEIR TLTVERLLEP LVTQVTTLVN TSNKGPSGKK KGRSKKAHVL
     AASVEQATQN FLEKGEQIAK ESQDLKEELV AAVEDVRKQG ETMRIASSEF ADDPCSSVKR
     GTMVRAARAL LSAVTRLLIL ADMADVMRLL SHLKIVEEAL EAVKNATNEQ DLANRFKEFG
     KEMVKLNYVA ARRQQELKDP HCRDEMAAAR GALKKNATML YTASQAFLRH PDVAATRANR
     DYVFKQVQEA IAGISNAAQA TSPTDEAKGH TGIGELAAAL NEFDNKIILD PMTFSEARFR
     PSLEERLESI ISGAALMADS SCTRDDRRER IVAECNAVRQ ALQDLLSEYM NNTGRKEKGD
     PLNIAIDKMT KKTRDLRRQL RKAVMDHISD SFLETNVPLL VLIEAAKSGN EKEVKEYAQV
     FREHANKLVE VANLACSISN NEEGVKLVRM AATQIDSLCP QVINAALTLA ARPQSKVAQD
     NMDVFKDQWE KQVRVLTEAV DDITSVDDFL SVSENHILED VNKCVIALQE GDVDTLDRTA
     GAIRGRAARV IHIINAEMEN YEAGVYTEKV LEATKLLSET VMPRFAEQVE VAIEALSANV
     PQPFEENEFI DASRLVYDGV RDIRKAVLMI RTPEELEDDS DFEQEDYDVR SRTSVQTEDD
     QLIAGQSARA IMAQLPQEEK AKIAEQVEIF HQEKSKLDAE VAKWDDSGND IIVLAKQMCM
     IMMEMTDFTR GKGPLKNTSD VINAAKKIAE AGSRMDKLAR AVADQCPDSA CKQDLLAYLQ
     RIALYCHQLN ICSKVKAEVQ NLGGELIVSG TGVQSTFTTF YEVDCDVIDG GRASQLSTHL
     PTCAEGAPIG SGSSDSSMLD SATSLIQAAK NLMNAVVLTV KASYVASTKY QKVYGTAAVN
     SPVVSWKMKA PEKKPLVKRE KPEEFQTRVR RGSQKKHISP VQALSEFKAM DSF
//
ID   Q49AD3_HUMAN            Unreviewed;       687 AA.
AC   Q49AD3;
DT   13-SEP-2005, integrated into UniProtKB/TrEMBL.
DT   13-SEP-2005, sequence version 1.
DT   31-JAN-2018, entry version 63.
DE   SubName: Full=CTNNA2 protein {ECO:0000313|EMBL:AAH40458.1};
GN   Name=CTNNA2 {ECO:0000313|EMBL:AAH40458.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:AAH40458.1};
RN   [1] {ECO:0000313|EMBL:AAH40458.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain {ECO:0000313|EMBL:AAH40458.1};
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RA   Gerhard D.S., Wagner L., Feingold E.A., Shenmen C.M., Grouse L.H.,
RA   Schuler G., Klein S.L., Old S., Rasooly R., Good P., Guyer M.,
RA   Peck A.M., Derge J.G., Lipman D., Collins F.S., Jang W., Sherry S.,
RA   Feolo M., Misquitta L., Lee E., Rotmistrovsky K., Greenhut S.F.,
RA   Schaefer C.F., Buetow K., Bonner T.I., Haussler D., Kent J.,
RA   Kiekhaus M., Furey T., Brent M., Prange C., Schreiber K., Shapiro N.,
RA   Bhat N.K., Hopkins R.F., Hsie F., Driscoll T., Soares M.B.,
RA   Casavant T.L., Scheetz T.E., Brown-stein M.J., Usdin T.B.,
RA   Toshiyuki S., Carninci P., Piao Y., Dudekula D.B., Ko M.S.,
RA   Kawakami K., Suzuki Y., Sugano S., Gruber C.E., Smith M.R.,
RA   Simmons B., Moore T., Waterman R., Johnson S.L., Ruan Y., Wei C.L.,
RA   Mathavan S., Gunaratne P.H., Wu J., Garcia A.M., Hulyk S.W., Fuh E.,
RA   Yuan Y., Sneed A., Kowis C., Hodgson A., Muzny D.M., McPherson J.,
RA   Gibbs R.A., Fahey J., Helton E., Ketteman M., Madan A., Rodrigues S.,
RA   Sanchez A., Whiting M., Madari A., Young A.C., Wetherby K.D.,
RA   Granite S.J., Kwong P.N., Brinkley C.P., Pearson R.L., Bouffard G.G.,
RA   Blakesly R.W., Green E.D., Dickson M.C., Rodriguez A.C., Grimwood J.,
RA   Schmutz J., Myers R.M., Butterfield Y.S., Griffith M., Griffith O.L.,
RA   Krzywinski M.I., Liao N., Morin R., Morrin R., Palmquist D.,
RA   Petrescu A.S., Skalska U., Smailus D.E., Stott J.M., Schnerch A.,
RA   Schein J.E., Jones S.J., Holt R.A., Baross A., Marra M.A., Clifton S.,
RA   Makowski K.A., Bosak S., Malek J.;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; BC040458; AAH40458.1; -; mRNA.
DR   RefSeq; NP_004380.2; NM_004389.3.
DR   UniGene; Hs.167368; -.
DR   PeptideAtlas; Q49AD3; -.
DR   PRIDE; Q49AD3; -.
DR   GeneID; 1496; -.
DR   CTD; 1496; -.
DR   PharmGKB; PA27009; -.
DR   eggNOG; KOG3681; Eukaryota.
DR   eggNOG; ENOG410XSRU; LUCA.
DR   HOVERGEN; HBG000069; -.
DR   ChiTaRS; CTNNA2; human.
DR   GenomeRNAi; 1496; -.
DR   Genevisible; Q49AD3; HS.
DR   GO; GO:0005913; C:cell-cell adherens junction; IEA:InterPro.
DR   GO; GO:0051015; F:actin filament binding; IEA:InterPro.
DR   GO; GO:0045296; F:cadherin binding; IEA:InterPro.
DR   GO; GO:0048854; P:brain morphogenesis; IEA:InterPro.
DR   GO; GO:0007155; P:cell adhesion; IEA:InterPro.
DR   InterPro; IPR036723; Alpha-catenin/vinculin-like_sf.
DR   InterPro; IPR001033; Alpha_catenin.
DR   InterPro; IPR030046; CTNNA2.
DR   InterPro; IPR006077; Vinculin/catenin.
DR   PANTHER; PTHR18914; PTHR18914; 1.
DR   PANTHER; PTHR18914:SF23; PTHR18914:SF23; 1.
DR   Pfam; PF01044; Vinculin; 2.
DR   PRINTS; PR00805; ALPHACATENIN.
DR   SUPFAM; SSF47220; SSF47220; 4.
PE   2: Evidence at transcript level;
SQ   SEQUENCE   687 AA;  76384 MW;  C7FB874BFAFCA16D CRC64;
     MLYTASQAFL RHPDVAATRA NRDYVFKQVQ EAIAGISNAA QATSPTDEAK GHTGIGELAA
     ALNEFDNKII LDPMTFSEAR FRQSLEERLE SIISGAALMA DSSCTRDDRR ERIVAECNAV
     RQALQDLLSE YMNNTGRKEK GDPLNIAIDK MTKKTRDLRR QLRKAVMDHI SDSFLETNVP
     LLVLIEAAKS GNEKEVKEYA QVFREHANKL VEVANLACSI SNNEEGVKLV RMAATQIDSL
     CPQVINAALT LAARPQSKVA QDNMDVFKDQ WEKQVRVLTE AVDDITSVDD FLSVSENHIL
     EDVNKCVIAL QEGDVDTLDR TAGAIRGRAA RVIHIINAEM ENYEAGVYTE KVLEATKLLS
     ETVMPRFAEQ VEVAIEALSA NVPQPFEENE FIDASRLVYD GVRDIRKAVL MIRTPEELED
     DSDFEQEDYD VRSRTSVQTE DDQLIAGQSA RAIMAQLPQE EKAKIAEQVE IFHQEKSKLD
     AEVAKWDDSG NDIIVLAKQM CMIMMEMTDF TRGKGPLKNT SDVINAAKKI AEAGSRMDKL
     ARAVADQCPD SACKQDLLAY LQRIALYCHQ LNICSKVKAE VQNLGGELIV SGLDSATSLI
     QAAKNLMNAV VLTVKASYVA STKYQKVYGT AAVNSPVVSW KMKAPEKKPL VKREKPEEFQ
     TRVRRGSQKK HISPVQALSE FKAMDSF
//
ID   B4DJU1_HUMAN            Unreviewed;       792 AA.
AC   B4DJU1;
DT   23-SEP-2008, integrated into UniProtKB/TrEMBL.
DT   23-SEP-2008, sequence version 1.
DT   28-FEB-2018, entry version 50.
DE   SubName: Full=cDNA FLJ61296, highly similar to Catenin delta-2 {ECO:0000313|EMBL:BAG58953.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAG58953.1};
RN   [1] {ECO:0000313|EMBL:BAG58953.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Thalamus {ECO:0000313|EMBL:BAG58953.1};
RA   Wakamatsu A., Yamamoto J., Kimura K., Ishii S., Watanabe K.,
RA   Sugiyama A., Murakawa K., Kaida T., Tsuchiya K., Fukuzumi Y.,
RA   Kumagai A., Oishi Y., Yamamoto S., Ono Y., Komori Y., Yamazaki M.,
RA   Kisu Y., Nishikawa T., Sugano S., Nomura N., Isogai T.;
RT   "NEDO human cDNA sequencing project focused on splicing variants.";
RL   Submitted (OCT-2007) to the EMBL/GenBank/DDBJ databases.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK296232; BAG58953.1; -; mRNA.
DR   RefSeq; NP_001275646.1; NM_001288717.1.
DR   UniGene; Hs.314543; -.
DR   ProteinModelPortal; B4DJU1; -.
DR   PeptideAtlas; B4DJU1; -.
DR   PRIDE; B4DJU1; -.
DR   GeneID; 1501; -.
DR   CTD; 1501; -.
DR   eggNOG; KOG1048; Eukaryota.
DR   eggNOG; ENOG410Y21Q; LUCA.
DR   HOVERGEN; HBG004284; -.
DR   SignaLink; B4DJU1; -.
DR   GenomeRNAi; 1501; -.
DR   GO; GO:0098609; P:cell-cell adhesion; IEA:InterPro.
DR   Gene3D; 1.25.10.10; -; 1.
DR   InterPro; IPR011989; ARM-like.
DR   InterPro; IPR016024; ARM-type_fold.
DR   InterPro; IPR000225; Armadillo.
DR   InterPro; IPR028435; Plakophilin/d_Catenin.
DR   PANTHER; PTHR10372; PTHR10372; 1.
DR   Pfam; PF00514; Arm; 4.
DR   SMART; SM00185; ARM; 7.
DR   SUPFAM; SSF48371; SSF48371; 1.
DR   PROSITE; PS50176; ARM_REPEAT; 3.
PE   2: Evidence at transcript level;
FT   REPEAT      159    192       ARM. {ECO:0000256|PROSITE-
FT                                ProRule:PRU00259}.
FT   REPEAT      203    246       ARM. {ECO:0000256|PROSITE-
FT                                ProRule:PRU00259}.
FT   REPEAT      459    496       ARM. {ECO:0000256|PROSITE-
FT                                ProRule:PRU00259}.
SQ   SEQUENCE   792 AA;  87216 MW;  CECEED1CD929EA20 CRC64;
     MRSLSQSQGD PLPPAHTGTY RTSTAPSSPG VDSVPLQRTG SQHGPQNAAA ATFQRASYAA
     GPASNYADPY RQLQYCPSVE SPYSKSGPAL PPEGTLARSP SIDSIQKDPR EFGWRDPELP
     EVIQMLQHQF PSVQSNAAAY LQHLCFGDNK IKAEIRRQGG IQLLVDLLDH RMTEVHRSAC
     GALRNLVYGK ANDDNKIALK NCGGIPALVR LLRKTTDLEI RELVTGVLWN LSSCDALKMP
     IIQDALAVLT NAVIIPHSGW ENSPLQDDRK IQLHSSQVLR NATGCLRNVS SAGEEARRRM
     RECDGLTDAL LYVIQSALGS SEIDSKTVEN CVCILRNLSY RLAAETSQGQ HMGTDELDGL
     LCGEANGKDA ESSGCWGKKK KKKKSQDQWD GVGPLPDCAE PPKGIQMLWH PSIVKPYLTL
     LSECSNPDTL EGAAGALQNL AAGSWKWSVY IRAAVRKEKG LPILVELLRI NNDRVVCAVA
     TALRNMALDV RNKELIGKYA MRDLVHRLPG GNNSNNTASK AMSDDTVTAV CCTLHEVITK
     NMENAKALRD AGGIEKLVGI SKSKGDKHSP KVVKAASQVL NSMWQYRDLR SLYKKDGWSQ
     YHFVASSSTI ERDRQRPYSS SRTPSISPVR VSPNNRSASA PASPREMISL KERKTDYECT
     GSNATYHGAK GEHTSRKDAM TAQNTGISTL YRNSYGAPAE DIKHNQVSAQ PVPQEPSRKD
     YETYQPFQNS TRNYDESFFE DQVHHRPPAS EYTMHLGLKS TGNYVDFYSA ARPYSELNYE
     TSHYPASPDS WV
//
ID   B4DRK2_HUMAN            Unreviewed;       888 AA.
AC   B4DRK2;
DT   23-SEP-2008, integrated into UniProtKB/TrEMBL.
DT   23-SEP-2008, sequence version 1.
DT   25-APR-2018, entry version 78.
DE   SubName: Full=Catenin delta-2 {ECO:0000313|Ensembl:ENSP00000426887};
DE   SubName: Full=cDNA FLJ56233, highly similar to Catenin delta-2 {ECO:0000313|EMBL:BAG61314.1};
GN   Name=CTNND2 {ECO:0000313|Ensembl:ENSP00000426887};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAG61314.1};
RN   [1] {ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15372022; DOI=10.1038/nature02919;
RA   Schmutz J., Martin J., Terry A., Couronne O., Grimwood J., Lowry S.,
RA   Gordon L.A., Scott D., Xie G., Huang W., Hellsten U., Tran-Gyamfi M.,
RA   She X., Prabhakar S., Aerts A., Altherr M., Bajorek E., Black S.,
RA   Branscomb E., Caoile C., Challacombe J.F., Chan Y.M., Denys M.,
RA   Detter J.C., Escobar J., Flowers D., Fotopulos D., Glavina T.,
RA   Gomez M., Gonzales E., Goodstein D., Grigoriev I., Groza M.,
RA   Hammon N., Hawkins T., Haydu L., Israni S., Jett J., Kadner K.,
RA   Kimball H., Kobayashi A., Lopez F., Lou Y., Martinez D., Medina C.,
RA   Morgan J., Nandkeshwar R., Noonan J.P., Pitluck S., Pollard M.,
RA   Predki P., Priest J., Ramirez L., Retterer J., Rodriguez A.,
RA   Rogers S., Salamov A., Salazar A., Thayer N., Tice H., Tsai M.,
RA   Ustaszewska A., Vo N., Wheeler J., Wu K., Yang J., Dickson M.,
RA   Cheng J.-F., Eichler E.E., Olsen A., Pennacchio L.A., Rokhsar D.S.,
RA   Richardson P., Lucas S.M., Myers R.M., Rubin E.M.;
RT   "The DNA sequence and comparative analysis of human chromosome 5.";
RL   Nature 431:268-274(2004).
RN   [2] {ECO:0000313|Ensembl:ENSP00000426887}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [3] {ECO:0000313|EMBL:BAG61314.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Wakamatsu A., Yamamoto J., Kimura K., Ishii S., Watanabe K.,
RA   Sugiyama A., Murakawa K., Kaida T., Tsuchiya K., Fukuzumi Y.,
RA   Kumagai A., Oishi Y., Yamamoto S., Ono Y., Komori Y., Yamazaki M.,
RA   Kisu Y., Nishikawa T., Sugano S., Nomura N., Isogai T.;
RT   "NEDO human cDNA sequencing project focused on splicing variants.";
RL   Submitted (OCT-2007) to the EMBL/GenBank/DDBJ databases.
RN   [4] {ECO:0000313|Ensembl:ENSP00000426887}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (JUN-2011) to UniProtKB.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AC003954; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC004648; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC005367; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC005610; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC010626; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; KC876929; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; KC876931; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; KF457862; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AK299300; BAG61314.1; -; mRNA.
DR   RefSeq; NP_001275645.1; NM_001288716.1.
DR   UniGene; Hs.314543; -.
DR   MaxQB; B4DRK2; -.
DR   PeptideAtlas; B4DRK2; -.
DR   Ensembl; ENST00000503622; ENSP00000426887; ENSG00000169862.
DR   GeneID; 1501; -.
DR   UCSC; uc011cmy.3; human.
DR   CTD; 1501; -.
DR   EuPathDB; HostDB:ENSG00000169862.18; -.
DR   HGNC; HGNC:2516; CTNND2.
DR   OpenTargets; ENSG00000169862; -.
DR   eggNOG; KOG1048; Eukaryota.
DR   eggNOG; ENOG410Y21Q; LUCA.
DR   GeneTree; ENSGT00760000119167; -.
DR   HOGENOM; HOG000231863; -.
DR   HOVERGEN; HBG004284; -.
DR   ChiTaRS; CTNND2; human.
DR   GenomeRNAi; 1501; -.
DR   Proteomes; UP000005640; Chromosome 5.
DR   Bgee; ENSG00000169862; -.
DR   GO; GO:0098609; P:cell-cell adhesion; IEA:InterPro.
DR   Gene3D; 1.25.10.10; -; 1.
DR   InterPro; IPR011989; ARM-like.
DR   InterPro; IPR016024; ARM-type_fold.
DR   InterPro; IPR000225; Armadillo.
DR   InterPro; IPR028435; Plakophilin/d_Catenin.
DR   PANTHER; PTHR10372; PTHR10372; 2.
DR   Pfam; PF00514; Arm; 4.
DR   SMART; SM00185; ARM; 7.
DR   SUPFAM; SSF48371; SSF48371; 1.
DR   PROSITE; PS50176; ARM_REPEAT; 3.
PE   1: Evidence at protein level;
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   Proteomics identification {ECO:0000213|MaxQB:B4DRK2,
KW   ECO:0000213|PeptideAtlas:B4DRK2};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640}.
FT   REPEAT      255    288       ARM. {ECO:0000256|PROSITE-
FT                                ProRule:PRU00259}.
FT   REPEAT      299    342       ARM. {ECO:0000256|PROSITE-
FT                                ProRule:PRU00259}.
FT   REPEAT      555    592       ARM. {ECO:0000256|PROSITE-
FT                                ProRule:PRU00259}.
SQ   SEQUENCE   888 AA;  97980 MW;  26FB89944FD220C5 CRC64;
     MSSMSSAEEQ FQWQSQDGQK DIEDELTTGL ELVDSCIRSL QESGILDPQD YSTGETGSRA
     SYSSQHGHLG PELRALQSPE HHIDPIYEDR VYQKPPMRSL SQSQGDPLPP AHTGTYRTST
     APSSPGVDSV PLQRTGSQHG PQNAAAATFQ RASYAAGPAS NYADPYRQLQ YCPSVESPYS
     KSGPALPPEG TLARSPSIDS IQKDPREFGW RDPELPEVIQ MLQHQFPSVQ SNAAAYLQHL
     CFGDNKIKAE IRRQGGIQLL VDLLDHRMTE VHRSACGALR NLVYGKANDD NKIALKNCGG
     IPALVRLLRK TTDLEIRELV TGVLWNLSSC DALKMPIIQD ALAVLTNAVI IPHSGWENSP
     LQDDRKIQLH SSQVLRNATG CLRNVSSAGE EARRRMRECD GLTDALLYVI QSALGSSEID
     SKTVENCVCI LRNLSYRLAA ETSQGQHMGT DELDGLLCGE ANGKDAESSG CWGKKKKKKK
     SQDQWDGVGP LPDCAEPPKG IQMLWHPSIV KPYLTLLSEC SNPDTLEGAA GALQNLAAGS
     WKWSVYIRAA VRKEKGLPIL VELLRIDNDR VVCAVATALR NMALDVRNKE LIGKYAMRDL
     VHRLPGGNNS NNTASKAMSD DTVTAVCCTL HEVITKNMEN AKALRDAGGI EKLVGISKSK
     GDKHSPKVVK AASQVLNSMW QYRDLRSLYK KDGWSQYHFV ASSSTIERDR QRPYSSSRTP
     SISPVRVSPN NRSASAPASP REMISLKERK TDYECTGSNA TYHGAKGEHT SRKDAMTAQN
     TGISTLYRNS YGAPAEDIKH NQVSAQPVPQ EPSRKDYETY QPFQNSTRNY DESFFEDQVH
     HRPPASEYTM HLGLKSTGNY VDFYSAARPY SELNYETSHY PASPDSWV
//
ID   E7EPC8_HUMAN            Unreviewed;      1134 AA.
AC   E7EPC8;
DT   08-MAR-2011, integrated into UniProtKB/TrEMBL.
DT   08-MAR-2011, sequence version 1.
DT   28-MAR-2018, entry version 55.
DE   SubName: Full=Catenin delta-2 {ECO:0000313|Ensembl:ENSP00000426510};
GN   Name=CTNND2 {ECO:0000313|Ensembl:ENSP00000426510};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000426510, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15372022; DOI=10.1038/nature02919;
RA   Schmutz J., Martin J., Terry A., Couronne O., Grimwood J., Lowry S.,
RA   Gordon L.A., Scott D., Xie G., Huang W., Hellsten U., Tran-Gyamfi M.,
RA   She X., Prabhakar S., Aerts A., Altherr M., Bajorek E., Black S.,
RA   Branscomb E., Caoile C., Challacombe J.F., Chan Y.M., Denys M.,
RA   Detter J.C., Escobar J., Flowers D., Fotopulos D., Glavina T.,
RA   Gomez M., Gonzales E., Goodstein D., Grigoriev I., Groza M.,
RA   Hammon N., Hawkins T., Haydu L., Israni S., Jett J., Kadner K.,
RA   Kimball H., Kobayashi A., Lopez F., Lou Y., Martinez D., Medina C.,
RA   Morgan J., Nandkeshwar R., Noonan J.P., Pitluck S., Pollard M.,
RA   Predki P., Priest J., Ramirez L., Retterer J., Rodriguez A.,
RA   Rogers S., Salamov A., Salazar A., Thayer N., Tice H., Tsai M.,
RA   Ustaszewska A., Vo N., Wheeler J., Wu K., Yang J., Dickson M.,
RA   Cheng J.-F., Eichler E.E., Olsen A., Pennacchio L.A., Rokhsar D.S.,
RA   Richardson P., Lucas S.M., Myers R.M., Rubin E.M.;
RT   "The DNA sequence and comparative analysis of human chromosome 5.";
RL   Nature 431:268-274(2004).
RN   [2] {ECO:0000313|Ensembl:ENSP00000426510}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [3] {ECO:0000313|Ensembl:ENSP00000426510}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (JUL-2011) to UniProtKB.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AC003954; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC004648; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC005367; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC005610; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC010626; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; KC876929; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; KC876931; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; KF457862; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   RefSeq; NP_001275644.1; NM_001288715.1.
DR   UniGene; Hs.314543; -.
DR   ProteinModelPortal; E7EPC8; -.
DR   SMR; E7EPC8; -.
DR   MaxQB; E7EPC8; -.
DR   PeptideAtlas; E7EPC8; -.
DR   PRIDE; E7EPC8; -.
DR   Ensembl; ENST00000511377; ENSP00000426510; ENSG00000169862.
DR   GeneID; 1501; -.
DR   UCSC; uc010itt.4; human.
DR   CTD; 1501; -.
DR   EuPathDB; HostDB:ENSG00000169862.18; -.
DR   HGNC; HGNC:2516; CTNND2.
DR   OpenTargets; ENSG00000169862; -.
DR   eggNOG; KOG1048; Eukaryota.
DR   eggNOG; ENOG410Y21Q; LUCA.
DR   GeneTree; ENSGT00760000119167; -.
DR   SignaLink; E7EPC8; -.
DR   ChiTaRS; CTNND2; human.
DR   GenomeRNAi; 1501; -.
DR   Proteomes; UP000005640; Chromosome 5.
DR   Bgee; ENSG00000169862; -.
DR   ExpressionAtlas; E7EPC8; baseline and differential.
DR   GO; GO:0098609; P:cell-cell adhesion; IEA:InterPro.
DR   Gene3D; 1.25.10.10; -; 1.
DR   InterPro; IPR011989; ARM-like.
DR   InterPro; IPR016024; ARM-type_fold.
DR   InterPro; IPR000225; Armadillo.
DR   InterPro; IPR028435; Plakophilin/d_Catenin.
DR   PANTHER; PTHR10372; PTHR10372; 1.
DR   Pfam; PF00514; Arm; 4.
DR   SMART; SM00185; ARM; 7.
DR   SUPFAM; SSF48371; SSF48371; 1.
DR   PROSITE; PS50176; ARM_REPEAT; 3.
PE   1: Evidence at protein level;
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   Proteomics identification {ECO:0000213|MaxQB:E7EPC8,
KW   ECO:0000213|PeptideAtlas:E7EPC8};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640}.
FT   REPEAT      501    534       ARM. {ECO:0000256|PROSITE-
FT                                ProRule:PRU00259}.
FT   REPEAT      545    588       ARM. {ECO:0000256|PROSITE-
FT                                ProRule:PRU00259}.
FT   REPEAT      801    838       ARM. {ECO:0000256|PROSITE-
FT                                ProRule:PRU00259}.
SQ   SEQUENCE   1134 AA;  123083 MW;  331E63AC6B230E3D CRC64;
     MSSMSSAEEQ FQWQSQDGQK DIEDELTTGL ELVDSCIRSL QESGILDPQD YSTGERPSLL
     SQSALQLNSK PEGSFQYPAS YHSNQTLALG ETTPSQLPAR GTQARATGQS FSQGTTSRAG
     HLAGPEPAPP PPPPPREPFA PSLGSAFHLP DAPPAAAAAA LYYSSSTLPA PPRGGSPLAA
     PQGGSPTKLQ RGGSAPEGAT YAAPRGSSPK QSPSRLAKSY STSSPINIVV SSAGLSPIRV
     TSPPTVQSTI SSSPIHQLSS TIGTYATLSP TKRLVHASEQ YSKHSQELYA TATLQRPGSL
     AAGSRASYSS QHGHLGPELR ALQSPEHHID PIYEDRVYQK PPMRSLSQSQ GDPLPPAHTG
     TYRTSTAPSS PGVDSVPLQR TGSQHGPQNA AAATFQRASY AAGPASNYAD PYRQLQYCPS
     VESPYSKSGP ALPPEGTLAR SPSIDSIQKD PREFGWRDPE LPEVIQMLQH QFPSVQSNAA
     AYLQHLCFGD NKIKAEIRRQ GGIQLLVDLL DHRMTEVHRS ACGALRNLVY GKANDDNKIA
     LKNCGGIPAL VRLLRKTTDL EIRELVTGVL WNLSSCDALK MPIIQDALAV LTNAVIIPHS
     GWENSPLQDD RKIQLHSSQV LRNATGCLRN VSSAGEEARR RMRECDGLTD ALLYVIQSAL
     GSSEIDSKTV ENCVCILRNL SYRLAAETSQ GQHMGTDELD GLLCGEANGK DAESSGCWGK
     KKKKKKSQDQ WDGVGPLPDC AEPPKGIQML WHPSIVKPYL TLLSECSNPD TLEGAAGALQ
     NLAAGSWKWS VYIRAAVRKE KGLPILVELL RIDNDRVVCA VATALRNMAL DVRNKELIGK
     YAMRDLVHRL PGGNNSNNTA SKAMSDDTVT AVCCTLHEVI TKNMENAKAL RDAGGIEKLV
     GISKSKGDKH SPKVVKAASQ VLNSMWQYRD LRSLYKKDGW SQYHFVASSS TIERDRQRPY
     SSSRTPSISP VRVSPNNRSA SAPASPREMI SLKERKTDYE CTGSNATYHG AKGEHTSRKD
     AMTAQNTGIS TLYRNSYGAP AEDIKHNQVS AQPVPQEPSR KDYETYQPFQ NSTRNYDESF
     FEDQVHHRPP ASEYTMHLGL KSTGNYVDFY SAARPYSELN YETSHYPASP DSWV
//
ID   CTND2_HUMAN             Reviewed;        1225 AA.
AC   Q9UQB3; B0FTZ7; O00379; O15390; O43206; O43840; Q13589; Q9UM66;
AC   Q9UPM3;
DT   16-APR-2002, integrated into UniProtKB/Swiss-Prot.
DT   20-DEC-2005, sequence version 3.
DT   28-FEB-2018, entry version 153.
DE   RecName: Full=Catenin delta-2;
DE   AltName: Full=Delta-catenin;
DE   AltName: Full=GT24;
DE   AltName: Full=Neural plakophilin-related ARM-repeat protein;
DE            Short=NPRAP;
DE   AltName: Full=Neurojungin;
GN   Name=CTNND2; Synonyms=NPRAP;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND INTERACTION WITH PSEN1.
RX   PubMed=9223106; DOI=10.1097/00001756-199705260-00054;
RA   Zhou J., Liyanage U., Medina M., Ho C., Simmons A.D., Lovett M.,
RA   Kosik K.S.;
RT   "Presenilin 1 interaction in the brain with a novel member of the
RT   Armadillo family.";
RL   NeuroReport 8:2085-2090(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND FUNCTION.
RC   TISSUE=Brain;
RX   PubMed=9971746; DOI=10.1083/jcb.144.3.519;
RA   Lu Q., Paredes M., Medina M., Zhou J., Cavallo R., Peifer M.,
RA   Orecchio L., Kosik K.S.;
RT   "Delta-catenin, an adhesive junction-associated protein which promotes
RT   cell scattering.";
RL   J. Cell Biol. 144:519-532(1999).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND INTERACTION WITH PSEN1.
RC   TISSUE=Fetal brain;
RX   PubMed=10208590; DOI=10.1097/00001756-199902250-00022;
RA   Tanahashi H., Tabira T.;
RT   "Isolation of human delta-catenin and its binding specificity with
RT   presenilin 1.";
RL   NeuroReport 10:563-568(1999).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS CYS-275; THR-482 AND
RP   ARG-810.
RG   NIEHS SNPs program;
RL   Submitted (DEC-2007) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15372022; DOI=10.1038/nature02919;
RA   Schmutz J., Martin J., Terry A., Couronne O., Grimwood J., Lowry S.,
RA   Gordon L.A., Scott D., Xie G., Huang W., Hellsten U., Tran-Gyamfi M.,
RA   She X., Prabhakar S., Aerts A., Altherr M., Bajorek E., Black S.,
RA   Branscomb E., Caoile C., Challacombe J.F., Chan Y.M., Denys M.,
RA   Detter J.C., Escobar J., Flowers D., Fotopulos D., Glavina T.,
RA   Gomez M., Gonzales E., Goodstein D., Grigoriev I., Groza M.,
RA   Hammon N., Hawkins T., Haydu L., Israni S., Jett J., Kadner K.,
RA   Kimball H., Kobayashi A., Lopez F., Lou Y., Martinez D., Medina C.,
RA   Morgan J., Nandkeshwar R., Noonan J.P., Pitluck S., Pollard M.,
RA   Predki P., Priest J., Ramirez L., Retterer J., Rodriguez A.,
RA   Rogers S., Salamov A., Salazar A., Thayer N., Tice H., Tsai M.,
RA   Ustaszewska A., Vo N., Wheeler J., Wu K., Yang J., Dickson M.,
RA   Cheng J.-F., Eichler E.E., Olsen A., Pennacchio L.A., Rokhsar D.S.,
RA   Richardson P., Lucas S.M., Myers R.M., Rubin E.M.;
RT   "The DNA sequence and comparative analysis of human chromosome 5.";
RL   Nature 431:268-274(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 186-1225 (ISOFORM 1), AND INTERACTION
RP   WITH PSEN1.
RC   TISSUE=Brain;
RX   PubMed=10037471; DOI=10.1046/j.1471-4159.1999.0720999.x;
RA   Levesque G., Yu G., Nishimura M., Zhang D.M., Levesque L., Yu H.,
RA   Xu D., Liang Y., Rogaeva E.A., Ikeda M., Duthie M., Murgolo N.,
RA   Wang L., VanderVere P., Bayne M.L., Strader C.D., Rommens J.M.,
RA   Fraser P.E., St George-Hyslop P.H.;
RT   "Presenilins interact with armadillo proteins including neural-
RT   specific plakophilin-related protein and beta-catenin.";
RL   J. Neurochem. 72:999-1008(1999).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 350-1225 (ISOFORM 1), AND ALTERNATIVE
RP   SPLICING.
RC   TISSUE=Fetal brain;
RX   PubMed=9342840; DOI=10.1046/j.1432-0436.1997.6150293.x;
RA   Paffenholz R., Franke W.W.;
RT   "Identification and localization of a neurally expressed member of the
RT   plakoglobin/armadillo multigene family.";
RL   Differentiation 61:293-304(1997).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 689-1225 (ISOFORM 1).
RA   Fraser P.E., Levesque G., Rogaeva E.A., Yu G., St George-Hyslop P.H.;
RT   "A novel gene from the arm family.";
RL   Submitted (SEP-1996) to the EMBL/GenBank/DDBJ databases.
RN   [10]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 746-1225 (ISOFORM 1).
RC   TISSUE=Brain;
RA   Yu W., Sarginson J., Gibbs R.A.;
RL   Submitted (NOV-1997) to the EMBL/GenBank/DDBJ databases.
RN   [11]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 865-1225 (ISOFORMS 1/2).
RX   PubMed=9049630; DOI=10.1101/gr.7.2.118;
RA   Simmons A.D., Overhauser J., Lovett M.;
RT   "Isolation of cDNAs from the Cri-du-chat critical region by direct
RT   screening of a chromosome 5-specific cDNA library.";
RL   Genome Res. 7:118-127(1997).
RN   [12]
RP   INTERACTION WITH ARHGEF28.
RX   PubMed=17993462; DOI=10.1074/jbc.M707158200;
RA   Kim H., Han J.-R., Park J., Oh M., James S.E., Chang S., Lu Q.,
RA   Lee K.Y., Ki H., Song W.-J., Kim K.;
RT   "Delta-catenin-induced dendritic morphogenesis. An essential role of
RT   p190RhoGEF interaction through Akt1-mediated phosphorylation.";
RL   J. Biol. Chem. 283:977-987(2008).
RN   [13]
RP   INTERACTION WITH GSK3A AND GSK3B, AND PHOSPHORYLATION BY GSK3B.
RX   PubMed=19706605; DOI=10.1074/jbc.M109.002659;
RA   Oh M., Kim H., Yang I., Park J.H., Cong W.T., Baek M.C., Bareiss S.,
RA   Ki H., Lu Q., No J., Kwon I., Choi J.K., Kim K.;
RT   "GSK-3 phosphorylates delta-catenin and negatively regulates its
RT   stability via ubiquitination/proteosome-mediated proteolysis.";
RL   J. Biol. Chem. 284:28579-28589(2009).
RN   [14]
RP   INTERACTION WITH FRMPD2.
RX   PubMed=19706687; DOI=10.1242/jcs.046854;
RA   Stenzel N., Fetzer C.P., Heumann R., Erdmann K.S.;
RT   "PDZ-domain-directed basolateral targeting of the peripheral membrane
RT   protein FRMPD2 in epithelial cells.";
RL   J. Cell Sci. 122:3374-3384(2009).
RN   [15]
RP   SUBCELLULAR LOCATION, AND INTERACTION WITH DNM2.
RX   PubMed=22022388; DOI=10.1371/journal.pone.0025379;
RA   Koutras C., Levesque G.;
RT   "Identification of novel NPRAP/delta-catenin-interacting proteins and
RT   the direct association of NPRAP with dynamin 2.";
RL   PLoS ONE 6:E25379-E25379(2011).
RN   [16]
RP   FUNCTION, TISSUE SPECIFICITY, INTERACTION WITH CTNNB1, INVOLVEMENT IN
RP   AUTISM, VARIANTS SER-34; LEU-189; LEU-224; CYS-275; HIS-330; HIS-454;
RP   ASN-465; THR-482; PRO-507; CYS-713 AND MET-862, AND CHARACTERIZATION
RP   OF VARIANTS SER-34; LEU-189; LEU-224; CYS-275; HIS-330; HIS-454;
RP   ASN-465; THR-482; PRO-507; CYS-713; ARG-810 AND MET-862.
RX   PubMed=25807484; DOI=10.1038/nature14186;
RA   Turner T.N., Sharma K., Oh E.C., Liu Y.P., Collins R.L., Sosa M.X.,
RA   Auer D.R., Brand H., Sanders S.J., Moreno-De-Luca D., Pihur V.,
RA   Plona T., Pike K., Soppet D.R., Smith M.W., Cheung S.W., Martin C.L.,
RA   State M.W., Talkowski M.E., Cook E., Huganir R., Katsanis N.,
RA   Chakravarti A.;
RT   "Loss of delta-catenin function in severe autism.";
RL   Nature 520:51-56(2015).
RN   [17]
RP   VARIANT [LARGE SCALE ANALYSIS] SER-1159.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S.,
RA   Buckhaults P., Farrell C., Meeh P., Markowitz S.D., Willis J.,
RA   Dawson D., Willson J.K.V., Gazdar A.F., Hartigan J., Wu L., Liu C.,
RA   Parmigiani G., Park B.H., Bachman K.E., Papadopoulos N.,
RA   Vogelstein B., Kinzler K.W., Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal
RT   cancers.";
RL   Science 314:268-274(2006).
CC   -!- FUNCTION: Has a critical role in neuronal development,
CC       particularly in the formation and/or maintenance of dendritic
CC       spines and synapses (PubMed:25807484). Involved in the regulation
CC       of Wnt signaling (PubMed:25807484). It probably acts on beta-
CC       catenin turnover, facilitating beta-catenin interaction with
CC       GSK3B, phosphorylation, ubiquitination and degradation (By
CC       similarity). Functions as a transcriptional activator when bound
CC       to ZBTB33 (By similarity). May be involved in neuronal cell
CC       adhesion and tissue morphogenesis and integrity by regulating
CC       adhesion molecules. {ECO:0000250|UniProtKB:O35927,
CC       ECO:0000269|PubMed:25807484, ECO:0000269|PubMed:9971746}.
CC   -!- SUBUNIT: Binds to E-cadherin at a juxtamembrane site within the
CC       cytoplasmic domain (By similarity). Interacts with PDZD2 (By
CC       similarity). Interacts with ZBTB33 (By similarity). Binds to PSEN1
CC       (PubMed:10037471) (PubMed:10208590) (PubMed:9223106). Interacts
CC       with ARHGEF28 (PubMed:17993462). Interacts (via the extreme C-
CC       terminus) with FRMPD2 (via the PDZ 2 domain) (PubMed:19706687).
CC       Interacts with CDK5 (By similarity). Interacts with CTNNB1
CC       (PubMed:25807484). Interacts with GSK3A and GSK3B
CC       (PubMed:19706605). Interacts with DNM2 (PubMed:22022388).
CC       {ECO:0000250|UniProtKB:O35116, ECO:0000250|UniProtKB:O35927,
CC       ECO:0000269|PubMed:10037471, ECO:0000269|PubMed:10208590,
CC       ECO:0000269|PubMed:17993462, ECO:0000269|PubMed:19706605,
CC       ECO:0000269|PubMed:19706687, ECO:0000269|PubMed:22022388,
CC       ECO:0000269|PubMed:25807484, ECO:0000269|PubMed:9223106}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:O35927}. Cell
CC       junction, adherens junction {ECO:0000250|UniProtKB:O35927}. Cell
CC       projection, dendrite {ECO:0000250|UniProtKB:O35116}. Perikaryon
CC       {ECO:0000269|PubMed:22022388}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC         Comment=Additional isoforms seem to exist.;
CC       Name=1; Synonyms=NPRAPa;
CC         IsoId=Q9UQB3-1; Sequence=Displayed;
CC       Name=2; Synonyms=NPRAPc;
CC         IsoId=Q9UQB3-2; Sequence=VSP_006746;
CC   -!- TISSUE SPECIFICITY: Expressed in brain; highest expression is
CC       observed in fetal brain (PubMed:25807484).
CC       {ECO:0000269|PubMed:25807484}.
CC   -!- PTM: O-glycosylated. {ECO:0000250}.
CC   -!- PTM: Phosphorylated by CDK5 (By similarity). Phosphorylated by
CC       GSK3B (PubMed:19706605). {ECO:0000250|UniProtKB:O35116,
CC       ECO:0000269|PubMed:19706605}.
CC   -!- DISEASE: Note=Defects in CTNND2, including deleterious missense
CC       and copy number variants (CNVs) are involved in autism, a complex
CC       multifactorial, pervasive developmental disorder characterized by
CC       impairments in reciprocal social interaction and communication,
CC       restricted and stereotyped patterns of interests and activities,
CC       and the presence of developmental abnormalities by 3 years of age.
CC       Most individuals with autism also manifest moderate mental
CC       retardation. {ECO:0000269|PubMed:25807484}.
CC   -!- SIMILARITY: Belongs to the beta-catenin family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAB68599.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC       Sequence=AAB88185.1; Type=Frameshift; Positions=913; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=NIEHS-SNPs;
CC       URL="http://egp.gs.washington.edu/data/ctnnd2/";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U96136; AAC63103.1; -; mRNA.
DR   EMBL; AB013805; BAA36163.1; -; mRNA.
DR   EMBL; AC003089; AAB83940.1; -; Genomic_DNA.
DR   EMBL; EU350953; ABY59658.1; -; Genomic_DNA.
DR   EMBL; AC003954; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC004633; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC004648; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC005367; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC005610; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC010433; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC010626; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC113390; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC127460; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471102; EAX08053.1; -; Genomic_DNA.
DR   EMBL; U81004; AAD00453.1; -; mRNA.
DR   EMBL; U52351; AAB97957.1; -; mRNA.
DR   EMBL; U72665; AAB68599.1; ALT_INIT; mRNA.
DR   EMBL; AF035302; AAB88185.1; ALT_FRAME; mRNA.
DR   EMBL; U52828; AAB96357.1; -; mRNA.
DR   CCDS; CCDS3881.1; -. [Q9UQB3-1]
DR   RefSeq; NP_001275644.1; NM_001288715.1.
DR   RefSeq; NP_001275645.1; NM_001288716.1.
DR   RefSeq; NP_001275646.1; NM_001288717.1.
DR   RefSeq; NP_001323.1; NM_001332.3. [Q9UQB3-1]
DR   UniGene; Hs.314543; -.
DR   ProteinModelPortal; Q9UQB3; -.
DR   SMR; Q9UQB3; -.
DR   BioGrid; 107882; 9.
DR   CORUM; Q9UQB3; -.
DR   DIP; DIP-1138N; -.
DR   IntAct; Q9UQB3; 6.
DR   MINT; Q9UQB3; -.
DR   STRING; 9606.ENSP00000307134; -.
DR   iPTMnet; Q9UQB3; -.
DR   PhosphoSitePlus; Q9UQB3; -.
DR   DMDM; 84028193; -.
DR   PaxDb; Q9UQB3; -.
DR   PeptideAtlas; Q9UQB3; -.
DR   PRIDE; Q9UQB3; -.
DR   DNASU; 1501; -.
DR   Ensembl; ENST00000304623; ENSP00000307134; ENSG00000169862. [Q9UQB3-1]
DR   GeneID; 1501; -.
DR   KEGG; hsa:1501; -.
DR   UCSC; uc003jfa.3; human. [Q9UQB3-1]
DR   CTD; 1501; -.
DR   DisGeNET; 1501; -.
DR   EuPathDB; HostDB:ENSG00000169862.18; -.
DR   GeneCards; CTNND2; -.
DR   HGNC; HGNC:2516; CTNND2.
DR   HPA; CAB037339; -.
DR   HPA; HPA015077; -.
DR   MalaCards; CTNND2; -.
DR   MIM; 604275; gene.
DR   neXtProt; NX_Q9UQB3; -.
DR   OpenTargets; ENSG00000169862; -.
DR   Orphanet; 281; Monosomy 5p.
DR   PharmGKB; PA27017; -.
DR   eggNOG; KOG1048; Eukaryota.
DR   eggNOG; ENOG410Y21Q; LUCA.
DR   GeneTree; ENSGT00760000119167; -.
DR   HOVERGEN; HBG004284; -.
DR   InParanoid; Q9UQB3; -.
DR   OMA; SYADPYR; -.
DR   OrthoDB; EOG091G0S7K; -.
DR   PhylomeDB; Q9UQB3; -.
DR   TreeFam; TF321877; -.
DR   SignaLink; Q9UQB3; -.
DR   SIGNOR; Q9UQB3; -.
DR   ChiTaRS; CTNND2; human.
DR   GenomeRNAi; 1501; -.
DR   PRO; PR:Q9UQB3; -.
DR   Proteomes; UP000005640; Chromosome 5.
DR   Bgee; ENSG00000169862; -.
DR   CleanEx; HS_CTNND2; -.
DR   ExpressionAtlas; Q9UQB3; baseline and differential.
DR   Genevisible; Q9UQB3; HS.
DR   GO; GO:0005912; C:adherens junction; IEA:UniProtKB-SubCell.
DR   GO; GO:0005737; C:cytoplasm; TAS:ProtInc.
DR   GO; GO:0030425; C:dendrite; IEA:UniProtKB-SubCell.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0043204; C:perikaryon; IDA:UniProtKB.
DR   GO; GO:0008013; F:beta-catenin binding; IPI:UniProtKB.
DR   GO; GO:0007155; P:cell adhesion; TAS:ProtInc.
DR   GO; GO:0098609; P:cell-cell adhesion; IEA:InterPro.
DR   GO; GO:0060997; P:dendritic spine morphogenesis; IMP:UniProtKB.
DR   GO; GO:0060828; P:regulation of canonical Wnt signaling pathway; IMP:UniProtKB.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW.
DR   GO; GO:0007165; P:signal transduction; TAS:ProtInc.
DR   GO; GO:0050808; P:synapse organization; IMP:UniProtKB.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
DR   GO; GO:0016055; P:Wnt signaling pathway; IEA:UniProtKB-KW.
DR   Gene3D; 1.25.10.10; -; 1.
DR   InterPro; IPR011989; ARM-like.
DR   InterPro; IPR016024; ARM-type_fold.
DR   InterPro; IPR000225; Armadillo.
DR   InterPro; IPR028435; Plakophilin/d_Catenin.
DR   PANTHER; PTHR10372; PTHR10372; 1.
DR   Pfam; PF00514; Arm; 4.
DR   SMART; SM00185; ARM; 7.
DR   SUPFAM; SSF48371; SSF48371; 1.
DR   PROSITE; PS50176; ARM_REPEAT; 3.
PE   1: Evidence at protein level;
KW   Alternative splicing; Autism; Autism spectrum disorder; Cell adhesion;
KW   Cell junction; Cell projection; Coiled coil; Complete proteome;
KW   Developmental protein; Disease mutation; Glycoprotein; Methylation;
KW   Nucleus; Phosphoprotein; Polymorphism; Reference proteome; Repeat;
KW   Transcription; Transcription regulation; Wnt signaling pathway.
FT   CHAIN         1   1225       Catenin delta-2.
FT                                /FTId=PRO_0000064299.
FT   REPEAT      394    438       ARM 1.
FT   REPEAT      540    579       ARM 2.
FT   REPEAT      582    621       ARM 3.
FT   REPEAT      626    666       ARM 4.
FT   REPEAT      682    724       ARM 5.
FT   REPEAT      728    773       ARM 6.
FT   REPEAT      835    875       ARM 7.
FT   REPEAT      882    921       ARM 8.
FT   REPEAT      975   1018       ARM 9.
FT   COILED       49     84       {ECO:0000255}.
FT   COMPBIAS    216    226       Poly-Pro.
FT   COMPBIAS    811    817       Poly-Lys.
FT   MOD_RES     209    209       Omega-N-methylarginine.
FT                                {ECO:0000250|UniProtKB:O35927}.
FT   MOD_RES     264    264       Omega-N-methylarginine.
FT                                {ECO:0000250|UniProtKB:O35927}.
FT   MOD_RES     267    267       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:O35927}.
FT   MOD_RES     276    276       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:O35927}.
FT   MOD_RES     282    282       Omega-N-methylarginine.
FT                                {ECO:0000250|UniProtKB:O35927}.
FT   MOD_RES     296    296       Omega-N-methylarginine.
FT                                {ECO:0000250|UniProtKB:O35927}.
FT   MOD_RES     327    327       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:O35927}.
FT   MOD_RES     360    360       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:O35927}.
FT   MOD_RES     415    415       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:O35927}.
FT   MOD_RES     461    461       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:O35927}.
FT   MOD_RES     514    514       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:O35927}.
FT   MOD_RES     516    516       Phosphotyrosine.
FT                                {ECO:0000250|UniProtKB:O35927}.
FT   MOD_RES    1065   1065       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:O35927}.
FT   MOD_RES    1076   1076       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:O35927}.
FT   VAR_SEQ     823    880       Missing (in isoform 2). {ECO:0000305}.
FT                                /FTId=VSP_006746.
FT   VARIANT      34     34       G -> S (probable disease-associated
FT                                mutation found in autism; hypomorphic
FT                                mutation affecting dendritic spines
FT                                development and maintenance; results in
FT                                reduced interaction with CTNNB1;
FT                                dbSNP:rs151129181).
FT                                {ECO:0000269|PubMed:25807484}.
FT                                /FTId=VAR_073387.
FT   VARIANT     189    189       P -> L (probable disease-associated
FT                                mutation found in autism; hypomorphic
FT                                mutation affecting Wnt signaling;
FT                                dbSNP:rs149573037).
FT                                {ECO:0000269|PubMed:25807484}.
FT                                /FTId=VAR_073388.
FT   VARIANT     224    224       P -> L (probable disease-associated
FT                                mutation found in autism; hypomorphic
FT                                mutation affecting Wnt signaling;
FT                                dbSNP:rs769623284).
FT                                {ECO:0000269|PubMed:25807484}.
FT                                /FTId=VAR_073389.
FT   VARIANT     275    275       G -> C (found in patients with autism;
FT                                unknown pathological significance; has no
FT                                effect on Wnt signaling;
FT                                dbSNP:rs61749844).
FT                                {ECO:0000269|PubMed:25807484,
FT                                ECO:0000269|Ref.4}.
FT                                /FTId=VAR_062270.
FT   VARIANT     330    330       R -> H (polymorphism; has no effect on
FT                                Wnt signaling; dbSNP:rs199506424).
FT                                {ECO:0000269|PubMed:25807484}.
FT                                /FTId=VAR_073390.
FT   VARIANT     454    454       R -> H (probable disease-associated
FT                                mutation found in autism; hypomorphic
FT                                mutation affecting Wnt signaling;
FT                                dbSNP:rs750266236).
FT                                {ECO:0000269|PubMed:25807484}.
FT                                /FTId=VAR_073391.
FT   VARIANT     465    465       D -> N (polymorphism; has no effect on
FT                                Wnt signaling; dbSNP:rs200377770).
FT                                {ECO:0000269|PubMed:25807484}.
FT                                /FTId=VAR_073392.
FT   VARIANT     482    482       A -> T (polymorphism; has no effect on
FT                                Wnt signaling; dbSNP:rs61750706).
FT                                {ECO:0000269|PubMed:25807484,
FT                                ECO:0000269|Ref.4}.
FT                                /FTId=VAR_062271.
FT   VARIANT     507    507       Q -> P (probable disease-associated
FT                                mutation found in autism; hypomorphic
FT                                mutation affecting Wnt signaling;
FT                                dbSNP:rs142843736).
FT                                {ECO:0000269|PubMed:25807484}.
FT                                /FTId=VAR_073393.
FT   VARIANT     713    713       R -> C (probable disease-associated
FT                                mutation found in autism; loss-of-
FT                                function mutation affecting dendritic
FT                                spines development and maintenance;
FT                                results in reduced interaction with
FT                                CTNNB1; dbSNP:rs768575356).
FT                                {ECO:0000269|PubMed:25807484}.
FT                                /FTId=VAR_073394.
FT   VARIANT     810    810       G -> R (polymorphism; has no effect on
FT                                Wnt signaling; dbSNP:rs61754599).
FT                                {ECO:0000269|PubMed:25807484,
FT                                ECO:0000269|Ref.4}.
FT                                /FTId=VAR_062272.
FT   VARIANT     862    862       T -> M (found in patients with autism;
FT                                unknown pathological significance; has no
FT                                effect on Wnt signaling;
FT                                dbSNP:rs773517967).
FT                                {ECO:0000269|PubMed:25807484}.
FT                                /FTId=VAR_073395.
FT   VARIANT    1159   1159       P -> S (in a colorectal cancer sample;
FT                                somatic mutation).
FT                                {ECO:0000269|PubMed:16959974}.
FT                                /FTId=VAR_036162.
FT   CONFLICT    426    426       D -> V (in Ref. 1; AAC63103).
FT                                {ECO:0000305}.
FT   CONFLICT    443    443       D -> V (in Ref. 1; AAC63103).
FT                                {ECO:0000305}.
FT   CONFLICT    725    725       A -> P (in Ref. 1; AAC63103).
FT                                {ECO:0000305}.
FT   CONFLICT    894    894       L -> R (in Ref. 1; AAC63103 and 11;
FT                                AAB96357). {ECO:0000305}.
FT   CONFLICT    909    909       V -> A (in Ref. 1; AAC63103 and 11;
FT                                AAB96357). {ECO:0000305}.
FT   CONFLICT    980    980       A -> G (in Ref. 8; AAB97957).
FT                                {ECO:0000305}.
FT   CONFLICT   1102   1102       A -> G (in Ref. 7; AAD00453 and 9;
FT                                AAB68599). {ECO:0000305}.
SQ   SEQUENCE   1225 AA;  132656 MW;  4A24ACC3E22BFE83 CRC64;
     MFARKPPGAA PLGAMPVPDQ PSSASEKTSS LSPGLNTSNG DGSETETTSA ILASVKEQEL
     QFERLTRELE AERQIVASQL ERCKLGSETG SMSSMSSAEE QFQWQSQDGQ KDIEDELTTG
     LELVDSCIRS LQESGILDPQ DYSTGERPSL LSQSALQLNS KPEGSFQYPA SYHSNQTLAL
     GETTPSQLPA RGTQARATGQ SFSQGTTSRA GHLAGPEPAP PPPPPPREPF APSLGSAFHL
     PDAPPAAAAA ALYYSSSTLP APPRGGSPLA APQGGSPTKL QRGGSAPEGA TYAAPRGSSP
     KQSPSRLAKS YSTSSPINIV VSSAGLSPIR VTSPPTVQST ISSSPIHQLS STIGTYATLS
     PTKRLVHASE QYSKHSQELY ATATLQRPGS LAAGSRASYS SQHGHLGPEL RALQSPEHHI
     DPIYEDRVYQ KPPMRSLSQS QGDPLPPAHT GTYRTSTAPS SPGVDSVPLQ RTGSQHGPQN
     AAAATFQRAS YAAGPASNYA DPYRQLQYCP SVESPYSKSG PALPPEGTLA RSPSIDSIQK
     DPREFGWRDP ELPEVIQMLQ HQFPSVQSNA AAYLQHLCFG DNKIKAEIRR QGGIQLLVDL
     LDHRMTEVHR SACGALRNLV YGKANDDNKI ALKNCGGIPA LVRLLRKTTD LEIRELVTGV
     LWNLSSCDAL KMPIIQDALA VLTNAVIIPH SGWENSPLQD DRKIQLHSSQ VLRNATGCLR
     NVSSAGEEAR RRMRECDGLT DALLYVIQSA LGSSEIDSKT VENCVCILRN LSYRLAAETS
     QGQHMGTDEL DGLLCGEANG KDAESSGCWG KKKKKKKSQD QWDGVGPLPD CAEPPKGIQM
     LWHPSIVKPY LTLLSECSNP DTLEGAAGAL QNLAAGSWKW SVYIRAAVRK EKGLPILVEL
     LRIDNDRVVC AVATALRNMA LDVRNKELIG KYAMRDLVHR LPGGNNSNNT ASKAMSDDTV
     TAVCCTLHEV ITKNMENAKA LRDAGGIEKL VGISKSKGDK HSPKVVKAAS QVLNSMWQYR
     DLRSLYKKDG WSQYHFVASS STIERDRQRP YSSSRTPSIS PVRVSPNNRS ASAPASPREM
     ISLKERKTDY ECTGSNATYH GAKGEHTSRK DAMTAQNTGI STLYRNSYGA PAEDIKHNQV
     SAQPVPQEPS RKDYETYQPF QNSTRNYDES FFEDQVHHRP PASEYTMHLG LKSTGNYVDF
     YSAARPYSEL NYETSHYPAS PDSWV
//
ID   A4ZKH2_HUMAN            Unreviewed;        15 AA.
AC   A4ZKH2; A0A087WYR9; A0A0K0K1D3;
DT   29-MAY-2007, integrated into UniProtKB/TrEMBL.
DT   29-MAY-2007, sequence version 1.
DT   07-JUN-2017, entry version 39.
DE   SubName: Full=Cysteinyl leukotriene receptor 2 splice variant I {ECO:0000313|EMBL:ABO61874.1};
DE   SubName: Full=Cysteinyl leukotriene receptor 2 splice variant II {ECO:0000313|EMBL:ABO61875.1};
DE   SubName: Full=Cysteinyl leukotriene receptor 2 splice variant III {ECO:0000313|EMBL:ABO61876.1};
DE   SubName: Full=Cysteinyl leukotriene receptor 2 splice variant IV {ECO:0000313|EMBL:ABO61877.1};
DE   SubName: Full=Cysteinyl leukotriene receptor 2 splice variant V {ECO:0000313|EMBL:ABO61878.1};
DE   SubName: Full=Cysteinyl leukotriene receptor 2 splice variant VI {ECO:0000313|EMBL:ABO61879.1};
DE   SubName: Full=Cysteinyl leukotriene receptor 2 splice variant VII {ECO:0000313|EMBL:ABO61880.1};
DE   SubName: Full=Cysteinyl leukotriene receptor 2 splice variant VIII {ECO:0000313|EMBL:ABO61881.1};
DE   Flags: Fragment;
GN   Name=CYSLTR2 {ECO:0000313|EMBL:ABO61874.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:ABO61874.1};
RN   [1] {ECO:0000313|EMBL:ABO61874.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=17404310;
RA   Woszczek G., Chen L.Y., Nagineni S., Alsaaty S., Harry A., Logun C.,
RA   Pawliczak R., Shelhamer J.H.;
RT   "IFN-gamma induces cysteinyl leukotriene receptor 2 expression and
RT   enhances the responsiveness of human endothelial cells to cysteinyl
RT   leukotrienes.";
RL   J. Immunol. 178:5262-5270(2007).
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; EF141523; ABO61874.1; -; mRNA.
DR   EMBL; EF141524; ABO61875.1; -; mRNA.
DR   EMBL; EF141525; ABO61876.1; -; mRNA.
DR   EMBL; EF141526; ABO61877.1; -; mRNA.
DR   EMBL; EF141527; ABO61878.1; -; mRNA.
DR   EMBL; EF141528; ABO61879.1; -; mRNA.
DR   EMBL; EF141529; ABO61880.1; -; mRNA.
DR   EMBL; EF141530; ABO61881.1; -; mRNA.
DR   RefSeq; NP_001295394.1; NM_001308465.2.
DR   RefSeq; NP_001295396.1; NM_001308467.2.
DR   RefSeq; NP_001295397.1; NM_001308468.2.
DR   RefSeq; NP_001295398.1; NM_001308469.2.
DR   RefSeq; NP_001295399.1; NM_001308470.2.
DR   RefSeq; NP_001295400.1; NM_001308471.2.
DR   RefSeq; NP_001295405.1; NM_001308476.2.
DR   UniGene; Hs.253706; -.
DR   UniGene; Hs.614318; -.
DR   GeneID; 57105; -.
DR   KEGG; hsa:57105; -.
DR   UCSC; uc058wyy.1; human.
DR   CTD; 57105; -.
DR   KO; K04323; -.
DR   GenomeRNAi; 57105; -.
PE   2: Evidence at transcript level;
KW   Receptor {ECO:0000313|EMBL:ABO61874.1}.
FT   NON_TER      15     15       {ECO:0000313|EMBL:ABO61874.1}.
SQ   SEQUENCE   15 AA;  1740 MW;  5F22BA36A56838EE CRC64;
     MERKFMSLQP SISVS
//
ID   Q5KU17_HUMAN            Unreviewed;       346 AA.
AC   Q5KU17;
DT   10-MAY-2005, integrated into UniProtKB/TrEMBL.
DT   10-MAY-2005, sequence version 1.
DT   25-OCT-2017, entry version 110.
DE   SubName: Full=Cysteinyl leukotriene receptor 2 {ECO:0000313|EMBL:AAH96832.1};
DE   SubName: Full=G-protein coupled receptor protein {ECO:0000313|EMBL:BAD83598.1};
DE   SubName: Full=cDNA FLJ78284, highly similar to Homo sapiens cysteinyl leukotriene receptor 2 (CYSLTR2), mRNA {ECO:0000313|EMBL:BAF84428.1};
GN   Name=KPG_011 {ECO:0000313|EMBL:BAD83598.1};
GN   Synonyms=CYSLTR2 {ECO:0000313|EMBL:AAH96832.1};
GN   ORFNames=hCG_1647464 {ECO:0000313|EMBL:EAX08802.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAD83598.1};
RN   [1] {ECO:0000313|EMBL:BAD83598.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Ina K., Urakawa I., Mizutani S., Okazaki H.;
RT   "Probable G-protein coupled receptor.";
RL   Submitted (APR-2000) to the EMBL/GenBank/DDBJ databases.
RN   [2] {ECO:0000313|EMBL:EAX08802.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D.,
RA   Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q.,
RA   Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G.,
RA   Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S.,
RA   Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J.,
RA   Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R.,
RA   Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A.,
RA   Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K.,
RA   Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V.,
RA   Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z.,
RA   Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A.,
RA   Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V.,
RA   Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B.,
RA   Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J.,
RA   Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C.,
RA   Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L.,
RA   Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S.,
RA   Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A.,
RA   Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D.,
RA   Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L.,
RA   Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N.,
RA   Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S.,
RA   Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F.,
RA   Kline L., Koduru S., Love A., Mann F., May D., McCawley S.,
RA   McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K.,
RA   Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N.,
RA   Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M.,
RA   Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F.,
RA   Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A.,
RA   Mi H., Lazareva B., Hatton T., Narechania A., Diemer K.,
RA   Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R.,
RA   Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J.,
RA   Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H.,
RA   Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D.,
RA   Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A.,
RA   Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S.,
RA   Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L.,
RA   Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W.,
RA   McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M.,
RA   Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [3] {ECO:0000313|EMBL:AAH96832.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RA   Gerhard D.S., Wagner L., Feingold E.A., Shenmen C.M., Grouse L.H.,
RA   Schuler G., Klein S.L., Old S., Rasooly R., Good P., Guyer M.,
RA   Peck A.M., Derge J.G., Lipman D., Collins F.S., Jang W., Sherry S.,
RA   Feolo M., Misquitta L., Lee E., Rotmistrovsky K., Greenhut S.F.,
RA   Schaefer C.F., Buetow K., Bonner T.I., Haussler D., Kent J.,
RA   Kiekhaus M., Furey T., Brent M., Prange C., Schreiber K., Shapiro N.,
RA   Bhat N.K., Hopkins R.F., Hsie F., Driscoll T., Soares M.B.,
RA   Casavant T.L., Scheetz T.E., Brown-stein M.J., Usdin T.B.,
RA   Toshiyuki S., Carninci P., Piao Y., Dudekula D.B., Ko M.S.,
RA   Kawakami K., Suzuki Y., Sugano S., Gruber C.E., Smith M.R.,
RA   Simmons B., Moore T., Waterman R., Johnson S.L., Ruan Y., Wei C.L.,
RA   Mathavan S., Gunaratne P.H., Wu J., Garcia A.M., Hulyk S.W., Fuh E.,
RA   Yuan Y., Sneed A., Kowis C., Hodgson A., Muzny D.M., McPherson J.,
RA   Gibbs R.A., Fahey J., Helton E., Ketteman M., Madan A., Rodrigues S.,
RA   Sanchez A., Whiting M., Madari A., Young A.C., Wetherby K.D.,
RA   Granite S.J., Kwong P.N., Brinkley C.P., Pearson R.L., Bouffard G.G.,
RA   Blakesly R.W., Green E.D., Dickson M.C., Rodriguez A.C., Grimwood J.,
RA   Schmutz J., Myers R.M., Butterfield Y.S., Griffith M., Griffith O.L.,
RA   Krzywinski M.I., Liao N., Morin R., Morrin R., Palmquist D.,
RA   Petrescu A.S., Skalska U., Smailus D.E., Stott J.M., Schnerch A.,
RA   Schein J.E., Jones S.J., Holt R.A., Baross A., Marra M.A., Clifton S.,
RA   Makowski K.A., Bosak S., Malek J.;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4] {ECO:0000313|EMBL:AAW47925.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Fukai H., Ogasawara Y., Migita O., Koga M., Ichikawa K., Shibasaki M.,
RA   Arinami T., Noguchi E.;
RT   "Association between a polymorphism in cysteinyl leukotriene receptor
RT   2 on chromosome 13q14 and atopic asthma.";
RL   Pharmacogenetics 10:683-690(2004).
RN   [5] {ECO:0000313|EMBL:EAX08802.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6] {ECO:0000313|EMBL:BAF84428.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Placenta {ECO:0000313|EMBL:BAF84428.1};
RA   Wakamatsu A., Yamamoto J., Kimura K., Ishii S., Watanabe K.,
RA   Sugiyama A., Murakawa K., Kaida T., Tsuchiya K., Fukuzumi Y.,
RA   Kumagai A., Oishi Y., Yamamoto S., Ono Y., Komori Y., Yamazaki M.,
RA   Kisu Y., Nishikawa T., Sugano S., Nomura N., Isogai T.;
RT   "NEDO human cDNA sequencing project.";
RL   Submitted (OCT-2007) to the EMBL/GenBank/DDBJ databases.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; BC096832; AAH96832.1; -; mRNA.
DR   EMBL; AY853711; AAW47925.1; -; mRNA.
DR   EMBL; AB041947; BAD83598.1; -; mRNA.
DR   EMBL; AK291739; BAF84428.1; -; mRNA.
DR   EMBL; CH471075; EAX08802.1; -; Genomic_DNA.
DR   RefSeq; NP_001295394.1; NM_001308465.2.
DR   RefSeq; NP_001295396.1; NM_001308467.2.
DR   RefSeq; NP_001295397.1; NM_001308468.2.
DR   RefSeq; NP_001295398.1; NM_001308469.2.
DR   RefSeq; NP_001295399.1; NM_001308470.2.
DR   RefSeq; NP_001295400.1; NM_001308471.2.
DR   RefSeq; NP_001295405.1; NM_001308476.2.
DR   RefSeq; NP_065110.1; NM_020377.4.
DR   UniGene; Hs.253706; -.
DR   UniGene; Hs.614318; -.
DR   DNASU; 57105; -.
DR   GeneID; 57105; -.
DR   KEGG; hsa:57105; -.
DR   CTD; 57105; -.
DR   EuPathDB; HostDB:ENSG00000152207.7; -.
DR   PharmGKB; PA38518; -.
DR   eggNOG; ENOG410IGJM; Eukaryota.
DR   eggNOG; ENOG410YDV0; LUCA.
DR   HOVERGEN; HBG099611; -.
DR   KO; K04323; -.
DR   OMA; SVNVFML; -.
DR   OrthoDB; EOG091G0EA7; -.
DR   GenomeRNAi; 57105; -.
DR   Bgee; ENSG00000152207; -.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0001631; F:cysteinyl leukotriene receptor activity; IEA:Ensembl.
DR   GO; GO:0045766; P:positive regulation of angiogenesis; IEA:Ensembl.
DR   GO; GO:0010942; P:positive regulation of cell death; IEA:Ensembl.
DR   GO; GO:0070374; P:positive regulation of ERK1 and ERK2 cascade; IEA:Ensembl.
DR   InterPro; IPR013311; CLT2_recept.
DR   InterPro; IPR004071; Cyst_leuk_rcpt.
DR   InterPro; IPR000276; GPCR_Rhodpsn.
DR   InterPro; IPR017452; GPCR_Rhodpsn_7TM.
DR   Pfam; PF00001; 7tm_1; 1.
DR   PRINTS; PR01903; CYSLT2RECPTR.
DR   PRINTS; PR01533; CYSLTRECPTR.
DR   PRINTS; PR00237; GPCRRHODOPSN.
DR   PROSITE; PS50262; G_PROTEIN_RECEP_F1_2; 1.
PE   2: Evidence at transcript level;
KW   Membrane {ECO:0000256|SAM:Phobius};
KW   Receptor {ECO:0000313|EMBL:BAD83598.1};
KW   Transmembrane {ECO:0000256|SAM:Phobius};
KW   Transmembrane helix {ECO:0000256|SAM:Phobius}.
FT   TRANSMEM     43     64       Helical. {ECO:0000256|SAM:Phobius}.
FT   TRANSMEM     76     93       Helical. {ECO:0000256|SAM:Phobius}.
FT   TRANSMEM    113    135       Helical. {ECO:0000256|SAM:Phobius}.
FT   TRANSMEM    155    174       Helical. {ECO:0000256|SAM:Phobius}.
FT   TRANSMEM    203    224       Helical. {ECO:0000256|SAM:Phobius}.
FT   TRANSMEM    245    266       Helical. {ECO:0000256|SAM:Phobius}.
FT   TRANSMEM    286    308       Helical. {ECO:0000256|SAM:Phobius}.
FT   DOMAIN       55    305       G_PROTEIN_RECEP_F1_2.
FT                                {ECO:0000259|PROSITE:PS50262}.
SQ   SEQUENCE   346 AA;  39635 MW;  EB54A4A2DDCE5EE4 CRC64;
     MERKFMSLQP SISVSEMEPN GTFSNNNSRN CTIENFKREF FPIVYLIIFF WGVLGNGLSI
     YVFLQPYKKS TSVNVFMLNL AISDLLFIST LPFRADYYLR GSNWIFGDLA CRIMSYSLYV
     NMYSSIYFLT VLSVVRFLAM VHPFRLLHVT SIRSAWILCG IIWILIMASS IMLLDSGSEQ
     NGSVTSCLEL NLYKIAKLQT MNYIALVVGC LLPFFTLSIC YLLIIRVLLK VEVPESGLRV
     SHRKALTTII ITLIIFFLCF LPYHTLRTVH LTTWKVGLCK DRLHKALVIT LALAAANACF
     NPLLYYFAGE NFKDRLKSAL RKGHPQKAKT KCVFPVSVWL RKETRV
//
ID   CLTR2_HUMAN             Reviewed;         346 AA.
AC   Q9NS75; Q9HCQ2;
DT   11-FEB-2002, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2000, sequence version 1.
DT   28-FEB-2018, entry version 149.
DE   RecName: Full=Cysteinyl leukotriene receptor 2;
DE            Short=CysLTR2;
DE   AltName: Full=G-protein coupled receptor GPCR21;
DE            Short=hGPCR21;
DE   AltName: Full=G-protein coupled receptor HG57;
DE   AltName: Full=HPN321;
GN   Name=CYSLTR2; Synonyms=CYSLT2, CYSLT2R; ORFNames=PSEC0146;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Placenta;
RX   PubMed=10913337; DOI=10.1006/bbrc.2000.3140;
RA   Takasaki J., Kamohara M., Matsumoto M., Saito T., Sugimoto T., Ota T.,
RA   Nishikawa T., Kawai Y., Masuho Y., Isogai T., Suzuki Y., Sugano S.,
RA   Furuichi K.;
RT   "The molecular characterization and tissue distribution of the human
RT   cysteinyl leukotriene CysLT2 receptor.";
RL   Biochem. Biophys. Res. Commun. 274:316-322(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=10851239; DOI=10.1074/jbc.M003490200;
RA   Heise C.E., O'Dowd B.F., Figueroa D.J., Sawyer N., Nguyen T.,
RA   Im D.-S., Stocco R., Bellefeuille J.N., Abramovitz M., Cheng R.,
RA   Williams D.L. Jr., Zeng Z., Liu Q., Ma L., Clements M.K., Coulombe N.,
RA   Liu Y., Austin C.P., George S.R., O'Neill G.P., Metters K.M.,
RA   Lynch K.R., Evans J.F.;
RT   "Characterization of the human cysteinyl leukotriene 2 receptor.";
RL   J. Biol. Chem. 275:30531-30536(2000).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=11093801;
RA   Nothacker H.-P., Wang Z., Zhu Y., Reinscheid R.K., Lin S.H.S.,
RA   Civelli O.;
RT   "Molecular cloning and characterization of a second human cysteinyl
RT   leukotriene receptor: discovery of a subtype selective agonist.";
RL   Mol. Pharmacol. 58:1601-1608(2000).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12044878; DOI=10.1016/S0014-5793(02)02775-8;
RA   Takeda S., Kadowaki S., Haga T., Takaesu H., Mitaku S.;
RT   "Identification of G protein-coupled receptor genes from the human
RT   genome sequence.";
RL   FEBS Lett. 520:97-101(2002).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Kopatz S.A., Aronstam R.S., Sharma S.V.;
RT   "cDNA clones of human proteins involved in signal transduction
RT   sequenced by the Guthrie cDNA resource center (www.cdna.org).";
RL   Submitted (SEP-2003) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057823; DOI=10.1038/nature02379;
RA   Dunham A., Matthews L.H., Burton J., Ashurst J.L., Howe K.L.,
RA   Ashcroft K.J., Beare D.M., Burford D.C., Hunt S.E.,
RA   Griffiths-Jones S., Jones M.C., Keenan S.J., Oliver K., Scott C.E.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Andrews D.T.,
RA   Ashwell R.I.S., Babbage A.K., Bagguley C.L., Bailey J., Bannerjee R.,
RA   Barlow K.F., Bates K., Beasley H., Bird C.P., Bray-Allen S.,
RA   Brown A.J., Brown J.Y., Burrill W., Carder C., Carter N.P.,
RA   Chapman J.C., Clamp M.E., Clark S.Y., Clarke G., Clee C.M.,
RA   Clegg S.C., Cobley V., Collins J.E., Corby N., Coville G.J.,
RA   Deloukas P., Dhami P., Dunham I., Dunn M., Earthrowl M.E.,
RA   Ellington A.G., Faulkner L., Frankish A.G., Frankland J., French L.,
RA   Garner P., Garnett J., Gilbert J.G.R., Gilson C.J., Ghori J.,
RA   Grafham D.V., Gribble S.M., Griffiths C., Hall R.E., Hammond S.,
RA   Harley J.L., Hart E.A., Heath P.D., Howden P.J., Huckle E.J.,
RA   Hunt P.J., Hunt A.R., Johnson C., Johnson D., Kay M., Kimberley A.M.,
RA   King A., Laird G.K., Langford C.J., Lawlor S., Leongamornlert D.A.,
RA   Lloyd D.M., Lloyd C., Loveland J.E., Lovell J., Martin S.,
RA   Mashreghi-Mohammadi M., McLaren S.J., McMurray A., Milne S.,
RA   Moore M.J.F., Nickerson T., Palmer S.A., Pearce A.V., Peck A.I.,
RA   Pelan S., Phillimore B., Porter K.M., Rice C.M., Searle S.,
RA   Sehra H.K., Shownkeen R., Skuce C.D., Smith M., Steward C.A.,
RA   Sycamore N., Tester J., Thomas D.W., Tracey A., Tromans A., Tubby B.,
RA   Wall M., Wallis J.M., West A.P., Whitehead S.L., Willey D.L.,
RA   Wilming L., Wray P.W., Wright M.W., Young L., Coulson A., Durbin R.M.,
RA   Hubbard T., Sulston J.E., Beck S., Bentley D.R., Rogers J., Ross M.T.;
RT   "The DNA sequence and analysis of human chromosome 13.";
RL   Nature 428:522-528(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 17-346.
RA   Suga H.;
RT   "Homo sapiens cysteinyl leukotriene receptor 1 like receptor.";
RL   Submitted (APR-2000) to the EMBL/GenBank/DDBJ databases.
CC   -!- FUNCTION: Receptor for cysteinyl leukotrienes. The response is
CC       mediated via a G-protein that activates a phosphatidylinositol-
CC       calcium second messenger system. Stimulation by BAY u9773, a
CC       partial agonist, induces specific contractions of pulmonary veins
CC       and might also have an indirect role in the relaxation of the
CC       pulmonary vascular endothelium. The rank order of affinities for
CC       the leukotrienes is LTC4 = LTD4 >> LTE4.
CC   -!- INTERACTION:
CC       Q9Y271:CYSLTR1; NbExp=2; IntAct=EBI-3843579, EBI-9347754;
CC       Q12959:DLG1; NbExp=3; IntAct=EBI-3843579, EBI-357481;
CC   -!- SUBCELLULAR LOCATION: Cell membrane; Multi-pass membrane protein.
CC   -!- TISSUE SPECIFICITY: Widely expressed, with highest levels in the
CC       heart, placenta, spleen, peripheral blood leukocytes and adrenal
CC       gland. In lung, expressed in the interstitial macrophages, and
CC       slightly in smooth muscle cells.
CC   -!- SIMILARITY: Belongs to the G-protein coupled receptor 1 family.
CC       {ECO:0000255|PROSITE-ProRule:PRU00521}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB038269; BAB03601.1; -; mRNA.
DR   EMBL; AF254664; AAG17281.1; -; Genomic_DNA.
DR   EMBL; AF279611; AAK69485.1; -; Genomic_DNA.
DR   EMBL; AB083603; BAB89316.1; -; Genomic_DNA.
DR   EMBL; AY389504; AAQ91330.1; -; Genomic_DNA.
DR   EMBL; AL137118; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC069160; AAH69160.1; -; mRNA.
DR   EMBL; AB041644; BAB16379.1; -; Genomic_DNA.
DR   CCDS; CCDS9412.1; -.
DR   RefSeq; NP_001295394.1; NM_001308465.2.
DR   RefSeq; NP_001295396.1; NM_001308467.2.
DR   RefSeq; NP_001295397.1; NM_001308468.2.
DR   RefSeq; NP_001295398.1; NM_001308469.2.
DR   RefSeq; NP_001295399.1; NM_001308470.2.
DR   RefSeq; NP_001295400.1; NM_001308471.2.
DR   RefSeq; NP_001295405.1; NM_001308476.2.
DR   RefSeq; NP_065110.1; NM_020377.4.
DR   UniGene; Hs.253706; -.
DR   UniGene; Hs.614318; -.
DR   ProteinModelPortal; Q9NS75; -.
DR   BioGrid; 121371; 1.
DR   IntAct; Q9NS75; 5.
DR   MINT; Q9NS75; -.
DR   STRING; 9606.ENSP00000282018; -.
DR   BindingDB; Q9NS75; -.
DR   ChEMBL; CHEMBL4330; -.
DR   DrugBank; DB00716; Nedocromil.
DR   GuidetoPHARMACOLOGY; 270; -.
DR   SwissLipids; SLP:000001584; -.
DR   iPTMnet; Q9NS75; -.
DR   PhosphoSitePlus; Q9NS75; -.
DR   BioMuta; CYSLTR2; -.
DR   DMDM; 20138034; -.
DR   PaxDb; Q9NS75; -.
DR   PeptideAtlas; Q9NS75; -.
DR   PRIDE; Q9NS75; -.
DR   DNASU; 57105; -.
DR   Ensembl; ENST00000282018; ENSP00000282018; ENSG00000152207.
DR   Ensembl; ENST00000614739; ENSP00000477930; ENSG00000152207.
DR   GeneID; 57105; -.
DR   KEGG; hsa:57105; -.
DR   UCSC; uc010ada.2; human.
DR   CTD; 57105; -.
DR   DisGeNET; 57105; -.
DR   EuPathDB; HostDB:ENSG00000152207.7; -.
DR   GeneCards; CYSLTR2; -.
DR   HGNC; HGNC:18274; CYSLTR2.
DR   HPA; HPA046528; -.
DR   MalaCards; CYSLTR2; -.
DR   MIM; 605666; gene.
DR   neXtProt; NX_Q9NS75; -.
DR   OpenTargets; ENSG00000152207; -.
DR   PharmGKB; PA38518; -.
DR   eggNOG; ENOG410IGJM; Eukaryota.
DR   eggNOG; ENOG410YDV0; LUCA.
DR   GeneTree; ENSGT00910000144002; -.
DR   HOGENOM; HOG000236328; -.
DR   HOVERGEN; HBG099611; -.
DR   InParanoid; Q9NS75; -.
DR   KO; K04323; -.
DR   OMA; SVNVFML; -.
DR   OrthoDB; EOG091G0EA7; -.
DR   PhylomeDB; Q9NS75; -.
DR   TreeFam; TF350009; -.
DR   Reactome; R-HSA-391906; Leukotriene receptors.
DR   Reactome; R-HSA-416476; G alpha (q) signalling events.
DR   GeneWiki; Cysteinyl_leukotriene_receptor_2; -.
DR   GenomeRNAi; 57105; -.
DR   PRO; PR:Q9NS75; -.
DR   Proteomes; UP000005640; Chromosome 13.
DR   Bgee; ENSG00000152207; -.
DR   CleanEx; HS_CYSLTR2; -.
DR   ExpressionAtlas; Q9NS75; baseline and differential.
DR   Genevisible; Q9NS75; HS.
DR   GO; GO:0005887; C:integral component of plasma membrane; IBA:GO_Central.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0001631; F:cysteinyl leukotriene receptor activity; IEA:Ensembl.
DR   GO; GO:0008528; F:G-protein coupled peptide receptor activity; IBA:GO_Central.
DR   GO; GO:0004974; F:leukotriene receptor activity; NAS:UniProtKB.
DR   GO; GO:0007186; P:G-protein coupled receptor signaling pathway; TAS:Reactome.
DR   GO; GO:0006955; P:immune response; NAS:UniProtKB.
DR   GO; GO:0007218; P:neuropeptide signaling pathway; IBA:GO_Central.
DR   GO; GO:0007200; P:phospholipase C-activating G-protein coupled receptor signaling pathway; IBA:GO_Central.
DR   GO; GO:0045766; P:positive regulation of angiogenesis; IEA:Ensembl.
DR   GO; GO:0010942; P:positive regulation of cell death; IEA:Ensembl.
DR   GO; GO:0070374; P:positive regulation of ERK1 and ERK2 cascade; IEA:Ensembl.
DR   InterPro; IPR013311; CLT2_recept.
DR   InterPro; IPR004071; Cyst_leuk_rcpt.
DR   InterPro; IPR000276; GPCR_Rhodpsn.
DR   InterPro; IPR017452; GPCR_Rhodpsn_7TM.
DR   Pfam; PF00001; 7tm_1; 1.
DR   PRINTS; PR01903; CYSLT2RECPTR.
DR   PRINTS; PR01533; CYSLTRECPTR.
DR   PRINTS; PR00237; GPCRRHODOPSN.
DR   PROSITE; PS50262; G_PROTEIN_RECEP_F1_2; 1.
PE   1: Evidence at protein level;
KW   Cell membrane; Complete proteome; Disulfide bond;
KW   G-protein coupled receptor; Glycoprotein; Membrane; Receptor;
KW   Reference proteome; Transducer; Transmembrane; Transmembrane helix.
FT   CHAIN         1    346       Cysteinyl leukotriene receptor 2.
FT                                /FTId=PRO_0000069303.
FT   TOPO_DOM      1     42       Extracellular. {ECO:0000255}.
FT   TRANSMEM     43     63       Helical; Name=1. {ECO:0000255}.
FT   TOPO_DOM     64     72       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     73     93       Helical; Name=2. {ECO:0000255}.
FT   TOPO_DOM     94    123       Extracellular. {ECO:0000255}.
FT   TRANSMEM    124    144       Helical; Name=3. {ECO:0000255}.
FT   TOPO_DOM    145    153       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    154    174       Helical; Name=4. {ECO:0000255}.
FT   TOPO_DOM    175    204       Extracellular. {ECO:0000255}.
FT   TRANSMEM    205    225       Helical; Name=5. {ECO:0000255}.
FT   TOPO_DOM    226    245       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    246    266       Helical; Name=6. {ECO:0000255}.
FT   TOPO_DOM    267    286       Extracellular. {ECO:0000255}.
FT   TRANSMEM    287    307       Helical; Name=7. {ECO:0000255}.
FT   TOPO_DOM    308    346       Cytoplasmic. {ECO:0000255}.
FT   CARBOHYD     20     20       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD     26     26       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD     30     30       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    181    181       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID    111    187       {ECO:0000255|PROSITE-ProRule:PRU00521}.
SQ   SEQUENCE   346 AA;  39635 MW;  EB54A4A2DDCE5EE4 CRC64;
     MERKFMSLQP SISVSEMEPN GTFSNNNSRN CTIENFKREF FPIVYLIIFF WGVLGNGLSI
     YVFLQPYKKS TSVNVFMLNL AISDLLFIST LPFRADYYLR GSNWIFGDLA CRIMSYSLYV
     NMYSSIYFLT VLSVVRFLAM VHPFRLLHVT SIRSAWILCG IIWILIMASS IMLLDSGSEQ
     NGSVTSCLEL NLYKIAKLQT MNYIALVVGC LLPFFTLSIC YLLIIRVLLK VEVPESGLRV
     SHRKALTTII ITLIIFFLCF LPYHTLRTVH LTTWKVGLCK DRLHKALVIT LALAAANACF
     NPLLYYFAGE NFKDRLKSAL RKGHPQKAKT KCVFPVSVWL RKETRV
//
ID   DGCR8_HUMAN             Reviewed;         773 AA.
AC   Q8WYQ5; B2R8G1; Q6DCB2; Q6MZE9; Q6Y2L0; Q96G39; Q96GP8; Q9H6L8;
AC   Q9H6T7; Q9NRW2;
DT   10-OCT-2002, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2002, sequence version 1.
DT   28-FEB-2018, entry version 165.
DE   RecName: Full=Microprocessor complex subunit DGCR8;
DE   AltName: Full=DiGeorge syndrome critical region 8;
GN   Name=DGCR8; Synonyms=C22orf12, DGCRK6; ORFNames=LP4941;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM 1), AND TISSUE SPECIFICITY.
RX   PubMed=12705904; DOI=10.1016/S0006-291X(03)00554-0;
RA   Shiohama A., Sasaki T., Noda S., Minoshima S., Shimizu N.;
RT   "Molecular cloning and expression analysis of a novel gene DGCR8
RT   located in the DiGeorge syndrome chromosomal region.";
RL   Biochem. Biophys. Res. Commun. 304:184-190(2003).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RX   PubMed=15461802; DOI=10.1186/gb-2004-5-10-r84;
RA   Collins J.E., Wright C.L., Edwards C.A., Davis M.P., Grinham J.A.,
RA   Cole C.G., Goward M.E., Aguado B., Mallya M., Mokrab Y., Huckle E.J.,
RA   Beare D.M., Dunham I.;
RT   "A genome annotation-driven approach to cloning the human ORFeome.";
RL   Genome Biol. 5:R84.1-R84.11(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2), AND NUCLEOTIDE
RP   SEQUENCE [LARGE SCALE MRNA] OF 204-773 (ISOFORM 1).
RC   TISSUE=Hepatoma, and Testis;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=10591208; DOI=10.1038/990031;
RA   Dunham I., Hunt A.R., Collins J.E., Bruskiewich R., Beare D.M.,
RA   Clamp M., Smink L.J., Ainscough R., Almeida J.P., Babbage A.K.,
RA   Bagguley C., Bailey J., Barlow K.F., Bates K.N., Beasley O.P.,
RA   Bird C.P., Blakey S.E., Bridgeman A.M., Buck D., Burgess J.,
RA   Burrill W.D., Burton J., Carder C., Carter N.P., Chen Y., Clark G.,
RA   Clegg S.M., Cobley V.E., Cole C.G., Collier R.E., Connor R.,
RA   Conroy D., Corby N.R., Coville G.J., Cox A.V., Davis J., Dawson E.,
RA   Dhami P.D., Dockree C., Dodsworth S.J., Durbin R.M., Ellington A.G.,
RA   Evans K.L., Fey J.M., Fleming K., French L., Garner A.A.,
RA   Gilbert J.G.R., Goward M.E., Grafham D.V., Griffiths M.N.D., Hall C.,
RA   Hall R.E., Hall-Tamlyn G., Heathcott R.W., Ho S., Holmes S.,
RA   Hunt S.E., Jones M.C., Kershaw J., Kimberley A.M., King A.,
RA   Laird G.K., Langford C.F., Leversha M.A., Lloyd C., Lloyd D.M.,
RA   Martyn I.D., Mashreghi-Mohammadi M., Matthews L.H., Mccann O.T.,
RA   Mcclay J., Mclaren S., McMurray A.A., Milne S.A., Mortimore B.J.,
RA   Odell C.N., Pavitt R., Pearce A.V., Pearson D., Phillimore B.J.C.T.,
RA   Phillips S.H., Plumb R.W., Ramsay H., Ramsey Y., Rogers L., Ross M.T.,
RA   Scott C.E., Sehra H.K., Skuce C.D., Smalley S., Smith M.L.,
RA   Soderlund C., Spragon L., Steward C.A., Sulston J.E., Swann R.M.,
RA   Vaudin M., Wall M., Wallis J.M., Whiteley M.N., Willey D.L.,
RA   Williams L., Williams S.A., Williamson H., Wilmer T.E., Wilming L.,
RA   Wright C.L., Hubbard T., Bentley D.R., Beck S., Rogers J., Shimizu N.,
RA   Minoshima S., Kawasaki K., Sasaki T., Asakawa S., Kudoh J.,
RA   Shintani A., Shibuya K., Yoshizaki Y., Aoki N., Mitsuyama S.,
RA   Roe B.A., Chen F., Chu L., Crabtree J., Deschamps S., Do A., Do T.,
RA   Dorman A., Fang F., Fu Y., Hu P., Hua A., Kenton S., Lai H., Lao H.I.,
RA   Lewis J., Lewis S., Lin S.-P., Loh P., Malaj E., Nguyen T., Pan H.,
RA   Phan S., Qi S., Qian Y., Ray L., Ren Q., Shaull S., Sloan D., Song L.,
RA   Wang Q., Wang Y., Wang Z., White J., Willingham D., Wu H., Yao Z.,
RA   Zhan M., Zhang G., Chissoe S., Murray J., Miller N., Minx P.,
RA   Fulton R., Johnson D., Bemis G., Bentley D., Bradshaw H., Bourne S.,
RA   Cordes M., Du Z., Fulton L., Goela D., Graves T., Hawkins J.,
RA   Hinds K., Kemp K., Latreille P., Layman D., Ozersky P., Rohlfing T.,
RA   Scheet P., Walker C., Wamsley A., Wohldmann P., Pepin K., Nelson J.,
RA   Korf I., Bedell J.A., Hillier L.W., Mardis E., Waterston R.,
RA   Wilson R., Emanuel B.S., Shaikh T., Kurahashi H., Saitta S.,
RA   Budarf M.L., McDermid H.E., Johnson A., Wong A.C.C., Morrow B.E.,
RA   Edelmann L., Kim U.J., Shizuya H., Simon M.I., Dumanski J.P.,
RA   Peyrard M., Kedra D., Seroussi E., Fransson I., Tapia I., Bruder C.E.,
RA   O'Brien K.P., Wilkinson P., Bodenteich A., Hartman K., Hu X.,
RA   Khan A.S., Lane L., Tilahun Y., Wright H.;
RT   "The DNA sequence of human chromosome 22.";
RL   Nature 402:489-495(1999).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1; 2 AND 3).
RC   TISSUE=Brain, Muscle, and Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-247.
RC   TISSUE=Heart;
RA   Gong L., Millas S., Jen J., Yeh E.T.H.;
RT   "Isolation and characterization of a novel human gene deleted in
RT   DiGeorge syndrome.";
RL   Submitted (JUL-1999) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 282-773.
RC   TISSUE=Salivary gland;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 427-773.
RX   PubMed=15498874; DOI=10.1073/pnas.0404089101;
RA   Wan D., Gong Y., Qin W., Zhang P., Li J., Wei L., Zhou X., Li H.,
RA   Qiu X., Zhong F., He L., Yu J., Yao G., Jiang H., Qian L., Yu Y.,
RA   Shu H., Chen X., Xu H., Guo M., Pan Z., Chen Y., Ge C., Yang S.,
RA   Gu J.;
RT   "Large-scale cDNA transfection screening for genes related to cancer
RT   development and progression.";
RL   Proc. Natl. Acad. Sci. U.S.A. 101:15724-15729(2004).
RN   [9]
RP   FUNCTION, AND INTERACTION WITH DROSHA.
RX   PubMed=15589161; DOI=10.1016/j.cub.2004.11.001;
RA   Landthaler M., Yalcin A., Tuschl T.;
RT   "The human DiGeorge syndrome critical region gene 8 and its D.
RT   melanogaster homolog are required for miRNA biogenesis.";
RL   Curr. Biol. 14:2162-2167(2004).
RN   [10]
RP   FUNCTION, AND IDENTIFICATION IN THE MICROPROCESSOR COMPLEX.
RX   PubMed=15574589; DOI=10.1101/gad.1262504;
RA   Han J., Lee Y., Yeom K.-H., Kim Y.-K., Jin H., Kim V.N.;
RT   "The Drosha-DGCR8 complex in primary microRNA processing.";
RL   Genes Dev. 18:3016-3027(2004).
RN   [11]
RP   FUNCTION, AND IDENTIFICATION IN THE MICROPROCESSOR COMPLEX.
RX   PubMed=15531877; DOI=10.1038/nature03120;
RA   Gregory R.I., Yan K.-P., Amuthan G., Chendrimada T., Doratotaj B.,
RA   Cooch N., Shiekhattar R.;
RT   "The microprocessor complex mediates the genesis of microRNAs.";
RL   Nature 432:235-240(2004).
RN   [12]
RP   FUNCTION, IDENTIFICATION IN THE MICROPROCESSOR COMPLEX, AND
RP   RNA-BINDING.
RX   PubMed=16751099; DOI=10.1016/j.cell.2006.03.043;
RA   Han J., Lee Y., Yeom K.-H., Nam J.-W., Heo I., Rhee J.-K., Sohn S.Y.,
RA   Cho Y., Zhang B.-T., Kim V.N.;
RT   "Molecular basis for the recognition of primary microRNAs by the
RT   Drosha-DGCR8 complex.";
RL   Cell 125:887-901(2006).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [14]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=16906129; DOI=10.1038/sj.embor.7400783;
RA   Pauley K.M., Eystathioy T., Jakymiw A., Hamel J.C., Fritzler M.J.,
RA   Chan E.K.L.;
RT   "Formation of GW bodies is a consequence of microRNA genesis.";
RL   EMBO Rep. 7:904-910(2006).
RN   [15]
RP   FUNCTION, INTERACTION WITH DROSHA, RNA-BINDING, SUBCELLULAR LOCATION,
RP   AND MUTAGENESIS OF 568-ALA-ALA-569 AND 676-ALA-SER-677.
RX   PubMed=16963499; DOI=10.1093/nar/gkl458;
RA   Yeom K.-H., Lee Y., Han J., Suh M.R., Kim V.N.;
RT   "Characterization of DGCR8/Pasha, the essential cofactor for Drosha in
RT   primary miRNA processing.";
RL   Nucleic Acids Res. 34:4622-4629(2006).
RN   [16]
RP   INTERACTION WITH ILF3; NCL AND DROSHA, SUBCELLULAR LOCATION, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=17765891; DOI=10.1016/j.yexcr.2007.07.020;
RA   Shiohama A., Sasaki T., Noda S., Minoshima S., Shimizu N.;
RT   "Nucleolar localization of DGCR8 and identification of eleven DGCR8-
RT   associated proteins.";
RL   Exp. Cell Res. 313:4196-4207(2007).
RN   [17]
RP   FUNCTION, SUBUNIT, COFACTOR, AND MUTAGENESIS OF CYS-352 AND CYS-430.
RX   PubMed=17159994; DOI=10.1038/nsmb1182;
RA   Faller M., Matsunaga M., Yin S., Loo J.A., Guo F.;
RT   "Heme is involved in microRNA processing.";
RL   Nat. Struct. Mol. Biol. 14:23-29(2007).
RN   [18]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-95, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18220336; DOI=10.1021/pr0705441;
RA   Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,
RA   Yates J.R. III;
RT   "Combining protein-based IMAC, peptide-based IMAC, and MudPIT for
RT   efficient phosphoproteomic analysis.";
RL   J. Proteome Res. 7:1346-1351(2008).
RN   [19]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-271; SER-275 AND
RP   SER-377, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [20]
RP   INTERACTION WITH DROSHA.
RX   PubMed=19135890; DOI=10.1016/j.cell.2008.10.053;
RA   Han J., Pedersen J.S., Kwon S.C., Belair C.D., Kim Y.-K., Yeom K.-H.,
RA   Yang W.-Y., Haussler D., Blelloch R., Kim V.N.;
RT   "Posttranscriptional crossregulation between Drosha and DGCR8.";
RL   Cell 136:75-84(2009).
RN   [21]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-271 AND SER-275, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [22]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [23]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [24]
RP   SUBCELLULAR LOCATION.
RX   PubMed=22118463; DOI=10.1016/j.cell.2011.10.039;
RA   Piskounova E., Polytarchou C., Thornton J.E., LaPierre R.J.,
RA   Pothoulakis C., Hagan J.P., Iliopoulos D., Gregory R.I.;
RT   "Lin28A and Lin28B inhibit let-7 microRNA biogenesis by distinct
RT   mechanisms.";
RL   Cell 147:1066-1079(2011).
RN   [25]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-95; THR-371 AND SER-377,
RP   AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [26]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-95; SER-275; SER-373 AND
RP   SER-377, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [27]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-35 AND SER-92, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [28]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-707, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25218447; DOI=10.1038/nsmb.2890;
RA   Hendriks I.A., D'Souza R.C., Yang B., Verlaan-de Vries M., Mann M.,
RA   Vertegaal A.C.;
RT   "Uncovering global SUMOylation signaling networks in a site-specific
RT   manner.";
RL   Nat. Struct. Mol. Biol. 21:927-936(2014).
RN   [29]
RP   FUNCTION, INTERACTION WITH DROSHA, AND SUBUNIT.
RX   PubMed=26027739; DOI=10.1016/j.cell.2015.05.010;
RA   Nguyen T.A., Jo M.H., Choi Y.G., Park J., Kwon S.C., Hohng S.,
RA   Kim V.N., Woo J.S.;
RT   "Functional anatomy of the human microprocessor.";
RL   Cell 161:1374-1387(2015).
RN   [30]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-500 AND LYS-707, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25755297; DOI=10.1074/mcp.O114.044792;
RA   Xiao Z., Chang J.G., Hendriks I.A., Sigurdsson J.O., Olsen J.V.,
RA   Vertegaal A.C.;
RT   "System-wide analysis of SUMOylation dynamics in response to
RT   replication stress reveals novel small ubiquitin-like modified target
RT   proteins and acceptor lysines relevant for genome stability.";
RL   Mol. Cell. Proteomics 14:1419-1434(2015).
RN   [31]
RP   FUNCTION, AND RNA-BINDING.
RX   PubMed=25799998; DOI=10.1038/nature14281;
RA   Alarcon C.R., Lee H., Goodarzi H., Halberg N., Tavazoie S.F.;
RT   "N6-methyladenosine marks primary microRNAs for processing.";
RL   Nature 519:482-485(2015).
RN   [32]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-424 AND LYS-500, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-
RT   modification with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
RN   [33]
RP   X-RAY CRYSTALLOGRAPHY (2.6 ANGSTROMS) OF 493-720, RNA-BINDING, AND
RP   MUTAGENESIS OF 561-LYS--LYS-565 AND 669-LYS--LYS-673.
RX   PubMed=17704815; DOI=10.1038/nsmb1294;
RA   Sohn S.Y., Bae W.J., Kim J.J., Yeom K.-H., Kim V.N., Cho Y.;
RT   "Crystal structure of human DGCR8 core.";
RL   Nat. Struct. Mol. Biol. 14:847-853(2007).
RN   [34]
RP   STRUCTURE BY NMR OF 502-586.
RG   RIKEN structural genomics initiative (RSGI);
RT   "Solution structure of DSRM domain in DGCR8 protein.";
RL   Submitted (NOV-2005) to the PDB data bank.
RN   [35]
RP   X-RAY CRYSTALLOGRAPHY (3.20 ANGSTROMS) OF 728-750 IN COMPLEX WITH
RP   DROSHA, FUNCTION, INTERACTION WITH DROSHA, AND SUBUNIT.
RX   PubMed=26748718; DOI=10.1016/j.cell.2015.12.019;
RA   Kwon S.C., Nguyen T.A., Choi Y.G., Jo M.H., Hohng S., Kim V.N.,
RA   Woo J.S.;
RT   "Structure of human DROSHA.";
RL   Cell 164:81-90(2016).
CC   -!- FUNCTION: Component of the microprocessor complex that acts as a
CC       RNA- and heme-binding protein that is involved in the initial step
CC       of microRNA (miRNA) biogenesis. Component of the microprocessor
CC       complex that is required to process primary miRNA transcripts
CC       (pri-miRNAs) to release precursor miRNA (pre-miRNA) in the
CC       nucleus. Within the microprocessor complex, DGCR8 function as a
CC       molecular anchor necessary for the recognition of pri-miRNA at
CC       dsRNA-ssRNA junction and directs DROSHA to cleave 11 bp away form
CC       the junction to release hairpin-shaped pre-miRNAs that are
CC       subsequently cut by the cytoplasmic DICER to generate mature
CC       miRNAs (PubMed:26027739, PubMed:26748718). The heme-bound DGCR8
CC       dimer binds pri-miRNAs as a cooperative trimer (of dimers) and is
CC       active in triggering pri-miRNA cleavage, whereas the heme-free
CC       DGCR8 monomer binds pri-miRNAs as a dimer and is much less active.
CC       Both double-stranded and single-stranded regions of a pri-miRNA
CC       are required for its binding (PubMed:15531877, PubMed:15574589,
CC       PubMed:15589161, PubMed:16751099, PubMed:16906129,
CC       PubMed:16963499, PubMed:17159994). Specifically recognizes and
CC       binds N6-methyladenosine (m6A)-containing pri-miRNAs, a
CC       modification required for pri-miRNAs processing (PubMed:25799998).
CC       Involved in the silencing of embryonic stem cell self-renewal (By
CC       similarity). {ECO:0000250|UniProtKB:Q9EQM6,
CC       ECO:0000269|PubMed:15531877, ECO:0000269|PubMed:15574589,
CC       ECO:0000269|PubMed:15589161, ECO:0000269|PubMed:16751099,
CC       ECO:0000269|PubMed:16906129, ECO:0000269|PubMed:16963499,
CC       ECO:0000269|PubMed:17159994, ECO:0000269|PubMed:25799998,
CC       ECO:0000269|PubMed:26027739, ECO:0000269|PubMed:26748718}.
CC   -!- COFACTOR:
CC       Name=heme; Xref=ChEBI:CHEBI:30413;
CC         Evidence={ECO:0000269|PubMed:17159994};
CC       Note=Binds 1 heme group per homodimer.
CC       {ECO:0000269|PubMed:17159994};
CC   -!- SUBUNIT: Monomer; in absence of heme. Homodimer; the association
CC       with heme promotes its dimerization (PubMed:17159994). Component
CC       of the microprocessor complex, or pri-miRNA processing protein
CC       complex, which is composed of DROSHA and DGCR8 (PubMed:15589161,
CC       PubMed:15574589, PubMed:15531877, PubMed:16751099,
CC       PubMed:19135890, PubMed:26027739, PubMed:26748718). The
CC       microprocessor complex is a heterotrimer; each of the two DROSHA
CC       RNase III domains binds one DGCR8 (via C-terminal region)
CC       (PubMed:26027739, PubMed:26748718). Interacts with ILF3, NCL and
CC       DROSHA (PubMed:17765891). {ECO:0000269|PubMed:15531877,
CC       ECO:0000269|PubMed:15574589, ECO:0000269|PubMed:15589161,
CC       ECO:0000269|PubMed:16751099, ECO:0000269|PubMed:16963499,
CC       ECO:0000269|PubMed:17159994, ECO:0000269|PubMed:17765891,
CC       ECO:0000269|PubMed:19135890, ECO:0000269|PubMed:26748718}.
CC   -!- INTERACTION:
CC       Self; NbExp=2; IntAct=EBI-528411, EBI-528411;
CC       Q9NRR4:DROSHA; NbExp=13; IntAct=EBI-528411, EBI-528367;
CC       P50222:MEOX2; NbExp=3; IntAct=EBI-528411, EBI-748397;
CC       Q96SB4:SRPK1; NbExp=3; IntAct=EBI-528411, EBI-539478;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:16906129,
CC       ECO:0000269|PubMed:16963499, ECO:0000269|PubMed:17159994,
CC       ECO:0000269|PubMed:22118463}. Nucleus, nucleolus
CC       {ECO:0000269|PubMed:17159994}. Note=Colocalizes with nucleolin and
CC       DROSHA in the nucleolus. Mostly detected in the nucleolus as
CC       electron-dense granular patches around the fibrillar center (FC)
CC       and granular component (GC). Also detected in the nucleoplasm as
CC       small foci adjacent to splicing speckles near the chromatin
CC       structure. Localized with DROSHA in GW bodies (GWBs), also known
CC       as P-bodies (PubMed:17159994).
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q8WYQ5-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q8WYQ5-2; Sequence=VSP_003847, VSP_003848;
CC       Name=3;
CC         IsoId=Q8WYQ5-3; Sequence=VSP_012707;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Ubiquitously expressed.
CC       {ECO:0000269|PubMed:12705904}.
CC   -!- DOMAIN: Both DRBM domains are required for efficient binding to
CC       pri-miRNA. The region between residues 276 and 498 has an
CC       autoinhibitory function on pri-miRNA processing activity.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAO86726.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC       Sequence=BAB15165.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC       Sequence=BAB15238.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB050770; BAB83032.1; -; Genomic_DNA.
DR   EMBL; CR456356; CAG30242.1; -; mRNA.
DR   EMBL; AK025539; BAB15165.1; ALT_INIT; mRNA.
DR   EMBL; AK025780; BAB15238.1; ALT_INIT; mRNA.
DR   EMBL; AK313357; BAG36158.1; -; mRNA.
DR   EMBL; AC006547; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC009323; AAH09323.2; -; mRNA.
DR   EMBL; BC009984; AAH09984.1; -; mRNA.
DR   EMBL; BC078147; AAH78147.1; -; mRNA.
DR   EMBL; AF165527; AAF82263.1; -; mRNA.
DR   EMBL; BX649187; CAE46205.2; -; mRNA.
DR   EMBL; AY189282; AAO86726.1; ALT_INIT; mRNA.
DR   CCDS; CCDS13773.1; -. [Q8WYQ5-1]
DR   CCDS; CCDS54501.1; -. [Q8WYQ5-3]
DR   RefSeq; NP_001177255.1; NM_001190326.1. [Q8WYQ5-3]
DR   RefSeq; NP_073557.3; NM_022720.6. [Q8WYQ5-1]
DR   UniGene; Hs.643452; -.
DR   UniGene; Hs.713579; -.
DR   PDB; 1X47; NMR; -; A=502-586.
DR   PDB; 2YT4; X-ray; 2.60 A; A=493-720.
DR   PDB; 3LE4; X-ray; 1.70 A; A=275-353.
DR   PDB; 5B16; X-ray; 3.20 A; B/C=728-750.
DR   PDBsum; 1X47; -.
DR   PDBsum; 2YT4; -.
DR   PDBsum; 3LE4; -.
DR   PDBsum; 5B16; -.
DR   ProteinModelPortal; Q8WYQ5; -.
DR   SMR; Q8WYQ5; -.
DR   BioGrid; 119986; 156.
DR   CORUM; Q8WYQ5; -.
DR   DIP; DIP-29261N; -.
DR   IntAct; Q8WYQ5; 26.
DR   MINT; Q8WYQ5; -.
DR   STRING; 9606.ENSP00000263209; -.
DR   iPTMnet; Q8WYQ5; -.
DR   PhosphoSitePlus; Q8WYQ5; -.
DR   BioMuta; DGCR8; -.
DR   DMDM; 23813990; -.
DR   EPD; Q8WYQ5; -.
DR   MaxQB; Q8WYQ5; -.
DR   PaxDb; Q8WYQ5; -.
DR   PeptideAtlas; Q8WYQ5; -.
DR   PRIDE; Q8WYQ5; -.
DR   DNASU; 54487; -.
DR   Ensembl; ENST00000351989; ENSP00000263209; ENSG00000128191. [Q8WYQ5-1]
DR   Ensembl; ENST00000383024; ENSP00000372488; ENSG00000128191. [Q8WYQ5-3]
DR   Ensembl; ENST00000407755; ENSP00000384726; ENSG00000128191. [Q8WYQ5-3]
DR   GeneID; 54487; -.
DR   KEGG; hsa:54487; -.
DR   UCSC; uc002zri.4; human. [Q8WYQ5-1]
DR   CTD; 54487; -.
DR   DisGeNET; 54487; -.
DR   EuPathDB; HostDB:ENSG00000128191.13; -.
DR   GeneCards; DGCR8; -.
DR   GeneReviews; DGCR8; -.
DR   HGNC; HGNC:2847; DGCR8.
DR   MIM; 609030; gene.
DR   neXtProt; NX_Q8WYQ5; -.
DR   OpenTargets; ENSG00000128191; -.
DR   PharmGKB; PA27309; -.
DR   eggNOG; KOG4334; Eukaryota.
DR   eggNOG; ENOG410XS9I; LUCA.
DR   GeneTree; ENSGT00390000015977; -.
DR   HOVERGEN; HBG051344; -.
DR   InParanoid; Q8WYQ5; -.
DR   KO; K18419; -.
DR   OMA; METYESP; -.
DR   OrthoDB; EOG091G09GA; -.
DR   PhylomeDB; Q8WYQ5; -.
DR   TreeFam; TF324256; -.
DR   Reactome; R-HSA-203927; MicroRNA (miRNA) biogenesis.
DR   ChiTaRS; DGCR8; human.
DR   EvolutionaryTrace; Q8WYQ5; -.
DR   GeneWiki; DGCR8_(gene); -.
DR   GenomeRNAi; 54487; -.
DR   PRO; PR:Q8WYQ5; -.
DR   Proteomes; UP000005640; Chromosome 22.
DR   Bgee; ENSG00000128191; -.
DR   ExpressionAtlas; Q8WYQ5; baseline and differential.
DR   Genevisible; Q8WYQ5; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:LIFEdb.
DR   GO; GO:0070877; C:microprocessor complex; IDA:BHF-UCL.
DR   GO; GO:0005730; C:nucleolus; IEA:UniProtKB-SubCell.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0005634; C:nucleus; IDA:MGI.
DR   GO; GO:0014069; C:postsynaptic density; IEA:Ensembl.
DR   GO; GO:0003725; F:double-stranded RNA binding; IDA:UniProtKB.
DR   GO; GO:0020037; F:heme binding; IDA:BHF-UCL.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0070878; F:primary miRNA binding; IDA:BHF-UCL.
DR   GO; GO:0042803; F:protein homodimerization activity; IDA:BHF-UCL.
DR   GO; GO:0010586; P:miRNA metabolic process; TAS:Reactome.
DR   GO; GO:0031053; P:primary miRNA processing; IDA:BHF-UCL.
DR   GO; GO:0072091; P:regulation of stem cell proliferation; IEA:Ensembl.
DR   GO; GO:0090502; P:RNA phosphodiester bond hydrolysis, endonucleolytic; IEA:GOC.
DR   CDD; cd00201; WW; 1.
DR   InterPro; IPR014720; dsRBD_dom.
DR   InterPro; IPR001202; WW_dom.
DR   InterPro; IPR036020; WW_dom_sf.
DR   Pfam; PF00035; dsrm; 2.
DR   SMART; SM00358; DSRM; 2.
DR   SMART; SM00456; WW; 1.
DR   SUPFAM; SSF51045; SSF51045; 1.
DR   PROSITE; PS50137; DS_RBD; 1.
DR   PROSITE; PS50020; WW_DOMAIN_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Complete proteome; Heme; Iron;
KW   Isopeptide bond; Metal-binding; Nucleus; Phosphoprotein; Polymorphism;
KW   Reference proteome; Repeat; RNA-binding; Ubl conjugation.
FT   CHAIN         1    773       Microprocessor complex subunit DGCR8.
FT                                /FTId=PRO_0000079878.
FT   DOMAIN      301    334       WW. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00224}.
FT   DOMAIN      511    578       DRBM 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00266}.
FT   DOMAIN      620    685       DRBM 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00266}.
FT   REGION        1    342       Necessary for interaction with NCL.
FT                                {ECO:0000269|PubMed:17765891}.
FT   REGION        1    275       Necessary for nuclear localization and
FT                                retention.
FT   REGION      276    751       Necessary for heme-binding and pri-miRNA
FT                                processing.
FT   REGION      701    773       Interaction with DROSHA.
FT                                {ECO:0000269|PubMed:26748718}.
FT   METAL       352    352       Iron (heme axial ligand).
FT                                {ECO:0000305|PubMed:17159994}.
FT   MOD_RES      35     35       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES      92     92       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES      95     95       Phosphoserine.
FT                                {ECO:0000244|PubMed:18220336,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     271    271       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19690332}.
FT   MOD_RES     275    275       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     279    279       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:Q9EQM6}.
FT   MOD_RES     371    371       Phosphothreonine.
FT                                {ECO:0000244|PubMed:21406692}.
FT   MOD_RES     373    373       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     377    377       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163}.
FT   CROSSLNK    424    424       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    500    500       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:25755297,
FT                                ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    707    707       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:25218447,
FT                                ECO:0000244|PubMed:25755297}.
FT   VAR_SEQ     303    304       LP -> VL (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_003847.
FT   VAR_SEQ     305    773       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_003848.
FT   VAR_SEQ     536    568       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_012707.
FT   VARIANT     174    174       I -> V (in dbSNP:rs35987994).
FT                                /FTId=VAR_050952.
FT   VARIANT     725    725       N -> D (in dbSNP:rs11546015).
FT                                /FTId=VAR_050953.
FT   MUTAGEN     352    352       C->A,H: Inhibits heme-binding and
FT                                dimerization.
FT                                {ECO:0000269|PubMed:17159994}.
FT   MUTAGEN     430    430       C->A: Does not inhibit heme-binding and
FT                                dimerization.
FT                                {ECO:0000269|PubMed:17159994}.
FT   MUTAGEN     561    565       KKLAK->AALAA: Strongly reduces pri-miRNA
FT                                binding affinity.
FT                                {ECO:0000269|PubMed:17704815}.
FT   MUTAGEN     568    569       AA->KK: Reduces pri-miRNA binding
FT                                affinity and pri-miRNA processing
FT                                activity. Does not inhibit interaction
FT                                with DROSHA. When associated with A-676
FT                                and S-677, strongly reduces binding
FT                                affinity and pri-miRNA processing
FT                                activity. {ECO:0000269|PubMed:16963499}.
FT   MUTAGEN     669    673       KRVGK->AAVGA: Strongly reduces pri-miRNA
FT                                binding affinity.
FT                                {ECO:0000269|PubMed:17704815}.
FT   MUTAGEN     676    677       AS->KK: Reduces pri-miRNA binding
FT                                affinity and pri-miRNA processing
FT                                activity. Slightly inhibits interaction
FT                                with DROSHA. When associated with A-568
FT                                and A-568, strongly reduces binding
FT                                affinity and pri-miRNA processing
FT                                activity. {ECO:0000269|PubMed:16963499}.
FT   CONFLICT    241    247       DDFDNDV -> VCWQPLL (in Ref. 6; AAF82263).
FT                                {ECO:0000305}.
FT   CONFLICT    274    274       P -> L (in Ref. 3; BAB15165).
FT                                {ECO:0000305}.
FT   CONFLICT    343    343       H -> Y (in Ref. 3; BAB15165).
FT                                {ECO:0000305}.
FT   CONFLICT    706    706       V -> A (in Ref. 3; BAB15165).
FT                                {ECO:0000305}.
FT   STRAND      307    311       {ECO:0000244|PDB:3LE4}.
FT   STRAND      315    321       {ECO:0000244|PDB:3LE4}.
FT   TURN        322    325       {ECO:0000244|PDB:3LE4}.
FT   STRAND      326    330       {ECO:0000244|PDB:3LE4}.
FT   TURN        340    342       {ECO:0000244|PDB:3LE4}.
FT   HELIX       347    349       {ECO:0000244|PDB:3LE4}.
FT   STRAND      493    495       {ECO:0000244|PDB:2YT4}.
FT   STRAND      502    505       {ECO:0000244|PDB:2YT4}.
FT   HELIX       512    522       {ECO:0000244|PDB:2YT4}.
FT   STRAND      529    534       {ECO:0000244|PDB:2YT4}.
FT   STRAND      536    539       {ECO:0000244|PDB:1X47}.
FT   STRAND      542    548       {ECO:0000244|PDB:2YT4}.
FT   STRAND      551    560       {ECO:0000244|PDB:2YT4}.
FT   HELIX       561    576       {ECO:0000244|PDB:2YT4}.
FT   TURN        578    582       {ECO:0000244|PDB:2YT4}.
FT   HELIX       594    600       {ECO:0000244|PDB:2YT4}.
FT   HELIX       608    615       {ECO:0000244|PDB:2YT4}.
FT   HELIX       620    629       {ECO:0000244|PDB:2YT4}.
FT   STRAND      631    633       {ECO:0000244|PDB:2YT4}.
FT   STRAND      637    640       {ECO:0000244|PDB:2YT4}.
FT   STRAND      651    657       {ECO:0000244|PDB:2YT4}.
FT   STRAND      660    668       {ECO:0000244|PDB:2YT4}.
FT   HELIX       669    684       {ECO:0000244|PDB:2YT4}.
FT   HELIX       691    698       {ECO:0000244|PDB:2YT4}.
FT   HELIX       728    749       {ECO:0000244|PDB:5B16}.
SQ   SEQUENCE   773 AA;  86045 MW;  72D962BBE32890EC CRC64;
     METDESPSPL PCGPAGEAVM ESRARPFQAL PREQSPPPPL QTSSGAEVMD VGSGGDGQSE
     LPAEDPFNFY GASLLSKGSF SKGRLLIDPN CSGHSPRTAR HAPAVRKFSP DLKLLKDVKI
     SVSFTESCRS KDRKVLYTGA ERDVRAECGL LLSPVSGDVH ACPFGGSVGD GVGIGGESAD
     KKDEENELDQ EKRVEYAVLD ELEDFTDNLE LDEEGAGGFT AKAIVQRDRV DEEALNFPYE
     DDFDNDVDAL LEEGLCAPKK RRTEEKYGGD SDHPSDGETS VQPMMTKIKT VLKSRGRPPT
     EPLPDGWIMT FHNSGVPVYL HRESRVVTWS RPYFLGTGSI RKHDPPLSSI PCLHYKKMKD
     NEEREQSSDL TPSGDVSPVK PLSRSAELEF PLDEPDSMGA DPGPPDEKDP LGAEAAPGAL
     GQVKAKVEVC KDESVDLEEF RSYLEKRFDF EQVTVKKFRT WAERRQFNRE MKRKQAESER
     PILPANQKLI TLSVQDAPTK KEFVINPNGK SEVCILHEYM QRVLKVRPVY NFFECENPSE
     PFGASVTIDG VTYGSGTASS KKLAKNKAAR ATLEILIPDF VKQTSEEKPK DSEELEYFNH
     ISIEDSRVYE LTSKAGLLSP YQILHECLKR NHGMGDTSIK FEVVPGKNQK SEYVMACGKH
     TVRGWCKNKR VGKQLASQKI LQLLHPHVKN WGSLLRMYGR ESSKMVKQET SDKSVIELQQ
     YAKKNKPNLH ILSKLQEEMK RLAEEREETR KKPKMSIVAS AQPGGEPLCT VDV
//
ID   A4D1D0_HUMAN            Unreviewed;       879 AA.
AC   A4D1D0;
DT   03-APR-2007, integrated into UniProtKB/TrEMBL.
DT   03-APR-2007, sequence version 1.
DT   25-APR-2018, entry version 109.
DE   SubName: Full=Glutamate metabotropic receptor 3 {ECO:0000313|EMBL:ABY87922.1};
DE   SubName: Full=Glutamate receptor, metabotropic 3 {ECO:0000313|EMBL:EAL24182.1};
DE   SubName: Full=Glutamate receptor, metabotropic 3, isoform CRA_b {ECO:0000313|EMBL:EAW76972.1};
GN   Name=GRM3 {ECO:0000313|EMBL:EAL24182.1};
GN   ORFNames=hCG_17203 {ECO:0000313|EMBL:EAW76972.1},
GN   tcag7.244 {ECO:0000313|EMBL:EAL24182.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:EAL24182.1};
RN   [1] {ECO:0000313|EMBL:EAW76972.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D.,
RA   Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q.,
RA   Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G.,
RA   Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S.,
RA   Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J.,
RA   Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R.,
RA   Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A.,
RA   Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K.,
RA   Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V.,
RA   Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z.,
RA   Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A.,
RA   Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V.,
RA   Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B.,
RA   Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J.,
RA   Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C.,
RA   Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L.,
RA   Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S.,
RA   Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A.,
RA   Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D.,
RA   Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L.,
RA   Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N.,
RA   Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S.,
RA   Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F.,
RA   Kline L., Koduru S., Love A., Mann F., May D., McCawley S.,
RA   McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K.,
RA   Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N.,
RA   Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M.,
RA   Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F.,
RA   Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A.,
RA   Mi H., Lazareva B., Hatton T., Narechania A., Diemer K.,
RA   Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R.,
RA   Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J.,
RA   Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H.,
RA   Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D.,
RA   Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A.,
RA   Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S.,
RA   Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L.,
RA   Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W.,
RA   McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M.,
RA   Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAL24182.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12690205; DOI=10.1126/science.1083423;
RA   Scherer S.W., Cheung J., MacDonald J.R., Osborne L.R., Nakabayashi K.,
RA   Herbrick J.A., Carson A.R., Parker-Katiraee L., Skaug J., Khaja R.,
RA   Zhang J., Hudek A.K., Li M., Haddad M., Duggan G.E., Fernandez B.A.,
RA   Kanematsu E., Gentles S., Christopoulos C.C., Choufani S.,
RA   Kwasnicka D., Zheng X.H., Lai Z., Nusskern D., Zhang Q., Gu Z., Lu F.,
RA   Zeesman S., Nowaczyk M.J., Teshima I., Chitayat D., Shuman C.,
RA   Weksberg R., Zackai E.H., Grebe T.A., Cox S.R., Kirkpatrick S.J.,
RA   Rahman N., Friedman J.M., Heng H.H., Pelicci P.G., Lo-Coco F.,
RA   Belloni E., Shaffer L.G., Pober B., Morton C.C., Gusella J.F.,
RA   Bruns G.A., Korf B.R., Quade B.J., Ligon A.H., Ferguson H.,
RA   Higgins A.W., Leach N.T., Herrick S.R., Lemyre E., Farra C.G.,
RA   Kim H.G., Summers A.M., Gripp K.W., Roberts W., Szatmari P.,
RA   Winsor E.J., Grzeschik K.H., Teebi A., Minassian B.A., Kere J.,
RA   Armengol L., Pujana M.A., Estivill X., Wilson M.D., Koop B.F.,
RA   Tosi S., Moore G.E., Boright A.P., Zlotorynski E., Kerem B.,
RA   Kroisel P.M., Petek E., Oscier D.G., Mould S.J., Dohner H., Dohner K.,
RA   Rommens J.M., Vincent J.B., Venter J.C., Li P.W., Mural R.J.,
RA   Adams M.D., Tsui L.C.;
RT   "Human chromosome 7: DNA sequence and biology.";
RL   Science 300:767-772(2003).
RN   [3] {ECO:0000313|EMBL:EAL24182.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Scherer S.W., Cheung J., MacDonald J.R., Osborne L.R., Nakabayashi K.,
RA   Herbrick J.-A., Carson A.R., Parker-Katiraee L., Skaug J., Khaja R.,
RA   Zhang J., Hudek A.K., Li M., Haddad M., Duggan G.E., Fernandez B.A.,
RA   Kanematsu E., Gentles S., Christopoulos C.C., Choufani S.,
RA   Kwasnicka D., Zheng X.H., Nusskern D., Zhang Q., Gu Z., Lu F.,
RA   Zeesman S., Teshima I., Chitayat D., Shuman C., Weksberg R.,
RA   Zackai E.H., Grebe T.A., Cox S.R., Kirkpatrick S.J., Rahman N.,
RA   Friedman J.M., Heng H.H.Q., Pelicci P., Lococo F., Belloni E.,
RA   Shaffer L.G., Morton C.C., Pober B., Gusella J., Bruns G., Korf B.R.,
RA   Quade B.J., Ligon A.H., Ferguson H., Higgins A.W., Leach N.T.,
RA   Herrick S.R., Lemyre E., Farra C.G., Kim H.-G., Summers A.M.,
RA   Gripp K.W., Roberts W., Szatmari P., Winsor E.J.T., Grzeschik K.-H.,
RA   Teebi A., Minassian B.A., Kere J., Armengol L., Pujana M.Angel.,
RA   Estivill X., Wilson M.D., Koop B.F., Tosi S., Moore G.E.,
RA   Boright A.P., Zlotorynski E., Kerem B., Kroisel P.M., Petek E.,
RA   Oscier D.G., Mould S.J., Doehner H., Doehner K., Rommens J.M.,
RA   Vincent J.B., Venter J.C., Li P.W., Mural R.J., Adams M.D.,
RA   Tsui L.-C.;
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [4] {ECO:0000313|EMBL:EAW76972.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5] {ECO:0000313|EMBL:ABY87922.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Whole brain {ECO:0000313|EMBL:ABY87922.1};
RA   Kaighin V.A., Martin A.L., Aronstam R.S.;
RL   Submitted (DEC-2007) to the EMBL/GenBank/DDBJ databases.
CC   -!- SUBCELLULAR LOCATION: Cell membrane
CC       {ECO:0000256|SAAS:SAAS00543559}; Multi-pass membrane protein
CC       {ECO:0000256|SAAS:SAAS00543559}.
CC   -!- SIMILARITY: Belongs to the G-protein coupled receptor 3 family.
CC       {ECO:0000256|SAAS:SAAS00547813}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; EU432123; ABY87922.1; -; mRNA.
DR   EMBL; CH236949; EAL24182.1; -; Genomic_DNA.
DR   EMBL; CH471091; EAW76972.1; -; Genomic_DNA.
DR   RefSeq; NP_000831.2; NM_000840.2.
DR   UniGene; Hs.590575; -.
DR   DNASU; 2913; -.
DR   GeneID; 2913; -.
DR   KEGG; hsa:2913; -.
DR   CTD; 2913; -.
DR   EuPathDB; HostDB:ENSG00000198822.10; -.
DR   PharmGKB; PA28992; -.
DR   eggNOG; KOG1056; Eukaryota.
DR   eggNOG; ENOG410XR6W; LUCA.
DR   HOVERGEN; HBG107965; -.
DR   KO; K04605; -.
DR   OMA; TYVPTVC; -.
DR   OrthoDB; EOG091G177R; -.
DR   ChiTaRS; GRM3; human.
DR   GenomeRNAi; 2913; -.
DR   Bgee; ENSG00000198822; -.
DR   GO; GO:0030424; C:axon; IEA:Ensembl.
DR   GO; GO:0043197; C:dendritic spine; IEA:Ensembl.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0014069; C:postsynaptic density; IEA:Ensembl.
DR   GO; GO:0045211; C:postsynaptic membrane; IEA:Ensembl.
DR   GO; GO:0042734; C:presynaptic membrane; IEA:Ensembl.
DR   GO; GO:0005246; F:calcium channel regulator activity; IEA:Ensembl.
DR   GO; GO:0001641; F:group II metabotropic glutamate receptor activity; IEA:Ensembl.
DR   Gene3D; 2.10.50.30; -; 1.
DR   InterPro; IPR001828; ANF_lig-bd_rcpt.
DR   InterPro; IPR000337; GPCR_3.
DR   InterPro; IPR011500; GPCR_3_9-Cys_dom.
DR   InterPro; IPR038550; GPCR_3_9-Cys_sf.
DR   InterPro; IPR017978; GPCR_3_C.
DR   InterPro; IPR017979; GPCR_3_CS.
DR   InterPro; IPR000162; GPCR_3_mtglu_rcpt.
DR   InterPro; IPR001234; GPCR_3_mtglu_rcpt_3.
DR   InterPro; IPR028082; Peripla_BP_I.
DR   Pfam; PF00003; 7tm_3; 1.
DR   Pfam; PF01094; ANF_receptor; 1.
DR   Pfam; PF07562; NCD3G; 1.
DR   PRINTS; PR00248; GPCRMGR.
DR   PRINTS; PR01053; MTABOTROPC3R.
DR   PRINTS; PR00593; MTABOTROPICR.
DR   SUPFAM; SSF53822; SSF53822; 1.
DR   PROSITE; PS00979; G_PROTEIN_RECEP_F3_1; 1.
DR   PROSITE; PS00980; G_PROTEIN_RECEP_F3_2; 1.
DR   PROSITE; PS00981; G_PROTEIN_RECEP_F3_3; 1.
DR   PROSITE; PS50259; G_PROTEIN_RECEP_F3_4; 1.
PE   2: Evidence at transcript level;
KW   Cell membrane {ECO:0000256|SAAS:SAAS00138752};
KW   G-protein coupled receptor {ECO:0000256|SAAS:SAAS00497975};
KW   Membrane {ECO:0000256|SAAS:SAAS00138752,
KW   ECO:0000256|SAAS:SAAS00425515, ECO:0000256|SAM:Phobius};
KW   Receptor {ECO:0000256|SAAS:SAAS00497975};
KW   Signal {ECO:0000256|SAM:SignalP};
KW   Transducer {ECO:0000256|SAAS:SAAS00497975};
KW   Transmembrane {ECO:0000256|SAAS:SAAS00425515,
KW   ECO:0000256|SAM:Phobius};
KW   Transmembrane helix {ECO:0000256|SAAS:SAAS00425515,
KW   ECO:0000256|SAM:Phobius}.
FT   SIGNAL        1     24       {ECO:0000256|SAM:SignalP}.
FT   CHAIN        25    879       {ECO:0000256|SAM:SignalP}.
FT                                /FTId=PRO_5014296875.
FT   TRANSMEM    575    599       Helical. {ECO:0000256|SAM:Phobius}.
FT   TRANSMEM    614    634       Helical. {ECO:0000256|SAM:Phobius}.
FT   TRANSMEM    688    709       Helical. {ECO:0000256|SAM:Phobius}.
FT   TRANSMEM    737    756       Helical. {ECO:0000256|SAM:Phobius}.
FT   TRANSMEM    768    790       Helical. {ECO:0000256|SAM:Phobius}.
FT   TRANSMEM    796    820       Helical. {ECO:0000256|SAM:Phobius}.
FT   DOMAIN      576    842       G_PROTEIN_RECEP_F3_4.
FT                                {ECO:0000259|PROSITE:PS50259}.
SQ   SEQUENCE   879 AA;  98879 MW;  7EB84521676E8304 CRC64;
     MKMLTRLQVL TLALFSKGFL LSLGDHNFLR REIKIEGDLV LGGLFPINEK GTGTEECGRI
     NEDRGIQRLE AMLFAIDEIN KDDYLLPGVK LGVHILDTCS RDTYALEQSL EFVRASLTKV
     DEAEYMCPDG SYAIQENIPL LIAGVIGGSY SSVSIQVANL LRLFQIPQIS YASTSAKLSD
     KSRYDYFART VPPDFYQAKA MAEILRFFNW TYVSTVASEG DYGETGIEAF EQEARLRNIC
     IATAEKVGRS NIRKSYDSVI RELLQKPNAR VVVLFMRSDD SRELIAAASR ANASFTWVAS
     DGWGAQESII KGSEHVAYGA ITLELASQPV RQFDRYFQSL NPYNNHRNPW FRDFWEQKFQ
     CSLQNKRNHR RVCDKHLAID SSNYEQESKI MFVVNAVYAM AHALHKMQRT LCPNTTKLCD
     AMKILDGKKL YKDYLLKINF TAPFNPNKDA DSIVKFDTFG DGMGRYNVFN FQNVGGKYSY
     LKVGHWAETL SLDVNSIHWS RNSVPTSQCS DPCAPNEMKN MQPGDVCCWI CIPCEPYEYL
     ADEFTCMDCG SGQWPTADLT GCYDLPEDYI RWEDAWAIGP VTIACLGFMC TCMVVTVFIK
     HNNTPLVKAS GRELCYILLF GVGLSYCMTF FFIAKPSPVI CALRRLGLGS SFAICYSALL
     TKTNCIARIF DGVKNGAQRP KFISPSSQVF ICLGLILVQI VMVSVWLILE APGTRRYTLA
     EKRETVILKC NVKDSSMLIS LTYDVILVIL CTVYAFKTRK CPENFNEAKF IGFTMYTTCI
     IWLAFLPIFY VTSSDYRVQT TTMCISVSLS GFVVLGCLFA PKVHIILFQP QKNVVTHRLH
     LNRFSVSGTG TTYSQSSAST YVPTVCNGRE VLDSTTSSL
//
ID   GRM3_HUMAN              Reviewed;         879 AA.
AC   Q14832; Q2PNZ6; Q75MV4; Q75N17; Q86YG6; Q8TBH9;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   27-SEP-2005, sequence version 2.
DT   28-MAR-2018, entry version 160.
DE   RecName: Full=Metabotropic glutamate receptor 3;
DE            Short=mGluR3;
DE   Flags: Precursor;
GN   Name=GRM3; Synonyms=GPRC1C, MGLUR3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, SUBCELLULAR
RP   LOCATION, AND TISSUE SPECIFICITY.
RC   TISSUE=Brain;
RX   PubMed=8840013; DOI=10.1016/0169-328X(96)00037-X;
RA   Makoff A., Volpe F., Lelchuk R., Harrington K., Emson P.;
RT   "Molecular characterization and localization of human metabotropic
RT   glutamate receptor type 3.";
RL   Brain Res. Mol. Brain Res. 40:55-63(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), AND ALTERNATIVE SPLICING.
RC   TISSUE=Lymphoblast;
RX   PubMed=16417579; DOI=10.1111/j.1471-4159.2005.03609.x;
RA   Sartorius L.J., Nagappan G., Lipska B.K., Lu B., Sei Y.,
RA   Ren-Patterson R., Li Z., Weinberger D.R., Harrison P.J.;
RT   "Alternative splicing of human metabotropic glutamate receptor 3.";
RL   J. Neurochem. 96:1139-1148(2006).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12853948; DOI=10.1038/nature01782;
RA   Hillier L.W., Fulton R.S., Fulton L.A., Graves T.A., Pepin K.H.,
RA   Wagner-McPherson C., Layman D., Maas J., Jaeger S., Walker R.,
RA   Wylie K., Sekhon M., Becker M.C., O'Laughlin M.D., Schaller M.E.,
RA   Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Cordes M., Du H.,
RA   Sun H., Edwards J., Bradshaw-Cordum H., Ali J., Andrews S., Isak A.,
RA   Vanbrunt A., Nguyen C., Du F., Lamar B., Courtney L., Kalicki J.,
RA   Ozersky P., Bielicki L., Scott K., Holmes A., Harkins R., Harris A.,
RA   Strong C.M., Hou S., Tomlinson C., Dauphin-Kohlberg S.,
RA   Kozlowicz-Reilly A., Leonard S., Rohlfing T., Rock S.M.,
RA   Tin-Wollam A.-M., Abbott A., Minx P., Maupin R., Strowmatt C.,
RA   Latreille P., Miller N., Johnson D., Murray J., Woessner J.P.,
RA   Wendl M.C., Yang S.-P., Schultz B.R., Wallis J.W., Spieth J.,
RA   Bieri T.A., Nelson J.O., Berkowicz N., Wohldmann P.E., Cook L.L.,
RA   Hickenbotham M.T., Eldred J., Williams D., Bedell J.A., Mardis E.R.,
RA   Clifton S.W., Chissoe S.L., Marra M.A., Raymond C., Haugen E.,
RA   Gillett W., Zhou Y., James R., Phelps K., Iadanoto S., Bubb K.,
RA   Simms E., Levy R., Clendenning J., Kaul R., Kent W.J., Furey T.S.,
RA   Baertsch R.A., Brent M.R., Keibler E., Flicek P., Bork P., Suyama M.,
RA   Bailey J.A., Portnoy M.E., Torrents D., Chinwalla A.T., Gish W.R.,
RA   Eddy S.R., McPherson J.D., Olson M.V., Eichler E.E., Green E.D.,
RA   Waterston R.H., Wilson R.K.;
RT   "The DNA sequence of human chromosome 7.";
RL   Nature 424:157-164(2003).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   X-RAY CRYSTALLOGRAPHY (2.26 ANGSTROMS) OF 26-504 OF MUTANT SER-240,
RP   AND DISULFIDE BONDS.
RG   Structural genomics consortium (SGC);
RT   "Crystal structure of metabotropic glutamate receptor 3 precursor in
RT   presence of LY341495 antagonist.";
RL   Submitted (JUL-2011) to the PDB data bank.
CC   -!- FUNCTION: G-protein coupled receptor for glutamate. Ligand binding
CC       causes a conformation change that triggers signaling via guanine
CC       nucleotide-binding proteins (G proteins) and modulates the
CC       activity of down-stream effectors. Signaling inhibits adenylate
CC       cyclase activity. {ECO:0000269|PubMed:8840013}.
CC   -!- SUBUNIT: Interacts with GRASP. {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:8840013};
CC       Multi-pass membrane protein {ECO:0000269|PubMed:8840013}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q14832-1; Sequence=Displayed;
CC       Name=2; Synonyms=GRM3Delta4;
CC         IsoId=Q14832-2; Sequence=VSP_047679, VSP_047680;
CC         Note=Appears to be membrane-associated, despite the absence of
CC         the seven-transmembrane domain.;
CC   -!- TISSUE SPECIFICITY: Detected in brain cortex, thalamus,
CC       subthalamic nucleus, substantia nigra, hypothalamus, hippocampus,
CC       corpus callosum, caudate nucleus and amygdala.
CC       {ECO:0000269|PubMed:8840013}.
CC   -!- SIMILARITY: Belongs to the G-protein coupled receptor 3 family.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAD15616.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC       Sequence=ABC47402.1; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};
CC       Sequence=CAA54796.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X77748; CAA54796.1; ALT_INIT; mRNA.
DR   EMBL; DQ315361; ABC47402.1; ALT_INIT; mRNA.
DR   EMBL; AC004829; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC005009; AAD15616.1; ALT_INIT; Genomic_DNA.
DR   EMBL; AC002081; AAC60379.2; -; Genomic_DNA.
DR   EMBL; BC022496; AAH22496.2; -; mRNA.
DR   EMBL; BC041407; AAH41407.1; -; mRNA.
DR   CCDS; CCDS5600.1; -. [Q14832-1]
DR   RefSeq; NP_000831.2; NM_000840.2. [Q14832-1]
DR   RefSeq; XP_011514390.1; XM_011516088.1. [Q14832-2]
DR   UniGene; Hs.590575; -.
DR   PDB; 1S8M; Model; -; A=30-499.
DR   PDB; 3SM9; X-ray; 2.26 A; A=26-504.
DR   PDB; 4XAR; X-ray; 2.26 A; A=2-508.
DR   PDB; 5CNK; X-ray; 3.15 A; A/B/C=2-507.
DR   PDB; 5CNM; X-ray; 2.84 A; A=2-507.
DR   PDBsum; 1S8M; -.
DR   PDBsum; 3SM9; -.
DR   PDBsum; 4XAR; -.
DR   PDBsum; 5CNK; -.
DR   PDBsum; 5CNM; -.
DR   ProteinModelPortal; Q14832; -.
DR   SMR; Q14832; -.
DR   BioGrid; 109170; 5.
DR   CORUM; Q14832; -.
DR   STRING; 9606.ENSP00000355316; -.
DR   BindingDB; Q14832; -.
DR   ChEMBL; CHEMBL2888; -.
DR   DrugBank; DB05096; LY2140023.
DR   GuidetoPHARMACOLOGY; 291; -.
DR   iPTMnet; Q14832; -.
DR   PhosphoSitePlus; Q14832; -.
DR   BioMuta; GRM3; -.
DR   DMDM; 76803803; -.
DR   PaxDb; Q14832; -.
DR   PeptideAtlas; Q14832; -.
DR   PRIDE; Q14832; -.
DR   DNASU; 2913; -.
DR   Ensembl; ENST00000361669; ENSP00000355316; ENSG00000198822. [Q14832-1]
DR   Ensembl; ENST00000439827; ENSP00000398767; ENSG00000198822. [Q14832-2]
DR   GeneID; 2913; -.
DR   KEGG; hsa:2913; -.
DR   UCSC; uc003uid.4; human. [Q14832-1]
DR   CTD; 2913; -.
DR   DisGeNET; 2913; -.
DR   EuPathDB; HostDB:ENSG00000198822.10; -.
DR   GeneCards; GRM3; -.
DR   HGNC; HGNC:4595; GRM3.
DR   MIM; 601115; gene.
DR   neXtProt; NX_Q14832; -.
DR   OpenTargets; ENSG00000198822; -.
DR   PharmGKB; PA28992; -.
DR   eggNOG; KOG1056; Eukaryota.
DR   eggNOG; ENOG410XR6W; LUCA.
DR   GeneTree; ENSGT00760000118884; -.
DR   HOGENOM; HOG000218635; -.
DR   HOVERGEN; HBG107965; -.
DR   InParanoid; Q14832; -.
DR   KO; K04605; -.
DR   OMA; TYVPTVC; -.
DR   OrthoDB; EOG091G177R; -.
DR   PhylomeDB; Q14832; -.
DR   TreeFam; TF313240; -.
DR   Reactome; R-HSA-418594; G alpha (i) signalling events.
DR   Reactome; R-HSA-420499; Class C/3 (Metabotropic glutamate/pheromone receptors).
DR   SignaLink; Q14832; -.
DR   SIGNOR; Q14832; -.
DR   ChiTaRS; GRM3; human.
DR   GeneWiki; Metabotropic_glutamate_receptor_3; -.
DR   GenomeRNAi; 2913; -.
DR   PRO; PR:Q14832; -.
DR   Proteomes; UP000005640; Chromosome 7.
DR   Bgee; ENSG00000198822; -.
DR   CleanEx; HS_GRM3; -.
DR   ExpressionAtlas; Q14832; baseline and differential.
DR   Genevisible; Q14832; HS.
DR   GO; GO:0030424; C:axon; IEA:Ensembl.
DR   GO; GO:0043197; C:dendritic spine; IEA:Ensembl.
DR   GO; GO:0005887; C:integral component of plasma membrane; TAS:ProtInc.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0014069; C:postsynaptic density; IEA:Ensembl.
DR   GO; GO:0045211; C:postsynaptic membrane; IEA:Ensembl.
DR   GO; GO:0042734; C:presynaptic membrane; IEA:Ensembl.
DR   GO; GO:0005246; F:calcium channel regulator activity; IEA:Ensembl.
DR   GO; GO:0004930; F:G-protein coupled receptor activity; TAS:UniProtKB.
DR   GO; GO:0008066; F:glutamate receptor activity; TAS:UniProtKB.
DR   GO; GO:0001641; F:group II metabotropic glutamate receptor activity; IEA:Ensembl.
DR   GO; GO:0007268; P:chemical synaptic transmission; TAS:ProtInc.
DR   GO; GO:0007216; P:G-protein coupled glutamate receptor signaling pathway; IBA:GO_Central.
DR   GO; GO:0007186; P:G-protein coupled receptor signaling pathway; TAS:Reactome.
DR   GO; GO:0007194; P:negative regulation of adenylate cyclase activity; TAS:ProtInc.
DR   GO; GO:0051966; P:regulation of synaptic transmission, glutamatergic; IBA:GO_Central.
DR   Gene3D; 2.10.50.30; -; 1.
DR   InterPro; IPR001828; ANF_lig-bd_rcpt.
DR   InterPro; IPR000337; GPCR_3.
DR   InterPro; IPR011500; GPCR_3_9-Cys_dom.
DR   InterPro; IPR038550; GPCR_3_9-Cys_sf.
DR   InterPro; IPR017978; GPCR_3_C.
DR   InterPro; IPR017979; GPCR_3_CS.
DR   InterPro; IPR000162; GPCR_3_mtglu_rcpt.
DR   InterPro; IPR001234; GPCR_3_mtglu_rcpt_3.
DR   InterPro; IPR028082; Peripla_BP_I.
DR   Pfam; PF00003; 7tm_3; 1.
DR   Pfam; PF01094; ANF_receptor; 1.
DR   Pfam; PF07562; NCD3G; 1.
DR   PRINTS; PR00248; GPCRMGR.
DR   PRINTS; PR01053; MTABOTROPC3R.
DR   PRINTS; PR00593; MTABOTROPICR.
DR   SUPFAM; SSF53822; SSF53822; 1.
DR   PROSITE; PS00979; G_PROTEIN_RECEP_F3_1; 1.
DR   PROSITE; PS00980; G_PROTEIN_RECEP_F3_2; 1.
DR   PROSITE; PS00981; G_PROTEIN_RECEP_F3_3; 1.
DR   PROSITE; PS50259; G_PROTEIN_RECEP_F3_4; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Cell membrane; Complete proteome;
KW   Disulfide bond; G-protein coupled receptor; Glycoprotein; Membrane;
KW   Polymorphism; Receptor; Reference proteome; Signal; Transducer;
KW   Transmembrane; Transmembrane helix.
FT   SIGNAL        1     22       {ECO:0000255}.
FT   CHAIN        23    879       Metabotropic glutamate receptor 3.
FT                                /FTId=PRO_0000012927.
FT   TOPO_DOM     23    576       Extracellular. {ECO:0000255}.
FT   TRANSMEM    577    599       Helical; Name=1. {ECO:0000255}.
FT   TOPO_DOM    600    613       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    614    634       Helical; Name=2. {ECO:0000255}.
FT   TOPO_DOM    635    645       Extracellular. {ECO:0000255}.
FT   TRANSMEM    646    664       Helical; Name=3. {ECO:0000255}.
FT   TOPO_DOM    665    688       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    689    709       Helical; Name=4. {ECO:0000255}.
FT   TOPO_DOM    710    734       Extracellular. {ECO:0000255}.
FT   TRANSMEM    735    756       Helical; Name=5. {ECO:0000255}.
FT   TOPO_DOM    757    769       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    770    792       Helical; Name=6. {ECO:0000255}.
FT   TOPO_DOM    793    802       Extracellular. {ECO:0000255}.
FT   TRANSMEM    803    828       Helical; Name=7. {ECO:0000255}.
FT   TOPO_DOM    829    879       Cytoplasmic. {ECO:0000255}.
FT   REGION      172    174       Glutamate binding. {ECO:0000250}.
FT   BINDING     151    151       Glutamate. {ECO:0000250}.
FT   BINDING     222    222       Glutamate. {ECO:0000250}.
FT   BINDING     301    301       Glutamate. {ECO:0000250}.
FT   BINDING     389    389       Glutamate. {ECO:0000250}.
FT   CARBOHYD    209    209       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    292    292       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    414    414       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    439    439       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID     57     99       {ECO:0000269|Ref.5}.
FT   DISULFID    240    527       {ECO:0000250}.
FT   DISULFID    361    373       {ECO:0000269|Ref.5}.
FT   DISULFID    412    419       {ECO:0000269|Ref.5}.
FT   DISULFID    509    528       {ECO:0000250}.
FT   DISULFID    513    531       {ECO:0000250}.
FT   DISULFID    534    546       {ECO:0000250}.
FT   DISULFID    549    562       {ECO:0000250}.
FT   VAR_SEQ     442    537       APFNPNKDADSIVKFDTFGDGMGRYNVFNFQNVGGKYSYLK
FT                                VGHWAETLSLDVNSIHWSRNSVPTSQCSDPCAPNEMKNMQP
FT                                GDVCCWICIPCEPY -> GADDNHVHLCQPEWLCGLGLFVC
FT                                TQGSHHPVSTPEECCHTQTAPQQVQCQWNWDHILSVLCKHV
FT                                CANGVQWAGSPRLHHLISVIVNCSSVLVFLDC (in
FT                                isoform 2).
FT                                {ECO:0000303|PubMed:16417579}.
FT                                /FTId=VSP_047679.
FT   VAR_SEQ     538    879       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:16417579}.
FT                                /FTId=VSP_047680.
FT   VARIANT     475    475       G -> D (in dbSNP:rs17161026).
FT                                /FTId=VAR_049274.
FT   CONFLICT     96     96       L -> F (in Ref. 4; AAH41407).
FT                                {ECO:0000305}.
FT   CONFLICT    446    446       P -> T (in Ref. 4; AAH22496).
FT                                {ECO:0000305}.
FT   CONFLICT    512    512       P -> A (in Ref. 4; AAH22496).
FT                                {ECO:0000305}.
FT   CONFLICT    856    856       S -> Y (in Ref. 4; AAH22496).
FT                                {ECO:0000305}.
FT   STRAND       33     35       {ECO:0000244|PDB:3SM9}.
FT   STRAND       38     45       {ECO:0000244|PDB:3SM9}.
FT   STRAND       48     50       {ECO:0000244|PDB:3SM9}.
FT   STRAND       56     60       {ECO:0000244|PDB:3SM9}.
FT   TURN         62     65       {ECO:0000244|PDB:3SM9}.
FT   HELIX        66     81       {ECO:0000244|PDB:3SM9}.
FT   STRAND       83     86       {ECO:0000244|PDB:3SM9}.
FT   STRAND       91     97       {ECO:0000244|PDB:3SM9}.
FT   HELIX       102    114       {ECO:0000244|PDB:3SM9}.
FT   STRAND      142    146       {ECO:0000244|PDB:3SM9}.
FT   HELIX       151    161       {ECO:0000244|PDB:3SM9}.
FT   HELIX       162    164       {ECO:0000244|PDB:3SM9}.
FT   STRAND      168    172       {ECO:0000244|PDB:3SM9}.
FT   HELIX       176    179       {ECO:0000244|PDB:3SM9}.
FT   TURN        181    186       {ECO:0000244|PDB:3SM9}.
FT   STRAND      187    191       {ECO:0000244|PDB:3SM9}.
FT   HELIX       195    207       {ECO:0000244|PDB:3SM9}.
FT   STRAND      212    220       {ECO:0000244|PDB:3SM9}.
FT   HELIX       221    235       {ECO:0000244|PDB:3SM9}.
FT   TURN        236    238       {ECO:0000244|PDB:3SM9}.
FT   STRAND      240    247       {ECO:0000244|PDB:3SM9}.
FT   HELIX       253    264       {ECO:0000244|PDB:3SM9}.
FT   STRAND      271    275       {ECO:0000244|PDB:3SM9}.
FT   HELIX       278    290       {ECO:0000244|PDB:3SM9}.
FT   STRAND      296    299       {ECO:0000244|PDB:3SM9}.
FT   TURN        301    305       {ECO:0000244|PDB:3SM9}.
FT   HELIX       307    310       {ECO:0000244|PDB:3SM9}.
FT   TURN        314    319       {ECO:0000244|PDB:3SM9}.
FT   STRAND      321    325       {ECO:0000244|PDB:3SM9}.
FT   HELIX       331    338       {ECO:0000244|PDB:3SM9}.
FT   TURN        342    344       {ECO:0000244|PDB:3SM9}.
FT   HELIX       351    359       {ECO:0000244|PDB:3SM9}.
FT   TURN        381    383       {ECO:0000244|PDB:3SM9}.
FT   HELIX       390    411       {ECO:0000244|PDB:3SM9}.
FT   HELIX       420    423       {ECO:0000244|PDB:3SM9}.
FT   HELIX       427    433       {ECO:0000244|PDB:3SM9}.
FT   HELIX       435    437       {ECO:0000244|PDB:3SM9}.
FT   STRAND      438    440       {ECO:0000244|PDB:4XAR}.
FT   HELIX       450    452       {ECO:0000244|PDB:5CNM}.
FT   STRAND      453    455       {ECO:0000244|PDB:4XAR}.
FT   STRAND      466    476       {ECO:0000244|PDB:3SM9}.
FT   STRAND      478    492       {ECO:0000244|PDB:3SM9}.
FT   HELIX       494    496       {ECO:0000244|PDB:3SM9}.
SQ   SEQUENCE   879 AA;  98879 MW;  7EB84521676E8304 CRC64;
     MKMLTRLQVL TLALFSKGFL LSLGDHNFLR REIKIEGDLV LGGLFPINEK GTGTEECGRI
     NEDRGIQRLE AMLFAIDEIN KDDYLLPGVK LGVHILDTCS RDTYALEQSL EFVRASLTKV
     DEAEYMCPDG SYAIQENIPL LIAGVIGGSY SSVSIQVANL LRLFQIPQIS YASTSAKLSD
     KSRYDYFART VPPDFYQAKA MAEILRFFNW TYVSTVASEG DYGETGIEAF EQEARLRNIC
     IATAEKVGRS NIRKSYDSVI RELLQKPNAR VVVLFMRSDD SRELIAAASR ANASFTWVAS
     DGWGAQESII KGSEHVAYGA ITLELASQPV RQFDRYFQSL NPYNNHRNPW FRDFWEQKFQ
     CSLQNKRNHR RVCDKHLAID SSNYEQESKI MFVVNAVYAM AHALHKMQRT LCPNTTKLCD
     AMKILDGKKL YKDYLLKINF TAPFNPNKDA DSIVKFDTFG DGMGRYNVFN FQNVGGKYSY
     LKVGHWAETL SLDVNSIHWS RNSVPTSQCS DPCAPNEMKN MQPGDVCCWI CIPCEPYEYL
     ADEFTCMDCG SGQWPTADLT GCYDLPEDYI RWEDAWAIGP VTIACLGFMC TCMVVTVFIK
     HNNTPLVKAS GRELCYILLF GVGLSYCMTF FFIAKPSPVI CALRRLGLGS SFAICYSALL
     TKTNCIARIF DGVKNGAQRP KFISPSSQVF ICLGLILVQI VMVSVWLILE APGTRRYTLA
     EKRETVILKC NVKDSSMLIS LTYDVILVIL CTVYAFKTRK CPENFNEAKF IGFTMYTTCI
     IWLAFLPIFY VTSSDYRVQT TTMCISVSLS GFVVLGCLFA PKVHIILFQP QKNVVTHRLH
     LNRFSVSGTG TTYSQSSAST YVPTVCNGRE VLDSTTSSL
//
ID   KAT7_HUMAN              Reviewed;         611 AA.
AC   O95251; B3KN74; B4DF85; B4DFB4; B4DFE0; B4DGY4; E7ER15; G5E9K7;
DT   05-JUL-2005, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-1999, sequence version 1.
DT   28-MAR-2018, entry version 164.
DE   RecName: Full=Histone acetyltransferase KAT7;
DE            EC=2.3.1.48 {ECO:0000269|PubMed:10438470};
DE   AltName: Full=Histone acetyltransferase binding to ORC1;
DE   AltName: Full=Lysine acetyltransferase 7;
DE   AltName: Full=MOZ, YBF2/SAS3, SAS2 and TIP60 protein 2;
DE            Short=MYST-2;
GN   Name=KAT7; Synonyms=HBO1, HBOa, MYST2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), INTERACTION WITH ORC1,
RP   FUNCTION, CATALYTIC ACTIVITY, AND TISSUE SPECIFICITY.
RC   TISSUE=Epithelium;
RX   PubMed=10438470; DOI=10.1074/jbc.274.33.23027;
RA   Iizuka M., Stillman B.;
RT   "Histone acetyltransferase HBO1 interacts with the ORC1 subunit of the
RT   human initiator protein.";
RL   J. Biol. Chem. 274:23027-23034(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), TISSUE SPECIFICITY,
RP   SUBCELLULAR LOCATION, INTERACTION WITH AR, AND FUNCTION.
RC   TISSUE=Prostate;
RX   PubMed=10930412; DOI=10.1074/jbc.M004838200;
RA   Sharma M., Zarnegar M., Li X., Lim B., Sun Z.;
RT   "Androgen receptor interacts with a novel MYST protein, HBO1.";
RL   J. Biol. Chem. 275:35200-35208(2000).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RA   Jian J., Guangtao L., Guangwei D., Yan Z., Jianhe C., Jiangang Y.,
RA   Boqin Q.;
RT   "Cloning and identifying histone acetyltransferase HBOa.";
RL   Submitted (APR-1999) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RA   Borrow J., Housman D.E.;
RT   "Structure and function of the human MYST family: MOZ2, MYST1 and
RT   MYST2.";
RL   Submitted (DEC-1999) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1; 2; 3; 4 AND 5).
RC   TISSUE=Brain, Cerebellum, and Thyroid;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16625196; DOI=10.1038/nature04689;
RA   Zody M.C., Garber M., Adams D.J., Sharpe T., Harrow J., Lupski J.R.,
RA   Nicholson C., Searle S.M., Wilming L., Young S.K., Abouelleil A.,
RA   Allen N.R., Bi W., Bloom T., Borowsky M.L., Bugalter B.E., Butler J.,
RA   Chang J.L., Chen C.-K., Cook A., Corum B., Cuomo C.A., de Jong P.J.,
RA   DeCaprio D., Dewar K., FitzGerald M., Gilbert J., Gibson R.,
RA   Gnerre S., Goldstein S., Grafham D.V., Grocock R., Hafez N.,
RA   Hagopian D.S., Hart E., Norman C.H., Humphray S., Jaffe D.B.,
RA   Jones M., Kamal M., Khodiyar V.K., LaButti K., Laird G., Lehoczky J.,
RA   Liu X., Lokyitsang T., Loveland J., Lui A., Macdonald P., Major J.E.,
RA   Matthews L., Mauceli E., McCarroll S.A., Mihalev A.H., Mudge J.,
RA   Nguyen C., Nicol R., O'Leary S.B., Osoegawa K., Schwartz D.C.,
RA   Shaw-Smith C., Stankiewicz P., Steward C., Swarbreck D.,
RA   Venkataraman V., Whittaker C.A., Yang X., Zimmer A.R., Bradley A.,
RA   Hubbard T., Birren B.W., Rogers J., Lander E.S., Nusbaum C.;
RT   "DNA sequence of human chromosome 17 and analysis of rearrangement in
RT   the human lineage.";
RL   Nature 440:1045-1049(2006).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Lymph;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   INTERACTION WITH MCM2 AND ORC1, DOMAIN, SUBCELLULAR LOCATION,
RP   FUNCTION, AND MUTAGENESIS OF CYS-371.
RX   PubMed=11278932; DOI=10.1074/jbc.M011556200;
RA   Burke T.W., Cook J.G., Asano M., Nevins J.R.;
RT   "Replication factors MCM2 and ORC1 interact with the histone
RT   acetyltransferase HBO1.";
RL   J. Biol. Chem. 276:15397-15408(2001).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [11]
RP   FUNCTION IN HISTONE ACETYLATION, FUNCTION IN DNA REPLICATION, FUNCTION
RP   IN TP53-MEDIATED TRANSCRIPTION, IDENTIFICATION IN THE HBO1 COMPLEX,
RP   INTERACTION WITH MCM2, AND SUBCELLULAR LOCATION.
RX   PubMed=16387653; DOI=10.1016/j.molcel.2005.12.007;
RA   Doyon Y., Cayrou C., Ullah M., Landry A.-J., Cote V., Selleck W.,
RA   Lane W.S., Tan S., Yang X.-J., Cote J.;
RT   "ING tumor suppressor proteins are critical regulators of chromatin
RT   acetylation required for genome expression and perpetuation.";
RL   Mol. Cell 21:51-64(2006).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-88, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=16964243; DOI=10.1038/nbt1240;
RA   Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;
RT   "A probability-based approach for high-throughput protein
RT   phosphorylation analysis and site localization.";
RL   Nat. Biotechnol. 24:1285-1292(2006).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Embryonic kidney;
RX   PubMed=17525332; DOI=10.1126/science.1140321;
RA   Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,
RA   Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,
RA   Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.;
RT   "ATM and ATR substrate analysis reveals extensive protein networks
RT   responsive to DNA damage.";
RL   Science 316:1160-1166(2007).
RN   [14]
RP   INTERACTION WITH CDT1, AND SUBCELLULAR LOCATION.
RX   PubMed=18832067; DOI=10.1101/gad.1674108;
RA   Miotto B., Struhl K.;
RT   "HBO1 histone acetylase is a coactivator of the replication licensing
RT   factor Cdt1.";
RL   Genes Dev. 22:2633-2638(2008).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-50; SER-57; THR-85;
RP   THR-88 AND SER-102, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE
RP   SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [16]
RP   PHOSPHORYLATION AT SER-57 BY PLK1, AND PHOSPHORYLATION AT THR-85 AND
RP   THR-88 BY CDK1.
RX   PubMed=18250300; DOI=10.1073/pnas.0712063105;
RA   Wu Z.Q., Liu X.;
RT   "Role for Plk1 phosphorylation of Hbo1 in regulation of replication
RT   licensing.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:1919-1924(2008).
RN   [17]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [18]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-57; THR-85; THR-88 AND
RP   SER-102, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [19]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-199, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [20]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-162 AND SER-506, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [21]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-57; THR-88; SER-102;
RP   SER-124; SER-162 AND SER-164, AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [22]
RP   MUTAGENESIS OF LYS-338, AND UBIQUITINATION AT LYS-338.
RX   PubMed=23319590; DOI=10.1074/jbc.M112.426882;
RA   Zou C., Chen Y., Smith R.M., Snavely C., Li J., Coon T.A., Chen B.B.,
RA   Zhao Y., Mallampalli R.K.;
RT   "SCF(Fbxw15) mediates histone acetyltransferase binding to origin
RT   recognition complex (HBO1) ubiquitin-proteasomal degradation to
RT   regulate cell proliferation.";
RL   J. Biol. Chem. 288:6306-6316(2013).
RN   [23]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-10; SER-50; SER-57;
RP   SER-64; SER-102; SER-111; SER-162; SER-164; SER-178 AND SER-506, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [24]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-158, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [25]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-323, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-
RT   modification with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
CC   -!- FUNCTION: Component of the HBO1 complex which has a histone H4-
CC       specific acetyltransferase activity, a reduced activity toward
CC       histone H3 and is responsible for the bulk of histone H4
CC       acetylation in vivo. Involved in H3K14 (histone H3 lysine 14)
CC       acetylation and cell proliferation (By similarity). Through
CC       chromatin acetylation it may regulate DNA replication and act as a
CC       coactivator of TP53-dependent transcription. Acts as a coactivator
CC       of the licensing factor CDT1 (PubMed:18832067). Specifically
CC       represses AR-mediated transcription.
CC       {ECO:0000250|UniProtKB:Q5SVQ0, ECO:0000269|PubMed:10438470,
CC       ECO:0000269|PubMed:10930412, ECO:0000269|PubMed:11278932,
CC       ECO:0000269|PubMed:16387653, ECO:0000269|PubMed:18832067}.
CC   -!- CATALYTIC ACTIVITY: Acetyl-CoA + [protein]-L-lysine = CoA +
CC       [protein]-N(6)-acetyl-L-lysine. {ECO:0000269|PubMed:10438470}.
CC   -!- SUBUNIT: Component of the HBO1 complex composed at least of ING4
CC       or ING5, KAT7/HBO1, MEAF6, and one of JADE1, JADE2 and JADE3.
CC       Interacts with MCM2 and ORC1. Interacts with the androgen receptor
CC       (AR) in the presence of dihydrotestosterone (PubMed:10930412).
CC       Interacts with CDT1 (PubMed:18832067). Interacts with MAP2K1 and
CC       CUL1 (By similarity). {ECO:0000250|UniProtKB:Q5SVQ0,
CC       ECO:0000269|PubMed:10438470, ECO:0000269|PubMed:10930412,
CC       ECO:0000269|PubMed:11278932, ECO:0000269|PubMed:16387653,
CC       ECO:0000269|PubMed:18832067}.
CC   -!- INTERACTION:
CC       P10275:AR; NbExp=5; IntAct=EBI-473199, EBI-608057;
CC       Q99728:BARD1; NbExp=2; IntAct=EBI-473199, EBI-473181;
CC       P21127:CDK11B; NbExp=7; IntAct=EBI-473199, EBI-1298;
CC       Q9P2H0:CEP126; NbExp=2; IntAct=EBI-473199, EBI-473176;
CC       P53350:PLK1; NbExp=6; IntAct=EBI-473199, EBI-476768;
CC       P08670:VIM; NbExp=4; IntAct=EBI-473199, EBI-353844;
CC   -!- SUBCELLULAR LOCATION: Nucleus, nucleoplasm
CC       {ECO:0000269|PubMed:10930412, ECO:0000269|PubMed:11278932,
CC       ECO:0000269|PubMed:16387653}. Cytoplasm, cytosol
CC       {ECO:0000250|UniProtKB:Q5SVQ0}. Nucleus
CC       {ECO:0000250|UniProtKB:Q5SVQ0}. Note=Associates with replication
CC       origins specifically during the G1 phase of the cell cycle
CC       (PubMed:18832067). {ECO:0000269|PubMed:18832067}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=5;
CC       Name=1;
CC         IsoId=O95251-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=O95251-2; Sequence=VSP_042553, VSP_042554;
CC         Note=No experimental confirmation available.;
CC       Name=3;
CC         IsoId=O95251-3; Sequence=VSP_042552, VSP_042553, VSP_042554;
CC         Note=No experimental confirmation available.;
CC       Name=4;
CC         IsoId=O95251-4; Sequence=VSP_042554;
CC         Note=No experimental confirmation available.;
CC       Name=5;
CC         IsoId=O95251-5; Sequence=VSP_042552, VSP_042553;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Ubiquitously expressed, with highest levels in
CC       testis. {ECO:0000269|PubMed:10438470,
CC       ECO:0000269|PubMed:10930412}.
CC   -!- DOMAIN: The C2HC MYST-type zinc finger is required for interaction
CC       with MCM2 and ORC1. {ECO:0000269|PubMed:11278932}.
CC   -!- DOMAIN: The N-terminus is involved in transcriptional repression,
CC       while the C-terminus mediates AR-interaction. {ECO:0000250}.
CC   -!- PTM: Phosphorylation at Ser-57 by PLK1 during mitosis seems
CC       important for prereplicative complex formation and DNA replication
CC       licensing, and requires prior phosphorylation at Thr-85 and Thr-88
CC       by CDK1 (PubMed:18250300). Phosphorylated by MAP2K1, which
CC       accelerates its degradation (By similarity).
CC       {ECO:0000250|UniProtKB:Q5SVQ0, ECO:0000269|PubMed:18250300}.
CC   -!- PTM: Autoacetylation at Lys-432 is required for proper function.
CC       {ECO:0000250|UniProtKB:Q9H7Z6}.
CC   -!- PTM: Ubiquitinated at Lys-338, leading to proteasomal degradation.
CC       {ECO:0000269|PubMed:23319590}.
CC   -!- SIMILARITY: Belongs to the MYST (SAS/MOZ) family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF074606; AAC99368.1; -; mRNA.
DR   EMBL; AF140360; AAD42348.1; -; mRNA.
DR   EMBL; AF217502; AAL56649.1; -; mRNA.
DR   EMBL; AK023890; BAG51236.1; -; mRNA.
DR   EMBL; AK293976; BAG57346.1; -; mRNA.
DR   EMBL; AK294014; BAG57375.1; -; mRNA.
DR   EMBL; AK294052; BAG57401.1; -; mRNA.
DR   EMBL; AK294836; BAG57945.1; -; mRNA.
DR   EMBL; AC015795; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC027801; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471109; EAW94658.1; -; Genomic_DNA.
DR   EMBL; CH471109; EAW94659.1; -; Genomic_DNA.
DR   EMBL; BC032640; AAH32640.1; -; mRNA.
DR   CCDS; CCDS11554.1; -. [O95251-1]
DR   CCDS; CCDS56035.1; -. [O95251-4]
DR   CCDS; CCDS56036.1; -. [O95251-2]
DR   CCDS; CCDS56037.1; -. [O95251-5]
DR   CCDS; CCDS56038.1; -. [O95251-3]
DR   RefSeq; NP_001186084.1; NM_001199155.1. [O95251-4]
DR   RefSeq; NP_001186085.1; NM_001199156.1. [O95251-5]
DR   RefSeq; NP_001186086.1; NM_001199157.1. [O95251-2]
DR   RefSeq; NP_001186087.1; NM_001199158.1. [O95251-3]
DR   RefSeq; NP_008998.1; NM_007067.4. [O95251-1]
DR   UniGene; Hs.21907; -.
DR   PDB; 5GK9; X-ray; 2.40 A; A=336-611.
DR   PDBsum; 5GK9; -.
DR   ProteinModelPortal; O95251; -.
DR   SMR; O95251; -.
DR   BioGrid; 116315; 68.
DR   CORUM; O95251; -.
DR   DIP; DIP-29697N; -.
DR   IntAct; O95251; 55.
DR   MINT; O95251; -.
DR   STRING; 9606.ENSP00000259021; -.
DR   ChEMBL; CHEMBL3774299; -.
DR   iPTMnet; O95251; -.
DR   PhosphoSitePlus; O95251; -.
DR   BioMuta; KAT7; -.
DR   EPD; O95251; -.
DR   MaxQB; O95251; -.
DR   PaxDb; O95251; -.
DR   PeptideAtlas; O95251; -.
DR   PRIDE; O95251; -.
DR   DNASU; 11143; -.
DR   Ensembl; ENST00000259021; ENSP00000259021; ENSG00000136504. [O95251-1]
DR   Ensembl; ENST00000424009; ENSP00000398961; ENSG00000136504. [O95251-4]
DR   Ensembl; ENST00000454930; ENSP00000413415; ENSG00000136504. [O95251-5]
DR   Ensembl; ENST00000509773; ENSP00000424577; ENSG00000136504. [O95251-2]
DR   Ensembl; ENST00000510819; ENSP00000423385; ENSG00000136504. [O95251-3]
DR   GeneID; 11143; -.
DR   KEGG; hsa:11143; -.
DR   UCSC; uc002ipl.3; human. [O95251-1]
DR   CTD; 11143; -.
DR   DisGeNET; 11143; -.
DR   EuPathDB; HostDB:ENSG00000136504.11; -.
DR   GeneCards; KAT7; -.
DR   HGNC; HGNC:17016; KAT7.
DR   HPA; HPA044470; -.
DR   MIM; 609880; gene.
DR   neXtProt; NX_O95251; -.
DR   OpenTargets; ENSG00000136504; -.
DR   PharmGKB; PA134886407; -.
DR   eggNOG; KOG2747; Eukaryota.
DR   eggNOG; COG5027; LUCA.
DR   GeneTree; ENSGT00910000144012; -.
DR   HOGENOM; HOG000182457; -.
DR   HOVERGEN; HBG053268; -.
DR   InParanoid; O95251; -.
DR   KO; K11307; -.
DR   OMA; VYSTRRV; -.
DR   OrthoDB; EOG091G00D2; -.
DR   PhylomeDB; O95251; -.
DR   TreeFam; TF317619; -.
DR   Reactome; R-HSA-3214847; HATs acetylate histones.
DR   SIGNOR; O95251; -.
DR   ChiTaRS; KAT7; human.
DR   GeneWiki; MYST2; -.
DR   GenomeRNAi; 11143; -.
DR   PRO; PR:O95251; -.
DR   Proteomes; UP000005640; Chromosome 17.
DR   Bgee; ENSG00000136504; -.
DR   CleanEx; HS_MYST2; -.
DR   ExpressionAtlas; O95251; baseline and differential.
DR   Genevisible; O95251; HS.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0000123; C:histone acetyltransferase complex; IDA:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; IDA:UniProtKB.
DR   GO; GO:0005634; C:nucleus; IDA:GO_Central.
DR   GO; GO:0003700; F:DNA binding transcription factor activity; IEA:InterPro.
DR   GO; GO:0003688; F:DNA replication origin binding; IMP:CAFA.
DR   GO; GO:0004402; F:histone acetyltransferase activity; IEA:UniProtKB-EC.
DR   GO; GO:0044212; F:transcription regulatory region DNA binding; IMP:CAFA.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:0006260; P:DNA replication; IDA:UniProtKB.
DR   GO; GO:0043966; P:histone H3 acetylation; IDA:UniProtKB.
DR   GO; GO:0043983; P:histone H4-K12 acetylation; IDA:UniProtKB.
DR   GO; GO:0043981; P:histone H4-K5 acetylation; IDA:UniProtKB.
DR   GO; GO:0043982; P:histone H4-K8 acetylation; IDA:UniProtKB.
DR   GO; GO:0090240; P:positive regulation of histone H4 acetylation; IMP:CAFA.
DR   GO; GO:1900182; P:positive regulation of protein localization to nucleus; IDA:GO_Central.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; IMP:CAFA.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; TAS:ProtInc.
DR   GO; GO:0072716; P:response to actinomycin D; IMP:CAFA.
DR   GO; GO:0072739; P:response to anisomycin; IMP:CAFA.
DR   GO; GO:0072720; P:response to dithiothreitol; IMP:CAFA.
DR   GO; GO:0072710; P:response to hydroxyurea; IMP:CAFA.
DR   GO; GO:0072708; P:response to sorbitol; IMP:CAFA.
DR   GO; GO:0031098; P:stress-activated protein kinase signaling cascade; IDA:CAFA.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
DR   Gene3D; 1.10.10.10; -; 1.
DR   InterPro; IPR016181; Acyl_CoA_acyltransferase.
DR   InterPro; IPR002717; HAT_MYST-type.
DR   InterPro; IPR036388; WH-like_DNA-bd_sf.
DR   InterPro; IPR002515; Znf_C2HC.
DR   InterPro; IPR036060; Znf_C2HC_sf.
DR   Pfam; PF01853; MOZ_SAS; 1.
DR   Pfam; PF01530; zf-C2HC; 1.
DR   SUPFAM; SSF103637; SSF103637; 1.
DR   SUPFAM; SSF55729; SSF55729; 1.
DR   PROSITE; PS51726; MYST_HAT; 1.
DR   PROSITE; PS51802; ZF_CCHHC; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Acyltransferase; Alternative splicing;
KW   Chromatin regulator; Complete proteome; Cytoplasm; DNA replication;
KW   Isopeptide bond; Metal-binding; Nucleus; Phosphoprotein;
KW   Reference proteome; Transcription; Transcription regulation;
KW   Transferase; Ubl conjugation; Zinc; Zinc-finger.
FT   CHAIN         1    611       Histone acetyltransferase KAT7.
FT                                /FTId=PRO_0000051569.
FT   DOMAIN      332    607       MYST-type HAT. {ECO:0000255|PROSITE-
FT                                ProRule:PRU01063}.
FT   ZN_FING     176    219       CCHHC-type. {ECO:0000255|PROSITE-
FT                                ProRule:PRU01143}.
FT   ZN_FING     365    390       C2HC MYST-type. {ECO:0000255|PROSITE-
FT                                ProRule:PRU01063}.
FT   REGION      475    477       Acetyl-CoA binding.
FT                                {ECO:0000250|UniProtKB:Q9H7Z6}.
FT   REGION      482    488       Acetyl-CoA binding.
FT                                {ECO:0000250|UniProtKB:Q9H7Z6}.
FT   COMPBIAS     10     57       Ser-rich.
FT   ACT_SITE    508    508       Proton donor/acceptor.
FT                                {ECO:0000250|UniProtKB:Q9H7Z6}.
FT   BINDING     512    512       Acetyl-CoA.
FT                                {ECO:0000250|UniProtKB:Q9H7Z6}.
FT   BINDING     521    521       Acetyl-CoA.
FT                                {ECO:0000250|UniProtKB:Q9H7Z6}.
FT   MOD_RES      10     10       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES      50     50       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES      57     57       Phosphoserine; by PLK1.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000269|PubMed:18250300}.
FT   MOD_RES      64     64       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES      85     85       Phosphothreonine; by CDK1.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000269|PubMed:18250300}.
FT   MOD_RES      88     88       Phosphothreonine; by CDK1.
FT                                {ECO:0000244|PubMed:16964243,
FT                                ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000269|PubMed:18250300}.
FT   MOD_RES     102    102       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     104    104       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:Q5SVQ0}.
FT   MOD_RES     111    111       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     124    124       Phosphoserine.
FT                                {ECO:0000244|PubMed:21406692}.
FT   MOD_RES     128    128       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:Q5SVQ0}.
FT   MOD_RES     158    158       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     162    162       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     164    164       Phosphoserine.
FT                                {ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     178    178       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     199    199       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     277    277       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:Q5SVQ0}.
FT   MOD_RES     432    432       N6-acetyllysine; by autocatalysis.
FT                                {ECO:0000250|UniProtKB:Q9H7Z6}.
FT   MOD_RES     506    506       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163}.
FT   CROSSLNK    323    323       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    338    338       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in ubiquitin).
FT                                {ECO:0000269|PubMed:23319590}.
FT   VAR_SEQ      55    113       Missing (in isoform 3 and isoform 5).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_042552.
FT   VAR_SEQ     114    193       Missing (in isoform 2, isoform 3 and
FT                                isoform 5).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_042553.
FT   VAR_SEQ     222    251       Missing (in isoform 2, isoform 3 and
FT                                isoform 4).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_042554.
FT   MUTAGEN     338    338       K->R: Decreases ubiquitination.
FT                                {ECO:0000269|PubMed:23319590}.
FT   MUTAGEN     371    371       C->A: No interaction with MCM2 and ORC1.
FT                                {ECO:0000269|PubMed:11278932}.
FT   CONFLICT     38     44       Missing (in Ref. 5; BAG57945).
FT                                {ECO:0000305}.
FT   CONFLICT     41     41       R -> Q (in Ref. 5; BAG57346).
FT                                {ECO:0000305}.
FT   STRAND      339    342       {ECO:0000244|PDB:5GK9}.
FT   STRAND      345    348       {ECO:0000244|PDB:5GK9}.
FT   HELIX       357    360       {ECO:0000244|PDB:5GK9}.
FT   STRAND      362    367       {ECO:0000244|PDB:5GK9}.
FT   TURN        369    371       {ECO:0000244|PDB:5GK9}.
FT   STRAND      374    376       {ECO:0000244|PDB:5GK9}.
FT   HELIX       378    387       {ECO:0000244|PDB:5GK9}.
FT   STRAND      394    401       {ECO:0000244|PDB:5GK9}.
FT   STRAND      404    410       {ECO:0000244|PDB:5GK9}.
FT   TURN        411    414       {ECO:0000244|PDB:5GK9}.
FT   HELIX       415    426       {ECO:0000244|PDB:5GK9}.
FT   STRAND      441    450       {ECO:0000244|PDB:5GK9}.
FT   STRAND      453    465       {ECO:0000244|PDB:5GK9}.
FT   STRAND      470    477       {ECO:0000244|PDB:5GK9}.
FT   HELIX       479    481       {ECO:0000244|PDB:5GK9}.
FT   HELIX       486    500       {ECO:0000244|PDB:5GK9}.
FT   STRAND      505    507       {ECO:0000244|PDB:5GK9}.
FT   HELIX       513    533       {ECO:0000244|PDB:5GK9}.
FT   STRAND      536    539       {ECO:0000244|PDB:5GK9}.
FT   HELIX       541    548       {ECO:0000244|PDB:5GK9}.
FT   HELIX       552    561       {ECO:0000244|PDB:5GK9}.
FT   STRAND      565    568       {ECO:0000244|PDB:5GK9}.
FT   STRAND      571    575       {ECO:0000244|PDB:5GK9}.
FT   HELIX       578    583       {ECO:0000244|PDB:5GK9}.
FT   HELIX       600    602       {ECO:0000244|PDB:5GK9}.
SQ   SEQUENCE   611 AA;  70642 MW;  8368E7C4F07D8D7C CRC64;
     MPRRKRNAGS SSDGTEDSDF STDLEHTDSS ESDGTSRRSA RVTRSSARLS QSSQDSSPVR
     NLQSFGTEEP AYSTRRVTRS QQQPTPVTPK KYPLRQTRSS GSETEQVVDF SDRETKNTAD
     HDESPPRTPT GNAPSSESDI DISSPNVSHD ESIAKDMSLK DSGSDLSHRP KRRRFHESYN
     FNMKCPTPGC NSLGHLTGKH ERHFSISGCP LYHNLSADEC KVRAQSRDKQ IEERMLSHRQ
     DDNNRHATRH QAPTERQLRY KEKVAELRKK RNSGLSKEQK EKYMEHRQTY GNTREPLLEN
     LTSEYDLDLF RRAQARASED LEKLRLQGQI TEGSNMIKTI AFGRYELDTW YHSPYPEEYA
     RLGRLYMCEF CLKYMKSQTI LRRHMAKCVW KHPPGDEIYR KGSISVFEVD GKKNKIYCQN
     LCLLAKLFLD HKTLYYDVEP FLFYVMTEAD NTGCHLIGYF SKEKNSFLNY NVSCILTMPQ
     YMRQGYGKML IDFSYLLSKV EEKVGSPERP LSDLGLISYR SYWKEVLLRY LHNFQGKEIS
     IKEISQETAV NPVDIVSTLQ ALQMLKYWKG KHLVLKRQDL IDEWIAKEAK RSNSNKTMDP
     SCLKWTPPKG T
//
ID   SKAP_HUMAN              Reviewed;         316 AA.
AC   Q9Y448; B4DXA7; Q147U5; Q32Q57; Q5ISJ0; Q6P2S5; Q6PJM0; Q86XB4;
DT   06-FEB-2007, integrated into UniProtKB/Swiss-Prot.
DT   06-FEB-2007, sequence version 2.
DT   28-FEB-2018, entry version 109.
DE   RecName: Full=Small kinetochore-associated protein {ECO:0000303|PubMed:19667759};
DE            Short=SKAP {ECO:0000303|PubMed:19667759};
DE   AltName: Full=Kinetochore-localized astrin-binding protein {ECO:0000303|PubMed:21402792};
DE            Short=Kinastrin {ECO:0000303|PubMed:21402792};
DE   AltName: Full=Kinetochore-localized astrin/SPAG5-binding protein;
DE   AltName: Full=TRAF4-associated factor 1;
GN   Name=KNSTRN {ECO:0000312|HGNC:HGNC:30767};
GN   Synonyms=C15orf23 {ECO:0000312|HGNC:HGNC:30767},
GN   SKAP {ECO:0000303|PubMed:19667759}, TRAF4AF1; ORFNames=HSD11;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Testis;
RA   Cai C.L., Liu N., Lin W., Miao S.Y., Wang L.F.;
RT   "A spermatogenesis related gene expressed in nucleus.";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Testis;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16572171; DOI=10.1038/nature04601;
RA   Zody M.C., Garber M., Sharpe T., Young S.K., Rowen L., O'Neill K.,
RA   Whittaker C.A., Kamal M., Chang J.L., Cuomo C.A., Dewar K.,
RA   FitzGerald M.G., Kodira C.D., Madan A., Qin S., Yang X., Abbasi N.,
RA   Abouelleil A., Arachchi H.M., Baradarani L., Birditt B., Bloom S.,
RA   Bloom T., Borowsky M.L., Burke J., Butler J., Cook A., DeArellano K.,
RA   DeCaprio D., Dorris L. III, Dors M., Eichler E.E., Engels R.,
RA   Fahey J., Fleetwood P., Friedman C., Gearin G., Hall J.L., Hensley G.,
RA   Johnson E., Jones C., Kamat A., Kaur A., Locke D.P., Madan A.,
RA   Munson G., Jaffe D.B., Lui A., Macdonald P., Mauceli E., Naylor J.W.,
RA   Nesbitt R., Nicol R., O'Leary S.B., Ratcliffe A., Rounsley S., She X.,
RA   Sneddon K.M.B., Stewart S., Sougnez C., Stone S.M., Topham K.,
RA   Vincent D., Wang S., Zimmer A.R., Birren B.W., Hood L., Lander E.S.,
RA   Nusbaum C.;
RT   "Analysis of the DNA sequence and duplication history of human
RT   chromosome 15.";
RL   Nature 440:671-675(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANTS
RP   GLU-40; LEU-75 AND SER-92.
RC   TISSUE=Kidney, Ovary, and Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 39-316 (ISOFORM 3), AND
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 55-316 (ISOFORM 2).
RC   TISSUE=Neuroblastoma;
RA   Li W.B., Gruber C., Jessee J., Polayes D.;
RT   "Full-length cDNA libraries and normalization.";
RL   Submitted (JUL-2004) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 44-316 (ISOFORM 1).
RA   Touji S., Yano M., Kobayasi A., Tamai K.;
RL   Submitted (DEC-1996) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   INDUCTION BY NITRIC OXIDE.
RX   PubMed=15855057; DOI=10.1016/j.freeradbiomed.2005.02.002;
RA   Turpaev K., Bouton C., Diet A., Glatigny A., Drapier J.-C.;
RT   "Analysis of differentially expressed genes in nitric oxide-exposed
RT   human monocytic cells.";
RL   Free Radic. Biol. Med. 38:1392-1400(2005).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-128, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [9]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=19667759; DOI=10.4161/cc.8.17.9514;
RA   Fang L., Seki A., Fang G.;
RT   "SKAP associates with kinetochores and promotes the metaphase-to-
RT   anaphase transition.";
RL   Cell Cycle 8:2819-2827(2009).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [11]
RP   FUNCTION, SUBCELLULAR LOCATION, IDENTIFICATION IN A COMPLEX WITH
RP   SPAG5; PLK1; DYNLL1 AND SGO2, AND INTERACTION WITH SPAG5.
RX   PubMed=21402792; DOI=10.1083/jcb.201008023;
RA   Dunsch A.K., Linnane E., Barr F.A., Gruneberg U.;
RT   "The astrin-kinastrin/SKAP complex localizes to microtubule plus ends
RT   and facilitates chromosome alignment.";
RL   J. Cell Biol. 192:959-968(2011).
RN   [12]
RP   FUNCTION, INTERACTION WITH CENPE, BINDING TO MICROTUBULES, SUBCELLULAR
RP   LOCATION, AND INDUCTION.
RX   PubMed=22110139; DOI=10.1074/jbc.M111.277194;
RA   Huang Y., Wang W., Yao P., Wang X., Liu X., Zhuang X., Yan F.,
RA   Zhou J., Du J., Ward T., Zou H., Zhang J., Fang G., Ding X., Dou Z.,
RA   Yao X.;
RT   "CENP-E kinesin interacts with SKAP protein to orchestrate accurate
RT   chromosome segregation in mitosis.";
RL   J. Biol. Chem. 287:1500-1509(2012).
RN   [13]
RP   FUNCTION, SUBCELLULAR LOCATION, AND INTERACTION WITH DSN1 AND MAPRE1.
RX   PubMed=23035123; DOI=10.1074/jbc.M112.406652;
RA   Wang X., Zhuang X., Cao D., Chu Y., Yao P., Liu W., Liu L., Adams G.,
RA   Fang G., Dou Z., Ding X., Huang Y., Wang D., Yao X.;
RT   "Mitotic regulator SKAP forms a link between kinetochore core complex
RT   KMN and dynamic spindle microtubules.";
RL   J. Biol. Chem. 287:39380-39390(2012).
RN   [14]
RP   INVOLVEMENT IN SCC, VARIANT SCC PHE-24, FUNCTION, AND TISSUE
RP   SPECIFICITY.
RX   PubMed=25194279; DOI=10.1038/ng.3091;
RA   Lee C.S., Bhaduri A., Mah A., Johnson W.L., Ungewickell A., Aros C.J.,
RA   Nguyen C.B., Rios E.J., Siprashvili Z., Straight A., Kim J.,
RA   Aasi S.Z., Khavari P.A.;
RT   "Recurrent point mutations in the kinetochore gene KNSTRN in cutaneous
RT   squamous cell carcinoma.";
RL   Nat. Genet. 46:1060-1062(2014).
RN   [15]
RP   INTERACTION WITH PRPF19, AND SUBCELLULAR LOCATION.
RX   PubMed=24718257; DOI=10.1371/journal.pone.0092712;
RA   Lu S., Wang R., Cai C., Liang J., Xu L., Miao S., Wang L., Song W.;
RT   "Small kinetochore associated protein (SKAP) promotes UV-induced cell
RT   apoptosis through negatively regulating pre-mRNA processing factor 19
RT   (Prp19).";
RL   PLoS ONE 9:E92712-E92712(2014).
CC   -!- FUNCTION: Essential component of the mitotic spindle required for
CC       faithful chromosome segregation and progression into anaphase
CC       (PubMed:19667759). Promotes the metaphase-to-anaphase transition
CC       and is required for chromosome alignment, normal timing of sister
CC       chromatid segregation, and maintenance of spindle pole
CC       architecture (PubMed:19667759, PubMed:22110139). The astrin
CC       (SPAG5)-kinastrin (SKAP) complex promotes stable microtubule-
CC       kinetochore attachments (PubMed:21402792). Required for
CC       kinetochore oscillations and dynamics of microtubule plus-ends
CC       during live cell mitosis, possibly by forming a link between
CC       spindle microtubule plus-ends and mitotic chromosomes to achieve
CC       faithful cell division (PubMed:23035123). May be involved in UV-
CC       induced apoptosis via its interaction with PRPF19; however, these
CC       results need additional evidences (PubMed:24718257).
CC       {ECO:0000269|PubMed:19667759, ECO:0000269|PubMed:21402792,
CC       ECO:0000269|PubMed:22110139, ECO:0000269|PubMed:23035123,
CC       ECO:0000305|PubMed:24718257}.
CC   -!- SUBUNIT: Part of an astrin (SPAG5)-kinastrin (SKAP) complex
CC       containing KNSTRN, SPAG5, PLK1, DYNLL1 and SGO2. Interacts with
CC       SPAG5. Directly binds to microtubules, although at relatively low
CC       affinity. Interacts with CENPE; this interaction greatly favors
CC       microtubule-binding. Interacts with DSN1/MIS13; leading to
CC       localization to kinetochores. Interacts with MAPRE1/EB1; leading
CC       to localization to the microtubule plus ends. Interacts with
CC       PRPF19. {ECO:0000269|PubMed:21402792, ECO:0000269|PubMed:22110139,
CC       ECO:0000269|PubMed:23035123}.
CC   -!- INTERACTION:
CC       Q15691:MAPRE1; NbExp=3; IntAct=EBI-373334, EBI-1004115;
CC       Q9UPY8:MAPRE3; NbExp=4; IntAct=EBI-373334, EBI-726739;
CC       Q9Y3C0:WASHC3; NbExp=4; IntAct=EBI-373334, EBI-712969;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:24718257}.
CC       Chromosome, centromere, kinetochore {ECO:0000269|PubMed:19667759,
CC       ECO:0000269|PubMed:21402792, ECO:0000269|PubMed:22110139,
CC       ECO:0000269|PubMed:23035123}. Cytoplasm, cytoskeleton, spindle
CC       pole {ECO:0000269|PubMed:19667759}. Note=Colocalizes with
CC       microtubules around centrosomes in prophase and with the mitotic
CC       spindle at prometaphase and metaphase. From late prometaphase to
CC       anaphase, is highly concentrated on kinetochores. Located at the
CC       kinetochore-microtubule interface. The astrin (SPAG5)-kinastrin
CC       (SKAP) complex localizes to the microtubule plus ends
CC       (PubMed:23035123). {ECO:0000269|PubMed:19667759,
CC       ECO:0000269|PubMed:21402792, ECO:0000269|PubMed:22110139,
CC       ECO:0000269|PubMed:23035123}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q9Y448-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9Y448-2; Sequence=VSP_041070;
CC       Name=3;
CC         IsoId=Q9Y448-3; Sequence=VSP_041069;
CC   -!- TISSUE SPECIFICITY: Widely expressed, including in skin.
CC       {ECO:0000269|PubMed:25194279}.
CC   -!- INDUCTION: Degraded at the end of mitosis. Down-regulated upon
CC       exposure to nitric oxide. {ECO:0000269|PubMed:15855057,
CC       ECO:0000269|PubMed:22110139}.
CC   -!- DOMAIN: The coiled coil regions mediate binding to kinetochores.
CC       {ECO:0000269|PubMed:23035123}.
CC   -!- DISEASE: Note=Cutaneous squamous cell carcinomas (SCC): A
CC       malignancy of the skin. The hallmark of cutaneous SCC is malignant
CC       transformation of normal epidermal keratinocytes. Disease
CC       susceptibility is associated with variations affecting the gene
CC       represented in this entry. Variant Phe-24 appears specific for UV-
CC       associated malignancies (PubMed:25194279).
CC       {ECO:0000269|PubMed:25194279}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH04543.1; Type=Erroneous termination; Positions=174; Note=Translated as Glu.; Evidence={ECO:0000305};
CC       Sequence=AAH14060.1; Type=Erroneous termination; Positions=174; Note=Translated as Glu.; Evidence={ECO:0000305};
CC       Sequence=AAI07803.1; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AY652615; AAT66172.1; -; mRNA.
DR   EMBL; AK301887; BAG63319.1; -; mRNA.
DR   EMBL; AC013356; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC004543; AAH04543.1; ALT_TERM; mRNA.
DR   EMBL; BC014060; AAH14060.1; ALT_TERM; mRNA.
DR   EMBL; BC045739; AAH45739.1; -; mRNA.
DR   EMBL; BC064344; AAH64344.1; -; mRNA.
DR   EMBL; BC107802; AAI07803.1; ALT_INIT; mRNA.
DR   EMBL; BC118559; AAI18560.1; -; mRNA.
DR   EMBL; BC118639; AAI18640.1; -; mRNA.
DR   EMBL; CR602848; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; CR611451; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; U81002; AAD24201.1; -; mRNA.
DR   CCDS; CCDS42021.1; -. [Q9Y448-1]
DR   CCDS; CCDS45226.1; -. [Q9Y448-2]
DR   CCDS; CCDS45227.1; -. [Q9Y448-3]
DR   RefSeq; NP_001136233.1; NM_001142761.1. [Q9Y448-2]
DR   RefSeq; NP_001136234.1; NM_001142762.1. [Q9Y448-3]
DR   RefSeq; NP_150628.3; NM_033286.3. [Q9Y448-1]
DR   UniGene; Hs.525796; -.
DR   ProteinModelPortal; Q9Y448; -.
DR   SMR; Q9Y448; -.
DR   BioGrid; 124714; 46.
DR   DIP; DIP-31247N; -.
DR   IntAct; Q9Y448; 31.
DR   MINT; Q9Y448; -.
DR   STRING; 9606.ENSP00000249776; -.
DR   iPTMnet; Q9Y448; -.
DR   PhosphoSitePlus; Q9Y448; -.
DR   BioMuta; KNSTRN; -.
DR   DMDM; 125991199; -.
DR   EPD; Q9Y448; -.
DR   PaxDb; Q9Y448; -.
DR   PeptideAtlas; Q9Y448; -.
DR   PRIDE; Q9Y448; -.
DR   Ensembl; ENST00000249776; ENSP00000249776; ENSG00000128944. [Q9Y448-1]
DR   Ensembl; ENST00000416151; ENSP00000391233; ENSG00000128944. [Q9Y448-2]
DR   Ensembl; ENST00000448395; ENSP00000393001; ENSG00000128944. [Q9Y448-3]
DR   GeneID; 90417; -.
DR   KEGG; hsa:90417; -.
DR   UCSC; uc001zll.4; human. [Q9Y448-1]
DR   CTD; 90417; -.
DR   DisGeNET; 90417; -.
DR   EuPathDB; HostDB:ENSG00000128944.13; -.
DR   GeneCards; KNSTRN; -.
DR   HGNC; HGNC:30767; KNSTRN.
DR   HPA; HPA042027; -.
DR   MIM; 614718; gene.
DR   neXtProt; NX_Q9Y448; -.
DR   OpenTargets; ENSG00000128944; -.
DR   PharmGKB; PA134895025; -.
DR   eggNOG; ENOG410IKUT; Eukaryota.
DR   eggNOG; ENOG4111DW5; LUCA.
DR   GeneTree; ENSGT00390000010376; -.
DR   HOVERGEN; HBG083924; -.
DR   InParanoid; Q9Y448; -.
DR   OMA; QESTTDH; -.
DR   OrthoDB; EOG091G0J0K; -.
DR   PhylomeDB; Q9Y448; -.
DR   TreeFam; TF336302; -.
DR   SIGNOR; Q9Y448; -.
DR   GenomeRNAi; 90417; -.
DR   PRO; PR:Q9Y448; -.
DR   Proteomes; UP000005640; Chromosome 15.
DR   Bgee; ENSG00000128944; -.
DR   CleanEx; HS_C15orf23; -.
DR   ExpressionAtlas; Q9Y448; baseline and differential.
DR   Genevisible; Q9Y448; HS.
DR   GO; GO:0000777; C:condensed chromosome kinetochore; IEA:UniProtKB-SubCell.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0000776; C:kinetochore; IDA:UniProtKB.
DR   GO; GO:0015630; C:microtubule cytoskeleton; IDA:HPA.
DR   GO; GO:0035371; C:microtubule plus-end; IDA:UniProtKB.
DR   GO; GO:0072686; C:mitotic spindle; IDA:UniProtKB.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0000922; C:spindle pole; IEA:UniProtKB-SubCell.
DR   GO; GO:0051301; P:cell division; IEA:UniProtKB-KW.
DR   GO; GO:0007059; P:chromosome segregation; IMP:UniProtKB.
DR   GO; GO:0000070; P:mitotic sister chromatid segregation; IMP:UniProtKB.
DR   GO; GO:0051988; P:regulation of attachment of spindle microtubules to kinetochore; IMP:UniProtKB.
DR   GO; GO:0007051; P:spindle organization; IMP:UniProtKB.
DR   InterPro; IPR033373; SKAP.
DR   PANTHER; PTHR31940; PTHR31940; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cell cycle; Cell division; Centromere;
KW   Chromosome; Coiled coil; Complete proteome; Cytoplasm; Cytoskeleton;
KW   Disease mutation; Kinetochore; Microtubule; Mitosis; Nucleus;
KW   Phosphoprotein; Polymorphism; Reference proteome.
FT   CHAIN         1    316       Small kinetochore-associated protein.
FT                                /FTId=PRO_0000274512.
FT   REGION      159    316       Interaction with SPAG5.
FT                                {ECO:0000269|PubMed:21402792}.
FT   COILED      166    216       {ECO:0000255}.
FT   COILED      248    316       {ECO:0000255}.
FT   MOD_RES     128    128       Phosphoserine.
FT                                {ECO:0000244|PubMed:18691976}.
FT   VAR_SEQ     229    316       ALGSETLASRQESTTDHMDSMLLLETLQEELKLFNETAKKQ
FT                                MEELQALKVKLEMKEERVRFLEQQTLCNNQVNDLTTALKEM
FT                                EQLLEM -> VAVRNFARGAEAF (in isoform 3).
FT                                {ECO:0000303|Ref.5}.
FT                                /FTId=VSP_041069.
FT   VAR_SEQ     275    316       ALKVKLEMKEERVRFLEQQTLCNNQVNDLTTALKEMEQLLE
FT                                M -> IAWMNHGILHQM (in isoform 2).
FT                                {ECO:0000303|Ref.5}.
FT                                /FTId=VSP_041070.
FT   VARIANT      24     24       S -> F (in SCC; impaired chromatid
FT                                cohesion; dbSNP:rs868438023).
FT                                {ECO:0000269|PubMed:25194279}.
FT                                /FTId=VAR_071857.
FT   VARIANT      40     40       A -> E (in dbSNP:rs7164132).
FT                                {ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_030304.
FT   VARIANT      75     75       R -> L (in dbSNP:rs7169404).
FT                                {ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_030305.
FT   VARIANT      92     92       P -> S (in dbSNP:rs7169262).
FT                                {ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_030306.
FT   CONFLICT     47     47       T -> K (in Ref. 4; AAH45739).
FT                                {ECO:0000305}.
FT   CONFLICT    232    232       S -> G (in Ref. 4; AAI18640).
FT                                {ECO:0000305}.
FT   CONFLICT    236    236       A -> S (in Ref. 6; AAD24201).
FT                                {ECO:0000305}.
SQ   SEQUENCE   316 AA;  35438 MW;  6FC6745DBA6B70D8 CRC64;
     MAAPEAPPLD RVFRTTWLST ECDSHPLPPS YRKFLFETQA ADLAGGTTVA AGNLLNESEK
     DCGQDRRAPG VQPCRLVTMT SVVKTVYSLQ PPSALSGGQP ADTQTRATSK SLLPVRSKEV
     DVSKQLHSGG PENDVTKITK LRRENGQMKA TDTATRRNVR KGYKPLSKQK SEEELKDKNQ
     LLEAVNKQLH QKLTETQGEL KDLTQKVELL EKFRDNCLAI LESKGLDPAL GSETLASRQE
     STTDHMDSML LLETLQEELK LFNETAKKQM EELQALKVKL EMKEERVRFL EQQTLCNNQV
     NDLTTALKEM EQLLEM
//
ID   B3KY81_HUMAN            Unreviewed;      1647 AA.
AC   B3KY81;
DT   02-SEP-2008, integrated into UniProtKB/TrEMBL.
DT   02-SEP-2008, sequence version 1.
DT   25-OCT-2017, entry version 39.
DE   SubName: Full=cDNA FLJ46662 fis, clone TRACH3006800, highly similar to Homo sapiens mucin 16, cell surface associated (MUC16), mRNA {ECO:0000313|EMBL:BAG54743.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAG54743.1};
RN   [1] {ECO:0000313|EMBL:BAG54743.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Trachea {ECO:0000313|EMBL:BAG54743.1};
RA   Ninomiya K., Wagatsuma M., Kanda K., Kondo H., Yokoi T., Kodaira H.,
RA   Furuya T., Takahashi M., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Sugiyama T., Irie R.,
RA   Otsuki T., Sato H., Ota T., Wakamatsu A., Ishii S., Yamamoto J.,
RA   Isono Y., Kawai-Hio Y., Saito K., Nishikawa T., Kimura K.,
RA   Yamashita H., Matsuo K., Nakamura Y., Sekine M., Kikuchi H.,
RA   Murakawa K., Kanehori K., Takahashi-Fujii A., Oshima A., Sugiyama A.,
RA   Kawakami B., Suzuki Y., Sugano S., Nagahari K., Masuho Y., Nagai K.,
RA   Isogai T.;
RT   "NEDO human cDNA sequencing project.";
RL   Submitted (JUL-2003) to the EMBL/GenBank/DDBJ databases.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK128857; BAG54743.1; -; mRNA.
DR   RefSeq; NP_078966.2; NM_024690.2.
DR   UniGene; Hs.432676; -.
DR   PeptideAtlas; B3KY81; -.
DR   PRIDE; B3KY81; -.
DR   GeneID; 94025; -.
DR   KEGG; hsa:94025; -.
DR   CTD; 94025; -.
DR   HOGENOM; HOG000203664; -.
DR   HOVERGEN; HBG077669; -.
DR   KO; K16145; -.
DR   GenomeRNAi; 94025; -.
DR   Genevisible; B3KY81; HS.
DR   Gene3D; 3.30.70.960; -; 12.
DR   InterPro; IPR028850; MUC16.
DR   InterPro; IPR000082; SEA_dom.
DR   InterPro; IPR036364; SEA_dom_sf.
DR   PANTHER; PTHR14672; PTHR14672; 5.
DR   Pfam; PF01390; SEA; 12.
DR   SUPFAM; SSF82671; SSF82671; 12.
DR   PROSITE; PS50024; SEA; 12.
PE   2: Evidence at transcript level;
FT   DOMAIN        1    103       SEA. {ECO:0000259|PROSITE:PS50024}.
FT   DOMAIN      138    259       SEA. {ECO:0000259|PROSITE:PS50024}.
FT   DOMAIN      294    415       SEA. {ECO:0000259|PROSITE:PS50024}.
FT   DOMAIN      428    549       SEA. {ECO:0000259|PROSITE:PS50024}.
FT   DOMAIN      584    705       SEA. {ECO:0000259|PROSITE:PS50024}.
FT   DOMAIN      740    861       SEA. {ECO:0000259|PROSITE:PS50024}.
FT   DOMAIN      896   1017       SEA. {ECO:0000259|PROSITE:PS50024}.
FT   DOMAIN     1030   1150       SEA. {ECO:0000259|PROSITE:PS50024}.
FT   DOMAIN     1163   1284       SEA. {ECO:0000259|PROSITE:PS50024}.
FT   DOMAIN     1314   1434       SEA. {ECO:0000259|PROSITE:PS50024}.
FT   DOMAIN     1439   1550       SEA. {ECO:0000259|PROSITE:PS50024}.
FT   DOMAIN     1560   1647       SEA. {ECO:0000259|PROSITE:PS50024}.
SQ   SEQUENCE   1647 AA;  182991 MW;  D09D2739F82B4899 CRC64;
     MQHPGSRKFN TTERVLQGLL KPLFKSTSVG PLYSGCRLTL LRPEKHGAAT GVDAICTLRL
     DPTGPGLDRE WLYWELSQLT NSVTELGPYT LDRDSLYVNG FTHRSSVPTT SIPGTSAVHL
     ETSGTPASLP GHTAPGPLLV PFTLNFTITN LQYEEDMRHP GSRKFNTTER VLQGLLKPLF
     KSTSVGPLYS GCRLTLLRPE KRGAATGVDT ICTHRLDPLN PGLDREQLYW ELSKLTHGII
     ELGPYLLDRG SLYVNGFTHR NFVPITSTPG TSTVHLGTSE TPSSLPRPIV PGPLLVPFTL
     NFTITNLQYE EAMRHPGSRK FNTTERVLQG LLRPLFKNTS IGPLYSSCRL TLLRPEKDKA
     ATRVDAICTH HPDPQSPGLN REQLYWELSQ LTHGITELGP YTLDRDSLYV DGFTHWSPIP
     TTSTTGPLLM PFTLNFTITN LQYEENMGHP GSRKFNITES VLQGLLKPLF KSTSVGPLYS
     GCRLTLLRPE KDGVATRVDA ICTHRPDPKI PGLDRQQLYW ELSQLTHSIT ELGPYTLDRD
     SLYVNGFTQR SSVPTTSTPG TFTVQPETSE TPSSLPGPTA TGPVLLPFTL NFTITNLQYE
     EDMHRPGSRK FNTTERVLQG LLMPLFKNTS VSSLYSGCRL TLLRPEKDGA ATRVDAVCTH
     RPDPKSPGLD RERLYWKLSQ LTHGITELGP YTLDRHSLYV NGFTHQSSMT TTRTPDTSTM
     HLATSRTPAS LSGPTTASPL LVLFTINFTI TNLRYEENMH HPGSRKFNTT ERVLQGLLRP
     VFKNTSVGPL YSGCRLTLLR PKKDGAATKV DAICTYRPDP KSPGLDREQL YWELSQLTHS
     ITELGPYTLD RDSLYVNGFT QRSSVPTTSI PGTPTVDLGT SGTPVSKPGP SAASPLLVLF
     TLNFTITNLR YEENMQHPGS RKFNTTERVL QGLLRSLFKS TSVGPLYSGC RLTLLRPEKD
     GTATGVDAIC THHPDPKSPR LDREQLYWEL SQLTHNITEL GPYALDNDSL FVNGFTHRSS
     VSTTSTASHL LILFTLNFTI TNLRYEENMW PGSRKFNTTE RVLQGLLRPL FKNTSVGPLY
     SGCRLTLLRP EKDGEATGVD AICTHRPDPT GPGLDREQLY LELSQLTHSI TELGPYTLDR
     DSLYVNGFTH RSSVPTTSTG VVSEEPFTLN FTINNLRYMA DMGQPGSLKF NITDNVMKHL
     LSPLFQRSSL GARYTGCRVI ALRSVKNGAE TRVDLLCTYL QPLSGPGLPI KQVFHELSQQ
     THGITRLGPY SLDKDSLYLN GYNEPGPDEP PTTPKPATTF LPPLSEATTA MGYHLKTLTL
     NFTISNLQYS PDMGKGSATF NSTEGVLQHL LRPLFQKSSM GPFYLGCQLI SLRPEKDGAA
     TGVDTTCTYH PDPVGPGLDI QQLYWELSQL THGVTQLGFY VLDRDSLFIN GYAPQNLSIR
     GEYQINFHIV NWNLSNPDPT SSEYITLLRD IQDKVTTLYK GSQLHDTFRF CLVTNLTMDS
     VLVTVKALFS SNLDPSLVEQ VFLDKTLNAS FHWLGSTYQL VDIHVTEMES SVYQPTSSSS
     TQHFYLNFTI TNLPYSQDKA QPGTTNYQRN KRNIEDAVRR GCSTNSSETA ASRVIFLTVK
     FQHSGLSPTG TTPGWTPCVT SRHWLGE
//
ID   MUC16_HUMAN             Reviewed;       14507 AA.
AC   Q8WXI7; B5ME49; Q6ZQW5; Q96RK2;
DT   31-OCT-2006, integrated into UniProtKB/Swiss-Prot.
DT   11-MAY-2016, sequence version 3.
DT   28-MAR-2018, entry version 120.
DE   RecName: Full=Mucin-16 {ECO:0000305};
DE            Short=MUC-16;
DE   AltName: Full=Ovarian cancer-related tumor marker CA125 {ECO:0000303|PubMed:12218296};
DE            Short=CA-125 {ECO:0000303|PubMed:12218296};
DE   AltName: Full=Ovarian carcinoma antigen CA125 {ECO:0000303|PubMed:11369781};
GN   Name=MUC16 {ECO:0000312|HGNC:HGNC:15582};
GN   Synonyms=CA125 {ECO:0000303|PubMed:11786729};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057824; DOI=10.1038/nature02399;
RA   Grimwood J., Gordon L.A., Olsen A.S., Terry A., Schmutz J.,
RA   Lamerdin J.E., Hellsten U., Goodstein D., Couronne O., Tran-Gyamfi M.,
RA   Aerts A., Altherr M., Ashworth L., Bajorek E., Black S., Branscomb E.,
RA   Caenepeel S., Carrano A.V., Caoile C., Chan Y.M., Christensen M.,
RA   Cleland C.A., Copeland A., Dalin E., Dehal P., Denys M., Detter J.C.,
RA   Escobar J., Flowers D., Fotopulos D., Garcia C., Georgescu A.M.,
RA   Glavina T., Gomez M., Gonzales E., Groza M., Hammon N., Hawkins T.,
RA   Haydu L., Ho I., Huang W., Israni S., Jett J., Kadner K., Kimball H.,
RA   Kobayashi A., Larionov V., Leem S.-H., Lopez F., Lou Y., Lowry S.,
RA   Malfatti S., Martinez D., McCready P.M., Medina C., Morgan J.,
RA   Nelson K., Nolan M., Ovcharenko I., Pitluck S., Pollard M.,
RA   Popkie A.P., Predki P., Quan G., Ramirez L., Rash S., Retterer J.,
RA   Rodriguez A., Rogers S., Salamov A., Salazar A., She X., Smith D.,
RA   Slezak T., Solovyev V., Thayer N., Tice H., Tsai M., Ustaszewska A.,
RA   Vo N., Wagner M., Wheeler J., Wu K., Xie G., Yang J., Dubchak I.,
RA   Furey T.S., DeJong P., Dickson M., Gordon D., Eichler E.E.,
RA   Pennacchio L.A., Richardson P., Stubbs L., Rokhsar D.S., Myers R.M.,
RA   Rubin E.M., Lucas S.M.;
RT   "The DNA sequence and biology of human chromosome 19.";
RL   Nature 428:529-535(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-10429, SEQUENCE REVISION TO
RP   N-TERMINUS, TISSUE SPECIFICITY, AND INDUCTION.
RX   PubMed=12218296; DOI=10.1159/000064032;
RA   O'Brien T.J., Beard J.B., Underwood L.J., Shigemasa K.;
RT   "The CA 125 gene: a newly discovered extension of the glycosylated N-
RT   terminal domain doubles the size of this extracellular
RT   superstructure.";
RL   Tumor Biol. 23:154-169(2002).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 10430-14507, REGION, AND POLYMORPHISM.
RX   PubMed=11786729; DOI=10.1159/000050638;
RA   O'Brien T.J., Beard J.B., Underwood L.J., Dennis R.A., Santin A.D.,
RA   York L.;
RT   "The CA 125 gene: an extracellular superstructure dominated by repeat
RT   sequences.";
RL   Tumor Biol. 22:348-366(2001).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 8295-14507, PROTEIN SEQUENCE OF
RP   13715-13720 AND 14338-14350, AND TISSUE SPECIFICITY.
RX   PubMed=11369781; DOI=10.1074/jbc.M103554200;
RA   Yin B.W.T., Lloyd K.O.;
RT   "Molecular cloning of the CA125 ovarian cancer antigen: identification
RT   as a new mucin, MUC16.";
RL   J. Biol. Chem. 276:27371-27375(2001).
RN   [5]
RP   SEQUENCE REVISION.
RA   Lloyd K.O., Yin B.W.T.;
RL   Submitted (SEP-2003) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 12828-14050.
RC   TISSUE=Uterus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [7]
RP   PHOSPHORYLATION.
RX   PubMed=9276028;
RA   Fendrick J.L., Konishi I., Geary S.M., Parmley T.H., Quirk J.G. Jr.,
RA   O'Brien T.J.;
RT   "CA125 phosphorylation is associated with its secretion from the WISH
RT   human amnion cell line.";
RL   Tumor Biol. 18:278-289(1997).
RN   [8]
RP   GLYCOSYLATION.
RX   PubMed=12734200; DOI=10.1074/jbc.M302741200;
RA   Kui Wong N., Easton R.L., Panico M., Sutton-Smith M., Morrison J.C.,
RA   Lattanzio F.A., Morris H.R., Clark G.F., Dell A., Patankar M.S.;
RT   "Characterization of the oligosaccharides associated with the human
RT   ovarian tumor marker CA125.";
RL   J. Biol. Chem. 278:28619-28634(2003).
RN   [9]
RP   INTERACTION WITH MSLN.
RX   PubMed=14676194; DOI=10.1074/jbc.M312372200;
RA   Rump A., Morikawa Y., Tanaka M., Minami S., Umesaki N., Takeuchi M.,
RA   Miyajima A.;
RT   "Binding of ovarian cancer antigen CA125/MUC16 to mesothelin mediates
RT   cell adhesion.";
RL   J. Biol. Chem. 279:9190-9198(2004).
RN   [10]
RP   REVIEW, AND POLYMORPHISM.
RX   PubMed=15788735; DOI=10.1177/1099800404274445;
RA   McLemore M.R., Aouizerat B.;
RT   "Introducing the MUC16 gene: implications for prevention and early
RT   detection in epithelial ovarian cancer.";
RL   Biol. Res. Nurs. 6:262-267(2005).
RN   [11]
RP   TISSUE SPECIFICITY.
RX   PubMed=16384952; DOI=10.1167/iovs.05-0735;
RA   Argueso P., Tisdale A., Spurr-Michaud S., Sumiyoshi M., Gipson I.K.;
RT   "Mucin characteristics of human corneal-limbal epithelial cells that
RT   exclude the rose bengal anionic dye.";
RL   Invest. Ophthalmol. Vis. Sci. 47:113-119(2006).
CC   -!- FUNCTION: Thought to provide a protective, lubricating barrier
CC       against particles and infectious agents at mucosal surfaces.
CC       {ECO:0000250}.
CC   -!- SUBUNIT: Binds to MSLN. Binding to MSLN mediates heterotypic cell
CC       adhesion. This may contribute to the metastasis of ovarian cancer
CC       to the peritoneum by initiating cell attachment to the mesothelial
CC       epithelium via binding to MSLN.
CC   -!- SUBCELLULAR LOCATION: Cell membrane; Single-pass type I membrane
CC       protein. Secreted, extracellular space. Note=May be liberated into
CC       the extracellular space following the phosphorylation of the
CC       intracellular C-terminus which induces the proteolytic cleavage
CC       and liberation of the extracellular domain.
CC   -!- TISSUE SPECIFICITY: Expressed in corneal and conjunctival
CC       epithelia (at protein level). Overexpressed in ovarian carcinomas
CC       and ovarian low malignant potential (LMP) tumors as compared to
CC       the expression in normal ovarian tissue and ovarian adenomas.
CC       {ECO:0000269|PubMed:11369781, ECO:0000269|PubMed:12218296,
CC       ECO:0000269|PubMed:16384952}.
CC   -!- INDUCTION: Up-regulated in ovarian cancer cells.
CC       {ECO:0000269|PubMed:12218296}.
CC   -!- DOMAIN: Composed of three domains, a Ser-, Thr-rich N-terminal
CC       domain, a repeated domain containing between 12 and 60 partially
CC       conserved tandem repeats of 156 amino acids and a C-terminal
CC       transmembrane contain domain with a short cytoplasmic tail.
CC       {ECO:0000269|PubMed:11786729}.
CC   -!- PTM: Heavily O-glycosylated; expresses both type 1 and type 2 core
CC       glycans. {ECO:0000269|PubMed:12734200}.
CC   -!- PTM: Heavily N-glycosylated; expresses primarily high mannose and
CC       complex bisecting type N-linked glycans.
CC       {ECO:0000269|PubMed:12734200}.
CC   -!- PTM: May be phosphorylated. Phosphorylation of the intracellular
CC       C-terminal domain may induce proteolytic cleavage and the
CC       liberation of the extracellular domain into the extracellular
CC       space. {ECO:0000269|PubMed:9276028}.
CC   -!- PTM: May contain numerous disulfide bridges. Association of
CC       several molecules of the secreted form may occur through
CC       interchain disulfide bridges providing an extraordinarily large
CC       gel-like matrix in the extracellular space or in the lumen of
CC       secretory ducts.
CC   -!- POLYMORPHISM: The number of repeats is highly polymorphic and can
CC       be composed between 12 and 60 extracellular mucin repeats.
CC       {ECO:0000305|PubMed:11786729}.
CC   -!- MISCELLANEOUS: Antigen that is the basis for a widely used serum
CC       assay for the monitoring of patients with ovarian epithelial
CC       cancer. Due to lack of sensitivity for stage I disease and lack of
CC       specificity, it is of little value in the detection of early
CC       ovarian cancer. Due to its similarly elevated levels in some
CC       nonmalignant conditions, it is not specific enough to be used for
CC       population screening.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAL65133.2; Type=Frameshift; Positions=3905, 3924, 3940; Evidence={ECO:0000305};
CC       Sequence=BAC87568.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/MUC16ID41455ch19q13.html";
CC   -!- WEB RESOURCE: Name=Mucin database;
CC       URL="http://www.medkem.gu.se/mucinbiology/databases/";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AC008734; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; KF456494; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC016584; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AF414442; AAL65133.2; ALT_FRAME; mRNA.
DR   EMBL; AF361486; AAK74120.3; -; mRNA.
DR   EMBL; AK128681; BAC87568.1; ALT_INIT; mRNA.
DR   CCDS; CCDS54212.1; -.
DR   RefSeq; NP_078966.2; NM_024690.2.
DR   UniGene; Hs.432676; -.
DR   ProteinModelPortal; Q8WXI7; -.
DR   SMR; Q8WXI7; -.
DR   BioGrid; 125094; 10.
DR   IntAct; Q8WXI7; 2.
DR   STRING; 9606.ENSP00000381008; -.
DR   ChEMBL; CHEMBL3580482; -.
DR   DrugBank; DB04964; Oregovomab.
DR   iPTMnet; Q8WXI7; -.
DR   PhosphoSitePlus; Q8WXI7; -.
DR   SwissPalm; Q8WXI7; -.
DR   BioMuta; MUC16; -.
DR   EPD; Q8WXI7; -.
DR   MaxQB; Q8WXI7; -.
DR   PaxDb; Q8WXI7; -.
DR   PeptideAtlas; Q8WXI7; -.
DR   PRIDE; Q8WXI7; -.
DR   Ensembl; ENST00000397910; ENSP00000381008; ENSG00000181143.
DR   GeneID; 94025; -.
DR   KEGG; hsa:94025; -.
DR   UCSC; uc002mkp.3; human.
DR   CTD; 94025; -.
DR   DisGeNET; 94025; -.
DR   EuPathDB; HostDB:ENSG00000181143.15; -.
DR   GeneCards; MUC16; -.
DR   H-InvDB; HIX0021715; -.
DR   HGNC; HGNC:15582; MUC16.
DR   MIM; 606154; gene.
DR   neXtProt; NX_Q8WXI7; -.
DR   OpenTargets; ENSG00000181143; -.
DR   PharmGKB; PA31314; -.
DR   eggNOG; ENOG410IEHG; Eukaryota.
DR   eggNOG; ENOG4111B0P; LUCA.
DR   GeneTree; ENSGT00440000039287; -.
DR   KO; K16145; -.
DR   OrthoDB; EOG091G00SO; -.
DR   PhylomeDB; Q8WXI7; -.
DR   TreeFam; TF335600; -.
DR   Reactome; R-HSA-5083625; Defective GALNT3 causes familial hyperphosphatemic tumoral calcinosis (HFTC).
DR   Reactome; R-HSA-5083632; Defective C1GALT1C1 causes Tn polyagglutination syndrome (TNPS).
DR   Reactome; R-HSA-5083636; Defective GALNT12 causes colorectal cancer 1 (CRCS1).
DR   Reactome; R-HSA-5621480; Dectin-2 family.
DR   Reactome; R-HSA-913709; O-linked glycosylation of mucins.
DR   Reactome; R-HSA-977068; Termination of O-glycan biosynthesis.
DR   ChiTaRS; MUC16; human.
DR   GeneWiki; CA-125; -.
DR   GenomeRNAi; 94025; -.
DR   PRO; PR:Q8WXI7; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   Bgee; ENSG00000181143; -.
DR   CleanEx; HS_MUC16; -.
DR   ExpressionAtlas; Q8WXI7; baseline and differential.
DR   Genevisible; B5ME49; HS.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0019898; C:extrinsic component of membrane; IDA:UniProtKB.
DR   GO; GO:0005796; C:Golgi lumen; TAS:Reactome.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0031982; C:vesicle; HDA:UniProtKB.
DR   GO; GO:0007155; P:cell adhesion; NAS:UniProtKB.
DR   GO; GO:0016266; P:O-glycan processing; TAS:Reactome.
DR   GO; GO:0002223; P:stimulatory C-type lectin receptor signaling pathway; TAS:Reactome.
DR   Gene3D; 3.30.70.960; -; 16.
DR   InterPro; IPR028850; MUC16.
DR   InterPro; IPR000082; SEA_dom.
DR   InterPro; IPR036364; SEA_dom_sf.
DR   PANTHER; PTHR14672; PTHR14672; 25.
DR   Pfam; PF01390; SEA; 16.
DR   SMART; SM00200; SEA; 7.
DR   SUPFAM; SSF82671; SSF82671; 16.
DR   PROSITE; PS50024; SEA; 65.
PE   1: Evidence at protein level;
KW   Cell membrane; Complete proteome; Direct protein sequencing;
KW   Disulfide bond; Glycoprotein; Membrane; Phosphoprotein; Polymorphism;
KW   Reference proteome; Repeat; Secreted; Transmembrane;
KW   Transmembrane helix.
FT   CHAIN         1  14507       Mucin-16.
FT                                /FTId=PRO_0000436078.
FT   TOPO_DOM      1  14451       Extracellular. {ECO:0000305}.
FT   TRANSMEM  14452  14472       Helical. {ECO:0000255}.
FT   TOPO_DOM  14473  14507       Cytoplasmic. {ECO:0000305}.
FT   REPEAT    12067  12223       1. {ECO:0000269|PubMed:11786729}.
FT   DOMAIN    12072  12193       SEA 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00188}.
FT   REPEAT    12224  12381       2. {ECO:0000269|PubMed:11786729}.
FT   DOMAIN    12228  12349       SEA 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00188}.
FT   REPEAT    12382  12537       3. {ECO:0000269|PubMed:11786729}.
FT   DOMAIN    12386  12507       SEA 3. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00188}.
FT   REPEAT    12538  12692       4. {ECO:0000269|PubMed:11786729}.
FT   DOMAIN    12542  12663       SEA 4. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00188}.
FT   REPEAT    12693  12848       5. {ECO:0000269|PubMed:11786729}.
FT   DOMAIN    12697  12818       SEA 5. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00188}.
FT   REPEAT    12849  13004       6. {ECO:0000269|PubMed:11786729}.
FT   DOMAIN    12853  12974       SEA 6. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00188}.
FT   REPEAT    13005  13160       7. {ECO:0000269|PubMed:11786729}.
FT   DOMAIN    13009  13130       SEA 7. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00188}.
FT   REPEAT    13161  13316       8. {ECO:0000269|PubMed:11786729}.
FT   DOMAIN    13165  13286       SEA 8. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00188}.
FT   REPEAT    13317  13472       9. {ECO:0000269|PubMed:11786729}.
FT   DOMAIN    13321  13442       SEA 9. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00188}.
FT   REPEAT    13473  13628       10. {ECO:0000269|PubMed:11786729}.
FT   DOMAIN    13477  13598       SEA 10. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00188}.
FT   REPEAT    13629  13784       11. {ECO:0000269|PubMed:11786729}.
FT   DOMAIN    13633  13754       SEA 11. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00188}.
FT   REPEAT    13785  13939       12. {ECO:0000269|PubMed:11786729}.
FT   DOMAIN    13789  13909       SEA 12. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00188}.
FT   DOMAIN    13922  14043       SEA 13. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00188}.
FT   DOMAIN    14073  14193       SEA 14. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00188}.
FT   DOMAIN    14198  14309       SEA 15. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00188}.
FT   DOMAIN    14319  14438       SEA 16. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00188}.
FT   REGION    12067  13939       12 X approximate tandem repeats.
FT                                {ECO:0000269|PubMed:11786729}.
FT   COMPBIAS     14  12083       Thr-rich. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00017}.
FT   COMPBIAS   1638   3054       Ser-rich. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00016}.
FT   COMPBIAS   2365   2371       Poly-Ser. {ECO:0000255}.
FT   COMPBIAS   3899   4383       Ser-rich. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00016}.
FT   COMPBIAS   4743   4953       Ser-rich. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00016}.
FT   COMPBIAS   7083  10394       Ser-rich. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00016}.
FT   CARBOHYD    139    139       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    434    434       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    787    787       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    930    930       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    957    957       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1375   1375       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1633   1633       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1840   1840       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1877   1877       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1890   1890       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   2345   2345       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   2375   2375       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   2737   2737       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   3085   3085       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   3178   3178       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   3501   3501       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   4220   4220       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   4498   4498       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   4606   4606       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   4613   4613       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   4624   4624       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   4861   4861       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   5096   5096       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   5131   5131       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   5228   5228       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   5320   5320       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   5394   5394       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   5470   5470       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   5689   5689       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   5863   5863       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   6088   6088       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   6732   6732       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   6859   6859       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   6961   6961       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   8029   8029       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   8055   8055       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   8324   8324       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   8618   8618       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   8684   8684       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   8913   8913       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   9202   9202       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   9493   9493       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   9785   9785       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD  10075  10075       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD  10173  10173       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD  10510  10510       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD  10700  10700       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD  10749  10749       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD  11053  11053       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD  11224  11224       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD  11263  11263       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD  11367  11367       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD  11594  11594       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD  12079  12079       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD  12100  12100       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD  12116  12116       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD  12168  12168       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD  12235  12235       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD  12272  12272       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD  12393  12393       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD  12414  12414       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD  12430  12430       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD  12549  12549       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD  12570  12570       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD  12586  12586       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD  12704  12704       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD  12725  12725       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD  12741  12741       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD  12824  12824       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD  12860  12860       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD  12881  12881       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD  12897  12897       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD  13016  13016       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD  13037  13037       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD  13053  13053       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD  13172  13172       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD  13193  13193       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD  13328  13328       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD  13349  13349       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD  13365  13365       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD  13484  13484       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD  13505  13505       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD  13521  13521       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD  13640  13640       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD  13661  13661       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD  13733  13733       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD  13744  13744       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD  13796  13796       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD  13816  13816       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD  13832  13832       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD  13929  13929       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD  13950  13950       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD  14080  14080       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD  14100  14100       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD  14195  14195       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD  14212  14212       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD  14254  14254       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD  14287  14287       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD  14326  14326       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD  14363  14363       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD  14417  14417       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD  14423  14423       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID  12126  12146       {ECO:0000255}.
FT   DISULFID  12282  12302       {ECO:0000255}.
FT   DISULFID  12440  12460       {ECO:0000255}.
FT   DISULFID  12596  12616       {ECO:0000255}.
FT   DISULFID  12751  12771       {ECO:0000255}.
FT   DISULFID  12907  12927       {ECO:0000255}.
FT   DISULFID  13063  13083       {ECO:0000255}.
FT   DISULFID  13219  13239       {ECO:0000255}.
FT   DISULFID  13375  13395       {ECO:0000255}.
FT   DISULFID  13531  13551       {ECO:0000255}.
FT   DISULFID  13687  13707       {ECO:0000255}.
FT   DISULFID  13976  13996       {ECO:0000255}.
FT   DISULFID  14126  14146       {ECO:0000255}.
FT   DISULFID  14373  14393       {ECO:0000255}.
FT   VARIANT     545    545       T -> A (in dbSNP:rs17000957).
FT                                /FTId=VAR_056592.
FT   VARIANT    1015   1015       R -> G (in dbSNP:rs17000950).
FT                                /FTId=VAR_056593.
FT   VARIANT    1032   1032       S -> T (in dbSNP:rs10411228).
FT                                /FTId=VAR_056594.
FT   VARIANT    1041   1041       P -> S (in dbSNP:rs10406202).
FT                                /FTId=VAR_056595.
FT   VARIANT    1162   1162       T -> I (in dbSNP:rs17000947).
FT                                /FTId=VAR_056596.
FT   VARIANT    1266   1266       K -> N (in dbSNP:rs1596797).
FT                                /FTId=VAR_056597.
FT   VARIANT    1353   1353       H -> Y (in dbSNP:rs12611293).
FT                                /FTId=VAR_056598.
FT   VARIANT    1400   1400       K -> N (in dbSNP:rs1596798).
FT                                /FTId=VAR_056599.
FT   VARIANT    1833   1833       L -> F (in dbSNP:rs4520945).
FT                                /FTId=VAR_056600.
FT   VARIANT    1953   1953       S -> P (in dbSNP:rs1108380).
FT                                /FTId=VAR_056601.
FT   VARIANT    2058   2058       S -> P (in dbSNP:rs1574479).
FT                                /FTId=VAR_056602.
FT   VARIANT    2150   2150       I -> V (in dbSNP:rs10407633).
FT                                /FTId=VAR_056603.
FT   VARIANT    2271   2271       T -> A (in dbSNP:rs11085805).
FT                                /FTId=VAR_056604.
FT   VARIANT    2288   2288       V -> L (in dbSNP:rs10410933).
FT                                /FTId=VAR_056605.
FT   VARIANT    2356   2356       D -> E (in dbSNP:rs10416013).
FT                                /FTId=VAR_056606.
FT   VARIANT    2747   2747       A -> T (in dbSNP:rs10402538).
FT                                /FTId=VAR_056607.
FT   VARIANT    2786   2786       M -> I (in dbSNP:rs17000886).
FT                                /FTId=VAR_056608.
FT   VARIANT    2834   2834       T -> M (in dbSNP:rs10407623).
FT                                /FTId=VAR_056609.
FT   VARIANT    3573   3573       R -> H (in dbSNP:rs2591594).
FT                                /FTId=VAR_056610.
FT   VARIANT    5741   5741       H -> D (in dbSNP:rs1559172).
FT                                /FTId=VAR_056611.
FT   VARIANT    5754   5754       A -> T (in dbSNP:rs1559171).
FT                                /FTId=VAR_056612.
FT   VARIANT    5852   5852       F -> V (in dbSNP:rs1862460).
FT                                /FTId=VAR_056613.
FT   VARIANT    7063   7063       T -> A (in dbSNP:rs17000770).
FT                                /FTId=VAR_056614.
FT   VARIANT    7272   7272       I -> V (in dbSNP:rs1867691).
FT                                /FTId=VAR_056615.
FT   VARIANT   10507  10507       T -> N (in dbSNP:rs11670461).
FT                                /FTId=VAR_056616.
FT   CONFLICT   1898   1898       Y -> D (in Ref. 2; AAL65133).
FT                                {ECO:0000305}.
FT   CONFLICT   2506   2506       T -> A (in Ref. 2; AAL65133).
FT                                {ECO:0000305}.
FT   CONFLICT   3190   3190       S -> T (in Ref. 2; AAL65133).
FT                                {ECO:0000305}.
FT   CONFLICT   3202   3202       M -> V (in Ref. 2; AAL65133).
FT                                {ECO:0000305}.
FT   CONFLICT   3932   3932       I -> V (in Ref. 2; AAL65133).
FT                                {ECO:0000305}.
FT   CONFLICT   4440   4440       S -> T (in Ref. 2; AAL65133).
FT                                {ECO:0000305}.
FT   CONFLICT   5682   5682       P -> T (in Ref. 2; AAL65133).
FT                                {ECO:0000305}.
FT   CONFLICT   6303   6303       V -> M (in Ref. 2; AAL65133).
FT                                {ECO:0000305}.
FT   CONFLICT   6655   6655       L -> V (in Ref. 2; AAL65133).
FT                                {ECO:0000305}.
FT   CONFLICT   6866   6866       E -> V (in Ref. 2; AAL65133).
FT                                {ECO:0000305}.
FT   CONFLICT   6895   6895       S -> C (in Ref. 2; AAL65133).
FT                                {ECO:0000305}.
FT   CONFLICT   6906   6906       A -> T (in Ref. 2; AAL65133).
FT                                {ECO:0000305}.
FT   CONFLICT   7191   7191       S -> F (in Ref. 2; AAL65133).
FT                                {ECO:0000305}.
FT   CONFLICT   7425   7425       L -> P (in Ref. 2; AAL65133).
FT                                {ECO:0000305}.
FT   CONFLICT   7475   7475       S -> P (in Ref. 2; AAL65133).
FT                                {ECO:0000305}.
FT   CONFLICT   7923   7923       D -> A (in Ref. 2; AAL65133).
FT                                {ECO:0000305}.
FT   CONFLICT   8301   8301       N -> T (in Ref. 2; AAL65133 and 4;
FT                                AAK74120). {ECO:0000305}.
FT   CONFLICT   8344   8344       D -> A (in Ref. 4; AAK74120).
FT                                {ECO:0000305}.
FT   CONFLICT   8578   8578       T -> A (in Ref. 2; AAL65133).
FT                                {ECO:0000305}.
FT   CONFLICT   9059   9059       T -> S (in Ref. 2; AAL65133).
FT                                {ECO:0000305}.
FT   CONFLICT   9072   9072       T -> A (in Ref. 2; AAL65133).
FT                                {ECO:0000305}.
FT   CONFLICT   9129   9129       D -> E (in Ref. 4; AAK74120).
FT                                {ECO:0000305}.
FT   CONFLICT   9213   9213       I -> T (in Ref. 2; AAL65133 and 4;
FT                                AAK74120). {ECO:0000305}.
FT   CONFLICT   9405   9405       Q -> R (in Ref. 4; AAK74120).
FT                                {ECO:0000305}.
FT   CONFLICT   9502   9502       A -> T (in Ref. 2; AAL65133).
FT                                {ECO:0000305}.
FT   CONFLICT   9608   9608       P -> S (in Ref. 2; AAL65133).
FT                                {ECO:0000305}.
FT   CONFLICT   9850   9850       D -> E (in Ref. 4; AAK74120).
FT                                {ECO:0000305}.
FT   CONFLICT   9899   9899       Y -> F (in Ref. 4; AAK74120).
FT                                {ECO:0000305}.
FT   CONFLICT   9920   9920       I -> T (in Ref. 2; AAL65133 and 4;
FT                                AAK74120). {ECO:0000305}.
FT   CONFLICT  10013  10013       L -> P (in Ref. 2; AAL65133 and 4;
FT                                AAK74120). {ECO:0000305}.
FT   CONFLICT  10169  10169       F -> L (in Ref. 4; AAK74120).
FT                                {ECO:0000305}.
FT   CONFLICT  10394  10394       S -> T (in Ref. 2; AAL65133).
FT                                {ECO:0000305}.
FT   CONFLICT  10828  10828       P -> S (in Ref. 4; AAK74120).
FT                                {ECO:0000305}.
FT   CONFLICT  11154  11154       S -> F (in Ref. 4; AAK74120).
FT                                {ECO:0000305}.
FT   CONFLICT  11199  11199       A -> G (in Ref. 4; AAK74120).
FT                                {ECO:0000305}.
FT   CONFLICT  11455  11455       G -> D (in Ref. 4; AAK74120).
FT                                {ECO:0000305}.
FT   CONFLICT  12514  12514       S -> T (in Ref. 4; AAK74120).
FT                                {ECO:0000305}.
FT   CONFLICT  12580  12580       L -> V (in Ref. 4; AAK74120).
FT                                {ECO:0000305}.
FT   CONFLICT  12692  12692       T -> TSA (in Ref. 4; AAK74120).
FT                                {ECO:0000305}.
FT   CONFLICT  12832  12832       T -> A (in Ref. 6; BAC87568).
FT                                {ECO:0000305}.
FT   CONFLICT  12834  12834       D -> H (in Ref. 6; BAC87568).
FT                                {ECO:0000305}.
FT   CONFLICT  12836  12836       G -> E (in Ref. 6; BAC87568).
FT                                {ECO:0000305}.
FT   CONFLICT  12842  12842       S -> A (in Ref. 6; BAC87568).
FT                                {ECO:0000305}.
FT   CONFLICT  12846  12847       SP -> GH (in Ref. 6; BAC87568).
FT                                {ECO:0000305}.
FT   CONFLICT  12849  12850       SA -> AP (in Ref. 6; BAC87568).
FT                                {ECO:0000305}.
FT   CONFLICT  12873  12873       H -> R (in Ref. 6; BAC87568).
FT                                {ECO:0000305}.
FT   CONFLICT  12892  12894       GPM -> KPL (in Ref. 6; BAC87568).
FT                                {ECO:0000305}.
FT   CONFLICT  12897  12897       N -> S (in Ref. 6; BAC87568).
FT                                {ECO:0000305}.
FT   CONFLICT  12902  12902       L -> P (in Ref. 6; BAC87568).
FT                                {ECO:0000305}.
FT   CONFLICT  12917  12917       N -> R (in Ref. 6; BAC87568).
FT                                {ECO:0000305}.
FT   CONFLICT  12923  12925       MDA -> VDT (in Ref. 6; BAC87568).
FT                                {ECO:0000305}.
FT   CONFLICT  12928  12928       S -> T (in Ref. 6; BAC87568).
FT                                {ECO:0000305}.
FT   CONFLICT  12934  12935       KS -> LN (in Ref. 6; BAC87568).
FT                                {ECO:0000305}.
FT   CONFLICT  12939  12939       N -> D (in Ref. 6; BAC87568).
FT                                {ECO:0000305}.
FT   CONFLICT  12949  12949       Q -> K (in Ref. 6; BAC87568).
FT                                {ECO:0000305}.
FT   CONFLICT  12952  12952       H -> R (in Ref. 6; BAC87568).
FT                                {ECO:0000305}.
FT   CONFLICT  12955  12955       K -> I (in Ref. 6; BAC87568).
FT                                {ECO:0000305}.
FT   CONFLICT  12961  12961       T -> L (in Ref. 6; BAC87568).
FT                                {ECO:0000305}.
FT   CONFLICT  12965  12965       N -> G (in Ref. 6; BAC87568).
FT                                {ECO:0000305}.
FT   CONFLICT  12976  12977       SS -> NF (in Ref. 6; BAC87568).
FT                                {ECO:0000305}.
FT   CONFLICT  12979  12980       AP -> PI (in Ref. 6; BAC87568).
FT                                {ECO:0000305}.
FT   CONFLICT  12990  12990       D -> H (in Ref. 6; BAC87568).
FT                                {ECO:0000305}.
FT   CONFLICT  12995  12995       G -> E (in Ref. 6; BAC87568).
FT                                {ECO:0000305}.
FT   CONFLICT  13002  13007       SPTTAV -> RPIVPG (in Ref. 6; BAC87568).
FT                                {ECO:0000305}.
FT   CONFLICT  13025  13027       GED -> EEA (in Ref. 6; BAC87568).
FT                                {ECO:0000305}.
FT   CONFLICT  13048  13048       G -> R (in Ref. 6; BAC87568).
FT                                {ECO:0000305}.
FT   CONFLICT  13054  13056       SSV -> TSI (in Ref. 6; BAC87568).
FT                                {ECO:0000305}.
FT   CONFLICT  13062  13062       G -> S (in Ref. 6; BAC87568).
FT                                {ECO:0000305}.
FT   CONFLICT  13332  13332       T -> I (in Ref. 4; AAK74120).
FT                                {ECO:0000305}.
FT   CONFLICT  13341  13341       R -> H (in Ref. 4; AAK74120).
FT                                {ECO:0000305}.
FT   CONFLICT  13386  13386       G -> K (in Ref. 6; BAC87568).
FT                                {ECO:0000305}.
FT   CONFLICT  13394  13394       V -> I (in Ref. 6; BAC87568).
FT                                {ECO:0000305}.
FT   CONFLICT  13398  13398       R -> H (in Ref. 6; BAC87568).
FT                                {ECO:0000305}.
FT   CONFLICT  13402  13402       K -> Q (in Ref. 6; BAC87568).
FT                                {ECO:0000305}.
FT   CONFLICT  13407  13407       D -> N (in Ref. 6; BAC87568).
FT                                {ECO:0000305}.
FT   CONFLICT  13410  13410       R -> Q (in Ref. 6; BAC87568).
FT                                {ECO:0000305}.
FT   CONFLICT  13414  13414       K -> E (in Ref. 6; BAC87568).
FT                                {ECO:0000305}.
FT   CONFLICT  13472  13472       M -> T (in Ref. 6; BAC87568 and 4;
FT                                AAK74120). {ECO:0000305}.
FT   CONFLICT  14041  14050       YNEPGPDEPP -> HHTLQRQSTT (in Ref. 6;
FT                                BAC87568). {ECO:0000305}.
FT   CONFLICT  14466  14466       V -> L (in Ref. 4; AAK74120).
FT                                {ECO:0000305}.
SQ   SEQUENCE   14507 AA;  1519175 MW;  7D5E9A14F70EB90A CRC64;
     MLKPSGLPGS SSPTRSLMTG SRSTKATPEM DSGLTGATLS PKTSTGAIVV TEHTLPFTSP
     DKTLASPTSS VVGRTTQSLG VMSSALPEST SRGMTHSEQR TSPSLSPQVN GTPSRNYPAT
     SMVSGLSSPR TRTSSTEGNF TKEASTYTLT VETTSGPVTE KYTVPTETST TEGDSTETPW
     DTRYIPVKIT SPMKTFADST ASKENAPVSM TPAETTVTDS HTPGRTNPSF GTLYSSFLDL
     SPKGTPNSRG ETSLELILST TGYPFSSPEP GSAGHSRIST SAPLSSSASV LDNKISETSI
     FSGQSLTSPL SPGVPEARAS TMPNSAIPFS MTLSNAETSA ERVRSTISSL GTPSISTKQT
     AETILTFHAF AETMDIPSTH IAKTLASEWL GSPGTLGGTS TSALTTTSPS TTLVSEETNT
     HHSTSGKETE GTLNTSMTPL ETSAPGEESE MTATLVPTLG FTTLDSKIRS PSQVSSSHPT
     RELRTTGSTS GRQSSSTAAH GSSDILRATT SSTSKASSWT SESTAQQFSE PQHTQWVETS
     PSMKTERPPA STSVAAPITT SVPSVVSGFT TLKTSSTKGI WLEETSADTL IGESTAGPTT
     HQFAVPTGIS MTGGSSTRGS QGTTHLLTRA TASSETSADL TLATNGVPVS VSPAVSKTAA
     GSSPPGGTKP SYTMVSSVIP ETSSLQSSAF REGTSLGLTP LNTRHPFSSP EPDSAGHTKI
     STSIPLLSSA SVLEDKVSAT STFSHHKATS SITTGTPEIS TKTKPSSAVL SSMTLSNAAT
     SPERVRNATS PLTHPSPSGE ETAGSVLTLS TSAETTDSPN IHPTGTLTSE SSESPSTLSL
     PSVSGVKTTF SSSTPSTHLF TSGEETEETS NPSVSQPETS VSRVRTTLAS TSVPTPVFPT
     MDTWPTRSAQ FSSSHLVSEL RATSSTSVTN STGSALPKIS HLTGTATMSQ TNRDTFNDSA
     APQSTTWPET SPRFKTGLPS ATTTVSTSAT SLSATVMVSK FTSPATSSME ATSIREPSTT
     ILTTETTNGP GSMAVASTNI PIGKGYITEG RLDTSHLPIG TTASSETSMD FTMAKESVSM
     SVSPSQSMDA AGSSTPGRTS QFVDTFSDDV YHLTSREITI PRDGTSSALT PQMTATHPPS
     PDPGSARSTW LGILSSSPSS PTPKVTMSST FSTQRVTTSM IMDTVETSRW NMPNLPSTTS
     LTPSNIPTSG AIGKSTLVPL DTPSPATSLE ASEGGLPTLS TYPESTNTPS IHLGAHASSE
     SPSTIKLTMA SVVKPGSYTP LTFPSIETHI HVSTARMAYS SGSSPEMTAP GETNTGSTWD
     PTTYITTTDP KDTSSAQVST PHSVRTLRTT ENHPKTESAT PAAYSGSPKI SSSPNLTSPA
     TKAWTITDTT EHSTQLHYTK LAEKSSGFET QSAPGPVSVV IPTSPTIGSS TLELTSDVPG
     EPLVLAPSEQ TTITLPMATW LSTSLTEEMA STDLDISSPS SPMSTFAIFP PMSTPSHELS
     KSEADTSAIR NTDSTTLDQH LGIRSLGRTG DLTTVPITPL TTTWTSVIEH STQAQDTLSA
     TMSPTHVTQS LKDQTSIPAS ASPSHLTEVY PELGTQGRSS SEATTFWKPS TDTLSREIET
     GPTNIQSTPP MDNTTTGSSS SGVTLGIAHL PIGTSSPAET STNMALERRS STATVSMAGT
     MGLLVTSAPG RSISQSLGRV SSVLSESTTE GVTDSSKGSS PRLNTQGNTA LSSSLEPSYA
     EGSQMSTSIP LTSSPTTPDV EFIGGSTFWT KEVTTVMTSD ISKSSARTES SSATLMSTAL
     GSTENTGKEK LRTASMDLPS PTPSMEVTPW ISLTLSNAPN TTDSLDLSHG VHTSSAGTLA
     TDRSLNTGVT RASRLENGSD TSSKSLSMGN STHTSMTYTE KSEVSSSIHP RPETSAPGAE
     TTLTSTPGNR AISLTLPFSS IPVEEVISTG ITSGPDINSA PMTHSPITPP TIVWTSTGTI
     EQSTQPLHAV SSEKVSVQTQ STPYVNSVAV SASPTHENSV SSGSSTSSPY SSASLESLDS
     TISRRNAITS WLWDLTTSLP TTTWPSTSLS EALSSGHSGV SNPSSTTTEF PLFSAASTSA
     AKQRNPETET HGPQNTAAST LNTDASSVTG LSETPVGASI SSEVPLPMAI TSRSDVSGLT
     SESTANPSLG TASSAGTKLT RTISLPTSES LVSFRMNKDP WTVSIPLGSH PTTNTETSIP
     VNSAGPPGLS TVASDVIDTP SDGAESIPTV SFSPSPDTEV TTISHFPEKT THSFRTISSL
     THELTSRVTP IPGDWMSSAM STKPTGASPS ITLGERRTIT SAAPTTSPIV LTASFTETST
     VSLDNETTVK TSDILDARKT NELPSDSSSS SDLINTSIAS STMDVTKTAS ISPTSISGMT
     ASSSPSLFSS DRPQVPTSTT ETNTATSPSV SSNTYSLDGG SNVGGTPSTL PPFTITHPVE
     TSSALLAWSR PVRTFSTMVS TDTASGENPT SSNSVVTSVP APGTWTSVGS TTDLPAMGFL
     KTSPAGEAHS LLASTIEPAT AFTPHLSAAV VTGSSATSEA SLLTTSESKA IHSSPQTPTT
     PTSGANWETS ATPESLLVVT ETSDTTLTSK ILVTDTILFS TVSTPPSKFP STGTLSGASF
     PTLLPDTPAI PLTATEPTSS LATSFDSTPL VTIASDSLGT VPETTLTMSE TSNGDALVLK
     TVSNPDRSIP GITIQGVTES PLHPSSTSPS KIVAPRNTTY EGSITVALST LPAGTTGSLV
     FSQSSENSET TALVDSSAGL ERASVMPLTT GSQGMASSGG IRSGSTHSTG TKTFSSLPLT
     MNPGEVTAMS EITTNRLTAT QSTAPKGIPV KPTSAESGLL TPVSASSSPS KAFASLTTAP
     PTWGIPQSTL TFEFSEVPSL DTKSASLPTP GQSLNTIPDS DASTASSSLS KSPEKNPRAR
     MMTSTKAISA SSFQSTGFTE TPEGSASPSM AGHEPRVPTS GTGDPRYASE SMSYPDPSKA
     SSAMTSTSLA SKLTTLFSTG QAARSGSSSS PISLSTEKET SFLSPTASTS RKTSLFLGPS
     MARQPNILVH LQTSALTLSP TSTLNMSQEE PPELTSSQTI AEEEGTTAET QTLTFTPSET
     PTSLLPVSSP TEPTARRKSS PETWASSISV PAKTSLVETT DGTLVTTIKM SSQAAQGNST
     WPAPAEETGS SPAGTSPGSP EMSTTLKIMS SKEPSISPEI RSTVRNSPWK TPETTVPMET
     TVEPVTLQST ALGSGSTSIS HLPTGTTSPT KSPTENMLAT ERVSLSPSPP EAWTNLYSGT
     PGGTRQSLAT MSSVSLESPT ARSITGTGQQ SSPELVSKTT GMEFSMWHGS TGGTTGDTHV
     SLSTSSNILE DPVTSPNSVS SLTDKSKHKT ETWVSTTAIP STVLNNKIMA AEQQTSRSVD
     EAYSSTSSWS DQTSGSDITL GASPDVTNTL YITSTAQTTS LVSLPSGDQG ITSLTNPSGG
     KTSSASSVTS PSIGLETLRA NVSAVKSDIA PTAGHLSQTS SPAEVSILDV TTAPTPGIST
     TITTMGTNSI STTTPNPEVG MSTMDSTPAT ERRTTSTEHP STWSSTAASD SWTVTDMTSN
     LKVARSPGTI STMHTTSFLA SSTELDSMST PHGRITVIGT SLVTPSSDAS AVKTETSTSE
     RTLSPSDTTA STPISTFSRV QRMSISVPDI LSTSWTPSST EAEDVPVSMV STDHASTKTD
     PNTPLSTFLF DSLSTLDWDT GRSLSSATAT TSAPQGATTP QELTLETMIS PATSQLPFSI
     GHITSAVTPA AMARSSGVTF SRPDPTSKKA EQTSTQLPTT TSAHPGQVPR SAATTLDVIP
     HTAKTPDATF QRQGQTALTT EARATSDSWN EKEKSTPSAP WITEMMNSVS EDTIKEVTSS
     SSVLRTLNTL DINLESGTTS SPSWKSSPYE RIAPSESTTD KEAIHPSTNT VETTGWVTSS
     EHASHSTIPA HSASSKLTSP VVTTSTREQA IVSMSTTTWP ESTRARTEPN SFLTIELRDV
     SPYMDTSSTT QTSIISSPGS TAITKGPRTE ITSSKRISSS FLAQSMRSSD SPSEAITRLS
     NFPAMTESGG MILAMQTSPP GATSLSAPTL DTSATASWTG TPLATTQRFT YSEKTTLFSK
     GPEDTSQPSP PSVEETSSSS SLVPIHATTS PSNILLTSQG HSPSSTPPVT SVFLSETSGL
     GKTTDMSRIS LEPGTSLPPN LSSTAGEALS TYEASRDTKA IHHSADTAVT NMEATSSEYS
     PIPGHTKPSK ATSPLVTSHI MGDITSSTSV FGSSETTEIE TVSSVNQGLQ ERSTSQVASS
     ATETSTVITH VSSGDATTHV TKTQATFSSG TSISSPHQFI TSTNTFTDVS TNPSTSLIMT
     ESSGVTITTQ TGPTGAATQG PYLLDTSTMP YLTETPLAVT PDFMQSEKTT LISKGPKDVS
     WTSPPSVAET SYPSSLTPFL VTTIPPATST LQGQHTSSPV SATSVLTSGL VKTTDMLNTS
     MEPVTNSPQN LNNPSNEILA TLAATTDIET IHPSINKAVT NMGTASSAHV LHSTLPVSSE
     PSTATSPMVP ASSMGDALAS ISIPGSETTD IEGEPTSSLT AGRKENSTLQ EMNSTTESNI
     ILSNVSVGAI TEATKMEVPS FDATFIPTPA QSTKFPDIFS VASSRLSNSP PMTISTHMTT
     TQTGSSGATS KIPLALDTST LETSAGTPSV VTEGFAHSKI TTAMNNDVKD VSQTNPPFQD
     EASSPSSQAP VLVTTLPSSV AFTPQWHSTS SPVSMSSVLT SSLVKTAGKV DTSLETVTSS
     PQSMSNTLDD ISVTSAATTD IETTHPSINT VVTNVGTTGS AFESHSTVSA YPEPSKVTSP
     NVTTSTMEDT TISRSIPKSS KTTRTETETT SSLTPKLRET SISQEITSST ETSTVPYKEL
     TGATTEVSRT DVTSSSSTSF PGPDQSTVSL DISTETNTRL STSPIMTESA EITITTQTGP
     HGATSQDTFT MDPSNTTPQA GIHSAMTHGF SQLDVTTLMS RIPQDVSWTS PPSVDKTSSP
     SSFLSSPAMT TPSLISSTLP EDKLSSPMTS LLTSGLVKIT DILRTRLEPV TSSLPNFSST
     SDKILATSKD SKDTKEIFPS INTEETNVKA NNSGHESHSP ALADSETPKA TTQMVITTTV
     GDPAPSTSMP VHGSSETTNI KREPTYFLTP RLRETSTSQE SSFPTDTSFL LSKVPTGTIT
     EVSSTGVNSS SKISTPDHDK STVPPDTFTG EIPRVFTSSI KTKSAEMTIT TQASPPESAS
     HSTLPLDTST TLSQGGTHST VTQGFPYSEV TTLMGMGPGN VSWMTTPPVE ETSSVSSLMS
     SPAMTSPSPV SSTSPQSIPS SPLPVTALPT SVLVTTTDVL GTTSPESVTS SPPNLSSITH
     ERPATYKDTA HTEAAMHHST NTAVTNVGTS GSGHKSQSSV LADSETSKAT PLMSTTSTLG
     DTSVSTSTPN ISQTNQIQTE PTASLSPRLR ESSTSEKTSS TTETNTAFSY VPTGAITQAS
     RTEISSSRTS ISDLDRPTIA PDISTGMITR LFTSPIMTKS AEMTVTTQTT TPGATSQGIL
     PWDTSTTLFQ GGTHSTVSQG FPHSEITTLR SRTPGDVSWM TTPPVEETSS GFSLMSPSMT
     SPSPVSSTSP ESIPSSPLPV TALLTSVLVT TTNVLGTTSP EPVTSSPPNL SSPTQERLTT
     YKDTAHTEAM HASMHTNTAV ANVGTSISGH ESQSSVPADS HTSKATSPMG ITFAMGDTSV
     STSTPAFFET RIQTESTSSL IPGLRDTRTS EEINTVTETS TVLSEVPTTT TTEVSRTEVI
     TSSRTTISGP DHSKMSPYIS TETITRLSTF PFVTGSTEMA ITNQTGPIGT ISQATLTLDT
     SSTASWEGTH SPVTQRFPHS EETTTMSRST KGVSWQSPPS VEETSSPSSP VPLPAITSHS
     SLYSAVSGSS PTSALPVTSL LTSGRRKTID MLDTHSELVT SSLPSASSFS GEILTSEAST
     NTETIHFSEN TAETNMGTTN SMHKLHSSVS IHSQPSGHTP PKVTGSMMED AIVSTSTPGS
     PETKNVDRDS TSPLTPELKE DSTALVMNST TESNTVFSSV SLDAATEVSR AEVTYYDPTF
     MPASAQSTKS PDISPEASSS HSNSPPLTIS THKTIATQTG PSGVTSLGQL TLDTSTIATS
     AGTPSARTQD FVDSETTSVM NNDLNDVLKT SPFSAEEANS LSSQAPLLVT TSPSPVTSTL
     QEHSTSSLVS VTSVPTPTLA KITDMDTNLE PVTRSPQNLR NTLATSEATT DTHTMHPSIN
     TAVANVGTTS SPNEFYFTVS PDSDPYKATS AVVITSTSGD SIVSTSMPRS SAMKKIESET
     TFSLIFRLRE TSTSQKIGSS SDTSTVFDKA FTAATTEVSR TELTSSSRTS IQGTEKPTMS
     PDTSTRSVTM LSTFAGLTKS EERTIATQTG PHRATSQGTL TWDTSITTSQ AGTHSAMTHG
     FSQLDLSTLT SRVPEYISGT SPPSVEKTSS SSSLLSLPAI TSPSPVPTTL PESRPSSPVH
     LTSLPTSGLV KTTDMLASVA SLPPNLGSTS HKIPTTSEDI KDTEKMYPST NIAVTNVGTT
     TSEKESYSSV PAYSEPPKVT SPMVTSFNIR DTIVSTSMPG SSEITRIEME STFSLAHGLK
     GTSTSQDPIV STEKSAVLHK LTTGATETSR TEVASSRRTS IPGPDHSTES PDISTEVIPS
     LPISLGITES SNMTIITRTG PPLGSTSQGT FTLDTPTTSS RAGTHSMATQ EFPHSEMTTV
     MNKDPEILSW TIPPSIEKTS FSSSLMPSPA MTSPPVSSTL PKTIHTTPSP MTSLLTPSLV
     MTTDTLGTSP EPTTSSPPNL SSTSHEILTT DEDTTAIEAM HPSTSTAATN VETTSSGHGS
     QSSVLADSEK TKATAPMDTT STMGHTTVST SMSVSSETTK IKRESTYSLT PGLRETSISQ
     NASFSTDTSI VLSEVPTGTT AEVSRTEVTS SGRTSIPGPS QSTVLPEIST RTMTRLFASP
     TMTESAEMTI PTQTGPSGST SQDTLTLDTS TTKSQAKTHS TLTQRFPHSE MTTLMSRGPG
     DMSWQSSPSL ENPSSLPSLL SLPATTSPPP ISSTLPVTIS SSPLPVTSLL TSSPVTTTDM
     LHTSPELVTS SPPKLSHTSD ERLTTGKDTT NTEAVHPSTN TAASNVEIPS SGHESPSSAL
     ADSETSKATS PMFITSTQED TTVAISTPHF LETSRIQKES ISSLSPKLRE TGSSVETSSA
     IETSAVLSEV SIGATTEISR TEVTSSSRTS ISGSAESTML PEISTTRKII KFPTSPILAE
     SSEMTIKTQT SPPGSTSEST FTLDTSTTPS LVITHSTMTQ RLPHSEITTL VSRGAGDVPR
     PSSLPVEETS PPSSQLSLSA MISPSPVSST LPASSHSSSA SVTSLLTPGQ VKTTEVLDAS
     AEPETSSPPS LSSTSVEILA TSEVTTDTEK IHPFSNTAVT KVGTSSSGHE SPSSVLPDSE
     TTKATSAMGT ISIMGDTSVS TLTPALSNTR KIQSEPASSL TTRLRETSTS EETSLATEAN
     TVLSKVSTGA TTEVSRTEAI SFSRTSMSGP EQSTMSQDIS IGTIPRISAS SVLTESAKMT
     ITTQTGPSES TLESTLNLNT ATTPSWVETH SIVIQGFPHP EMTTSMGRGP GGVSWPSPPF
     VKETSPPSSP LSLPAVTSPH PVSTTFLAHI PPSPLPVTSL LTSGPATTTD ILGTSTEPGT
     SSSSSLSTTS HERLTTYKDT AHTEAVHPST NTGGTNVATT SSGYKSQSSV LADSSPMCTT
     STMGDTSVLT STPAFLETRR IQTELASSLT PGLRESSGSE GTSSGTKMST VLSKVPTGAT
     TEISKEDVTS IPGPAQSTIS PDISTRTVSW FSTSPVMTES AEITMNTHTS PLGATTQGTS
     TLDTSSTTSL TMTHSTISQG FSHSQMSTLM RRGPEDVSWM SPPLLEKTRP SFSLMSSPAT
     TSPSPVSSTL PESISSSPLP VTSLLTSGLA KTTDMLHKSS EPVTNSPANL SSTSVEILAT
     SEVTTDTEKT HPSSNRTVTD VGTSSSGHES TSFVLADSQT SKVTSPMVIT STMEDTSVST
     STPGFFETSR IQTEPTSSLT LGLRKTSSSE GTSLATEMST VLSGVPTGAT AEVSRTEVTS
     SSRTSISGFA QLTVSPETST ETITRLPTSS IMTESAEMMI KTQTDPPGST PESTHTVDIS
     TTPNWVETHS TVTQRFSHSE MTTLVSRSPG DMLWPSQSSV EETSSASSLL SLPATTSPSP
     VSSTLVEDFP SASLPVTSLL NPGLVITTDR MGISREPGTS STSNLSSTSH ERLTTLEDTV
     DTEDMQPSTH TAVTNVRTSI SGHESQSSVL SDSETPKATS PMGTTYTMGE TSVSISTSDF
     FETSRIQIEP TSSLTSGLRE TSSSERISSA TEGSTVLSEV PSGATTEVSR TEVISSRGTS
     MSGPDQFTIS PDISTEAITR LSTSPIMTES AESAITIETG SPGATSEGTL TLDTSTTTFW
     SGTHSTASPG FSHSEMTTLM SRTPGDVPWP SLPSVEEASS VSSSLSSPAM TSTSFFSTLP
     ESISSSPHPV TALLTLGPVK TTDMLRTSSE PETSSPPNLS STSAEILATS EVTKDREKIH
     PSSNTPVVNV GTVIYKHLSP SSVLADLVTT KPTSPMATTS TLGNTSVSTS TPAFPETMMT
     QPTSSLTSGL REISTSQETS SATERSASLS GMPTGATTKV SRTEALSLGR TSTPGPAQST
     ISPEISTETI TRISTPLTTT GSAEMTITPK TGHSGASSQG TFTLDTSSRA SWPGTHSAAT
     HRSPHSGMTT PMSRGPEDVS WPSRPSVEKT SPPSSLVSLS AVTSPSPLYS TPSESSHSSP
     LRVTSLFTPV MMKTTDMLDT SLEPVTTSPP SMNITSDESL ATSKATMETE AIQLSENTAV
     TQMGTISARQ EFYSSYPGLP EPSKVTSPVV TSSTIKDIVS TTIPASSEIT RIEMESTSTL
     TPTPRETSTS QEIHSATKPS TVPYKALTSA TIEDSMTQVM SSSRGPSPDQ STMSQDISTE
     VITRLSTSPI KTESTEMTIT TQTGSPGATS RGTLTLDTST TFMSGTHSTA SQGFSHSQMT
     ALMSRTPGDV PWLSHPSVEE ASSASFSLSS PVMTSSSPVS STLPDSIHSS SLPVTSLLTS
     GLVKTTELLG TSSEPETSSP PNLSSTSAEI LAITEVTTDT EKLEMTNVVT SGYTHESPSS
     VLADSVTTKA TSSMGITYPT GDTNVLTSTP AFSDTSRIQT KSKLSLTPGL METSISEETS
     SATEKSTVLS SVPTGATTEV SRTEAISSSR TSIPGPAQST MSSDTSMETI TRISTPLTRK
     ESTDMAITPK TGPSGATSQG TFTLDSSSTA SWPGTHSATT QRFPQSVVTT PMSRGPEDVS
     WPSPLSVEKN SPPSSLVSSS SVTSPSPLYS TPSGSSHSSP VPVTSLFTSI MMKATDMLDA
     SLEPETTSAP NMNITSDESL AASKATTETE AIHVFENTAA SHVETTSATE ELYSSSPGFS
     EPTKVISPVV TSSSIRDNMV STTMPGSSGI TRIEIESMSS LTPGLRETRT SQDITSSTET
     STVLYKMPSG ATPEVSRTEV MPSSRTSIPG PAQSTMSLDI SDEVVTRLST SPIMTESAEI
     TITTQTGYSL ATSQVTLPLG TSMTFLSGTH STMSQGLSHS EMTNLMSRGP ESLSWTSPRF
     VETTRSSSSL TSLPLTTSLS PVSSTLLDSS PSSPLPVTSL ILPGLVKTTE VLDTSSEPKT
     SSSPNLSSTS VEIPATSEIM TDTEKIHPSS NTAVAKVRTS SSVHESHSSV LADSETTITI
     PSMGITSAVD DTTVFTSNPA FSETRRIPTE PTFSLTPGFR ETSTSEETTS ITETSAVLYG
     VPTSATTEVS MTEIMSSNRI HIPDSDQSTM SPDIITEVIT RLSSSSMMSE STQMTITTQK
     SSPGATAQST LTLATTTAPL ARTHSTVPPR FLHSEMTTLM SRSPENPSWK SSLFVEKTSS
     SSSLLSLPVT TSPSVSSTLP QSIPSSSFSV TSLLTPGMVK TTDTSTEPGT SLSPNLSGTS
     VEILAASEVT TDTEKIHPSS SMAVTNVGTT SSGHELYSSV SIHSEPSKAT YPVGTPSSMA
     ETSISTSMPA NFETTGFEAE PFSHLTSGFR KTNMSLDTSS VTPTNTPSSP GSTHLLQSSK
     TDFTSSAKTS SPDWPPASQY TEIPVDIITP FNASPSITES TGITSFPESR FTMSVTESTH
     HLSTDLLPSA ETISTGTVMP SLSEAMTSFA TTGVPRAISG SGSPFSRTES GPGDATLSTI
     AESLPSSTPV PFSSSTFTTT DSSTIPALHE ITSSSATPYR VDTSLGTESS TTEGRLVMVS
     TLDTSSQPGR TSSSPILDTR MTESVELGTV TSAYQVPSLS TRLTRTDGIM EHITKIPNEA
     AHRGTIRPVK GPQTSTSPAS PKGLHTGGTK RMETTTTALK TTTTALKTTS RATLTTSVYT
     PTLGTLTPLN ASMQMASTIP TEMMITTPYV FPDVPETTSS LATSLGAETS TALPRTTPSV
     FNRESETTAS LVSRSGAERS PVIQTLDVSS SEPDTTASWV IHPAETIPTV SKTTPNFFHS
     ELDTVSSTAT SHGADVSSAI PTNISPSELD ALTPLVTISG TDTSTTFPTL TKSPHETETR
     TTWLTHPAET SSTIPRTIPN FSHHESDATP SIATSPGAET SSAIPIMTVS PGAEDLVTSQ
     VTSSGTDRNM TIPTLTLSPG EPKTIASLVT HPEAQTSSAI PTSTISPAVS RLVTSMVTSL
     AAKTSTTNRA LTNSPGEPAT TVSLVTHPAQ TSPTVPWTTS IFFHSKSDTT PSMTTSHGAE
     SSSAVPTPTV STEVPGVVTP LVTSSRAVIS TTIPILTLSP GEPETTPSMA TSHGEEASSA
     IPTPTVSPGV PGVVTSLVTS SRAVTSTTIP ILTFSLGEPE TTPSMATSHG TEAGSAVPTV
     LPEVPGMVTS LVASSRAVTS TTLPTLTLSP GEPETTPSMA TSHGAEASST VPTVSPEVPG
     VVTSLVTSSS GVNSTSIPTL ILSPGELETT PSMATSHGAE ASSAVPTPTV SPGVSGVVTP
     LVTSSRAVTS TTIPILTLSS SEPETTPSMA TSHGVEASSA VLTVSPEVPG MVTSLVTSSR
     AVTSTTIPTL TISSDEPETT TSLVTHSEAK MISAIPTLAV SPTVQGLVTS LVTSSGSETS
     AFSNLTVASS QPETIDSWVA HPGTEASSVV PTLTVSTGEP FTNISLVTHP AESSSTLPRT
     TSRFSHSELD TMPSTVTSPE AESSSAISTT ISPGIPGVLT SLVTSSGRDI SATFPTVPES
     PHESEATASW VTHPAVTSTT VPRTTPNYSH SEPDTTPSIA TSPGAEATSD FPTITVSPDV
     PDMVTSQVTS SGTDTSITIP TLTLSSGEPE TTTSFITYSE THTSSAIPTL PVSPGASKML
     TSLVISSGTD STTTFPTLTE TPYEPETTAI QLIHPAETNT MVPRTTPKFS HSKSDTTLPV
     AITSPGPEAS SAVSTTTISP DMSDLVTSLV PSSGTDTSTT FPTLSETPYE PETTATWLTH
     PAETSTTVSG TIPNFSHRGS DTAPSMVTSP GVDTRSGVPT TTIPPSIPGV VTSQVTSSAT
     DTSTAIPTLT PSPGEPETTA SSATHPGTQT GFTVPIRTVP SSEPDTMASW VTHPPQTSTP
     VSRTTSSFSH SSPDATPVMA TSPRTEASSA VLTTISPGAP EMVTSQITSS GAATSTTVPT
     LTHSPGMPET TALLSTHPRT ETSKTFPAST VFPQVSETTA SLTIRPGAET STALPTQTTS
     SLFTLLVTGT SRVDLSPTAS PGVSAKTAPL STHPGTETST MIPTSTLSLG LLETTGLLAT
     SSSAETSTST LTLTVSPAVS GLSSASITTD KPQTVTSWNT ETSPSVTSVG PPEFSRTVTG
     TTMTLIPSEM PTPPKTSHGE GVSPTTILRT TMVEATNLAT TGSSPTVAKT TTTFNTLAGS
     LFTPLTTPGM STLASESVTS RTSYNHRSWI STTSSYNRRY WTPATSTPVT STFSPGISTS
     SIPSSTAATV PFMVPFTLNF TITNLQYEED MRHPGSRKFN ATERELQGLL KPLFRNSSLE
     YLYSGCRLAS LRPEKDSSAT AVDAICTHRP DPEDLGLDRE RLYWELSNLT NGIQELGPYT
     LDRNSLYVNG FTHRSSMPTT STPGTSTVDV GTSGTPSSSP SPTTAGPLLM PFTLNFTITN
     LQYEEDMRRT GSRKFNTMES VLQGLLKPLF KNTSVGPLYS GCRLTLLRPE KDGAATGVDA
     ICTHRLDPKS PGLNREQLYW ELSKLTNDIE ELGPYTLDRN SLYVNGFTHQ SSVSTTSTPG
     TSTVDLRTSG TPSSLSSPTI MAAGPLLVPF TLNFTITNLQ YGEDMGHPGS RKFNTTERVL
     QGLLGPIFKN TSVGPLYSGC RLTSLRSEKD GAATGVDAIC IHHLDPKSPG LNRERLYWEL
     SQLTNGIKEL GPYTLDRNSL YVNGFTHRTS VPTSSTPGTS TVDLGTSGTP FSLPSPATAG
     PLLVLFTLNF TITNLKYEED MHRPGSRKFN TTERVLQTLL GPMFKNTSVG LLYSGCRLTL
     LRSEKDGAAT GVDAICTHRL DPKSPGVDRE QLYWELSQLT NGIKELGPYT LDRNSLYVNG
     FTHWIPVPTS STPGTSTVDL GSGTPSSLPS PTTAGPLLVP FTLNFTITNL KYEEDMHCPG
     SRKFNTTERV LQSLLGPMFK NTSVGPLYSG CRLTLLRSEK DGAATGVDAI CTHRLDPKSP
     GVDREQLYWE LSQLTNGIKE LGPYTLDRNS LYVNGFTHQT SAPNTSTPGT STVDLGTSGT
     PSSLPSPTSA GPLLVPFTLN FTITNLQYEE DMHHPGSRKF NTTERVLQGL LGPMFKNTSV
     GLLYSGCRLT LLRPEKNGAA TGMDAICSHR LDPKSPGLNR EQLYWELSQL THGIKELGPY
     TLDRNSLYVN GFTHRSSVAP TSTPGTSTVD LGTSGTPSSL PSPTTAVPLL VPFTLNFTIT
     NLQYGEDMRH PGSRKFNTTE RVLQGLLGPL FKNSSVGPLY SGCRLISLRS EKDGAATGVD
     AICTHHLNPQ SPGLDREQLY WQLSQMTNGI KELGPYTLDR NSLYVNGFTH RSSGLTTSTP
     WTSTVDLGTS GTPSPVPSPT TTGPLLVPFT LNFTITNLQY EENMGHPGSR KFNITESVLQ
     GLLKPLFKST SVGPLYSGCR LTLLRPEKDG VATRVDAICT HRPDPKIPGL DRQQLYWELS
     QLTHSITELG PYTLDRDSLY VNGFTQRSSV PTTSTPGTFT VQPETSETPS SLPGPTATGP
     VLLPFTLNFT ITNLQYEEDM RRPGSRKFNT TERVLQGLLM PLFKNTSVSS LYSGCRLTLL
     RPEKDGAATR VDAVCTHRPD PKSPGLDRER LYWKLSQLTH GITELGPYTL DRHSLYVNGF
     THQSSMTTTR TPDTSTMHLA TSRTPASLSG PMTASPLLVL FTINFTITNL RYEENMHHPG
     SRKFNTTERV LQGLLRPVFK NTSVGPLYSG CRLTLLRPKK DGAATKVDAI CTYRPDPKSP
     GLDREQLYWE LSQLTHSITE LGPYTLDRDS LYVNGFTQRS SVPTTSIPGT PTVDLGTSGT
     PVSKPGPSAA SPLLVLFTLN FTITNLRYEE NMQHPGSRKF NTTERVLQGL LRSLFKSTSV
     GPLYSGCRLT LLRPEKDGTA TGVDAICTHH PDPKSPRLDR EQLYWELSQL THNITELGPY
     ALDNDSLFVN GFTHRSSVST TSTPGTPTVY LGASKTPASI FGPSAASHLL ILFTLNFTIT
     NLRYEENMWP GSRKFNTTER VLQGLLRPLF KNTSVGPLYS GCRLTLLRPE KDGEATGVDA
     ICTHRPDPTG PGLDREQLYL ELSQLTHSIT ELGPYTLDRD SLYVNGFTHR SSVPTTSTGV
     VSEEPFTLNF TINNLRYMAD MGQPGSLKFN ITDNVMQHLL SPLFQRSSLG ARYTGCRVIA
     LRSVKNGAET RVDLLCTYLQ PLSGPGLPIK QVFHELSQQT HGITRLGPYS LDKDSLYLNG
     YNEPGPDEPP TTPKPATTFL PPLSEATTAM GYHLKTLTLN FTISNLQYSP DMGKGSATFN
     STEGVLQHLL RPLFQKSSMG PFYLGCQLIS LRPEKDGAAT GVDTTCTYHP DPVGPGLDIQ
     QLYWELSQLT HGVTQLGFYV LDRDSLFING YAPQNLSIRG EYQINFHIVN WNLSNPDPTS
     SEYITLLRDI QDKVTTLYKG SQLHDTFRFC LVTNLTMDSV LVTVKALFSS NLDPSLVEQV
     FLDKTLNASF HWLGSTYQLV DIHVTEMESS VYQPTSSSST QHFYLNFTIT NLPYSQDKAQ
     PGTTNYQRNK RNIEDALNQL FRNSSIKSYF SDCQVSTFRS VPNRHHTGVD SLCNFSPLAR
     RVDRVAIYEE FLRMTRNGTQ LQNFTLDRSS VLVDGYSPNR NEPLTGNSDL PFWAVILIGL
     AGLLGVITCL ICGVLVTTRR RKKEGEYNVQ QQCPGYYQSH LDLEDLQ
//
ID   A0A0G2JS65_HUMAN        Unreviewed;      7418 AA.
AC   A0A0G2JS65;
DT   22-JUL-2015, integrated into UniProtKB/TrEMBL.
DT   22-JUL-2015, sequence version 1.
DT   28-MAR-2018, entry version 16.
DE   SubName: Full=Mucin-4 {ECO:0000313|Ensembl:ENSP00000487383};
GN   Name=MUC4 {ECO:0000313|Ensembl:ENSP00000487383};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000487383, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Ensembl:ENSP00000487383}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [2] {ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16641997; DOI=10.1038/nature04728;
RA   Muzny D.M., Scherer S.E., Kaul R., Wang J., Yu J., Sudbrak R.,
RA   Buhay C.J., Chen R., Cree A., Ding Y., Dugan-Rocha S., Gill R.,
RA   Gunaratne P., Harris R.A., Hawes A.C., Hernandez J., Hodgson A.V.,
RA   Hume J., Jackson A., Khan Z.M., Kovar-Smith C., Lewis L.R.,
RA   Lozado R.J., Metzker M.L., Milosavljevic A., Miner G.R., Morgan M.B.,
RA   Nazareth L.V., Scott G., Sodergren E., Song X.Z., Steffen D., Wei S.,
RA   Wheeler D.A., Wright M.W., Worley K.C., Yuan Y., Zhang Z., Adams C.Q.,
RA   Ansari-Lari M.A., Ayele M., Brown M.J., Chen G., Chen Z.,
RA   Clendenning J., Clerc-Blankenburg K.P., Chen R., Chen Z., Davis C.,
RA   Delgado O., Dinh H.H., Dong W., Draper H., Ernst S., Fu G.,
RA   Gonzalez-Garay M.L., Garcia D.K., Gillett W., Gu J., Hao B.,
RA   Haugen E., Havlak P., He X., Hennig S., Hu S., Huang W., Jackson L.R.,
RA   Jacob L.S., Kelly S.H., Kube M., Levy R., Li Z., Liu B., Liu J.,
RA   Liu W., Lu J., Maheshwari M., Nguyen B.V., Okwuonu G.O., Palmeiri A.,
RA   Pasternak S., Perez L.M., Phelps K.A., Plopper F.J., Qiang B.,
RA   Raymond C., Rodriguez R., Saenphimmachak C., Santibanez J., Shen H.,
RA   Shen Y., Subramanian S., Tabor P.E., Verduzco D., Waldron L., Wang J.,
RA   Wang J., Wang Q., Williams G.A., Wong G.K., Yao Z., Zhang J.,
RA   Zhang X., Zhao G., Zhou J., Zhou Y., Nelson D., Lehrach H.,
RA   Reinhardt R., Naylor S.L., Yang H., Olson M., Weinstock G.,
RA   Gibbs R.A.;
RT   "The DNA sequence, annotation and analysis of human chromosome 3.";
RL   Nature 440:1194-1198(2006).
RN   [3] {ECO:0000313|Ensembl:ENSP00000487383}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (JUN-2015) to UniProtKB.
CC   -!- CAUTION: Lacks conserved residue(s) required for the propagation
CC       of feature annotation. {ECO:0000256|PROSITE-ProRule:PRU00076}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AC069513; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC233280; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC239646; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   RefSeq; NP_001309397.1; NM_001322468.1.
DR   UniGene; Hs.369646; -.
DR   ProteinModelPortal; A0A0G2JS65; -.
DR   PeptideAtlas; A0A0G2JS65; -.
DR   Ensembl; ENST00000626947; ENSP00000487383; ENSG00000277585.
DR   GeneID; 4585; -.
DR   CTD; 4585; -.
DR   HGNC; HGNC:7514; MUC4.
DR   OrthoDB; EOG091G01CZ; -.
DR   ChiTaRS; MUC4; human.
DR   Proteomes; UP000005640; Chromosome 3.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0007160; P:cell-matrix adhesion; IEA:InterPro.
DR   InterPro; IPR005533; AMOP_dom.
DR   InterPro; IPR000742; EGF-like_dom.
DR   InterPro; IPR003886; NIDO_dom.
DR   InterPro; IPR001846; VWF_type-D.
DR   Pfam; PF06119; NIDO; 1.
DR   Pfam; PF00094; VWD; 1.
DR   SMART; SM00723; AMOP; 1.
DR   SMART; SM00181; EGF; 3.
DR   SMART; SM00539; NIDO; 1.
DR   SMART; SM00216; VWD; 1.
DR   PROSITE; PS50856; AMOP; 1.
DR   PROSITE; PS50026; EGF_3; 2.
DR   PROSITE; PS51220; NIDO; 1.
DR   PROSITE; PS51233; VWFD; 1.
PE   1: Evidence at protein level;
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   Disulfide bond {ECO:0000256|PROSITE-ProRule:PRU00076};
KW   EGF-like domain {ECO:0000256|PROSITE-ProRule:PRU00076};
KW   Membrane {ECO:0000256|SAM:Phobius};
KW   Proteomics identification {ECO:0000213|MaxQB:A0A0G2JS65,
KW   ECO:0000213|PeptideAtlas:A0A0G2JS65};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640};
KW   Signal {ECO:0000256|SAM:SignalP};
KW   Transmembrane {ECO:0000256|SAM:Phobius};
KW   Transmembrane helix {ECO:0000256|SAM:Phobius}.
FT   SIGNAL        1     28       {ECO:0000256|SAM:SignalP}.
FT   CHAIN        29   7418       {ECO:0000256|SAM:SignalP}.
FT                                /FTId=PRO_5002546446.
FT   TRANSMEM   7374   7400       Helical. {ECO:0000256|SAM:Phobius}.
FT   DOMAIN     6403   6558       NIDO. {ECO:0000259|PROSITE:PS51220}.
FT   DOMAIN     6559   6674       AMOP. {ECO:0000259|PROSITE:PS50856}.
FT   DOMAIN     6687   6922       VWFD. {ECO:0000259|PROSITE:PS51233}.
FT   DOMAIN     7124   7163       EGF-like. {ECO:0000259|PROSITE:PS50026}.
FT   DOMAIN     7327   7366       EGF-like. {ECO:0000259|PROSITE:PS50026}.
FT   DISULFID   7153   7162       {ECO:0000256|PROSITE-ProRule:PRU00076}.
SQ   SEQUENCE   7418 AA;  734618 MW;  E9A9AE68920B0159 CRC64;
     MKGARWRRVP WVSLSCLCLC LLPHVVPGTT EDTLITGSKT PAPVTSTGST TATLEGQSTA
     ASSRTSNQDI SASSQNHQTK STETTSKAQT DTLTQMMTST LFSSPSVHNV METVTQETAP
     PDEMTTSFPS SVTNTLMMTS KTITMTTSTD STLGNTEETS TAGTESSTPV TSAVSITAGQ
     EGQSRTTSWR TSIQDTSASS QNHWTRSTQT TRESQTSTLT HRTTSTPSFS PSVHNVTGTV
     SQKTSPSGET ATSSLCSVTN TSMMTSEKIT VTTSTGSTLG NPGETSSVPV TGSLMPVTSA
     ALVTVDPEGQ SPVTFSRTST QDTTAFSKNH QTQSVETTRV SQINTLNTLT PVTTSTVLSS
     PSGFNPSGTV SQETFPSGET TISSPSSVSN TFLVTSKVFR MPISRDSTLG NTEETSLSVS
     GTISAITSKV STIWWSDTLS TALSPSSLPP KISTAFHTQQ SEGAETTGRP HERSSFSPGV
     SQEIFTLHET TTWPSSFSSK GHTTWSQTEL PSTSTGAATR LVTGNPSTGA AGTIPRVPSK
     VSAIGEPGEP TTYSSHSTTL PKTTGAGAQT QWTQETGTTG EALLSSPSYS VTQMIKTATS
     PSSSPMLDRH TSQQITTAPS TNHSTIHSTS TSPQESPAVS QRGHTQAPQT TQESQTTRSV
     SPMTDTKTVT TPGSSFTASG HSPSEIVPQD APTISAATTF APAPTGDGHT TQAPTTALQA
     APSSHDATLG PSGGTSLSKT GALTLANSVV STPGGPEGQW TSASASTSPD TAAAMTHTHQ
     AESTEASGQT QTSEPASSGS RTTSAGTATP SSSGASGTTP SGSEGISTSG ETTRFSSNPS
     RDSHTTQSTT ELLSASASHG AIPVSTGMAS SIVPGTFHPT LSEASTAGRP TGQSSPTSPS
     ASPQETAAIS RMAQTQRTRT SRGSDTISLA SQATDTFSTV PPTPPSITSS GLTSPQTQTH
     TLSPSGSGKT FTTALISNAT PLPVTYASSA STGHTTPLHV TDASSVSTGH ATPLPVTDTS
     SESTGHATPL PVTSPSSVST GHTTPLPVTD TSSESTGHVT PLPVTSLSSA STGDSTPLPV
     TDTSSASTGH VTPLPVTSLS SASTGDTTPL PVTDTSSAST GHATSLPVTD TSSVSTGHTT
     PLPVTDTSSA STGHATSLPV TDTSSVSTAH ATPLPVTGLS SASTDDTTRL PVTDVSSAST
     GQAIPLPVTS PSSASTGDTT PLPVTDASSA STGDTTSLPV TIPSSASSGH TTSLPVTDAS
     SVSTGHATSL LVTDASSVST GDTTPLPVTD TNSASTGDTT PLHVTDASSV STGHATSLPV
     TSLSSASTGD TTPLPVTSPS SASSGHTTPL PVTDASSVPT GHATSLPVTD ASSVSTGHAT
     PLPVTDASSV STGHATPLPV TDTSSVSTGQ ATPLPVTSLS SASTGDTTPL PVTDTSSAST
     GQDTPLPVTS LSSVSTGDTT PLPVTSPSSA STGHATPLLV TDASSVSTGH ATSLLVTDAS
     SVSTGHATAL HVTDASSLST GDTTPLPVTS PSSASTGDTT PLPVTDTSSA STGHATSLPV
     TDTSSASTGH ATPLPVTDTS SASTGQATPL PVTGPSSAST GHAIPLLVTD TSSASTGQAT
     PLPVTSLSSA STGDTTPLPV TDASSVSTGH ATSLPVTSLS SVSTGDTTPL PVTSPSSASS
     GHTTPLPVTD ASSVSTGDTT PLPVTSPSSA SSGHTTPLPV TSPSSASSGH TTPLPVTDAS
     SASTGDTTPL PVTDTSSAST GHATHLPVTG LSSASTGDTT RLPVTNVSSA STGHATPLPV
     TSTSSASTGD TTPLPGTDTS SVSTGHTTPL LVTDASSVST GDTTRLPVTS PSSASTGHTT
     PLPVTDTPSA STGDTTPLPV TNASSLSTRH TTSLHVTSPS SASTGHATSL PVTDTSSVST
     GHATPLHVTS PSSASTGDTT PLPVTDTYSA STGQATPLPV TDTSSASTGD TTPLPVTDTS
     SASTGHATPL PVTNTSSVST GHATPLHVTS PSSASTGHTT PLPVTDASSV STGHATSLPV
     TDASSVFTGH ATSLPVTIPS SASSGHTTPL PVTDASSVST GHATSLPVTD ASSVSTGHAT
     PLPVTDASSV STGHATPLPV TDTSSVSTGH ATPLPLTSLS SVSTGDTTPL PVTDTSSAST
     GQATPLPVTS LSSVSTGDTT PLPVTDTSSA STGHATSLPV TDTSSASTGH ATPLPDTDTS
     SASTGHATPL PVTDTSSAST GHATLLPVTD TSSASIGHAT PLPVTDTSSI STGHATPLHV
     TSPSSASTGH ATPLPVTDTS SASTGHANPL HVTSPSSAST GHATPLPVTD TSSASTGHAT
     PLPVTSLSSV STGDTTPLPV TSPSSASTGH TTPLPVTDTS SASTGQATAL PVTSTSSAST
     GDTTPLPVTD TSSASTGQAT PLPVTSLSSV STGDTTPLPV TSPSSASTGH ATPLLVTDAS
     SASTGQATPL PVTDTSSAYT GDTTSLPVTD TSSSSTGDTT PLLVTETSSA STGHATPLHV
     TSPSSASTGD TTPVPVTDTS SVSTGHATPL PVTGLSSAST GDTTRLPVTD ISSASTGQAT
     PLPVTNTSSA STGHATPLPV TGLSSASTGD TTRLPVTDIS SASTGQATPL PVTNTSSVST
     GDTMPLPVTS PSSASTGHAT PLPVTSTSSA STGHATPVPV TSTSSASTGH TTPLPVTDTS
     SASTGDTTPL PVTSPSSAST GHTTPLHVTI PSSASTGDTS TLPVTGASSA STGHATPLPV
     TDTSSVSTGH ATPLPVTSFS SVSTGDTTPL PVTDTSSVST GHATPLPVTS FSSVSTGDTT
     PLPVTDASSA STGHATPLPV TDTSSVSTGH ATPLPLTSLS SVSTGDTTTL PVTDTSSVST
     GHATPLPVTS FSSVSTGDTT PLPVTDASSA STGHATPLPV TDTSSVSTGH ATPLPVTSLS
     SVSTGDTTPL PVTDASSAST GQATPLPVTS LSSVSTGDTT PLPVTIPSSA SSGHTTSLPV
     TDTSSASTGQ ATPLPVTSLS SVSTGDTTPL LVTDASSVST GHATPLPVTD TSSASTGDTT
     RLPVTDTSSA STGQATPLPV TSLSSVSTGD TTPLLVTNTS SVSRGHATSL PVTIPSSSSS
     GHTTPLPVTS TSSVSTGHVT PLPVTSTSSA STGHATSLPV TDTSSVSTGH ATSLPVTDTS
     SVSTGHATPL PVTDASSVST GHATPLPVTD ASSASTGDTT PLPVTNTSSA STGQATPLPV
     TSLSSVSTGD TMPLPVTSPS SASTGHATPL PVTGLSSAST GDTTPLPVTD TSSASTGHVT
     PLPVTSLSSA STGDSTPLPV TDTSSASTGH VTPLPVTSLS SASTGDTTPL PVTDTSSAST
     GHATPLHVTD ASSASTGQAT LLPVTSLSSV STGDTTPLPV TSPSSASTGH ATPLLVTDTS
     SASTGHATPL PVTDASSVST GHATSLPVTI RSSGSTGHTT PLPVTDTSSA STGQATSLLV
     TDTSSVSTGD TTPLPVTSTS SASTGHVTPL HVTSPSSAST GHATPLPVTS LSSASTGDTM
     PLPVTSPSSA STGDTTPLPV TDASSVSTGH TTPLPVTSPS SASTGHTTPL PVTDTTSASK
     GDTTPLPVTS PSSASTGHTT PLPVTDTSSA STGDTTPLPV TSPSSASTGH ATPLPVTNAS
     SLSTGHATPL HVTSPSSAST GHATPLPVTS TSSASTGHAT SLPVTSTSSA STGHATPLPV
     TDNSSVSTGH ATPLPVTGLS SATTDDTTRL PVTDVSSAST GQATPLPVTS LSSVSTGDTT
     PLPVTSPSSA STGHASPLLV TDASSASTGQ ATPLPVTDTS SVSTAHATPL PVTGLSSAST
     DDTTRLPVTD VSSASTGQAI PLPVTSPSSA STGDTTPLPV TDASSASTGD TTSLPVTIPS
     SASSGHTTSL PVTDASSVST GHATSLLVTD ASSVSTGDTT PLPVTDTNSA STGDTTPLHV
     TDASSVSTGH ATSLPVTSLS SASTGDTTPL PVTSPSSASS GDTTPLPVTD TSSASTGHAT
     HLPVTGLSSA STGDTTRLPV TNVSSASTGH ATPLPVTSTS SASTGDTTPL PGTDTSSVST
     GHTTPLLVTD ASSVSTGDTT RLPVTSPSSA STGHTTPLHV TDASSVSTGH TTPLPVTDTS
     SASTGQATSL LVTDTSSVST GDTTPLPVTS TSSASTGHVT PLHVTSPSSA STGHATPLPV
     TSLSSASTGD TTPLPVTDTS SVSTGHTTPL PVTSPSSAST GHTTPLPVTD TSSASKGDTT
     PLPVTSPSSA STGHTTPLPV TDTSSASTGD TTPLPVTNAS SLSTGHATPL HVTSPSSAST
     GHATPLPVTS TSSASTGHAT PLPVTSTSSA STGHATPLPV TDNSSVSTGH ATPLPVTGLS
     SATTDDTTRL PVTDVSSAST GQATPLPVTS LSSVSTGDTT PLPVTSPSSA STGHASPLLV
     TDASSASTGQ ATPLPVTDTS SVSTAHATPL PVTGLSSAST DDTTRLPVTD VSSASTGQAI
     PLPVTSPSSA STGDTTPLPV TDASSASTGD TTSLPVTIPS SASSGHTTSL PVTDASSVST
     GHATSLLVTD ASSVSTGDTT PLPVTDTNSA STGDTTPLHV TDASSVSTGH ATSLPVTSLS
     SASTGDTTPL PVTSPSSASS GHTTSLPVTD ASSVSTGHAT SLPVTIPSSA SSGHTTPLPV
     TDASSVPTGH ATSLPVTDAS SVSTGHATPL PVTDASSVST GHATPLPVTD TSSVSTGQAT
     PLPVTSLSSA SSTGDTTPLP VTDTSSASTG QDTPLPVTSL FSVSTGDTTP LPVTSPSSAS
     TGHATHLLVT DASSVSTGHA TSLLVTDASS VSTGHATALH VTDASSLSTG DTTPLPVTSP
     SSASTGDTTP LPVTDTSSVS TGHATSLPVT DTSSASTGHA TSLPVTDTSS ASTGQATPLP
     VTSPSSASTG HAIPLLVTDT SSASTGQATP LPVTSLSSAS TGDTTPLPVT DASSVSTGHA
     TSLPVTSLSS VSTGDTTPLP VTSPSSASTG HATPLHVTSP SSASTGHATP LPVTSLSSAS
     TGDTTPLPVT SPSSASTGHA TPLHVTDASS VSTGDTTPLP VTSPSSASSG HTTPLPVTDA
     SSASTGDTTP LPVTDTSSAS TGHATHLPVT GLSSASTGDT TRLPVTDVSS ASTGHATPLP
     VTSTSSASTG DTTPLPGTDT SSVSTGHTTP LLVTDASSVS TGDTTRLPVT SPSSASTGHT
     TPLPVTDTPS ASTGDTTPLP VTNASSLSTR HATSLHVTSP SSASTGHATP LPVTDTSAAS
     TGHATPLPVT STSSASTGDT TPLPVTDTSS ASTGHATPLP VTNTSSVSTG HATPLHVTSP
     SSASTGHTTP LPVTDASSVS TGHATSLPVT DASSVSTGHA TPLPVTDASS VSTGHATPLP
     LTSLSSVSTG DTTPLPVTDT SSASTGQATP LPVTSLSSVS TGDTTPLPVT DTSSASTGHA
     TSLPVTDTSS ASTGHATPLP VTDTSSISTG HATPLHVTSP SSASTGHATP LPVTDTSSAS
     TGHATPLPVT SLSSVSTGDT TPLPVTSPSS ASTGHATPLL VTDASSASTG QATPLPVTSL
     SSVSTGDTTP LPVTSPSSAS TGHATSLPVT DTSSASTGDT TSLPVTDTSS AYTGDTTSLP
     VTDTSSSSTG DTTPLLVTET SSASTGDTTP VPVTDTSSVS TGHATPLPVT GLSSASTGDT
     TRLPVTDISS ASTGQATPLP VTNTSSVSTG DTMPLPVTSP SSASTGHATP LPVTSTSSAS
     TGHATPVPVT STSLASTGHT TPLPVTSPSS ASTGHTTPLP VTDTSSASTG DTTPLPVTNA
     SSLSTGHTTP LHVTIPSSAS TGDTSTLPVT GASSASTGHA TPLPVTDTSS VSTGHATPLP
     VTSFSSVSTG DTTPLPVTDA SSASTGHATP LPVTDTSSAS TGDTTPLPVT DASSASTGQA
     TPLPVTSLSS VSTGDTTPLP VTIPSSASSG HTTSLPVSDT SSASTGQATP LPVTSLSSVS
     TGDTTPLLVT DASSVSTGHA TPLPVTDTSS ASTGDTTRLP VTDTSSASTG QATPLPVTSL
     SSVSTGDTTP LLVTNTSSVS TGHATSLPVT IPSSSSSGHT TPLPVTSTSS VSTGHVTPLH
     VTSPSSSSTG QATPLPVTST SSVSTGHVTP LHVTSPSSAS TGHATPLPVT STSSASTGHA
     TPLPVTDASS VSTGHATPLP VTDTSSASTG DTTPLPVTDT SSASTGQATP LPVTSLSSVS
     TGHATPLAVS SATSASTVSS DSPLKMETSG MTTPSLKTDG GRRTATSPPP TTSQTIISTI
     PSTAMHTRST AAPIPILPER GVSLFPYGAD AGDLEFVRRT VDFTSPLFKP ATGFPLGSSL
     RDSLYFTDNG QIIFPESDYQ IFSYPNPLPT GFTGRDPVAL VAPFWDDADF STGRGTTFYQ
     EYETFYGEHS LLVQQAESWI RKMTNNGGYK ARWALKVTWV NAHAYPAQWT LGSNTYQAIL
     STDGSRSYAL FLYQSGGMQW DVAQRSGNPV LMGFSSGDGY FENSPLMSQP VWERYRPDRF
     LNSNSGLQGL QFYRLHREER PNYRLECLQW LKSQPRWPSW GWNQVSCPCS WQQGRRDLRF
     QPVSIGRWGL GSRQLCSFTS WRGGVCCSYG PWGEFREGWH VQRPWQLAQE LEPQSWCCRW
     NDKPYLCALY QQRRPHVGCA TYRPPQPAWM FGDPHITTLD GVSYTFNGLG DFLLVGAQDG
     NSSFLLQGRT AQTGSAQATN FIAFAAQYRS SSLGPVTVQW LLEPHDAIRV LLDNQTVTFQ
     PDHEDGGGQE TFNATGVLLS RNGSEVSASF DGWATVSVIA LSNILHASAS LPPEYQNRTE
     GLLGVWNNNP EDDFRMPNGS TIPPGSPEEM LFHFGMTWQI NGTGLLGKRN DQLPSNFTPV
     FYSQLQKNSS WAEHLISNCD GDSSCIYDTL ALRNASIGLH TREVSKNYEQ ANATLNQYPP
     SINGGRVIEA YKGQTTLIQY TSNAEDANFT LRDSCTDLEL FENGTLLWTP KSLEPFTLEI
     LARSAKIGLA SALQPRTVVC HCNAESQCLY NQTSRVGNSS LEVAGCKCDG GTFGRYCEGS
     EDACEEPCFP SVHCVPGKGC EACPPNLTGD GRHCAALGSS FLCQNQSCPV NYCYNQGHCY
     ISQTLGCQPM CTCPPAFTDS RCFLAGNNFS PTVNLELPLR VIQLLLSEEE NASMAEVNAS
     VAYRLGTLDM RAFLRNSQVE RIDSAAPASG SPIQHWMVIS EFQYRPRGPV IDFLNNQLLA
     AVVEAFLYHV PRRSEEPRND VVFQPISGED VRDVTALNVS TLKAYFRCDG YKGYDLVYSP
     QSGFTCVSPC SRGYCDHGGQ CQHLPSGPRC SCVSFSIYTA WGEHCEHLSM KLDAFFGIFF
     GALGGLLLLG VGTFVVLRFW GCSGARFSYF LNSAEALP
//
ID   A0T3F4_HUMAN            Unreviewed;      1437 AA.
AC   A0T3F4;
DT   09-JAN-2007, integrated into UniProtKB/TrEMBL.
DT   09-JAN-2007, sequence version 1.
DT   31-JAN-2018, entry version 55.
DE   SubName: Full=Mucin 4 {ECO:0000313|EMBL:ABK78776.1};
DE   Flags: Fragment;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:ABK78776.1};
RN   [1] {ECO:0000313|EMBL:ABK78776.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Wei J., Miao Y., Gao W.;
RT   "A New Splicing Variant of the Human Pancreatic Tumor-Associated Mucin
RT   MUC4 cDNA.";
RL   Submitted (OCT-2006) to the EMBL/GenBank/DDBJ databases.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; EF091824; ABK78776.1; -; mRNA.
DR   RefSeq; NP_004523.3; NM_004532.5.
DR   RefSeq; NP_612154.2; NM_138297.4.
DR   UniGene; Hs.369646; -.
DR   PeptideAtlas; A0T3F4; -.
DR   PRIDE; A0T3F4; -.
DR   GeneID; 4585; -.
DR   KEGG; hsa:4585; -.
DR   CTD; 4585; -.
DR   PharmGKB; PA31319; -.
DR   eggNOG; ENOG410IHUZ; Eukaryota.
DR   eggNOG; ENOG4111F6U; LUCA.
DR   HOVERGEN; HBG081997; -.
DR   KO; K22017; -.
DR   GenomeRNAi; 4585; -.
DR   Genevisible; A0T3F4; HS.
DR   GO; GO:0007160; P:cell-matrix adhesion; IEA:InterPro.
DR   InterPro; IPR005533; AMOP_dom.
DR   InterPro; IPR003886; NIDO_dom.
DR   InterPro; IPR001846; VWF_type-D.
DR   Pfam; PF06119; NIDO; 1.
DR   SMART; SM00723; AMOP; 1.
DR   SMART; SM00539; NIDO; 1.
DR   PROSITE; PS50856; AMOP; 1.
DR   PROSITE; PS51220; NIDO; 1.
DR   PROSITE; PS51233; VWFD; 1.
PE   2: Evidence at transcript level;
KW   Signal {ECO:0000256|SAM:SignalP}.
FT   SIGNAL        1     28       {ECO:0000256|SAM:SignalP}.
FT   CHAIN        29   1437       {ECO:0000256|SAM:SignalP}.
FT                                /FTId=PRO_5002630483.
FT   DOMAIN     1132   1287       NIDO. {ECO:0000259|PROSITE:PS51220}.
FT   DOMAIN     1288   1403       AMOP. {ECO:0000259|PROSITE:PS50856}.
FT   DOMAIN     1416   1437       VWFD. {ECO:0000259|PROSITE:PS51233}.
FT   NON_TER    1437   1437       {ECO:0000313|EMBL:ABK78776.1}.
SQ   SEQUENCE   1437 AA;  151953 MW;  CE57979138FC3A4B CRC64;
     MKGARWRRVP WVSLSCLCLC LLPHVVPGTT EDTLITGSKT PAPVTSTGST TATLEGQSTA
     ASSRTSNQDI SASSQNHQTK STETTSKAQT DTLTQMMTST LFSSPSVHNV METVTQETAP
     PDEMTTSFPS SVTNTLMMTS KTITMTTSTD STLGNTEETS TAGTESSTPV TSAVSITAGQ
     EGQSRTTSWR TSIQDTSASS QNHWTRSTQT TRESQTSTLT HRTTSTPSFS PSVHNVTGTV
     SQKTSPSGET ATSSLCSVTN TSMMTSEKIT VTTSTGSTLG NPGETSSVPV TGSLMPVTSA
     ALVTVDPEGQ SPATFSRTST QDTTAFSKNH QTQSVETTRV SQINTLNTLT PVTTSTVLSS
     PSGFNPSGTV SQETFPSGET TISSPSSVSN TFLVTSKVFR MPISRDSTLG NTEETSLSVS
     GTISAITSKV STIWWSDTLS TALSPSSLPP KISTAFHTQQ SEGAETTGRP HERSSFSPGV
     SQEIFTLHET TTWPSSFSSK GHTTWSQTEL PSTSTGAATR LVTGNPSTGA AGTIPRVPSK
     VSAIGEPGEP TTYSSHSTTL PKTTGAGAQT QWTQETGTTG EALLSSPSYS VTQMIKTATS
     PSSSPMLDRH TSQQITTAPS TNHSTIHSTS TSPQESPAVS QRGHTQAPQT TQESQTTRSV
     SPMTDTKTVT TPGSSFTASG HSPSEIVPQD APTISAATTF APAPTGDGHT TQAPTTALQA
     APSSHDATLG PSGGTSLSKT GALTLANSVV STPGGPEGQW TSASASTSPD TAAAMTHTHQ
     AESTEASGQT QTSEPASSGS RTTSAGTATP SSSGASGTTP SGSEGISTSG ETTRFSSNPS
     RDSHTTQSTT ELLSASASHG AIPVSTGMAS SIVPGTFHPT LSEASTAGRP TGQSSPTSPS
     ASPQETAAIS RMAQTQRTRT SRGSDTISLA SQATDTFSTV PPTPPSITSS GLTSPQTQTH
     TLSPSGSVST GHATPLAVSS ATSASTVSSD SPLKMETSGM TTPSLKTDGG RRTATSPPPT
     TSQTIISTIP STAMHTRSTA APIPILPERG VSLFPYGAGA GDLEFVRRTV DFTSPLFKPA
     TGFPLGSSLR DSLYFTDNGQ IIFPESDYQI FSYPNPLPTG FTGRDPVALV APFWDDADFS
     TGRGTTFYQE YETFYGEHSL LVQQAESWIR KITNNGGYKA RWALKVTWVN AHAYPAQWTL
     GSNTYQAILS TDGSRSYALF LYQSGGMQWD VAQRSGNPVL MGFSSGDGYF ENSPLMSQPV
     WERYRPDRFL NSNSGLQGLQ FYRLHREERP NYRLECLQWL KSQPRWPSWG WNQVSCPCSW
     QQGRRDLRFQ PVSIGRWGLG SRQLCSFTSW RGGVCCSYGP WGEFREGWHV QRPWQLAQEL
     EPQSWCCRWN DKPYLCALYQ QRRPHVGCAT YRPPQPAWMF GDPHITTLDG VSYTFNG
//
ID   E9PDY6_HUMAN            Unreviewed;      5412 AA.
AC   E9PDY6;
DT   05-APR-2011, integrated into UniProtKB/TrEMBL.
DT   05-APR-2011, sequence version 1.
DT   28-MAR-2018, entry version 51.
DE   SubName: Full=Mucin-4 {ECO:0000313|Ensembl:ENSP00000417498};
GN   Name=MUC4 {ECO:0000313|Ensembl:ENSP00000417498};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000417498, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Ensembl:ENSP00000417498}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [2] {ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16641997; DOI=10.1038/nature04728;
RA   Muzny D.M., Scherer S.E., Kaul R., Wang J., Yu J., Sudbrak R.,
RA   Buhay C.J., Chen R., Cree A., Ding Y., Dugan-Rocha S., Gill R.,
RA   Gunaratne P., Harris R.A., Hawes A.C., Hernandez J., Hodgson A.V.,
RA   Hume J., Jackson A., Khan Z.M., Kovar-Smith C., Lewis L.R.,
RA   Lozado R.J., Metzker M.L., Milosavljevic A., Miner G.R., Morgan M.B.,
RA   Nazareth L.V., Scott G., Sodergren E., Song X.Z., Steffen D., Wei S.,
RA   Wheeler D.A., Wright M.W., Worley K.C., Yuan Y., Zhang Z., Adams C.Q.,
RA   Ansari-Lari M.A., Ayele M., Brown M.J., Chen G., Chen Z.,
RA   Clendenning J., Clerc-Blankenburg K.P., Chen R., Chen Z., Davis C.,
RA   Delgado O., Dinh H.H., Dong W., Draper H., Ernst S., Fu G.,
RA   Gonzalez-Garay M.L., Garcia D.K., Gillett W., Gu J., Hao B.,
RA   Haugen E., Havlak P., He X., Hennig S., Hu S., Huang W., Jackson L.R.,
RA   Jacob L.S., Kelly S.H., Kube M., Levy R., Li Z., Liu B., Liu J.,
RA   Liu W., Lu J., Maheshwari M., Nguyen B.V., Okwuonu G.O., Palmeiri A.,
RA   Pasternak S., Perez L.M., Phelps K.A., Plopper F.J., Qiang B.,
RA   Raymond C., Rodriguez R., Saenphimmachak C., Santibanez J., Shen H.,
RA   Shen Y., Subramanian S., Tabor P.E., Verduzco D., Waldron L., Wang J.,
RA   Wang J., Wang Q., Williams G.A., Wong G.K., Yao Z., Zhang J.,
RA   Zhang X., Zhao G., Zhou J., Zhou Y., Nelson D., Lehrach H.,
RA   Reinhardt R., Naylor S.L., Yang H., Olson M., Weinstock G.,
RA   Gibbs R.A.;
RT   "The DNA sequence, annotation and analysis of human chromosome 3.";
RL   Nature 440:1194-1198(2006).
RN   [3] {ECO:0000313|Ensembl:ENSP00000417498}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (JUL-2011) to UniProtKB.
CC   -!- CAUTION: Lacks conserved residue(s) required for the propagation
CC       of feature annotation. {ECO:0000256|PROSITE-ProRule:PRU00076}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AC069513; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC233280; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   RefSeq; NP_060876.5; NM_018406.6.
DR   UniGene; Hs.369646; -.
DR   ProteinModelPortal; E9PDY6; -.
DR   iPTMnet; E9PDY6; -.
DR   MaxQB; E9PDY6; -.
DR   PRIDE; E9PDY6; -.
DR   Ensembl; ENST00000463781; ENSP00000417498; ENSG00000145113.
DR   GeneID; 4585; -.
DR   UCSC; uc021xjp.3; human.
DR   CTD; 4585; -.
DR   EuPathDB; HostDB:ENSG00000145113.21; -.
DR   HGNC; HGNC:7514; MUC4.
DR   OpenTargets; ENSG00000145113; -.
DR   eggNOG; ENOG410IHUZ; Eukaryota.
DR   eggNOG; ENOG4111F6U; LUCA.
DR   GeneTree; ENSGT00730000110943; -.
DR   OMA; DTVIEIV; -.
DR   OrthoDB; EOG091G01CZ; -.
DR   TreeFam; TF330652; -.
DR   ChiTaRS; MUC4; human.
DR   GenomeRNAi; 4585; -.
DR   Proteomes; UP000005640; Chromosome 3.
DR   Bgee; ENSG00000145113; -.
DR   ExpressionAtlas; E9PDY6; baseline and differential.
DR   Genevisible; E9PDY6; HS.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0007160; P:cell-matrix adhesion; IEA:InterPro.
DR   InterPro; IPR005533; AMOP_dom.
DR   InterPro; IPR000742; EGF-like_dom.
DR   InterPro; IPR003886; NIDO_dom.
DR   InterPro; IPR001846; VWF_type-D.
DR   Pfam; PF06119; NIDO; 1.
DR   Pfam; PF00094; VWD; 1.
DR   SMART; SM00723; AMOP; 1.
DR   SMART; SM00181; EGF; 3.
DR   SMART; SM00539; NIDO; 1.
DR   SMART; SM00216; VWD; 1.
DR   PROSITE; PS50856; AMOP; 1.
DR   PROSITE; PS50026; EGF_3; 2.
DR   PROSITE; PS51220; NIDO; 1.
DR   PROSITE; PS51233; VWFD; 1.
PE   1: Evidence at protein level;
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   Disulfide bond {ECO:0000256|PROSITE-ProRule:PRU00076};
KW   EGF-like domain {ECO:0000256|PROSITE-ProRule:PRU00076};
KW   Membrane {ECO:0000256|SAM:Phobius};
KW   Proteomics identification {ECO:0000213|MaxQB:E9PDY6,
KW   ECO:0000213|PeptideAtlas:E9PDY6};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640};
KW   Signal {ECO:0000256|SAM:SignalP};
KW   Transmembrane {ECO:0000256|SAM:Phobius};
KW   Transmembrane helix {ECO:0000256|SAM:Phobius}.
FT   SIGNAL        1     28       {ECO:0000256|SAM:SignalP}.
FT   CHAIN        29   5412       {ECO:0000256|SAM:SignalP}.
FT                                /FTId=PRO_5003242818.
FT   TRANSMEM   5368   5394       Helical. {ECO:0000256|SAM:Phobius}.
FT   DOMAIN     4397   4552       NIDO. {ECO:0000259|PROSITE:PS51220}.
FT   DOMAIN     4553   4668       AMOP. {ECO:0000259|PROSITE:PS50856}.
FT   DOMAIN     4681   4916       VWFD. {ECO:0000259|PROSITE:PS51233}.
FT   DOMAIN     5118   5157       EGF-like. {ECO:0000259|PROSITE:PS50026}.
FT   DOMAIN     5321   5360       EGF-like. {ECO:0000259|PROSITE:PS50026}.
FT   DISULFID   5147   5156       {ECO:0000256|PROSITE-ProRule:PRU00076}.
SQ   SEQUENCE   5412 AA;  542307 MW;  CA70610C2C0FC5B0 CRC64;
     MKGARWRRVP WVSLSCLCLC LLPHVVPGTT EDTLITGSKT AAPVTSTGST TATLEGQSTA
     ASSRTSNQDI SASSQNHQTK STETTSKAQT DTLTQMMTST LFSSPSVHNV METAPPDEMT
     TSFPSSVTNT LMMTSKTITM TTSTDSTLGN TEETSTAGTE SSTPVTSAVS ITAGQEGQSR
     TTSWRTSIQD TSASSQNHWT RSTQTTRESQ TSTLTHRTTS TPSFSPSVHN VTGTVSQKTS
     PSGETATSSL CSVTNTSMMT SEKITVTTST GSTLGNPGET SSVPVTGSLM PVTSAALVTF
     DPEGQSPATF SRTSTQDTTA FSKNHQTQSV ETTRVSQINT LNTLTPVTTS TVLSSPSGFN
     PSGTVSQETF PSGETTTSSP SSVSNTFLVT SKVFRMPTSR DSTLGNTEET SLSVSGTISA
     ITSKVSTIWW SDTLSTALSP SSLPPKISTA FHTQQSEGAE TTGRPHERSS FSPGVSQEIF
     TLHETTTWPS SFSSKGHTTW SQTELPSTST GAATRLVTGN PSTGTAGTIP RVPSKVSAIG
     EPGEPTTYSS HSTTLPKTTG AGAQTQWTQE TGTTGEALLS SPSYSVTQMI KTATSPSSSP
     MLDRHTSQQI TTAPSTNHST IHSTSTSPQE SPAVSQRGHT QAPQTTQESQ TTRSVSPMTD
     TKTVTTPGSS FTASGHSPSE IVPQDAPTIS AATTFAPAPT GDGHTTQAPT TALQAAPSSH
     DATLGPSGGT SLSKTGALTL ANSVVSTPGG PEGQWTSASA STSPDTAAAM THTHQAESTE
     ASGQTQTSEP ASSGSRTTSA GTATPSSSGA SGTTPSGSEG ISTSGETTRF SSNPSRDSHT
     TQSTTELLSA SASHGAIPVS TGMASSIVPG TFHPTLSEAS TAGRPTGQSS PTSPSASPQE
     TAAISRMAQT QRTRTSRGSD TISLASQATD TFSTVPPTPP SITSTGLTSP QTETHTLSPS
     GSGKTFTTAL ISNATPLPVT YASSASTGHT TPLHVTDASS VSTGHATPLP VTSPSSVSTG
     HTTPLPVTDT SSESTGHVTP LPVTSFSSAS TGDSTPLPVT DTSSASTGHV TPLPVTSLSS
     ASTGDTTPLP VTDTSSASTG HATSLPVTDT SSVSTGHTTP LPVTDTSSAS TGHATSLPVT
     DTSSVSTGHT TPLHVTDASS ASTGQATPLP VTSLSSVSTG DTTPLPVTSP SSASTGHATP
     LLVTDTSSAS TGHATPLPVT DASSVSTDHA TSLPVTIPSA ASTGHTTPLP VTDTSSASTG
     QATSLLVTDT SSVSTGDTTP LPVTSTSSAS TGHVTPLHVT SPSSASTGHA TPLPVTSLSS
     ASTGDTMPLP VTSPSSASTG DTTPLPVTDA SSVSTGHTTP LHVTDASSAS TGQATPLPVT
     SLSSVSTGDT TPLPVTSPSS ASTGHATPLL VTDTSSASTG HATPLPVTDA SSVSTDHATS
     LPVTIPSAAS TGHTTPLPVT DTSSASTGQA TSLLVTDTSS VSTGDTTPLP VTSTSSASTG
     HVTPLHVTSP SSASTGHATP LPVTSLSSAS TGDTMPLPVT SPSSASTGDT TPLPVTDASS
     VSTGHTTPLP VTSPSSASTG HTTPLPVTDT SSASKGDTTP LPVTSPSSAS TGHTTPLPVT
     DTSSASTGDT TPLPVTNASS LSTGHATPLH VTSPSSASTG HATPLPVTST SSASTGHATP
     LPVTGLSSAT TDDTTRLPVT DVSSASTGQA TPLPVTSLSS VSTGDTTPLP VTSPSSASTG
     HASPLLVTDA SSASTGQATP LPVTDTSSVS TAHATPLPVT GLSSASTDDT TRLPVTDVSS
     ASTGQAIPLP VTSPSSASTG DTTPLPVTDA SSASTGDTTS LPVTIPSSAS SGHTTSLPVT
     DASSVSTGHA TSLLVTDASS VSTGDTTPLP VTDTNSASTG DTTPLHVTDA SSVSTGHATS
     LPVTSLSSAS TGDTTPLPVT SPSSASSGHT TPLPVTDASS VPTGHATSLP VTDASSVSTG
     HATPLPVTDA SSVSTGHATP LPVTDTSSVS TGQATPLPVT SLSSASTGDT TPLPVTDTSS
     ASTGQDTPLP VTSLSSVSTG DTTPLPVTNP SSASTGHATP LLVTDASSIS TGHATSLLVT
     DASSVSTGHA TALHDTDASS LSTGDTTPLP VTSPSSTSTG DTTPLPVTET SSVSTGHATS
     LPVTDTSSAS TGHATSLPVT DTSSASTGHA TPLPVTDTSS ASTGQATPLP VTSPSSASTG
     HAIPLLVTDT SSASTGQATP LPVTSLSSAS TGDTTPLPVT DASSVSTGHA TSLPVTSLSS
     VSTGDTTPLP VTSPSSASTG HATPLHVTDA SSASTGHATP LPVTSLSSAS TGDTTPLPVT
     SPSSASTGHA TPLHVTDASS VSTGDTTPLP VTSSSSASSG HTTPLPVTDA SSASTGDTTP
     LPVTDTSSAS TGHATHLPVT GLSSASTGDT TRLPVTNVSS ASTGHATPLP VTSTSSASTG
     DTTPLPGTDT SSVSTGHTTP LLVTDASSVS TGDTTRLPVT SPSSASTGHT TPLPVTDTPS
     ASTGDTTPLP VTNASSLSTR HATSLHVTSP SSASTGHATS LPVTDTSAAS TGHATPLPVT
     STSSASTGDT TPLPVTDTYS ASTGQATPLP VTSLSSVSTG DTTPLPVTSP SSASTGHATP
     LLVTDASSAS TGQATPLPVT SLSSVSTGDT TPLPVTSPSS ASTGHATSLP VTDTSSASTG
     DTTSLPVTDT SSAYTGDTTS LPVTDTSSSS TGDTTPLLVT ETSSVSTGDT TPLPVTDTSS
     ASTGHATPLP VTNTSSVSTG HATPLHVTSP SSASTGHTTP LPVTDASSVS TGHATSLPVT
     DASSVFTGHA TSLPVTIPSS ASSGHTTPLP VTDASSVSTG HATSLPVTDA SSVSTGHATP
     LPVTDASSVS TGHATPLPLT SLSSVSTGDT TPLPVTDTSS ASTGQATPLP VTSLSSVSTG
     DTTPLPVTDT SSASTGHATS LPVTDTSSAS TGHATPLPDT DTSSASTGHA TLLPVTDTSS
     ASIGHATSLP VTDTSSISTG HATPLHVTSP SSASTGHATP LPVTDTSSAS TGHANPLHVT
     SPSSASTGHA TPLPVTDTSS ASTGHATPLP VTSLSSVSTG DTTPLPVTSP SSASTGHTTP
     LPVTDTSSAS TGQATALPVT STSSASTGDT TPLPVTDTSS ASTGQATPLP VTSLSSVSTG
     DTTPLPVTSP SSASTGHATP LLVTDASSAS TGQATPLPVT SLSSVSTGDT TPLPVTSPSS
     ASTGHATSLP VTDTSSASTG DTTSLPVTDT SSAYTGDTTS LPVTDTSSSS TGDTTPLLVT
     ETSSVSTGHA TPLLVTDASS ASTGHATPLH VTSPSSASTG DTTPVPVTDT SSVSTGHATP
     LPVTGLSSAS TGDTTRLPVT DISSASTGQA TPLPVTNTSS VSTGDTMPLP VTSPSSASTG
     HATPLPVTST SSASTGHATP VPVTSTSSAS TGHTTPLPVT DTSSASTGDT TPLPVTSPSS
     ASTGHTTPLH VTIPSSASTG DTSTLPVTGA SSASTGHATP LPVTDTSSVS TGHATPLPVT
     SLSSVSTGDT TPLPVTDASS ASTGQATPLP VTSLSSVSTG DTTPLLVTDA SSVSTGHATP
     LPVTDTSSAS TGDTTRLPVT DTSSASTGQA TPLPVTSLSS VSTGDTTPLL VTDASSVSTG
     HATPLPVTDT SSASTGDTTR LPVTDTSSAS TGQATPLPVT IPSSSSSGHT TPLPVTSTSS
     VSTGHVTPLH VTSPSSASTG HVTPLPVTST SSASTGHATP LLVTDASSVS TGHATPLPVT
     DASSASTGDT TPLPVTDTSS ASTGQATPLP VTSLSSVSTG DTTPLPVTDA SSASTGHATP
     LPVTIPSSVS TGDTMPLPVT SPSSASTGHA TPLPVTGLSS ASTGDTTPLP VTDTSSASTR
     HATPLPVTDT SSASTDDTTR LPVTDVSSAS TGHATPLPVT STSSASTGDT TPLPVTDTSS
     VSTGHATSLP VTSRSSASTG HATPLPVTDT SSVSTGHATP LPVTSTSSVS TGHATPLPVT
     SPSSASTGHA TPVPVTSTSS ASTGDTTPLP VTNASSLSTG HATPLHVTSP SSASRGDTST
     LPVTDASSAS TGHATPLPLT SLSSVSTGDT TPLPVTDTSS ASTGQATPLP VTSLSSVSTG
     DTTPLPVTIP SSASSGHTTS LPVTDASSVS TGHGTPLPVT STSSASTGDT TPLPVTDTSS
     ASTGHATPLP VTDTSSASTG HATPLPVTSL SSVSTGHATP LAVSSATSAS TVSSDSPLKM
     ETPGMTTPSL KTDGGRRTAT SPPPTTSQTI ISTIPSTAMH TRSTAAPIPI LPERGVSLFP
     YGAGAGDLEF VRRTVDFTSP LFKPATGFPL GSSLRDSLYF TDNGQIIFPE SDYQIFSYPN
     PLPTGFTGRD PVALVAPFWD DADFSTGRGT TFYQEYETFY GEHSLLVQQA ESWIRKMTNN
     GGYKARWALK VTWVNAHAYP AQWTLGSNTY QAILSTDGSR SYALFLYQSG GMQWDVAQRS
     GNPVLMGFSS GDGYFENSPL MSQPVWERYR PDRFLNSNSG LQGLQFYRLH REERPNYRLE
     CLQWLKSQPR WPSWGWNQVS CPCSWQQGRR DLRFQPVSIG RWGLGSRQLC SFTSWRGGVC
     CSYGPWGEFR EGWHVQRPWQ LAQELEPQSW CCRWNDKPYL CALYQQRRPH VGCATYRPPQ
     PAWMFGDPHI TTLDGVSYTF NGLGDFLLVG AQDGNSSFLL QGRTAQTGSA QATNFIAFAA
     QYRSSSLGPV TVQWLLEPHD AIRVLLDNQT VTFQPDHEDG GGQETFNATG VLLSRNGSEV
     SASFDGWATV SVIALSNILH ASASLPPEYQ NRTEGLLGVW NNNPEDDFRM PNGSTIPPGS
     PEEMLFHFGM TWQINGTGLL GKRNDQLPSN FTPVFYSQLQ KNSSWAEHLI SNCDGDSSCI
     YDTLALRNAS IGLHTREVSK NYEQANATLN QYPPSINGGR VIEAYKGQTT LIQYTSNAED
     ANFTLRDSCT DLELFENGTL LWTPKSLEPF TLEILARSAK IGLASALQPR TVVCHCNAES
     QCLYNQTSRV GNSSLEVAGC KCDGGTFGRY CEGSEDACEE PCFPSVHCVP GKGCEACPPN
     LTGDGRHCAA LGSSFLCQNQ SCPVNYCYNQ GHCYISQTLG CQPMCTCPPA FTDSRCFLAG
     NNFSPTVNLE LPLRVIQLLL SEEENASMAE VNASVAYRLG TLDMRAFLRN SQVERIDSAA
     PASGSPIQHW MVISEFQYRP RGPVIDFLNN QLLAAVVEAF LYHVPRRSEE PRNDVVFQPI
     SGEDVRDVTA LNVSTLKAYF RCDGYKGYDL VYSPQSGFTC VSPCSRGYCD HGGQCQHLPS
     GPRCSCVSFS IYTAWGEHCE HLSMKLDAFF GIFFGALGGL LLLGVGTFVV LRFWGCSGAR
     FSYFLNSAEA LP
//
ID   MUC4_HUMAN              Reviewed;        2169 AA.
AC   Q99102; O95938; Q9GZM2; Q9GZV6; Q9H481; Q9H482; Q9H483; Q9H484;
AC   Q9H485; Q9H486; Q9H487; Q9H4D6; Q9H4D8; Q9NPJ0; Q9NY09; Q9NY75;
AC   Q9NY76; Q9NY77; Q9NY78; Q9NY79; Q9NY80; Q9NY81;
DT   01-JUN-1994, integrated into UniProtKB/Swiss-Prot.
DT   28-JUN-2011, sequence version 4.
DT   25-APR-2018, entry version 145.
DE   RecName: Full=Mucin-4;
DE            Short=MUC-4;
DE   AltName: Full=Ascites sialoglycoprotein;
DE            Short=ASGP;
DE   AltName: Full=Pancreatic adenocarcinoma mucin;
DE   AltName: Full=Testis mucin;
DE   AltName: Full=Tracheobronchial mucin;
DE   Contains:
DE     RecName: Full=Mucin-4 alpha chain;
DE     AltName: Full=Ascites sialoglycoprotein 1;
DE              Short=ASGP-1;
DE   Contains:
DE     RecName: Full=Mucin-4 beta chain;
DE     AltName: Full=Ascites sialoglycoprotein 2;
DE              Short=ASGP-2;
DE   Flags: Precursor;
GN   Name=MUC4;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 12 AND 13), PARTIAL NUCLEOTIDE
RP   SEQUENCE [MRNA] (ISOFORMS 2; 3; 11; 15; 16 AND 17), TISSUE
RP   SPECIFICITY, AND VARIANT ASP-1081.
RC   TISSUE=Lung, and Testis;
RX   PubMed=10880978; DOI=10.1046/j.1432-1327.2000.01504.x;
RA   Moniaux N., Escande F., Batra S.K., Porchet N., Laine A.,
RA   Aubert J.-P.;
RT   "Alternative splicing generates a family of putative secreted and
RT   membrane-associated MUC4 mucins.";
RL   Eur. J. Biochem. 267:4536-4544(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1; 2; 3; 5; 7; 8; 9; 10 AND 11),
RP   TISSUE SPECIFICITY, AND VARIANTS PRO-41 AND ASP-1081.
RC   TISSUE=Pancreatic tumor;
RX   PubMed=10920259; DOI=10.1093/oxfordjournals.jbchem.a022746;
RA   Choudhury A., Moniaux N., Winpenny J.P., Hollingsworth M.A.,
RA   Aubert J.-P., Batra S.K.;
RT   "Human MUC4 mucin cDNA and its variants in pancreatic carcinoma.";
RL   J. Biochem. 128:233-243(2000).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS PRO-41; ASP-1081 AND
RP   SER-1578.
RX   PubMed=12084055; DOI=10.1046/j.1432-1033.2002.02988.x;
RA   Desseyn J.-L., Clavereau I., Laine A.;
RT   "Cloning, chromosomal localization and characterization of the murine
RT   mucin gene orthologous to human MUC4.";
RL   Eur. J. Biochem. 269:3150-3159(2002).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1014-2169 (ISOFORM 1), TISSUE
RP   SPECIFICITY, AND VARIANT ASP-1081.
RC   TISSUE=Colon mucosa;
RX   PubMed=10024507; DOI=10.1042/bj3380325;
RA   Moniaux N., Nollet S., Porchet N., Degand P., Laine A., Aubert J.-P.;
RT   "Complete sequence of the human mucin MUC4: a putative cell membrane-
RT   associated mucin.";
RL   Biochem. J. 338:325-333(1999).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1014-2169, AND VARIANT ASP-1081.
RX   PubMed=12153560; DOI=10.1046/j.1432-1033.2002.03032.x;
RA   Escande F., Lemaitre L., Moniaux N., Batra S.K., Aubert J.-P.,
RA   Buisine M.P.;
RT   "Genomic organization of MUC4 mucin gene: towards the characterization
RT   of splice variants.";
RL   Eur. J. Biochem. 269:3637-3644(2002).
RN   [6]
RP   PRELIMINARY PARTIAL NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=1673336; DOI=10.1016/0006-291X(91)91580-6;
RA   Porchet N., van Cong N., Dufosse J., Audie J.P., Guyonnet-Duperat V.,
RA   Gross M.S., Denis C., Degand P., Bernheim A., Aubert J.-P.;
RT   "Molecular cloning and chromosomal localization of a novel human
RT   tracheo-bronchial mucin cDNA containing tandemly repeated sequences of
RT   48 base pairs.";
RL   Biochem. Biophys. Res. Commun. 175:414-422(1991).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16641997; DOI=10.1038/nature04728;
RA   Muzny D.M., Scherer S.E., Kaul R., Wang J., Yu J., Sudbrak R.,
RA   Buhay C.J., Chen R., Cree A., Ding Y., Dugan-Rocha S., Gill R.,
RA   Gunaratne P., Harris R.A., Hawes A.C., Hernandez J., Hodgson A.V.,
RA   Hume J., Jackson A., Khan Z.M., Kovar-Smith C., Lewis L.R.,
RA   Lozado R.J., Metzker M.L., Milosavljevic A., Miner G.R., Morgan M.B.,
RA   Nazareth L.V., Scott G., Sodergren E., Song X.-Z., Steffen D., Wei S.,
RA   Wheeler D.A., Wright M.W., Worley K.C., Yuan Y., Zhang Z., Adams C.Q.,
RA   Ansari-Lari M.A., Ayele M., Brown M.J., Chen G., Chen Z.,
RA   Clendenning J., Clerc-Blankenburg K.P., Chen R., Chen Z., Davis C.,
RA   Delgado O., Dinh H.H., Dong W., Draper H., Ernst S., Fu G.,
RA   Gonzalez-Garay M.L., Garcia D.K., Gillett W., Gu J., Hao B.,
RA   Haugen E., Havlak P., He X., Hennig S., Hu S., Huang W., Jackson L.R.,
RA   Jacob L.S., Kelly S.H., Kube M., Levy R., Li Z., Liu B., Liu J.,
RA   Liu W., Lu J., Maheshwari M., Nguyen B.-V., Okwuonu G.O., Palmeiri A.,
RA   Pasternak S., Perez L.M., Phelps K.A., Plopper F.J., Qiang B.,
RA   Raymond C., Rodriguez R., Saenphimmachak C., Santibanez J., Shen H.,
RA   Shen Y., Subramanian S., Tabor P.E., Verduzco D., Waldron L., Wang J.,
RA   Wang J., Wang Q., Williams G.A., Wong G.K.-S., Yao Z., Zhang J.,
RA   Zhang X., Zhao G., Zhou J., Zhou Y., Nelson D., Lehrach H.,
RA   Reinhardt R., Naylor S.L., Yang H., Olson M., Weinstock G.,
RA   Gibbs R.A.;
RT   "The DNA sequence, annotation and analysis of human chromosome 3.";
RL   Nature 440:1194-1198(2006).
RN   [8]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=12102554; DOI=10.1016/S0079-6603(02)71043-X;
RA   Carraway K.L., Perez A., Idris N., Jepson S., Arango M.E., Komatsu M.,
RA   Haq B., Price-Schiavi S.A., Zhang J., Carraway C.A.;
RT   "Muc4/sialomucin complex, the intramembrane ErbB2 ligand, in cancer
RT   and epithelia: to protect and to survive.";
RL   Prog. Nucleic Acid Res. Mol. Biol. 71:149-185(2002).
RN   [9]
RP   FUNCTION.
RX   PubMed=16049287; DOI=10.1136/jcp.2004.023572;
RA   Saitou M., Goto M., Horinouchi M., Tamada S., Nagata K., Hamada T.,
RA   Osako M., Takao S., Batra S.K., Aikou T., Imai K., Yonezawa S.;
RT   "MUC4 expression is a novel prognostic factor in patients with
RT   invasive ductal carcinoma of the pancreas.";
RL   J. Clin. Pathol. 58:845-852(2005).
RN   [10]
RP   TISSUE SPECIFICITY, AND FUNCTION.
RX   PubMed=16814944; DOI=10.1016/j.prp.2006.04.002;
RA   Karg A., Dinc Z.A., Basok O., Ucvet A.;
RT   "MUC4 expression and its relation to ErbB2 expression, apoptosis,
RT   proliferation, differentiation, and tumor stage in non-small cell lung
RT   cancer (NSCLC).";
RL   Pathol. Res. Pract. 202:577-583(2006).
RN   [11]
RP   DEVELOPMENTAL STAGE, AND FUNCTION.
RX   PubMed=16914178; DOI=10.1016/j.tice.2006.06.004;
RA   Zhang J., Yasin M., Carraway C.A., Carraway K.L.;
RT   "MUC4 expression and localization in gastrointestinal tract and skin
RT   of human embryos.";
RL   Tissue Cell 38:271-275(2006).
RN   [12]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-1809.
RC   TISSUE=Milk;
RX   PubMed=18780401; DOI=10.1002/pmic.200701057;
RA   Picariello G., Ferranti P., Mamone G., Roepstorff P., Addeo F.;
RT   "Identification of N-linked glycoproteins in human milk by hydrophilic
RT   interaction liquid chromatography and mass spectrometry.";
RL   Proteomics 8:3833-3847(2008).
CC   -!- FUNCTION: May play a role in tumor progression. Ability to promote
CC       tumor growth may be mainly due to repression of apoptosis as
CC       opposed to proliferation. Has anti-adhesive properties. Seems to
CC       alter cellular behavior through both anti-adhesive effects on
CC       cell-cell and cell-extracellular matrix interactions and in its
CC       ability to act as an intramembrane ligand for ERBB2. Plays an
CC       important role in cell proliferation and differentiation of
CC       epithelial cells by inducing specific phosphorylation of ERBB2.
CC       The MUC4-ERBB2 complex causes site-specific phosphorylation of the
CC       ERBB2 'Tyr-1248'. In polarized epithelial cells segregates ERBB2
CC       and other ERBB receptors and prevents ERBB2 from acting as a
CC       coreceptor. The interaction with ERBB2 leads to enhanced
CC       expression of CDKN1B. The formation of a MUC4-ERBB2-ERBB3-NRG1
CC       complex leads to down-regulation of CDKN1B, resulting in
CC       repression of apoptosis and stimulation of proliferation.
CC       {ECO:0000269|PubMed:12102554, ECO:0000269|PubMed:16049287,
CC       ECO:0000269|PubMed:16814944, ECO:0000269|PubMed:16914178}.
CC   -!- SUBUNIT: A heterodimeric complex, composed of a mucin-4 alpha
CC       chain and a cysteine-rich transmembrane mucin-4 beta chain. Mucin-
CC       4 beta chain interacts with ERBB2 via the EGF-like domain 1. In
CC       nonpolarized cells, associates with ERBB2 and ERBB3 (By
CC       similarity). {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Single-pass membrane
CC       protein {ECO:0000305}. Secreted {ECO:0000269|PubMed:12102554}.
CC       Note=Isoforms lacking the Cys-rich region, EGF-like domains and
CC       transmembrane region are secreted. Secretion occurs by splicing or
CC       proteolytic processing.
CC   -!- SUBCELLULAR LOCATION: Mucin-4 beta chain: Cell membrane; Single-
CC       pass membrane protein.
CC   -!- SUBCELLULAR LOCATION: Mucin-4 alpha chain: Secreted.
CC   -!- SUBCELLULAR LOCATION: Isoform 3: Cell membrane; Single-pass
CC       membrane protein.
CC   -!- SUBCELLULAR LOCATION: Isoform 11: Secreted.
CC   -!- SUBCELLULAR LOCATION: Isoform 15: Secreted.
CC   -!- SUBCELLULAR LOCATION: Isoform 17: Cell membrane; Single-pass
CC       membrane protein.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=14;
CC         Comment=Additional isoforms exist.;
CC       Name=1;
CC         IsoId=Q99102-1; Sequence=Displayed;
CC       Name=2; Synonyms=Sv12, Sv13;
CC         IsoId=Q99102-2; Sequence=VSP_022658, VSP_022659;
CC         Note=May be produced at very low levels due to a premature stop
CC         codon in the mRNA, leading to nonsense-mediated mRNA decay.;
CC       Name=3; Synonyms=Sv20;
CC         IsoId=Q99102-3; Sequence=VSP_022674, VSP_022675;
CC         Note=May be produced at very low levels due to a premature stop
CC         codon in the mRNA, leading to nonsense-mediated mRNA decay.;
CC       Name=5; Synonyms=Sv18, Sv19;
CC         IsoId=Q99102-5; Sequence=VSP_022661, VSP_022669, VSP_022670;
CC         Note=May be produced at very low levels due to a premature stop
CC         codon in the mRNA, leading to nonsense-mediated mRNA decay.;
CC       Name=7; Synonyms=Sv16;
CC         IsoId=Q99102-7; Sequence=VSP_022656, VSP_022665;
CC         Note=May be produced at very low levels due to a premature stop
CC         codon in the mRNA, leading to nonsense-mediated mRNA decay.;
CC       Name=8; Synonyms=Sv15;
CC         IsoId=Q99102-8; Sequence=VSP_022657, VSP_022664;
CC         Note=May be produced at very low levels due to a premature stop
CC         codon in the mRNA, leading to nonsense-mediated mRNA decay.;
CC       Name=9; Synonyms=Sv11;
CC         IsoId=Q99102-9; Sequence=VSP_022652, VSP_022655;
CC         Note=Dubious isoform produced through aberrant splice sites.;
CC       Name=10; Synonyms=Sv3, Sv17;
CC         IsoId=Q99102-10; Sequence=VSP_022661;
CC       Name=11; Synonyms=Sv2;
CC         IsoId=Q99102-11; Sequence=VSP_022653, VSP_022663;
CC         Note=May be produced at very low levels due to a premature stop
CC         codon in the mRNA, leading to nonsense-mediated mRNA decay.;
CC       Name=12; Synonyms=SvX;
CC         IsoId=Q99102-12; Sequence=VSP_022650;
CC         Note=May be preferentially expressed in tumor tissues.;
CC       Name=13; Synonyms=SvY;
CC         IsoId=Q99102-13; Sequence=VSP_022651;
CC         Note=May be preferentially expressed in tumor tissues.;
CC       Name=15; Synonyms=Sv1;
CC         IsoId=Q99102-15; Sequence=VSP_022654, VSP_022662;
CC         Note=May be produced at very low levels due to a premature stop
CC         codon in the mRNA, leading to nonsense-mediated mRNA decay.;
CC       Name=16; Synonyms=Sv6;
CC         IsoId=Q99102-16; Sequence=VSP_022671, VSP_022673;
CC         Note=Dubious isoform produced through aberrant splice sites.;
CC       Name=17; Synonyms=Sv8;
CC         IsoId=Q99102-17; Sequence=VSP_022672;
CC         Note=Dubious isoform produced through aberrant splice sites.;
CC   -!- TISSUE SPECIFICITY: Expressed in the thymus, thyroid, lung,
CC       trachea, esophagus, stomach, small intestine, colon, testis,
CC       prostate, ovary, uterus, placenta, and mammary and salivary
CC       glands. Expressed in carcinomas arising from some of these
CC       epithelia, such as lung cancers, squamous cell carcinomas of the
CC       upper aerodigestive tract, mammary carcinomas, biliary tract,
CC       colon, and cervix cancers. Minimally or not expressed in the
CC       normal pancreas or chronic pancreatitis, but is highly expressed
CC       in pancreatic tumors and pancreatic tumor cell lines.
CC       {ECO:0000269|PubMed:10024507, ECO:0000269|PubMed:10880978,
CC       ECO:0000269|PubMed:10920259, ECO:0000269|PubMed:16814944}.
CC   -!- DEVELOPMENTAL STAGE: Expressed early in the primitive gut before
CC       respiratory and digestive epithelial cells have acquired their
CC       tissue and cell specificity. Expressed at the basal surface of the
CC       epithelium from week 14 to 26 weeks and then predominantly
CC       localized in only parietal cells. Immediately before birth, found
CC       in the cytoplasm of the mucous columnar epithelial cells. In the
CC       embryo expressed in skin, then disappears late in gestation.
CC       {ECO:0000269|PubMed:16914178}.
CC   -!- PTM: Proteolytically cleaved into 2 chains, mucin-4 alpha chain
CC       and mucin-4 beta chain.
CC   -!- PTM: mucrnin-4 alpha chain is highly O-glycosylated.
CC       {ECO:0000269|PubMed:18780401}.
CC   -!- PTM: mucin-4 beta chain is predominantly N-glycosylated.
CC       {ECO:0000269|PubMed:18780401}.
CC   -!- MISCELLANEOUS: Expression is a very useful predictor of poor
CC       prognosis in patients with invasive ductal carcinoma and
CC       intrahepatic cholangiocarcinoma, mass forming type (IDC,ICC-MF).
CC       Patients with IDC or ICC-MF who have high MUC4 expression had a
CC       worse survival rate than those with low MUC4 expression.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAA63230.1; Type=Miscellaneous discrepancy; Note=May be derived from an intron translation.; Evidence={ECO:0000305};
CC       Sequence=CAC14139.1; Type=Frameshift; Positions=1171; Evidence={ECO:0000305};
CC       Sequence=CAC14141.1; Type=Frameshift; Positions=1256; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Mucin database;
CC       URL="http://www.medkem.gu.se/mucinbiology/databases/";
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/MUC4ID41459ch3q29.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AJ242541; CAB85597.1; -; mRNA.
DR   EMBL; AJ242542; CAB85598.1; -; mRNA.
DR   EMBL; AJ242543; CAB85599.1; -; mRNA.
DR   EMBL; AJ242544; CAB85600.1; -; mRNA.
DR   EMBL; AJ242545; CAB85601.1; -; mRNA.
DR   EMBL; AJ242546; CAB85602.1; -; mRNA.
DR   EMBL; AJ242547; CAB85603.1; -; mRNA.
DR   EMBL; AJ242548; CAB85604.1; -; mRNA.
DR   EMBL; AJ242549; CAB85605.1; -; mRNA.
DR   EMBL; AJ242550; CAB85606.1; -; mRNA.
DR   EMBL; AJ276359; CAB81773.1; -; mRNA.
DR   EMBL; AJ277412; CAC10061.1; -; mRNA.
DR   EMBL; AJ277505; CAC14585.1; -; mRNA.
DR   EMBL; AJ400633; CAC10062.1; -; mRNA.
DR   EMBL; AJ400849; CAC14134.1; -; mRNA.
DR   EMBL; AJ400850; CAC14135.1; -; mRNA.
DR   EMBL; AJ400851; CAC14136.1; -; mRNA.
DR   EMBL; AJ400852; CAC14137.1; -; mRNA.
DR   EMBL; AJ400855; CAC14140.1; -; mRNA.
DR   EMBL; AJ400853; CAC14138.1; -; mRNA.
DR   EMBL; AJ400854; CAC14139.1; ALT_FRAME; mRNA.
DR   EMBL; AJ400856; CAC14141.1; ALT_FRAME; mRNA.
DR   EMBL; AJ400857; CAC14142.1; -; mRNA.
DR   EMBL; AJ400858; CAC14143.1; -; mRNA.
DR   EMBL; AF522055; AAM66747.1; -; Genomic_DNA.
DR   EMBL; AF522031; AAM66747.1; JOINED; Genomic_DNA.
DR   EMBL; AF522032; AAM66747.1; JOINED; Genomic_DNA.
DR   EMBL; AF522033; AAM66747.1; JOINED; Genomic_DNA.
DR   EMBL; AF522034; AAM66747.1; JOINED; Genomic_DNA.
DR   EMBL; AF522035; AAM66747.1; JOINED; Genomic_DNA.
DR   EMBL; AF522036; AAM66747.1; JOINED; Genomic_DNA.
DR   EMBL; AF522037; AAM66747.1; JOINED; Genomic_DNA.
DR   EMBL; AF522038; AAM66747.1; JOINED; Genomic_DNA.
DR   EMBL; AF522039; AAM66747.1; JOINED; Genomic_DNA.
DR   EMBL; AF522040; AAM66747.1; JOINED; Genomic_DNA.
DR   EMBL; AF522041; AAM66747.1; JOINED; Genomic_DNA.
DR   EMBL; AF522042; AAM66747.1; JOINED; Genomic_DNA.
DR   EMBL; AF522043; AAM66747.1; JOINED; Genomic_DNA.
DR   EMBL; AF522044; AAM66747.1; JOINED; Genomic_DNA.
DR   EMBL; AF522045; AAM66747.1; JOINED; Genomic_DNA.
DR   EMBL; AF522046; AAM66747.1; JOINED; Genomic_DNA.
DR   EMBL; AF522047; AAM66747.1; JOINED; Genomic_DNA.
DR   EMBL; AF522048; AAM66747.1; JOINED; Genomic_DNA.
DR   EMBL; AF522049; AAM66747.1; JOINED; Genomic_DNA.
DR   EMBL; AF522050; AAM66747.1; JOINED; Genomic_DNA.
DR   EMBL; AF522051; AAM66747.1; JOINED; Genomic_DNA.
DR   EMBL; AF522052; AAM66747.1; JOINED; Genomic_DNA.
DR   EMBL; AF522053; AAM66747.1; JOINED; Genomic_DNA.
DR   EMBL; AF522054; AAM66747.1; JOINED; Genomic_DNA.
DR   EMBL; AJ010901; CAB38059.1; -; mRNA.
DR   EMBL; AJ430032; CAD22550.1; -; Genomic_DNA.
DR   EMBL; AJ430033; CAD22550.1; JOINED; Genomic_DNA.
DR   EMBL; AJ430034; CAD22550.1; JOINED; Genomic_DNA.
DR   EMBL; M64594; AAA63230.1; ALT_SEQ; mRNA.
DR   EMBL; AC069513; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC233280; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   CCDS; CCDS3310.1; -. [Q99102-13]
DR   CCDS; CCDS3311.1; -. [Q99102-12]
DR   PIR; PN0012; PN0012.
DR   RefSeq; NP_004523.3; NM_004532.5. [Q99102-13]
DR   RefSeq; NP_060876.5; NM_018406.6.
DR   RefSeq; NP_612154.2; NM_138297.4. [Q99102-12]
DR   UniGene; Hs.369646; -.
DR   SMR; Q99102; -.
DR   IntAct; Q99102; 1.
DR   STRING; 9606.ENSP00000417498; -.
DR   GlyConnect; 374; -.
DR   iPTMnet; Q99102; -.
DR   PhosphoSitePlus; Q99102; -.
DR   UniCarbKB; Q99102; -.
DR   BioMuta; MUC4; -.
DR   DMDM; 338817990; -.
DR   MaxQB; Q99102; -.
DR   PaxDb; Q99102; -.
DR   PeptideAtlas; Q99102; -.
DR   PRIDE; Q99102; -.
DR   TopDownProteomics; Q99102-3; -. [Q99102-3]
DR   Ensembl; ENST00000346145; ENSP00000304207; ENSG00000145113. [Q99102-13]
DR   Ensembl; ENST00000349607; ENSP00000338109; ENSG00000145113. [Q99102-12]
DR   GeneID; 4585; -.
DR   KEGG; hsa:4585; -.
DR   UCSC; uc003fvo.5; human. [Q99102-1]
DR   CTD; 4585; -.
DR   DisGeNET; 4585; -.
DR   EuPathDB; HostDB:ENSG00000145113.21; -.
DR   GeneCards; MUC4; -.
DR   H-InvDB; HIX0003957; -.
DR   H-InvDB; HIX0163449; -.
DR   HGNC; HGNC:7514; MUC4.
DR   HPA; CAB013536; -.
DR   HPA; HPA005895; -.
DR   MIM; 158372; gene.
DR   neXtProt; NX_Q99102; -.
DR   OpenTargets; ENSG00000145113; -.
DR   PharmGKB; PA31319; -.
DR   eggNOG; ENOG410IHUZ; Eukaryota.
DR   eggNOG; ENOG4111F6U; LUCA.
DR   GeneTree; ENSGT00730000110943; -.
DR   HOVERGEN; HBG081997; -.
DR   InParanoid; Q99102; -.
DR   KO; K22017; -.
DR   Reactome; R-HSA-5083625; Defective GALNT3 causes familial hyperphosphatemic tumoral calcinosis (HFTC).
DR   Reactome; R-HSA-5083632; Defective C1GALT1C1 causes Tn polyagglutination syndrome (TNPS).
DR   Reactome; R-HSA-5083636; Defective GALNT12 causes colorectal cancer 1 (CRCS1).
DR   Reactome; R-HSA-5621480; Dectin-2 family.
DR   Reactome; R-HSA-913709; O-linked glycosylation of mucins.
DR   Reactome; R-HSA-977068; Termination of O-glycan biosynthesis.
DR   SIGNOR; Q99102; -.
DR   ChiTaRS; MUC4; human.
DR   GeneWiki; MUC4; -.
DR   GenomeRNAi; 4585; -.
DR   PRO; PR:Q99102; -.
DR   Proteomes; UP000005640; Chromosome 3.
DR   Bgee; ENSG00000145113; -.
DR   ExpressionAtlas; Q99102; baseline and differential.
DR   Genevisible; Q99102; HS.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0005615; C:extracellular space; HDA:UniProtKB.
DR   GO; GO:0005796; C:Golgi lumen; TAS:Reactome.
DR   GO; GO:0005887; C:integral component of plasma membrane; TAS:ProtInc.
DR   GO; GO:0016020; C:membrane; NAS:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0005578; C:proteinaceous extracellular matrix; NAS:UniProtKB.
DR   GO; GO:0031982; C:vesicle; HDA:UniProtKB.
DR   GO; GO:0005176; F:ErbB-2 class receptor binding; TAS:ProtInc.
DR   GO; GO:0030197; F:extracellular matrix constituent, lubricant activity; NAS:UniProtKB.
DR   GO; GO:0007160; P:cell-matrix adhesion; IEA:InterPro.
DR   GO; GO:0030277; P:maintenance of gastrointestinal epithelium; IMP:UniProtKB.
DR   GO; GO:0016266; P:O-glycan processing; TAS:Reactome.
DR   GO; GO:0002223; P:stimulatory C-type lectin receptor signaling pathway; TAS:Reactome.
DR   InterPro; IPR005533; AMOP_dom.
DR   InterPro; IPR000742; EGF-like_dom.
DR   InterPro; IPR003886; NIDO_dom.
DR   InterPro; IPR001846; VWF_type-D.
DR   Pfam; PF06119; NIDO; 1.
DR   Pfam; PF00094; VWD; 1.
DR   SMART; SM00723; AMOP; 1.
DR   SMART; SM00181; EGF; 3.
DR   SMART; SM00539; NIDO; 1.
DR   SMART; SM00216; VWD; 1.
DR   PROSITE; PS50856; AMOP; 1.
DR   PROSITE; PS00022; EGF_1; 1.
DR   PROSITE; PS50026; EGF_3; 2.
DR   PROSITE; PS51220; NIDO; 1.
DR   PROSITE; PS51233; VWFD; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cell adhesion; Cell membrane; Complete proteome;
KW   Disulfide bond; EGF-like domain; Glycoprotein; Membrane; Polymorphism;
KW   Reference proteome; Repeat; Secreted; Signal; Transmembrane;
KW   Transmembrane helix.
FT   SIGNAL        1     28       {ECO:0000255}.
FT   CHAIN        29   2169       Mucin-4.
FT                                /FTId=PRO_0000158956.
FT   CHAIN        29   1444       Mucin-4 alpha chain.
FT                                /FTId=PRO_0000274225.
FT   CHAIN      1445   2169       Mucin-4 beta chain.
FT                                /FTId=PRO_0000274226.
FT   TRANSMEM   2126   2146       Helical. {ECO:0000255}.
FT   DOMAIN     1154   1309       NIDO. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00570}.
FT   DOMAIN     1310   1425       AMOP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00347}.
FT   DOMAIN     1438   1673       VWFD. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00580}.
FT   DOMAIN     1875   1914       EGF-like 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN     2078   2117       EGF-like 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   REGION     1002   1038       Repeat.
FT   COMPBIAS    793   1013       Ser-rich.
FT   SITE       1444   1445       Cleavage.
FT   CARBOHYD    161    161       O-linked (GalNAc...) threonine.
FT                                {ECO:0000255}.
FT   CARBOHYD    235    235       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    260    260       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    622    622       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1472   1472       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1525   1525       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1544   1544       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1553   1553       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1588   1588       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1609   1609       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1632   1632       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1659   1659       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1685   1685       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1703   1703       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1739   1739       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1754   1754       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1802   1802       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1809   1809       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:18780401}.
FT   CARBOHYD   1857   1857       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1876   1876       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1942   1942       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1949   1949       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   2049   2049       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID   1879   1890       {ECO:0000250}.
FT   DISULFID   1884   1902       {ECO:0000250}.
FT   DISULFID   1904   1913       {ECO:0000250}.
FT   DISULFID   2081   2092       {ECO:0000250}.
FT   DISULFID   2086   2101       {ECO:0000250}.
FT   DISULFID   2103   2116       {ECO:0000250}.
FT   VAR_SEQ      29   1072       Missing (in isoform 12).
FT                                {ECO:0000303|PubMed:10880978}.
FT                                /FTId=VSP_022650.
FT   VAR_SEQ      29   1021       Missing (in isoform 13).
FT                                {ECO:0000303|PubMed:10880978}.
FT                                /FTId=VSP_022651.
FT   VAR_SEQ    1071   1107       RGVSLFPYGAGAGDLEFVRRTVDFTSPLFKPATGFPL ->
FT                                SPLWGRRRGPGVRQEDRGLHLPTLQAGDWLPP (in
FT                                isoform 9).
FT                                {ECO:0000303|PubMed:10920259}.
FT                                /FTId=VSP_022652.
FT   VAR_SEQ    1073   1187       VSLFPYGAGAGDLEFVRRTVDFTSPLFKPATGFPLGSSLRD
FT                                SLYFTDNGQIIFPESDYQIFSYPNPLPTGFTGRDPVALVAP
FT                                FWDDADFSTGRGTTFYQEYETFYGEHSLLVQQA -> EAIQ
FT                                EFPSSPMGQTPGTWSSSGGPWTSPPHSSSRRLASPLAPLSV
FT                                IPSTSQTMARSSSQSQTTRFSPTPTHSQQASQAGTLWPWWL
FT                                RSGTMLTSPLVGGPHFIRNTRRSMVNTAC (in isoform
FT                                11). {ECO:0000303|PubMed:10920259}.
FT                                /FTId=VSP_022653.
FT   VAR_SEQ    1073   1177       VSLFPYGAGAGDLEFVRRTVDFTSPLFKPATGFPLGSSLRD
FT                                SLYFTDNGQIIFPESDYQIFSYPNPLPTGFTGRDPVALVAP
FT                                FWDDADFSTGRGTTFYQEYETFY -> AIQEFPSSPMGQTP
FT                                GTWSSSGGPWTSPPHSSSRRLASPLAPLSVIPSTSQTMARS
FT                                SSQSQTTRFSPTPTHSQQASQAGTLWPWWLRSGTMLTSPLV
FT                                GGPHFIRL (in isoform 15). {ECO:0000305}.
FT                                /FTId=VSP_022654.
FT   VAR_SEQ    1108   2169       Missing (in isoform 9).
FT                                {ECO:0000303|PubMed:10920259}.
FT                                /FTId=VSP_022655.
FT   VAR_SEQ    1117   1201       FTDNGQIIFPESDYQIFSYPNPLPTGFTGRDPVALVAPFWD
FT                                DADFSTGRGTTFYQEYETFYGEHSLLVQQAESWIRKMTNNG
FT                                GYK -> ASQAGTLWPWWLRSGTMLTSPLVGGPHFIRATPT
FT                                KPSSPRTGAGPMPCFSTRAVGCSGTWPSAQWRWLFRKQPTD
FT                                VPASVGEVSP (in isoform 7).
FT                                {ECO:0000303|PubMed:10920259}.
FT                                /FTId=VSP_022656.
FT   VAR_SEQ    1117   1199       FTDNGQIIFPESDYQIFSYPNPLPTGFTGRDPVALVAPFWD
FT                                DADFSTGRGTTFYQEYETFYGEHSLLVQQAESWIRKMTNNG
FT                                G -> ASQAGTLWPWWLRSGTMLTSPLVGGPHFIRATPTKP
FT                                SSPRTGAGPMPCFSTRAVGCSGTWPSAQASRCSWASLVEMA
FT                                FSKTAH (in isoform 8).
FT                                {ECO:0000303|PubMed:10920259}.
FT                                /FTId=VSP_022657.
FT   VAR_SEQ    1117   1157       FTDNGQIIFPESDYQIFSYPNPLPTGFTGRDPVALVAPFWD
FT                                -> ASQAGTLWPWWLRSGTMLTSPLVGGPHFIRNTRRSMVN
FT                                TAC (in isoform 2).
FT                                {ECO:0000303|PubMed:10920259}.
FT                                /FTId=VSP_022658.
FT   VAR_SEQ    1158   2169       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:10920259}.
FT                                /FTId=VSP_022659.
FT   VAR_SEQ    1172   1223       Missing (in isoform 5 and isoform 10).
FT                                {ECO:0000303|PubMed:10920259}.
FT                                /FTId=VSP_022661.
FT   VAR_SEQ    1178   2169       Missing (in isoform 15). {ECO:0000305}.
FT                                /FTId=VSP_022662.
FT   VAR_SEQ    1188   2169       Missing (in isoform 11).
FT                                {ECO:0000303|PubMed:10920259}.
FT                                /FTId=VSP_022663.
FT   VAR_SEQ    1200   2169       Missing (in isoform 8).
FT                                {ECO:0000303|PubMed:10920259}.
FT                                /FTId=VSP_022664.
FT   VAR_SEQ    1202   2169       Missing (in isoform 7).
FT                                {ECO:0000303|PubMed:10920259}.
FT                                /FTId=VSP_022665.
FT   VAR_SEQ    1258   1267       GNPVLMGFSS -> VEMAFSKTAH (in isoform 5).
FT                                {ECO:0000303|PubMed:10920259}.
FT                                /FTId=VSP_022669.
FT   VAR_SEQ    1268   2169       Missing (in isoform 5).
FT                                {ECO:0000303|PubMed:10920259}.
FT                                /FTId=VSP_022670.
FT   VAR_SEQ    1336   1384       VSCPCSWQQGRRDLRFQPVSIGRWGLGSRQLCSFTSWRGGV
FT                                CCSYGPWG -> AAPPRLAQPRPPTSSPLRLSTAPAAWAPS
FT                                RSNGSLSLTTQSVSCWITRL (in isoform 16).
FT                                {ECO:0000305}.
FT                                /FTId=VSP_022671.
FT   VAR_SEQ    1354   1579       Missing (in isoform 17). {ECO:0000305}.
FT                                /FTId=VSP_022672.
FT   VAR_SEQ    1385   2169       Missing (in isoform 16). {ECO:0000305}.
FT                                /FTId=VSP_022673.
FT   VAR_SEQ    1814   1827       VAGCKCDGGTFGRY -> LWGALSCVRTSPAL (in
FT                                isoform 3).
FT                                {ECO:0000303|PubMed:10920259}.
FT                                /FTId=VSP_022674.
FT   VAR_SEQ    1828   2169       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:10920259}.
FT                                /FTId=VSP_022675.
FT   VARIANT      37     37       G -> D (in dbSNP:rs2259292).
FT                                /FTId=VAR_030211.
FT   VARIANT      41     41       A -> P (in dbSNP:rs3107764).
FT                                {ECO:0000269|PubMed:10920259,
FT                                ECO:0000269|PubMed:12084055}.
FT                                /FTId=VAR_065261.
FT   VARIANT     161    161       T -> A (in dbSNP:rs2293232).
FT                                /FTId=VAR_030212.
FT   VARIANT     585    585       S -> A (in dbSNP:rs2246901).
FT                                /FTId=VAR_030213.
FT   VARIANT     721    721       A -> T (in dbSNP:rs3749331).
FT                                /FTId=VAR_056585.
FT   VARIANT    1081   1081       G -> D (in dbSNP:rs2259292).
FT                                {ECO:0000269|PubMed:10024507,
FT                                ECO:0000269|PubMed:10880978,
FT                                ECO:0000269|PubMed:10920259,
FT                                ECO:0000269|PubMed:12084055,
FT                                ECO:0000269|PubMed:12153560}.
FT                                /FTId=VAR_065262.
FT   VARIANT    1205   1205       A -> T (in dbSNP:rs2293232).
FT                                /FTId=VAR_056586.
FT   VARIANT    1578   1578       A -> S (in dbSNP:rs2246901).
FT                                {ECO:0000269|PubMed:12084055}.
FT                                /FTId=VAR_056587.
FT   CONFLICT   1194   1194       M -> I (in Ref. 1; CAB85602/CAB85603/
FT                                CAB85604/CAB85605/CAB85606, 2; CAB81773/
FT                                CAC14141/CAC14142/CAC14143, 3; AAM66747,
FT                                4; CAD22550 and 5; CAB38059).
FT                                {ECO:0000305}.
FT   CONFLICT   1259   1259       N -> K (in Ref. 2; CAB81773/CAC14143/
FT                                CAC10061 and 3; AAM66747). {ECO:0000305}.
FT   CONFLICT   1271   1271       Y -> F (in Ref. 2; CAB81773/CAC14143/
FT                                CAC10061 and 3; AAM66747). {ECO:0000305}.
FT   CONFLICT   1305   1305       R -> G (in Ref. 2; CAB81773/CAC14143/
FT                                CAC10061 and 3; AAM66747). {ECO:0000305}.
FT   CONFLICT   1557   1557       V -> A (in Ref. 2; CAB81773/CAC14143/
FT                                CAC10061 and 3; AAM66747). {ECO:0000305}.
FT   CONFLICT   1920   1921       Missing (in Ref. 2; CAC14143).
FT                                {ECO:0000305}.
FT   CONFLICT   2039   2039       G -> E (in Ref. 1; CAB85604/CAB85605/
FT                                CAB85606, 4; CAD22550 and 5; CAB38059).
FT                                {ECO:0000305}.
SQ   SEQUENCE   2169 AA;  231518 MW;  53615AF8DD416957 CRC64;
     MKGARWRRVP WVSLSCLCLC LLPHVVPGTT EDTLITGSKT AAPVTSTGST TATLEGQSTA
     ASSRTSNQDI SASSQNHQTK STETTSKAQT DTLTQMMTST LFSSPSVHNV METVTQETAP
     PDEMTTSFPS SVTNTLMMTS KTITMTTSTD STLGNTEETS TAGTESSTPV TSAVSITAGQ
     EGQSRTTSWR TSIQDTSASS QNHWTRSTQT TRESQTSTLT HRTTSTPSFS PSVHNVTGTV
     SQKTSPSGET ATSSLCSVTN TSMMTSEKIT VTTSTGSTLG NPGETSSVPV TGSLMPVTSA
     ALVTVDPEGQ SPATFSRTST QDTTAFSKNH QTQSVETTRV SQINTLNTLT PVTTSTVLSS
     PSGFNPSGTV SQETFPSGET TISSPSSVSN TFLVTSKVFR MPISRDSTLG NTEETSLSVS
     GTISAITSKV STIWWSDTLS TALSPSSLPP KISTAFHTQQ SEGAETTGRP HERSSFSPGV
     SQEIFTLHET TTWPSSFSSK GHTTWSQTEL PSTSTGAATR LVTGNPSTRA AGTIPRVPSK
     VSAIGEPGEP TTYSSHSTTL PKTTGAGAQT QWTQETGTTG EALLSSPSYS VIQMIKTATS
     PSSSPMLDRH TSQQITTAPS TNHSTIHSTS TSPQESPAVS QRGHTRAPQT TQESQTTRSV
     SPMTDTKTVT TPGSSFTASG HSPSEIVPQD APTISAATTF APAPTGNGHT TQAPTTALQA
     APSSHDATLG PSGGTSLSKT GALTLANSVV STPGGPEGQW TSASASTSPD TAAAMTHTHQ
     AESTEASGQT QTSEPASSGS RTTSAGTATP SSSGASGTTP SGSEGISTSG ETTRFSSNPS
     RDSHTTQSTT ELLSASASHG AIPVSTGMAS SIVPGTFHPT LSEASTAGRP TGQSSPTSPS
     ASPQETAAIS RMAQTQRTGT SRGSDTISLA SQATDTFSTV PPTPPSITSS GLTSPQTQTH
     TLSPSGSGKT FTTALISNAT PLPVTSTSSA STGHATPLAV SSATSASTVS SDSPLKMETS
     GMTTPSLKTD GGRRTATSPP PTTSQTIIST IPSTAMHTRS TAAPIPILPE RGVSLFPYGA
     GAGDLEFVRR TVDFTSPLFK PATGFPLGSS LRDSLYFTDN GQIIFPESDY QIFSYPNPLP
     TGFTGRDPVA LVAPFWDDAD FSTGRGTTFY QEYETFYGEH SLLVQQAESW IRKMTNNGGY
     KARWALKVTW VNAHAYPAQW TLGSNTYQAI LSTDGSRSYA LFLYQSGGMQ WDVAQRSGNP
     VLMGFSSGDG YFENSPLMSQ PVWERYRPDR FLNSNSGLQG LQFYRLHREE RPNYRLECLQ
     WLKSQPRWPS WGWNQVSCPC SWQQGRRDLR FQPVSIGRWG LGSRQLCSFT SWRGGVCCSY
     GPWGEFREGW HVQRPWQLAQ ELEPQSWCCR WNDKPYLCAL YQQRRPHVGC ATYRPPQPAW
     MFGDPHITTL DGVSYTFNGL GDFLLVGAQD GNSSFLLQGR TAQTGSAQAT NFIAFAAQYR
     SSSLGPVTVQ WLLEPHDAIR VLLDNQTVTF QPDHEDGGGQ ETFNATGVLL SRNGSEVSAS
     FDGWATVSVI ALSNILHASA SLPPEYQNRT EGLLGVWNNN PEDDFRMPNG STIPPGSPEE
     MLFHFGMTWQ INGTGLLGKR NDQLPSNFTP VFYSQLQKNS SWAEHLISNC DGDSSCIYDT
     LALRNASIGL HTREVSKNYE QANATLNQYP PSINGGRVIE AYKGQTTLIQ YTSNAEDANF
     TLRDSCTDLE LFENGTLLWT PKSLEPFTLE ILARSAKIGL ASALQPRTVV CHCNAESQCL
     YNQTSRVGNS SLEVAGCKCD GGTFGRYCEG SEDACEEPCF PSVHCVPGKG CEACPPNLTG
     DGRHCAALGS SFLCQNQSCP VNYCYNQGHC YISQTLGCQP MCTCPPAFTD SRCFLAGNNF
     SPTVNLELPL RVIQLLLSEE ENASMAEVNA SVAYRLGTLD MRAFLRNSQV ERIDSAAPAS
     GSPIQHWMVI SEFQYRPRGP VIDFLNNQLL AAVVEAFLYH VPRRSEEPRN DVVFQPISGE
     DVRDVTALNV STLKAYFRCD GYKGYDLVYS PQSGFTCVSP CSRGYCDHGG QCQHLPSGPR
     CSCVSFSIYT AWGEHCEHLS MKLDAFFGIF FGALGGLLLL GVGTFVVLRF WGCSGARFSY
     FLNSAEALP
//
ID   B7Z325_HUMAN            Unreviewed;       387 AA.
AC   B7Z325;
DT   03-MAR-2009, integrated into UniProtKB/TrEMBL.
DT   03-MAR-2009, sequence version 1.
DT   28-MAR-2018, entry version 43.
DE   RecName: Full=Non-specific serine/threonine protein kinase {ECO:0000256|SAAS:SAAS01030073};
DE            EC=2.7.11.1 {ECO:0000256|SAAS:SAAS01030073};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAH12061.1};
RN   [1] {ECO:0000313|EMBL:BAH12061.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Corpus callosum {ECO:0000313|EMBL:BAH12061.1};
RA   Wakamatsu A., Yamamoto J., Kimura K., Ishii S., Watanabe K.,
RA   Sugiyama A., Murakawa K., Kaida T., Tsuchiya K., Fukuzumi Y.,
RA   Kumagai A., Oishi Y., Yamamoto S., Ono Y., Komori Y., Yamazaki M.,
RA   Kisu Y., Nishikawa T., Sugano S., Nomura N., Isogai T.;
RT   "NEDO human cDNA sequencing project focused on splicing variants.";
RL   Submitted (OCT-2007) to the EMBL/GenBank/DDBJ databases.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC       {ECO:0000256|SAAS:SAAS00935732}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily.
CC       {ECO:0000256|RuleBase:RU000304}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK295422; BAH12061.1; -; mRNA.
DR   RefSeq; NP_001278924.1; NM_001291995.1.
DR   UniGene; Hs.510078; -.
DR   ProteinModelPortal; B7Z325; -.
DR   PeptideAtlas; B7Z325; -.
DR   PRIDE; B7Z325; -.
DR   GeneID; 6446; -.
DR   CTD; 6446; -.
DR   HOVERGEN; HBG108317; -.
DR   SignaLink; B7Z325; -.
DR   GenomeRNAi; 6446; -.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IEA:UniProtKB-KW.
DR   InterPro; IPR000961; AGC-kinase_C.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR017892; Pkinase_C.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   Pfam; PF00069; Pkinase; 1.
DR   Pfam; PF00433; Pkinase_C; 1.
DR   SMART; SM00133; S_TK_X; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS51285; AGC_KINASE_CTER; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   2: Evidence at transcript level;
KW   ATP-binding {ECO:0000256|RuleBase:RU000304,
KW   ECO:0000256|SAAS:SAAS00593399};
KW   Kinase {ECO:0000256|RuleBase:RU000304, ECO:0000256|SAAS:SAAS00593706};
KW   Nucleotide-binding {ECO:0000256|RuleBase:RU000304,
KW   ECO:0000256|SAAS:SAAS00593399};
KW   Serine/threonine-protein kinase {ECO:0000256|RuleBase:RU000304,
KW   ECO:0000256|SAAS:SAAS00593706};
KW   Transferase {ECO:0000256|RuleBase:RU000304,
KW   ECO:0000256|SAAS:SAAS00593706}.
FT   DOMAIN        1    311       Protein kinase.
FT                                {ECO:0000259|PROSITE:PS50011}.
FT   DOMAIN      312    387       AGC-kinase C-terminal.
FT                                {ECO:0000259|PROSITE:PS51285}.
SQ   SEQUENCE   387 AA;  43783 MW;  34775AE1248702D7 CRC64;
     MTVKTEAAKG TLTYSRMRGM VAILIAFMKQ RRMGLNDFIQ KIANNSYACK HPEVQSILKI
     SQPQEPELMN ANPSPPPSPS QQINLGPSSN PHAKPSDFHF LKVIGKGSFG KVLLARHKAE
     EVFYAVKVLQ KKAILKKKEL FYHLQRERCF LEPRARFYAA EIASALGYLH SLNIVYRDLK
     PENILLDSQG HIVLTDFGLC KENIEHNSTT STFCGTPEYL APEVLHKQPY DRTVDWWCLG
     AVLYEMLYGL PPFYSRNTAE MYDNILNKPL QLKPNITNSA RHLLEGLLQK DRTKRLGAKD
     DFMEIKSHVF FSLINWDDLI NKKITPPFNP NVSGPNDLRH FDPEFTEEPV PNSIGKSPDS
     VLVTASAKEA AEAFLGFSYA PPTDSFL
//
ID   E9PR89_HUMAN            Unreviewed;       387 AA.
AC   E9PR89;
DT   05-APR-2011, integrated into UniProtKB/TrEMBL.
DT   05-APR-2011, sequence version 1.
DT   25-APR-2018, entry version 62.
DE   RecName: Full=Non-specific serine/threonine protein kinase {ECO:0000256|SAAS:SAAS01030073};
DE            EC=2.7.11.1 {ECO:0000256|SAAS:SAAS01030073};
GN   Name=SGK1 {ECO:0000313|Ensembl:ENSP00000434302};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000434302, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=14574404; DOI=10.1038/nature02055;
RA   Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA   Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E.,
RA   Gilbert J.G.R., Clamp M.E., Bethel G., Milne S., Ainscough R.,
RA   Almeida J.P., Ambrose K.D., Andrews T.D., Ashwell R.I.S.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Banerjee R., Barker D.J.,
RA   Barlow K.F., Bates K., Beare D.M., Beasley H., Beasley O., Bird C.P.,
RA   Blakey S.E., Bray-Allen S., Brook J., Brown A.J., Brown J.Y.,
RA   Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA   Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA   Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E.,
RA   Ellington A.E., Evans K.A., Faulkner L., Francis M.D., Frankish A.,
RA   Frankland J., French L., Garner P., Garnett J., Ghori M.J.,
RA   Gilby L.M., Gillson C.J., Glithero R.J., Grafham D.V., Grant M.,
RA   Gribble S., Griffiths C., Griffiths M.N.D., Hall R., Halls K.S.,
RA   Hammond S., Harley J.L., Hart E.A., Heath P.D., Heathcott R.,
RA   Holmes S.J., Howden P.J., Howe K.L., Howell G.R., Huckle E.,
RA   Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M., Joy A.A.,
RA   Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R., Lloyd D.M.,
RA   Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA   Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K.,
RA   McMurray A., Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T.,
RA   Novik K.L., Oliver K., Overton-Larty E.K., Parker A., Patel R.,
RA   Pearce A.V., Peck A.I., Phillimore B.J.C.T., Phillips S., Plumb R.W.,
RA   Porter K.M., Ramsey Y., Ranby S.A., Rice C.M., Ross M.T., Searle S.M.,
RA   Sehra H.K., Sheridan E., Skuce C.D., Smith S., Smith M., Spraggon L.,
RA   Squares S.L., Steward C.A., Sycamore N., Tamlyn-Hall G., Tester J.,
RA   Theaker A.J., Thomas D.W., Thorpe A., Tracey A., Tromans A., Tubby B.,
RA   Wall M., Wallis J.M., West A.P., White S.S., Whitehead S.L.,
RA   Whittaker H., Wild A., Willey D.J., Wilmer T.E., Wood J.M., Wray P.W.,
RA   Wyatt J.C., Young L., Younger R.M., Bentley D.R., Coulson A.,
RA   Durbin R., Hubbard T., Sulston J.E., Dunham I., Rogers J., Beck S.;
RT   "The DNA sequence and analysis of human chromosome 6.";
RL   Nature 425:805-811(2003).
RN   [2] {ECO:0000313|Ensembl:ENSP00000434302}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [3] {ECO:0000213|PubMed:18691976}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [4] {ECO:0000213|PubMed:19369195}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [5] {ECO:0000213|PubMed:20068231}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:ra3-RA3(2010).
RN   [6] {ECO:0000313|Ensembl:ENSP00000434302}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (JUL-2011) to UniProtKB.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC       {ECO:0000256|SAAS:SAAS00935732}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily.
CC       {ECO:0000256|RuleBase:RU000304}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AL135839; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL355881; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; KF458297; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; Z84486; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   RefSeq; NP_001278924.1; NM_001291995.1.
DR   UniGene; Hs.510078; -.
DR   ProteinModelPortal; E9PR89; -.
DR   MaxQB; E9PR89; -.
DR   PRIDE; E9PR89; -.
DR   Ensembl; ENST00000475719; ENSP00000434302; ENSG00000118515.
DR   GeneID; 6446; -.
DR   UCSC; uc011ecu.3; human.
DR   CTD; 6446; -.
DR   EuPathDB; HostDB:ENSG00000118515.11; -.
DR   HGNC; HGNC:10810; SGK1.
DR   OpenTargets; ENSG00000118515; -.
DR   GeneTree; ENSGT00890000139324; -.
DR   SignaLink; E9PR89; -.
DR   ChiTaRS; SGK1; human.
DR   GenomeRNAi; 6446; -.
DR   Proteomes; UP000005640; Chromosome 6.
DR   Bgee; ENSG00000118515; -.
DR   ExpressionAtlas; E9PR89; baseline and differential.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0016607; C:nuclear speck; IDA:HPA.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IEA:UniProtKB-KW.
DR   InterPro; IPR000961; AGC-kinase_C.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR017892; Pkinase_C.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   Pfam; PF00069; Pkinase; 1.
DR   Pfam; PF00433; Pkinase_C; 1.
DR   SMART; SM00133; S_TK_X; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS51285; AGC_KINASE_CTER; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   ATP-binding {ECO:0000256|RuleBase:RU000304,
KW   ECO:0000256|SAAS:SAAS00593399};
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   Kinase {ECO:0000256|RuleBase:RU000304, ECO:0000256|SAAS:SAAS00593706};
KW   Nucleotide-binding {ECO:0000256|RuleBase:RU000304,
KW   ECO:0000256|SAAS:SAAS00593399};
KW   Proteomics identification {ECO:0000213|MaxQB:E9PR89,
KW   ECO:0000213|PeptideAtlas:E9PR89};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640};
KW   Serine/threonine-protein kinase {ECO:0000256|RuleBase:RU000304,
KW   ECO:0000256|SAAS:SAAS00593706};
KW   Transferase {ECO:0000256|RuleBase:RU000304,
KW   ECO:0000256|SAAS:SAAS00593706}.
FT   DOMAIN        1    311       Protein kinase.
FT                                {ECO:0000259|PROSITE:PS50011}.
FT   DOMAIN      312    387       AGC-kinase C-terminal.
FT                                {ECO:0000259|PROSITE:PS51285}.
SQ   SEQUENCE   387 AA;  43811 MW;  34775AE13C3052D7 CRC64;
     MTVKTEAAKG TLTYSRMRGM VAILIAFMKQ RRMGLNDFIQ KIANNSYACK HPEVQSILKI
     SQPQEPELMN ANPSPPPSPS QQINLGPSSN PHAKPSDFHF LKVIGKGSFG KVLLARHKAE
     EVFYAVKVLQ KKAILKKKEL FYHLQRERCF LEPRARFYAA EIASALGYLH SLNIVYRDLK
     PENILLDSQG HIVLTDFGLC KENIEHNSTT STFCGTPEYL APEVLHKQPY DRTVDWWCLG
     AVLYEMLYGL PPFYSRNTAE MYDNILNKPL QLKPNITNSA RHLLEGLLQK DRTKRLGAKD
     DFMEIKSHVF FSLINWDDLI NKKITPPFNP NVSGPNDLRH FDPEFTEEPV PNSIGKSPDS
     VLVTASVKEA AEAFLGFSYA PPTDSFL
//
ID   SGK1_HUMAN              Reviewed;         431 AA.
AC   O00141; B7UUP7; B7UUP8; B7UUP9; B7Z5B2; E1P583; Q5TCN2; Q5TCN3;
AC   Q5TCN4; Q5VY65; Q9UN56;
DT   15-DEC-1998, integrated into UniProtKB/Swiss-Prot.
DT   07-MAR-2006, sequence version 2.
DT   28-MAR-2018, entry version 184.
DE   RecName: Full=Serine/threonine-protein kinase Sgk1;
DE            EC=2.7.11.1;
DE   AltName: Full=Serum/glucocorticoid-regulated kinase 1;
GN   Name=SGK1; Synonyms=SGK;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=9114008; DOI=10.1073/pnas.94.9.4440;
RA   Waldegger S., Barth P., Raber G., Lang F.;
RT   "Cloning and characterization of a putative human serine/threonine
RT   protein kinase transcriptionally modified during anisotonic and
RT   isotonic alterations of cell volume.";
RL   Proc. Natl. Acad. Sci. U.S.A. 94:4440-4445(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND ALTERNATIVE SPLICING (ISOFORM
RP   1).
RX   PubMed=9722955; DOI=10.1006/geno.1998.5258;
RA   Waldegger S., Erdel M., Nagl U.O., Barth P., Raber G., Steuer S.,
RA   Utermann G., Paulmichl M., Lang F.;
RT   "Genomic organization and chromosomal localization of the human SGK
RT   protein kinase gene.";
RL   Genomics 51:299-302(1998).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), FUNCTION, ALTERNATIVE PROMOTER
RP   USAGE, INDUCTION, SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RC   TISSUE=Brain;
RX   PubMed=18753299; DOI=10.1152/ajprenal.90239.2008;
RA   Raikwar N.S., Snyder P.M., Thomas C.P.;
RT   "An evolutionarily conserved N-terminal Sgk1 variant with enhanced
RT   stability and improved function.";
RL   Am. J. Physiol. 295:F1440-F1448(2008).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 2; 3; 4 AND 5), AND ALTERNATIVE
RP   PROMOTER USAGE.
RC   TISSUE=Glioblastoma, Hippocampus, and Skin;
RA   Hall B.A., Blakeley S., Daniels N.A., Jamieson D., Brickley D.,
RA   Reynolds N.J., Conzen S.D., Jackson T.R.;
RT   "Transcriptional variants of serum/glucocorticoid regulated kinase 1
RT   show differential localisation and regulation.";
RL   Submitted (AUG-2008) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Hair follicle dermal papilla;
RA   Kim M.K., Kim Y.H., Seo J.M., Lee H.M., Chung H.J., Sohn M.Y.,
RA   Hwang S.Y., Im S.U., Jung E.J., Lee J.H., Kim J.C.;
RT   "A catalogue of genes in the human dermal papilla cells as identified
RT   by expressed sequence tags.";
RL   Submitted (MAY-1999) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 2 AND 3).
RC   TISSUE=Brain;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=14574404; DOI=10.1038/nature02055;
RA   Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA   Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E.,
RA   Gilbert J.G.R., Clamp M.E., Bethel G., Milne S., Ainscough R.,
RA   Almeida J.P., Ambrose K.D., Andrews T.D., Ashwell R.I.S.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Banerjee R., Barker D.J.,
RA   Barlow K.F., Bates K., Beare D.M., Beasley H., Beasley O., Bird C.P.,
RA   Blakey S.E., Bray-Allen S., Brook J., Brown A.J., Brown J.Y.,
RA   Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA   Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA   Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E.,
RA   Ellington A.E., Evans K.A., Faulkner L., Francis M.D., Frankish A.,
RA   Frankland J., French L., Garner P., Garnett J., Ghori M.J.,
RA   Gilby L.M., Gillson C.J., Glithero R.J., Grafham D.V., Grant M.,
RA   Gribble S., Griffiths C., Griffiths M.N.D., Hall R., Halls K.S.,
RA   Hammond S., Harley J.L., Hart E.A., Heath P.D., Heathcott R.,
RA   Holmes S.J., Howden P.J., Howe K.L., Howell G.R., Huckle E.,
RA   Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M., Joy A.A.,
RA   Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R., Lloyd D.M.,
RA   Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA   Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K.,
RA   McMurray A., Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T.,
RA   Novik K.L., Oliver K., Overton-Larty E.K., Parker A., Patel R.,
RA   Pearce A.V., Peck A.I., Phillimore B.J.C.T., Phillips S., Plumb R.W.,
RA   Porter K.M., Ramsey Y., Ranby S.A., Rice C.M., Ross M.T., Searle S.M.,
RA   Sehra H.K., Sheridan E., Skuce C.D., Smith S., Smith M., Spraggon L.,
RA   Squares S.L., Steward C.A., Sycamore N., Tamlyn-Hall G., Tester J.,
RA   Theaker A.J., Thomas D.W., Thorpe A., Tracey A., Tromans A., Tubby B.,
RA   Wall M., Wallis J.M., West A.P., White S.S., Whitehead S.L.,
RA   Whittaker H., Wild A., Willey D.J., Wilmer T.E., Wood J.M., Wray P.W.,
RA   Wyatt J.C., Young L., Younger R.M., Bentley D.R., Coulson A.,
RA   Durbin R.M., Hubbard T., Sulston J.E., Dunham I., Rogers J., Beck S.;
RT   "The DNA sequence and analysis of human chromosome 6.";
RL   Nature 425:805-811(2003).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Cervix;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [10]
RP   TISSUE SPECIFICITY.
RX   PubMed=10548550; DOI=10.1042/bj3440189;
RA   Kobayashi T., Deak M., Morrice N., Cohen P.;
RT   "Characterization of the structure and regulation of two novel
RT   isoforms of serum- and glucocorticoid-induced protein kinase.";
RL   Biochem. J. 344:189-197(1999).
RN   [11]
RP   PHOSPHORYLATION AT THR-256 AND SER-422, AND MUTAGENESIS OF THR-256 AND
RP   SER-422.
RC   TISSUE=Brain;
RX   PubMed=10191262; DOI=10.1042/bj3390319;
RA   Kobayashi T., Cohen P.;
RT   "Activation of serum- and glucocorticoid-regulated protein kinase by
RT   agonists that activate phosphatidylinositide 3-kinase is mediated by
RT   3-phosphoinositide-dependent protein kinase-1 (PDK1) and PDK2.";
RL   Biochem. J. 339:319-328(1999).
RN   [12]
RP   CHARACTERIZATION.
RX   PubMed=10884438; DOI=10.1073/pnas.97.14.8157;
RA   Lang F., Klingel K., Wagner C.A., Stegen C., Waerntges S.,
RA   Friedrich B., Lanzendoerfer M., Melzig J., Moschen I., Steuer S.,
RA   Waldegger S., Sauter M., Paulmichl M., Gerke V., Risler T., Gamba G.,
RA   Capasso G., Kandolf R., Hebert S.C., Massry S.G., Broer S.;
RT   "Deranged transcriptional regulation of cell-volume-sensitive kinase
RT   hSGK in diabetic nephropathy.";
RL   Proc. Natl. Acad. Sci. U.S.A. 97:8157-8162(2000).
RN   [13]
RP   PHOSPHORYLATION AT SER-78 BY MAPK7, AND INTERACTION WITH MAPK7.
RX   PubMed=11254654; DOI=10.1074/jbc.C000838200;
RA   Hayashi M., Tapping R.I., Chao T.H., Lo J.F., King C.C., Yang Y.,
RA   Lee J.D.;
RT   "BMK1 mediates growth factor-induced cell proliferation through direct
RT   cellular activation of serum and glucocorticoid-inducible kinase.";
RL   J. Biol. Chem. 276:8631-8634(2001).
RN   [14]
RP   PHOSPHORYLATION AT THR-369 BY PKA.
RX   PubMed=11096081; DOI=10.1074/jbc.M007052200;
RA   Perrotti N., He R.A., Phillips S.A., Haft C.R., Taylor S.I.;
RT   "Activation of serum- and glucocorticoid-induced protein kinase (Sgk)
RT   by cyclic AMP and insulin.";
RL   J. Biol. Chem. 276:9406-9412(2001).
RN   [15]
RP   FUNCTION IN PHOSPHORYLATION OF BRAF.
RX   PubMed=11410590; DOI=10.1074/jbc.M102808200;
RA   Zhang B.H., Tang E.D., Zhu T., Greenberg M.E., Vojtek A.B., Guan K.L.;
RT   "Serum- and glucocorticoid-inducible kinase SGK phosphorylates and
RT   negatively regulates B-Raf.";
RL   J. Biol. Chem. 276:31620-31626(2001).
RN   [16]
RP   FUNCTION.
RX   PubMed=11154281; DOI=10.1128/MCB.21.3.952-965.2001;
RA   Brunet A., Park J., Tran H., Hu L.S., Hemmings B.A., Greenberg M.E.;
RT   "Protein kinase SGK mediates survival signals by phosphorylating the
RT   forkhead transcription factor FKHRL1 (FOXO3a).";
RL   Mol. Cell. Biol. 21:952-965(2001).
RN   [17]
RP   INTERACTION WITH NEDD4 AND NEDD4L, MUTAGENESIS OF LYS-127; TYR-298 AND
RP   SER-422, AND FUNCTION.
RX   PubMed=11696533; DOI=10.1074/jbc.C100623200;
RA   Snyder P.M., Olson D.R., Thomas B.C.;
RT   "Serum and glucocorticoid-regulated kinase modulates Nedd4-2-mediated
RT   inhibition of the epithelial Na+ channel.";
RL   J. Biol. Chem. 277:5-8(2002).
RN   [18]
RP   FUNCTION IN REGULATION OF NA(+)/K(+) ATPASE.
RX   PubMed=12590200; DOI=10.1159/000068699;
RA   Henke G., Setiawan I., Boehmer C., Lang F.;
RT   "Activation of Na+/K+-ATPase by the serum and glucocorticoid-dependent
RT   kinase isoforms.";
RL   Kidney Blood Press. Res. 25:370-374(2002).
RN   [19]
RP   FUNCTION.
RX   PubMed=12397388; DOI=10.1007/s00424-002-0873-2;
RA   Gamper N., Fillon S., Feng Y., Friedrich B., Lang P.A., Henke G.,
RA   Huber S.M., Kobayashi T., Cohen P., Lang F.;
RT   "K(+) channel activation by all three isoforms of serum- and
RT   glucocorticoid-dependent protein kinase SGK.";
RL   Pflugers Arch. 445:60-66(2002).
RN   [20]
RP   FUNCTION, AND INTERACTION WITH SLC9A3R2/NHERF2 AND KCNJ1/ROMK1.
RX   PubMed=14623317; DOI=10.1016/j.bbrc.2003.10.037;
RA   Palmada M., Embark H.M., Yun C., Bohmer C., Lang F.;
RT   "Molecular requirements for the regulation of the renal outer
RT   medullary K(+) channel ROMK1 by the serum- and glucocorticoid-
RT   inducible kinase SGK1.";
RL   Biochem. Biophys. Res. Commun. 311:629-634(2003).
RN   [21]
RP   FUNCTION IN REGULATION OF SCN5A.
RX   PubMed=12650886; DOI=10.1016/S0008-6363(02)00837-4;
RA   Boehmer C., Wilhelm V., Palmada M., Wallisch S., Henke G.,
RA   Brinkmeier H., Cohen P., Pieske B., Lang F.;
RT   "Serum and glucocorticoid inducible kinases in the regulation of the
RT   cardiac sodium channel SCN5A.";
RL   Cardiovasc. Res. 57:1079-1084(2003).
RN   [22]
RP   FUNCTION IN PHOSPHORYLATION OF MAP3K3/MEKK3.
RX   PubMed=12761204; DOI=10.1093/jb/mvg010;
RA   Chun J., Kwon T., Kim D.J., Park I., Chung G., Lee E.J., Hong S.K.,
RA   Chang S.I., Kim H.Y., Kang S.S.;
RT   "Inhibition of mitogen-activated kinase kinase kinase 3 activity
RT   through phosphorylation by the serum- and glucocorticoid-induced
RT   kinase 1.";
RL   J. Biochem. 133:103-108(2003).
RN   [23]
RP   FUNCTION IN REGULATION OF KCNA3/KV1.3, AND MUTAGENESIS OF LYS-127 AND
RP   SER-422.
RX   PubMed=12911626;
RA   Boehmer C., Henke G., Schniepp R., Palmada M., Rothstein J.D.,
RA   Broeer S., Lang F.;
RT   "Regulation of the glutamate transporter EAAT1 by the ubiquitin ligase
RT   Nedd4-2 and the serum and glucocorticoid-inducible kinase isoforms
RT   SGK1/3 and protein kinase B.";
RL   J. Neurochem. 86:1181-1188(2003).
RN   [24]
RP   NUCLEAR LOCALIZATION SIGNAL.
RX   PubMed=12631736; DOI=10.1091/mbc.E02-03-0170;
RA   Maiyar A.C., Leong M.L., Firestone G.L.;
RT   "Importin-alpha mediates the regulated nuclear targeting of serum- and
RT   glucocorticoid-inducible protein kinase (Sgk) by recognition of a
RT   nuclear localization signal in the kinase central domain.";
RL   Mol. Biol. Cell 14:1221-1239(2003).
RN   [25]
RP   FUNCTION IN REGULATION OF KCNE1 AND KCNQ1.
RX   PubMed=12634932; DOI=10.1007/s00424-002-0982-y;
RA   Embark H.M., Boehmer C., Vallon V., Luft F., Lang F.;
RT   "Regulation of KCNE1-dependent K(+) current by the serum and
RT   glucocorticoid-inducible kinase (SGK) isoforms.";
RL   Pflugers Arch. 445:601-606(2003).
RN   [26]
RP   FUNCTION IN REGULATION OF SLC34A2/NAPI-2B, AND FUNCTION IN
RP   PHOSPHORYLATION OF NEDD4L.
RX   PubMed=15044175; DOI=10.1152/ajpgi.00121.2003;
RA   Palmada M., Dieter M., Speil A., Boehmer C., Mack A.F., Wagner H.J.,
RA   Klingel K., Kandolf R., Murer H., Biber J., Closs E.I., Lang F.;
RT   "Regulation of intestinal phosphate cotransporter NaPi IIb by
RT   ubiquitin ligase Nedd4-2 and by serum- and glucocorticoid-dependent
RT   kinase 1.";
RL   Am. J. Physiol. 287:G143-G150(2004).
RN   [27]
RP   FUNCTION IN REGULATION OF SLC13A2/NADC1.
RX   PubMed=14706641; DOI=10.1016/j.bbrc.2003.12.011;
RA   Boehmer C., Embark H.M., Bauer A., Palmada M., Yun C.H., Weinman E.J.,
RA   Endou H., Cohen P., Lahme S., Bichler K.H., Lang F.;
RT   "Stimulation of renal Na+ dicarboxylate cotransporter 1 by Na+/H+
RT   exchanger regulating factor 2, serum and glucocorticoid inducible
RT   kinase isoforms, and protein kinase B.";
RL   Biochem. Biophys. Res. Commun. 313:998-1003(2004).
RN   [28]
RP   FUNCTION IN REGULATION OF TRPV5.
RX   PubMed=15319523; DOI=10.1159/000080329;
RA   Embark H.M., Setiawan I., Poppendieck S., van de Graaf S.F.,
RA   Boehmer C., Palmada M., Wieder T., Gerstberger R., Cohen P., Yun C.C.,
RA   Bindels R.J., Lang F.;
RT   "Regulation of the epithelial Ca2+ channel TRPV5 by the NHE regulating
RT   factor NHERF2 and the serum and glucocorticoid inducible kinase
RT   isoforms SGK1 and SGK3 expressed in Xenopus oocytes.";
RL   Cell. Physiol. Biochem. 14:203-212(2004).
RN   [29]
RP   FUNCTION.
RX   PubMed=15234985; DOI=10.1074/jbc.M403260200;
RA   Diakov A., Korbmacher C.;
RT   "A novel pathway of epithelial sodium channel activation involves a
RT   serum- and glucocorticoid-inducible kinase consensus motif in the C
RT   terminus of the channel's alpha-subunit.";
RL   J. Biol. Chem. 279:38134-38142(2004).
RN   [30]
RP   FUNCTION, AND MUTAGENESIS OF LYS-127 AND SER-422.
RX   PubMed=15040001; DOI=10.1002/jcp.10430;
RA   Henke G., Maier G., Wallisch S., Boehmer C., Lang F.;
RT   "Regulation of the voltage gated K+ channel Kv1.3 by the ubiquitin
RT   ligase Nedd4-2 and the serum and glucocorticoid inducible kinase
RT   SGK1.";
RL   J. Cell. Physiol. 199:194-199(2004).
RN   [31]
RP   FUNCTION IN REGULATION OF BSND.
RX   PubMed=15496163; DOI=10.1111/j.1523-1755.2004.00966.x;
RA   Embark H.M., Boehmer C., Palmada M., Rajamanickam J., Wyatt A.W.,
RA   Wallisch S., Capasso G., Waldegger P., Seyberth H.W., Waldegger S.,
RA   Lang F.;
RT   "Regulation of CLC-Ka/barttin by the ubiquitin ligase Nedd4-2 and the
RT   serum- and glucocorticoid-dependent kinases.";
RL   Kidney Int. 66:1918-1925(2004).
RN   [32]
RP   FUNCTION IN PHOSPHORYLATION OF SLC9A3/NHE3.
RX   PubMed=15888551; DOI=10.1152/ajpcell.00597.2004;
RA   Wang D., Sun H., Lang F., Yun C.C.;
RT   "Activation of NHE3 by dexamethasone requires phosphorylation of NHE3
RT   at Ser663 by SGK1.";
RL   Am. J. Physiol. 289:C802-C810(2005).
RN   [33]
RP   FUNCTION IN REGULATION OF SLC1A5/ASCT2.
RX   PubMed=15845389; DOI=10.1016/j.bbrc.2005.03.159;
RA   Palmada M., Speil A., Jeyaraj S., Boehmer C., Lang F.;
RT   "The serine/threonine kinases SGK1, 3 and PKB stimulate the amino acid
RT   transporter ASCT2.";
RL   Biochem. Biophys. Res. Commun. 331:272-277(2005).
RN   [34]
RP   FUNCTION IN REGULATION OF SLC1A7/EAAT5.
RX   PubMed=15737648; DOI=10.1016/j.bbrc.2005.02.035;
RA   Boehmer C., Rajamanickam J., Schniepp R., Kohler K., Wulff P.,
RA   Kuhl D., Palmada M., Lang F.;
RT   "Regulation of the excitatory amino acid transporter EAAT5 by the
RT   serum and glucocorticoid dependent kinases SGK1 and SGK3.";
RL   Biochem. Biophys. Res. Commun. 329:738-742(2005).
RN   [35]
RP   FUNCTION IN REGULATION OF SLC6A8.
RX   PubMed=16036218; DOI=10.1016/j.bbrc.2005.06.164;
RA   Shojaiefard M., Christie D.L., Lang F.;
RT   "Stimulation of the creatine transporter SLC6A8 by the protein kinases
RT   SGK1 and SGK3.";
RL   Biochem. Biophys. Res. Commun. 334:742-746(2005).
RN   [36]
RP   FUNCTION IN PHOSPHORYLATION OF CREB1, AND INTERACTION WITH CREB1.
RX   PubMed=15733869; DOI=10.1016/j.febslet.2005.01.040;
RA   David S., Kalb R.G.;
RT   "Serum/glucocorticoid-inducible kinase can phosphorylate the cyclic
RT   AMP response element binding protein, CREB.";
RL   FEBS Lett. 579:1534-1538(2005).
RN   [37]
RP   UBIQUITINATION.
RX   PubMed=15576372; DOI=10.1074/jbc.M411053200;
RA   Zhou R., Snyder P.M.;
RT   "Nedd4-2 phosphorylation induces serum and glucocorticoid-regulated
RT   kinase (SGK) ubiquitination and degradation.";
RL   J. Biol. Chem. 280:4518-4523(2005).
RN   [38]
RP   FUNCTION IN REGULATION OF SLC2A1/GLUT1.
RX   PubMed=16443776; DOI=10.2337/diabetes.55.02.06.db05-0720;
RA   Palmada M., Boehmer C., Akel A., Rajamanickam J., Jeyaraj S.,
RA   Keller K., Lang F.;
RT   "SGK1 kinase upregulates GLUT1 activity and plasma membrane
RT   expression.";
RL   Diabetes 55:421-427(2006).
RN   [39]
RP   FUNCTION IN PHOSPHORYLATION OF MAPT/TAU, AND INTERACTION WITH
RP   MAPT/TAU.
RX   PubMed=16982696; DOI=10.1128/MCB.01017-06;
RA   Yang Y.C., Lin C.H., Lee E.H.;
RT   "Serum- and glucocorticoid-inducible kinase 1 (SGK1) increases neurite
RT   formation through microtubule depolymerization by SGK1 and by SGK1
RT   phosphorylation of tau.";
RL   Mol. Cell. Biol. 26:8357-8370(2006).
RN   [40]
RP   SUBCELLULAR LOCATION.
RX   PubMed=17202226; DOI=10.1152/ajpcell.00399.2006;
RA   Cordas E., Naray-Fejes-Toth A., Fejes-Toth G.;
RT   "Subcellular location of serum- and glucocorticoid-induced kinase-1 in
RT   renal and mammary epithelial cells.";
RL   Am. J. Physiol. 292:C1971-C1981(2007).
RN   [41]
RP   FUNCTION IN PHOSPHORYLATION OF SLC2A4/GLUT4.
RX   PubMed=17382906; DOI=10.1016/j.bbrc.2007.03.029;
RA   Jeyaraj S., Boehmer C., Lang F., Palmada M.;
RT   "Role of SGK1 kinase in regulating glucose transport via glucose
RT   transporter GLUT4.";
RL   Biochem. Biophys. Res. Commun. 356:629-635(2007).
RN   [42]
RP   FUNCTION IN REGULATION OF TRPV6.
RX   PubMed=18005662; DOI=10.1016/j.febslet.2007.11.006;
RA   Boehmer C., Palmada M., Kenngott C., Lindner R., Klaus F., Laufer J.,
RA   Lang F.;
RT   "Regulation of the epithelial calcium channel TRPV6 by the serum and
RT   glucocorticoid-inducible kinase isoforms SGK1 and SGK3.";
RL   FEBS Lett. 581:5586-5590(2007).
RN   [43]
RP   FUNCTION IN PHOSPHORYLATION OF APBB1/FE65.
RX   PubMed=18304449; DOI=10.5483/BMBRep.2008.41.1.041;
RA   Lee E.J., Chun J., Hyun S., Ahn H.R., Jeong J.M., Hong S.K.,
RA   Hong J.T., Chang I.K., Jeon H.Y., Han Y.S., Auh C.K., Park J.I.,
RA   Kang S.S.;
RT   "Regulation Fe65 localization to the nucleus by SGK1 phosphorylation
RT   of its Ser566 residue.";
RL   BMB Rep. 41:41-47(2008).
RN   [44]
RP   PHOSPHORYLATION AT SER-422 BY MTORC2.
RX   PubMed=18925875; DOI=10.1042/BJ20081668;
RA   Garcia-Martinez J.M., Alessi D.R.;
RT   "mTOR complex 2 (mTORC2) controls hydrophobic motif phosphorylation
RT   and activation of serum- and glucocorticoid-induced protein kinase 1
RT   (SGK1).";
RL   Biochem. J. 416:375-385(2008).
RN   [45]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-74; SER-397 AND SER-401,
RP   AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [46]
RP   ALTERNATIVE PROMOTER USAGE (ISOFORMS 2 AND 3).
RX   PubMed=18334630; DOI=10.1073/pnas.0800958105;
RA   Arteaga M.F., Coric T., Straub C., Canessa C.M.;
RT   "A brain-specific SGK1 splice isoform regulates expression of ASIC1 in
RT   neurons.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:4459-4464(2008).
RN   [47]
RP   PHOSPHORYLATION AT SER-397 AND SER-401.
RX   PubMed=19068477; DOI=10.1074/jbc.M807502200;
RA   Chen W., Chen Y., Xu B.E., Juang Y.C., Stippec S., Zhao Y., Cobb M.H.;
RT   "Regulation of a third conserved phosphorylation site in SGK1.";
RL   J. Biol. Chem. 284:3453-3460(2009).
RN   [48]
RP   FUNCTION IN PHOSPHORYLATION OF MAPK1/ERK2, AND INTERACTION WITH
RP   MAPK3/ERK1; MAPK1/ERK2; MAP2K1/MEK1 AND MAP2K2/MEK2.
RX   PubMed=19447520; DOI=10.1016/j.jhep.2009.02.027;
RA   Won M., Park K.A., Byun H.S., Kim Y.R., Choi B.L., Hong J.H., Park J.,
RA   Seok J.H., Lee Y.H., Cho C.H., Song I.S., Kim Y.K., Shen H.M.,
RA   Hur G.M.;
RT   "Protein kinase SGK1 enhances MEK/ERK complex formation through the
RT   phosphorylation of ERK2: implication for the positive regulatory role
RT   of SGK1 on the ERK function during liver regeneration.";
RL   J. Hepatol. 51:67-76(2009).
RN   [49]
RP   FUNCTION IN PHOSPHORYLATION OF MDM2.
RX   PubMed=19756449; DOI=10.1007/s00109-009-0525-5;
RA   Amato R., D'Antona L., Porciatti G., Agosti V., Menniti M.,
RA   Rinaldo C., Costa N., Bellacchio E., Mattarocci S., Fuiano G.,
RA   Soddu S., Paggi M.G., Lang F., Perrotti N.;
RT   "Sgk1 activates MDM2-dependent p53 degradation and affects cell
RT   proliferation, survival, and differentiation.";
RL   J. Mol. Med. 87:1221-1239(2009).
RN   [50]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-74; SER-397 AND SER-401,
RP   AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [51]
RP   FUNCTION IN REGULATION OF SLC6A19.
RX   PubMed=20511718; DOI=10.1159/000315092;
RA   Boehmer C., Sopjani M., Klaus F., Lindner R., Laufer J., Jeyaraj S.,
RA   Lang F., Palmada M.;
RT   "The serum and glucocorticoid inducible kinases SGK1-3 stimulate the
RT   neutral amino acid transporter SLC6A19.";
RL   Cell. Physiol. Biochem. 25:723-732(2010).
RN   [52]
RP   PHOSPHORYLATION AT SER-422 BY MTORC2, AND INTERACTION WITH MTORC2.
RX   PubMed=20338997; DOI=10.1681/ASN.2009111168;
RA   Lu M., Wang J., Jones K.T., Ives H.E., Feldman M.E., Yao L.J.,
RA   Shokat K.M., Ashrafi K., Pearce D.;
RT   "mTOR complex-2 activates ENaC by phosphorylating SGK1.";
RL   J. Am. Soc. Nephrol. 21:811-818(2010).
RN   [53]
RP   FUNCTION.
RX   PubMed=20730100; DOI=10.1371/journal.pone.0012163;
RA   Wiemuth D., Lott J.S., Ly K., Ke Y., Teesdale-Spittle P., Snyder P.M.,
RA   McDonald F.J.;
RT   "Interaction of serum- and glucocorticoid regulated kinase 1 (SGK1)
RT   with the WW-domains of Nedd4-2 is required for epithelial sodium
RT   channel regulation.";
RL   PLoS ONE 5:E12163-E12163(2010).
RN   [54]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-397, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [55]
RP   FUNCTION IN REGULATION OF SLC9A3/NHE3, AND SUBCELLULAR LOCATION.
RX   PubMed=21865597; DOI=10.1091/mbc.E11-04-0328;
RA   He P., Lee S.J., Lin S., Seidler U., Lang F., Fejes-Toth G.,
RA   Naray-Fejes-Toth A., Yun C.C.;
RT   "Serum- and glucocorticoid-induced kinase 3 in recycling endosomes
RT   mediates acute activation of Na+/H+ exchanger NHE3 by
RT   glucocorticoids.";
RL   Mol. Biol. Cell 22:3812-3825(2011).
RN   [56]
RP   REVIEW.
RX   PubMed=12649597; DOI=10.1159/000070244;
RA   Firestone G.L., Giampaolo J.R., O'Keeffe B.A.;
RT   "Stimulus-dependent regulation of serum and glucocorticoid inducible
RT   protein kinase (SGK) transcription, subcellular localization and
RT   enzymatic activity.";
RL   Cell. Physiol. Biochem. 13:1-12(2003).
RN   [57]
RP   REVIEW.
RX   PubMed=16460280; DOI=10.1146/annurev.physiol.68.040104.131654;
RA   Loffing J., Flores S.Y., Staub O.;
RT   "Sgk kinases and their role in epithelial transport.";
RL   Annu. Rev. Physiol. 68:461-490(2006).
RN   [58]
RP   REVIEW ON FUNCTION.
RX   PubMed=20919962; DOI=10.3109/08977194.2010.518616;
RA   Bruhn M.A., Pearson R.B., Hannan R.D., Sheppard K.E.;
RT   "Second AKT: the rise of SGK in cancer signalling.";
RL   Growth Factors 28:394-408(2010).
RN   [59]
RP   REVIEW ON FUNCTION.
RX   PubMed=20530112; DOI=10.1113/jphysiol.2010.190926;
RA   Lang F., Strutz-Seebohm N., Seebohm G., Lang U.E.;
RT   "Significance of SGK1 in the regulation of neuronal function.";
RL   J. Physiol. (Lond.) 588:3349-3354(2010).
RN   [60]
RP   X-RAY CRYSTALLOGRAPHY (1.90 ANGSTROMS) OF 60-431, SUBUNIT, AND
RP   DISULFIDE BOND.
RX   PubMed=17965184; DOI=10.1110/ps.073161707;
RA   Zhao B., Lehr R., Smallwood A.M., Ho T.F., Maley K., Randall T.,
RA   Head M.S., Koretke K.K., Schnackenberg C.G.;
RT   "Crystal structure of the kinase domain of serum and glucocorticoid-
RT   regulated kinase 1 in complex with AMP PNP.";
RL   Protein Sci. 16:2761-2769(2007).
RN   [61]
RP   VARIANTS [LARGE SCALE ANALYSIS] ILE-219 AND VAL-342.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Serine/threonine-protein kinase which is involved in the
CC       regulation of a wide variety of ion channels, membrane
CC       transporters, cellular enzymes, transcription factors, neuronal
CC       excitability, cell growth, proliferation, survival, migration and
CC       apoptosis. Plays an important role in cellular stress response.
CC       Contributes to regulation of renal Na(+) retention, renal K(+)
CC       elimination, salt appetite, gastric acid secretion, intestinal
CC       Na(+)/H(+) exchange and nutrient transport, insulin-dependent salt
CC       sensitivity of blood pressure, salt sensitivity of peripheral
CC       glucose uptake, cardiac repolarization and memory consolidation.
CC       Up-regulates Na(+) channels: SCNN1A/ENAC, SCN5A and ASIC1/ACCN2,
CC       K(+) channels: KCNJ1/ROMK1, KCNA1-5, KCNQ1-5 and KCNE1, epithelial
CC       Ca(2+) channels: TRPV5 and TRPV6, chloride channels: BSND, CLCN2
CC       and CFTR, glutamate transporters: SLC1A3/EAAT1, SLC1A2 /EAAT2,
CC       SLC1A1/EAAT3, SLC1A6/EAAT4 and SLC1A7/EAAT5, amino acid
CC       transporters: SLC1A5/ASCT2, SLC38A1/SN1 and SLC6A19, creatine
CC       transporter: SLC6A8, Na(+)/dicarboxylate cotransporter:
CC       SLC13A2/NADC1, Na(+)-dependent phosphate cotransporter:
CC       SLC34A2/NAPI-2B, glutamate receptor: GRIK2/GLUR6. Up-regulates
CC       carriers: SLC9A3/NHE3, SLC12A1/NKCC2, SLC12A3/NCC, SLC5A3/SMIT,
CC       SLC2A1/GLUT1, SLC5A1/SGLT1 and SLC15A2/PEPT2. Regulates enzymes:
CC       GSK3A/B, PMM2 and Na(+)/K(+) ATPase, and transcription factors:
CC       CTNNB1 and nuclear factor NF-kappa-B. Stimulates sodium transport
CC       into epithelial cells by enhancing the stability and expression of
CC       SCNN1A/ENAC. This is achieved by phosphorylating the NEDD4L
CC       ubiquitin E3 ligase, promoting its interaction with 14-3-3
CC       proteins, thereby preventing it from binding to SCNN1A/ENAC and
CC       targeting it for degradation. Regulates store-operated Ca(+2)
CC       entry (SOCE) by stimulating ORAI1 and STIM1. Regulates KCNJ1/ROMK1
CC       directly via its phosphorylation or indirectly via increased
CC       interaction with SLC9A3R2/NHERF2. Phosphorylates MDM2 and
CC       activates MDM2-dependent ubiquitination of p53/TP53.
CC       Phosphorylates MAPT/TAU and mediates microtubule depolymerization
CC       and neurite formation in hippocampal neurons. Phosphorylates
CC       SLC2A4/GLUT4 and up-regulates its activity. Phosphorylates
CC       APBB1/FE65 and promotes its localization to the nucleus.
CC       Phosphorylates MAPK1/ERK2 and activates it by enhancing its
CC       interaction with MAP2K1/MEK1 and MAP2K2/MEK2. Phosphorylates FBXW7
CC       and plays an inhibitory role in the NOTCH1 signaling.
CC       Phosphorylates FOXO1 resulting in its relocalization from the
CC       nucleus to the cytoplasm. Phosphorylates FOXO3, promoting its exit
CC       from the nucleus and interference with FOXO3-dependent
CC       transcription. Phosphorylates BRAF and MAP3K3/MEKK3 and inhibits
CC       their activity. Phosphorylates SLC9A3/NHE3 in response to
CC       dexamethasone, resulting in its activation and increased
CC       localization at the cell membrane. Phosphorylates CREB1. Necessary
CC       for vascular remodeling during angiogenesis. Sustained high levels
CC       and activity may contribute to conditions such as hypertension and
CC       diabetic nephropathy. Isoform 2 exhibited a greater effect on cell
CC       plasma membrane expression of SCNN1A/ENAC and Na(+) transport than
CC       isoform 1. {ECO:0000269|PubMed:11154281,
CC       ECO:0000269|PubMed:11410590, ECO:0000269|PubMed:11696533,
CC       ECO:0000269|PubMed:12397388, ECO:0000269|PubMed:12590200,
CC       ECO:0000269|PubMed:12634932, ECO:0000269|PubMed:12650886,
CC       ECO:0000269|PubMed:12761204, ECO:0000269|PubMed:12911626,
CC       ECO:0000269|PubMed:14623317, ECO:0000269|PubMed:14706641,
CC       ECO:0000269|PubMed:15040001, ECO:0000269|PubMed:15044175,
CC       ECO:0000269|PubMed:15234985, ECO:0000269|PubMed:15319523,
CC       ECO:0000269|PubMed:15496163, ECO:0000269|PubMed:15733869,
CC       ECO:0000269|PubMed:15737648, ECO:0000269|PubMed:15845389,
CC       ECO:0000269|PubMed:15888551, ECO:0000269|PubMed:16036218,
CC       ECO:0000269|PubMed:16443776, ECO:0000269|PubMed:16982696,
CC       ECO:0000269|PubMed:17382906, ECO:0000269|PubMed:18005662,
CC       ECO:0000269|PubMed:18304449, ECO:0000269|PubMed:18753299,
CC       ECO:0000269|PubMed:19447520, ECO:0000269|PubMed:19756449,
CC       ECO:0000269|PubMed:20511718, ECO:0000269|PubMed:20730100,
CC       ECO:0000269|PubMed:21865597}.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- ENZYME REGULATION: Two specific sites, one in the kinase domain
CC       (Thr-256) and the other in the C-terminal regulatory region (Ser-
CC       422), need to be phosphorylated for its full activation.
CC       Phosphorylation at Ser-397 and Ser-401 are also essential for its
CC       activity. Activated by WNK1, WNK2, WNK3 and WNK4.
CC   -!- SUBUNIT: Homodimer; disulfide-linked. Forms a trimeric complex
CC       with FBXW7 and NOTCH1. Interacts with MAPK3/ERK1, MAPK1/ERK2,
CC       MAP2K1/MEK1, MAP2K2/MEK2, NEDD4, NEDD4L, MAPT/TAU, MAPK7, CREB1,
CC       SLC9A3R2/NHERF2 and KCNJ1/ROMK1. Associates with the mammalian
CC       target of rapamycin complex 2 (mTORC2) via an interaction with
CC       MAPKAP1/SIN1. {ECO:0000269|PubMed:11254654,
CC       ECO:0000269|PubMed:11696533, ECO:0000269|PubMed:14623317,
CC       ECO:0000269|PubMed:15733869, ECO:0000269|PubMed:16982696,
CC       ECO:0000269|PubMed:17965184, ECO:0000269|PubMed:19447520,
CC       ECO:0000269|PubMed:20338997}.
CC   -!- INTERACTION:
CC       P16220:CREB1; NbExp=2; IntAct=EBI-1042854, EBI-711855;
CC       P49815:TSC2; NbExp=4; IntAct=EBI-1042854, EBI-396587;
CC       Q80UE6:Wnk4 (xeno); NbExp=2; IntAct=EBI-1042854, EBI-295378;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm. Nucleus. Endoplasmic reticulum
CC       membrane. Cell membrane. Mitochondrion. Note=The subcellular
CC       localization is controlled by the cell cycle, as well as by
CC       exposure to specific hormones and environmental stress stimuli. In
CC       proliferating cells, it shuttles between the nucleus and cytoplasm
CC       in synchrony with the cell cycle, and in serum/growth factor-
CC       stimulated cells it resides in the nucleus. In contrast, after
CC       exposure to environmental stress or treatment with
CC       glucocorticoids, it is detected in the cytoplasm and with certain
CC       stress conditions is associated with the mitochondria. In
CC       osmoregulation through the epithelial sodium channel, it can be
CC       localized to the cytoplasmic surface of the cell membrane.
CC       Nuclear, upon phosphorylation.
CC   -!- SUBCELLULAR LOCATION: Isoform 2: Cell membrane.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative promoter usage, Alternative splicing; Named isoforms=5;
CC       Name=1;
CC         IsoId=O00141-1; Sequence=Displayed;
CC       Name=2; Synonyms=Sgk1.1, Sgk1_v2;
CC         IsoId=O00141-2; Sequence=VSP_037784;
CC         Note=Produced by alternative promoter usage.;
CC       Name=3; Synonyms=Sgk1.2;
CC         IsoId=O00141-3; Sequence=VSP_037785;
CC         Note=Produced by alternative promoter usage.;
CC       Name=4;
CC         IsoId=O00141-4; Sequence=VSP_037786;
CC         Note=Produced by alternative splicing of isoform 1.;
CC       Name=5;
CC         IsoId=O00141-5; Sequence=VSP_037787;
CC         Note=Produced by alternative promoter usage.;
CC   -!- TISSUE SPECIFICITY: Expressed in most tissues with highest levels
CC       in the pancreas, followed by placenta, kidney and lung. Isoform 2
CC       is strongly expressed in brain and pancreas, weaker in heart,
CC       placenta, lung, liver and skeletal muscle.
CC       {ECO:0000269|PubMed:10548550, ECO:0000269|PubMed:18753299}.
CC   -!- INDUCTION: Induced by a very large spectrum of stimuli distinct
CC       from glucocorticoids and serum. These include aldosterone, cell
CC       shrinkage, cell swelling, TGF-beta, ischemic injury of the brain,
CC       neuronal excitotoxicity memory consolidation, chronic viral
CC       hepatitis, DNA-damaging agents, vitamin D3 psychophysiological
CC       stress, iron, glucose, EDN1, CSF2, fibroblast growth factor,
CC       platelet-derived growth factor, phorbolesters, follicle-
CC       stimulating hormone, sorbitol, heat shock, oxidative stress, UV
CC       irradiation, and p53/TP53. Many of these stimuli are highly cell-
CC       specific, as is the case, for example for aldosterone, which has
CC       been found to stimulate its expression only in cells derived from
CC       aldosterone-responsive epithelia. Isoform 2 is not induced by
CC       glucocorticoids but by excessive extracellular glucose and by
CC       TGFB1, in cultured cells. {ECO:0000269|PubMed:18753299}.
CC   -!- DOMAIN: Isoform 2 subcellular localization at the cell membrane
CC       and resistance to proteasomal degradation is mediated by the
CC       sequences within the first 120 amino acids.
CC   -!- PTM: Regulated by phosphorylation. Activated by phosphorylation on
CC       Ser-422 by mTORC2, transforming it into a substrate for PDPK1
CC       which phosphorylates it on Thr-256. Phosphorylation on Ser-397 and
CC       Ser-401 are also essential for its activity. Phosphorylation on
CC       Ser-78 by MAPK7 is required for growth factor-induced cell cycle
CC       progression. {ECO:0000269|PubMed:10191262,
CC       ECO:0000269|PubMed:11096081, ECO:0000269|PubMed:11254654,
CC       ECO:0000269|PubMed:18925875, ECO:0000269|PubMed:19068477,
CC       ECO:0000269|PubMed:20338997}.
CC   -!- PTM: Ubiquitinated by NEDD4L; which promotes proteasomal
CC       degradation. Ubiquitinated by SYVN1 at the endoplasmic reticulum;
CC       which promotes rapid proteasomal degradation and maintains a high
CC       turnover rate in resting cells. Isoform 2 shows enhanced
CC       stability. {ECO:0000269|PubMed:15576372}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. AGC Ser/Thr
CC       protein kinase family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; Y10032; CAA71138.1; -; mRNA.
DR   EMBL; AJ000512; CAA04146.1; -; Genomic_DNA.
DR   EMBL; EU518415; ACD35864.1; -; mRNA.
DR   EMBL; FM205707; CAR58095.1; -; mRNA.
DR   EMBL; FM205708; CAR58096.1; -; mRNA.
DR   EMBL; FM205709; CAR58097.1; -; mRNA.
DR   EMBL; FM205710; CAR58098.1; -; mRNA.
DR   EMBL; AF153609; AAD41091.1; -; mRNA.
DR   EMBL; AK055077; BAG51463.1; -; mRNA.
DR   EMBL; AK298688; BAH12848.1; -; mRNA.
DR   EMBL; AL355881; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL135839; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; Z84486; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471051; EAW47991.1; -; Genomic_DNA.
DR   EMBL; CH471051; EAW47992.1; -; Genomic_DNA.
DR   EMBL; CH471051; EAW47993.1; -; Genomic_DNA.
DR   EMBL; BC001263; AAH01263.1; -; mRNA.
DR   CCDS; CCDS47476.1; -. [O00141-2]
DR   CCDS; CCDS47477.1; -. [O00141-5]
DR   CCDS; CCDS47478.1; -. [O00141-3]
DR   CCDS; CCDS5170.1; -. [O00141-1]
DR   RefSeq; NP_001137148.1; NM_001143676.1. [O00141-2]
DR   RefSeq; NP_001137149.1; NM_001143677.1. [O00141-5]
DR   RefSeq; NP_001137150.1; NM_001143678.1. [O00141-3]
DR   RefSeq; NP_001278924.1; NM_001291995.1.
DR   RefSeq; NP_005618.2; NM_005627.3. [O00141-1]
DR   RefSeq; XP_011534373.1; XM_011536071.1. [O00141-2]
DR   UniGene; Hs.510078; -.
DR   PDB; 2R5T; X-ray; 1.90 A; A=60-431.
DR   PDB; 3HDM; X-ray; 2.60 A; A=60-431.
DR   PDB; 3HDN; X-ray; 3.10 A; A=60-431.
DR   PDBsum; 2R5T; -.
DR   PDBsum; 3HDM; -.
DR   PDBsum; 3HDN; -.
DR   ProteinModelPortal; O00141; -.
DR   SMR; O00141; -.
DR   BioGrid; 112344; 63.
DR   CORUM; O00141; -.
DR   DIP; DIP-42464N; -.
DR   ELM; O00141; -.
DR   IntAct; O00141; 56.
DR   MINT; O00141; -.
DR   STRING; 9606.ENSP00000356832; -.
DR   BindingDB; O00141; -.
DR   ChEMBL; CHEMBL2343; -.
DR   DrugBank; DB03247; Riboflavin Monophosphate.
DR   GuidetoPHARMACOLOGY; 1534; -.
DR   iPTMnet; O00141; -.
DR   PhosphoSitePlus; O00141; -.
DR   BioMuta; SGK1; -.
DR   EPD; O00141; -.
DR   MaxQB; O00141; -.
DR   PaxDb; O00141; -.
DR   PeptideAtlas; O00141; -.
DR   PRIDE; O00141; -.
DR   DNASU; 6446; -.
DR   Ensembl; ENST00000237305; ENSP00000237305; ENSG00000118515. [O00141-1]
DR   Ensembl; ENST00000367857; ENSP00000356831; ENSG00000118515. [O00141-4]
DR   Ensembl; ENST00000367858; ENSP00000356832; ENSG00000118515. [O00141-2]
DR   Ensembl; ENST00000413996; ENSP00000396242; ENSG00000118515. [O00141-3]
DR   Ensembl; ENST00000528577; ENSP00000434450; ENSG00000118515. [O00141-5]
DR   GeneID; 6446; -.
DR   KEGG; hsa:6446; -.
DR   UCSC; uc003qen.5; human. [O00141-1]
DR   CTD; 6446; -.
DR   DisGeNET; 6446; -.
DR   EuPathDB; HostDB:ENSG00000118515.11; -.
DR   GeneCards; SGK1; -.
DR   HGNC; HGNC:10810; SGK1.
DR   HPA; CAB022085; -.
DR   HPA; CAB025148; -.
DR   HPA; HPA051251; -.
DR   MIM; 602958; gene.
DR   neXtProt; NX_O00141; -.
DR   OpenTargets; ENSG00000118515; -.
DR   PharmGKB; PA162403013; -.
DR   eggNOG; KOG0598; Eukaryota.
DR   eggNOG; ENOG410XNPH; LUCA.
DR   GeneTree; ENSGT00890000139324; -.
DR   HOVERGEN; HBG108317; -.
DR   InParanoid; O00141; -.
DR   KO; K13302; -.
DR   OMA; EVKEPCN; -.
DR   OrthoDB; EOG091G06FF; -.
DR   PhylomeDB; O00141; -.
DR   TreeFam; TF320906; -.
DR   BRENDA; 2.7.11.1; 2681.
DR   Reactome; R-HSA-2672351; Stimuli-sensing channels.
DR   Reactome; R-HSA-6804757; Regulation of TP53 Degradation.
DR   SignaLink; O00141; -.
DR   SIGNOR; O00141; -.
DR   ChiTaRS; SGK1; human.
DR   EvolutionaryTrace; O00141; -.
DR   GeneWiki; SGK; -.
DR   GenomeRNAi; 6446; -.
DR   PRO; PR:O00141; -.
DR   Proteomes; UP000005640; Chromosome 6.
DR   Bgee; ENSG00000118515; -.
DR   CleanEx; HS_SGK1; -.
DR   ExpressionAtlas; O00141; baseline and differential.
DR   Genevisible; O00141; HS.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005739; C:mitochondrion; IEA:UniProtKB-SubCell.
DR   GO; GO:0016607; C:nuclear speck; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0005246; F:calcium channel regulator activity; TAS:UniProtKB.
DR   GO; GO:0017081; F:chloride channel regulator activity; TAS:UniProtKB.
DR   GO; GO:0015459; F:potassium channel regulator activity; TAS:UniProtKB.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IBA:GO_Central.
DR   GO; GO:0004712; F:protein serine/threonine/tyrosine kinase activity; IDA:MGI.
DR   GO; GO:0017080; F:sodium channel regulator activity; TAS:UniProtKB.
DR   GO; GO:0006915; P:apoptotic process; IEA:UniProtKB-KW.
DR   GO; GO:0006974; P:cellular response to DNA damage stimulus; IEA:Ensembl.
DR   GO; GO:0035556; P:intracellular signal transduction; IBA:GO_Central.
DR   GO; GO:0034220; P:ion transmembrane transport; TAS:Reactome.
DR   GO; GO:0007616; P:long-term memory; TAS:UniProtKB.
DR   GO; GO:0048812; P:neuron projection morphogenesis; IBA:GO_Central.
DR   GO; GO:0018105; P:peptidyl-serine phosphorylation; IBA:GO_Central.
DR   GO; GO:0032411; P:positive regulation of transporter activity; TAS:UniProtKB.
DR   GO; GO:0006468; P:protein phosphorylation; TAS:ProtInc.
DR   GO; GO:0042981; P:regulation of apoptotic process; TAS:UniProtKB.
DR   GO; GO:0008217; P:regulation of blood pressure; TAS:UniProtKB.
DR   GO; GO:0050790; P:regulation of catalytic activity; TAS:UniProtKB.
DR   GO; GO:0001558; P:regulation of cell growth; TAS:UniProtKB.
DR   GO; GO:0030334; P:regulation of cell migration; TAS:UniProtKB.
DR   GO; GO:0042127; P:regulation of cell proliferation; TAS:UniProtKB.
DR   GO; GO:0051090; P:regulation of DNA binding transcription factor activity; TAS:UniProtKB.
DR   GO; GO:0060453; P:regulation of gastric acid secretion; TAS:UniProtKB.
DR   GO; GO:0070294; P:renal sodium ion absorption; TAS:UniProtKB.
DR   GO; GO:0006814; P:sodium ion transport; TAS:ProtInc.
DR   InterPro; IPR000961; AGC-kinase_C.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR017892; Pkinase_C.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   Pfam; PF00069; Pkinase; 1.
DR   Pfam; PF00433; Pkinase_C; 1.
DR   SMART; SM00133; S_TK_X; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS51285; AGC_KINASE_CTER; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative promoter usage; Alternative splicing;
KW   Apoptosis; ATP-binding; Cell membrane; Complete proteome; Cytoplasm;
KW   Disulfide bond; Endoplasmic reticulum; Kinase; Membrane;
KW   Mitochondrion; Nucleotide-binding; Nucleus; Phosphoprotein;
KW   Polymorphism; Reference proteome; Serine/threonine-protein kinase;
KW   Stress response; Transferase; Ubl conjugation.
FT   CHAIN         1    431       Serine/threonine-protein kinase Sgk1.
FT                                /FTId=PRO_0000086642.
FT   DOMAIN       98    355       Protein kinase. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   DOMAIN      356    431       AGC-kinase C-terminal.
FT   NP_BIND     104    112       ATP.
FT   REGION        1     60       Necessary for localization to the
FT                                mitochondria.
FT   MOTIF       131    141       Nuclear localization signal.
FT                                {ECO:0000269|PubMed:12631736}.
FT   COMPBIAS    131    141       Glu/Lys-rich.
FT   ACT_SITE    222    222       Proton acceptor.
FT   BINDING     127    127       ATP.
FT   MOD_RES      74     74       Phosphoserine.
FT                                {ECO:0000244|PubMed:18691976,
FT                                ECO:0000244|PubMed:19369195}.
FT   MOD_RES      78     78       Phosphoserine; by MAPK7.
FT                                {ECO:0000269|PubMed:11254654}.
FT   MOD_RES     256    256       Phosphothreonine; by PDPK1.
FT                                {ECO:0000269|PubMed:10191262}.
FT   MOD_RES     369    369       Phosphothreonine; by PKA.
FT                                {ECO:0000269|PubMed:11096081}.
FT   MOD_RES     397    397       Phosphoserine.
FT                                {ECO:0000244|PubMed:18691976,
FT                                ECO:0000244|PubMed:19369195,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000269|PubMed:19068477}.
FT   MOD_RES     401    401       Phosphoserine.
FT                                {ECO:0000244|PubMed:18691976,
FT                                ECO:0000244|PubMed:19369195,
FT                                ECO:0000269|PubMed:19068477}.
FT   MOD_RES     422    422       Phosphoserine.
FT                                {ECO:0000269|PubMed:10191262,
FT                                ECO:0000269|PubMed:18925875,
FT                                ECO:0000269|PubMed:20338997}.
FT   DISULFID    193    193       Interchain (with C-258).
FT                                {ECO:0000269|PubMed:17965184}.
FT   DISULFID    258    258       Interchain (with C-193).
FT                                {ECO:0000269|PubMed:17965184}.
FT   VAR_SEQ       1     25       MTVKTEAAKGTLTYSRMRGMVAILI -> MVNKDMNGFPVK
FT                                KCSAFQFFKKRVRRWIKSPMVSVDKHQSPSLKYTGSSMVHI
FT                                PPGEPDFESSLCQTCLGEHAFQRGVLPQENESCSWETQSGC
FT                                EVREPCNHANILTKPDPRTFWTNDDP (in isoform
FT                                2). {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:18753299,
FT                                ECO:0000303|Ref.4}.
FT                                /FTId=VSP_037784.
FT   VAR_SEQ       1     25       MTVKTEAAKGTLTYSRMRGMVAILI -> MGEMQGALARAR
FT                                LESLLRPRHKKRAEAQKRSESFLLSGL (in isoform
FT                                3). {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|Ref.4}.
FT                                /FTId=VSP_037785.
FT   VAR_SEQ       1     25       MTVKTEAAKGTLTYSRMRGMVAILI -> MKPSKRFFISPP
FT                                SST (in isoform 4). {ECO:0000303|Ref.4}.
FT                                /FTId=VSP_037786.
FT   VAR_SEQ       1     25       MTVKTEAAKGTLTYSRMRGMVAILI -> MSSQSSSLSEAC
FT                                SREAYSSHNWALPPASRSNPQPAYPWATRRMKEEAIKPPLK
FT                                (in isoform 5). {ECO:0000303|Ref.4}.
FT                                /FTId=VSP_037787.
FT   VARIANT     219    219       V -> I (in dbSNP:rs34133418).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041071.
FT   VARIANT     342    342       A -> V (in dbSNP:rs55932330).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041072.
FT   MUTAGEN     127    127       K->M: Abolishes enzymatic activity.
FT                                {ECO:0000269|PubMed:11696533,
FT                                ECO:0000269|PubMed:12911626,
FT                                ECO:0000269|PubMed:15040001}.
FT   MUTAGEN     256    256       T->A: Low activity.
FT                                {ECO:0000269|PubMed:10191262}.
FT   MUTAGEN     256    256       T->D: Low activity.
FT                                {ECO:0000269|PubMed:10191262}.
FT   MUTAGEN     256    256       T->E: Low activity.
FT                                {ECO:0000269|PubMed:10191262}.
FT   MUTAGEN     298    298       Y->A: Abolishes interaction with NEDD4
FT                                and NEDD4L.
FT                                {ECO:0000269|PubMed:11696533}.
FT   MUTAGEN     422    422       S->A: Low activity.
FT                                {ECO:0000269|PubMed:10191262,
FT                                ECO:0000269|PubMed:11696533,
FT                                ECO:0000269|PubMed:12911626,
FT                                ECO:0000269|PubMed:15040001}.
FT   MUTAGEN     422    422       S->D: 10-fold activation.
FT                                {ECO:0000269|PubMed:10191262,
FT                                ECO:0000269|PubMed:11696533,
FT                                ECO:0000269|PubMed:12911626,
FT                                ECO:0000269|PubMed:15040001}.
FT   CONFLICT     62     62       Q -> E (in Ref. 4; CAR58097).
FT                                {ECO:0000305}.
FT   CONFLICT    152    152       K -> R (in Ref. 4; CAR58096).
FT                                {ECO:0000305}.
FT   CONFLICT    196    196       E -> G (in Ref. 4; CAR58095).
FT                                {ECO:0000305}.
FT   CONFLICT    228    228       I -> V (in Ref. 6; BAH12848).
FT                                {ECO:0000305}.
FT   CONFLICT    371    371       P -> R (in Ref. 4; CAR58097).
FT                                {ECO:0000305}.
FT   CONFLICT    381    381       D -> E (in Ref. 1; CAA71138 and 2;
FT                                CAA04146). {ECO:0000305}.
FT   HELIX        95     97       {ECO:0000244|PDB:2R5T}.
FT   STRAND       98    105       {ECO:0000244|PDB:2R5T}.
FT   STRAND      111    117       {ECO:0000244|PDB:2R5T}.
FT   TURN        118    120       {ECO:0000244|PDB:2R5T}.
FT   STRAND      123    130       {ECO:0000244|PDB:2R5T}.
FT   HELIX       131    133       {ECO:0000244|PDB:2R5T}.
FT   STRAND      162    167       {ECO:0000244|PDB:2R5T}.
FT   STRAND      169    177       {ECO:0000244|PDB:2R5T}.
FT   HELIX       184    191       {ECO:0000244|PDB:2R5T}.
FT   HELIX       196    215       {ECO:0000244|PDB:2R5T}.
FT   HELIX       225    227       {ECO:0000244|PDB:2R5T}.
FT   STRAND      228    230       {ECO:0000244|PDB:2R5T}.
FT   STRAND      232    234       {ECO:0000244|PDB:3HDN}.
FT   STRAND      236    238       {ECO:0000244|PDB:2R5T}.
FT   HELIX       245    247       {ECO:0000244|PDB:2R5T}.
FT   STRAND      256    258       {ECO:0000244|PDB:2R5T}.
FT   HELIX       266    269       {ECO:0000244|PDB:2R5T}.
FT   HELIX       277    292       {ECO:0000244|PDB:2R5T}.
FT   HELIX       302    311       {ECO:0000244|PDB:2R5T}.
FT   STRAND      318    320       {ECO:0000244|PDB:2R5T}.
FT   HELIX       322    331       {ECO:0000244|PDB:2R5T}.
FT   HELIX       336    338       {ECO:0000244|PDB:2R5T}.
FT   TURN        340    345       {ECO:0000244|PDB:2R5T}.
FT   HELIX       346    350       {ECO:0000244|PDB:2R5T}.
FT   HELIX       353    355       {ECO:0000244|PDB:2R5T}.
FT   HELIX       360    364       {ECO:0000244|PDB:2R5T}.
SQ   SEQUENCE   431 AA;  48942 MW;  F3697C63AB1F499D CRC64;
     MTVKTEAAKG TLTYSRMRGM VAILIAFMKQ RRMGLNDFIQ KIANNSYACK HPEVQSILKI
     SQPQEPELMN ANPSPPPSPS QQINLGPSSN PHAKPSDFHF LKVIGKGSFG KVLLARHKAE
     EVFYAVKVLQ KKAILKKKEE KHIMSERNVL LKNVKHPFLV GLHFSFQTAD KLYFVLDYIN
     GGELFYHLQR ERCFLEPRAR FYAAEIASAL GYLHSLNIVY RDLKPENILL DSQGHIVLTD
     FGLCKENIEH NSTTSTFCGT PEYLAPEVLH KQPYDRTVDW WCLGAVLYEM LYGLPPFYSR
     NTAEMYDNIL NKPLQLKPNI TNSARHLLEG LLQKDRTKRL GAKDDFMEIK SHVFFSLINW
     DDLINKKITP PFNPNVSGPN DLRHFDPEFT EEPVPNSIGK SPDSVLVTAS VKEAAEAFLG
     FSYAPPTDSF L
//
ID   Q8TBA2_HUMAN            Unreviewed;       291 AA.
AC   Q8TBA2;
DT   01-JUN-2002, integrated into UniProtKB/TrEMBL.
DT   01-JUN-2002, sequence version 1.
DT   28-MAR-2018, entry version 97.
DE   SubName: Full=SIX homeobox 2 {ECO:0000313|EMBL:AAH24033.1};
GN   Name=SIX2 {ECO:0000313|EMBL:AAH24033.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:AAH24033.1};
RN   [1] {ECO:0000313|EMBL:AAH24033.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Muscle {ECO:0000313|EMBL:AAH24033.1};
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RA   Gerhard D.S., Wagner L., Feingold E.A., Shenmen C.M., Grouse L.H.,
RA   Schuler G., Klein S.L., Old S., Rasooly R., Good P., Guyer M.,
RA   Peck A.M., Derge J.G., Lipman D., Collins F.S., Jang W., Sherry S.,
RA   Feolo M., Misquitta L., Lee E., Rotmistrovsky K., Greenhut S.F.,
RA   Schaefer C.F., Buetow K., Bonner T.I., Haussler D., Kent J.,
RA   Kiekhaus M., Furey T., Brent M., Prange C., Schreiber K., Shapiro N.,
RA   Bhat N.K., Hopkins R.F., Hsie F., Driscoll T., Soares M.B.,
RA   Casavant T.L., Scheetz T.E., Brown-stein M.J., Usdin T.B.,
RA   Toshiyuki S., Carninci P., Piao Y., Dudekula D.B., Ko M.S.,
RA   Kawakami K., Suzuki Y., Sugano S., Gruber C.E., Smith M.R.,
RA   Simmons B., Moore T., Waterman R., Johnson S.L., Ruan Y., Wei C.L.,
RA   Mathavan S., Gunaratne P.H., Wu J., Garcia A.M., Hulyk S.W., Fuh E.,
RA   Yuan Y., Sneed A., Kowis C., Hodgson A., Muzny D.M., McPherson J.,
RA   Gibbs R.A., Fahey J., Helton E., Ketteman M., Madan A., Rodrigues S.,
RA   Sanchez A., Whiting M., Madari A., Young A.C., Wetherby K.D.,
RA   Granite S.J., Kwong P.N., Brinkley C.P., Pearson R.L., Bouffard G.G.,
RA   Blakesly R.W., Green E.D., Dickson M.C., Rodriguez A.C., Grimwood J.,
RA   Schmutz J., Myers R.M., Butterfield Y.S., Griffith M., Griffith O.L.,
RA   Krzywinski M.I., Liao N., Morin R., Morrin R., Palmquist D.,
RA   Petrescu A.S., Skalska U., Smailus D.E., Stott J.M., Schnerch A.,
RA   Schein J.E., Jones S.J., Holt R.A., Baross A., Marra M.A., Clifton S.,
RA   Makowski K.A., Bosak S., Malek J.;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000256|PROSITE-
CC       ProRule:PRU00108, ECO:0000256|RuleBase:RU000682}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; BC024033; AAH24033.1; -; mRNA.
DR   RefSeq; NP_058628.3; NM_016932.4.
DR   UniGene; Hs.101937; -.
DR   ProteinModelPortal; Q8TBA2; -.
DR   PeptideAtlas; Q8TBA2; -.
DR   PRIDE; Q8TBA2; -.
DR   DNASU; 10736; -.
DR   GeneID; 10736; -.
DR   KEGG; hsa:10736; -.
DR   CTD; 10736; -.
DR   PharmGKB; PA35788; -.
DR   eggNOG; KOG0775; Eukaryota.
DR   eggNOG; ENOG410XRPB; LUCA.
DR   HOVERGEN; HBG003609; -.
DR   KO; K19472; -.
DR   ChiTaRS; SIX2; human.
DR   GenomeRNAi; 10736; -.
DR   Genevisible; Q8TBA2; HS.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0003677; F:DNA binding; IEA:UniProtKB-UniRule.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR009057; Homeobox-like_sf.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR031701; SIX1_SD.
DR   Pfam; PF00046; Homeobox; 1.
DR   Pfam; PF16878; SIX1_SD; 1.
DR   SMART; SM00389; HOX; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
PE   2: Evidence at transcript level;
KW   Coiled coil {ECO:0000256|SAM:Coils};
KW   DNA-binding {ECO:0000256|PROSITE-ProRule:PRU00108,
KW   ECO:0000256|RuleBase:RU000682, ECO:0000313|EMBL:AAH24033.1};
KW   Homeobox {ECO:0000256|PROSITE-ProRule:PRU00108,
KW   ECO:0000256|RuleBase:RU000682, ECO:0000313|EMBL:AAH24033.1};
KW   Nucleus {ECO:0000256|PROSITE-ProRule:PRU00108,
KW   ECO:0000256|RuleBase:RU000682}.
FT   DOMAIN      122    182       Homeobox. {ECO:0000259|PROSITE:PS50071}.
FT   DNA_BIND    124    183       Homeobox. {ECO:0000256|PROSITE-
FT                                ProRule:PRU00108}.
FT   COILED      174    194       {ECO:0000256|SAM:Coils}.
SQ   SEQUENCE   291 AA;  32316 MW;  C288C3D3305B2AC1 CRC64;
     MSMLPTFGFT QEQVACVCEV LQQGGNIERL GRFLWSLPAC EHLHKNESVL KAKAVVAFHR
     GNFRELYKIL ESHQFSPHNH AKLQQLWLKA HYIEAEKLRG RPLGAVGKYR VRRKFPLPRS
     IWDGEETSYC FKEKSRSVLR EWYAHNPYPS PREKRELTEA TGLTTTQVSN WFKNRRQRDR
     AAEAKERENN ENSNSNSHNP LNGSGKSVLG SSEDEKTPSG TPDHSSSSPA LLLSPPPPGL
     PSLHSLGHPP GPSAVPVPVP GGGGADPLQH HHGLQDSILN PMSANLVDLG S
//
ID   SIX2_HUMAN              Reviewed;         291 AA.
AC   Q9NPC8; Q9BXH7;
DT   11-JAN-2001, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2000, sequence version 1.
DT   25-APR-2018, entry version 138.
DE   RecName: Full=Homeobox protein SIX2;
DE   AltName: Full=Sine oculis homeobox homolog 2;
GN   Name=SIX2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=10677303; DOI=10.1086/302779;
RA   Celli J., Van Beusekom E., Hennekam R.C.M., Gallardo M.E.,
RA   Smeets D.F.C.M., Rodriguez de Cordoba S., Innis J.W., Frydman M.,
RA   Konig R., Kingston H., Tolmie J., Lutgarde L.C.P., van Bokhoven H.,
RA   Brunner H.G.;
RT   "Familial syndromic esophageal atresia maps to 2p23-p24.";
RL   Am. J. Hum. Genet. 66:436-444(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA].
RX   PubMed=10773454; DOI=10.1016/S0378-1119(00)00105-0;
RA   Boucher C.A., Winchester C.L., Hamilton G.M., Winter A.D.,
RA   Johnson K.J., Bailey M.E.S.;
RT   "Structure, mapping and expression of the human gene encoding the
RT   homeodomain protein, SIX2.";
RL   Gene 247:145-151(2000).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA].
RC   TISSUE=Salivary gland;
RA   Hedrich K., Hehr A.J., Hansmann I., Hehr U.;
RT   "Molecular characterization of the human SIX2 gene: alternative
RT   polyadenylation and localization within the HPE2 critical region
RT   2p21.";
RL   Submitted (DEC-2000) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor
RT   vector.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   DEVELOPMENTAL STAGE.
RX   PubMed=20515681; DOI=10.1016/j.ydbio.2010.05.509;
RA   He G., Tavella S., Hanley K.P., Self M., Oliver G., Grifone R.,
RA   Hanley N., Ward C., Bobola N.;
RT   "Inactivation of Six2 in mouse identifies a novel genetic mechanism
RT   controlling development and growth of the cranial base.";
RL   Dev. Biol. 344:720-730(2010).
RN   [6]
RP   TISSUE SPECIFICITY.
RX   PubMed=22703800; DOI=10.1016/j.jpedsurg.2012.03.034;
RA   Murphy A.J., Pierce J., de Caestecker C., Taylor C., Anderson J.R.,
RA   Perantoni A.O., de Caestecker M.P., Lovvorn H.N. III;
RT   "SIX2 and CITED1, markers of nephronic progenitor self-renewal, remain
RT   active in primitive elements of Wilms' tumor.";
RL   J. Pediatr. Surg. 47:1239-1249(2012).
RN   [7]
RP   FUNCTION IN CELL MIGRATION AND CELL PROLIFERATION.
RX   PubMed=22995329; DOI=10.1016/j.humpath.2012.05.021;
RA   Senanayake U., Koller K., Pichler M., Leuschner I., Strohmaier H.,
RA   Hadler U., Das S., Hoefler G., Guertl B.;
RT   "The pluripotent renal stem cell regulator SIX2 is activated in renal
RT   neoplasms and influences cellular proliferation and migration.";
RL   Hum. Pathol. 44:336-345(2013).
RN   [8]
RP   VARIANTS PHE-43; LEU-241 AND ASN-276.
RX   PubMed=18305125; DOI=10.1681/ASN.2006111282;
RA   Weber S., Taylor J.C., Winyard P., Baker K.F., Sullivan-Brown J.,
RA   Schild R., Knueppel T., Zurowska A.M., Caldas-Alfonso A., Litwin M.,
RA   Emre S., Ghiggeri G.M., Bakkaloglu A., Mehls O., Antignac C.,
RA   Schaefer F., Burdine R.D.;
RT   "SIX2 and BMP4 mutations associate with anomalous kidney
RT   development.";
RL   J. Am. Soc. Nephrol. 19:891-903(2008).
CC   -!- FUNCTION: Transcription factor that plays an important role in the
CC       development of several organs, including kidney, skull and
CC       stomach. During kidney development, maintains cap mesenchyme
CC       multipotent nephron progenitor cells in an undifferentiated state
CC       by opposing the inductive signals emanating from the ureteric bud
CC       and cooperates with WNT9B to promote renewing progenitor cells
CC       proliferation. Acts through its interaction with TCF7L2 and OSR1
CC       in a canonical Wnt signaling independent manner preventing
CC       transcription of differentiation genes in cap mesenchyme such as
CC       WNT4. Also acts independently of OSR1 to activate expression of
CC       many cap mesenchyme genes, including itself, GDNF and OSR1. During
CC       craniofacial development plays a role in growth and elongation of
CC       the cranial base through regulation of chondrocyte
CC       differentiation. During stomach organogenesis, controls pyloric
CC       sphincter formation and mucosal growth through regulation of a
CC       gene network including NKX2-5, BMPR1B, BMP4, SOX9 and GREM1.
CC       During branchial arch development, acts to mediate HOXA2 control
CC       over the insulin-like growth factor pathway. Also may be involved
CC       in limb tendon and ligament development (By similarity). Plays a
CC       role in cell proliferation and migration.
CC       {ECO:0000250|UniProtKB:Q62232, ECO:0000269|PubMed:22995329}.
CC   -!- SUBUNIT: Interacts with TCF7L2; in a canonical Wnt signaling
CC       independent manner; prevents transcription of differentiation
CC       genes in cap mesenchyme. Interacts with OSR1; form a strong
CC       repressor complex with TCF7L2, TLE2 and TLE3 to prevent the
CC       activation of Wnt/beta-catenin target genes in the cap mesenchyme.
CC       Interacts with HOXA11, EYA1 and EYA3.
CC       {ECO:0000250|UniProtKB:Q62232}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:Q62232}.
CC   -!- TISSUE SPECIFICITY: Strongly expressed in skeletal muscle.
CC       Expressed in Wilms' tumor and in the cap mesenchyme of fetal
CC       kidney (at protein level). {ECO:0000269|PubMed:22703800}.
CC   -!- DEVELOPMENTAL STAGE: Found at 48 dpc in the anterior cranial base
CC       with detection concentrated in the sphenoid precursor. Expression
CC       is also detected in the pituitary gland.
CC       {ECO:0000269|PubMed:20515681}.
CC   -!- SIMILARITY: Belongs to the SIX/Sine oculis homeobox family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF136939; AAF69031.1; -; Genomic_DNA.
DR   EMBL; AF136940; AAF69032.1; -; mRNA.
DR   EMBL; AF332196; AAK16581.1; -; mRNA.
DR   EMBL; AF332197; AAK16582.1; -; mRNA.
DR   EMBL; AF332198; AAK16583.1; -; Genomic_DNA.
DR   EMBL; AF323498; AAK06773.1; -; Genomic_DNA.
DR   EMBL; BT020100; AAV38903.1; -; mRNA.
DR   CCDS; CCDS1822.1; -.
DR   RefSeq; NP_058628.3; NM_016932.4.
DR   UniGene; Hs.101937; -.
DR   ProteinModelPortal; Q9NPC8; -.
DR   SMR; Q9NPC8; -.
DR   BioGrid; 115959; 22.
DR   STRING; 9606.ENSP00000304502; -.
DR   iPTMnet; Q9NPC8; -.
DR   PhosphoSitePlus; Q9NPC8; -.
DR   BioMuta; SIX2; -.
DR   DMDM; 12230598; -.
DR   EPD; Q9NPC8; -.
DR   MaxQB; Q9NPC8; -.
DR   PaxDb; Q9NPC8; -.
DR   PeptideAtlas; Q9NPC8; -.
DR   PRIDE; Q9NPC8; -.
DR   DNASU; 10736; -.
DR   Ensembl; ENST00000303077; ENSP00000304502; ENSG00000170577.
DR   GeneID; 10736; -.
DR   KEGG; hsa:10736; -.
DR   UCSC; uc002ruo.4; human.
DR   CTD; 10736; -.
DR   DisGeNET; 10736; -.
DR   EuPathDB; HostDB:ENSG00000170577.7; -.
DR   GeneCards; SIX2; -.
DR   HGNC; HGNC:10888; SIX2.
DR   HPA; HPA052782; -.
DR   HPA; HPA056958; -.
DR   MalaCards; SIX2; -.
DR   MIM; 604994; gene.
DR   neXtProt; NX_Q9NPC8; -.
DR   OpenTargets; ENSG00000170577; -.
DR   PharmGKB; PA35788; -.
DR   eggNOG; KOG0775; Eukaryota.
DR   eggNOG; ENOG410XRPB; LUCA.
DR   GeneTree; ENSGT00540000070251; -.
DR   HOGENOM; HOG000261680; -.
DR   HOVERGEN; HBG003609; -.
DR   InParanoid; Q9NPC8; -.
DR   KO; K19472; -.
DR   OMA; HSLHHET; -.
DR   OrthoDB; EOG091G083I; -.
DR   PhylomeDB; Q9NPC8; -.
DR   TreeFam; TF315545; -.
DR   ChiTaRS; SIX2; human.
DR   GeneWiki; SIX2; -.
DR   GenomeRNAi; 10736; -.
DR   PRO; PR:Q9NPC8; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   Bgee; ENSG00000170577; -.
DR   CleanEx; HS_SIX2; -.
DR   Genevisible; Q9NPC8; HS.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0003700; F:DNA binding transcription factor activity; NAS:ProtInc.
DR   GO; GO:0044877; F:protein-containing complex binding; IEA:Ensembl.
DR   GO; GO:0000978; F:RNA polymerase II proximal promoter sequence-specific DNA binding; IEA:Ensembl.
DR   GO; GO:0000981; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; ISM:NTNU_SB.
DR   GO; GO:0008134; F:transcription factor binding; IEA:Ensembl.
DR   GO; GO:0001077; F:transcriptional activator activity, RNA polymerase II proximal promoter sequence-specific DNA binding; IEA:Ensembl.
DR   GO; GO:0009653; P:anatomical structure morphogenesis; TAS:ProtInc.
DR   GO; GO:0009948; P:anterior/posterior axis specification; ISS:UniProtKB.
DR   GO; GO:0016477; P:cell migration; IDA:UniProtKB.
DR   GO; GO:0008283; P:cell proliferation; IDA:UniProtKB.
DR   GO; GO:0002062; P:chondrocyte differentiation; IEA:Ensembl.
DR   GO; GO:0072137; P:condensed mesenchymal cell proliferation; IEA:Ensembl.
DR   GO; GO:0048701; P:embryonic cranial skeleton morphogenesis; IEA:Ensembl.
DR   GO; GO:0048557; P:embryonic digestive tract morphogenesis; ISS:UniProtKB.
DR   GO; GO:0001822; P:kidney development; IMP:UniProtKB.
DR   GO; GO:0072161; P:mesenchymal cell differentiation involved in kidney development; ISS:UniProtKB.
DR   GO; GO:0072038; P:mesenchymal stem cell maintenance involved in nephron morphogenesis; ISS:UniProtKB.
DR   GO; GO:0097168; P:mesenchymal stem cell proliferation; ISS:UniProtKB.
DR   GO; GO:0003337; P:mesenchymal to epithelial transition involved in metanephros morphogenesis; ISS:UniProtKB.
DR   GO; GO:0007501; P:mesodermal cell fate specification; ISS:UniProtKB.
DR   GO; GO:0042474; P:middle ear morphogenesis; IEA:Ensembl.
DR   GO; GO:0045596; P:negative regulation of cell differentiation; IEA:Ensembl.
DR   GO; GO:0072006; P:nephron development; ISS:UniProtKB.
DR   GO; GO:0072028; P:nephron morphogenesis; ISS:UniProtKB.
DR   GO; GO:1902732; P:positive regulation of chondrocyte proliferation; ISS:UniProtKB.
DR   GO; GO:0006606; P:protein import into nucleus; IEA:Ensembl.
DR   GO; GO:0090189; P:regulation of branching involved in ureteric bud morphogenesis; ISS:UniProtKB.
DR   GO; GO:0032330; P:regulation of chondrocyte differentiation; IEA:Ensembl.
DR   GO; GO:0030278; P:regulation of ossification; IEA:Ensembl.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR009057; Homeobox-like_sf.
DR   InterPro; IPR017970; Homeobox_CS.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR031701; SIX1_SD.
DR   Pfam; PF00046; Homeobox; 1.
DR   Pfam; PF16878; SIX1_SD; 1.
DR   SMART; SM00389; HOX; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS00027; HOMEOBOX_1; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
PE   1: Evidence at protein level;
KW   Complete proteome; Developmental protein; DNA-binding; Homeobox;
KW   Nucleus; Polymorphism; Reference proteome.
FT   CHAIN         1    291       Homeobox protein SIX2.
FT                                /FTId=PRO_0000049297.
FT   DNA_BIND    124    183       Homeobox. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00108}.
FT   VARIANT      43     43       L -> F (in a renal hypodysplasia patient;
FT                                dbSNP:rs142188105).
FT                                {ECO:0000269|PubMed:18305125}.
FT                                /FTId=VAR_071207.
FT   VARIANT     241    241       P -> L (in a renal hypodysplasia patient;
FT                                dbSNP:rs147806994).
FT                                {ECO:0000269|PubMed:18305125}.
FT                                /FTId=VAR_071208.
FT   VARIANT     276    276       D -> N (in a renal hypodysplasia patient;
FT                                dbSNP:rs201675842).
FT                                {ECO:0000269|PubMed:18305125}.
FT                                /FTId=VAR_071209.
SQ   SEQUENCE   291 AA;  32286 MW;  8388C3C331575BDD CRC64;
     MSMLPTFGFT QEQVACVCEV LQQGGNIERL GRFLWSLPAC EHLHKNESVL KAKAVVAFHR
     GNFRELYKIL ESHQFSPHNH AKLQQLWLKA HYIEAEKLRG RPLGAVGKYR VRRKFPLPRS
     IWDGEETSYC FKEKSRSVLR EWYAHNPYPS PREKRELAEA TGLTTTQVSN WFKNRRQRDR
     AAEAKERENN ENSNSNSHNP LNGSGKSVLG SSEDEKTPSG TPDHSSSSPA LLLSPPPPGL
     PSLHSLGHPP GPSAVPVPVP GGGGADPLQH HHGLQDSILN PMSANLVDLG S
//
ID   SKI_HUMAN               Reviewed;         728 AA.
AC   P12755; Q5SYT7;
DT   01-OCT-1989, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-1989, sequence version 1.
DT   25-APR-2018, entry version 178.
DE   RecName: Full=Ski oncogene;
DE   AltName: Full=Proto-oncogene c-Ski;
GN   Name=SKI;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=2762147; DOI=10.1093/nar/17.14.5489;
RA   Nomura N., Sasamoto S., Ishii S., Date T., Matsui M., Ishizaki R.;
RT   "Isolation of human cDNA clones of ski and the ski-related gene,
RT   sno.";
RL   Nucleic Acids Res. 17:5489-5500(1989).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [3]
RP   INTERACTION WITH HIPK2; SMAD2; SMAD3 AND SMAD4.
RX   PubMed=12874272; DOI=10.1074/jbc.M307112200;
RA   Harada J., Kokura K., Kanei-Ishii C., Nomura T., Khan M.M., Kim Y.,
RA   Ishii S.;
RT   "Requirement of the co-repressor homeodomain-interacting protein
RT   kinase 2 for ski-mediated inhibition of bone morphogenetic protein-
RT   induced transcriptional activation.";
RL   J. Biol. Chem. 278:38998-39005(2003).
RN   [4]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [5]
RP   FUNCTION, AND INTERACTION WITH PRDM16 AND SMAD3.
RX   PubMed=19049980; DOI=10.1074/jbc.M808989200;
RA   Takahata M., Inoue Y., Tsuda H., Imoto I., Koinuma D., Hayashi M.,
RA   Ichikura T., Yamori T., Nagasaki K., Yoshida M., Matsuoka M.,
RA   Morishita K., Yuki K., Hanyu A., Miyazawa K., Inazawa J., Miyazono K.,
RA   Imamura T.;
RT   "SKI and MEL1 cooperate to inhibit transforming growth factor-beta
RT   signal in gastric cancer cells.";
RL   J. Biol. Chem. 284:3334-3344(2009).
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-480, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-383; SER-432 AND
RP   SER-720, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [8]
RP   VARIANTS SGS LEU-31; VAL-32; PRO-32; CYS-34; VAL-34; SER-34; GLN-35;
RP   SER-35; 94-SER--SER-97 DEL AND 95-ASP--SER-97 DEL.
RX   PubMed=23103230; DOI=10.1016/j.ajhg.2012.10.002;
RA   Carmignac V., Thevenon J., Ades L., Callewaert B., Julia S.,
RA   Thauvin-Robinet C., Gueneau L., Courcet J.B., Lopez E., Holman K.,
RA   Renard M., Plauchu H., Plessis G., De Backer J., Child A., Arno G.,
RA   Duplomb L., Callier P., Aral B., Vabres P., Gigot N., Arbustini E.,
RA   Grasso M., Robinson P.N., Goizet C., Baumann C., Di Rocco M.,
RA   Sanchez Del Pozo J., Huet F., Jondeau G., Collod-Beroud G., Beroud C.,
RA   Amiel J., Cormier-Daire V., Riviere J.B., Boileau C., De Paepe A.,
RA   Faivre L.;
RT   "In-frame mutations in exon 1 of SKI cause dominant Shprintzen-
RT   Goldberg syndrome.";
RL   Am. J. Hum. Genet. 91:950-957(2012).
RN   [9]
RP   VARIANTS SGS ARG-21; VAL-32; ASP-34; CYS-34; SER-34; SER-35;
RP   95-ASP--SER-97 DEL; GLU-116 AND ARG-117.
RX   PubMed=23023332; DOI=10.1038/ng.2421;
RA   Doyle A.J., Doyle J.J., Bessling S.L., Maragh S., Lindsay M.E.,
RA   Schepers D., Gillis E., Mortier G., Homfray T., Sauls K., Norris R.A.,
RA   Huso N.D., Leahy D., Mohr D.W., Caulfield M.J., Scott A.F.,
RA   Destree A., Hennekam R.C., Arn P.H., Curry C.J., Van Laer L.,
RA   McCallion A.S., Loeys B.L., Dietz H.C.;
RT   "Mutations in the TGF-beta repressor SKI cause Shprintzen-Goldberg
RT   syndrome with aortic aneurysm.";
RL   Nat. Genet. 44:1249-1254(2012).
RN   [10]
RP   VARIANTS SGS SER-35 AND GLU-116.
RX   PubMed=24357594; DOI=10.1002/ajmg.a.36340;
RG   FORGE Canada Consortium;
RA   Au P.Y., Racher H.E., Graham J.M. Jr., Kramer N., Lowry R.B.,
RA   Parboosingh J.S., Innes A.M.;
RT   "De novo exon 1 missense mutations of SKI and Shprintzen-Goldberg
RT   syndrome: two new cases and a clinical review.";
RL   Am. J. Med. Genet. A 164A:676-684(2014).
RN   [11]
RP   VARIANTS SGS THR-28; LEU-31; VAL-32; VAL-34; ALA-34; ASP-34; SER-34
RP   AND SER-35.
RX   PubMed=24736733; DOI=10.1038/ejhg.2014.61;
RA   Schepers D., Doyle A.J., Oswald G., Sparks E., Myers L., Willems P.J.,
RA   Mansour S., Simpson M.A., Frysira H., Maat-Kievit A., Van Minkelen R.,
RA   Hoogeboom J.M., Mortier G.R., Titheradge H., Brueton L., Starr L.,
RA   Stark Z., Ockeloen C., Lourenco C.M., Blair E., Hobson E., Hurst J.,
RA   Maystadt I., Destree A., Girisha K.M., Miller M., Dietz H.C.,
RA   Loeys B., Van Laer L.;
RT   "The SMAD-binding domain of SKI: a hotspot for de novo mutations
RT   causing Shprintzen-Goldberg syndrome.";
RL   Eur. J. Hum. Genet. 23:224-228(2015).
CC   -!- FUNCTION: May play a role in terminal differentiation of skeletal
CC       muscle cells but not in the determination of cells to the myogenic
CC       lineage. Functions as a repressor of TGF-beta signaling.
CC       {ECO:0000269|PubMed:19049980}.
CC   -!- SUBUNIT: Interacts with SMAD2, SMAD3 and SMAD4. Interacts with
CC       HIPK2. Part of a complex with HIPK2 and SMAD1/2/3. Interacts with
CC       PRDM16 and SMAD3; the interaction with PRDM16 promotes the
CC       recruitment SMAD3-HDAC1 complex on the promoter of TGF-beta target
CC       genes. {ECO:0000269|PubMed:12874272, ECO:0000269|PubMed:19049980}.
CC   -!- INTERACTION:
CC       Q9QUI1:Fam89b (xeno); NbExp=6; IntAct=EBI-347281, EBI-6503100;
CC       O75376:NCOR1; NbExp=4; IntAct=EBI-347281, EBI-347233;
CC       Q60974:Ncor1 (xeno); NbExp=5; IntAct=EBI-347281, EBI-349004;
CC       Q6ZSG1:RNF165; NbExp=2; IntAct=EBI-347281, EBI-2129206;
CC       Q8VI24:Satb2 (xeno); NbExp=2; IntAct=EBI-347281, EBI-5737999;
CC       Q96ST3:SIN3A; NbExp=3; IntAct=EBI-347281, EBI-347218;
CC       Q15796:SMAD2; NbExp=10; IntAct=EBI-347281, EBI-1040141;
CC       P84022:SMAD3; NbExp=11; IntAct=EBI-347281, EBI-347161;
CC       Q13485:SMAD4; NbExp=13; IntAct=EBI-347281, EBI-347263;
CC   -!- SUBCELLULAR LOCATION: Nucleus.
CC   -!- PTM: Ubiquitinated by RNF165, promoting proteasomal degradation,
CC       leading to enhance the BMP-Smad signaling.
CC       {ECO:0000250|UniProtKB:Q60698}.
CC   -!- DISEASE: Shprintzen-Goldberg craniosynostosis syndrome (SGS)
CC       [MIM:182212]: A very rare syndrome characterized by a marfanoid
CC       habitus, craniosynostosis, characteristic dysmorphic facial
CC       features, skeletal and cardiovascular abnormalities, mental
CC       retardation, developmental delay and learning disabilities.
CC       {ECO:0000269|PubMed:23023332, ECO:0000269|PubMed:23103230,
CC       ECO:0000269|PubMed:24357594, ECO:0000269|PubMed:24736733}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- SIMILARITY: Belongs to the SKI family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X15218; CAA33288.1; -; mRNA.
DR   EMBL; AL590822; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   CCDS; CCDS39.1; -.
DR   PIR; S06053; TVHUSK.
DR   RefSeq; NP_003027.1; NM_003036.3.
DR   UniGene; Hs.656507; -.
DR   PDB; 1MR1; X-ray; 2.85 A; C/D=219-313.
DR   PDB; 1SBX; X-ray; 1.65 A; A=91-192.
DR   PDBsum; 1MR1; -.
DR   PDBsum; 1SBX; -.
DR   ProteinModelPortal; P12755; -.
DR   SMR; P12755; -.
DR   BioGrid; 112388; 122.
DR   CORUM; P12755; -.
DR   DIP; DIP-31514N; -.
DR   IntAct; P12755; 17.
DR   MINT; P12755; -.
DR   STRING; 9606.ENSP00000367797; -.
DR   iPTMnet; P12755; -.
DR   PhosphoSitePlus; P12755; -.
DR   BioMuta; SKI; -.
DR   DMDM; 134517; -.
DR   EPD; P12755; -.
DR   MaxQB; P12755; -.
DR   PaxDb; P12755; -.
DR   PeptideAtlas; P12755; -.
DR   PRIDE; P12755; -.
DR   Ensembl; ENST00000378536; ENSP00000367797; ENSG00000157933.
DR   GeneID; 6497; -.
DR   KEGG; hsa:6497; -.
DR   UCSC; uc001aja.5; human.
DR   CTD; 6497; -.
DR   DisGeNET; 6497; -.
DR   EuPathDB; HostDB:ENSG00000157933.9; -.
DR   GeneCards; SKI; -.
DR   GeneReviews; SKI; -.
DR   HGNC; HGNC:10896; SKI.
DR   HPA; CAB010449; -.
DR   HPA; HPA066567; -.
DR   MalaCards; SKI; -.
DR   MIM; 164780; gene.
DR   MIM; 182212; phenotype.
DR   neXtProt; NX_P12755; -.
DR   OpenTargets; ENSG00000157933; -.
DR   Orphanet; 1606; 1p36 deletion syndrome.
DR   Orphanet; 2462; Shprintzen-Goldberg syndrome.
DR   PharmGKB; PA35796; -.
DR   eggNOG; ENOG410IFDK; Eukaryota.
DR   eggNOG; ENOG410Y8AU; LUCA.
DR   GeneTree; ENSGT00530000063040; -.
DR   HOGENOM; HOG000039989; -.
DR   HOVERGEN; HBG006599; -.
DR   InParanoid; P12755; -.
DR   OMA; EQLWPRP; -.
DR   OrthoDB; EOG091G0O02; -.
DR   PhylomeDB; P12755; -.
DR   TreeFam; TF324133; -.
DR   Reactome; R-HSA-201451; Signaling by BMP.
DR   Reactome; R-HSA-2173795; Downregulation of SMAD2/3:SMAD4 transcriptional activity.
DR   SignaLink; P12755; -.
DR   SIGNOR; P12755; -.
DR   ChiTaRS; SKI; human.
DR   EvolutionaryTrace; P12755; -.
DR   GeneWiki; SKI_protein; -.
DR   GenomeRNAi; 6497; -.
DR   PRO; PR:P12755; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000157933; -.
DR   CleanEx; HS_SKI; -.
DR   Genevisible; P12755; HS.
DR   GO; GO:0005813; C:centrosome; IDA:MGI.
DR   GO; GO:0005737; C:cytoplasm; ISS:BHF-UCL.
DR   GO; GO:0016604; C:nuclear body; IDA:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0016605; C:PML body; IDA:UniProtKB.
DR   GO; GO:0032991; C:protein-containing complex; IDA:MGI.
DR   GO; GO:0005667; C:transcription factor complex; ISS:BHF-UCL.
DR   GO; GO:0017053; C:transcriptional repressor complex; ISS:BHF-UCL.
DR   GO; GO:0046811; F:histone deacetylase inhibitor activity; ISS:BHF-UCL.
DR   GO; GO:0019904; F:protein domain specific binding; IPI:UniProtKB.
DR   GO; GO:0019901; F:protein kinase binding; IPI:UniProtKB.
DR   GO; GO:0070491; F:repressing transcription factor binding; IPI:UniProtKB.
DR   GO; GO:0000981; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; ISM:NTNU_SB.
DR   GO; GO:0046332; F:SMAD binding; IPI:UniProtKB.
DR   GO; GO:0003714; F:transcription corepressor activity; IDA:UniProtKB.
DR   GO; GO:0031625; F:ubiquitin protein ligase binding; IPI:UniProtKB.
DR   GO; GO:0008270; F:zinc ion binding; IDA:UniProtKB.
DR   GO; GO:0009948; P:anterior/posterior axis specification; ISS:BHF-UCL.
DR   GO; GO:0030509; P:BMP signaling pathway; TAS:Reactome.
DR   GO; GO:0060349; P:bone morphogenesis; ISS:BHF-UCL.
DR   GO; GO:0043010; P:camera-type eye development; ISS:BHF-UCL.
DR   GO; GO:0048593; P:camera-type eye morphogenesis; ISS:BHF-UCL.
DR   GO; GO:0048870; P:cell motility; NAS:BHF-UCL.
DR   GO; GO:0008283; P:cell proliferation; NAS:BHF-UCL.
DR   GO; GO:0030326; P:embryonic limb morphogenesis; ISS:BHF-UCL.
DR   GO; GO:0060325; P:face morphogenesis; ISS:BHF-UCL.
DR   GO; GO:0002089; P:lens morphogenesis in camera-type eye; ISS:BHF-UCL.
DR   GO; GO:0022011; P:myelination in peripheral nervous system; ISS:BHF-UCL.
DR   GO; GO:0014902; P:myotube differentiation; IDA:UniProtKB.
DR   GO; GO:0032926; P:negative regulation of activin receptor signaling pathway; IDA:UniProtKB.
DR   GO; GO:0030514; P:negative regulation of BMP signaling pathway; IDA:UniProtKB.
DR   GO; GO:0008285; P:negative regulation of cell proliferation; IDA:UniProtKB.
DR   GO; GO:0048147; P:negative regulation of fibroblast proliferation; ISS:BHF-UCL.
DR   GO; GO:0045668; P:negative regulation of osteoblast differentiation; IDA:UniProtKB.
DR   GO; GO:0010626; P:negative regulation of Schwann cell proliferation; IGI:MGI.
DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; IDA:UniProtKB.
DR   GO; GO:0030512; P:negative regulation of transforming growth factor beta receptor signaling pathway; IDA:UniProtKB.
DR   GO; GO:0001843; P:neural tube closure; ISS:BHF-UCL.
DR   GO; GO:0048666; P:neuron development; IBA:GO_Central.
DR   GO; GO:0043585; P:nose morphogenesis; ISS:BHF-UCL.
DR   GO; GO:0021772; P:olfactory bulb development; ISS:BHF-UCL.
DR   GO; GO:0060021; P:palate development; ISS:BHF-UCL.
DR   GO; GO:0043388; P:positive regulation of DNA binding; IDA:UniProtKB.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; ISS:BHF-UCL.
DR   GO; GO:0030177; P:positive regulation of Wnt signaling pathway; NAS:BHF-UCL.
DR   GO; GO:0070207; P:protein homotrimerization; IDA:UniProtKB.
DR   GO; GO:0060041; P:retina development in camera-type eye; ISS:BHF-UCL.
DR   GO; GO:0048741; P:skeletal muscle fiber development; ISS:BHF-UCL.
DR   GO; GO:0060395; P:SMAD protein signal transduction; IDA:UniProtKB.
DR   GO; GO:0035019; P:somatic stem cell population maintenance; ISS:BHF-UCL.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:InterPro.
DR   GO; GO:0007179; P:transforming growth factor beta receptor signaling pathway; NAS:BHF-UCL.
DR   Gene3D; 3.10.260.20; -; 1.
DR   Gene3D; 3.10.390.10; -; 1.
DR   InterPro; IPR014890; c-SKI_SMAD4-bd_dom.
DR   InterPro; IPR009061; DNA-bd_dom_put_sf.
DR   InterPro; IPR010919; SAND-like_dom_sf.
DR   InterPro; IPR028760; Ski.
DR   InterPro; IPR003380; SKI/SNO/DAC.
DR   InterPro; IPR037000; Ski_DNA-bd_sf.
DR   InterPro; IPR023216; Tscrpt_reg_SKI_SnoN.
DR   PANTHER; PTHR10005; PTHR10005; 1.
DR   PANTHER; PTHR10005:SF15; PTHR10005:SF15; 1.
DR   Pfam; PF08782; c-SKI_SMAD_bind; 1.
DR   Pfam; PF02437; Ski_Sno; 1.
DR   SMART; SM01046; c-SKI_SMAD_bind; 1.
DR   SUPFAM; SSF46955; SSF46955; 1.
DR   SUPFAM; SSF63763; SSF63763; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Coiled coil; Complete proteome; Craniosynostosis;
KW   Disease mutation; Nucleus; Phosphoprotein; Proto-oncogene;
KW   Reference proteome; Repeat; Ubl conjugation.
FT   CHAIN         1    728       Ski oncogene.
FT                                /FTId=PRO_0000129382.
FT   COILED      536    710       {ECO:0000255}.
FT   MOD_RES     383    383       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     432    432       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     480    480       Phosphoserine.
FT                                {ECO:0000244|PubMed:19690332}.
FT   MOD_RES     720    720       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   VARIANT      21     21       L -> R (in SGS; dbSNP:rs869312902).
FT                                {ECO:0000269|PubMed:23023332}.
FT                                /FTId=VAR_071170.
FT   VARIANT      28     28       S -> T (in SGS).
FT                                {ECO:0000269|PubMed:24736733}.
FT                                /FTId=VAR_071659.
FT   VARIANT      31     31       S -> L (in SGS).
FT                                {ECO:0000269|PubMed:23103230,
FT                                ECO:0000269|PubMed:24736733}.
FT                                /FTId=VAR_071171.
FT   VARIANT      32     32       L -> P (in SGS).
FT                                {ECO:0000269|PubMed:23103230}.
FT                                /FTId=VAR_071172.
FT   VARIANT      32     32       L -> V (in SGS; dbSNP:rs387907304).
FT                                {ECO:0000269|PubMed:23023332,
FT                                ECO:0000269|PubMed:23103230,
FT                                ECO:0000269|PubMed:24736733}.
FT                                /FTId=VAR_071173.
FT   VARIANT      34     34       G -> A (in SGS).
FT                                {ECO:0000269|PubMed:24736733}.
FT                                /FTId=VAR_071660.
FT   VARIANT      34     34       G -> C (in SGS; dbSNP:rs387907306).
FT                                {ECO:0000269|PubMed:23023332,
FT                                ECO:0000269|PubMed:23103230}.
FT                                /FTId=VAR_071174.
FT   VARIANT      34     34       G -> D (in SGS; dbSNP:rs387907305).
FT                                {ECO:0000269|PubMed:23023332,
FT                                ECO:0000269|PubMed:24736733}.
FT                                /FTId=VAR_071175.
FT   VARIANT      34     34       G -> S (in SGS; dbSNP:rs387907306).
FT                                {ECO:0000269|PubMed:23023332,
FT                                ECO:0000269|PubMed:23103230,
FT                                ECO:0000269|PubMed:24736733}.
FT                                /FTId=VAR_071176.
FT   VARIANT      34     34       G -> V (in SGS; dbSNP:rs387907305).
FT                                {ECO:0000269|PubMed:23103230,
FT                                ECO:0000269|PubMed:24736733}.
FT                                /FTId=VAR_071177.
FT   VARIANT      35     35       P -> Q (in SGS; dbSNP:rs397514589).
FT                                {ECO:0000269|PubMed:23103230}.
FT                                /FTId=VAR_071178.
FT   VARIANT      35     35       P -> S (in SGS; dbSNP:rs397514590).
FT                                {ECO:0000269|PubMed:23023332,
FT                                ECO:0000269|PubMed:23103230,
FT                                ECO:0000269|PubMed:24357594,
FT                                ECO:0000269|PubMed:24736733}.
FT                                /FTId=VAR_071179.
FT   VARIANT      94     97       Missing (in SGS).
FT                                {ECO:0000269|PubMed:23103230}.
FT                                /FTId=VAR_071180.
FT   VARIANT      95     97       Missing (in SGS).
FT                                {ECO:0000269|PubMed:23023332,
FT                                ECO:0000269|PubMed:23103230}.
FT                                /FTId=VAR_071181.
FT   VARIANT     116    116       G -> E (in SGS; dbSNP:rs387907303).
FT                                {ECO:0000269|PubMed:23023332,
FT                                ECO:0000269|PubMed:24357594}.
FT                                /FTId=VAR_071182.
FT   VARIANT     117    117       G -> R (in SGS; dbSNP:rs869312901).
FT                                {ECO:0000269|PubMed:23023332}.
FT                                /FTId=VAR_071183.
FT   STRAND      101    105       {ECO:0000244|PDB:1SBX}.
FT   STRAND      108    115       {ECO:0000244|PDB:1SBX}.
FT   STRAND      118    122       {ECO:0000244|PDB:1SBX}.
FT   HELIX       123    127       {ECO:0000244|PDB:1SBX}.
FT   TURN        128    133       {ECO:0000244|PDB:1SBX}.
FT   HELIX       136    145       {ECO:0000244|PDB:1SBX}.
FT   HELIX       155    163       {ECO:0000244|PDB:1SBX}.
FT   STRAND      175    178       {ECO:0000244|PDB:1SBX}.
FT   HELIX       179    190       {ECO:0000244|PDB:1SBX}.
FT   STRAND      219    222       {ECO:0000244|PDB:1MR1}.
FT   STRAND      228    232       {ECO:0000244|PDB:1MR1}.
FT   HELIX       234    236       {ECO:0000244|PDB:1MR1}.
FT   STRAND      245    247       {ECO:0000244|PDB:1MR1}.
FT   TURN        248    250       {ECO:0000244|PDB:1MR1}.
FT   HELIX       256    259       {ECO:0000244|PDB:1MR1}.
FT   STRAND      269    275       {ECO:0000244|PDB:1MR1}.
FT   HELIX       278    280       {ECO:0000244|PDB:1MR1}.
FT   HELIX       281    284       {ECO:0000244|PDB:1MR1}.
FT   HELIX       296    310       {ECO:0000244|PDB:1MR1}.
SQ   SEQUENCE   728 AA;  80005 MW;  9B78C4840A28C2DA CRC64;
     MEAAAGGRGC FQPHPGLQKT LEQFHLSSMS SLGGPAAFSA RWAQEAYKKE SAKEAGAAAV
     PAPVPAATEP PPVLHLPAIQ PPPPVLPGPF FMPSDRSTER CETVLEGETI SCFVVGGEKR
     LCLPQILNSV LRDFSLQQIN AVCDELHIYC SRCTADQLEI LKVMGILPFS APSCGLITKT
     DAERLCNALL YGGAYPPPCK KELAASLALG LELSERSVRV YHECFGKCKG LLVPELYSSP
     SAACIQCLDC RLMYPPHKFV VHSHKALENR TCHWGFDSAN WRAYILLSQD YTGKEEQARL
     GRCLDDVKEK FDYGNKYKRR VPRVSSEPPA SIRPKTDDTS SQSPAPSEKD KPSSWLRTLA
     GSSNKSLGCV HPRQRLSAFR PWSPAVSASE KELSPHLPAL IRDSFYSYKS FETAVAPNVA
     LAPPAQQKVV SSPPCAAAVS RAPEPLATCT QPRKRKLTVD TPGAPETLAP VAAPEEDKDS
     EAEVEVESRE EFTSSLSSLS SPSFTSSSSA KDLGSPGARA LPSAVPDAAA PADAPSGLEA
     ELEHLRQALE GGLDTKEAKE KFLHEVVKMR VKQEEKLSAA LQAKRSLHQE LEFLRVAKKE
     KLREATEAKR NLRKEIERLR AENEKKMKEA NESRLRLKRE LEQARQARVC DKGCEAGRLR
     AKYSAQIEDL QVKLQHAEAD REQLRADLLR EREAREHLEK VVKELQEQLW PRARPEAAGS
     EGAAELEP
//
ID   B4E1W8_HUMAN            Unreviewed;      1080 AA.
AC   B4E1W8;
DT   23-SEP-2008, integrated into UniProtKB/TrEMBL.
DT   23-SEP-2008, sequence version 1.
DT   20-DEC-2017, entry version 62.
DE   SubName: Full=cDNA FLJ60213, highly similar to Tenascin {ECO:0000313|EMBL:BAG64930.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAG64930.1};
RN   [1] {ECO:0000313|EMBL:BAG64930.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Trachea {ECO:0000313|EMBL:BAG64930.1};
RA   Wakamatsu A., Yamamoto J., Kimura K., Ishii S., Watanabe K.,
RA   Sugiyama A., Murakawa K., Kaida T., Tsuchiya K., Fukuzumi Y.,
RA   Kumagai A., Oishi Y., Yamamoto S., Ono Y., Komori Y., Yamazaki M.,
RA   Kisu Y., Nishikawa T., Sugano S., Nomura N., Isogai T.;
RT   "NEDO human cDNA sequencing project focused on splicing variants.";
RL   Submitted (OCT-2007) to the EMBL/GenBank/DDBJ databases.
CC   -!- CAUTION: Lacks conserved residue(s) required for the propagation
CC       of feature annotation. {ECO:0000256|PROSITE-ProRule:PRU00076}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK304015; BAG64930.1; -; mRNA.
DR   RefSeq; NP_002151.2; NM_002160.3.
DR   UniGene; Hs.143250; -.
DR   UniGene; Hs.684865; -.
DR   UniGene; Hs.734766; -.
DR   ProteinModelPortal; B4E1W8; -.
DR   MaxQB; B4E1W8; -.
DR   PeptideAtlas; B4E1W8; -.
DR   PRIDE; B4E1W8; -.
DR   GeneID; 3371; -.
DR   KEGG; hsa:3371; -.
DR   CTD; 3371; -.
DR   HOGENOM; HOG000234355; -.
DR   HOVERGEN; HBG008949; -.
DR   KO; K06252; -.
DR   GenomeRNAi; 3371; -.
DR   Genevisible; B4E1W8; HS.
DR   CDD; cd00063; FN3; 5.
DR   Gene3D; 2.60.40.10; -; 5.
DR   InterPro; IPR013032; EGF-like_CS.
DR   InterPro; IPR000742; EGF-like_dom.
DR   InterPro; IPR013111; EGF_extracell.
DR   InterPro; IPR003961; FN3_dom.
DR   InterPro; IPR036116; FN3_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   Pfam; PF07974; EGF_2; 6.
DR   Pfam; PF00041; fn3; 5.
DR   SMART; SM00181; EGF; 14.
DR   SMART; SM00060; FN3; 4.
DR   SUPFAM; SSF49265; SSF49265; 4.
DR   PROSITE; PS00022; EGF_1; 5.
DR   PROSITE; PS01186; EGF_2; 5.
DR   PROSITE; PS50026; EGF_3; 5.
DR   PROSITE; PS50853; FN3; 4.
PE   2: Evidence at transcript level;
KW   Coiled coil {ECO:0000256|SAM:Coils};
KW   Disulfide bond {ECO:0000256|PROSITE-ProRule:PRU00076};
KW   EGF-like domain {ECO:0000256|PROSITE-ProRule:PRU00076};
KW   Signal {ECO:0000256|SAM:SignalP}.
FT   SIGNAL        1     19       {ECO:0000256|SAM:SignalP}.
FT   CHAIN        20   1080       {ECO:0000256|SAM:SignalP}.
FT                                /FTId=PRO_5002804054.
FT   DOMAIN      186    217       EGF-like. {ECO:0000259|PROSITE:PS50026}.
FT   DOMAIN      280    311       EGF-like. {ECO:0000259|PROSITE:PS50026}.
FT   DOMAIN      373    404       EGF-like. {ECO:0000259|PROSITE:PS50026}.
FT   DOMAIN      466    497       EGF-like. {ECO:0000259|PROSITE:PS50026}.
FT   DOMAIN      559    590       EGF-like. {ECO:0000259|PROSITE:PS50026}.
FT   DOMAIN      625    715       Fibronectin type-III.
FT                                {ECO:0000259|PROSITE:PS50853}.
FT   DOMAIN      716    804       Fibronectin type-III.
FT                                {ECO:0000259|PROSITE:PS50853}.
FT   DOMAIN      805    896       Fibronectin type-III.
FT                                {ECO:0000259|PROSITE:PS50853}.
FT   DOMAIN      961   1052       Fibronectin type-III.
FT                                {ECO:0000259|PROSITE:PS50853}.
FT   COILED      119    139       {ECO:0000256|SAM:Coils}.
FT   DISULFID    190    200       {ECO:0000256|PROSITE-ProRule:PRU00076}.
FT   DISULFID    207    216       {ECO:0000256|PROSITE-ProRule:PRU00076}.
FT   DISULFID    284    294       {ECO:0000256|PROSITE-ProRule:PRU00076}.
FT   DISULFID    301    310       {ECO:0000256|PROSITE-ProRule:PRU00076}.
FT   DISULFID    377    387       {ECO:0000256|PROSITE-ProRule:PRU00076}.
FT   DISULFID    394    403       {ECO:0000256|PROSITE-ProRule:PRU00076}.
FT   DISULFID    470    480       {ECO:0000256|PROSITE-ProRule:PRU00076}.
FT   DISULFID    487    496       {ECO:0000256|PROSITE-ProRule:PRU00076}.
FT   DISULFID    563    573       {ECO:0000256|PROSITE-ProRule:PRU00076}.
FT   DISULFID    580    589       {ECO:0000256|PROSITE-ProRule:PRU00076}.
SQ   SEQUENCE   1080 AA;  118424 MW;  88ED7B4760FF9310 CRC64;
     MGAMTQLLAG VFLAFLALAT EGGVLKKVIR HKRQSGVNAT LPEENQPVVF NHVYNIKLPV
     GSQCSVDLES ASGEKDLAPP SEPSESFQEH TVDGENQIVF THRINIPRRA CGCAAAPDVK
     ELLSRLEELE NLVSSLREQC TAGAGCCLQP ATGRLDTRPF CSGRGNFSTE GCGCVCEPGW
     KGPNCSEPEC PGNCHLRGRC IDGQCICDDG FTGEDCSQLA CPSDCNDQGK CVNGVCICFE
     GYAGADCSRE ICPVPCSEEH GTCVDGLCVC HDGFAGDDCN KPLCLNNCYN RGRCVENECV
     CDEGFTGEDC SELICPNDCF DRGRCINGTC YCEEGFTGED CGKPTCPHAC HTQGRCEEGQ
     CVCDEGFAGV DCSEKRCPAD CHNRGRCVDG RCECDDGFTG ADCGELKCPN GCSGHGRCVN
     GQCVCDEGYT GEDCSQLRCP NDCHSRGRCV EGKCVCEQGF KGYDCSDMSC PNDCHQHGRC
     VNGMCVCDDG YTGEDCRDRQ CPRDCSNRGL CVDGQCVCED GFTGPDCAEL SCPNDCHGRG
     RCVNGQCVCH EGFMGKDCKE QRCPSDCHGQ GRCVDGQCIC HEGFTGLDCG QHSCPSDCNN
     LGQCVSGRCI CNEGYSGEDC SEVSPPKDLV VTEVTEETVN LAWDNEMRVT EYLVVYTPTH
     EGGLEMQFRV PGDQTSTIIQ ELEPGVEYFI RVFAILENKK SIPVSARVAT YLPAPEGLKF
     KSIKETSVEV EWDPLDIAFE TWEIIFRNMN KEDEGEITKS LRRPETSYRQ TGLAPGQEYE
     ISLHIVKNNT RGPGLKRVTT TRLDAPSQIE VKDVTDTTAL ITWFKPLAEI DGIELTYGIK
     DVPGDRTTID LTEDENQYSI GNLKPDTEYE VSLISRRGDM SSNPAKETFT TGLDAPRNLR
     RVSQTDNSIT LEWRNGKAAI DSYRIKYAPI SGGDHAEVDV PKSQQATTKT ITAKFTTDLD
     SPRDLTATEV QSETALLTWR PPRASVTGYL LVYESVDGTV KEVIVGPDTT SYSLADLSPS
     LFLHFIQQKP EKQYCFHFKD MINIINIIMM MMMMKTKDFS RDLSFQNISG QYLIVFFFFK
//
ID   J3QSU6_HUMAN            Unreviewed;      2019 AA.
AC   J3QSU6;
DT   03-OCT-2012, integrated into UniProtKB/TrEMBL.
DT   03-OCT-2012, sequence version 1.
DT   28-MAR-2018, entry version 48.
DE   SubName: Full=Tenascin {ECO:0000313|Ensembl:ENSP00000339553};
GN   Name=TNC {ECO:0000313|Ensembl:ENSP00000339553};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000339553, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164053; DOI=10.1038/nature02465;
RA   Humphray S.J., Oliver K., Hunt A.R., Plumb R.W., Loveland J.E.,
RA   Howe K.L., Andrews T.D., Searle S., Hunt S.E., Scott C.E., Jones M.C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Ashwell R.I.S.,
RA   Babbage A.K., Babbage S., Bagguley C.L., Bailey J., Banerjee R.,
RA   Barker D.J., Barlow K.F., Bates K., Beasley H., Beasley O., Bird C.P.,
RA   Bray-Allen S., Brown A.J., Brown J.Y., Burford D., Burrill W.,
RA   Burton J., Carder C., Carter N.P., Chapman J.C., Chen Y., Clarke G.,
RA   Clark S.Y., Clee C.M., Clegg S., Collier R.E., Corby N., Crosier M.,
RA   Cummings A.T., Davies J., Dhami P., Dunn M., Dutta I., Dyer L.W.,
RA   Earthrowl M.E., Faulkner L., Fleming C.J., Frankish A.,
RA   Frankland J.A., French L., Fricker D.G., Garner P., Garnett J.,
RA   Ghori J., Gilbert J.G.R., Glison C., Grafham D.V., Gribble S.,
RA   Griffiths C., Griffiths-Jones S., Grocock R., Guy J., Hall R.E.,
RA   Hammond S., Harley J.L., Harrison E.S.I., Hart E.A., Heath P.D.,
RA   Henderson C.D., Hopkins B.L., Howard P.J., Howden P.J., Huckle E.,
RA   Johnson C., Johnson D., Joy A.A., Kay M., Keenan S., Kershaw J.K.,
RA   Kimberley A.M., King A., Knights A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C., Lloyd D.M.,
RA   Lovell J., Martin S., Mashreghi-Mohammadi M., Matthews L., McLaren S.,
RA   McLay K.E., McMurray A., Milne S., Nickerson T., Nisbett J.,
RA   Nordsiek G., Pearce A.V., Peck A.I., Porter K.M., Pandian R.,
RA   Pelan S., Phillimore B., Povey S., Ramsey Y., Rand V., Scharfe M.,
RA   Sehra H.K., Shownkeen R., Sims S.K., Skuce C.D., Smith M.,
RA   Steward C.A., Swarbreck D., Sycamore N., Tester J., Thorpe A.,
RA   Tracey A., Tromans A., Thomas D.W., Wall M., Wallis J.M., West A.P.,
RA   Whitehead S.L., Willey D.L., Williams S.A., Wilming L., Wray P.W.,
RA   Young L., Ashurst J.L., Coulson A., Blocker H., Durbin R.,
RA   Sulston J.E., Hubbard T., Jackson M.J., Bentley D.R., Beck S.,
RA   Rogers J., Dunham I.;
RT   "DNA sequence and analysis of human chromosome 9.";
RL   Nature 429:369-374(2004).
RN   [2] {ECO:0000313|Ensembl:ENSP00000339553}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [3] {ECO:0000213|PubMed:21269460}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Burckstummer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [4] {ECO:0000313|Ensembl:ENSP00000339553}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (AUG-2012) to UniProtKB.
RN   [5] {ECO:0000213|PubMed:24275569}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
CC   -!- CAUTION: Lacks conserved residue(s) required for the propagation
CC       of feature annotation. {ECO:0000256|PROSITE-ProRule:PRU00076}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AL162425; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   RefSeq; XP_006717161.1; XM_006717098.3.
DR   UniGene; Hs.143250; -.
DR   UniGene; Hs.684865; -.
DR   UniGene; Hs.734766; -.
DR   ProteinModelPortal; J3QSU6; -.
DR   PeptideAtlas; J3QSU6; -.
DR   PRIDE; J3QSU6; -.
DR   Ensembl; ENST00000341037; ENSP00000339553; ENSG00000041982.
DR   GeneID; 3371; -.
DR   UCSC; uc064vgq.1; human.
DR   CTD; 3371; -.
DR   EuPathDB; HostDB:ENSG00000041982.15; -.
DR   HGNC; HGNC:5318; TNC.
DR   OpenTargets; ENSG00000041982; -.
DR   GeneTree; ENSGT00830000128240; -.
DR   ChiTaRS; TNC; human.
DR   GenomeRNAi; 3371; -.
DR   Proteomes; UP000005640; Chromosome 9.
DR   Bgee; ENSG00000041982; -.
DR   ExpressionAtlas; J3QSU6; baseline and differential.
DR   GO; GO:0031012; C:extracellular matrix; IEA:InterPro.
DR   GO; GO:0007155; P:cell adhesion; IEA:InterPro.
DR   GO; GO:0042127; P:regulation of cell proliferation; IEA:InterPro.
DR   CDD; cd00063; FN3; 13.
DR   CDD; cd00087; FReD; 1.
DR   Gene3D; 2.60.40.10; -; 13.
DR   InterPro; IPR013032; EGF-like_CS.
DR   InterPro; IPR000742; EGF-like_dom.
DR   InterPro; IPR013111; EGF_extracell.
DR   InterPro; IPR036056; Fibrinogen-like_C.
DR   InterPro; IPR002181; Fibrinogen_a/b/g_C_dom.
DR   InterPro; IPR003961; FN3_dom.
DR   InterPro; IPR036116; FN3_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR033078; TNC.
DR   PANTHER; PTHR19143:SF38; PTHR19143:SF38; 7.
DR   Pfam; PF07974; EGF_2; 6.
DR   Pfam; PF00147; Fibrinogen_C; 1.
DR   Pfam; PF00041; fn3; 13.
DR   SMART; SM00181; EGF; 14.
DR   SMART; SM00186; FBG; 1.
DR   SMART; SM00060; FN3; 13.
DR   SUPFAM; SSF49265; SSF49265; 10.
DR   SUPFAM; SSF56496; SSF56496; 1.
DR   PROSITE; PS00022; EGF_1; 5.
DR   PROSITE; PS01186; EGF_2; 5.
DR   PROSITE; PS50026; EGF_3; 5.
DR   PROSITE; PS51406; FIBRINOGEN_C_2; 1.
DR   PROSITE; PS50853; FN3; 13.
PE   1: Evidence at protein level;
KW   Coiled coil {ECO:0000256|SAM:Coils};
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   Disulfide bond {ECO:0000256|PROSITE-ProRule:PRU00076};
KW   EGF-like domain {ECO:0000256|PROSITE-ProRule:PRU00076};
KW   Proteomics identification {ECO:0000213|EPD:J3QSU6,
KW   ECO:0000213|MaxQB:J3QSU6, ECO:0000213|PeptideAtlas:J3QSU6};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640};
KW   Signal {ECO:0000256|SAM:SignalP}.
FT   SIGNAL        1     19       {ECO:0000256|SAM:SignalP}.
FT   CHAIN        20   2019       {ECO:0000256|SAM:SignalP}.
FT                                /FTId=PRO_5003777214.
FT   DOMAIN      186    217       EGF-like. {ECO:0000259|PROSITE:PS50026}.
FT   DOMAIN      280    311       EGF-like. {ECO:0000259|PROSITE:PS50026}.
FT   DOMAIN      373    404       EGF-like. {ECO:0000259|PROSITE:PS50026}.
FT   DOMAIN      466    497       EGF-like. {ECO:0000259|PROSITE:PS50026}.
FT   DOMAIN      559    590       EGF-like. {ECO:0000259|PROSITE:PS50026}.
FT   DOMAIN      625    715       Fibronectin type-III.
FT                                {ECO:0000259|PROSITE:PS50853}.
FT   DOMAIN      716    804       Fibronectin type-III.
FT                                {ECO:0000259|PROSITE:PS50853}.
FT   DOMAIN      805    894       Fibronectin type-III.
FT                                {ECO:0000259|PROSITE:PS50853}.
FT   DOMAIN      895    990       Fibronectin type-III.
FT                                {ECO:0000259|PROSITE:PS50853}.
FT   DOMAIN      991   1075       Fibronectin type-III.
FT                                {ECO:0000259|PROSITE:PS50853}.
FT   DOMAIN     1076   1165       Fibronectin type-III.
FT                                {ECO:0000259|PROSITE:PS50853}.
FT   DOMAIN     1167   1259       Fibronectin type-III.
FT                                {ECO:0000259|PROSITE:PS50853}.
FT   DOMAIN     1260   1348       Fibronectin type-III.
FT                                {ECO:0000259|PROSITE:PS50853}.
FT   DOMAIN     1349   1438       Fibronectin type-III.
FT                                {ECO:0000259|PROSITE:PS50853}.
FT   DOMAIN     1440   1529       Fibronectin type-III.
FT                                {ECO:0000259|PROSITE:PS50853}.
FT   DOMAIN     1530   1619       Fibronectin type-III.
FT                                {ECO:0000259|PROSITE:PS50853}.
FT   DOMAIN     1620   1706       Fibronectin type-III.
FT                                {ECO:0000259|PROSITE:PS50853}.
FT   DOMAIN     1707   1795       Fibronectin type-III.
FT                                {ECO:0000259|PROSITE:PS50853}.
FT   DOMAIN     1793   2008       Fibrinogen C-terminal.
FT                                {ECO:0000259|PROSITE:PS51406}.
FT   COILED      119    139       {ECO:0000256|SAM:Coils}.
FT   DISULFID    190    200       {ECO:0000256|PROSITE-ProRule:PRU00076}.
FT   DISULFID    207    216       {ECO:0000256|PROSITE-ProRule:PRU00076}.
FT   DISULFID    284    294       {ECO:0000256|PROSITE-ProRule:PRU00076}.
FT   DISULFID    301    310       {ECO:0000256|PROSITE-ProRule:PRU00076}.
FT   DISULFID    377    387       {ECO:0000256|PROSITE-ProRule:PRU00076}.
FT   DISULFID    394    403       {ECO:0000256|PROSITE-ProRule:PRU00076}.
FT   DISULFID    470    480       {ECO:0000256|PROSITE-ProRule:PRU00076}.
FT   DISULFID    487    496       {ECO:0000256|PROSITE-ProRule:PRU00076}.
FT   DISULFID    563    573       {ECO:0000256|PROSITE-ProRule:PRU00076}.
FT   DISULFID    580    589       {ECO:0000256|PROSITE-ProRule:PRU00076}.
FT   DISULFID   1954   1967       {ECO:0000256|PROSITE-ProRule:PRU00739}.
SQ   SEQUENCE   2019 AA;  220853 MW;  8390133DD3663EE9 CRC64;
     MGAMTQLLAG VFLAFLALAT EGGVLKKVIR HKRQSGVNAT LPEENQPVVF NHVYNIKLPV
     GSQCSVDLES ASGEKDLAPP SEPSESFQEH TVDGENQIVF THRINIPRRA CGCAAAPDVK
     ELLSRLEELE NLVSSLREQC TAGAGCCLQP ATGRLDTRPF CSGRGNFSTE GCGCVCEPGW
     KGPNCSEPEC PGNCHLRGRC IDGQCICDDG FTGEDCSQLA CPSDCNDQGK CVNGVCICFE
     GYAGADCSRE ICPVPCSEEH GTCVDGLCVC HDGFAGDDCN KPLCLNNCYN RGRCVENECV
     CDEGFTGEDC SELICPNDCF DRGRCINGTC YCEEGFTGED CGKPTCPHAC HTQGRCEEGQ
     CVCDEGFAGV DCSEKRCPAD CHNRGRCVDG RCECDDGFTG ADCGELKCPN GCSGHGRCVN
     GQCVCDEGYT GEDCSQLRCP NDCHSRGRCV EGKCVCEQGF KGYDCSDMSC PNDCHQHGRC
     VNGMCVCDDG YTGEDCRDRQ CPRDCSNRGL CVDGQCVCED GFTGPDCAEL SCPNDCHGQG
     RCVNGQCVCH EGFMGKDCKE QRCPSDCHGQ GRCVDGQCIC HEGFTGLDCG QHSCPSDCNN
     LGQCVSGRCI CNEGYSGEDC SEVSPPKDLV VTEVTEETVN LAWDNEMRVT EYLVVYTPTH
     EGGLEMQFRV PGDQTSTIIQ ELEPGVEYFI RVFAILENKK SIPVSARVAT YLPAPEGLKF
     KSIKETSVEV EWDPLDIAFE TWEIIFRNMN KEDEGEITKS LRRPETSYRQ TGLAPGQEYE
     ISLHIVKNNT RGPGLKRVTT TRLDAPSQIE VKDVTDTTAL ITWFKPLAEI DGIELTYGIK
     DVPGDRTTID LTEDENQYSI GNLKPDTEYE VSLISRRGDM SSNPAKETFT TGLDAPRNLR
     RVSQTDNSIT LEWRNGKAAI DSYRIKYAPI SGGDHAEVDV PKSQQATTKT TLTGLRPGTE
     YGIGVSAVKE DKESNPATIN AATELDTPKD LQVSETAETS LTLLWKTPLA KFDRYRLNYS
     LPTGQWVGVQ LPRNTTSYVL RGLEPGQEYN VLLTAEKGRH KSKPARVKAS TEQAPELENL
     TVTEVGWDGL RLNWTAADQA YEHFIIQVQE ANKVEAARNL TVPGSLRAVD IPGLKAATPY
     TVSIYGVIQG YRTPVLSAEA STGETPNLGE VVVAEVGWDA LKLNWTAPEG AYEYFFIQVQ
     EADTVEAAQN LTVPGGLRST DLPGLKAATH YTITIRGVTQ DFSTTPLSVE VLTEDLPQLG
     DLAVSEVGWD GLRLNWTAAD NAYEHFVIQV QEVNKVEAAQ NLTLPGSLRA VDIPGLEAAT
     PYRVSIYGVI RGYRTPVLSA EASTAKEPEI GNLNVSDITP ESFNLSWMAT DGIFETFTIE
     IIDSNRLLET VEYNISGAER TAHISGLPPS TDFIVYLSGL APSIRTKTIS ATATTEAEPE
     VDNLLVSDAT PDGFRLSWTA DEGVFDNFVL KIRDTKKQSE PLEITLLAPE RTRDITGLRE
     ATEYEIELYG ISKGRRSQTV SAIATTAMGS PKEVIFSDIT ENSATVSWRA PTAQVESFRI
     TYVPITGGTP SMVTVDGTKT QTRLVKLIPG VEYLVSIIAM KGFEESEPVS GSFTTALDGP
     SGLVTANITD SEALARWQPA IATVDSYVIS YTGEKVPEIT RTVSGNTVEY ALTDLEPATE
     YTLRIFAEKG PQKSSTITAK FTTDLDSPRD LTATEVQSET ALLTWRPPRA SVTGYLLVYE
     SVDGTVKEVI VGPDTTSYSL ADLSPSTHYT AKIQALNGPL RSNMIQTIFT TIGLLYPFPK
     DCSQAMLNGD TTSGLYTIYL NGDKAEALEV FCDMTSDGGG WIVFLRRKNG RENFYQNWKA
     YAAGFGDRRE EFWLGLDNLN KITAQGQYEL RVDLRDHGET AFAVYDKFSV GDAKTRYKLK
     VEGYSGTAGD SMAYHNGRSF STFDKDTDSA ITNCALSYKG AFWYRNCHRV NLMGRYGDNN
     HSQGVNWFHW KGHEHSIQFA EMKLRPSNFR NLEGRRKRA
//
ID   TENA_HUMAN              Reviewed;        2201 AA.
AC   P24821; C9IYT7; C9J575; C9J6D9; C9J848; Q14583; Q15567; Q5T7S3;
DT   01-MAR-1992, integrated into UniProtKB/Swiss-Prot.
DT   15-DEC-2009, sequence version 3.
DT   28-FEB-2018, entry version 207.
DE   RecName: Full=Tenascin;
DE            Short=TN;
DE   AltName: Full=Cytotactin;
DE   AltName: Full=GMEM;
DE   AltName: Full=GP 150-225;
DE   AltName: Full=Glioma-associated-extracellular matrix antigen;
DE   AltName: Full=Hexabrachion;
DE   AltName: Full=JI;
DE   AltName: Full=Myotendinous antigen;
DE   AltName: Full=Neuronectin;
DE   AltName: Full=Tenascin-C;
DE            Short=TN-C;
DE   Flags: Precursor;
GN   Name=TNC; Synonyms=HXB;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANTS ARG-539; LEU-1677
RP   AND GLN-2008.
RX   PubMed=1704365;
RA   Nies D.E., Hemesath T.J., Kim J.H., Gulcher J.R., Stefansson K.;
RT   "The complete cDNA sequence of human hexabrachion (Tenascin). A
RT   multidomain protein containing unique epidermal growth factor
RT   repeats.";
RL   J. Biol. Chem. 266:2818-2823(1991).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1; 2; 4 AND 5), PROTEIN SEQUENCE
RP   OF 23-32, AND VARIANTS ARG-680 AND GLN-2008.
RC   TISSUE=Fetal brain, and Melanoma;
RX   PubMed=1707164; DOI=10.1093/nar/19.3.525;
RA   Siri A., Carnemolla B., Saginati M., Leprini A., Casari G.,
RA   Baralle F., Zardi L.;
RT   "Human tenascin: primary structure, pre-mRNA splicing patterns and
RT   localization of the epitopes recognized by two monoclonal
RT   antibodies.";
RL   Nucleic Acids Res. 19:525-531(1991).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANTS ARG-539; LEU-1677
RP   AND GLN-2008.
RX   PubMed=1719530; DOI=10.1073/pnas.88.21.9438;
RA   Gulcher J.R., Nies D.E., Alexakos M.J., Ravikant N.A., Sturgill M.E.,
RA   Marton L.S., Stefansson K.;
RT   "Structure of the human hexabrachion (tenascin) gene.";
RL   Proc. Natl. Acad. Sci. U.S.A. 88:9438-9442(1991).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANTS LEU-1677 AND
RP   GLN-2008.
RX   PubMed=7531707; DOI=10.1074/jbc.270.7.3429;
RA   Gherzi R., Carnemolla B., Siri A., Ponassi M., Balza E., Zardi L.;
RT   "Human tenascin gene. Structure of the 5'-region, identification, and
RT   characterization of the transcription regulatory sequences.";
RL   J. Biol. Chem. 270:3429-3434(1995).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164053; DOI=10.1038/nature02465;
RA   Humphray S.J., Oliver K., Hunt A.R., Plumb R.W., Loveland J.E.,
RA   Howe K.L., Andrews T.D., Searle S., Hunt S.E., Scott C.E., Jones M.C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Ashwell R.I.S.,
RA   Babbage A.K., Babbage S., Bagguley C.L., Bailey J., Banerjee R.,
RA   Barker D.J., Barlow K.F., Bates K., Beasley H., Beasley O., Bird C.P.,
RA   Bray-Allen S., Brown A.J., Brown J.Y., Burford D., Burrill W.,
RA   Burton J., Carder C., Carter N.P., Chapman J.C., Chen Y., Clarke G.,
RA   Clark S.Y., Clee C.M., Clegg S., Collier R.E., Corby N., Crosier M.,
RA   Cummings A.T., Davies J., Dhami P., Dunn M., Dutta I., Dyer L.W.,
RA   Earthrowl M.E., Faulkner L., Fleming C.J., Frankish A.,
RA   Frankland J.A., French L., Fricker D.G., Garner P., Garnett J.,
RA   Ghori J., Gilbert J.G.R., Glison C., Grafham D.V., Gribble S.,
RA   Griffiths C., Griffiths-Jones S., Grocock R., Guy J., Hall R.E.,
RA   Hammond S., Harley J.L., Harrison E.S.I., Hart E.A., Heath P.D.,
RA   Henderson C.D., Hopkins B.L., Howard P.J., Howden P.J., Huckle E.,
RA   Johnson C., Johnson D., Joy A.A., Kay M., Keenan S., Kershaw J.K.,
RA   Kimberley A.M., King A., Knights A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C., Lloyd D.M.,
RA   Lovell J., Martin S., Mashreghi-Mohammadi M., Matthews L., McLaren S.,
RA   McLay K.E., McMurray A., Milne S., Nickerson T., Nisbett J.,
RA   Nordsiek G., Pearce A.V., Peck A.I., Porter K.M., Pandian R.,
RA   Pelan S., Phillimore B., Povey S., Ramsey Y., Rand V., Scharfe M.,
RA   Sehra H.K., Shownkeen R., Sims S.K., Skuce C.D., Smith M.,
RA   Steward C.A., Swarbreck D., Sycamore N., Tester J., Thorpe A.,
RA   Tracey A., Tromans A., Thomas D.W., Wall M., Wallis J.M., West A.P.,
RA   Whitehead S.L., Willey D.L., Williams S.A., Wilming L., Wray P.W.,
RA   Young L., Ashurst J.L., Coulson A., Blocker H., Durbin R.M.,
RA   Sulston J.E., Hubbard T., Jackson M.J., Bentley D.R., Beck S.,
RA   Rogers J., Dunham I.;
RT   "DNA sequence and analysis of human chromosome 9.";
RL   Nature 429:369-374(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 46-125 (ISOFORMS 1/2/3/4/5/6).
RC   TISSUE=Fetal cartilage;
RX   PubMed=7524681; DOI=10.1016/0167-4781(94)90220-8;
RA   Glumoff V., Savontaus M., Vehanen J., Vuorio E.;
RT   "Analysis of aggrecan and tenascin gene expression in mouse skeletal
RT   tissues by northern and in situ hybridization using species specific
RT   cDNA probes.";
RL   Biochim. Biophys. Acta 1219:613-622(1994).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 431-2055 (ISOFORMS 1 AND 6), AND
RP   VARIANTS ARG-539; LEU-1677 AND GLN-2008.
RC   TISSUE=Glioblastoma;
RX   PubMed=2466295; DOI=10.1073/pnas.86.5.1588;
RA   Gulcher J.R., Nies D.E., Marton L.S., Stefansson K.;
RT   "An alternatively spliced region of the human hexabrachion contains a
RT   repeat of potential N-glycosylation sites.";
RL   Proc. Natl. Acad. Sci. U.S.A. 86:1588-1592(1989).
RN   [8]
RP   INTERACTION WITH CSPG4.
RX   PubMed=8824254; DOI=10.1074/jbc.271.42.26110;
RA   Burg M.A., Tillet E., Timpl R., Stallcup W.B.;
RT   "Binding of the NG2 proteoglycan to type VI collagen and other
RT   extracellular matrix molecules.";
RL   J. Biol. Chem. 271:26110-26116(1996).
RN   [9]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-1809.
RC   TISSUE=Plasma;
RX   PubMed=16335952; DOI=10.1021/pr0502065;
RA   Liu T., Qian W.-J., Gritsenko M.A., Camp D.G. II, Monroe M.E.,
RA   Moore R.J., Smith R.D.;
RT   "Human plasma N-glycoproteome analysis by immunoaffinity subtraction,
RT   hydrazide chemistry, and mass spectrometry.";
RL   J. Proteome Res. 4:2070-2080(2005).
RN   [10]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-184; ASN-1079; ASN-1093;
RP   ASN-1261; ASN-1301; ASN-1485 AND ASN-2162.
RC   TISSUE=Milk;
RX   PubMed=18780401; DOI=10.1002/pmic.200701057;
RA   Picariello G., Ferranti P., Mamone G., Roepstorff P., Addeo F.;
RT   "Identification of N-linked glycoproteins in human milk by hydrophilic
RT   interaction liquid chromatography and mass spectrometry.";
RL   Proteomics 8:3833-3847(2008).
RN   [11]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-1018; ASN-1034; ASN-1184;
RP   ASN-1275; ASN-1301; ASN-1366 AND ASN-1485.
RC   TISSUE=Liver;
RX   PubMed=19159218; DOI=10.1021/pr8008012;
RA   Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.;
RT   "Glycoproteomics analysis of human liver tissue by combination of
RT   multiple enzyme digestion and hydrazide chemistry.";
RL   J. Proteome Res. 8:651-661(2009).
RN   [12]
RP   FUNCTION.
RX   PubMed=19884327; DOI=10.1096/fj.09-140491;
RA   Martina E., Degen M., Rueegg C., Merlo A., Lino M.M.,
RA   Chiquet-Ehrismann R., Brellier F.;
RT   "Tenascin-W is a specific marker of glioma-associated blood vessels
RT   and stimulates angiogenesis in vitro.";
RL   FASEB J. 24:778-787(2010).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-65; SER-70; SER-72 AND
RP   THR-905, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [15]
RP   PHOSPHORYLATION AT SER-72.
RX   PubMed=26091039; DOI=10.1016/j.cell.2015.05.028;
RA   Tagliabracci V.S., Wiley S.E., Guo X., Kinch L.N., Durrant E., Wen J.,
RA   Xiao J., Cui J., Nguyen K.B., Engel J.L., Coon J.J., Grishin N.,
RA   Pinna L.A., Pagliarini D.J., Dixon J.E.;
RT   "A single kinase generates the majority of the secreted
RT   phosphoproteome.";
RL   Cell 161:1619-1632(2015).
RN   [16]
RP   X-RAY CRYSTALLOGRAPHY (1.8 ANGSTROMS) OF FIBRONECTIN TYPE-III 3.
RX   PubMed=1279805; DOI=10.1126/science.1279805;
RA   Leahy D.J., Hendrickson W.A., Aukhil I., Erickson H.P.;
RT   "Structure of a fibronectin type III domain from tenascin phased by
RT   MAD analysis of the selenomethionyl protein.";
RL   Science 258:987-991(1992).
RN   [17]
RP   VARIANTS DFNA56 MET-1773 AND SER-1796.
RX   PubMed=23936043; DOI=10.1371/journal.pone.0069549;
RA   Zhao Y., Zhao F., Zong L., Zhang P., Guan L., Zhang J., Wang D.,
RA   Wang J., Chai W., Lan L., Li Q., Han B., Yang L., Jin X., Yang W.,
RA   Hu X., Wang X., Li N., Li Y., Petit C., Wang J., Wang H.Y., Wang Q.;
RT   "Exome sequencing and linkage analysis identified tenascin-C (TNC) as
RT   a novel causative gene in nonsyndromic hearing loss.";
RL   PLoS ONE 8:E69549-E69549(2013).
CC   -!- FUNCTION: Extracellular matrix protein implicated in guidance of
CC       migrating neurons as well as axons during development, synaptic
CC       plasticity as well as neuronal regeneration. Promotes neurite
CC       outgrowth from cortical neurons grown on a monolayer of
CC       astrocytes. Ligand for integrins alpha-8/beta-1, alpha-9/beta-1,
CC       alpha-V/beta-3 and alpha-V/beta-6. In tumors, stimulates
CC       angiogenesis by elongation, migration and sprouting of endothelial
CC       cells (PubMed:19884327). {ECO:0000269|PubMed:19884327}.
CC   -!- SUBUNIT: Homohexamer; disulfide-linked. A homotrimer may be formed
CC       in the triple coiled-coil region and may be stabilized by
CC       disulfide rings at both ends. Two of such half-hexabrachions may
CC       be disulfide linked within the central globule. Interacts with
CC       CSPG4. {ECO:0000269|PubMed:8824254}.
CC   -!- INTERACTION:
CC       P20908:COL5A1; NbExp=2; IntAct=EBI-9979894, EBI-2464511;
CC   -!- SUBCELLULAR LOCATION: Secreted, extracellular space, extracellular
CC       matrix.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=6;
CC         Comment=Isoforms are produced in a tissue- and time-specific
CC         manner during development.;
CC       Name=1;
CC         IsoId=P24821-1; Sequence=Displayed;
CC       Name=2; Synonyms=HT-5;
CC         IsoId=P24821-2; Sequence=VSP_001412, VSP_001413;
CC       Name=3;
CC         IsoId=P24821-3; Sequence=VSP_001412;
CC       Name=4; Synonyms=HT-33;
CC         IsoId=P24821-4; Sequence=VSP_001413;
CC       Name=5;
CC         IsoId=P24821-5; Sequence=VSP_001414;
CC       Name=6; Synonyms=P31;
CC         IsoId=P24821-6; Sequence=VSP_001415;
CC   -!- INDUCTION: By TGFB1.
CC   -!- DISEASE: Deafness, autosomal dominant, 56 (DFNA56) [MIM:615629]: A
CC       form of non-syndromic sensorineural hearing loss. Sensorineural
CC       deafness results from damage to the neural receptors of the inner
CC       ear, the nerve pathways to the brain, or the area of the brain
CC       that receives sound information. DFNA56 is characterized by
CC       progressive hearing impairment with post-lingual onset.
CC       {ECO:0000269|PubMed:23936043}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the tenascin family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/TNCID42597ch9q33.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M55618; AAA88083.1; -; mRNA.
DR   EMBL; X56160; CAA39628.1; -; mRNA.
DR   EMBL; X78565; CAA55309.1; -; mRNA.
DR   EMBL; AL162425; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; X80280; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; M24630; AAA52703.1; -; mRNA.
DR   CCDS; CCDS6811.1; -. [P24821-1]
DR   PIR; I38337; A32160.
DR   RefSeq; NP_002151.2; NM_002160.3. [P24821-1]
DR   RefSeq; XP_005252029.1; XM_005251972.3. [P24821-4]
DR   RefSeq; XP_005252031.1; XM_005251974.3. [P24821-5]
DR   RefSeq; XP_005252032.1; XM_005251975.3. [P24821-6]
DR   RefSeq; XP_011516931.1; XM_011518629.2. [P24821-2]
DR   UniGene; Hs.143250; -.
DR   UniGene; Hs.684865; -.
DR   UniGene; Hs.734766; -.
DR   PDB; 1TEN; X-ray; 1.80 A; A=802-891.
DR   PDB; 2RB8; X-ray; 1.45 A; A=802-893.
DR   PDB; 2RBL; X-ray; 2.10 A; A/B/M=802-893.
DR   PDBsum; 1TEN; -.
DR   PDBsum; 2RB8; -.
DR   PDBsum; 2RBL; -.
DR   ProteinModelPortal; P24821; -.
DR   SMR; P24821; -.
DR   BioGrid; 109602; 3.
DR   CORUM; P24821; -.
DR   IntAct; P24821; 1.
DR   STRING; 9606.ENSP00000265131; -.
DR   ChEMBL; CHEMBL3712856; -.
DR   iPTMnet; P24821; -.
DR   PhosphoSitePlus; P24821; -.
DR   BioMuta; TNC; -.
DR   DMDM; 281185495; -.
DR   EPD; P24821; -.
DR   MaxQB; P24821; -.
DR   PaxDb; P24821; -.
DR   PeptideAtlas; P24821; -.
DR   PRIDE; P24821; -.
DR   Ensembl; ENST00000350763; ENSP00000265131; ENSG00000041982. [P24821-1]
DR   Ensembl; ENST00000537320; ENSP00000443478; ENSG00000041982. [P24821-6]
DR   GeneID; 3371; -.
DR   KEGG; hsa:3371; -.
DR   UCSC; uc004bjj.6; human. [P24821-1]
DR   CTD; 3371; -.
DR   DisGeNET; 3371; -.
DR   EuPathDB; HostDB:ENSG00000041982.15; -.
DR   GeneCards; TNC; -.
DR   HGNC; HGNC:5318; TNC.
DR   HPA; CAB004592; -.
DR   HPA; HPA004823; -.
DR   MalaCards; TNC; -.
DR   MIM; 187380; gene.
DR   MIM; 615629; phenotype.
DR   neXtProt; NX_P24821; -.
DR   OpenTargets; ENSG00000041982; -.
DR   Orphanet; 90635; Autosomal dominant non-syndromic sensorineural deafness type DFNA.
DR   PharmGKB; PA35103; -.
DR   eggNOG; KOG1225; Eukaryota.
DR   eggNOG; KOG2579; Eukaryota.
DR   eggNOG; ENOG410ZYS4; LUCA.
DR   GeneTree; ENSGT00830000128240; -.
DR   HOVERGEN; HBG008949; -.
DR   InParanoid; P24821; -.
DR   KO; K06252; -.
DR   OMA; HYTAKIQ; -.
DR   OrthoDB; EOG091G03M1; -.
DR   PhylomeDB; P24821; -.
DR   TreeFam; TF329915; -.
DR   Reactome; R-HSA-216083; Integrin cell surface interactions.
DR   Reactome; R-HSA-3000170; Syndecan interactions.
DR   Reactome; R-HSA-3000178; ECM proteoglycans.
DR   Reactome; R-HSA-381426; Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs).
DR   Reactome; R-HSA-8957275; Post-translational protein phosphorylation.
DR   SIGNOR; P24821; -.
DR   ChiTaRS; TNC; human.
DR   EvolutionaryTrace; P24821; -.
DR   GeneWiki; Tenascin_C; -.
DR   GenomeRNAi; 3371; -.
DR   PRO; PR:P24821; -.
DR   Proteomes; UP000005640; Chromosome 9.
DR   Bgee; ENSG00000041982; -.
DR   CleanEx; HS_TNC; -.
DR   ExpressionAtlas; P24821; baseline and differential.
DR   Genevisible; P24821; HS.
DR   GO; GO:0005604; C:basement membrane; IEA:Ensembl.
DR   GO; GO:0005788; C:endoplasmic reticulum lumen; TAS:Reactome.
DR   GO; GO:0031012; C:extracellular matrix; IDA:BHF-UCL.
DR   GO; GO:0005576; C:extracellular region; IDA:BHF-UCL.
DR   GO; GO:0005615; C:extracellular space; IDA:BHF-UCL.
DR   GO; GO:0005925; C:focal adhesion; HDA:UniProtKB.
DR   GO; GO:0005614; C:interstitial matrix; IEA:Ensembl.
DR   GO; GO:0016020; C:membrane; HDA:UniProtKB.
DR   GO; GO:0045545; F:syndecan binding; IDA:MGI.
DR   GO; GO:0060447; P:bud outgrowth involved in lung branching; IEA:Ensembl.
DR   GO; GO:0007155; P:cell adhesion; TAS:ProtInc.
DR   GO; GO:0044267; P:cellular protein metabolic process; TAS:Reactome.
DR   GO; GO:0071799; P:cellular response to prostaglandin D stimulus; IEA:Ensembl.
DR   GO; GO:0071300; P:cellular response to retinoic acid; IEA:Ensembl.
DR   GO; GO:0071305; P:cellular response to vitamin D; IEA:Ensembl.
DR   GO; GO:0030198; P:extracellular matrix organization; TAS:Reactome.
DR   GO; GO:0060739; P:mesenchymal-epithelial cell signaling involved in prostate gland development; IEA:Ensembl.
DR   GO; GO:0007162; P:negative regulation of cell adhesion; IEA:Ensembl.
DR   GO; GO:0007528; P:neuromuscular junction development; IEA:Ensembl.
DR   GO; GO:0042475; P:odontogenesis of dentin-containing tooth; IEA:Ensembl.
DR   GO; GO:0001649; P:osteoblast differentiation; HDA:UniProtKB.
DR   GO; GO:0014012; P:peripheral nervous system axon regeneration; IEA:Ensembl.
DR   GO; GO:0008284; P:positive regulation of cell proliferation; IEA:Ensembl.
DR   GO; GO:0010628; P:positive regulation of gene expression; IEA:Ensembl.
DR   GO; GO:0043687; P:post-translational protein modification; TAS:Reactome.
DR   GO; GO:0060740; P:prostate gland epithelium morphogenesis; IEA:Ensembl.
DR   GO; GO:0045471; P:response to ethanol; IEA:Ensembl.
DR   GO; GO:0071774; P:response to fibroblast growth factor; IEA:Ensembl.
DR   GO; GO:0009612; P:response to mechanical stimulus; IEA:Ensembl.
DR   GO; GO:0009611; P:response to wounding; IEP:BHF-UCL.
DR   GO; GO:0042060; P:wound healing; IEA:Ensembl.
DR   CDD; cd00063; FN3; 15.
DR   CDD; cd00087; FReD; 1.
DR   Gene3D; 2.60.40.10; -; 15.
DR   InterPro; IPR013032; EGF-like_CS.
DR   InterPro; IPR000742; EGF-like_dom.
DR   InterPro; IPR013111; EGF_extracell.
DR   InterPro; IPR036056; Fibrinogen-like_C.
DR   InterPro; IPR002181; Fibrinogen_a/b/g_C_dom.
DR   InterPro; IPR003961; FN3_dom.
DR   InterPro; IPR036116; FN3_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR033078; TNC.
DR   PANTHER; PTHR19143:SF38; PTHR19143:SF38; 9.
DR   Pfam; PF07974; EGF_2; 6.
DR   Pfam; PF00147; Fibrinogen_C; 1.
DR   Pfam; PF00041; fn3; 15.
DR   SMART; SM00181; EGF; 14.
DR   SMART; SM00186; FBG; 1.
DR   SMART; SM00060; FN3; 15.
DR   SUPFAM; SSF49265; SSF49265; 12.
DR   SUPFAM; SSF56496; SSF56496; 1.
DR   PROSITE; PS00022; EGF_1; 15.
DR   PROSITE; PS01186; EGF_2; 15.
DR   PROSITE; PS50026; EGF_3; 5.
DR   PROSITE; PS51406; FIBRINOGEN_C_2; 1.
DR   PROSITE; PS50853; FN3; 15.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Cell adhesion; Coiled coil;
KW   Complete proteome; Deafness; Direct protein sequencing;
KW   Disease mutation; Disulfide bond; EGF-like domain;
KW   Extracellular matrix; Glycoprotein; Non-syndromic deafness;
KW   Phosphoprotein; Polymorphism; Reference proteome; Repeat; Secreted;
KW   Signal.
FT   SIGNAL        1     22       {ECO:0000269|PubMed:1707164}.
FT   CHAIN        23   2201       Tenascin.
FT                                /FTId=PRO_0000007741.
FT   DOMAIN      174    186       EGF-like 1; incomplete.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DOMAIN      186    217       EGF-like 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN      217    248       EGF-like 3. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN      248    280       EGF-like 4. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN      280    311       EGF-like 5. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN      311    342       EGF-like 6. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN      342    373       EGF-like 7. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN      373    404       EGF-like 8. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN      404    435       EGF-like 9. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN      435    466       EGF-like 10. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN      466    497       EGF-like 11. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN      497    528       EGF-like 12. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN      528    559       EGF-like 13. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN      559    590       EGF-like 14. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN      590    621       EGF-like 15. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN      625    715       Fibronectin type-III 1.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00316}.
FT   DOMAIN      716    804       Fibronectin type-III 2.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00316}.
FT   DOMAIN      805    894       Fibronectin type-III 3.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00316}.
FT   DOMAIN      895    990       Fibronectin type-III 4.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00316}.
FT   DOMAIN      991   1075       Fibronectin type-III 5.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00316}.
FT   DOMAIN     1076   1165       Fibronectin type-III 6.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00316}.
FT   DOMAIN     1167   1256       Fibronectin type-III 7.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00316}.
FT   DOMAIN     1258   1350       Fibronectin type-III 8.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00316}.
FT   DOMAIN     1351   1439       Fibronectin type-III 9.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00316}.
FT   DOMAIN     1440   1531       Fibronectin type-III 10.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00316}.
FT   DOMAIN     1533   1621       Fibronectin type-III 11.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00316}.
FT   DOMAIN     1622   1711       Fibronectin type-III 12.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00316}.
FT   DOMAIN     1712   1801       Fibronectin type-III 13.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00316}.
FT   DOMAIN     1802   1888       Fibronectin type-III 14.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00316}.
FT   DOMAIN     1889   1977       Fibronectin type-III 15.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00316}.
FT   DOMAIN     1975   2190       Fibrinogen C-terminal.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00739}.
FT   COILED      118    145       {ECO:0000255}.
FT   MOD_RES      65     65       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES      70     70       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES      72     72       Phosphoserine; by FAM20C.
FT                                {ECO:0000244|PubMed:24275569,
FT                                ECO:0000269|PubMed:26091039}.
FT   MOD_RES     905    905       Phosphothreonine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   CARBOHYD     38     38       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    166    166       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    184    184       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:18780401}.
FT   CARBOHYD    327    327       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    788    788       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1018   1018       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:19159218}.
FT   CARBOHYD   1034   1034       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:19159218}.
FT   CARBOHYD   1079   1079       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:18780401}.
FT   CARBOHYD   1093   1093       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:18780401}.
FT   CARBOHYD   1119   1119       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1184   1184       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:19159218}.
FT   CARBOHYD   1210   1210       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1261   1261       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:18780401}.
FT   CARBOHYD   1275   1275       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:19159218}.
FT   CARBOHYD   1301   1301       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:18780401,
FT                                ECO:0000269|PubMed:19159218}.
FT   CARBOHYD   1366   1366       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:19159218}.
FT   CARBOHYD   1392   1392       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1445   1445       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1455   1455       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1485   1485       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:18780401,
FT                                ECO:0000269|PubMed:19159218}.
FT   CARBOHYD   1534   1534       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD   1809   1809       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:16335952}.
FT   CARBOHYD   2162   2162       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:18780401}.
FT   DISULFID    190    200       {ECO:0000250}.
FT   DISULFID    194    205       {ECO:0000250}.
FT   DISULFID    207    216       {ECO:0000250}.
FT   DISULFID    221    231       {ECO:0000250}.
FT   DISULFID    225    236       {ECO:0000250}.
FT   DISULFID    238    247       {ECO:0000250}.
FT   DISULFID    252    263       {ECO:0000250}.
FT   DISULFID    256    268       {ECO:0000250}.
FT   DISULFID    270    279       {ECO:0000250}.
FT   DISULFID    284    294       {ECO:0000250}.
FT   DISULFID    288    299       {ECO:0000250}.
FT   DISULFID    301    310       {ECO:0000250}.
FT   DISULFID    315    325       {ECO:0000250}.
FT   DISULFID    319    330       {ECO:0000250}.
FT   DISULFID    332    341       {ECO:0000250}.
FT   DISULFID    346    356       {ECO:0000250}.
FT   DISULFID    350    361       {ECO:0000250}.
FT   DISULFID    363    372       {ECO:0000250}.
FT   DISULFID    377    387       {ECO:0000250}.
FT   DISULFID    381    392       {ECO:0000250}.
FT   DISULFID    394    403       {ECO:0000250}.
FT   DISULFID    408    418       {ECO:0000250}.
FT   DISULFID    412    423       {ECO:0000250}.
FT   DISULFID    425    434       {ECO:0000250}.
FT   DISULFID    439    449       {ECO:0000250}.
FT   DISULFID    443    454       {ECO:0000250}.
FT   DISULFID    456    465       {ECO:0000250}.
FT   DISULFID    470    480       {ECO:0000250}.
FT   DISULFID    474    485       {ECO:0000250}.
FT   DISULFID    487    496       {ECO:0000250}.
FT   DISULFID    501    511       {ECO:0000250}.
FT   DISULFID    505    516       {ECO:0000250}.
FT   DISULFID    518    527       {ECO:0000250}.
FT   DISULFID    532    542       {ECO:0000250}.
FT   DISULFID    536    547       {ECO:0000250}.
FT   DISULFID    549    558       {ECO:0000250}.
FT   DISULFID    563    573       {ECO:0000250}.
FT   DISULFID    567    578       {ECO:0000250}.
FT   DISULFID    580    589       {ECO:0000250}.
FT   DISULFID    594    604       {ECO:0000250}.
FT   DISULFID    598    609       {ECO:0000250}.
FT   DISULFID    611    620       {ECO:0000250}.
FT   VAR_SEQ    1072   1708       Missing (in isoform 6).
FT                                {ECO:0000303|PubMed:2466295}.
FT                                /FTId=VSP_001415.
FT   VAR_SEQ    1072   1617       Missing (in isoform 5).
FT                                {ECO:0000303|PubMed:1707164}.
FT                                /FTId=VSP_001414.
FT   VAR_SEQ    1072   1435       Missing (in isoform 2 and isoform 3).
FT                                {ECO:0000303|PubMed:1707164}.
FT                                /FTId=VSP_001412.
FT   VAR_SEQ    1527   1617       Missing (in isoform 2 and isoform 4).
FT                                {ECO:0000303|PubMed:1707164}.
FT                                /FTId=VSP_001413.
FT   VARIANT     213    213       G -> S (in dbSNP:rs7020958).
FT                                /FTId=VAR_055778.
FT   VARIANT     539    539       Q -> R (in dbSNP:rs1757095).
FT                                {ECO:0000269|PubMed:1704365,
FT                                ECO:0000269|PubMed:1719530,
FT                                ECO:0000269|PubMed:2466295}.
FT                                /FTId=VAR_024266.
FT   VARIANT     605    605       V -> I (in dbSNP:rs3827816).
FT                                /FTId=VAR_024267.
FT   VARIANT     680    680       Q -> R (in dbSNP:rs1061494).
FT                                {ECO:0000269|PubMed:1707164}.
FT                                /FTId=VAR_024268.
FT   VARIANT     850    850       D -> H (in dbSNP:rs3748169).
FT                                /FTId=VAR_055779.
FT   VARIANT    1677   1677       I -> L (in dbSNP:rs2104772).
FT                                {ECO:0000269|PubMed:1704365,
FT                                ECO:0000269|PubMed:1719530,
FT                                ECO:0000269|PubMed:2466295,
FT                                ECO:0000269|PubMed:7531707}.
FT                                /FTId=VAR_060738.
FT   VARIANT    1773   1773       V -> M (in DFNA56; dbSNP:rs137933052).
FT                                {ECO:0000269|PubMed:23936043}.
FT                                /FTId=VAR_070984.
FT   VARIANT    1781   1781       A -> T (in dbSNP:rs2274750).
FT                                /FTId=VAR_020169.
FT   VARIANT    1796   1796       T -> S (in DFNA56; dbSNP:rs431905513).
FT                                {ECO:0000269|PubMed:23936043}.
FT                                /FTId=VAR_070985.
FT   VARIANT    2008   2008       E -> Q (in dbSNP:rs13321).
FT                                {ECO:0000269|PubMed:1704365,
FT                                ECO:0000269|PubMed:1707164,
FT                                ECO:0000269|PubMed:1719530,
FT                                ECO:0000269|PubMed:2466295,
FT                                ECO:0000269|PubMed:7531707}.
FT                                /FTId=VAR_014665.
FT   CONFLICT    244    244       Missing (in Ref. 2; CAA39628).
FT                                {ECO:0000305}.
FT   CONFLICT    370    370       V -> L (in Ref. 1; no nucleotide entry,
FT                                3; AAA88083 and 4; CAA55309).
FT                                {ECO:0000305}.
FT   CONFLICT   1066   1066       R -> H (in Ref. 1; no nucleotide entry,
FT                                3; AAA88083 and 7; AAA52703).
FT                                {ECO:0000305}.
FT   CONFLICT   1600   1608       SGFTQGHQT -> LWLHPRASN (in Ref. 1; no
FT                                nucleotide entry, 3; AAA88083 and 7;
FT                                AAA52703). {ECO:0000305}.
FT   CONFLICT   2054   2054       F -> FLH (in Ref. 1; no nucleotide entry
FT                                and 3; AAA88083). {ECO:0000305}.
FT   CONFLICT   2055   2055       W -> L (in Ref. 7; AAA52703).
FT                                {ECO:0000305}.
FT   CONFLICT   2140   2143       YKGA -> TRG (in Ref. 2; CAA39628).
FT                                {ECO:0000305}.
FT   STRAND      807    813       {ECO:0000244|PDB:2RB8}.
FT   STRAND      819    824       {ECO:0000244|PDB:2RB8}.
FT   HELIX       827    829       {ECO:0000244|PDB:2RBL}.
FT   STRAND      831    839       {ECO:0000244|PDB:2RB8}.
FT   STRAND      842    844       {ECO:0000244|PDB:2RBL}.
FT   STRAND      847    852       {ECO:0000244|PDB:2RB8}.
FT   STRAND      857    860       {ECO:0000244|PDB:2RB8}.
FT   STRAND      868    877       {ECO:0000244|PDB:2RB8}.
FT   STRAND      885    890       {ECO:0000244|PDB:2RB8}.
SQ   SEQUENCE   2201 AA;  240853 MW;  B2BEF378AA6F1D85 CRC64;
     MGAMTQLLAG VFLAFLALAT EGGVLKKVIR HKRQSGVNAT LPEENQPVVF NHVYNIKLPV
     GSQCSVDLES ASGEKDLAPP SEPSESFQEH TVDGENQIVF THRINIPRRA CGCAAAPDVK
     ELLSRLEELE NLVSSLREQC TAGAGCCLQP ATGRLDTRPF CSGRGNFSTE GCGCVCEPGW
     KGPNCSEPEC PGNCHLRGRC IDGQCICDDG FTGEDCSQLA CPSDCNDQGK CVNGVCICFE
     GYAGADCSRE ICPVPCSEEH GTCVDGLCVC HDGFAGDDCN KPLCLNNCYN RGRCVENECV
     CDEGFTGEDC SELICPNDCF DRGRCINGTC YCEEGFTGED CGKPTCPHAC HTQGRCEEGQ
     CVCDEGFAGV DCSEKRCPAD CHNRGRCVDG RCECDDGFTG ADCGELKCPN GCSGHGRCVN
     GQCVCDEGYT GEDCSQLRCP NDCHSRGRCV EGKCVCEQGF KGYDCSDMSC PNDCHQHGRC
     VNGMCVCDDG YTGEDCRDRQ CPRDCSNRGL CVDGQCVCED GFTGPDCAEL SCPNDCHGQG
     RCVNGQCVCH EGFMGKDCKE QRCPSDCHGQ GRCVDGQCIC HEGFTGLDCG QHSCPSDCNN
     LGQCVSGRCI CNEGYSGEDC SEVSPPKDLV VTEVTEETVN LAWDNEMRVT EYLVVYTPTH
     EGGLEMQFRV PGDQTSTIIQ ELEPGVEYFI RVFAILENKK SIPVSARVAT YLPAPEGLKF
     KSIKETSVEV EWDPLDIAFE TWEIIFRNMN KEDEGEITKS LRRPETSYRQ TGLAPGQEYE
     ISLHIVKNNT RGPGLKRVTT TRLDAPSQIE VKDVTDTTAL ITWFKPLAEI DGIELTYGIK
     DVPGDRTTID LTEDENQYSI GNLKPDTEYE VSLISRRGDM SSNPAKETFT TGLDAPRNLR
     RVSQTDNSIT LEWRNGKAAI DSYRIKYAPI SGGDHAEVDV PKSQQATTKT TLTGLRPGTE
     YGIGVSAVKE DKESNPATIN AATELDTPKD LQVSETAETS LTLLWKTPLA KFDRYRLNYS
     LPTGQWVGVQ LPRNTTSYVL RGLEPGQEYN VLLTAEKGRH KSKPARVKAS TEQAPELENL
     TVTEVGWDGL RLNWTAADQA YEHFIIQVQE ANKVEAARNL TVPGSLRAVD IPGLKAATPY
     TVSIYGVIQG YRTPVLSAEA STGETPNLGE VVVAEVGWDA LKLNWTAPEG AYEYFFIQVQ
     EADTVEAAQN LTVPGGLRST DLPGLKAATH YTITIRGVTQ DFSTTPLSVE VLTEEVPDMG
     NLTVTEVSWD ALRLNWTTPD GTYDQFTIQV QEADQVEEAH NLTVPGSLRS MEIPGLRAGT
     PYTVTLHGEV RGHSTRPLAV EVVTEDLPQL GDLAVSEVGW DGLRLNWTAA DNAYEHFVIQ
     VQEVNKVEAA QNLTLPGSLR AVDIPGLEAA TPYRVSIYGV IRGYRTPVLS AEASTAKEPE
     IGNLNVSDIT PESFNLSWMA TDGIFETFTI EIIDSNRLLE TVEYNISGAE RTAHISGLPP
     STDFIVYLSG LAPSIRTKTI SATATTEALP LLENLTISDI NPYGFTVSWM ASENAFDSFL
     VTVVDSGKLL DPQEFTLSGT QRKLELRGLI TGIGYEVMVS GFTQGHQTKP LRAEIVTEAE
     PEVDNLLVSD ATPDGFRLSW TADEGVFDNF VLKIRDTKKQ SEPLEITLLA PERTRDITGL
     REATEYEIEL YGISKGRRSQ TVSAIATTAM GSPKEVIFSD ITENSATVSW RAPTAQVESF
     RITYVPITGG TPSMVTVDGT KTQTRLVKLI PGVEYLVSII AMKGFEESEP VSGSFTTALD
     GPSGLVTANI TDSEALARWQ PAIATVDSYV ISYTGEKVPE ITRTVSGNTV EYALTDLEPA
     TEYTLRIFAE KGPQKSSTIT AKFTTDLDSP RDLTATEVQS ETALLTWRPP RASVTGYLLV
     YESVDGTVKE VIVGPDTTSY SLADLSPSTH YTAKIQALNG PLRSNMIQTI FTTIGLLYPF
     PKDCSQAMLN GDTTSGLYTI YLNGDKAEAL EVFCDMTSDG GGWIVFLRRK NGRENFYQNW
     KAYAAGFGDR REEFWLGLDN LNKITAQGQY ELRVDLRDHG ETAFAVYDKF SVGDAKTRYK
     LKVEGYSGTA GDSMAYHNGR SFSTFDKDTD SAITNCALSY KGAFWYRNCH RVNLMGRYGD
     NNHSQGVNWF HWKGHEHSIQ FAEMKLRPSN FRNLEGRRKR A
//
ID   Q4LE33_HUMAN            Unreviewed;      2233 AA.
AC   Q4LE33;
DT   02-AUG-2005, integrated into UniProtKB/TrEMBL.
DT   02-AUG-2005, sequence version 1.
DT   28-FEB-2018, entry version 102.
DE   SubName: Full=TNC variant protein {ECO:0000313|EMBL:BAE06120.1};
DE   Flags: Fragment;
GN   Name=TNC variant protein {ECO:0000313|EMBL:BAE06120.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAE06120.1};
RN   [1] {ECO:0000313|EMBL:BAE06120.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Brain {ECO:0000313|EMBL:BAE06120.1};
RA   Nakajima D., Saito K., Yamakawa H., Kikuno R.F., Nakayama M.,
RA   Ohara R., Okazaki N., Koga H., Nagase T., Ohara O.;
RT   "Preparation of a set of expression-ready clones of mammalian long
RT   cDNAs encoding large proteins by the ORF trap cloning method.";
RL   Submitted (MAR-2005) to the EMBL/GenBank/DDBJ databases.
CC   -!- CAUTION: Lacks conserved residue(s) required for the propagation
CC       of feature annotation. {ECO:0000256|PROSITE-ProRule:PRU00076}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB210038; BAE06120.1; -; mRNA.
DR   RefSeq; NP_002151.2; NM_002160.3.
DR   UniGene; Hs.143250; -.
DR   UniGene; Hs.684865; -.
DR   UniGene; Hs.734766; -.
DR   ProteinModelPortal; Q4LE33; -.
DR   PeptideAtlas; Q4LE33; -.
DR   PRIDE; Q4LE33; -.
DR   GeneID; 3371; -.
DR   KEGG; hsa:3371; -.
DR   CTD; 3371; -.
DR   PharmGKB; PA35103; -.
DR   eggNOG; KOG1225; Eukaryota.
DR   eggNOG; KOG2579; Eukaryota.
DR   eggNOG; ENOG410ZYS4; LUCA.
DR   HOGENOM; HOG000234355; -.
DR   HOVERGEN; HBG008949; -.
DR   KO; K06252; -.
DR   ChiTaRS; TNC; human.
DR   GenomeRNAi; 3371; -.
DR   Genevisible; Q4LE33; HS.
DR   GO; GO:0031012; C:extracellular matrix; IEA:InterPro.
DR   GO; GO:0007155; P:cell adhesion; IEA:InterPro.
DR   GO; GO:0042127; P:regulation of cell proliferation; IEA:InterPro.
DR   CDD; cd00063; FN3; 15.
DR   CDD; cd00087; FReD; 1.
DR   Gene3D; 2.60.40.10; -; 15.
DR   InterPro; IPR013032; EGF-like_CS.
DR   InterPro; IPR000742; EGF-like_dom.
DR   InterPro; IPR013111; EGF_extracell.
DR   InterPro; IPR036056; Fibrinogen-like_C.
DR   InterPro; IPR002181; Fibrinogen_a/b/g_C_dom.
DR   InterPro; IPR003961; FN3_dom.
DR   InterPro; IPR036116; FN3_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR033078; TNC.
DR   PANTHER; PTHR19143:SF38; PTHR19143:SF38; 9.
DR   Pfam; PF07974; EGF_2; 6.
DR   Pfam; PF00147; Fibrinogen_C; 1.
DR   Pfam; PF00041; fn3; 15.
DR   SMART; SM00181; EGF; 14.
DR   SMART; SM00186; FBG; 1.
DR   SMART; SM00060; FN3; 15.
DR   SUPFAM; SSF49265; SSF49265; 12.
DR   SUPFAM; SSF56496; SSF56496; 1.
DR   PROSITE; PS00022; EGF_1; 5.
DR   PROSITE; PS01186; EGF_2; 5.
DR   PROSITE; PS50026; EGF_3; 5.
DR   PROSITE; PS51406; FIBRINOGEN_C_2; 1.
DR   PROSITE; PS50853; FN3; 15.
PE   2: Evidence at transcript level;
KW   Coiled coil {ECO:0000256|SAM:Coils};
KW   Disulfide bond {ECO:0000256|PROSITE-ProRule:PRU00076};
KW   EGF-like domain {ECO:0000256|PROSITE-ProRule:PRU00076}.
FT   DOMAIN      218    249       EGF-like. {ECO:0000259|PROSITE:PS50026}.
FT   DOMAIN      312    343       EGF-like. {ECO:0000259|PROSITE:PS50026}.
FT   DOMAIN      405    436       EGF-like. {ECO:0000259|PROSITE:PS50026}.
FT   DOMAIN      498    529       EGF-like. {ECO:0000259|PROSITE:PS50026}.
FT   DOMAIN      591    622       EGF-like. {ECO:0000259|PROSITE:PS50026}.
FT   DOMAIN      657    747       Fibronectin type-III.
FT                                {ECO:0000259|PROSITE:PS50853}.
FT   DOMAIN      748    836       Fibronectin type-III.
FT                                {ECO:0000259|PROSITE:PS50853}.
FT   DOMAIN      837    926       Fibronectin type-III.
FT                                {ECO:0000259|PROSITE:PS50853}.
FT   DOMAIN      927   1022       Fibronectin type-III.
FT                                {ECO:0000259|PROSITE:PS50853}.
FT   DOMAIN     1023   1107       Fibronectin type-III.
FT                                {ECO:0000259|PROSITE:PS50853}.
FT   DOMAIN     1108   1197       Fibronectin type-III.
FT                                {ECO:0000259|PROSITE:PS50853}.
FT   DOMAIN     1199   1288       Fibronectin type-III.
FT                                {ECO:0000259|PROSITE:PS50853}.
FT   DOMAIN     1290   1382       Fibronectin type-III.
FT                                {ECO:0000259|PROSITE:PS50853}.
FT   DOMAIN     1383   1471       Fibronectin type-III.
FT                                {ECO:0000259|PROSITE:PS50853}.
FT   DOMAIN     1472   1563       Fibronectin type-III.
FT                                {ECO:0000259|PROSITE:PS50853}.
FT   DOMAIN     1565   1653       Fibronectin type-III.
FT                                {ECO:0000259|PROSITE:PS50853}.
FT   DOMAIN     1654   1743       Fibronectin type-III.
FT                                {ECO:0000259|PROSITE:PS50853}.
FT   DOMAIN     1744   1833       Fibronectin type-III.
FT                                {ECO:0000259|PROSITE:PS50853}.
FT   DOMAIN     1834   1920       Fibronectin type-III.
FT                                {ECO:0000259|PROSITE:PS50853}.
FT   DOMAIN     1921   2009       Fibronectin type-III.
FT                                {ECO:0000259|PROSITE:PS50853}.
FT   DOMAIN     2007   2222       Fibrinogen C-terminal.
FT                                {ECO:0000259|PROSITE:PS51406}.
FT   COILED      151    171       {ECO:0000256|SAM:Coils}.
FT   DISULFID    222    232       {ECO:0000256|PROSITE-ProRule:PRU00076}.
FT   DISULFID    239    248       {ECO:0000256|PROSITE-ProRule:PRU00076}.
FT   DISULFID    316    326       {ECO:0000256|PROSITE-ProRule:PRU00076}.
FT   DISULFID    333    342       {ECO:0000256|PROSITE-ProRule:PRU00076}.
FT   DISULFID    409    419       {ECO:0000256|PROSITE-ProRule:PRU00076}.
FT   DISULFID    426    435       {ECO:0000256|PROSITE-ProRule:PRU00076}.
FT   DISULFID    502    512       {ECO:0000256|PROSITE-ProRule:PRU00076}.
FT   DISULFID    519    528       {ECO:0000256|PROSITE-ProRule:PRU00076}.
FT   DISULFID    595    605       {ECO:0000256|PROSITE-ProRule:PRU00076}.
FT   DISULFID    612    621       {ECO:0000256|PROSITE-ProRule:PRU00076}.
FT   DISULFID   2168   2181       {ECO:0000256|PROSITE-ProRule:PRU00739}.
FT   NON_TER       1      1       {ECO:0000313|EMBL:BAE06120.1}.
SQ   SEQUENCE   2233 AA;  244404 MW;  3AB15331FB1E92E7 CRC64;
     SLLCASKSPI LLKVRYPRAL EPQQHPAKPT STMGAMTQLL AGVFLAFLAL ATEGGVLKKV
     IRHKRQSGVN ATLPEENQPV VFNHVYNIKL PVGSQCSVDL ESASGEKDLA PPSEPSESFQ
     EHTVDGENQI VFTHRINIPR RACGCAAAPD VKELLSRLEE LENLVSSLRE QCTAGAGCCL
     QPATGRLDTR PFCSGRGNFS TEGCGCVCEP GWKGPNCSEP ECPGNCHLRG RCIDGQCICD
     DGFTGEDCSQ LACPSDCNDQ GKCVNGVCIC FEGYAGADCS REICPVPCSE EHGTCVDGLC
     VCHDGFAGDD CNKPLCLNNC YNRGRCVENE CVCDEGFTGE DCSELICPND CFDRGRCING
     TCYCEEGFTG EDCGKPTCPH ACHTQGRCEE GQCVCDEGFA GVDCSEKRCP ADCHNRGRCV
     DGRCECDDGF TGADCGELKC PNGCSGHGRC VNGQCVCDEG YTGEDCSQLR CPNDCHSRGR
     CVEGKCVCEQ GFKGYDCSDM SCPNDCHQHG RCVNGMCVCD DGYTGEDCRD RQCPRDCSNR
     GLCVDGQCVC EDGFTGPDCA ELSCPNDCHG RGRCVNGQCV CHEGFMGKDC KEQRCPSDCH
     GQGRCVDGQC ICHEGFTGLD CGQHSCPSDC NNLGQCVSGR CICNEGYSGE DCSEVSPPKD
     LVVTEVTEET VNLAWDNEMR VTEYLVVYTP THEGGLEMQF RVPGDQTSTI IRELEPGVEY
     FIRVFAILEN KKSIPVSARV ATYLPAPEGL KFKSIKETSV EVEWDPLDIA FETWEIIFRN
     MNKEDEGEIT KSLRRPETSY RQTGLAPGQE YEISLHIVKN NTRGPGLKRV TTTRLDAPSQ
     IEVKDVTDTT ALITWFKPLA EIDGIELTYG IKDVPGDRTT IDLTEDENQY SIGNLKPDTE
     YEVSLISRRG DMSSNPAKET FTTGLDAPRN LRRVSQTDNS ITLEWRNGKA AIDSYRIKYA
     PISGGDHAEV DVPKSQQATT KTTLTGLRPG TEYGIGVSAV KEDKESNPAT INAATELDTP
     KDLQVSETAE TSLTLLWKTP LAKFDRYRLN YSLPTGQWVG VQLPRNTTSY VLRGLEPGQE
     YNVLLTAEKG RHKSKPAHVK ASTEQAPELE NLTVTEVGWD GLRLNWTAAD QAYEHFIIQV
     QEANKVEAAR NLTVPGSLRA VDIPGLKAAT PYTVSIYGVI QGYRTPVLSA EASTGETPNL
     GEVVVAEVGW DALKLNWTAP EGAYEYFFIQ VQEADTVEAA QNLTVPGGLR STDLPGLKAA
     THYTITIRGV TQDFSTTPLS VEVLTEEVPD MGNLTVTEVS WDALRLNWTT PDGTYDQFTI
     QVQEADQVEE AHNLTVPGSL RSMEIPGLRA GTPYTVTLHG EVRGHSTRPL AVEVVTEDLP
     QLGDLAVSEV GWDGLRLNWT AADNAYEHFV IQVQEVNKVE AAQNLTLPGS LRAVDIPGLE
     AATPYRVSIY GVIRGYRTPV LSAEASTAKE PEIGNLNVSD ITPESFNLSW MATDGIFETF
     TIEIIDSNRL LETVEYNISG AERTAHISGL PPSTDFIVYL SGLAPSIRTK TISATATTEA
     LPLLENLTIS DINPYGFTVS WMASENAFDS FLVTVVDSGK LLDPQEFTLS GTQRKLELRG
     LITGIGYEVM VSGFTQGHQT KPLRAEIVTE AEPEVDNLLV SDATPDGFRL SWTADEGVFD
     NFVLKIRDTK KQSEPLEITL LAPERTRDIT GLREATEYEI ELYGISKGRR SQTVSAIATT
     AMGSPKEVIF SDITENSATV SWRAPTAQVE SFRITYVPIT GGTPSMVTVD GTKTQTRLVK
     LIPGVEYLVS IIAMKGFEES EPVSGSFTTA LDGPSGLVTA NITDSEALAR WQPAIATVDS
     YVISYTGEKV PEITRTVSGN TVEYALTDLE PATEYTLRIF AEKGPQKSST ITAKFTTDLD
     SPRDLTATEV QSETALLTWR PPRASVTGYL LVYESVDGTV KEVIVGPDTT SYSLADLSPS
     THYTAKIQAL NGPLRSNMIQ TIFTTIGLLY PFPKDCSQAM LNGDTTSGLY TIYLNGDKAE
     ALEVFCDMTS DGGGWIVFLR RKNGRENFYQ NWKAYAAGFG DRREEFWLGL DNLNKITAQG
     QYELRVDLRD HGETAFAVYD KFSVGDAKTR YKLKVEGYSG TAGDSMAYHN GRSFSTFDKD
     TDSAITNCAL SYKGAFWYRN CHRVNLMGRY GDNNHSQGVN WFHWKGHEHS IQFAEMKLRP
     SNFRNLEGRR KRA
//
ID   B2RBI8_HUMAN            Unreviewed;      1124 AA.
AC   B2RBI8;
DT   01-JUL-2008, integrated into UniProtKB/TrEMBL.
DT   01-JUL-2008, sequence version 1.
DT   25-APR-2018, entry version 63.
DE   SubName: Full=cDNA, FLJ95535, highly similar to Homo sapiens transcription factor 8 (represses interleukin 2 expression) (TCF8), mRNA {ECO:0000313|EMBL:BAG37235.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAG37235.1};
RN   [1] {ECO:0000313|EMBL:BAG37235.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Placenta {ECO:0000313|EMBL:BAG37235.1};
RA   Wakamatsu A., Yamamoto J., Kimura K., Kaida T., Tsuchiya K., Iida Y.,
RA   Takayama Y., Murakawa K., Kanehori K., Andoh T., Kagawa N., Sato R.,
RA   Kawamura Y., Tanaka S., Kisu Y., Sugano S., Goshima N., Nomura N.,
RA   Isogai T.;
RT   "NEDO functional analysis of protein and research application
RT   project.";
RL   Submitted (JAN-2008) to the EMBL/GenBank/DDBJ databases.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000256|RuleBase:RU000682}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK314683; BAG37235.1; -; mRNA.
DR   RefSeq; NP_001121600.1; NM_001128128.2.
DR   RefSeq; NP_001167565.1; NM_001174094.1.
DR   RefSeq; NP_001167566.1; NM_001174095.1.
DR   RefSeq; NP_110378.3; NM_030751.5.
DR   UniGene; Hs.124503; -.
DR   PeptideAtlas; B2RBI8; -.
DR   PRIDE; B2RBI8; -.
DR   GeneID; 6935; -.
DR   KEGG; hsa:6935; -.
DR   CTD; 6935; -.
DR   PharmGKB; PA162409589; -.
DR   eggNOG; KOG3623; Eukaryota.
DR   eggNOG; ENOG410ZFMZ; LUCA.
DR   HOVERGEN; HBG004697; -.
DR   KO; K09299; -.
DR   GenomeRNAi; 6935; -.
DR   Genevisible; B2RBI8; HS.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0003677; F:DNA binding; IEA:UniProtKB-KW.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR008598; Di19_Zn_binding_dom.
DR   InterPro; IPR009057; Homeobox-like_sf.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR036236; Znf_C2H2_sf.
DR   InterPro; IPR013087; Znf_C2H2_type.
DR   Pfam; PF00046; Homeobox; 1.
DR   Pfam; PF05605; zf-Di19; 1.
DR   SMART; SM00389; HOX; 1.
DR   SMART; SM00355; ZnF_C2H2; 7.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   SUPFAM; SSF57667; SSF57667; 4.
DR   PROSITE; PS00028; ZINC_FINGER_C2H2_1; 5.
DR   PROSITE; PS50157; ZINC_FINGER_C2H2_2; 6.
PE   2: Evidence at transcript level;
KW   Coiled coil {ECO:0000256|SAM:Coils};
KW   DNA-binding {ECO:0000256|RuleBase:RU000682};
KW   Homeobox {ECO:0000256|RuleBase:RU000682};
KW   Metal-binding {ECO:0000256|PROSITE-ProRule:PRU00042};
KW   Nucleus {ECO:0000256|RuleBase:RU000682};
KW   Zinc {ECO:0000256|PROSITE-ProRule:PRU00042};
KW   Zinc-finger {ECO:0000256|PROSITE-ProRule:PRU00042}.
FT   DOMAIN      170    198       C2H2-type. {ECO:0000259|PROSITE:PS50157}.
FT   DOMAIN      200    227       C2H2-type. {ECO:0000259|PROSITE:PS50157}.
FT   DOMAIN      240    267       C2H2-type. {ECO:0000259|PROSITE:PS50157}.
FT   DOMAIN      904    931       C2H2-type. {ECO:0000259|PROSITE:PS50157}.
FT   DOMAIN      932    959       C2H2-type. {ECO:0000259|PROSITE:PS50157}.
FT   DOMAIN      960    988       C2H2-type. {ECO:0000259|PROSITE:PS50157}.
FT   COILED     1033   1057       {ECO:0000256|SAM:Coils}.
FT   COILED     1062   1090       {ECO:0000256|SAM:Coils}.
SQ   SEQUENCE   1124 AA;  124060 MW;  109715DD36D859D0 CRC64;
     MADGPRCKRR KQANPRRNNV TNYNTVVETN SDSDDEDKLH IVEEESVTDA ADCEGVPEDD
     LPTDQTVLPG RSSEREGNAK NCWEDDRKEG QEILGPEAQA DEAGCTVKDD ECESDAENEQ
     NHDPNVEEFL QQQDTAVIFP EAPEEDQRQG TPEASGHDEN GTPDAFSQLL TCPYCDRGYK
     RFTSLKEHIK YRHEKNEDNF SCSLCSYTFA YRTQLERHMT SHKSGRDQRH VTQSGCNRKF
     KCTECGKAFK YKHHLKEHLR IHSGEKPYEC PNCKKRFSHS GSYSSHISSK KCISLIPVNG
     RPRTGLKTSQ CSSPSLSASP GSPTRPQIRQ KIENKPLQEQ LSVNQIKTEP VDYEFKPIVV
     ASGINCSTPL QNGVFTGGGP LQATSSPQGM VQAVVLPTVG LVSPISINLS DIQNVLKVAV
     DGNVIRQVLE NNQANLASKE QETINASPIQ QGGHSVISAI SLPLVDQDGT TKIIINYSLE
     QPSQLQVVPQ NLKKENPVAT NSCKSEKLPE DLTVKSEKDK SFEGGVNDST CLLCDDCPGD
     INALPELKHY DLKQPTQPPP LPAAEAEKPE SSVSSATGDG NLSPSQPPLK NLLSLLKAYY
     ALNAQPSAEE LSKIADSVNL PLDVVKKWFE KMQAGQISVQ SSEPSSPEPG KVNIPAKNND
     QPQSANANEP QDSTVNLQSP LKMTNSPVLP VGSTTNGSRS STPSPSPLNL SSSRNTQGYL
     YTAEGAQEEP QVEPLDLSLP KQQGELLERS TITSVYQNSV YSVQEEPLNL SCAKKEPQKD
     SCVTDSEPVV NVIPPSANPI NIAIPTVTAQ LPTIVAIADQ NSVPCLRALA ANKQTILIPQ
     VAYTYSTTVS PAVQEPPLKV IQPNGNQDER QDTSSEGVSN VEDQNDSDST PPKKKMRKTE
     NGMYACDLCD KIFQKSSSLL RHKYEHTGKR PHECGICKKA FKHKHHLIEH MRLHSGEKPY
     QCDKCGKRFS HSGSYSQHMN HRYSYCKREA EERDSTEQEE AGPEILSNEH VGARASPSQG
     DSDERESLTR EEDDDSEKEE EEEDKEMEEL QEEKECEKPQ GDEEEEEEEE EVEEEEVEEA
     ENEGEEAKTE GLMKDDRAES QASSLGQKVG ESSEQVSEEK TNEA
//
ID   B4DGU2_HUMAN            Unreviewed;       906 AA.
AC   B4DGU2;
DT   23-SEP-2008, integrated into UniProtKB/TrEMBL.
DT   23-SEP-2008, sequence version 1.
DT   31-JAN-2018, entry version 51.
DE   SubName: Full=cDNA FLJ61244, highly similar to Transcription factor 8 {ECO:0000313|EMBL:BAG57903.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAG57903.1};
RN   [1] {ECO:0000313|EMBL:BAG57903.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Brain {ECO:0000313|EMBL:BAG57903.1};
RA   Wakamatsu A., Yamamoto J., Kimura K., Ishii S., Watanabe K.,
RA   Sugiyama A., Murakawa K., Kaida T., Tsuchiya K., Fukuzumi Y.,
RA   Kumagai A., Oishi Y., Yamamoto S., Ono Y., Komori Y., Yamazaki M.,
RA   Kisu Y., Nishikawa T., Sugano S., Nomura N., Isogai T.;
RT   "NEDO human cDNA sequencing project focused on splicing variants.";
RL   Submitted (OCT-2007) to the EMBL/GenBank/DDBJ databases.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000256|RuleBase:RU000682}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK294775; BAG57903.1; -; mRNA.
DR   RefSeq; NP_001310570.1; NM_001323641.1.
DR   UniGene; Hs.124503; -.
DR   PeptideAtlas; B4DGU2; -.
DR   GeneID; 6935; -.
DR   CTD; 6935; -.
DR   eggNOG; KOG3623; Eukaryota.
DR   eggNOG; ENOG410ZFMZ; LUCA.
DR   HOVERGEN; HBG004697; -.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0003677; F:DNA binding; IEA:UniProtKB-KW.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR009057; Homeobox-like_sf.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR036236; Znf_C2H2_sf.
DR   InterPro; IPR013087; Znf_C2H2_type.
DR   Pfam; PF00046; Homeobox; 1.
DR   SMART; SM00389; HOX; 1.
DR   SMART; SM00355; ZnF_C2H2; 5.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   SUPFAM; SSF57667; SSF57667; 3.
DR   PROSITE; PS00028; ZINC_FINGER_C2H2_1; 3.
DR   PROSITE; PS50157; ZINC_FINGER_C2H2_2; 4.
PE   2: Evidence at transcript level;
KW   Coiled coil {ECO:0000256|SAM:Coils};
KW   DNA-binding {ECO:0000256|RuleBase:RU000682};
KW   Homeobox {ECO:0000256|RuleBase:RU000682};
KW   Metal-binding {ECO:0000256|PROSITE-ProRule:PRU00042};
KW   Nucleus {ECO:0000256|RuleBase:RU000682};
KW   Zinc {ECO:0000256|PROSITE-ProRule:PRU00042};
KW   Zinc-finger {ECO:0000256|PROSITE-ProRule:PRU00042}.
FT   DOMAIN       22     49       C2H2-type. {ECO:0000259|PROSITE:PS50157}.
FT   DOMAIN      686    713       C2H2-type. {ECO:0000259|PROSITE:PS50157}.
FT   DOMAIN      714    741       C2H2-type. {ECO:0000259|PROSITE:PS50157}.
FT   DOMAIN      742    770       C2H2-type. {ECO:0000259|PROSITE:PS50157}.
FT   COILED      807    839       {ECO:0000256|SAM:Coils}.
FT   COILED      844    872       {ECO:0000256|SAM:Coils}.
SQ   SEQUENCE   906 AA;  99336 MW;  C0D6C7726A054262 CRC64;
     MTSHKSGRDQ RHVTQSGCNR KFKCTECGKA FKYKHHLKEH LRIHSGEKPY ECPNCKKRFS
     HSGSYSSHIS SKKCISLIPV NGRPRTGLKT SQCSSPSLSA SPGSPTRPQI RQKIENKPLQ
     EQLSVNQIKT EPVDYEFKPI VVASGINCST PLQNGVFTGG GPLQATSSPQ GMVQAVVLPT
     VGLVSPISIN LSDIQNVLKV AVDGNVIRQV LENNQANLAS KEQEIINASP IQQGGHSVIS
     AISLPLVDQD GTTKIIINYS LEQPSQLQVV PQNLKKENPV ATNSCKSEKL PEDLTVKSEK
     DKSFEGGVND STCLLCDDCP GDINALPELK HYDLKQPTQP PPLPAAEAEK PESSVSSATG
     DGNLSPSQPP LKNLLSLLKA YYALNAQPSA EELSKIADSV NLPLDVVKKW FEKMQAGQIS
     VQSSEPSSPE PGKVNIPAKN NDQPQSANAN EPQDSTVNLQ SPLKMTNSPV LPVGSTTNGS
     RSSTPSPSPL NLSSSRNTQG YLYTAEGAQE EPQVEPLDLS LPKQQGELLE RSTITSVYQN
     SVYSVQEEPL NLSCAKKEPQ KDSCVTDSEP VVNVIPPSAN PINIAIPTVT AQLPTIVAIA
     DQNSVPCLRA LAANKQTILI PQVAYTYSTT VSPAVQEPPL KVIQPNGNQD ERQDTSSEGV
     SNVEDQNDSD STPPKKKMRK TENGMYACDL CDKIFQKSSS LLRHKYEHTG KRPHECGICK
     KAFKHKHHLI EHMRLHSGEK PYQCDKCGKR FSHSGSYSQH MNHRYSYCKR EAEERDSTEQ
     EEAGPEILSN EHVGARASPS QGDSDERESL TREEDEDSEK EEEEEDKEME ELQEEKECEK
     PQGDEEEEEE EEEVEEEEVE EAENEGEEAK TEGLMKDDRA ESQASSLGQK VGESSEQVSE
     EKTNEA
//
ID   ZEB1_HUMAN              Reviewed;        1124 AA.
AC   P37275; B4DJV0; B4DUW9; E9PCM7; F5H4I8; Q12924; Q13800; Q2KJ05;
AC   Q5T968; Q5VZ84; Q8NB68;
DT   01-OCT-1994, integrated into UniProtKB/Swiss-Prot.
DT   15-JUL-1999, sequence version 2.
DT   28-MAR-2018, entry version 186.
DE   RecName: Full=Zinc finger E-box-binding homeobox 1;
DE   AltName: Full=NIL-2-A zinc finger protein;
DE   AltName: Full=Negative regulator of IL2;
DE   AltName: Full=Transcription factor 8;
DE            Short=TCF-8;
GN   Name=ZEB1; Synonyms=AREB6, TCF8;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=8138542;
RA   Watanabe Y., Kawakami K., Hirayama Y., Nagano K.;
RT   "Transcription factors positively and negatively regulating the Na,K-
RT   ATPase alpha 1 subunit gene.";
RL   J. Biochem. 114:849-855(1993).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RA   Bachman N.J., Scarpulla R.C.;
RT   "A human zinc finger homeodomain protein homologous to the chicken
RT   delta-crystallin enhancer binding protein, delta EF1.";
RL   Submitted (JUL-1994) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 3 AND 4), AND
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1-798 (ISOFORM 5).
RC   TISSUE=Brain, and Thalamus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164054; DOI=10.1038/nature02462;
RA   Deloukas P., Earthrowl M.E., Grafham D.V., Rubenfield M., French L.,
RA   Steward C.A., Sims S.K., Jones M.C., Searle S., Scott C., Howe K.,
RA   Hunt S.E., Andrews T.D., Gilbert J.G.R., Swarbreck D., Ashurst J.L.,
RA   Taylor A., Battles J., Bird C.P., Ainscough R., Almeida J.P.,
RA   Ashwell R.I.S., Ambrose K.D., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Bates K., Beasley H., Bray-Allen S., Brown A.J.,
RA   Brown J.Y., Burford D.C., Burrill W., Burton J., Cahill P., Camire D.,
RA   Carter N.P., Chapman J.C., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Corby N., Coulson A., Dhami P., Dutta I., Dunn M., Faulkner L.,
RA   Frankish A., Frankland J.A., Garner P., Garnett J., Gribble S.,
RA   Griffiths C., Grocock R., Gustafson E., Hammond S., Harley J.L.,
RA   Hart E., Heath P.D., Ho T.P., Hopkins B., Horne J., Howden P.J.,
RA   Huckle E., Hynds C., Johnson C., Johnson D., Kana A., Kay M.,
RA   Kimberley A.M., Kershaw J.K., Kokkinaki M., Laird G.K., Lawlor S.,
RA   Lee H.M., Leongamornlert D.A., Laird G., Lloyd C., Lloyd D.M.,
RA   Loveland J., Lovell J., McLaren S., McLay K.E., McMurray A.,
RA   Mashreghi-Mohammadi M., Matthews L., Milne S., Nickerson T.,
RA   Nguyen M., Overton-Larty E., Palmer S.A., Pearce A.V., Peck A.I.,
RA   Pelan S., Phillimore B., Porter K., Rice C.M., Rogosin A., Ross M.T.,
RA   Sarafidou T., Sehra H.K., Shownkeen R., Skuce C.D., Smith M.,
RA   Standring L., Sycamore N., Tester J., Thorpe A., Torcasso W.,
RA   Tracey A., Tromans A., Tsolas J., Wall M., Walsh J., Wang H.,
RA   Weinstock K., West A.P., Willey D.L., Whitehead S.L., Wilming L.,
RA   Wray P.W., Young L., Chen Y., Lovering R.C., Moschonas N.K.,
RA   Siebert R., Fechtel K., Bentley D., Durbin R.M., Hubbard T.,
RA   Doucette-Stamm L., Beck S., Smith D.R., Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 10.";
RL   Nature 429:375-381(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 390-1124.
RX   PubMed=1840704; DOI=10.1126/science.1840704;
RA   Williams T.M., Moolten D., Burlein J., Romano J., Bhaerman R.,
RA   Godillot A., Mellon M., Rauscher F.J. III, Kant J.A.;
RT   "Identification of a zinc finger protein that inhibits IL-2 gene
RT   expression.";
RL   Science 254:1791-1794(1991).
RN   [8]
RP   INVOLVEMENT IN PPCD3.
RX   PubMed=16252232; DOI=10.1086/497348;
RA   Krafchak C.M., Pawar H., Moroi S.E., Sugar A., Lichter P.R.,
RA   Mackey D.A., Mian S., Nairus T., Elner V., Schteingart M.T.,
RA   Downs C.A., Kijek T.G., Johnson J.M., Trager E.H., Rozsa F.W.,
RA   Mandal M.N.A., Epstein M.P., Vollrath D., Ayyagari R., Boehnke M.,
RA   Richards J.E.;
RT   "Mutations in TCF8 cause posterior polymorphous corneal dystrophy and
RT   ectopic expression of COL4A3 by corneal endothelial cells.";
RL   Am. J. Hum. Genet. 77:694-708(2005).
RN   [9]
RP   SUMOYLATION AT LYS-347 AND LYS-774.
RX   PubMed=16061479; DOI=10.1074/jbc.M504477200;
RA   Long J., Zuo D., Park M.;
RT   "Pc2-mediated sumoylation of Smad-interacting protein 1 attenuates
RT   transcriptional repression of E-cadherin.";
RL   J. Biol. Chem. 280:35477-35489(2005).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-322, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [13]
RP   FUNCTION.
RX   PubMed=19935649; DOI=10.1038/ncb1998;
RA   Wellner U., Schubert J., Burk U.C., Schmalhofer O., Zhu F.,
RA   Sonntag A., Waldvogel B., Vannier C., Darling D., zur Hausen A.,
RA   Brunton V.G., Morton J., Sansom O., Schuler J., Stemmler M.P.,
RA   Herzberger C., Hopt U., Keck T., Brabletz S., Brabletz T.;
RT   "The EMT-activator ZEB1 promotes tumorigenicity by repressing
RT   stemness-inhibiting microRNAs.";
RL   Nat. Cell Biol. 11:1487-1495(2009).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-642; SER-679 AND
RP   THR-702, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [15]
RP   FUNCTION.
RX   PubMed=20175752; DOI=10.1042/BJ20091578;
RA   Papadopoulou V., Postigo A., Sanchez-Tillo E., Porter A.C.,
RA   Wagner S.D.;
RT   "ZEB1 and CtBP form a repressive complex at a distal promoter element
RT   of the BCL6 locus.";
RL   Biochem. J. 427:541-550(2010).
RN   [16]
RP   FUNCTION, SUBCELLULAR LOCATION, INTERACTION WITH SMARCA4, AND TISSUE
RP   SPECIFICITY.
RX   PubMed=20418909; DOI=10.1038/onc.2010.102;
RA   Sanchez-Tillo E., Lazaro A., Torrent R., Cuatrecasas M., Vaquero E.C.,
RA   Castells A., Engel P., Postigo A.;
RT   "ZEB1 represses E-cadherin and induces an EMT by recruiting the
RT   SWI/SNF chromatin-remodeling protein BRG1.";
RL   Oncogene 29:3490-3500(2010).
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-679, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [18]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [19]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-679 AND THR-702, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [20]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-493; LYS-504 AND LYS-515,
RP   AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25218447; DOI=10.1038/nsmb.2890;
RA   Hendriks I.A., D'Souza R.C., Yang B., Verlaan-de Vries M., Mann M.,
RA   Vertegaal A.C.;
RT   "Uncovering global SUMOylation signaling networks in a site-specific
RT   manner.";
RL   Nat. Struct. Mol. Biol. 21:927-936(2014).
RN   [21]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-493, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25114211; DOI=10.1073/pnas.1413825111;
RA   Impens F., Radoshevich L., Cossart P., Ribet D.;
RT   "Mapping of SUMO sites and analysis of SUMOylation changes induced by
RT   external stimuli.";
RL   Proc. Natl. Acad. Sci. U.S.A. 111:12432-12437(2014).
RN   [22]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-493; LYS-504 AND LYS-515,
RP   AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25772364; DOI=10.1016/j.celrep.2015.02.033;
RA   Hendriks I.A., Treffers L.W., Verlaan-de Vries M., Olsen J.V.,
RA   Vertegaal A.C.;
RT   "SUMO-2 orchestrates chromatin modifiers in response to DNA damage.";
RL   Cell Rep. 10:1778-1791(2015).
RN   [23]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-493; LYS-504 AND LYS-515,
RP   AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25755297; DOI=10.1074/mcp.O114.044792;
RA   Xiao Z., Chang J.G., Hendriks I.A., Sigurdsson J.O., Olsen J.V.,
RA   Vertegaal A.C.;
RT   "System-wide analysis of SUMOylation dynamics in response to
RT   replication stress reveals novel small ubiquitin-like modified target
RT   proteins and acceptor lysines relevant for genome stability.";
RL   Mol. Cell. Proteomics 14:1419-1434(2015).
RN   [24]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-186; LYS-195; LYS-307;
RP   LYS-331; LYS-335; LYS-347; LYS-439; LYS-493; LYS-504; LYS-515;
RP   LYS-548; LYS-553 AND LYS-774, AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-
RT   modification with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
RN   [25]
RP   STRUCTURE BY NMR OF 583-642.
RG   RIKEN structural genomics initiative (RSGI);
RT   "Solution structure of the homeobox domain from human NIL-2-A zinc
RT   finger protein, transcription factor 8.";
RL   Submitted (APR-2007) to the PDB data bank.
RN   [26]
RP   VARIANTS FECD6 THR-78; ALA-649; PRO-810; PRO-840 AND THR-905.
RX   PubMed=20036349; DOI=10.1016/j.ajhg.2009.12.001;
RA   Riazuddin S.A., Zaghloul N.A., Al-Saif A., Davey L., Diplas B.H.,
RA   Meadows D.N., Eghrari A.O., Minear M.A., Li Y.J., Klintworth G.K.,
RA   Afshari N., Gregory S.G., Gottsch J.D., Katsanis N.;
RT   "Missense mutations in TCF8 cause late-onset Fuchs corneal dystrophy
RT   and interact with FCD4 on chromosome 9p.";
RL   Am. J. Hum. Genet. 86:45-53(2010).
RN   [27]
RP   INVOLVEMENT IN FECD6 AND PPCD3, VARIANT FECD6 HIS-640,
RP   CHARACTERIZATION OF VARIANTS FECD6 THR-78 AND HIS-640, AND VARIANT
RP   GLU-525.
RX   PubMed=23599324; DOI=10.1167/iovs.13-11781;
RA   Lechner J., Dash D.P., Muszynska D., Hosseini M., Segev F., George S.,
RA   Frazer D.G., Moore J.E., Kaye S.B., Young T., Simpson D.A.,
RA   Churchill A.J., Heon E., Willoughby C.E.;
RT   "Mutational spectrum of the ZEB1 gene in corneal dystrophies supports
RT   a genotype-phenotype correlation.";
RL   Invest. Ophthalmol. Vis. Sci. 54:3215-3223(2013).
RN   [28]
RP   VARIANTS FECD6 THR-78; ALA-649; SER-696; PRO-810; PRO-840 AND GLY-905,
RP   CHARACTERIZATION OF VARIANTS FECD6 THR-78; ALA-649; SER-696; PRO-810;
RP   PRO-840 AND GLY-905, AND SUBCELLULAR LOCATION.
RX   PubMed=25190660; DOI=10.1167/iovs.14-15247;
RA   Chung D.W., Frausto R.F., Ann L.B., Jang M.S., Aldave A.J.;
RT   "Functional impact of ZEB1 mutations associated with posterior
RT   polymorphous and Fuchs' endothelial corneal dystrophies.";
RL   Invest. Ophthalmol. Vis. Sci. 55:6159-6166(2014).
CC   -!- FUNCTION: Acts as a transcriptional repressor. Inhibits
CC       interleukin-2 (IL-2) gene expression. Enhances or represses the
CC       promoter activity of the ATP1A1 gene depending on the quantity of
CC       cDNA and on the cell type. Represses E-cadherin promoter and
CC       induces an epithelial-mesenchymal transition (EMT) by recruiting
CC       SMARCA4/BRG1. Represses BCL6 transcription in the presence of the
CC       corepressor CTBP1. Positively regulates neuronal differentiation.
CC       Represses RCOR1 transcription activation during neurogenesis.
CC       Represses transcription by binding to the E box (5'-CANNTG-3').
CC       Promotes tumorigenicity by repressing stemness-inhibiting
CC       microRNAs. {ECO:0000269|PubMed:19935649,
CC       ECO:0000269|PubMed:20175752, ECO:0000269|PubMed:20418909}.
CC   -!- SUBUNIT: Interacts (via N-terminus) with SMARCA4/BRG1.
CC       {ECO:0000269|PubMed:20418909}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:20418909,
CC       ECO:0000269|PubMed:25190660}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=5;
CC       Name=1;
CC         IsoId=P37275-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P37275-2; Sequence=VSP_045184;
CC         Note=No experimental confirmation available.;
CC       Name=3;
CC         IsoId=P37275-3; Sequence=VSP_047280;
CC       Name=4;
CC         IsoId=P37275-4; Sequence=VSP_047281;
CC       Name=5;
CC         IsoId=P37275-5; Sequence=VSP_047279, VSP_045184;
CC   -!- TISSUE SPECIFICITY: Colocalizes with SMARCA4/BRG1 in E-cadherin-
CC       negative cells from established lines, and stroma of normal colon
CC       as well as in de-differentiated epithelial cells at the invasion
CC       front of colorectal carcinomas (at protein level). Expressed in
CC       heart and skeletal muscle, but not in liver, spleen, or pancreas.
CC       {ECO:0000269|PubMed:20418909}.
CC   -!- DISEASE: Corneal dystrophy, posterior polymorphous, 3 (PPCD3)
CC       [MIM:609141]: A subtype of posterior corneal dystrophy, a disease
CC       characterized by alterations of Descemet membrane presenting as
CC       vesicles, opacities or band-like lesions on slit-lamp examination
CC       and specular microscopy. Affected patient typically are
CC       asymptomatic. {ECO:0000269|PubMed:16252232,
CC       ECO:0000269|PubMed:23599324}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Corneal dystrophy, Fuchs endothelial, 6 (FECD6)
CC       [MIM:613270]: A corneal disease caused by loss of endothelium of
CC       the central cornea. It is characterized by focal wart-like guttata
CC       that arise from Descemet membrane and develop in the central
CC       cornea, epithelial blisters, reduced vision and pain. Descemet
CC       membrane is thickened by abnormal collagenous deposition.
CC       {ECO:0000269|PubMed:20036349, ECO:0000269|PubMed:23599324,
CC       ECO:0000269|PubMed:25190660}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the delta-EF1/ZFH-1 C2H2-type zinc-finger
CC       family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAG62481.1; Type=Frameshift; Positions=177; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; D15050; BAA03646.1; -; mRNA.
DR   EMBL; U12170; AAA20602.1; -; mRNA.
DR   EMBL; AK091478; BAC03673.1; -; mRNA.
DR   EMBL; AK296244; BAG58962.1; -; mRNA.
DR   EMBL; AK300830; BAG62481.1; ALT_FRAME; mRNA.
DR   EMBL; AL158080; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL161935; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL117340; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL355148; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471072; EAW85989.1; -; Genomic_DNA.
DR   EMBL; BC112392; AAI12393.1; -; mRNA.
DR   EMBL; M81699; -; NOT_ANNOTATED_CDS; mRNA.
DR   CCDS; CCDS44370.1; -. [P37275-5]
DR   CCDS; CCDS53505.1; -. [P37275-2]
DR   CCDS; CCDS53506.1; -. [P37275-4]
DR   CCDS; CCDS53507.1; -. [P37275-3]
DR   CCDS; CCDS7169.1; -. [P37275-1]
DR   PIR; JX0293; JX0293.
DR   RefSeq; NP_001121600.1; NM_001128128.2. [P37275-5]
DR   RefSeq; NP_001167564.1; NM_001174093.1. [P37275-4]
DR   RefSeq; NP_001167565.1; NM_001174094.1.
DR   RefSeq; NP_001167566.1; NM_001174095.1. [P37275-3]
DR   RefSeq; NP_001167567.1; NM_001174096.1. [P37275-2]
DR   RefSeq; NP_110378.3; NM_030751.5. [P37275-1]
DR   UniGene; Hs.124503; -.
DR   PDB; 2E19; NMR; -; A=586-642.
DR   PDBsum; 2E19; -.
DR   ProteinModelPortal; P37275; -.
DR   SMR; P37275; -.
DR   BioGrid; 112796; 38.
DR   CORUM; P37275; -.
DR   ELM; P37275; -.
DR   IntAct; P37275; 4.
DR   MINT; P37275; -.
DR   STRING; 9606.ENSP00000354487; -.
DR   iPTMnet; P37275; -.
DR   PhosphoSitePlus; P37275; -.
DR   BioMuta; ZEB1; -.
DR   DMDM; 6166575; -.
DR   EPD; P37275; -.
DR   MaxQB; P37275; -.
DR   PaxDb; P37275; -.
DR   PeptideAtlas; P37275; -.
DR   PRIDE; P37275; -.
DR   Ensembl; ENST00000320985; ENSP00000319248; ENSG00000148516. [P37275-1]
DR   Ensembl; ENST00000361642; ENSP00000354487; ENSG00000148516. [P37275-2]
DR   Ensembl; ENST00000446923; ENSP00000391612; ENSG00000148516. [P37275-5]
DR   Ensembl; ENST00000542815; ENSP00000444891; ENSG00000148516. [P37275-3]
DR   Ensembl; ENST00000560721; ENSP00000452787; ENSG00000148516. [P37275-4]
DR   GeneID; 6935; -.
DR   KEGG; hsa:6935; -.
DR   UCSC; uc001ivs.5; human. [P37275-1]
DR   CTD; 6935; -.
DR   DisGeNET; 6935; -.
DR   EuPathDB; HostDB:ENSG00000148516.21; -.
DR   GeneCards; ZEB1; -.
DR   HGNC; HGNC:11642; ZEB1.
DR   HPA; CAB058686; -.
DR   HPA; HPA027524; -.
DR   MalaCards; ZEB1; -.
DR   MIM; 189909; gene.
DR   MIM; 609141; phenotype.
DR   MIM; 613270; phenotype.
DR   neXtProt; NX_P37275; -.
DR   OpenTargets; ENSG00000148516; -.
DR   Orphanet; 98974; Fuchs endothelial corneal dystrophy.
DR   Orphanet; 98973; Posterior polymorphous corneal dystrophy.
DR   PharmGKB; PA162409589; -.
DR   eggNOG; KOG3623; Eukaryota.
DR   eggNOG; ENOG410ZFMZ; LUCA.
DR   GeneTree; ENSGT00630000089829; -.
DR   HOGENOM; HOG000264256; -.
DR   HOVERGEN; HBG004697; -.
DR   InParanoid; P37275; -.
DR   KO; K09299; -.
DR   OMA; ECEKPQG; -.
DR   OrthoDB; EOG091G0F7Y; -.
DR   PhylomeDB; P37275; -.
DR   TreeFam; TF331759; -.
DR   Reactome; R-HSA-6785807; Interleukin-4 and 13 signaling.
DR   SignaLink; P37275; -.
DR   SIGNOR; P37275; -.
DR   ChiTaRS; ZEB1; human.
DR   EvolutionaryTrace; P37275; -.
DR   GeneWiki; ZEB1; -.
DR   GenomeRNAi; 6935; -.
DR   PRO; PR:P37275; -.
DR   Proteomes; UP000005640; Chromosome 10.
DR   Bgee; ENSG00000148516; -.
DR   CleanEx; HS_ZEB1; -.
DR   ExpressionAtlas; P37275; baseline and differential.
DR   Genevisible; P37275; HS.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0005667; C:transcription factor complex; IEA:Ensembl.
DR   GO; GO:0003682; F:chromatin binding; IEA:Ensembl.
DR   GO; GO:0003700; F:DNA binding transcription factor activity; TAS:ProtInc.
DR   GO; GO:0070888; F:E-box binding; ISS:UniProtKB.
DR   GO; GO:0000981; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; ISM:NTNU_SB.
DR   GO; GO:0003713; F:transcription coactivator activity; TAS:ProtInc.
DR   GO; GO:0003714; F:transcription corepressor activity; TAS:ProtInc.
DR   GO; GO:0008134; F:transcription factor binding; IEA:Ensembl.
DR   GO; GO:0001227; F:transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific DNA binding; IDA:BHF-UCL.
DR   GO; GO:0008270; F:zinc ion binding; TAS:ProtInc.
DR   GO; GO:0051216; P:cartilage development; IEA:Ensembl.
DR   GO; GO:0008283; P:cell proliferation; TAS:ProtInc.
DR   GO; GO:0071230; P:cellular response to amino acid stimulus; IEA:Ensembl.
DR   GO; GO:0007417; P:central nervous system development; IEA:Ensembl.
DR   GO; GO:0090103; P:cochlea morphogenesis; IEA:Ensembl.
DR   GO; GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome.
DR   GO; GO:0048596; P:embryonic camera-type eye morphogenesis; IEA:Ensembl.
DR   GO; GO:0048704; P:embryonic skeletal system morphogenesis; IEA:Ensembl.
DR   GO; GO:0006955; P:immune response; TAS:ProtInc.
DR   GO; GO:0008285; P:negative regulation of cell proliferation; IEA:Ensembl.
DR   GO; GO:0045602; P:negative regulation of endothelial cell differentiation; IMP:BHF-UCL.
DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; IDA:BHF-UCL.
DR   GO; GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB.
DR   GO; GO:0007389; P:pattern specification process; IEA:Ensembl.
DR   GO; GO:0045666; P:positive regulation of neuron differentiation; ISS:UniProtKB.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; IEA:Ensembl.
DR   GO; GO:0010464; P:regulation of mesenchymal cell proliferation; IEA:Ensembl.
DR   GO; GO:0051150; P:regulation of smooth muscle cell differentiation; IEA:Ensembl.
DR   GO; GO:0033081; P:regulation of T cell differentiation in thymus; IEA:Ensembl.
DR   GO; GO:0006357; P:regulation of transcription by RNA polymerase II; TAS:ProtInc.
DR   GO; GO:0017015; P:regulation of transforming growth factor beta receptor signaling pathway; IEA:Ensembl.
DR   GO; GO:0048752; P:semicircular canal morphogenesis; IEA:Ensembl.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR008598; Di19_Zn_binding_dom.
DR   InterPro; IPR009057; Homeobox-like_sf.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR036236; Znf_C2H2_sf.
DR   InterPro; IPR013087; Znf_C2H2_type.
DR   Pfam; PF00046; Homeobox; 1.
DR   Pfam; PF05605; zf-Di19; 1.
DR   SMART; SM00389; HOX; 1.
DR   SMART; SM00355; ZnF_C2H2; 7.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   SUPFAM; SSF57667; SSF57667; 4.
DR   PROSITE; PS00028; ZINC_FINGER_C2H2_1; 5.
DR   PROSITE; PS50157; ZINC_FINGER_C2H2_2; 6.
PE   1: Evidence at protein level;
KW   3D-structure; Activator; Alternative splicing; Complete proteome;
KW   Corneal dystrophy; Differentiation; Disease mutation; DNA-binding;
KW   Homeobox; Isopeptide bond; Metal-binding; Neurogenesis; Nucleus;
KW   Phosphoprotein; Polymorphism; Reference proteome; Repeat; Repressor;
KW   Transcription; Transcription regulation; Ubl conjugation; Zinc;
KW   Zinc-finger.
FT   CHAIN         1   1124       Zinc finger E-box-binding homeobox 1.
FT                                /FTId=PRO_0000047231.
FT   ZN_FING     170    193       C2H2-type 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00042}.
FT   ZN_FING     200    222       C2H2-type 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00042}.
FT   ZN_FING     240    262       C2H2-type 3. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00042}.
FT   ZN_FING     268    292       C2H2-type 4; atypical.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00042}.
FT   DNA_BIND    581    640       Homeobox; atypical.
FT   ZN_FING     904    926       C2H2-type 5. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00042}.
FT   ZN_FING     932    954       C2H2-type 6. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00042}.
FT   ZN_FING     960    981       C2H2-type 7; atypical.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00042}.
FT   COMPBIAS    989   1124       Glu-rich (acidic).
FT   MOD_RES      31     31       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q62947}.
FT   MOD_RES      33     33       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q62947}.
FT   MOD_RES     313    313       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q64318}.
FT   MOD_RES     322    322       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   MOD_RES     642    642       Phosphoserine.
FT                                {ECO:0000244|PubMed:19690332}.
FT   MOD_RES     679    679       Phosphoserine.
FT                                {ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     686    686       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q64318}.
FT   MOD_RES     693    693       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q64318}.
FT   MOD_RES     700    700       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q64318}.
FT   MOD_RES     702    702       Phosphothreonine.
FT                                {ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     704    704       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q64318}.
FT   CROSSLNK    186    186       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    195    195       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    307    307       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    331    331       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    335    335       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    347    347       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO);
FT                                alternate.
FT   CROSSLNK    347    347       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2);
FT                                alternate. {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    439    439       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    493    493       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:25114211,
FT                                ECO:0000244|PubMed:25218447,
FT                                ECO:0000244|PubMed:25755297,
FT                                ECO:0000244|PubMed:25772364,
FT                                ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    504    504       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:25218447,
FT                                ECO:0000244|PubMed:25755297,
FT                                ECO:0000244|PubMed:25772364,
FT                                ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    515    515       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:25218447,
FT                                ECO:0000244|PubMed:25755297,
FT                                ECO:0000244|PubMed:25772364,
FT                                ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    548    548       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    553    553       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:28112733}.
FT   CROSSLNK    774    774       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO);
FT                                alternate.
FT   CROSSLNK    774    774       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2);
FT                                alternate. {ECO:0000244|PubMed:28112733}.
FT   VAR_SEQ       1     19       MADGPRCKRRKQANPRRNN -> MK (in isoform 5).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_047279.
FT   VAR_SEQ      20     87       VTNYNTVVETNSDSDDEDKLHIVEEESVTDAADCEGVPEDD
FT                                LPTDQTVLPGRSSEREGNAKNCWEDDR -> G (in
FT                                isoform 3).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_047280.
FT   VAR_SEQ      87    107       RKEGQEILGPEAQADEAGCTV -> I (in isoform
FT                                4). {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_047281.
FT   VAR_SEQ      87     87       R -> TG (in isoform 2 and isoform 5).
FT                                {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_045184.
FT   VARIANT      78     78       N -> T (in FECD6; no effect on protein
FT                                expression; no effect on nuclear
FT                                localization; dbSNP:rs80194531).
FT                                {ECO:0000269|PubMed:20036349,
FT                                ECO:0000269|PubMed:23599324,
FT                                ECO:0000269|PubMed:25190660}.
FT                                /FTId=VAR_063759.
FT   VARIANT      90     90       G -> R (in dbSNP:rs12217419).
FT                                /FTId=VAR_052731.
FT   VARIANT     525    525       G -> E (found in a patient with FECD6).
FT                                {ECO:0000269|PubMed:23599324}.
FT                                /FTId=VAR_072897.
FT   VARIANT     553    553       K -> R (in dbSNP:rs35753967).
FT                                /FTId=VAR_031824.
FT   VARIANT     640    640       Q -> H (in FECD6; down-regulation of
FT                                several collagen genes expression;
FT                                dbSNP:rs779148597).
FT                                {ECO:0000269|PubMed:23599324}.
FT                                /FTId=VAR_072898.
FT   VARIANT     649    649       P -> A (in FECD6; no effect on protein
FT                                expression; no effect on nuclear
FT                                localization; dbSNP:rs781750314).
FT                                {ECO:0000269|PubMed:20036349,
FT                                ECO:0000269|PubMed:25190660}.
FT                                /FTId=VAR_063760.
FT   VARIANT     696    696       N -> S (in FECD6; no effect on protein
FT                                expression; no effect on nuclear
FT                                localization; dbSNP:rs567252241).
FT                                {ECO:0000269|PubMed:25190660}.
FT                                /FTId=VAR_072899.
FT   VARIANT     810    810       Q -> P (in FECD6; no effect on protein
FT                                expression; no effect on nuclear
FT                                localization; dbSNP:rs199944415).
FT                                {ECO:0000269|PubMed:20036349,
FT                                ECO:0000269|PubMed:25190660}.
FT                                /FTId=VAR_063761.
FT   VARIANT     840    840       Q -> P (in FECD6; no effect on protein
FT                                expression; no effect on nuclear
FT                                localization; dbSNP:rs118020901).
FT                                {ECO:0000269|PubMed:20036349,
FT                                ECO:0000269|PubMed:25190660}.
FT                                /FTId=VAR_063762.
FT   VARIANT     905    905       A -> G (in FECD6; no effect on protein
FT                                expression; no effect on nuclear
FT                                localization; dbSNP:rs78449005).
FT                                {ECO:0000269|PubMed:25190660}.
FT                                /FTId=VAR_072900.
FT   VARIANT     905    905       A -> T (in FECD6).
FT                                {ECO:0000269|PubMed:20036349}.
FT                                /FTId=VAR_063763.
FT   CONFLICT     12     12       Q -> R (in Ref. 3; BAC03673).
FT                                {ECO:0000305}.
FT   CONFLICT     81     81       N -> S (in Ref. 3; BAC03673).
FT                                {ECO:0000305}.
FT   CONFLICT     84     84       E -> K (in Ref. 3; BAC03673).
FT                                {ECO:0000305}.
FT   CONFLICT    220    220       T -> A (in Ref. 3; BAG62481).
FT                                {ECO:0000305}.
FT   CONFLICT    390    390       M -> T (in Ref. 3; BAG62481).
FT                                {ECO:0000305}.
FT   CONFLICT    420    420       V -> I (in Ref. 2; AAA20602).
FT                                {ECO:0000305}.
FT   CONFLICT    472    472       K -> R (in Ref. 3; BAG58962).
FT                                {ECO:0000305}.
FT   CONFLICT    609    609       E -> Q (in Ref. 7; M81699).
FT                                {ECO:0000305}.
FT   CONFLICT    654    654       I -> T (in Ref. 2; AAA20602).
FT                                {ECO:0000305}.
FT   CONFLICT    672    672       D -> H (in Ref. 7; M81699).
FT                                {ECO:0000305}.
FT   CONFLICT    681    681       L -> S (in Ref. 7; M81699).
FT                                {ECO:0000305}.
FT   CONFLICT    775    775       K -> T (in Ref. 3; BAG62481).
FT                                {ECO:0000305}.
FT   CONFLICT    793    794       IP -> KY (in Ref. 3; BAG58962).
FT                                {ECO:0000305}.
FT   CONFLICT    797    797       A -> N (in Ref. 3; BAG58962).
FT                                {ECO:0000305}.
FT   CONFLICT    818    818       A -> V (in Ref. 3; BAG62481).
FT                                {ECO:0000305}.
FT   CONFLICT    838    838       I -> T (in Ref. 3; BAC03673).
FT                                {ECO:0000305}.
FT   CONFLICT   1066   1066       E -> G (in Ref. 3; BAC03673).
FT                                {ECO:0000305}.
FT   HELIX       590    600       {ECO:0000244|PDB:2E19}.
FT   HELIX       608    618       {ECO:0000244|PDB:2E19}.
FT   HELIX       622    634       {ECO:0000244|PDB:2E19}.
SQ   SEQUENCE   1124 AA;  124074 MW;  0A2714CC37C848D1 CRC64;
     MADGPRCKRR KQANPRRNNV TNYNTVVETN SDSDDEDKLH IVEEESVTDA ADCEGVPEDD
     LPTDQTVLPG RSSEREGNAK NCWEDDRKEG QEILGPEAQA DEAGCTVKDD ECESDAENEQ
     NHDPNVEEFL QQQDTAVIFP EAPEEDQRQG TPEASGHDEN GTPDAFSQLL TCPYCDRGYK
     RFTSLKEHIK YRHEKNEDNF SCSLCSYTFA YRTQLERHMT SHKSGRDQRH VTQSGCNRKF
     KCTECGKAFK YKHHLKEHLR IHSGEKPYEC PNCKKRFSHS GSYSSHISSK KCISLIPVNG
     RPRTGLKTSQ CSSPSLSASP GSPTRPQIRQ KIENKPLQEQ LSVNQIKTEP VDYEFKPIVV
     ASGINCSTPL QNGVFTGGGP LQATSSPQGM VQAVVLPTVG LVSPISINLS DIQNVLKVAV
     DGNVIRQVLE NNQANLASKE QETINASPIQ QGGHSVISAI SLPLVDQDGT TKIIINYSLE
     QPSQLQVVPQ NLKKENPVAT NSCKSEKLPE DLTVKSEKDK SFEGGVNDST CLLCDDCPGD
     INALPELKHY DLKQPTQPPP LPAAEAEKPE SSVSSATGDG NLSPSQPPLK NLLSLLKAYY
     ALNAQPSAEE LSKIADSVNL PLDVVKKWFE KMQAGQISVQ SSEPSSPEPG KVNIPAKNND
     QPQSANANEP QDSTVNLQSP LKMTNSPVLP VGSTTNGSRS STPSPSPLNL SSSRNTQGYL
     YTAEGAQEEP QVEPLDLSLP KQQGELLERS TITSVYQNSV YSVQEEPLNL SCAKKEPQKD
     SCVTDSEPVV NVIPPSANPI NIAIPTVTAQ LPTIVAIADQ NSVPCLRALA ANKQTILIPQ
     VAYTYSTTVS PAVQEPPLKV IQPNGNQDER QDTSSEGVSN VEDQNDSDST PPKKKMRKTE
     NGMYACDLCD KIFQKSSSLL RHKYEHTGKR PHECGICKKA FKHKHHLIEH MRLHSGEKPY
     QCDKCGKRFS HSGSYSQHMN HRYSYCKREA EERDSTEQEE AGPEILSNEH VGARASPSQG
     DSDERESLTR EEDEDSEKEE EEEDKEMEEL QEEKECEKPQ GDEEEEEEEE EVEEEEVEEA
     ENEGEEAKTE GLMKDDRAES QASSLGQKVG ESSEQVSEEK TNEA
//
